cell_line_id,drug_id,response
Raji,44202524,1.2005931973805375
HARA [Human squamous cell lung carcinoma],11404337,-1.2743672881567891
Kasumi-2,23635314,-3.2137156100627973
SNU-1033,5291,3.6453584755644366
EJM,3025944,4.146188688594528
TE 617.T,46926350,-4.642766988271582
SKM-1,44543605,3.543477995326012
NU-DHL-1,15983966,-4.432229151645776
HARA [Human squamous cell lung carcinoma],9956119,4.138225192842101
IST-Mes1,241158,4.374014389295604
KYSE-410,9825149,2.609127213924351
MM1.S,444795,4.170246109552412
SNU-1272,11656518,1.8045520914389075
GOS-3,serdemetan-SCH-529074 (1-1 mol-mol),2.2992374685315533
RPMI-7951,selumetinib-tretinoin (2-1 mol-mol),4.9955187390569105
HMCB,6917907,-5.7267155149499915
SEM,9967941,3.0889750042554267
NCI-H1395,5328940,2.584315328897391
AU565,6918837,-4.408945103298963
KMS-27,66577038,3.2035364529332298
BT 320,25150857,3.33324545252111
MCAS,5460769,1.176961037581758
LNCaP clone FGC,25161177,4.947661929093119
IST-Mes1,24951314,2.196137261882708
SNU-1214,654092,-0.8857733624045308
NCI-H2110,9826308,1.0215113237989006
RPMI-7951,3136844,3.4252156043373945
Kasumi-2,2871966,-1.247169917955711
NCI-H2110,tanespimycin-gemcitabine (1-1 mol-mol),-2.8428766738251965
PE/CA-PJ34 (clone C12),10231331,3.045773235767836
RERF-LC-Ad2,46398810,3.2113913243121757
NCI-H1092,25154868,3.3407457586417566
YKG-1,71304818,3.690747374674459
BT 139,24821094,1.6610897074199305
KMBC-2,4521392,4.682823382382271
NCI-H2110,selumetinib-vorinostat (8-1 mol-mol),2.8227636055377565
ML-1 [Human thyroid carcinoma],ISOX-bortezomib (250-1 mol-mol),0.9716953544539896
NCI-H2110,9908783,4.433738876921207
SEM,25183872,-3.2065373842883687
HMCB,15983966,-4.400200199699085
HARA [Human squamous cell lung carcinoma],vorinostat-navitoclax (4-1 mol-mol),1.9090977342000552
PaTu 8988s,25150857,0.8411246368631857
RPMI-7951,650361,3.986097803134267
AU565,46843906,2.01919943296107
PE/CA-PJ34 (clone C12),17755052,1.133637594911045
Aska-SS,72376,-2.7542136978541136
PaTu 8988s,11213558,1.0290753699028068
MM1.S,4378219,2.139277509194807
YKG-1,9866186,4.262068146062729
CML-T1,10410894,3.3337757256136245
BT 248,24775005,3.1653639365719553
HARA [Human squamous cell lung carcinoma],72193861,-0.0489023079435419
MM1.S,124202324,0.7291888929578118
HMCB,5113032,4.37953106967478
MCAS,219104,3.9637771027882662
SNU-8,24964624,1.488667826326175
MCAS,tanespimycin-gemcitabine (1-1 mol-mol),-1.1647059970883398
PE/CA-PJ34 (clone C12),6918328,0.8445281698362359
TE-15,44202524,1.0560243162430882
LNCaP clone FGC,JQ-1-MK-0752 (1-1 mol-mol),-0.0461588421219478
CA46,16720766,0.453567173389679
PaTu 8988s,3038522,2.9710508112698983
ML-1 [Human thyroid carcinoma],31703,-3.706133682115605
RERF-LC-Ad2,216468,3.9552651527096065
PaTu 8988s,piperlongumine-MST-312 (1-1 mol-mol),3.25367846765047
CML-T1,16720766,-1.7114419714530344
Hs 683,3634881,3.3169012356271574
SW1990,10427712,4.382583740281089
HSC-4,56649450,2.6853332826773144
SNU-1272,9903786,4.921324329124853
Hs 683,5329102,1.6753697513688257
SNU-8,49793307,-2.730453416599212
A4/Fukuda,2945648,2.3216808345706035
KMRC-2,5281321,-2.2228246492045476
IST-Mes1,2749,1.654199391381554
GOS-3,25262965,-1.0893957364274085
SKM-1,11625818,3.916071840286403
Kasumi-2,11234052,3.910537949204277
TE-15,2729026,3.117170834129398
KYSE-410,11719255,3.0201830274101464
MM1.S,ISOX-bortezomib (250-1 mol-mol),-0.3446289417675626
NCI-H2110,9915743,1.734073577383887
KMBC-2,31703,0.6113888072956629
CA46,119182,-4.388833865288787
BT 328,6438330,1.8463189750437397
NCI-H2172,637858,5.647730401907311
SNU-1214,126941,-4.3908189021889665
Aska-SS,676352,2.016488821538694
SW1990,44607531,1.5230636151558157
SKM-1,119182,-3.439658099339246
Ku812,49793307,-4.102016019806379
CA46,216345,3.098455032375494
CML-T1,16736978,1.2014198902848654
HARA [Human squamous cell lung carcinoma],5328940,0.878974684606101
NU-DHL-1,16722836,0.983509194691096
Raji,5978,-2.292357202104216
RERF-LC-Ad2,219104,4.076519133645829
PE/CA-PJ34 (clone C12),5329102,2.622202287503012
Kasumi-2,9926054,1.3771704127752784
A4/Fukuda,46843906,1.071626560517578
SET-2,44137675,2.73543784848982
NCI-N87,3815108,3.1427265495234513
Raji,4521392,4.1619167727464665
CML-T1,16038120,0.5708889366464743
HARA [Human squamous cell lung carcinoma],selumetinib-PLX-4032 (8-1 mol-mol),5.192132134204876
Raji,2874250,4.412187435297027
GOS-3,44566777,1.372759140356778
BT 248,11497983,5.371692371312494
NCI-H2110,56973724,3.970636480100385
D283 Med,31703,-2.9030613182863205
KMRC-2,168313200,3.0339404412127324
HMCB,135398516,2.391390650545516
AN3-CA,327653,2.9289784088078177
BT 330,65628,3.9363187212664488
HARA [Human squamous cell lung carcinoma],54143018,-1.1176720961651934
NCI-H1092,9911830,2.3624309911243313
CML-T1,25183872,-2.27655686726873
LNCaP clone FGC,25183872,-1.0962417460080476
PE/CA-PJ34 (clone C12),216345,4.0155895974355555
Aska-SS,11455910,2.343634234167196
NCI-H2110,54618164,3.868151773731383
NCI-H2110,9952709,3.429953856124601
Hs 683,docetaxel-tanespimycin (2-1 mol-mol),-6.250654311863999
NCI-H2110,6918638,0.2299759669474582
GOS-3,71751553,4.284016393111424
OE21,675434,4.4580240736273105
Aska-SS,135999136,2.4639426582272796
KMBC-2,9933475,1.7459888748592547
KYSE-410,31703,-0.1350071468847997
CML-T1,55508,2.709114480954857
A4/Fukuda,1716436,2.785785051354721
KMBC-2,168312962,0.6415345617808151
NCI-H1092,135999136,1.996402787689235
HMCB,9915743,1.6080279846600372
NCI-N87,10385095,0.9731458206829144
SW1990,57519531,1.8615678215575773
NCI-H2110,3038522,3.139256124703558
HARA [Human squamous cell lung carcinoma],654092,0.0602204093244996
ML-1 [Human thyroid carcinoma],tanespimycin-bortezomib (250-1 mol-mol),-0.335060121238308
AN3-CA,25154868,4.426580057954225
RPMI-7951,11178236,-3.653266948914448
Aska-SS,73707398,1.256290456128312
SEM,24785538,0.2976290069751733
NCI-H1395,alisertib-navitoclax (2-1 mol-mol),4.525296331369141
CA46,46215462,1.3062506059575565
BT 139,12003241,-0.7824976089919207
IST-Mes1,10074640,3.5425729050518053
BT 139,71304818,3.117060314680253
HARA [Human squamous cell lung carcinoma],6610216,4.810637550807952
KMBC-2,52947716,2.968056555180957
TE-15,46943432,2.615867274491135
SET-2,decitabine-carboplatin (1-1 mol-mol),-0.0783164861685106
CML-T1,25150857,1.621602747179882
RERF-LC-Ad1,11152667,0.5366755842825199
NU-DHL-1,46843906,1.439459382050455
SKM-1,tretinoin-navitoclax (4-1 mol-mol),0.5849402207655147
YKG-1,10127622,4.916424628114341
BT 330,25161177,3.61492722125511
Aska-SS,selumetinib-UNC0638 (4-1 mol-mol),3.105844363432866
KYSE-410,3384730,2.7655912994190706
SKM-1,6917907,-8.026488311304904
CA46,68056272,3.136594245199668
SNU-1272,9967941,2.3662546374553486
KMRC-2,4378219,1.94428185531496
RERF-LC-Ad2,11238147,1.9847745124514788
BT 330,piperlongumine-MST-312 (1-1 mol-mol),1.6726335041341065
NCI-H1092,45279963,3.5521369654749035
HSC-4,42611257,3.4394582921614933
SET-2,5311,-0.0842412480168777
KMS-20,6918837,-5.417214970743668
HSC-4,135423438,1.814117839489682
AN3-CA,3062316,1.3770411989146902
NU-DHL-1,16720766,-1.0246097126306042
SEM,969516,-0.0005595502936996
Hep-G2,60750,-4.7110516524032775
Raji,9887053,4.170344123457071
HCC2218,100016,5.089450081937329
D283 Med,11612883,1.593543211602983
LNCaP clone FGC,49836020,4.788899602776088
SET-2,119182,-4.272117935787393
NCI-H2110,25105715,3.722215242768395
HEC-151,51037431,2.702211818437642
LNCaP clone FGC,6918638,-0.3198952238594262
KMS-27,5328940,1.8509249776552708
NCI-H2081,6505803,1.279924414831301
KMS-20,9911830,3.122947091608452
TE 617.T,262093,2.7005370454000004
NU-DHL-1,16065773,1.845713529586983
RERF-LC-Ad2,selumetinib-navitoclax (8-1 mol-mol),1.7872800947486227
OE21,10231331,0.7094072975995727
KMS-27,16741245,2.5294483123867115
NCI-H2110,56946209,-5.165673550457206
NCI-H2081,6450551,1.1680905848909615
HEC-151,44241473,4.57695213454535
HSC-4,119182,0.0150561689419209
OE21,119182,0.647900745165355
LoVo,54143018,-0.354466194309244
KMBC-2,216345,4.370874186588204
SET-2,54639126,4.3899784036288825
KYSE-410,44589607,3.0538156762263435
SET-2,24964624,2.5464611805916326
NU-DHL-1,5291,3.690421399928162
HSC-4,107985,-2.2656284906222144
PE/CA-PJ34 (clone C12),2871966,-0.2106632494105586
SNU-8,9967941,2.953060128377935
OE21,119607,5.383595951688716
Ku812,24180125,2.3184854542342217
HSC-4,60750,-5.118377280037083
SET-2,16736978,1.494285339412499
MM1.S,73707386,0.9217883452214084
BT 320,11404337,0.6966185269279856
TE 617.T,2126,5.664159368526071
KMS-20,54613361,-1.869220280650564
ML-1 [Human thyroid carcinoma],24821094,3.2142530929148982
SNU-1272,3825829,5.135605064206703
A4/Fukuda,5351362,0.320845740356061
RPMI-7951,2828334,6.2799556772556775
HSC-4,11238147,3.6589845000918504
HCC2218,54143018,3.6519142988394098
Ku812,262093,1.3423418533813145
Hs 683,1750826,-1.5393828247496997
SKM-1,135440466,0.5492238324239911
SW1990,11228183,3.7055348049186354
CML-T1,9884685,1.1136090650670494
HSC-4,serdemetan-SCH-529074 (1-1 mol-mol),2.5503350460616505
SKM-1,613753,2.904024053377545
Aska-SS,9907093,3.884182057089656
KYSE-410,JQ-1-navitoclax (2-1 mol-mol),0.9940985435997014
HSC-4,3503,2.6271988960037502
SW1990,11707110,-2.3904983782670164
SNU-8,4788,5.895963539155099
HSC-4,4705,3.95336427523857
Aska-SS,4788,6.124702098349416
TE 617.T,119607,4.923325938404837
LoVo,doxorubicin-navitoclax (2-1 mol-mol),-1.249111657931932
TE 617.T,42642645,0.6329124315380535
SEM,568763,-0.2568424606167109
AU565,1242560,3.5510894145829286
YKG-1,selumetinib-MK-2206 (8-1 mol-mol),2.8155089157668627
AN3-CA,selumetinib-BRD-A02303741 (4-1 mol-mol),5.034678301732505
PaTu 8988s,11609586,3.1640342250274194
ML-1 [Human thyroid carcinoma],54649381,4.324070376451948
AN3-CA,54619267,3.846991016326593
BT 320,5281321,2.315886758261944
GOS-3,selumetinib-UNC0638 (4-1 mol-mol),3.7794346913779577
RPMI-7951,serdemetan-SCH-529074 (1-1 mol-mol),1.952151609806006
D283 Med,4096211,0.7263346692990906
MCAS,selumetinib-PLX-4032 (8-1 mol-mol),1.4461333725450911
EJM,25262965,-4.908290828803979
Hs 683,64971,3.6391231978651466
RPMI-7951,16720766,-0.004796168701453
A4/Fukuda,11625818,2.700159842549232
HMCB,135875424,3.5183087899290686
KMRC-2,10184653,2.3551240861075473
SKM-1,3854666,-0.271294085602593
HSC-4,448949,2.25928901468022
NU-DHL-1,25062766,1.3260870058815484
SEM,5738263,2.206097409243099
NCI-H2081,9915743,0.926591953046768
MM1.S,6438330,0.7925484040145825
EJM,168313200,3.7804211641471097
HMCB,16038120,1.4836068881756783
HSC-4,54618771,2.9865797342969564
SNU-1272,119607,5.048435737669013
BT 328,24772860,-1.739359818332389
RERF-LC-Ad2,24797083,1.7460478309528484
Hs 683,5470400,1.8519340134725737
Hs 683,3689413,-0.4207741938701824
KYSE-410,54618771,1.043731623373752
NCI-H2172,5311281,3.6090019324817626
NCI-H2172,51039095,3.282312932514956
RERF-LC-Ad2,73707398,1.2471079254460122
BT 248,25161177,3.821794472212993
OE21,11167602,2.1998769764079884
RPMI-7951,421610,2.0128260125538797
BT 328,11222830,1.4031048122319796
YKG-1,984333,1.4105650913207732
SET-2,56946209,-6.2120441469274175
BT 320,135440466,3.8135283916877625
EJM,tanespimycin-bortezomib (250-1 mol-mol),-0.1920922307802734
SEM,11719255,1.9160664785241357
Ku812,3634881,2.5120056948653
SNU-8,54686904,4.436891017984491
TE 617.T,9911463,3.539966110266211
SET-2,JQ-1-UNC0638 (2-1 mol-mol),-1.9472372996283749
MM1.S,54686904,2.8702453474373315
PE/CA-PJ34 (clone C12),3854666,0.7943523247128464
BT 320,serdemetan-SCH-529074 (1-1 mol-mol),2.392228056514646
PE/CA-PJ34 (clone C12),selumetinib-decitabine (4-1 mol-mol),1.8573238716263332
NCI-H2081,11507802,1.0351752373197651
AU565,375860,-0.7785666069738753
NCI-H2081,25227462,-3.2054871570484114
BT 330,10296883,4.249787142782667
TE 617.T,31703,-3.86675458975869
NCI-H2081,54596558,4.74743870920133
TE-15,9956119,3.858934118650968
SNU-1272,9911830,3.883073952142102
BT 248,sirolimus-bortezomib (250-1 mol-mol),0.4320618504093114
TE-15,1242560,2.8326724591930517
AU565,135411,0.1136824900578053
CML-T1,135411,-2.1332231058037796
SET-2,11222830,1.0396150805320925
AU565,613753,3.214352381260741
NCI-H2110,2828334,6.053691532060519
Raji,654092,-1.8737175642963104
SNU-1033,3552672,1.8370323194969735
YKG-1,5282054,4.677565101895448
HEC-151,9887053,2.104759905960382
RERF-LC-Ad1,selumetinib-MK-2206 (8-1 mol-mol),3.552195149911139
CML-T1,24901704,0.2948239854297986
NU-DHL-1,26596,-3.470221600864271
SNU-1033,BRD-A02303741-navitoclax (2-1 mol-mol),3.0862137384300015
SNU-8,67156097,-1.3396461393156114
D283 Med,24771867,-2.2450737191486883
LNCaP clone FGC,7251185,2.5221179443574493
MCAS,2113511,4.790363283284617
NCI-H2110,25227462,0.962572407565559
Raji,136227924,2.5188827267380116
SNU-308,400769,-0.6277123856254561
HARA [Human squamous cell lung carcinoma],135423438,3.0787654328489986
PE/CA-PJ34 (clone C12),40482356,5.160347507354427
HSC-4,55283,3.529343210540244
SNU-1214,969516,2.1576653261965917
SNU-8,44241473,4.763385234005065
CA46,445455,4.357290874085763
SKM-1,72193861,-0.5325335794598204
BT 330,44566777,0.3914033592885553
HMCB,53392493,2.956281764261595
CA46,9840324,5.575806842573594
SW1990,613753,3.313749610505739
YKG-1,10410894,4.5306444179161165
SW1990,11152667,-1.371942963553871
SNU-1272,6252,5.637284212439003
Kasumi-2,11955716,-2.6016781088205665
NCI-H2110,374536,1.903561652140828
KYSE-410,8515,3.4355456987988666
MCAS,16720766,0.9829581263949466
HCC2218,45279963,2.5786476360321324
OE21,6918837,-3.6471584113226534
NCI-H2081,11427553,0.4745229676826807
CA46,24856436,-0.7056093623802927
IST-Mes1,10296883,4.238957650390159
KMRC-2,135659046,5.230232657074779
CML-T1,262093,1.3151134240668207
LNCaP clone FGC,6450551,3.014319559444335
KMS-20,44486219,3.957177365137273
KYSE-410,119607,5.136595755641417
HSC-4,25126798,3.2488654911973196
SNU-8,31703,-0.3398671923044067
CML-T1,carboplatin-UNC0638 (2-1 mol-mol),2.1290435317203023
YKG-1,16065773,3.101018624838753
BT 328,24785538,0.2054381662017833
NCI-H1395,984333,2.1058514684040373
KMS-20,107970,1.4633641977001968
AN3-CA,6450551,0.9036335088039008
Raji,3634881,2.495614055557117
NCI-H2110,doxorubicin-navitoclax (2-1 mol-mol),-2.638354806422936
TE 617.T,445643,3.920587629900857
PaTu 8988s,644241,1.4748860636178889
SNU-308,doxorubicin-navitoclax (2-1 mol-mol),0.3495422569736602
NCI-N87,1716436,1.6921610156965474
PE/CA-PJ34 (clone C12),selumetinib-UNC0638 (4-1 mol-mol),2.452138408704013
SNU-1033,6918837,-2.690001447352867
TE-15,16736978,2.388321065089742
Ku812,46224516,1.585603002633456
HSC-4,4261,2.7283942469645424
KMS-20,104842,-4.95901486656118
LNCaP clone FGC,46926350,-4.319899748167567
CA46,11364421,-6.636542851208846
BT 330,6184667,3.969064593085041
CML-T1,navitoclax-MST-312 (1-1 mol-mol),0.6606923209980897
HMCB,123631,3.130302719689839
ML-1 [Human thyroid carcinoma],53495165,2.320007555236624
PaTu 8988s,docetaxel-tanespimycin (2-1 mol-mol),-3.736117907039699
HMCB,3634881,3.192903309408832
GOS-3,5281321,1.1585317053456523
HSC-4,5460769,1.9290612526481368
GOS-3,135440466,3.2261535122506295
MM1.S,carboplatin-etoposide (40-17 mol-mol),0.4992373169000672
SKM-1,4378219,1.146896788222022
MM1.S,44493528,4.254687888851587
NCI-H1395,19582717,5.560683797956257
HARA [Human squamous cell lung carcinoma],tretinoin-navitoclax (4-1 mol-mol),0.6020182307201102
NCI-H2110,135984461,4.3368706411004325
ML-1 [Human thyroid carcinoma],sirolimus-bortezomib (250-1 mol-mol),0.5199068018007997
HMCB,11964036,1.8216984030595027
OE21,252682,6.2458833625766665
Hep-G2,216345,3.0800650649903436
MCAS,15547703,2.7273456704873142
LNCaP clone FGC,11238147,1.713751089163336
HCC2218,23582824,1.521937184875748
RERF-LC-Ad2,11214940,1.66425243656515
SEM,11977753,-1.3254464144533478
CML-T1,10427712,1.89618534848285
LNCaP clone FGC,156414,1.7669501564667316
ML-1 [Human thyroid carcinoma],15953870,3.8046885468141016
AN3-CA,3689413,0.1719288482065274
D283 Med,1566236,1.5114731538286772
SNU-1214,10427712,5.041454770133842
LNCaP clone FGC,5311,1.482149606168657
TE-15,16725315,3.528829604172264
SKM-1,selumetinib-piperlongumine (8-1 mol-mol),-0.1043250108144624
CA46,12001922,1.4868064190708767
SEM,44484893,-1.5339295370272434
RERF-LC-Ad2,637858,1.7897797033938452
BT 330,9926054,2.1336209959126253
NCI-N87,2749,1.4538564926114168
KYSE-410,322968,4.816794476605758
OE21,2874250,4.449052629030129
D283 Med,5470400,-0.4295186800488584
KMS-20,52912189,-0.8192319241332332
Ku812,25183872,-1.9764593240115311
AU565,15547703,3.2970552657128325
HSC-4,51037431,1.5211622982639597
NU-DHL-1,753704,3.856303412590113
RPMI-7951,448949,0.8690324871561279
NCI-H1092,25183872,-0.0477909858083303
AN3-CA,JQ-1-vorinostat (2-1 mol-mol),2.0099922232895473
KMS-20,selumetinib-vorinostat (8-1 mol-mol),-0.0574541449020858
SEM,10296883,-0.6538100941325019
HCC2218,168313016,4.988518158983073
EJM,46943432,3.619668904272789
TE-15,selumetinib-tretinoin (2-1 mol-mol),1.8436837111735784
KMRC-2,24771867,3.343574460922249
SNU-308,erlotinib-PLX-4032 (2-1 mol-mol),3.159344954008492
Raji,57519531,1.2334704389871811
D283 Med,6918638,-2.490498776882626
SNU-308,25150857,2.5138578868567913
LoVo,5287620,-2.196691557023958
YKG-1,5479543,3.551055937780437
IST-Mes1,16722836,0.916062842065302
NCI-H1395,67156097,2.84144563210516
BT 320,25105715,3.591126909496077
HEC-151,11404337,-0.8422867477352739
LNCaP clone FGC,11234052,3.9715237356820032
BT 139,11234052,4.216816338162274
IST-Mes1,151289,3.762568892374828
CA46,462382,0.6475442737717811
NCI-H1092,64971,4.337644758899671
YKG-1,56946209,-4.319334777154593
SNU-8,11427553,3.552514953315588
OE21,409805,3.7550255149690943
SW1990,4477,0.8261455578387246
KMRC-2,4477,1.0568928101730144
RPMI-7951,salermide-PLX-4032 (12-1 mol-mol),5.001935410427482
BT 330,salermide-PLX-4032 (12-1 mol-mol),3.272323891336513
AN3-CA,6918736,-2.607088446666294
IST-Mes1,5113032,4.841043294054768
D283 Med,16038120,-1.2659800311805858
SET-2,5351362,0.9152088249518402
Aska-SS,selumetinib-vorinostat (8-1 mol-mol),2.5241370498286373
BT 248,44566777,-0.50911829246694
KMS-20,46191454,0.3124251362481014
BT 320,72193861,4.258668508473769
PE/CA-PJ34 (clone C12),11609586,2.637959736879632
KMRC-2,104842,0.4163688071678419
MCAS,568763,0.8857059564894935
Hep-G2,219104,4.303712261907195
Aska-SS,11238147,2.181555993543122
ML-1 [Human thyroid carcinoma],7326481,3.5221044039257037
PE/CA-PJ34 (clone C12),11656518,2.490076098843588
TE 617.T,446155,0.1543714294288768
TE 617.T,54626689,4.601521502493687
NCI-H1092,24889392,4.210253207752649
KMBC-2,2126,4.261822440706329
NCI-H2110,11167602,4.9824234878437395
ML-1 [Human thyroid carcinoma],9967941,2.6659391926085183
TE 617.T,44185566,1.73921904272988
HCC2218,71680916,4.066710263465823
A4/Fukuda,148124,-6.6912736941139865
EJM,10427712,3.7734158708408585
Kasumi-2,24978538,-3.812533145701136
TE-15,11213558,2.2393015872709663
YKG-1,navitoclax-sorafenib (1-1 mol-mol),3.836400183478217
MCAS,JQ-1-MK-0752 (1-1 mol-mol),0.9287029380340656
SNU-1272,11152667,1.552242826912863
KMS-20,25150857,1.1621716531202362
MM1.S,decitabine-navitoclax (2-1 mol-mol),0.5929032240981287
IST-Mes1,15547703,3.097349866450655
CA46,216239,1.3191761483145148
IST-Mes1,46215462,2.5624084058363676
BT 139,2949965,2.7755159833580554
YKG-1,44819697,0.3440551836908802
HCC2218,5287620,-0.7427500488535822
NCI-H1092,44607531,1.5993128596295003
NCI-H1395,46199207,3.5912826317512136
Hs 683,56649450,2.9783836223956097
RERF-LC-Ad2,702558,5.435441193828656
SW1990,285033,-1.268748448673105
Kasumi-2,5978,-3.933681438293164
HARA [Human squamous cell lung carcinoma],5291,4.037970789679042
SNU-8,10385095,1.1888093081137228
MM1.S,148198,-3.54523038003387
NCI-H1395,6918638,1.485308761584704
OE21,docetaxel-tanespimycin (2-1 mol-mol),-6.983016683122649
SNU-308,SNX-2112-bortezomib (250-1 mol-mol),-1.4321385103419753
EJM,46215462,1.2684837092951116
BT 320,JQ-1-vorinostat (2-1 mol-mol),2.723123137570139
SEM,156414,0.3224280721453019
NCI-H1395,71680916,4.653034119360089
KMBC-2,135659046,3.5104960306219155
NU-DHL-1,UNC0638-navitoclax (1-1 mol-mol),-2.039060237587124
A4/Fukuda,73707398,-0.4328093310020208
RERF-LC-Ad1,navitoclax-MST-312 (1-1 mol-mol),3.737696475545332
HMCB,216239,1.7149264696015345
SNU-1214,24753719,4.20428044650039
Kasumi-2,969516,1.973265868556714
HSC-4,24901704,4.088081803824046
SNU-1214,44489127,4.458368254164627
NCI-N87,decitabine-navitoclax (2-1 mol-mol),0.6446345774598216
NU-DHL-1,3384730,0.9179743420778778
BT 139,doxorubicin-navitoclax (2-1 mol-mol),-1.2563388109973497
SKM-1,23725625,3.72033085826658
CA46,11455910,-0.2967360934235351
TE 617.T,4521392,3.683082254263588
HMCB,46843906,3.827430396412732
CA46,2949965,2.263314804434843
KMBC-2,11612883,3.512280172644111
Ku812,119607,3.7153481440603984
KMS-20,6918328,-1.3033852220053452
KMRC-2,11167602,4.424264905666824
NCI-H1395,25183872,0.7237859951347151
HARA [Human squamous cell lung carcinoma],11167602,3.2969276962649823
IST-Mes1,285033,-1.625614851116669
PE/CA-PJ34 (clone C12),2828334,6.063143036105902
RPMI-7951,9868037,2.673802488787611
HSC-4,327653,3.5197711195347434
BT 320,16722836,3.1587292617762435
NCI-N87,52947716,-3.473486168283201
HEC-151,126941,-2.3305220825243533
MM1.S,54639665,4.38877596087519
NCI-H1092,11507802,0.7710347538539816
KMRC-2,sirolimus-bortezomib (250-1 mol-mol),0.567306978247713
SKM-1,3385,1.1892530781163966
HMCB,100016,6.123582467992384
RPMI-7951,654092,-0.1798670044623603
TE 617.T,selumetinib-decitabine (4-1 mol-mol),4.124849218027814
NCI-N87,tanespimycin-bortezomib (250-1 mol-mol),-5.300963645653278
NU-DHL-1,52912189,-0.4578007756599072
HARA [Human squamous cell lung carcinoma],serdemetan-SCH-529074 (1-1 mol-mol),2.4213259806317335
PE/CA-PJ34 (clone C12),54613361,0.0290460408179859
IST-Mes1,11152667,-0.1137559634255308
ML-1 [Human thyroid carcinoma],10302451,5.152653454280482
KMS-20,1716436,2.462007785368903
NU-DHL-1,3025986,-0.9340926836685216
SEM,156422,3.246663813247162
MCAS,24771867,2.4778802536032045
NCI-N87,16722836,0.5704530263405226
KMRC-2,9907093,4.749987652272065
SKM-1,selumetinib-navitoclax (8-1 mol-mol),-0.63098338976802
HARA [Human squamous cell lung carcinoma],262093,3.694607099499911
Raji,4477,0.6174679534102655
BT 330,9911463,3.351892794022171
KMRC-2,9823820,3.4713660880657016
NCI-H2110,1641662,4.22097007378697
IST-Mes1,439501,-2.4971864822052767
NCI-H2172,31703,1.6705454899623176
BT 330,60750,0.0644455877393972
KMS-27,navitoclax-PLX-4032 (1-1 mol-mol),-1.756220732176217
A4/Fukuda,carboplatin-etoposide (40-17 mol-mol),0.4853632935092173
SNU-8,17759555,3.801939868692788
HARA [Human squamous cell lung carcinoma],53481919,4.643044937502802
SEM,6918837,-6.186756041819131
Hs 683,16013152,4.045589709203498
Hs 683,3543504,5.0981277433978205
OE21,1242560,3.6647995918292424
SKM-1,6450551,0.4724418001355981
HARA [Human squamous cell lung carcinoma],9884685,2.402658407469787
KYSE-410,9915743,-1.3205440456701116
SW1990,24772860,-2.504887320110065
Raji,439501,-2.4044549184869872
SNU-1272,11175137,2.9649563467216207
Kasumi-2,24785538,0.7031648291020229
Aska-SS,568763,0.920290507458521
SNU-1214,44185566,1.1140589812850028
Hs 683,selumetinib-PLX-4032 (8-1 mol-mol),4.4747755051391
LoVo,136227924,4.6796674015936075
SNU-8,448949,2.187581111481743
NCI-H2110,216468,1.4609586053844608
HARA [Human squamous cell lung carcinoma],57330099,4.527264318285619
TE 617.T,52912189,2.3175017557302797
RPMI-7951,5281321,-2.0914965293356516
KMRC-2,568763,1.556710187113669
NCI-H2110,11214940,4.162880305003488
ML-1 [Human thyroid carcinoma],decitabine-navitoclax (2-1 mol-mol),2.5515685650410216
A4/Fukuda,3689413,-1.7998697854540155
NCI-H2110,54678924,1.637714485165824
CA46,9933475,1.582522184359856
KMS-20,piperlongumine-MST-312 (1-1 mol-mol),0.9360765316980608
Hep-G2,66577038,2.115823311856728
AN3-CA,11485656,-0.8274044857319752
CML-T1,2945648,2.7633194270668877
NU-DHL-1,5287969,-2.616412522743469
NCI-H2110,11234052,4.624815979691428
SNU-308,262093,4.9932279379660764
KYSE-410,2841722,4.557147350090864
SNU-308,24180125,4.244524360791015
SEM,44589607,1.526364309080405
LoVo,tanespimycin-gemcitabine (1-1 mol-mol),0.1756680673297083
A4/Fukuda,SNX-2112-bortezomib (250-1 mol-mol),-3.583227894628943
D283 Med,5278396,2.633233418079239
KMS-27,2749,1.0570748312778857
BT 139,44607531,0.6267654065816637
CA46,5278396,3.312720557512005
KMBC-2,984333,5.617764060349004
TE-15,107970,2.289738953976788
ML-1 [Human thyroid carcinoma],25154868,4.839556149748317
MCAS,6610355,4.210219409661457
CA46,selumetinib-PLX-4032 (8-1 mol-mol),4.812160149058309
KYSE-410,42611257,2.6736806454935276
EJM,135659046,3.4058346184663693
PE/CA-PJ34 (clone C12),11427553,3.5428497677945807
SKM-1,6918736,-4.119160923301796
TE 617.T,BRD-K55473186,4.156036847499281
YKG-1,1566236,3.4432239781359577
SNU-1272,ISOX-bortezomib (250-1 mol-mol),1.8833687902494112
IST-Mes1,36462,4.9786696220654845
HARA [Human squamous cell lung carcinoma],24771867,-1.145662696893675
SEM,24964624,1.6218762857386917
GOS-3,selumetinib-PLX-4032 (8-1 mol-mol),5.581542151485772
Raji,9911830,2.8944128431666636
BT 330,31703,-0.3476663206942247
OE21,6918638,0.1632098658801684
BT 248,tretinoin-navitoclax (4-1 mol-mol),2.6015159736685187
KMBC-2,135928012,4.465224778976871
NCI-H1395,9911463,3.814426972193391
GOS-3,9907093,6.267214731972656
Aska-SS,16725315,3.2387481752374203
NCI-H1092,3062316,3.749220976786342
RERF-LC-Ad1,navitoclax-pluripotin (1-1 mol-mol),-0.2842869888478678
EJM,23635314,-4.518162794650304
D283 Med,54613361,-0.9633976035183264
OE21,16659841,4.657122972409507
PE/CA-PJ34 (clone C12),53325874,4.873665514097965
PaTu 8988s,6918638,1.3708196410669105
OE21,52912189,0.4247065075406309
NCI-H2081,3062316,3.530909356574639
SNU-1033,selumetinib-vorinostat (8-1 mol-mol),2.0856562296145187
LoVo,3689413,-0.0015328635235731
TE-15,71466380,4.275249385620416
BT 330,6852167,3.461733809833727
SEM,2858523,2.9325299148032413
A4/Fukuda,969516,2.117405484631732
TE 617.T,54618164,3.769426855939867
EJM,327653,3.072072044008088
SEM,650361,3.800745597928697
PaTu 8988s,vorinostat-carboplatin (1-1 mol-mol),4.004118413507522
YKG-1,24772860,-1.277942485629484
NU-DHL-1,126941,-5.231246874864336
Aska-SS,23725625,6.049665130232764
KMBC-2,11656518,1.6500132439112432
BT 320,vorinostat-navitoclax (4-1 mol-mol),3.086351264141679
HEC-151,10302451,3.224057282004677
KYSE-410,53392493,3.1169004046390443
Aska-SS,126941,-2.750768473215521
Hep-G2,navitoclax-pluripotin (1-1 mol-mol),-0.1847699337637438
KMS-27,10302451,3.849053848839269
IST-Mes1,19582717,4.57770755362997
HSC-4,5278396,3.3910828172613128
AU565,44607530,-0.2063452249558506
SEM,53232,2.5377599613466746
KMS-20,UNC0638-navitoclax (1-1 mol-mol),1.0394785462110392
Aska-SS,10113978,3.4814618544469664
TE 617.T,445091,4.633106606112208
BT 320,JQ-1-UNC0638 (2-1 mol-mol),3.976442415564575
TE 617.T,60700,-2.179954799206808
MCAS,doxorubicin-navitoclax (2-1 mol-mol),-0.4598019759635088
CML-T1,tanespimycin-gemcitabine (1-1 mol-mol),-3.893519256585349
HARA [Human squamous cell lung carcinoma],123631,2.9564926917309635
LNCaP clone FGC,19582717,2.7383506613575745
KMBC-2,135440466,2.5056800348952053
KYSE-410,6918289,2.688908806706306
Hs 683,9927531,5.316569157291169
NCI-N87,44507138,1.5580904379761216
KMS-20,5460769,-0.4034471516809727
CML-T1,navitoclax-piperlongumine (1-1 mol-mol),0.6324311645871261
BT 320,BRD-K55473186,3.858960180173933
AN3-CA,44819697,-1.7532717318545563
PaTu 8988s,5287620,-2.2711432055313874
MCAS,5351362,1.7771601249531883
OE21,24951314,1.194971489666842
NCI-H2081,11167602,4.408206719858069
OE21,49836020,4.665936469802933
OE21,11455910,0.3483153837156987
D283 Med,54618771,1.215604089870786
ML-1 [Human thyroid carcinoma],6252,2.036085666454029
BT 320,156414,4.178952757446285
MCAS,3854666,1.0662273712961947
EJM,6918736,-2.1636905167867355
HEC-151,4917,3.5509211593087904
Ku812,JQ-1-navitoclax (2-1 mol-mol),-1.1866145933539507
CML-T1,445091,4.10308804654236
KMBC-2,5281321,-1.9570835424627304
AU565,9866186,0.5690553044247834
NCI-H2110,JQ-1-MK-0752 (1-1 mol-mol),2.610299424682689
CA46,72734382,3.577472012209052
HMCB,322968,4.304190812139685
GOS-3,11427553,2.487045066954577
CA46,5280436,1.6785665289286047
MCAS,5335621,4.384496350289802
KMS-20,5281321,-3.543869904687322
HSC-4,selumetinib-JQ-1 (4-1 mol-mol),3.950475054879744
HCC2218,24180719,3.079134814722543
OE21,51037431,3.791500924421856
SEM,selumetinib-navitoclax (8-1 mol-mol),-0.6843578882476046
OE21,135411,0.4173817790505238
D283 Med,4917,2.940199279345652
Aska-SS,11485656,2.660522165344914
GOS-3,7251185,3.0018815610418694
KYSE-410,136227924,3.831866760516254
NCI-H1092,42642645,1.4285528009484267
D283 Med,9911830,1.6953738838285617
NU-DHL-1,107970,1.0254507421459336
CML-T1,51039095,1.5406670560339248
NU-DHL-1,24978538,-3.3743364704490224
PaTu 8988s,44493528,4.319224054149941
BT 330,24797083,1.5615746632227108
KMS-20,6610355,3.4776734350028784
TE 617.T,10184653,-4.213351698818198
HCC2218,241158,2.2086061733116615
SET-2,16720766,0.4971129747207303
KMS-20,11238147,1.9305174496673645
TE 617.T,9956119,3.967002636875171
AU565,148198,-3.941648532890003
CA46,JQ-1-carboplatin (1-1 mol-mol),-0.7040949114758062
TE 617.T,16722836,1.5288602103234736
OE21,421610,2.7409789844233385
NCI-N87,60700,-1.3451868063168757
NCI-H2110,10296883,4.192584749950301
Kasumi-2,16720766,-0.2515973340383426
KMBC-2,16038120,0.25892741268573
SNU-1214,3543504,3.87558640728975
CA46,451668,2.285623139838705
SET-2,11717001,4.260121463162566
SET-2,136227331,4.340141921453115
BT 139,17755052,0.3641484354126661
BT 320,54649381,5.331321773509753
EJM,19582717,2.2813420198916057
SNU-1033,doxorubicin-navitoclax (2-1 mol-mol),1.1038361673569406
RERF-LC-Ad2,11485656,2.920676874689175
TE-15,4477,0.8329048028922312
CML-T1,2858523,2.0919777443937715
AU565,selumetinib-decitabine (4-1 mol-mol),5.684619389149027
TE-15,10074640,3.669455422609935
MM1.S,25022340,4.192040904321215
PaTu 8988s,46907787,4.297293150577968
MCAS,20959075,-2.7430469730457077
SNU-8,2729026,3.1220208939977097
ML-1 [Human thyroid carcinoma],375860,0.003862862725961
KMS-20,135423438,1.13023072719564
OE21,151289,0.7158800492725989
TE-15,2742550,3.96805077868976
EJM,selumetinib-JQ-1 (4-1 mol-mol),1.9175380074632984
D283 Med,4578,4.258576085653485
MCAS,44241473,5.035889660055443
TE-15,erlotinib-PLX-4032 (2-1 mol-mol),0.1642393511347769
SW1990,3025944,4.28252811259168
BT 139,10184653,1.800707038819732
SNU-1272,11238147,4.015797434617391
Hs 683,49766530,0.8674069188410214
RERF-LC-Ad2,3552672,2.262924134176728
PaTu 8988s,16038120,-0.9491700742017304
TE 617.T,216345,2.5267034047564807
SKM-1,216345,2.58392001557385
TE 617.T,135421197,0.8388775868881587
KMRC-2,2949965,2.6713021171496285
BT 330,9911830,2.954651946077228
AU565,24797083,1.2091873523376886
AU565,9911830,3.457946854316075
YKG-1,2746,3.802533592415727
NCI-H2081,10184653,0.9038087955146576
SET-2,135984461,1.767736462015104
NCI-H1092,53392493,1.721482373156668
Kasumi-2,57330099,4.668594265491518
NU-DHL-1,54649381,3.9562595650424375
HSC-4,676352,2.328446260179327
TE-15,9952709,3.278986592526564
SNU-1033,3384730,1.7215428531280956
CML-T1,11609586,-0.1617986940719625
SW1990,5566,3.2018418511552937
SKM-1,136227924,2.5339244468963407
RERF-LC-Ad2,49766530,0.0972135502095861
MM1.S,216468,1.1892471991509614
GOS-3,5328940,2.3255367780793432
NCI-H2110,serdemetan-SCH-529074 (1-1 mol-mol),2.3998932290242765
Hs 683,5746,0.3917971153624203
SET-2,11404337,0.2728842638306079
SNU-1033,5278396,3.240191745193955
HMCB,3825829,4.05483266037916
NCI-H2172,1750826,-0.2815484633093131
HSC-4,969516,2.6364274978390703
CML-T1,12003241,-4.650247315633356
PE/CA-PJ34 (clone C12),327653,3.4791017722352815
HSC-4,3025986,-1.9523671858491285
Hs 683,107985,-3.457154115132212
SET-2,6184667,2.5703106251838914
SET-2,2708,2.464948015256483
SET-2,1750826,-1.8928364956090873
RPMI-7951,23635314,-1.518044786135355
YKG-1,52947716,3.285514356728494
KMRC-2,16722836,1.0816974151224032
BT 320,135999136,1.9088296274535188
BT 330,119607,5.997382672500204
BT 139,448949,1.7108312586402246
OE21,16736978,0.6479424690306809
KYSE-410,serdemetan-SCH-529074 (1-1 mol-mol),2.1526193639948015
HCC2218,5494449,4.847439157122507
PE/CA-PJ34 (clone C12),60750,-1.7641821181444215
AU565,navitoclax-sorafenib (1-1 mol-mol),2.1956268758246225
BT 328,65064,5.830382460342701
SNU-1272,135875424,4.314381098584833
BT 139,5282054,3.3062021280481657
CA46,6917907,-5.812984110767001
Ku812,148198,-4.150507844489635
NCI-H2081,46224516,0.9232346266515704
SET-2,227681,2.8578313168643787
SNU-8,11175137,2.4587616442256603
KMS-27,25262965,-2.6525185132842406
KMRC-2,5278396,4.273818300386133
TE 617.T,selumetinib-BRD-A02303741 (4-1 mol-mol),2.6480104459269596
ML-1 [Human thyroid carcinoma],navitoclax-PLX-4032 (1-1 mol-mol),2.479159740244691
SNU-1033,24771867,4.258069767516097
KMS-20,5282054,2.484171809252808
CML-T1,9926054,1.696565612874625
AN3-CA,piperlongumine-MST-312 (1-1 mol-mol),0.9520021063279038
BT 248,3552672,1.5840638178238662
SW1990,65628,4.249281655519801
LoVo,3025986,-0.1762115912359206
SNU-1272,4259181,2.0481969958420683
RERF-LC-Ad1,10302451,4.5263361411635366
SEM,25227462,-4.562496215443916
HCC2218,46224516,2.8034252567283557
A4/Fukuda,5284329,2.3119801528783244
SNU-1272,11625818,6.086171109339369
AN3-CA,2871966,-0.11726525014801
LNCaP clone FGC,selumetinib-vorinostat (8-1 mol-mol),3.5283733311441208
MCAS,36314,4.089980392616843
SKM-1,46398810,2.0273283297042712
NCI-H2172,6918837,-1.0151074573651029
Raji,9868037,1.949547656703084
SKM-1,ISOX-bortezomib (250-1 mol-mol),-0.1246400707539527
Ku812,46943432,4.280814189443877
SNU-1272,168312962,-0.3156994107221632
A4/Fukuda,400769,-1.555916482707746
NCI-H2172,25195348,4.702714064642265
Hs 683,6852167,1.768664782954411
NCI-N87,vorinostat-carboplatin (1-1 mol-mol),2.026584102601564
MM1.S,375860,-0.3099552941005813
NCI-H1092,24785538,0.314823204123774
BT 139,alisertib-navitoclax (2-1 mol-mol),0.2427130322449746
BT 139,9933475,1.3002583684708735
MCAS,10427712,4.5640470140597165
NU-DHL-1,135928012,0.9972695617711916
NCI-H2110,675434,4.551322569606733
HEC-151,20959075,-3.1296550695223075
IST-Mes1,4578,4.452023444310014
NCI-H1395,241158,4.2689573120798165
HCC2218,16038120,1.660255245191623
SEM,navitoclax-piperlongumine (1-1 mol-mol),-2.550226748715502
NCI-H2110,vorinostat-navitoclax (4-1 mol-mol),2.084238396399879
KMS-20,9907093,3.4459916472834644
AN3-CA,44491742,4.617223070127138
SNU-1033,16736978,4.192553953720477
NCI-N87,89928392,0.9456157368763274
CA46,448949,1.4123991312197492
YKG-1,selumetinib-tretinoin (2-1 mol-mol),4.056935710637763
NU-DHL-1,16725315,3.081538232770875
KMRC-2,11656518,3.740037309052016
NCI-H2081,23725625,3.532612655790426
AU565,60750,-2.174078373186638
MCAS,10127622,1.8277619446104008
HCC2218,374536,1.547515633749918
GOS-3,6918837,-2.1176912664371144
IST-Mes1,3634881,3.096696127840678
SNU-1214,6918736,-2.2535813174061845
MM1.S,71466380,2.0255927209587545
Kasumi-2,168313016,3.99242446715415
HMCB,445455,4.664999175026341
RPMI-7951,9915743,0.6767769344324703
Hep-G2,11609586,2.605308217008377
Hs 683,9911830,1.9641699230536744
SEM,44819697,-3.860509167414776
MM1.S,selumetinib-decitabine (4-1 mol-mol),4.192899101848816
RERF-LC-Ad2,15953870,4.58156365468759
Kasumi-2,4259181,-0.4186991216348978
NCI-N87,5329102,2.120238068250485
NCI-N87,1239801,5.115918121174403
D283 Med,54619267,3.614000477543864
MCAS,2858523,3.142383195808636
HARA [Human squamous cell lung carcinoma],54618164,4.558968644978708
D283 Med,11167602,1.7563320025634743
BT 248,5287620,-3.0713737356172484
NCI-H2110,6438330,3.101663821546876
CA46,salermide-PLX-4032 (12-1 mol-mol),5.07380877764379
MM1.S,44202524,1.2152140209200315
TE-15,387447,-4.257900705403723
AN3-CA,doxorubicin-navitoclax (2-1 mol-mol),-0.1644094320922892
LNCaP clone FGC,44632017,1.0493161058029077
NU-DHL-1,71466445,1.452037118148276
D283 Med,54454,3.694221793159312
SKM-1,2746,1.6032420730880204
AN3-CA,5291,4.063376464775615
CML-T1,25062766,1.440222571379222
AU565,11609586,0.8886557909894768
KMRC-2,46398810,2.7180589797423167
LNCaP clone FGC,100016,6.505127339133147
TE-15,55508,6.278494515493491
Aska-SS,24951314,0.8841010020541346
Hs 683,10172275,4.903981746071532
KMRC-2,erlotinib-PLX-4032 (2-1 mol-mol),3.2851821343888137
KMBC-2,54626689,4.121176613845106
KYSE-410,selumetinib-vorinostat (8-1 mol-mol),2.854769391791397
Aska-SS,9803433,4.290162471771147
OE21,1716436,3.782733753033253
GOS-3,136227924,2.1351760440562533
KMRC-2,4788,6.118095865877025
EJM,4521392,4.5143467912480055
SW1990,JQ-1-carboplatin (1-1 mol-mol),4.363911496200424
IST-Mes1,54618771,0.8929247318821524
YKG-1,327653,3.641218936705474
BT 330,selumetinib-BRD-A02303741 (4-1 mol-mol),4.602699425351198
RERF-LC-Ad2,44589607,1.764039142360227
NCI-H2081,navitoclax-gemcitabine (1-1 mol-mol),-4.71616424296242
LNCaP clone FGC,613753,3.2056954535425235
HEC-151,12001922,2.1072309594101086
SEM,11497983,-3.9195966802486417
NU-DHL-1,44489675,3.995073579717184
HARA [Human squamous cell lung carcinoma],6438330,2.871193568039211
AU565,71304818,2.0398490425817144
KMS-27,452548,-2.159096065325925
NCI-H2110,46843906,2.832724697614329
D283 Med,6610355,3.4554564076272496
KYSE-410,5281321,-0.5490032374282351
NU-DHL-1,3689413,-2.5727806443741836
NCI-H1092,16013152,3.726585488555384
KMS-20,1641662,2.6653075673908564
MM1.S,16741245,2.4226245621755016
GOS-3,5566,2.9543896668680287
RERF-LC-Ad1,262093,3.285321037103647
SET-2,46215462,1.341717099433842
Hs 683,46843906,3.630992092073276
BT 328,16722836,1.9860843246282325
AU565,72199292,-0.5217195589045935
SKM-1,10410894,3.4215303234711065
SNU-1214,3025986,-0.5805769676199715
SNU-308,serdemetan-SCH-529074 (1-1 mol-mol),2.985440600627557
KMBC-2,9911830,3.153897570043922
HEC-151,16038120,1.8032484675245264
Ku812,11178236,-3.734217026428133
SET-2,selumetinib-decitabine (4-1 mol-mol),-1.4911047995108635
LoVo,11625818,2.0848313295223844
KMRC-2,44241473,4.436801876335884
SEM,3081361,1.342967789482049
LoVo,9935249,1.1872155844887071
Hs 683,44607530,2.2726737213749564
YKG-1,6505803,-0.4747915631752394
Hs 683,122327,4.192242521314138
A4/Fukuda,135411,0.1560078623072997
TE-15,6610216,4.337725089015336
HMCB,10074640,3.711732352742634
AU565,10184653,-2.737102807310711
SNU-1272,5328940,2.3850434958560407
LoVo,piperlongumine-MST-312 (1-1 mol-mol),2.135338171440717
CA46,9825149,2.310107059064329
NCI-H1092,6610216,4.21553350442545
MCAS,241158,4.420825214389376
EJM,2113511,5.268537886906316
Hs 683,387447,-4.17962939881664
BT 320,9840324,5.908905325340882
IST-Mes1,navitoclax-MST-312 (1-1 mol-mol),2.625426297409908
TE 617.T,44491742,3.9684227449531697
MCAS,107970,2.3689234635005274
IST-Mes1,107970,2.9610434925705773
SW1990,400769,0.0834550218555617
PE/CA-PJ34 (clone C12),46926350,-5.351224463970161
RPMI-7951,20959075,-3.4556844315099338
HMCB,11214940,4.410091116591445
EJM,3854666,0.5770225844187807
KMS-20,doxorubicin-navitoclax (2-1 mol-mol),-1.6675584741193203
BT 139,24772860,-2.647640860337615
KMS-20,676352,1.1111615273565725
HMCB,44462760,4.190588820303925
KMRC-2,107970,2.5476750010931446
MCAS,11152667,-0.1014639738878534
SEM,135423438,-3.9763751688577527
KMS-27,6918289,2.2477856087325603
SNU-1272,5311281,4.230708828078394
BT 139,72193861,3.223416508879562
TE 617.T,168313016,4.349421247778161
KMS-20,71680916,4.434197723022785
SNU-308,31703,0.6656471212282582
PE/CA-PJ34 (clone C12),7251185,3.0082102919143705
KYSE-410,445643,4.18343809737397
A4/Fukuda,24901704,2.035809268681581
NCI-H1092,doxorubicin-navitoclax (2-1 mol-mol),-2.111052945986695
PE/CA-PJ34 (clone C12),54618305,4.348682714943588
TE 617.T,60750,-7.010901382774134
SW1990,11612883,3.6109216532509985
HARA [Human squamous cell lung carcinoma],66577038,3.5726698245106445
AU565,4096211,1.4857810053347718
PE/CA-PJ34 (clone C12),54619267,4.022513572459868
Kasumi-2,tretinoin-navitoclax (4-1 mol-mol),-1.7233092596957704
KYSE-410,3634881,3.5659315968121645
HMCB,6918638,0.939566819440244
NCI-H2110,decitabine-navitoclax (2-1 mol-mol),4.889337790333301
NCI-H1395,9936388,2.8582059793440964
A4/Fukuda,5311,-0.1264358008137528
KMRC-2,23635314,3.8772911931885568
NCI-H2110,107970,2.6685379556569297
BT 330,56649450,4.0940833334268225
KMS-27,selumetinib-BRD-A02303741 (4-1 mol-mol),1.1339783497693052
SET-2,3136844,4.073170521818995
EJM,24785538,0.370264402749186
SEM,5328940,-0.9125059164303356
Hs 683,54619267,4.24261582571363
KYSE-410,2746,3.332005025730893
Aska-SS,60700,-1.5034109982704524
LoVo,6252,1.008875569338637
RERF-LC-Ad2,24753719,4.674751178496499
KMBC-2,5287620,-2.4056234930348963
LoVo,4378219,2.040258922351895
MM1.S,71304818,1.9525205980727691
NCI-H2172,16741245,4.1711298858904176
SNU-8,alisertib-navitoclax (2-1 mol-mol),0.4717323019340358
HMCB,375860,-0.2087542288186852
BT 328,53393127,6.034881823049704
AN3-CA,24964624,1.438954699001727
BT 330,3081361,3.42309290402186
BT 139,5284616,2.5107293050927457
BT 320,erlotinib-PLX-4032 (2-1 mol-mol),4.456521882362605
SNU-1033,11152667,-1.2864641909035752
CML-T1,57330099,4.076691821950742
ML-1 [Human thyroid carcinoma],17759555,4.838019485799326
ML-1 [Human thyroid carcinoma],navitoclax-sorafenib (1-1 mol-mol),2.2930044306717954
SEM,JQ-1-UNC0638 (2-1 mol-mol),-2.509155551335313
NCI-N87,44632017,1.346248550233927
LNCaP clone FGC,6918328,-1.08990996538289
LNCaP clone FGC,16038120,2.90049903396662
Kasumi-2,2858523,3.136381143278692
HCC2218,9936388,0.977315225187753
D283 Med,53392493,1.8196798066611335
KMS-20,11955716,-2.0378008092304323
NCI-H1395,54619267,3.786802198247579
OE21,24821094,-1.6479639852881638
ML-1 [Human thyroid carcinoma],1750826,-1.3031865689994189
EJM,9956119,3.780866112721705
HEC-151,11719255,4.240324425597553
AU565,446155,4.298434988536317
NCI-H2081,49766530,1.2305991234309177
IST-Mes1,16065773,3.0641757349077925
HSC-4,11364421,-0.0916399418549534
BT 139,navitoclax-piperlongumine (1-1 mol-mol),0.9371144639031332
KMS-27,selumetinib-tretinoin (2-1 mol-mol),-0.6348542440418741
AN3-CA,5282054,3.7164894333535745
BT 330,9936388,0.9619236718444248
Aska-SS,12001922,1.1901080826215733
BT 328,4259181,1.754792833603723
Kasumi-2,613000,1.0071641049539857
BT 248,45279963,3.7107289938294135
HMCB,54618164,4.179643558652394
EJM,10410894,1.930744280371102
Hs 683,9444,4.314878154306634
Ku812,57330099,2.587307401238269
AN3-CA,2729026,3.165325615874287
KYSE-410,10127622,6.217588658348878
LNCaP clone FGC,46215462,1.62932026806228
TE 617.T,4705,0.0619159999462867
TE-15,carboplatin-etoposide (40-17 mol-mol),1.7247988708379622
KMRC-2,44491742,3.971638428490517
NU-DHL-1,216345,1.6023590479795808
LNCaP clone FGC,10427712,4.507515988092667
SW1990,675434,4.671519194492311
PE/CA-PJ34 (clone C12),10074640,3.6571343520395794
EJM,9903786,2.5710642236856818
LoVo,24772860,-3.380615847351667
SKM-1,5335621,3.872375911033952
ML-1 [Human thyroid carcinoma],262093,3.5917492591420737
KMS-20,71304818,2.1480627398937284
Ku812,702558,3.01939584442747
GOS-3,11234052,4.638302294933858
OE21,11238147,1.5648824179168512
NCI-N87,5746,-2.0970985848352837
AU565,ISOX-bortezomib (250-1 mol-mol),0.4986344136338663
LNCaP clone FGC,6505803,-1.5170131166658098
KMS-27,9840324,5.417982870639934
KMS-27,JQ-1-MK-0752 (1-1 mol-mol),-3.7311302166854903
CA46,969516,2.1845952347247306
RERF-LC-Ad2,11234052,5.162064101365275
Raji,11507802,0.5089576366408277
SNU-1033,JQ-1-MK-0752 (1-1 mol-mol),1.3281748274410412
KMRC-2,2113511,8.452933982441557
Raji,5291,3.273680351166006
RPMI-7951,44505237,4.378502916493453
KMS-20,24753719,3.26753514652521
AN3-CA,31703,0.3464960160255474
NCI-H1092,piperlongumine-MST-312 (1-1 mol-mol),1.5005628811138385
KYSE-410,219104,4.514421987123987
BT 320,676352,2.325208402765908
KMS-20,11717001,3.5596278173639835
RPMI-7951,262093,2.547304876719483
YKG-1,11364421,-5.418729498974909
EJM,4917,3.5272313521273415
NCI-H2110,6505803,-2.3425437188382587
HSC-4,5329102,2.7247882686097458
PE/CA-PJ34 (clone C12),24821094,-0.2762581028984301
Kasumi-2,25262965,-2.503194884241619
SKM-1,676352,2.3445946302797984
SEM,9935249,-3.4494441375925153
HARA [Human squamous cell lung carcinoma],5746,1.191361240850758
HSC-4,4259181,1.301377168384764
Aska-SS,702558,5.279806161399073
BT 320,3062316,3.917549487062472
SKM-1,135398738,0.0508084825394364
KYSE-410,49850262,3.861570035849352
BT 248,9952709,2.726522372177628
LoVo,135398744,6.330186357549225
SET-2,57330099,4.519463071900052
SEM,selumetinib-PLX-4032 (8-1 mol-mol),4.899213225344207
NCI-H1092,24821094,3.179628760987399
CA46,3384730,2.283076300956678
LNCaP clone FGC,46199207,2.5599085856747323
SNU-1214,156414,-3.2304362437665812
MM1.S,44607530,1.747529731398438
Kasumi-2,135440466,2.9310364314773376
GOS-3,71466380,4.9000171792124
MM1.S,3025944,3.5237417636724215
AN3-CA,24753719,4.3754867797298544
PE/CA-PJ34 (clone C12),2708,4.740071919144502
LoVo,26596,-4.043483931746528
MM1.S,6505803,-0.1841114080814497
RERF-LC-Ad1,44507138,3.8186397004948343
IST-Mes1,5282054,4.276236228318484
KMBC-2,23725625,6.983046906431785
BT 248,10427712,4.022427006719253
SNU-1272,selumetinib-PLX-4032 (8-1 mol-mol),6.285014325142589
PaTu 8988s,navitoclax-piperlongumine (1-1 mol-mol),1.0029380137486594
CML-T1,5746,-2.1549173035879803
LoVo,56946209,-4.467950537911531
NCI-H2172,168312962,1.0879961512148657
SEM,2708,2.117173016792575
OE21,126941,-2.789719125532102
NCI-H1092,6505803,2.777743929422052
BT 139,10427712,3.8986944059479383
SW1990,53232,1.76868009043537
TE 617.T,54596558,3.8847882662433086
SNU-1033,9825149,1.4317957372190675
BT 139,3025986,0.2416849794736328
LoVo,46843906,2.381362357237743
LNCaP clone FGC,24856436,-0.0092886398073457
SKM-1,16065773,1.0791751756996522
SW1990,10410894,3.3215224279336937
A4/Fukuda,54618164,3.3817410387547575
Aska-SS,4578,5.1007948880015
SKM-1,5566,3.0901148412654877
Aska-SS,3689413,-0.2828072846638814
BT 328,4096211,3.6600455300853154
LNCaP clone FGC,15983966,-4.386183959225337
Hep-G2,selumetinib-vorinostat (8-1 mol-mol),-0.2891046147054946
HCC2218,12001922,1.1879364076303054
SNU-1214,44819697,-2.330970176435049
SET-2,25227462,-0.701000909642151
KMRC-2,252682,6.436582510875352
D283 Med,2871966,-1.8966862089774792
Kasumi-2,16219061,1.087081093705916
KMBC-2,44185566,3.018196319024016
MM1.S,451668,2.3967499935955083
SW1990,24771867,2.961729646695687
HMCB,16659841,4.044533184021594
HMCB,31703,-0.0757887186951435
SNU-1272,navitoclax-pluripotin (1-1 mol-mol),0.4939467184694363
Raji,53392493,2.607166976359352
SKM-1,sirolimus-bortezomib (250-1 mol-mol),0.3833247137434921
A4/Fukuda,selumetinib-GDC-0941 (4-1 mol-mol),-1.0916711617769086
NU-DHL-1,46174525,2.6554261934954546
Kasumi-2,107985,-4.524149027848321
HMCB,46907787,2.4282883374132256
SET-2,44607530,0.9874669623772268
MCAS,24785538,2.440371429478031
SEM,71466380,1.6371741531095363
A4/Fukuda,23725625,4.971593284778653
HARA [Human squamous cell lung carcinoma],3038522,4.1452744027346045
NU-DHL-1,24901704,2.6374466424788356
MM1.S,10184653,0.1720840981643339
SET-2,25126798,-2.3352287177137443
KMS-20,9911463,2.8485967740948284
OE21,25154868,5.314720620107449
NCI-H2081,2708,2.8987838262857264
NCI-H2081,23635314,-3.63845546552979
RPMI-7951,ISOX-bortezomib (250-1 mol-mol),0.1773808939731821
GOS-3,JQ-1-vorinostat (2-1 mol-mol),1.826489490547508
HEC-151,6918289,2.9359862334604085
TE 617.T,4261,1.6006330563406768
Ku812,tretinoin-carboplatin (2-1 mol-mol),4.0660943176260504
MM1.S,1566236,0.950221343647725
KMS-27,10427712,2.83371014836836
A4/Fukuda,2874250,4.0164309105299685
KMS-20,5738263,2.421562414606395
PaTu 8988s,16736978,1.6757685634038475
RERF-LC-Ad1,serdemetan-SCH-529074 (1-1 mol-mol),2.637264034786848
KMS-20,10427712,4.433037209532288
NCI-H2081,ISOX-bortezomib (250-1 mol-mol),0.1773494358411905
HEC-151,2874250,4.717571099068939
HARA [Human squamous cell lung carcinoma],135440466,2.4398826683273165
Kasumi-2,53232,4.135119610512006
KMS-27,9935249,2.590998934095406
RERF-LC-Ad1,5328940,2.4316696035248153
AU565,53393127,4.519828407362072
MM1.S,51039095,1.544841271457304
CA46,54596558,4.227379600712383
TE-15,docetaxel-tanespimycin (2-1 mol-mol),-6.9142501406211725
HEC-151,445091,4.618132291370935
MM1.S,71466445,1.6605389329514368
EJM,119607,4.869876061461073
NCI-H1395,2871966,-1.8514751727384056
Kasumi-2,10427712,4.152130511624211
MM1.S,72193861,1.743096021733494
TE 617.T,3081361,1.06773756844504
PE/CA-PJ34 (clone C12),4477,0.7585627353016603
Kasumi-2,4917,2.8909802401946565
RERF-LC-Ad1,11178236,-2.382860044467462
TE-15,46843906,2.4934004690142344
EJM,2729026,3.2130088601508247
TE 617.T,1566236,1.7943954235614814
SW1990,5329102,1.774987171180741
KMRC-2,15547703,4.90562893778179
KYSE-410,6610355,5.169195393353756
KMBC-2,JQ-1-vorinostat (2-1 mol-mol),1.1085928462642851
OE21,5746,0.6324178329845088
SNU-308,6610355,5.243493388653266
BT 248,135999136,1.3787773380664552
SNU-8,613753,3.0857459456597804
SEM,9908783,4.605938150893541
Hep-G2,3543504,4.31839273313728
LoVo,71304818,2.0724805960279027
AU565,66577038,2.656766135213886
Hs 683,10231331,6.307100182412671
SNU-8,6917907,-4.432679706023793
HEC-151,568763,1.1606004827121237
Hs 683,44491742,3.840304182439804
Kasumi-2,6918837,-5.725087899258232
KYSE-410,selumetinib-UNC0638 (4-1 mol-mol),4.750862854057562
BT 248,71304818,1.6499217451033
NCI-H2110,2742550,3.917163865497912
BT 330,11707110,0.5600292055298391
TE-15,135984461,4.740662203651603
EJM,675434,4.21924619538193
SW1990,56973724,4.7773565867531325
PaTu 8988s,72193861,3.4773628322581605
KYSE-410,9956119,3.754635391401796
AN3-CA,44202524,2.221803011886496
NCI-H2081,135421197,1.057518505455496
Ku812,107970,1.4051912271786118
IST-Mes1,5311,2.113640627204962
AN3-CA,448949,1.3403771585742368
Ku812,44202524,1.0653964547956452
AU565,57519531,1.889615726213954
CA46,6450551,1.1375422858810305
Hs 683,11234052,4.410991782811801
A4/Fukuda,tretinoin-navitoclax (4-1 mol-mol),2.572216751068698
SNU-8,11507802,1.7250586009549282
Hep-G2,374536,1.5546394927769718
D283 Med,15953870,2.787040507745561
KMRC-2,8515,5.486198436058084
D283 Med,46926350,-5.859080576387131
HMCB,11213558,3.5955546629304997
LNCaP clone FGC,31703,-2.79397639751077
BT 320,5329102,3.0266079626967928
BT 320,10410894,4.180150860885228
NU-DHL-1,sirolimus-bortezomib (250-1 mol-mol),-0.7283867124282789
Hs 683,49867926,4.153866914474468
CML-T1,56963564,-0.6939066710243597
NCI-H1092,selumetinib-vorinostat (8-1 mol-mol),2.4548144613596885
PE/CA-PJ34 (clone C12),11404337,0.4327507632811037
RERF-LC-Ad2,25262965,-2.693840311584002
SEM,1641662,2.508220365497951
GOS-3,navitoclax-piperlongumine (1-1 mol-mol),2.852873715439821
BT 328,71751553,4.608962030519419
NCI-H1092,969516,2.7305751680424573
YKG-1,11656518,3.2950724236560456
BT 139,25062766,2.3114298765215815
YKG-1,7251185,2.916667385040177
A4/Fukuda,4477,0.5783674149898913
NU-DHL-1,11955716,-1.5402141200018542
GOS-3,262093,3.1165245547903804
KMS-20,25161177,3.641930132688034
KYSE-410,11214940,4.79539855335964
Raji,71304818,2.348707554665557
NU-DHL-1,24748573,1.9153474255246443
ML-1 [Human thyroid carcinoma],2733526,3.914729894927785
D283 Med,3025944,3.966000560385046
SNU-308,123631,0.6743565736055448
SNU-1033,2708,5.22281661109988
SNU-8,568763,0.2503555108357383
TE-15,24856436,-0.9894737380847988
NCI-H2081,262093,2.026605801788383
SNU-308,3689413,0.3406956707675037
Raji,135398516,1.6921916464598077
NCI-H1395,148124,3.756905797674181
AU565,49766530,1.448288738772077
ML-1 [Human thyroid carcinoma],4259181,0.3770562232502641
HMCB,docetaxel-tanespimycin (2-1 mol-mol),-7.206922464155887
Hep-G2,9840324,5.75050852869845
KMS-27,serdemetan-SCH-529074 (1-1 mol-mol),1.3619921594172788
SNU-308,42642645,2.1176694587678617
RERF-LC-Ad2,sirolimus-bortezomib (250-1 mol-mol),2.075251911083675
SET-2,11707110,0.8817247620057471
NU-DHL-1,2871966,-1.1503582820032332
HSC-4,135398516,2.2759469773851224
TE-15,44566777,-0.1580764360549867
BT 328,168313200,2.3539430397400523
KMS-20,322968,1.9273054184406155
BT 248,doxorubicin-navitoclax (2-1 mol-mol),-1.9120530478094175
NCI-H2081,104842,-6.196868817242243
Raji,9903786,2.8365362494251394
CA46,carboplatin-etoposide (40-17 mol-mol),0.8336753262316364
EJM,7251185,1.248669965280625
RPMI-7951,44620216,4.631665310012847
CA46,24180719,4.114109141176105
IST-Mes1,219104,4.071310239310072
ML-1 [Human thyroid carcinoma],57519531,1.467564757525082
BT 330,57519531,2.9868357975460564
KMS-20,11167602,1.9500667412435135
AN3-CA,24821094,2.333650308154893
D283 Med,25262965,-4.463192676637634
NCI-H2172,5282054,5.216564599238412
BT 330,5287620,-3.02332319898901
NCI-H2081,54613361,-0.0228941732183183
TE-15,11497983,5.180725305113291
HCC2218,4261,0.480758694129974
Kasumi-2,448949,-0.5395388127141975
SNU-308,5746,0.7137982637485957
Aska-SS,46926350,-3.8852893541417455
SET-2,navitoclax-piperlongumine (1-1 mol-mol),-1.186634349144105
SNU-1033,4378219,1.9830509373994671
BT 139,25183872,-0.4307176707233577
ML-1 [Human thyroid carcinoma],24785538,0.9232201957937346
EJM,alisertib-navitoclax (2-1 mol-mol),1.7794919006305252
NCI-H2110,2746,2.5947990205927405
BT 330,3062316,2.567282780734098
TE 617.T,5284616,3.1382086796806954
NCI-H1092,984333,-1.1758296018465422
CA46,45279963,3.66447519946476
HEC-151,11625818,3.876789656510256
NCI-H1395,selumetinib-BRD-A02303741 (4-1 mol-mol),5.369939363502549
SEM,11152667,-6.712483327053162
SKM-1,135411,-0.1897153244847568
HMCB,11404337,-1.2429546984634874
NCI-N87,6610216,4.734758596227503
SNU-1033,44137675,3.659599107185258
RERF-LC-Ad2,107970,2.022505659566407
IST-Mes1,24785538,1.075792459113639
CML-T1,11364421,-5.082505847469849
MM1.S,3081361,2.3105527639319097
KMS-20,44185566,1.377137905176795
SET-2,2746,0.8916395455775363
MCAS,56649450,3.7534424582376222
CML-T1,10074640,0.1978471501959747
HSC-4,piperlongumine-MST-312 (1-1 mol-mol),1.1147970090966637
KMRC-2,1641662,4.678757518299194
ML-1 [Human thyroid carcinoma],SNX-2112-bortezomib (250-1 mol-mol),0.4585620616557309
BT 248,71576739,6.051378362255083
YKG-1,42642645,0.5403714198289554
MCAS,11485656,2.57416789640687
HSC-4,53301938,4.738168418112686
HEC-151,1566236,1.8834874590606951
PE/CA-PJ34 (clone C12),11647372,1.7004397362424115
HEC-151,168312962,-0.0086249053490707
A4/Fukuda,3854666,-0.0838776105349313
NU-DHL-1,BRD-A02303741-navitoclax (2-1 mol-mol),-1.4482260747427786
NCI-H1395,9866186,2.8046320736833894
MM1.S,4477,1.1148587916452
EJM,135398516,2.3604347567100965
YKG-1,156414,1.711503789054189
Ku812,10302451,-2.0253572962014617
AU565,9803433,4.3672163986823085
Kasumi-2,71680916,3.663022593238377
MM1.S,6623618,2.4719369503455257
MCAS,42642645,1.6659127430061134
MCAS,60750,-2.5665145901984943
IST-Mes1,6918638,1.4350648787515894
KMRC-2,UNC0638-navitoclax (1-1 mol-mol),2.5258787536181515
Hs 683,vorinostat-navitoclax (4-1 mol-mol),0.8152340271221348
CML-T1,11234052,1.4016611587884042
TE-15,3634881,3.8214660125087394
HEC-151,salermide-PLX-4032 (12-1 mol-mol),4.950081293482252
NCI-H2110,4378219,2.2471941094410752
SW1990,3689413,-1.271257676680656
CA46,16038120,1.1324791438314847
AU565,9887053,5.902090445564702
D283 Med,selumetinib-UNC0638 (4-1 mol-mol),5.192185535679209
Kasumi-2,3854666,0.5999676074569762
LNCaP clone FGC,176870,4.130944067195273
RERF-LC-Ad2,docetaxel-tanespimycin (2-1 mol-mol),0.5061822490526904
KYSE-410,168312962,3.075670045651394
KMRC-2,9825149,2.7901863927657247
LoVo,selumetinib-vorinostat (8-1 mol-mol),-0.5614711347851936
KMS-20,navitoclax-gemcitabine (1-1 mol-mol),-5.120550360626937
MCAS,71466578,4.945747928602411
TE-15,89183176,4.278773668184103
Raji,400769,-1.8811521380691785
HCC2218,56963564,-0.6513209132887624
Kasumi-2,60750,-5.618830215487252
BT 328,44607531,1.5766345227803793
SET-2,5746,-1.570988148221185
BT 320,54678924,3.6890866492224106
A4/Fukuda,36314,4.126705075384559
AU565,1716436,0.9342430141979629
SET-2,carboplatin-etoposide (40-17 mol-mol),1.454768246911245
Raji,5311,0.5368749929335932
SEM,9933475,1.6595519600408728
KMS-27,9915743,0.5712823893171636
SET-2,6918736,-1.0474538730050982
OE21,6852167,2.0185127581228763
NU-DHL-1,11612883,1.5610668318918748
SNU-1214,54618305,4.749041864711717
BT 330,644241,2.044782133454181
NCI-H2110,23725625,4.931230472859012
Hep-G2,44607530,1.8246078375377963
SNU-1214,11485656,2.376217579776436
Kasumi-2,9952709,2.8950386128563985
Raji,568763,2.0961925057450292
BT 330,25150857,1.3872666328964631
Hs 683,52947716,2.9909065947709856
Hep-G2,serdemetan-SCH-529074 (1-1 mol-mol),1.77689814586136
RERF-LC-Ad2,71751553,4.725836068423468
SET-2,71680916,4.354053511133045
KMS-20,52947716,2.1848836609690485
EJM,89183176,3.310519408856309
EJM,selumetinib-UNC0638 (4-1 mol-mol),4.085374328127957
NCI-H1395,135984461,4.376761136039875
Hep-G2,11626560,1.6326140498169086
NCI-H1092,10074640,3.1933502668870464
Raji,168312962,0.8665560177214189
KMS-27,10127622,-1.359556909337271
OE21,11640390,3.5513799311082175
BT 248,17755052,0.6696435234843453
HEC-151,selumetinib-JQ-1 (4-1 mol-mol),2.04219566232124
CML-T1,selumetinib-decitabine (4-1 mol-mol),-0.3389481007221296
GOS-3,387447,-4.946086426612472
D283 Med,25105715,3.463494794398442
NU-DHL-1,25150857,0.917723720261522
SW1990,100016,6.759971253936254
NU-DHL-1,55508,4.248888595165198
KMS-20,168312962,2.0534985084126895
Kasumi-2,4378219,6.192429128955844
YKG-1,462382,0.3807695493955695
NU-DHL-1,24785538,1.0329892667677911
KMS-20,4578,4.142060591748304
SNU-1272,11609586,3.189761140355052
RERF-LC-Ad2,9927531,7.758899930646885
MCAS,9911463,3.99734234256231
BT 328,4705,3.594890989297502
SNU-1272,409805,6.302573635067764
TE 617.T,tanespimycin-gemcitabine (1-1 mol-mol),-4.604968382262146
RERF-LC-Ad1,3503,3.3659937623050222
KMS-27,11234052,4.628774972835408
SNU-1272,6852167,2.886842068916118
LNCaP clone FGC,54765302,3.729529595013661
NCI-H1395,3634881,3.864261643428736
TE-15,2749,1.2362405825112004
HEC-151,23635314,-2.5037099558105727
PaTu 8988s,2113511,6.134434442381108
LNCaP clone FGC,2949965,2.2467264551243993
A4/Fukuda,44607531,1.1783204907000706
HSC-4,5282054,3.7951129778884822
AU565,6184667,2.5363760520525247
HEC-151,JQ-1-navitoclax (2-1 mol-mol),0.7409991193456812
Hs 683,5351362,1.147088427149933
BT 330,UNC0638-navitoclax (1-1 mol-mol),2.829713529856627
BT 139,168313016,5.38709248356601
RPMI-7951,49867926,4.495804760733926
Kasumi-2,49846579,-4.472892287565064
HCC2218,65064,5.398971779575134
TE-15,4521392,6.17609826401505
MM1.S,46174525,3.3961962324765764
LNCaP clone FGC,9933475,1.6920769507225688
TE-15,5311281,1.0813449483245536
CA46,119607,3.9558807366301374
BT 328,4378219,2.241353375973062
Hep-G2,46398810,2.254556195261035
ML-1 [Human thyroid carcinoma],613753,2.773006926215127
RERF-LC-Ad2,241158,4.786001291187356
KMBC-2,262093,2.431705852322835
A4/Fukuda,135421197,1.440002399326734
YKG-1,tretinoin-navitoclax (4-1 mol-mol),5.641897635503529
SET-2,selumetinib-tretinoin (2-1 mol-mol),3.45699617229081
SNU-1214,20959075,-3.1846059902986075
NCI-N87,53232,3.890681715203442
NCI-H2110,5470400,-1.567028418385665
RPMI-7951,5278396,2.740047026102501
A4/Fukuda,10322450,2.3588003127389277
BT 330,54618771,1.126600316617638
HSC-4,10074640,3.187745953835862
ML-1 [Human thyroid carcinoma],637858,1.1825057393141218
KMBC-2,135999136,4.121225006171559
GOS-3,66577038,3.060096848137411
SW1990,11609586,3.716895090235181
NCI-H2081,89928392,0.9325631325341028
Hs 683,11626560,1.4068701984399117
KMS-27,54454,1.928881135788404
LoVo,25262965,-3.8912736240644694
Ku812,24180719,2.5562197151601413
Hep-G2,11364421,-0.8819636691754982
TE 617.T,3854666,0.5346166749411773
KMBC-2,2842253,6.705227553529979
SNU-1214,44507138,1.7676229984085725
KMBC-2,42642645,1.3462679167777547
SKM-1,3634881,1.6208942767524477
AN3-CA,tretinoin-navitoclax (4-1 mol-mol),4.798194863439803
RERF-LC-Ad1,24964624,3.310681300814033
AU565,81146,6.247262332137589
NCI-H2081,10427712,3.8865371884271265
NCI-H2081,72376,-1.7545095760528466
TE 617.T,6918837,-4.053611738094944
PE/CA-PJ34 (clone C12),462382,1.1999827824546994
BT 139,11609586,2.914596514513223
HMCB,1242560,3.0802534848210947
KMS-20,2871966,0.6331264046561579
SET-2,9903786,0.1058309934713531
RPMI-7951,24772860,-2.8129043414212633
YKG-1,71680916,5.750185341340424
HEC-151,10127622,3.4193086476491814
NCI-H2110,89928392,2.605019986825885
BT 328,navitoclax-gemcitabine (1-1 mol-mol),1.6667788304977649
NCI-H1395,24797083,1.421721283570518
SET-2,65628,4.139593667952883
CA46,11719255,3.04595311036835
NCI-N87,5978,-2.9043455823279185
BT 320,6852167,5.054396580410171
CA46,5335621,3.676802077981384
HMCB,44137675,3.1016831628423542
HMCB,11364421,-5.583776675584482
HEC-151,5335621,6.1818969924575145
TE-15,9933475,1.5084956369379665
NCI-H2172,72193861,3.68298370013582
HSC-4,753704,4.983094182740762
Ku812,7326481,1.3104376334560923
MCAS,5280436,3.1569010943943003
EJM,25227462,-4.274317957574103
HEC-151,24821094,3.275946905421496
KMS-27,3825829,3.2801020801317917
CML-T1,6917907,-6.247910968385368
LoVo,selumetinib-piperlongumine (8-1 mol-mol),1.883455735434258
ML-1 [Human thyroid carcinoma],4788,6.371899932480547
KMS-27,26596,-2.324040117520084
SW1990,3503,1.938053759615162
BT 248,1716436,2.58950342299198
NCI-H2081,24772860,-1.2700497080166275
MCAS,16741245,1.8524285811133965
A4/Fukuda,BRD-A02303741-navitoclax (2-1 mol-mol),4.161880654149954
MCAS,322968,4.019295540139923
OE21,9956119,3.601171000116071
MM1.S,1716436,2.248600681663511
KMBC-2,12003241,-0.070536665370705
NCI-H2110,11707110,1.745114004919136
NCI-H1092,72376,-1.2021536382065705
SNU-1272,2729026,3.2131573278118015
NU-DHL-1,10184653,1.6775776447141315
OE21,44543605,3.861252295360997
NCI-N87,3543504,4.249309596150935
NCI-H1395,11455910,1.7673103520073516
BT 328,25126798,5.564385085332987
SNU-1214,11214940,0.7673101804446996
TE 617.T,5394,4.359465611245191
RPMI-7951,carboplatin-UNC0638 (2-1 mol-mol),2.186057143713863
NCI-N87,9936388,-5.070095106907016
TE 617.T,5284329,5.532660063790676
IST-Mes1,11612883,3.500237916670588
SKM-1,9549297,1.2494873676183296
SW1990,25102847,2.030149124763984
SNU-1214,159324,0.6558856370223802
HARA [Human squamous cell lung carcinoma],9866186,-0.525705997781229
IST-Mes1,54613361,2.804102088673467
MM1.S,3634881,3.159855284524507
TE 617.T,9903786,3.301651498076641
OE21,3503,1.8943716488769395
BT 330,73707398,1.1643905844402598
A4/Fukuda,JQ-1-MK-0752 (1-1 mol-mol),-0.933197038878086
Hs 683,8515,4.507985509607111
NCI-H1092,36462,1.746172568826328
SNU-1033,2945648,1.3952035242940846
NCI-H2110,984333,1.8873693488549352
BT 248,5978,2.367827241369892
KYSE-410,3025986,-0.9572320671493456
ML-1 [Human thyroid carcinoma],selumetinib-PLX-4032 (8-1 mol-mol),-0.2880991888537167
SNU-1214,119607,5.217980812355715
SNU-1272,23725625,5.0585620890398735
MCAS,5278396,3.716598283508606
AN3-CA,carboplatin-etoposide (40-17 mol-mol),3.7641975222911057
PE/CA-PJ34 (clone C12),11234052,4.957821880358116
Aska-SS,4378219,4.576786984257773
AN3-CA,969516,2.05001504854235
A4/Fukuda,4917,1.915641979161103
HEC-151,51039095,3.2248906020910444
SEM,71466445,-0.7002004774951326
PE/CA-PJ34 (clone C12),3136844,4.07403193003179
NCI-H1395,36462,4.192459813965937
SET-2,11427553,1.302198083186921
TE 617.T,613000,3.3643329298161935
NCI-H1092,24748573,1.407040997377024
EJM,UNC0638-navitoclax (1-1 mol-mol),1.2280431327330104
HEC-151,1641662,2.6005557069979703
TE-15,65064,3.5266887119836428
TE 617.T,15547703,3.0129955014018237
HSC-4,49850262,4.158516161733518
BT 330,9444,5.3130523291210014
TE-15,5281321,-1.7873256923649707
BT 139,11222830,1.7868119636115656
BT 328,25105715,3.784465780287459
TE-15,9907093,4.113523246440704
BT 330,25105715,3.681400132695821
AN3-CA,2874250,4.8162154482444715
HARA [Human squamous cell lung carcinoma],409805,4.942295126142001
HCC2218,5287969,-1.5340225232782678
ML-1 [Human thyroid carcinoma],carboplatin-etoposide (40-17 mol-mol),0.3624432437862623
Kasumi-2,selumetinib-tretinoin (2-1 mol-mol),7.516580529144076
AU565,54765302,2.5229399839825604
KMS-20,navitoclax-piperlongumine (1-1 mol-mol),0.7499609373098739
HARA [Human squamous cell lung carcinoma],selumetinib-vorinostat (8-1 mol-mol),4.369788913914824
KMS-27,24772860,-3.008057341051857
MM1.S,BRD-A02303741-navitoclax (2-1 mol-mol),2.21025426960287
LNCaP clone FGC,44607531,1.5778977096761553
SNU-308,5311,2.317161878139482
KMRC-2,navitoclax-sorafenib (1-1 mol-mol),2.1673044240978374
SW1990,2729026,3.047903080615765
D283 Med,selumetinib-navitoclax (8-1 mol-mol),1.217940754144839
LNCaP clone FGC,55283,3.3025309781827565
SET-2,9952709,2.441958952741518
Ku812,24785538,1.196998208063896
SET-2,carboplatin-UNC0638 (2-1 mol-mol),3.459451992795011
KMBC-2,11167602,2.9141077523233587
SKM-1,53232,2.0648261510736576
NCI-H2110,16722836,2.5325989448324493
Hs 683,135928012,3.6982239425483887
NCI-H1092,135421197,1.379439810077043
KMS-27,6623618,2.322817398104662
HSC-4,24797083,0.9836127584085878
NU-DHL-1,25154868,3.3783021431332085
HMCB,241158,3.538321708116031
NCI-H2081,135875424,3.067653141346589
Hs 683,24951314,1.6027905117261754
SKM-1,16725315,3.1863557694530495
Raji,10410894,0.2321339045385242
AU565,168312962,1.8906319972872971
MCAS,11507802,1.640527744084139
KYSE-410,135423438,1.615361831673466
SET-2,5426,5.550203665060653
RERF-LC-Ad2,5278396,3.853839058521952
ML-1 [Human thyroid carcinoma],12001922,2.2640831281012916
OE21,44491742,3.708692446594154
HEC-151,57519531,2.365873229813937
NCI-H2110,49793307,-2.5859284275056114
NCI-N87,vorinostat-navitoclax (4-1 mol-mol),0.7685195358482984
YKG-1,UNC0638-navitoclax (1-1 mol-mol),2.987622235126213
HARA [Human squamous cell lung carcinoma],613000,1.7145271439199108
HSC-4,176870,2.813832788377266
RPMI-7951,2126,3.125954532463681
HARA [Human squamous cell lung carcinoma],4259181,-0.0825087225465529
ML-1 [Human thyroid carcinoma],374536,-3.4857090018028956
LoVo,3038522,4.270533501697307
AN3-CA,40482356,5.1223591742849415
SET-2,64971,2.616449956920726
Hep-G2,89928392,3.967748323767258
ML-1 [Human thyroid carcinoma],54639126,4.430736107428324
KMS-20,BRD9876-MK-1775 (4-1 mol-mol),0.4683519431894999
A4/Fukuda,44491742,3.3943913096556444
Ku812,71466578,3.661514598735973
TE-15,5278396,2.640029564459249
NCI-H2081,135398738,4.309612048348404
ML-1 [Human thyroid carcinoma],9927531,5.643924198323062
LNCaP clone FGC,4578,3.885552721973244
AN3-CA,alisertib-navitoclax (2-1 mol-mol),-1.3737982896338972
HARA [Human squamous cell lung carcinoma],9903786,2.5216559880194263
SNU-1214,4259181,-2.0986949595329527
SNU-1214,11364421,-4.764362919019471
TE 617.T,11178236,-8.147664069324303
RERF-LC-Ad2,11494412,5.090684169686155
A4/Fukuda,5746,-1.1009867615741116
SEM,16736978,3.717756753629991
KYSE-410,107985,-2.92528025460227
SNU-8,2749,2.2827839907899645
YKG-1,3081361,3.493822674928686
SET-2,46843906,0.6075290988488133
Kasumi-2,135398738,1.5778578151552838
Hs 683,51037431,4.463172397129538
PaTu 8988s,16013152,4.180001717808194
AN3-CA,676352,1.6503096620706976
Kasumi-2,9884685,-1.7492969798518767
HEC-151,135440466,2.8083122233217335
Kasumi-2,7326481,4.035955767547482
SNU-1214,9911830,2.476886366604881
KMS-27,15953870,3.4686718283353453
SKM-1,24772860,-3.5610280198331705
LoVo,9908783,4.437010992006648
IST-Mes1,44202524,3.78616908386864
NCI-H1092,5460769,5.922318384562557
SNU-8,3062316,0.6780444328053429
SET-2,9887053,1.5615374832251925
SNU-1214,3503,2.330033043654758
RERF-LC-Ad2,11178236,-2.8552723706215812
SKM-1,doxorubicin-navitoclax (2-1 mol-mol),-1.9778957551235763
PaTu 8988s,3465537,1.2834975763885186
NCI-H1092,51037431,6.3894384839452725
HMCB,4788,5.563501322279771
Raji,36314,1.622497847644069
NCI-H2172,6852167,4.795805811514927
LoVo,52947716,-5.666189039665748
HARA [Human squamous cell lung carcinoma],16038120,0.7093520184689783
KMBC-2,71466445,4.930861718344141
NU-DHL-1,107985,-5.852649208769622
SW1990,44589607,3.43879529956881
ML-1 [Human thyroid carcinoma],56973724,3.438642865372283
CML-T1,24964624,2.008023563128915
KMS-20,387447,-4.754784447636382
AN3-CA,53392493,1.9117238552893072
TE 617.T,156422,3.304932757225741
PaTu 8988s,11455910,0.872430488696118
SNU-308,11364421,1.487320429758004
SET-2,2949965,1.3064818811189056
HSC-4,11485656,2.41592786996926
IST-Mes1,135440466,1.140650487435685
RERF-LC-Ad2,45279963,4.603927979704453
KMRC-2,5566,3.121461088888439
Ku812,9823820,0.8448235439574285
Aska-SS,216345,4.469243610618642
BT 330,702558,5.305426703437462
NCI-H2081,5743,3.6602518190396616
SNU-1033,44566777,1.4560071944280613
TE 617.T,151289,0.8146404071058262
SNU-1033,6918638,0.9929294920003592
HARA [Human squamous cell lung carcinoma],241158,4.240217877475157
CA46,56973724,2.349278499068081
Hep-G2,60700,1.3225339846103372
KMBC-2,9967941,1.9178199848644633
HSC-4,16741245,1.7716610997683242
BT 328,10184653,3.731010322665131
LNCaP clone FGC,49793307,-4.8595948386046155
NU-DHL-1,11213558,3.5998210227089036
SEM,24772860,-3.2932991831821767
KMS-20,11396600,3.251276500206743
PaTu 8988s,24775005,3.785412045398248
SKM-1,24797083,0.9734913560698324
HEC-151,2733526,3.519855754703022
KMS-27,selumetinib-UNC0638 (4-1 mol-mol),0.3361487415212352
SW1990,135398516,1.7693870648731356
BT 328,16065773,3.5166527038097906
BT 328,10427712,5.978304580808892
NU-DHL-1,5282054,2.5574961270689887
SNU-308,5460769,2.0996672061045976
PaTu 8988s,navitoclax-gemcitabine (1-1 mol-mol),-0.1588864518233156
Raji,10074640,2.867480106909446
PE/CA-PJ34 (clone C12),56949517,4.317826888670926
KYSE-410,984333,2.6992528768199313
OE21,6438330,2.9063571168826834
KMS-27,969516,1.8240446034664448
BT 248,11364421,0.4256883677591794
Raji,6918736,-3.4853704580797618
SET-2,5738263,3.0276812186300153
D283 Med,66577038,3.783588364889245
KMS-20,400769,-2.039979438204604
LoVo,23635314,-2.3980395881052723
RERF-LC-Ad2,selumetinib-PLX-4032 (8-1 mol-mol),3.375421683976003
KMS-27,71466445,4.755423613019404
SNU-8,9887053,4.177655211283038
AN3-CA,400769,-1.610122578962545
AU565,227681,3.7153411694983887
YKG-1,6918328,0.8877093194372333
BT 328,7251185,2.5751215328420676
Ku812,3689413,-1.935767376067546
GOS-3,11485656,3.367022375162814
Hep-G2,15547703,3.001617990319869
BT 328,387447,-3.18043057197166
AU565,2126,4.335330080531479
BT 330,123631,2.474720312975102
HSC-4,2708,2.9878251305615477
BT 248,6184667,2.4270302543682307
SNU-1214,42642645,1.0103419328558412
BT 320,11455910,4.86644863423661
EJM,16722836,1.936156340232378
CA46,135421197,1.13174100448049
SKM-1,6505803,-1.0817481083509812
OE21,selumetinib-PLX-4032 (8-1 mol-mol),2.235556808561001
CML-T1,67156097,-2.1928175380469477
KMS-20,4915,4.238712853992716
ML-1 [Human thyroid carcinoma],3815108,2.9979183689426723
CA46,navitoclax-gemcitabine (1-1 mol-mol),-1.1536671772218576
TE 617.T,24771867,4.245459071859496
SEM,navitoclax-PLX-4032 (1-1 mol-mol),-1.6228685659579063
HMCB,5470400,-3.7060636680278
TE-15,selumetinib-piperlongumine (8-1 mol-mol),3.655752274712541
HCC2218,9907093,4.588586152552087
RERF-LC-Ad2,11364421,2.718069260317397
NCI-H2172,6917907,1.1991748078755609
EJM,6918328,-1.265460040313133
AN3-CA,tanespimycin-bortezomib (250-1 mol-mol),-2.8889708448552196
Kasumi-2,11427553,1.2029720763459597
KYSE-410,1750826,-0.9328245850421172
KMBC-2,23582824,0.4991820200879616
NCI-H1092,6852167,4.811360661328789
KMS-27,49836020,5.305149991763679
MCAS,selumetinib-piperlongumine (8-1 mol-mol),0.763712530106266
Kasumi-2,5287969,-1.8638241340536708
SNU-308,387447,-4.108149171712701
KMS-20,selumetinib-MK-2206 (8-1 mol-mol),-0.1303266651447604
Raji,16736978,1.1642856059975797
Ku812,675434,3.5526828376641952
D283 Med,445091,3.8628212220629825
KMRC-2,9866186,4.373631240679055
BT 330,6918837,-1.1383844113587298
MM1.S,44632017,1.7374394851414656
HCC2218,753704,5.019549906399212
SET-2,BRD-K55473186,3.87067567297909
Hs 683,44486219,4.222974779104732
SKM-1,24785538,-1.0651885035802942
TE-15,6450551,2.7867234571621804
BT 330,135398516,1.8910897394720865
RERF-LC-Ad2,2749,2.8556039448512314
HEC-151,16725315,3.2456111016993585
CA46,374536,0.6029387131655304
KYSE-410,navitoclax-pluripotin (1-1 mol-mol),-0.8981907830687923
Hs 683,9887053,4.217541093528145
NU-DHL-1,crizotinib-PLX-4032 (2-1 mol-mol),1.8134352324623328
TE-15,10127622,7.615181314545947
Kasumi-2,2729026,2.278256361901275
TE-15,sirolimus-bortezomib (250-1 mol-mol),0.9127775689721958
HCC2218,5738263,2.5233825878614193
A4/Fukuda,9967941,2.4411204768161983
Kasumi-2,5470400,-0.4099593110944021
YKG-1,navitoclax-piperlongumine (1-1 mol-mol),3.397056870192574
KYSE-410,387447,-4.701677943314103
SEM,11228183,-2.6667255532270957
NCI-H1395,9927531,4.9557176619227015
NCI-H2081,16736978,1.7422337137610255
ML-1 [Human thyroid carcinoma],654092,0.5372247724983673
PE/CA-PJ34 (clone C12),11364421,-5.934192321219949
Ku812,124202324,0.8874162884237986
PE/CA-PJ34 (clone C12),44137675,3.7024298491160095
OE21,5284616,-5.631337139904208
RPMI-7951,24785538,2.5562188747130645
SNU-1214,5470400,0.3959808250570928
LNCaP clone FGC,9823820,2.7609881030084087
BT 328,9911463,3.726223215474182
HSC-4,6918289,2.856015155241233
NU-DHL-1,9967941,3.65346263984122
SW1990,15953870,4.463395728130823
AU565,5278396,3.257778157431963
KMS-27,24748573,1.0763276764001952
CML-T1,25126798,3.796147395391691
HARA [Human squamous cell lung carcinoma],151289,0.6137813450564443
MCAS,11625818,5.762210953784525
D283 Med,carboplatin-etoposide (40-17 mol-mol),0.662788733652507
BT 320,9887053,4.397401387197895
SNU-1214,11234052,4.291999723646573
SET-2,445091,4.080599416481313
GOS-3,selumetinib-vorinostat (8-1 mol-mol),4.505292657728925
RERF-LC-Ad1,3689413,-1.7788688033713365
ML-1 [Human thyroid carcinoma],9866186,0.3108629746931657
HARA [Human squamous cell lung carcinoma],15983966,-4.087930187377121
EJM,322968,2.5237519299290687
BT 330,24180125,2.435960640097673
KMS-27,126941,-3.059494952153393
KMS-27,sirolimus-bortezomib (250-1 mol-mol),0.0328786954835015
SNU-1272,5280436,4.574353860374468
HARA [Human squamous cell lung carcinoma],36462,1.692464431977034
AN3-CA,10385095,0.1159584530929505
AU565,71729975,2.800801196457704
Kasumi-2,9933475,1.7570111474767809
Hs 683,148198,-3.2312790086257057
OE21,selumetinib-BRD-A02303741 (4-1 mol-mol),1.5962384018267015
ML-1 [Human thyroid carcinoma],erlotinib-PLX-4032 (2-1 mol-mol),2.7869393467132344
Aska-SS,67291369,3.382785717613604
HSC-4,135421197,2.1482643592466495
SNU-1033,72193861,3.2223717057340493
AN3-CA,16720766,0.5918360933191997
NCI-H1395,vorinostat-carboplatin (1-1 mol-mol),4.5909845476881905
A4/Fukuda,crizotinib-PLX-4032 (2-1 mol-mol),-0.0418615820710858
Ku812,16720766,-0.9300961810556406
Kasumi-2,selumetinib-JQ-1 (4-1 mol-mol),-0.370012591860846
EJM,carboplatin-UNC0638 (2-1 mol-mol),3.206648557272409
LNCaP clone FGC,135440466,3.277240111201423
PaTu 8988s,31703,-0.3659547951330301
NU-DHL-1,148124,-5.1269699362990195
SW1990,11404337,0.292005149466272
AU565,53392493,1.7262495119460306
NCI-N87,262093,3.0008468279122607
HEC-151,5287620,-2.44893597251525
LoVo,11404337,-0.8407014552816361
RERF-LC-Ad2,25195348,1.2152722372109874
SNU-1033,JQ-1-carboplatin (1-1 mol-mol),1.515968870431384
SKM-1,selumetinib-tretinoin (2-1 mol-mol),-3.0324303149575904
Ku812,44632017,0.624416259441737
NCI-N87,16115403,-3.919428944380448
ML-1 [Human thyroid carcinoma],4917,3.4875612389510184
D283 Med,6852167,1.541783481002512
NCI-H1395,11396600,4.124168749082167
AU565,54618771,1.1954147839624212
PaTu 8988s,25195348,4.4301827617344
KMS-20,44202524,1.4561593053704711
EJM,72199292,1.3006755250597923
Kasumi-2,11640390,2.994278179386077
MCAS,11396600,3.718076439368648
HCC2218,11238147,2.0840075714063833
MCAS,3815108,2.6795391503759607
MM1.S,selumetinib-vorinostat (8-1 mol-mol),1.8050138059594567
LNCaP clone FGC,selumetinib-PLX-4032 (8-1 mol-mol),4.8180087843942045
IST-Mes1,6918878,2.524010054300984
SNU-8,71680916,3.8189095341297703
LoVo,135421197,2.0078610802467307
SNU-8,11612883,2.730749090245882
EJM,71466578,1.4924180595408962
HARA [Human squamous cell lung carcinoma],carboplatin-etoposide (40-17 mol-mol),3.125998778003278
SNU-1214,387447,-4.544627243417016
SW1990,16722836,2.0467561159840058
NCI-H1395,17755052,2.034281994914555
BT 328,11167602,4.034112762840579
CA46,984333,-2.431082434536014
RERF-LC-Ad1,54649381,3.845102321657733
RERF-LC-Ad2,4788,6.022465947744937
Hs 683,9866186,1.1103968225648688
A4/Fukuda,11152667,-2.4230854517211977
A4/Fukuda,4259181,-0.5702867723998835
SW1990,24753719,4.9557561363455624
TE 617.T,6252,-1.5755479268254928
SNU-1272,10322450,4.07877256776116
Hs 683,25262965,-2.449137301356105
YKG-1,tanespimycin-bortezomib (250-1 mol-mol),0.0684440375972302
HCC2218,11485656,1.6045404853234653
EJM,107970,2.184437882167209
Raji,54613361,-0.2783635116202357
HMCB,5978,-3.0634075828231757
RPMI-7951,49793307,-2.8906561335679473
NU-DHL-1,10127622,1.0560175006999375
BT 139,123631,1.829633498163757
KMRC-2,11152667,0.1110471147886436
NCI-H1395,5738263,4.098342920501159
AN3-CA,54143018,1.288994178377089
CML-T1,36462,-1.7431711247812498
LNCaP clone FGC,148124,-8.012505540487231
YKG-1,SNX-2112-bortezomib (250-1 mol-mol),-1.7572291199138872
HARA [Human squamous cell lung carcinoma],9826308,0.352829852370258
BT 139,176870,5.347456474975529
TE 617.T,44607530,-0.1464450418354875
HSC-4,387447,-4.060952426407354
HSC-4,57519531,1.2769425534379089
CA46,44607531,1.0933116261411373
SNU-1272,49850262,4.293787638544132
Raji,51039095,3.3155695679488355
SNU-1214,9866186,1.23539407217274
SNU-8,selumetinib-piperlongumine (8-1 mol-mol),1.802133871907447
CA46,54618164,3.845436645537388
SNU-8,53232,3.6338789299334513
RPMI-7951,3025986,-2.5294219808590888
SEM,5329102,-2.9466084154190124
Hs 683,52912189,4.080493710637406
Ku812,375860,-0.7042833930454624
BT 139,tanespimycin-gemcitabine (1-1 mol-mol),-3.724124078532147
HMCB,11955716,-0.0705026992658857
PE/CA-PJ34 (clone C12),15983966,4.022628798760432
NCI-N87,navitoclax-MST-312 (1-1 mol-mol),0.8705289738440536
A4/Fukuda,9903786,0.7546004224414102
KMBC-2,6918837,-1.8660869153498012
SW1990,135875424,4.251787213143329
HCC2218,3543504,0.7583357638948873
KMBC-2,15547703,2.177108839879538
HMCB,5282054,2.5555962503374254
MCAS,10231331,-0.2141548705956653
KMBC-2,24797083,1.4085550881351874
KMS-27,17755052,2.27081295525487
MCAS,3384730,1.4801567541736018
RPMI-7951,44489675,3.6085251470230224
EJM,11640390,1.8430526894462032
Kasumi-2,11257553,-0.3952076481824682
HARA [Human squamous cell lung carcinoma],docetaxel-tanespimycin (2-1 mol-mol),-6.628155731353656
Kasumi-2,135421197,0.8154486687594628
SET-2,24889392,4.339903723354472
KMBC-2,135411,-0.2962045954833053
SNU-1033,2742550,3.4354448610207555
EJM,216345,3.6507207430679616
YKG-1,448949,3.5998670928110745
KMBC-2,24775005,3.300529462732179
KMS-20,10231331,-0.0376220922185321
HARA [Human squamous cell lung carcinoma],452548,-0.3270885928487969
HARA [Human squamous cell lung carcinoma],sirolimus-bortezomib (250-1 mol-mol),1.6380791342220933
AU565,51039095,3.3315580468624795
LoVo,11609586,1.9215259939554383
TE 617.T,16219061,2.878352247115407
EJM,49766530,-0.6352274600767028
TE 617.T,25195348,2.9786244092709704
NU-DHL-1,104842,-6.390742979780276
HSC-4,tanespimycin-bortezomib (250-1 mol-mol),0.4907221930959023
HMCB,9903786,3.962700823971229
Hs 683,SNX-2112-bortezomib (250-1 mol-mol),-2.0866722674927876
EJM,44137675,3.342808530148661
NCI-H1395,45279963,4.172255756410215
BT 139,25154868,4.942516527102922
BT 330,5470400,0.2607731475044393
NCI-H2110,1474550,4.464144178106605
PE/CA-PJ34 (clone C12),10113978,3.852320224098887
CA46,3465537,3.345448990020783
MM1.S,25062766,2.021817164392542
ML-1 [Human thyroid carcinoma],11640390,3.608850000621235
KMS-20,25062766,1.6197159272669466
D283 Med,4521392,4.070852610455029
RERF-LC-Ad1,24889392,4.514749379565269
MM1.S,11427553,1.612283358238567
MCAS,439501,-1.7764971276715424
AU565,49836020,5.742264990221176
ML-1 [Human thyroid carcinoma],4477,0.6808915512553289
CML-T1,2749,0.3257235213594381
PE/CA-PJ34 (clone C12),135421197,2.056271924404355
OE21,54596558,5.583192649858686
SNU-1214,322968,3.163367067092735
Kasumi-2,JQ-1-MK-0752 (1-1 mol-mol),-0.4470190343146605
MM1.S,9911830,2.728285435741644
RPMI-7951,9866186,1.0352873659033723
PE/CA-PJ34 (clone C12),9840324,5.6753199284891505
PE/CA-PJ34 (clone C12),24785538,-0.2008088807094913
Ku812,156414,-0.0936884682974776
MM1.S,3038522,4.409032122825541
SET-2,erlotinib-PLX-4032 (2-1 mol-mol),2.8695240779606936
OE21,12003241,-2.4283256435660205
KMRC-2,selumetinib-tretinoin (2-1 mol-mol),4.708089069928908
KYSE-410,navitoclax-sorafenib (1-1 mol-mol),1.8928817442562549
PE/CA-PJ34 (clone C12),11640390,3.424218782856885
IST-Mes1,327653,2.848745693869025
KMS-20,navitoclax-pluripotin (1-1 mol-mol),-1.7464713167457526
PE/CA-PJ34 (clone C12),5978,-4.144154525901269
ML-1 [Human thyroid carcinoma],426756,5.157831333984941
SNU-1272,selumetinib-vorinostat (8-1 mol-mol),4.048227486527485
SNU-1214,3025944,3.789459190734729
Ku812,1641662,2.247994905759536
BT 248,carboplatin-UNC0638 (2-1 mol-mol),3.451491217767034
SET-2,5287969,-2.330112107554474
LNCaP clone FGC,9866186,1.1737969172744749
PaTu 8988s,135440466,1.1893530670174288
Raji,676352,2.12389585593329
Kasumi-2,6852167,0.8229890671000598
BT 330,11494412,3.1533604427813833
SW1990,9956119,4.049991809961811
Kasumi-2,45279963,3.7710739544623233
Kasumi-2,5287620,-1.535744105024607
ML-1 [Human thyroid carcinoma],11647372,1.3935699525801049
KMS-27,322968,2.986092739223029
SNU-1214,navitoclax-PLX-4032 (1-1 mol-mol),1.923242739192103
HCC2218,10385095,0.9355515453003532
SW1990,11656518,2.0447972596662
AN3-CA,9936388,-6.467722299824651
Raji,44543605,4.342270551881589
Hs 683,66577038,2.871437721836891
KMS-20,9825149,0.2596001529902395
CA46,decitabine-carboplatin (1-1 mol-mol),2.864981631125043
HARA [Human squamous cell lung carcinoma],44491742,4.175098575791361
Raji,11640390,3.644744225679567
BT 320,11640390,5.348028911341183
BT 330,72967,3.756952070615194
Raji,3854666,1.2627673053798778
NU-DHL-1,5311281,1.858827223103547
HARA [Human squamous cell lung carcinoma],vorinostat-carboplatin (1-1 mol-mol),4.151404263307493
BT 330,navitoclax-MST-312 (1-1 mol-mol),0.9583669176517168
HEC-151,7326481,2.637733193864536
GOS-3,2113511,5.9542710024554
NCI-H2081,9826308,-1.325713373036652
LNCaP clone FGC,72193861,0.7655554184680992
NCI-H2081,decitabine-carboplatin (1-1 mol-mol),5.393040193886032
TE-15,9935249,2.05768814929574
HSC-4,9907093,5.592562690426939
BT 330,6610216,4.420410954018115
SNU-1272,3025986,2.0429499224913927
MM1.S,3815108,1.971538783457294
SEM,3025986,-1.9982195321080336
NCI-H1092,16659841,4.30883248177806
RERF-LC-Ad1,65064,3.2062738089199176
SNU-1214,52947716,-4.751256114565385
ML-1 [Human thyroid carcinoma],44589607,3.064794245292079
SNU-308,54618771,1.0411941789938453
KMS-20,3676137,4.822799342742389
BT 139,54649381,3.76760719227815
KMBC-2,salermide-PLX-4032 (12-1 mol-mol),4.16483239560193
Hs 683,54618771,0.8006472003548896
SW1990,25262965,-2.702241544349275
AU565,5494449,3.8187307918252262
RERF-LC-Ad2,72376,-1.9609852844396736
KMS-20,5287969,-1.7447232595261333
HARA [Human squamous cell lung carcinoma],25195348,4.01900560130828
NCI-H2081,11964036,1.4263107800421957
KYSE-410,15547703,3.736490147642331
BT 320,5494449,4.096191424375148
RERF-LC-Ad2,46199207,3.5588718766495564
TE-15,4705,1.329912019407035
OE21,11214940,4.133615389454758
BT 248,12003241,-0.5635987052840526
AU565,9908783,4.7252597511686965
D283 Med,2828334,5.77841146939239
Ku812,selumetinib-MK-2206 (8-1 mol-mol),-1.6716664417855296
TE 617.T,984333,-0.2626607268984583
OE21,5287969,-2.513381714637816
Hs 683,104842,-1.7592192025796949
Kasumi-2,6610216,3.59110037414398
HEC-151,10322450,3.547902209799766
TE 617.T,24901704,3.3231457770531736
PE/CA-PJ34 (clone C12),19582717,5.2106352925132375
Hep-G2,10302451,3.0105378640601037
A4/Fukuda,19582717,0.7629696429231957
TE-15,9444,4.167765632206863
SNU-1033,24964624,2.601972187646178
KMBC-2,2746,3.623005517857566
RERF-LC-Ad2,613753,3.2848773144154384
Raji,72376,-4.086139502727304
Hep-G2,9926054,1.3870503906392218
NCI-H2110,11507802,3.0556812906398862
SKM-1,selumetinib-vorinostat (8-1 mol-mol),-1.297292884672553
CML-T1,568763,0.104759642693247
SNU-8,135398516,0.7053023430063577
KMBC-2,9840324,5.999315503440774
Hs 683,25195348,3.8192568466949024
Hep-G2,sirolimus-bortezomib (250-1 mol-mol),1.7771755554565365
BT 330,49766530,-1.7517349908544686
Kasumi-2,25105715,3.2709711323954536
BT 330,54596558,4.033632071999387
HEC-151,4261,1.908115663505495
CML-T1,72376,-3.431780344099396
SEM,53495165,-1.8232376140676845
PaTu 8988s,400769,-0.9091228865005044
GOS-3,44241473,4.447421169667303
KMS-20,156414,1.093109837922788
SNU-8,24772860,-2.786404079111214
HARA [Human squamous cell lung carcinoma],11427553,0.5044011516017802
HEC-151,16741245,2.6065582573051893
Hep-G2,168312962,-0.8172908968582097
KMS-20,3503,1.0882007303901744
Hs 683,navitoclax-piperlongumine (1-1 mol-mol),2.5400999036687617
KMS-27,73707398,0.1300509584750546
BT 248,613753,3.1927723368663976
AU565,46174525,5.4998307146624255
PaTu 8988s,5566,3.001668312879565
Ku812,6623618,1.7016648351323582
SNU-1214,54618771,-0.4857643216446591
HEC-151,135421197,1.9024476201303135
KMS-20,5978,-3.862125436085328
SNU-308,168313016,4.41321855315878
LoVo,44202524,1.5416570481285088
NCI-H1395,44607531,1.6381567273877196
SEM,decitabine-navitoclax (2-1 mol-mol),-3.4991748591618026
SKM-1,984333,0.5121971220732339
MCAS,168313047,1.9184235102562857
Ku812,15983966,-4.686318445484671
SW1990,24797083,1.929762568379247
SEM,11609586,1.7151177095712813
KYSE-410,23582824,0.2536678029172985
RPMI-7951,400769,-0.4881987174819877
MM1.S,168312962,-0.6288845561945676
KMS-27,71304818,1.7393876180441603
BT 330,241158,3.9809433714442166
EJM,462382,0.2605249998779805
RPMI-7951,11656518,3.155761627261377
Hs 683,462382,0.4916010012762787
HSC-4,2742550,4.46855499399167
OE21,11396600,3.3249407167750284
RERF-LC-Ad1,5746,2.3313775446459326
TE 617.T,2949965,2.1108985425245796
NCI-H1395,676352,2.20823720680155
A4/Fukuda,462382,-0.2406989279082468
NCI-H2172,6918878,5.33332551521151
NCI-H1092,67156097,2.7476633426389863
KMS-20,docetaxel-tanespimycin (2-1 mol-mol),-5.71277411020647
RPMI-7951,25062766,1.4776301133262697
SW1990,alisertib-navitoclax (2-1 mol-mol),1.968721211872207
RPMI-7951,6623618,1.951581302772224
TE 617.T,53392493,1.8253386460043184
HARA [Human squamous cell lung carcinoma],25126798,3.0348047735223935
BT 139,JQ-1-navitoclax (2-1 mol-mol),0.5774680712043125
NCI-H2081,374536,1.9264579533537656
KMS-27,5470400,0.9858362981297084
LoVo,65628,4.171555925906434
PE/CA-PJ34 (clone C12),135398516,2.5107066469062738
HEC-151,11964036,2.8276517069986027
HCC2218,10127622,4.243973317573093
HEC-151,73707371,4.4632705727221245
RPMI-7951,10127622,4.472394456540677
MCAS,24797083,1.7533121756428505
KMS-20,24779724,4.331285550613222
BT 139,2945648,2.7036265554332095
SNU-8,9866186,3.3154856187317643
RPMI-7951,159324,3.4055874402556725
AU565,doxorubicin-navitoclax (2-1 mol-mol),-1.8766069789082105
D283 Med,100016,3.728925578699804
BT 248,135398516,2.090653291947233
SET-2,25154868,3.772116503437056
GOS-3,46215462,1.654053851935072
BT 139,3543504,5.470750216796982
KMS-27,637858,1.2889744461011985
SET-2,navitoclax-PLX-4032 (1-1 mol-mol),-0.4800202266033647
SNU-8,JQ-1-UNC0638 (2-1 mol-mol),0.8314654213146081
D283 Med,BRD-A02303741-navitoclax (2-1 mol-mol),4.100647340597535
AN3-CA,16659841,1.6671523013965392
Hs 683,208908,1.8258770070851449
LNCaP clone FGC,11396600,3.414051330907707
NU-DHL-1,72199292,-0.8745527817020163
KMBC-2,6610216,4.214797525140246
NU-DHL-1,24771867,-3.1166811668070844
KMRC-2,16659841,2.6813951842594057
RERF-LC-Ad1,72376,-0.2773768081931954
EJM,3503,2.0967076650635543
Kasumi-2,navitoclax-MST-312 (1-1 mol-mol),-2.959240355083437
TE-15,vorinostat-carboplatin (1-1 mol-mol),3.032439168473077
AU565,24821094,-3.121521346886189
HMCB,5311,2.1964407346203627
GOS-3,salermide-PLX-4032 (12-1 mol-mol),5.528835129082399
NCI-N87,5479543,3.770784511292927
A4/Fukuda,5113032,4.450145517718883
NCI-N87,10302451,0.4744399528749561
KMBC-2,57519531,3.989886284892741
HMCB,107985,-2.41132307847832
Aska-SS,6918736,-2.1239055092676615
RERF-LC-Ad2,25102847,2.973897211120729
MCAS,53495165,-0.3458300431996322
SNU-1214,5282054,3.5501375835129756
Ku812,11427553,-0.0025143076889682
D283 Med,219104,2.423967848276844
SKM-1,322968,1.2808637064656738
HARA [Human squamous cell lung carcinoma],16115403,-4.2638303939611335
CML-T1,selumetinib-UNC0638 (4-1 mol-mol),2.45517668205048
SNU-1033,24856436,0.766095970885635
OE21,6610355,3.409175590102683
LNCaP clone FGC,445091,4.232041657449121
D283 Med,613753,3.0929826878056135
BT 139,4261,3.718644080720644
Kasumi-2,9803433,4.641295101837652
SET-2,2842253,3.6780344164215406
NCI-N87,168313047,2.984513904409232
NCI-N87,676352,1.7095816234371617
BT 139,10410894,2.5885383837649765
HMCB,3025944,4.29007552344394
NCI-H2081,44202524,1.210790184755557
LoVo,6918736,-4.296362304597629
SEM,2729026,1.911580026509944
BT 320,4917,2.82304614910839
Hs 683,136227924,2.524769704566026
CML-T1,168313016,4.15358640853123
KMS-27,3038522,3.4686403819900007
Hep-G2,2746,2.5421699123058383
KMRC-2,46215462,1.5871375052382457
HSC-4,5738263,3.918173826320675
MM1.S,135875424,3.0538620465615587
Ku812,67291369,1.446502731333229
SEM,54619267,2.973964414484695
KMS-20,serdemetan-SCH-529074 (1-1 mol-mol),1.5449813132699757
YKG-1,10184653,2.523602968950428
SNU-8,JQ-1-navitoclax (2-1 mol-mol),1.3845326513040788
BT 328,4788,5.982911703327575
SET-2,56649450,3.1911301169821367
HCC2218,1566236,1.7509931914659491
AN3-CA,6917907,-5.7065684857519186
KMBC-2,5311,1.615987624610291
TE-15,54618771,1.8265153099983404
RERF-LC-Ad2,285033,-1.387708870392153
NCI-H2081,148124,-3.831662126446776
CA46,327653,2.398308016277815
HEC-151,2858523,3.091480344450217
D283 Med,11152667,-1.23900039901842
Kasumi-2,135398744,8.02054113805855
AU565,44185566,1.721131526136141
HARA [Human squamous cell lung carcinoma],675434,4.319126364052166
PaTu 8988s,445091,4.284103172399486
Kasumi-2,71751553,4.151047970892257
BT 248,navitoclax-pluripotin (1-1 mol-mol),-1.2956772624371633
CA46,1242560,2.637858421223904
MM1.S,2746,1.322857724988492
SET-2,9911463,3.8788092570896184
AU565,4378219,1.7809295710052302
Aska-SS,36462,2.182690934298482
D283 Med,126941,-4.12717690100812
Hs 683,2949965,2.6175575845695933
NCI-H1395,439501,0.2163751108150007
SNU-1272,60700,2.5786985411143797
SNU-8,46907787,1.495459042873151
KMRC-2,136227924,3.1141635996197183
A4/Fukuda,7251185,1.076285820033946
IST-Mes1,119607,5.839609606963759
TE-15,11455910,-0.076849872958893
LoVo,654092,0.3814222362545946
LNCaP clone FGC,44241473,4.6222925565590085
PE/CA-PJ34 (clone C12),10127622,3.216554947417576
EJM,448949,1.6009250790915848
NCI-H1395,24821094,3.771001667275143
Raji,11214940,1.3092105754624663
SNU-1214,11497983,4.859477926792302
YKG-1,5329102,2.298479401722923
NCI-H2081,5470400,-3.843190665542197
RERF-LC-Ad2,24821094,4.198014955346009
EJM,71680916,4.438801841668279
RERF-LC-Ad2,969516,2.8404089798962646
KMS-27,selumetinib-navitoclax (8-1 mol-mol),-2.014253215631696
RERF-LC-Ad2,selumetinib-vorinostat (8-1 mol-mol),3.1653662861701157
NCI-H2081,salermide-PLX-4032 (12-1 mol-mol),5.178894750925086
LNCaP clone FGC,3854666,0.694335956852511
AN3-CA,135421197,1.808403236431818
SNU-1272,4477,1.2199769171135058
NU-DHL-1,selumetinib-JQ-1 (4-1 mol-mol),-0.9508883032540202
RPMI-7951,sirolimus-bortezomib (250-1 mol-mol),1.5520674857207382
TE 617.T,11427553,1.9207461631378344
BT 248,navitoclax-PLX-4032 (1-1 mol-mol),1.075952259913776
KMS-27,5738263,2.490078653325268
D283 Med,16659841,2.7868909453303337
NCI-H1395,1750826,-3.702055011401398
PaTu 8988s,25161177,3.043873631916992
OE21,46943432,2.2967121363038707
MCAS,66577038,3.1755673384775656
LoVo,24901704,1.9806347162028537
HMCB,753704,4.465795196553446
Hs 683,73707398,1.2895938784946597
NCI-N87,36462,0.3600781388020123
MM1.S,46843906,0.846343121160042
HCC2218,9444,3.687872411544604
CA46,25195348,1.4184238486273535
PE/CA-PJ34 (clone C12),3025944,4.287194818492555
AN3-CA,selumetinib-piperlongumine (8-1 mol-mol),3.440054563675044
YKG-1,107985,-2.4631339535317993
Hep-G2,71304818,2.021799775788192
KYSE-410,12003241,-2.1155115062785805
TE-15,3503,1.2930980496455542
Hs 683,219104,4.201816269396338
BT 248,7251185,2.921625124470224
TE-15,44819697,4.771661570365527
Ku812,72734382,3.515851965175783
KMBC-2,25126798,3.948124515247498
EJM,11656518,1.6048868934870253
Hs 683,3081361,1.8007329789984097
Ku812,decitabine-carboplatin (1-1 mol-mol),0.163228689649063
PaTu 8988s,5738263,3.8037236140642454
HARA [Human squamous cell lung carcinoma],4917,3.022180747101803
MM1.S,2749,2.045600082739513
TE 617.T,9444,4.54046469334786
NCI-H1395,5311281,3.3268012915389047
IST-Mes1,462382,1.0027449292382402
NCI-H2081,156414,1.7676788858922157
Kasumi-2,carboplatin-etoposide (40-17 mol-mol),0.2542153417603036
RPMI-7951,10090485,4.437995283311912
PaTu 8988s,1239801,3.962308527881551
CA46,vorinostat-carboplatin (1-1 mol-mol),1.5433198119850344
MM1.S,tanespimycin-gemcitabine (1-1 mol-mol),-5.682330250440317
BT 330,9868037,3.503197969188101
SW1990,5311281,1.7301970935112505
HEC-151,46224516,3.6184851885623592
NU-DHL-1,doxorubicin-navitoclax (2-1 mol-mol),-3.622223528982808
Kasumi-2,11656518,-0.8040408639715576
NCI-H1092,9935249,2.293612828813301
BT 248,135659046,3.5168747963796636
HSC-4,selumetinib-BRD-A02303741 (4-1 mol-mol),4.233119251645935
CML-T1,9903786,2.526700219209825
BT 328,119607,6.140002337362805
CML-T1,9825149,1.6129799202532635
BT 248,5460769,4.810999932000391
LoVo,262093,2.370412929490009
MCAS,6184667,3.214386090956169
OE21,25102847,2.68958768038217
SNU-8,135875424,4.308406363333984
Aska-SS,10385095,1.4450418871576047
SEM,5978,-6.46174172667932
A4/Fukuda,10410894,1.64506751408979
Kasumi-2,11626560,0.3916500490858549
AN3-CA,25161177,5.097942473778066
D283 Med,2749,1.8420962714891145
SW1990,44489675,3.717324941296481
OE21,387447,-4.65456656277309
Aska-SS,9956119,4.259319664009723
SW1990,25150857,3.0075549163777437
MM1.S,71680916,5.174704169094283
Hs 683,5281672,4.193849409575692
BT 139,25227462,1.6832598975023767
SET-2,23582824,0.7450424862816116
OE21,241158,4.080451555980482
NCI-H1395,16038120,3.027555805242751
TE 617.T,9825149,2.243732271836408
KMRC-2,156414,1.7005569347395115
LoVo,10427712,4.119455144779727
D283 Med,navitoclax-gemcitabine (1-1 mol-mol),-5.0092480687610035
D283 Med,969516,2.332007147829158
BT 330,2742550,3.720607437110895
MM1.S,135398738,3.10215639374587
BT 320,216345,4.58398991647949
OE21,24771867,2.4466208199603185
NCI-H1092,6450551,2.2597381563726433
SEM,5284616,2.3626206201017292
NCI-H2110,7251185,3.3996634094182725
AU565,151289,0.4389765151464501
A4/Fukuda,136227924,1.9204852137512072
LNCaP clone FGC,3136844,3.761028710298216
BT 320,10074640,3.68399538142115
SNU-308,448949,2.712847357418782
NU-DHL-1,11364421,-5.372844831594239
TE 617.T,6918638,0.5415631808582457
TE 617.T,4096211,1.584959611515095
SET-2,15547703,2.979815125731124
PE/CA-PJ34 (clone C12),12003241,-0.6178639171957262
KMS-27,44589607,2.129697097661726
Ku812,26596,-2.18380806647072
Kasumi-2,44632017,0.7335001301015701
LNCaP clone FGC,53232,3.656268546746555
PaTu 8988s,tretinoin-navitoclax (4-1 mol-mol),3.29267564859743
PE/CA-PJ34 (clone C12),5460769,-0.2838566207500756
HSC-4,10296883,4.12801319058873
SW1990,5746,1.3748376932131507
SNU-1214,241158,4.530958895072107
NCI-H1092,387447,-4.501071900555183
HARA [Human squamous cell lung carcinoma],BRD-A02303741-navitoclax (2-1 mol-mol),2.096379077317258
NCI-H2081,5738263,3.7116939105777687
HARA [Human squamous cell lung carcinoma],2749,1.5155233624959286
KMS-20,227681,1.9958834039585385
AN3-CA,6918328,0.7707692490833323
HEC-151,1242560,2.9912281070430815
BT 248,12001922,0.9128950259060647
MM1.S,11396600,2.9620457472616533
SET-2,57519531,1.5815611603941668
KMS-20,6918878,1.3372822623967346
TE 617.T,4788,5.030017330062183
KMBC-2,selumetinib-piperlongumine (8-1 mol-mol),4.480680006962565
NCI-H2110,5311281,2.5750016799213564
HCC2218,227681,1.686522402811817
AU565,23635314,-4.115690790244737
MCAS,452548,-0.1240356114015149
TE-15,31703,-1.9709825874210252
BT 328,salermide-PLX-4032 (12-1 mol-mol),4.7270242729207625
MM1.S,53392493,1.575283610163411
MCAS,54143018,-0.6447535043455573
TE-15,44486219,4.017048995117067
LoVo,11178236,-1.6059359070935737
TE-15,JQ-1-carboplatin (1-1 mol-mol),0.1114942232553469
AU565,3025944,3.700689922668097
HCC2218,135984461,4.242222575016064
Kasumi-2,11497983,-3.4342418883602406
LNCaP clone FGC,2945648,2.8217203916826645
LNCaP clone FGC,409805,5.792724487332009
HCC2218,5978,0.2771464646510415
HARA [Human squamous cell lung carcinoma],5282054,3.837128949835148
LNCaP clone FGC,448949,1.9163701600156855
AU565,carboplatin-etoposide (40-17 mol-mol),1.7469100851636217
SW1990,11640390,3.421819562355846
KMS-20,219104,2.1050805629757483
SW1990,25227462,0.0707797434593802
HARA [Human squamous cell lung carcinoma],10385095,1.0837341672046903
Kasumi-2,11485656,1.64011250363507
SET-2,54143018,0.6103556076462618
AU565,44507138,1.5217719455679517
MCAS,carboplatin-etoposide (40-17 mol-mol),2.123955752813359
SNU-8,46199207,3.4322546698168463
LNCaP clone FGC,2113511,4.114352668379086
RERF-LC-Ad1,24785538,2.8640497838765824
SNU-8,216468,3.852480687275417
EJM,16659841,3.8654950259269056
SEM,53481919,3.689698909946728
EJM,44819697,1.6195788474548276
NCI-H2081,25161177,4.359001869176978
SET-2,56949517,3.925434074551105
CA46,9907093,3.753589195065423
NCI-H2081,2746,1.7876165118995768
KMS-20,2828334,5.046366077488849
SNU-8,71304818,2.561757279775672
Kasumi-2,5311,-0.335738593661984
Hep-G2,25126798,4.0487954098404755
KMS-27,17759555,3.6183556062757263
BT 139,6918837,0.5361437768641526
KMBC-2,123631,1.9610940520550155
CA46,7326481,2.91557869092902
NU-DHL-1,19582717,3.0772227336893505
SNU-1033,7251185,1.3816282372442918
PE/CA-PJ34 (clone C12),25062766,1.9208580751990545
HEC-151,10184653,0.244741697598772
AU565,11485656,2.0156354686346174
HCC2218,24180125,2.93475065656583
LNCaP clone FGC,5281321,-3.3435432641320957
RPMI-7951,135440466,2.2545531481236014
YKG-1,4788,6.355492243434627
SNU-1272,11178236,-2.3936924408182265
TE-15,23582824,0.2191758972845394
NU-DHL-1,11626560,1.4033689860474627
HSC-4,11647372,1.1815136799972823
SNU-1214,4917,2.6474992622286555
SNU-1214,216468,0.5120468457029691
MCAS,docetaxel-tanespimycin (2-1 mol-mol),-7.434901685148422
AN3-CA,3025944,4.226836027530371
Aska-SS,241158,3.805565217473049
HEC-151,6918878,2.1820464530462163
Hs 683,11175137,1.575737295771595
LNCaP clone FGC,9911463,2.657029606210989
HARA [Human squamous cell lung carcinoma],9952709,3.695976506837269
KYSE-410,3689413,0.6720370091874901
KYSE-410,208908,1.6043849793411151
MCAS,16065773,3.0834384026968453
HMCB,71466380,3.936881687634452
SET-2,navitoclax-MST-312 (1-1 mol-mol),-0.8441968581506685
LNCaP clone FGC,241158,3.9934021722066784
TE 617.T,44589607,1.763754723578897
Hs 683,969516,2.6625175796891174
PaTu 8988s,11364421,-4.526893014804376
RERF-LC-Ad2,10296883,4.240676300513298
MCAS,44507138,1.683657005496222
HMCB,salermide-PLX-4032 (12-1 mol-mol),5.107969579791182
Ku812,2841722,3.36819681330492
Aska-SS,16065773,3.860549946793715
KMS-27,168313047,2.6565282166568034
NCI-H1092,4788,4.950756900369662
SNU-1214,44486219,2.005328572002171
RPMI-7951,SNX-2112-bortezomib (250-1 mol-mol),-2.272647558916823
SEM,49846579,-5.376308546778199
Aska-SS,25126798,4.010670771922856
AU565,444795,4.595530435398324
PE/CA-PJ34 (clone C12),44632017,0.8623565218793319
SNU-308,44489675,3.6982483700429816
PaTu 8988s,3543504,5.213357808010328
SNU-1033,sirolimus-bortezomib (250-1 mol-mol),0.349990621506149
PaTu 8988s,23582824,0.5896367967334025
RPMI-7951,11609586,1.9287484592067603
SEM,9927531,4.847523560791686
CML-T1,selumetinib-GDC-0941 (4-1 mol-mol),2.3571897890829323
NCI-H1092,25161177,3.963642294094328
NCI-H2081,26596,-1.5856459484869678
MM1.S,10302451,3.7035556434363808
PaTu 8988s,9884685,3.7069578425529257
Hs 683,53392493,3.1941471527840237
Kasumi-2,11167602,2.198810465874189
Hep-G2,11485656,-0.7210069253709863
BT 320,navitoclax-piperlongumine (1-1 mol-mol),3.22781533773438
MM1.S,11609586,-0.4904496149826149
KMS-27,9887053,2.6639337999908728
KMRC-2,71751553,4.728116551648532
BT 330,doxorubicin-navitoclax (2-1 mol-mol),-2.187349846488524
IST-Mes1,637858,2.1376990366589905
KYSE-410,3465537,2.783776931016741
TE 617.T,2749,1.8684574452896128
AU565,400769,-0.800888344050601
SNU-8,57330099,4.310413018030645
GOS-3,49766530,-1.0492623989714644
A4/Fukuda,71751553,4.0599050322296995
CML-T1,5282054,3.0197566265123754
IST-Mes1,selumetinib-PLX-4032 (8-1 mol-mol),4.413511328522001
NCI-H1395,12001922,2.192187193874862
BT 320,11364421,3.2966905188906717
BT 328,322968,2.861041928630023
KMS-20,11404337,-1.24048912938788
NCI-H2081,selumetinib-vorinostat (8-1 mol-mol),1.9423097889386416
MCAS,9936388,-6.436874065356807
BT 139,46215462,1.8129684234410115
GOS-3,3081361,3.4367790874806015
NCI-H1395,4705,3.4784735381586183
MM1.S,selumetinib-UNC0638 (4-1 mol-mol),1.889294879744257
HMCB,selumetinib-PLX-4032 (8-1 mol-mol),4.020315220819304
Aska-SS,doxorubicin-navitoclax (2-1 mol-mol),-1.3212983963393323
CA46,SNX-2112-bortezomib (250-1 mol-mol),-3.5188600200549507
NCI-N87,8515,4.286102801865053
NU-DHL-1,9884685,-1.1010004281847865
EJM,24772860,-3.292775584200783
PaTu 8988s,126941,-4.289594837447488
NU-DHL-1,54618164,4.2613527063162895
SET-2,11364421,-3.965823711365274
SNU-1033,9933475,1.7587283970069327
RERF-LC-Ad2,135398516,3.70367523902645
NU-DHL-1,5287620,-2.1832991437877056
KMRC-2,9935249,5.014843219573403
Aska-SS,navitoclax-pluripotin (1-1 mol-mol),4.6766362814007385
OE21,56946209,-6.583786952065454
IST-Mes1,5281672,4.409062773089972
HMCB,119607,5.35343199280946
NCI-H2110,vorinostat-carboplatin (1-1 mol-mol),3.477235305894441
SET-2,46199207,3.0903312204608464
CA46,selumetinib-JQ-1 (4-1 mol-mol),0.1147444107016205
RERF-LC-Ad2,16065773,2.896033119143574
NCI-H1395,11427553,4.002864688694153
SET-2,11719255,2.427527144997736
Raji,51037431,3.299758359424842
KMS-20,25227462,-3.9594980981183534
NCI-H2110,17755052,1.961446678639968
AN3-CA,46926350,-5.100633637937967
HCC2218,446155,4.288252010402634
RERF-LC-Ad1,carboplatin-etoposide (40-17 mol-mol),3.9878410003386
SNU-1033,176870,5.499937944877444
PaTu 8988s,JQ-1-carboplatin (1-1 mol-mol),3.780889611052604
NCI-H1092,66577038,3.0171960065263077
SNU-8,148198,-1.3128761791294046
SEM,135659046,3.5193041881341087
NCI-H2110,2945648,3.4982521508878763
LNCaP clone FGC,9884685,-0.2879888364865913
NCI-H1395,16736978,1.0598222504477564
Kasumi-2,6918736,-2.315158162333665
NCI-H2081,2742550,2.443856607923171
CML-T1,452548,-3.528686830959828
SNU-8,1750826,-4.897790030937784
NCI-H1395,387447,-2.916256020115362
NCI-N87,375860,-0.928197184659684
OE21,9549297,2.549848830295622
BT 320,216239,3.754471265318657
SKM-1,72376,-5.080407432720659
YKG-1,11175137,1.824320383587359
SW1990,navitoclax-sorafenib (1-1 mol-mol),2.681169669736164
SEM,9956119,1.5287909021793558
TE 617.T,107970,1.5986795918546095
HARA [Human squamous cell lung carcinoma],tanespimycin-bortezomib (250-1 mol-mol),0.1045864370631683
ML-1 [Human thyroid carcinoma],219104,3.7281299088831386
NU-DHL-1,36314,-4.32042645892424
CML-T1,24951314,-0.110872768404616
LoVo,25195348,3.880726101323461
NCI-H2081,crizotinib-PLX-4032 (2-1 mol-mol),0.7820959087513495
SKM-1,241158,1.623725861036911
SET-2,71466578,1.6940206430792373
NCI-N87,16038120,-0.0105690503285029
PE/CA-PJ34 (clone C12),25161177,5.151345189753289
Hs 683,613000,2.527426456384047
D283 Med,9907093,3.62208828367571
NCI-H2110,46215462,1.6348765239911385
HCC2218,54649381,3.8304752709798464
KMRC-2,15983966,1.552076724290525
KMRC-2,11222830,3.930801271298324
Hs 683,25126798,3.738392490105732
TE 617.T,24748573,2.899256600994788
SET-2,9907093,3.6028257763126144
AN3-CA,25062766,1.4749027306647764
IST-Mes1,53232,2.11135293708232
PE/CA-PJ34 (clone C12),4578,4.231677990703362
AN3-CA,753704,4.635041156511698
SEM,selumetinib-UNC0638 (4-1 mol-mol),3.022170285595094
Aska-SS,selumetinib-GDC-0941 (4-1 mol-mol),-0.3966051454003071
A4/Fukuda,11234052,3.83864189929063
HARA [Human squamous cell lung carcinoma],637858,2.3831379320922728
Kasumi-2,2746,1.0036072682129122
KMBC-2,24748573,2.0825637158480457
AN3-CA,409805,5.126415304640116
SNU-1214,11396600,3.7056462791365847
NCI-H2110,24797083,1.6464918448849135
A4/Fukuda,42642645,-1.373677794386147
NCI-H2081,serdemetan-SCH-529074 (1-1 mol-mol),0.921465468134936
KMBC-2,6610355,5.7367694497488895
CML-T1,6918289,0.3823031541189219
MM1.S,6610355,3.8482790769850017
RPMI-7951,135875424,3.929226739625062
HCC2218,16741245,2.792602257727281
KMBC-2,439501,-3.686477603107828
SW1990,969516,2.8420789096313057
RERF-LC-Ad1,89928392,3.1512603653574653
TE 617.T,5281672,4.03972695843784
EJM,44493528,4.28788220416213
ML-1 [Human thyroid carcinoma],46224516,1.5473988782080883
KMBC-2,676352,2.118156688654481
CML-T1,16722836,0.8135653137043857
Hs 683,selumetinib-JQ-1 (4-1 mol-mol),3.498842094614085
MM1.S,9935249,3.6617301245150498
BT 248,52947716,0.6891318567706715
RERF-LC-Ad1,49793307,-0.0254634862960308
HMCB,11485656,2.0030375268355116
TE 617.T,148198,-5.570836708197065
MM1.S,11175137,1.6497782551400215
NCI-H1395,11404337,2.1973197619817832
RERF-LC-Ad1,46199207,3.6404487316358014
BT 248,2945648,2.911977762170341
NCI-N87,5280436,4.116578666931142
CA46,11404337,-2.4021967063511434
CA46,selumetinib-tretinoin (2-1 mol-mol),4.988677002369049
A4/Fukuda,44632017,0.3391160528514481
LNCaP clone FGC,24753719,4.279348645230378
Aska-SS,9444,4.284255356775216
CML-T1,2729026,1.0181320426336582
SNU-8,71466578,4.470861654123333
KMRC-2,216239,3.7115665542039302
PaTu 8988s,16722836,0.5018089977346094
Hs 683,126941,-2.279190865540304
BT 330,10322450,4.515837789997584
SET-2,2130404,3.5383555094173667
PaTu 8988s,24889392,4.7009950355781065
KYSE-410,54678924,2.767561148050687
KMS-20,51037431,4.06192441494652
SET-2,24180125,3.520791323049292
NCI-H2110,11719255,4.204925011456819
SEM,9826308,-1.408975626974659
SW1990,11955716,-2.6949226775920745
PaTu 8988s,72734382,4.314558303317818
HMCB,54613361,-0.6563978019622596
KMRC-2,135928012,3.7345117496586937
NCI-N87,JQ-1-vorinostat (2-1 mol-mol),-1.1800761907808068
SET-2,alisertib-navitoclax (2-1 mol-mol),-1.6726061008876394
SNU-8,23725625,5.695206402753821
HMCB,44566777,1.6890977945598695
NU-DHL-1,6450551,1.9014057000217284
NU-DHL-1,25126798,3.605160224623971
Kasumi-2,JQ-1-navitoclax (2-1 mol-mol),-2.2721346445712896
AU565,9868037,3.1053436778875843
KMBC-2,53481919,5.533960714974802
SNU-8,3503,2.811796896000335
NCI-H1395,9444,4.051341414153912
KMRC-2,tanespimycin-bortezomib (250-1 mol-mol),2.039285304893744
TE-15,11955716,-2.743936917090752
GOS-3,16065773,2.51000734865302
KMRC-2,selumetinib-UNC0638 (4-1 mol-mol),2.8244446537596013
NCI-H2081,11955716,-2.042301690942712
SEM,3676137,4.192581322448915
TE-15,11364421,-6.1192537543756576
LNCaP clone FGC,11214940,3.923278804570468
NCI-H1092,10127622,5.156307996468707
D283 Med,23725625,2.5008033134469647
NCI-H2110,15953870,3.912079483220952
AN3-CA,9803433,6.356257322204903
SEM,42642645,-5.09846827798555
PE/CA-PJ34 (clone C12),9956119,3.8571372412004954
RPMI-7951,327653,2.8766150759858404
NCI-H2081,4261,0.6223961435689531
A4/Fukuda,11640390,-1.5428779369431247
CML-T1,44185566,0.9347798856606148
D283 Med,5978,-3.0503373024803557
Hep-G2,44498493,5.1826431923254335
HSC-4,11396600,3.0766488056466104
RPMI-7951,2749,2.4234285226525145
BT 330,9935249,0.442722317267438
BT 320,selumetinib-MK-2206 (8-1 mol-mol),3.122937537933898
ML-1 [Human thyroid carcinoma],216239,2.965937740464059
IST-Mes1,selumetinib-piperlongumine (8-1 mol-mol),4.502033014563436
A4/Fukuda,176870,1.9874765150136215
TE 617.T,46907787,1.8996212852232837
SNU-1272,54618771,3.136436186338116
A4/Fukuda,123631,1.573225246333458
SNU-308,selumetinib-vorinostat (8-1 mol-mol),3.2167042029880264
KMRC-2,1566236,2.2234157510538832
Aska-SS,10074640,2.970727178654189
ML-1 [Human thyroid carcinoma],676352,2.608959843452948
RERF-LC-Ad1,25150857,3.1338616756027173
CML-T1,23725625,2.2812581172519124
BT 320,51039095,3.427316698358292
KMS-27,3854666,0.5713663154579435
SNU-1033,10302451,2.931783952664607
PE/CA-PJ34 (clone C12),navitoclax-sorafenib (1-1 mol-mol),3.0314337084555656
SKM-1,11396600,2.556560537938587
LoVo,66577038,2.852951614414874
NCI-H2172,168313047,2.0397504068757693
KMRC-2,4259181,1.2333196545111071
GOS-3,3062316,3.7135401373010426
KMRC-2,135398516,3.3839358458345012
AN3-CA,5113032,4.840828582249248
PaTu 8988s,387447,-4.143715999712614
SNU-308,selumetinib-MK-2206 (8-1 mol-mol),1.728929604870732
AN3-CA,168312962,2.1984376085167057
D283 Med,11719255,2.806098134518819
KMS-27,1716436,3.601327816256154
ML-1 [Human thyroid carcinoma],navitoclax-piperlongumine (1-1 mol-mol),1.771267146894677
Ku812,tretinoin-navitoclax (4-1 mol-mol),0.7122097782880589
NCI-H2081,tanespimycin-bortezomib (250-1 mol-mol),0.018908734219335
SNU-1214,9936388,-5.365264992891118
NCI-H1092,9866186,1.8744947815698976
CA46,9956119,2.2503821303322864
KMBC-2,568763,1.5657625412671894
Ku812,135398738,1.774470065203487
KMS-20,2858523,2.998494544090686
NCI-H1395,44493528,4.373197971838804
SW1990,10385095,0.931801208429433
HARA [Human squamous cell lung carcinoma],5978,-4.046402058806829
Aska-SS,44819697,-2.0300758660488984
PaTu 8988s,salermide-PLX-4032 (12-1 mol-mol),6.000347868731987
Hs 683,2126,5.441583851055004
LoVo,44607530,0.9946707755477716
PaTu 8988s,65064,4.487458159070869
RPMI-7951,6914657,-4.365510801369332
NCI-H1395,46398810,3.2237740665235495
SET-2,tanespimycin-bortezomib (250-1 mol-mol),0.2740236023779227
KMS-27,159324,1.3693882554650931
Raji,46943432,0.8190341583035305
KMS-27,3062316,1.3205834399665888
HMCB,3081361,2.917485308140701
BT 328,3025986,-0.1303666559009026
CML-T1,135928012,3.921778036516406
LoVo,crizotinib-PLX-4032 (2-1 mol-mol),1.6425571440672022
HMCB,444795,4.365001038195376
KMRC-2,5738263,3.9706624221369617
KMS-27,72376,-2.9843864470588533
CA46,25062766,1.483751377697603
AN3-CA,11178236,-6.250252200331648
NCI-H1395,44491742,3.9607165302769514
TE-15,2746,3.020954904357082
AN3-CA,1242560,3.3233723476682115
HEC-151,44819697,0.1746671006919519
BT 248,10385095,1.1706577035646757
NCI-N87,42642645,0.5523493290598761
IST-Mes1,4477,0.8135431021107292
SET-2,46943432,0.0852924787187384
SW1990,navitoclax-pluripotin (1-1 mol-mol),-0.9911428992903798
CML-T1,6184667,4.239961832830672
NCI-H2081,168312962,2.2709613246712395
NU-DHL-1,10074640,2.3359840831804313
NU-DHL-1,11214940,0.1576497417416405
NCI-H1395,4259181,1.90835331362123
Kasumi-2,24180719,3.447908092121991
SKM-1,11485656,1.846158462004935
KMS-20,9887053,4.355785993783173
Hep-G2,3689413,1.297693127771037
SW1990,1716436,3.676749796387318
NU-DHL-1,54613361,-0.5915809815117075
CML-T1,46199207,2.0991647549590304
KMS-27,54143018,-1.1044690232436043
PE/CA-PJ34 (clone C12),42642645,1.4632083376153606
RERF-LC-Ad1,11175137,4.230605816025899
NCI-N87,17759555,3.435080423112301
HCC2218,selumetinib-GDC-0941 (4-1 mol-mol),1.5702207772151422
NCI-H2110,25102847,2.7229918825923276
TE-15,8515,2.4630178987516564
RPMI-7951,navitoclax-pluripotin (1-1 mol-mol),-0.4900724483768682
SNU-8,6918736,-2.3375998846881543
MM1.S,54649381,2.997921024059072
Aska-SS,10184653,1.785047997544531
SNU-1033,4261,1.9972549014264789
KMS-27,6918736,-2.259439743632793
KMS-27,702558,4.517511178766302
LoVo,104842,-3.39586805089817
KYSE-410,46398810,2.568742472735742
IST-Mes1,24821094,3.7341606082149776
RPMI-7951,73707398,0.5772291594495476
CML-T1,24753719,1.910679313408318
HSC-4,11640390,4.10313790521596
KMBC-2,navitoclax-MST-312 (1-1 mol-mol),0.0263119667661449
A4/Fukuda,446155,1.0805751863544764
Aska-SS,selumetinib-JQ-1 (4-1 mol-mol),-0.4940381618393021
BT 139,45279963,3.959806384472248
A4/Fukuda,5287969,-2.571307610380136
ML-1 [Human thyroid carcinoma],6623618,2.7004595127938686
LNCaP clone FGC,23635314,-4.3206947518061325
ML-1 [Human thyroid carcinoma],24180125,2.9342502769836263
KMRC-2,10302451,2.956766072446153
IST-Mes1,3825829,6.080187468224706
LoVo,135875424,3.182508442374063
TE-15,262093,3.281434334474844
SEM,56946209,-6.723586049186012
TE 617.T,2746,2.7076097617545276
LNCaP clone FGC,9911830,1.9985262700964304
Kasumi-2,26596,-3.0246532529835273
SEM,7251185,0.9533100433474536
Ku812,17759555,3.312444984916292
ML-1 [Human thyroid carcinoma],36314,-4.393977809452653
CML-T1,44507138,0.8933545312764144
NCI-H2172,285033,0.6169104755063226
A4/Fukuda,4521392,3.820585335578038
GOS-3,448949,2.9478585654130263
RERF-LC-Ad2,3025986,-1.6334496295077816
Aska-SS,25102847,-1.0664097342177898
Aska-SS,5291,3.606073155811232
SET-2,10172275,5.003847259947949
MCAS,16038120,1.8985243383940775
SNU-308,409805,5.466137259646633
Kasumi-2,56973724,0.9281139851854971
SET-2,49766530,-3.130186221857788
NCI-N87,46174525,4.699807035348161
SNU-1033,11485656,2.0602946184269917
Kasumi-2,49766530,-3.7396811929647513
CA46,3025944,4.264528242833472
RPMI-7951,25105715,2.9409610580806396
HCC2218,16720766,-1.1445454517220572
YKG-1,11640390,4.261360521088683
CA46,serdemetan-SCH-529074 (1-1 mol-mol),1.5485076626446956
AU565,11625818,3.8205404098717457
CML-T1,25105715,2.3891517916986684
NCI-H1395,57519531,3.1803418993490715
Hep-G2,148198,-2.3541136469085493
KYSE-410,11228183,1.825399411469892
SNU-1214,16720766,0.4119762972677722
NCI-H1395,123631,3.1178254055309553
IST-Mes1,17755052,1.8699185860343792
D283 Med,2729026,2.489679691216484
PaTu 8988s,11175137,3.15610689750579
Ku812,5328940,-1.8378811939347264
BT 248,72376,-0.6579483524735774
KMRC-2,46843906,3.6969408784619966
BT 328,327653,3.5942697932581344
Hep-G2,24772860,-3.6408811512611137
NCI-H2110,6610355,4.409375445265295
SET-2,46926350,-5.829442769281559
Hep-G2,119607,5.22772984823061
Kasumi-2,44491742,3.800345149395397
RPMI-7951,15547703,1.8715095189683175
KYSE-410,446155,3.849504807442918
D283 Med,JQ-1-carboplatin (1-1 mol-mol),3.772418054249175
AU565,4521392,3.744925242939049
ML-1 [Human thyroid carcinoma],123631,2.4078761561490025
LoVo,JQ-1-UNC0638 (2-1 mol-mol),3.1589551233195428
HMCB,6610216,4.4861904027359145
AU565,crizotinib-PLX-4032 (2-1 mol-mol),2.690947224555452
SNU-1033,57519531,1.8795255827777344
MM1.S,25150857,1.609855553563615
GOS-3,439501,-3.404828566068769
KMBC-2,46191454,1.5534245999123084
Kasumi-2,104842,-5.6475576104946565
SET-2,tretinoin-carboplatin (2-1 mol-mol),4.541519979051109
AN3-CA,8515,3.3149085250291632
PaTu 8988s,51039095,2.4568329937012123
AN3-CA,11497983,4.368419442647311
SW1990,5328940,1.5130831907204647
KMBC-2,448949,2.9773081298124726
NCI-N87,selumetinib-PLX-4032 (8-1 mol-mol),3.8712321401270406
HCC2218,5329102,2.177989682830739
BT 139,5287620,-4.157590212960767
TE 617.T,doxorubicin-navitoclax (2-1 mol-mol),-3.986680952457477
AN3-CA,vorinostat-carboplatin (1-1 mol-mol),3.9446751303054097
BT 139,637858,2.313744051526735
MCAS,375860,-0.3499242525784914
AN3-CA,5743,3.5735914556808197
BT 248,5494449,3.476308084030369
HMCB,6918736,-3.5722803082985064
HSC-4,3038522,3.958216901800584
NCI-N87,135875424,4.206412745126992
D283 Med,navitoclax-MST-312 (1-1 mol-mol),0.7013282040570831
BT 330,24951314,0.5033054509561667
TE 617.T,5351362,0.9742264058795986
NU-DHL-1,16736978,-0.1858099364077559
NU-DHL-1,89928392,-0.986320160270056
RERF-LC-Ad2,135875424,4.566580865948674
Kasumi-2,119182,-4.8733294561059255
YKG-1,2949965,2.7570477718162367
SNU-308,11609586,3.686939237017378
HEC-151,selumetinib-navitoclax (8-1 mol-mol),2.5500574298476657
KMBC-2,3385,5.16637302671959
BT 320,5281672,4.443718212515123
TE 617.T,25105715,3.234039412199738
KMS-27,5284373,-1.5478981430340564
HEC-151,54618164,3.8374774746461706
NCI-H2110,2749,2.4653527623396947
NCI-N87,selumetinib-navitoclax (8-1 mol-mol),1.647881556522465
HSC-4,selumetinib-vorinostat (8-1 mol-mol),2.2215922063973648
D283 Med,12001922,1.043249882837814
KMS-20,1714884,3.609076510233281
HCC2218,11222830,1.644249013842661
RPMI-7951,252682,6.468448714439519
EJM,7326481,2.7208134108803503
PE/CA-PJ34 (clone C12),52947716,2.849675512601996
TE-15,11657048,5.376807899993406
IST-Mes1,44819697,0.965138597180618
EJM,carboplatin-etoposide (40-17 mol-mol),1.4421874233068297
ML-1 [Human thyroid carcinoma],44507138,2.4759759240399206
RERF-LC-Ad1,9911830,3.638980358065119
KYSE-410,2742550,3.0781954877880797
TE-15,11175137,1.7379507922596151
SNU-1214,5284373,-0.8252665054261109
SNU-308,JQ-1-vorinostat (2-1 mol-mol),-1.218615882412746
Ku812,135398516,0.808826921913188
PE/CA-PJ34 (clone C12),613000,2.377303032798795
EJM,selumetinib-BRD-A02303741 (4-1 mol-mol),6.6447092258899625
LNCaP clone FGC,7326481,2.6276779263247136
TE 617.T,702558,4.450840732173967
Hep-G2,9936388,0.9252852669938214
SNU-308,46398810,3.035178089819383
HCC2218,6918736,1.572834496313944
Kasumi-2,25227462,-2.512802493882235
BT 139,16659841,4.09372938961613
BT 248,3465537,1.7130202551321618
NCI-H2081,9825149,1.369929435911088
AU565,54596490,4.681317358630495
SNU-1214,135421197,1.3172671598461234
SET-2,navitoclax-gemcitabine (1-1 mol-mol),-4.7544354875080055
Ku812,24889392,3.503331691270094
NCI-N87,JQ-1-navitoclax (2-1 mol-mol),0.0624511044953225
KMBC-2,3025986,-0.1359583035560626
KMS-20,16038120,-1.0263302002463832
Raji,24821094,3.3349426355455445
SNU-308,208908,1.459414363933131
SNU-1033,136227924,2.5540912421490387
SET-2,10296883,3.6220267482667943
BT 330,4788,5.911635060219132
HSC-4,25105715,3.6888708464756337
KYSE-410,9866186,2.7647131409969052
HCC2218,168312962,-2.061497863171819
KMRC-2,24821094,3.495546791316723
NCI-H1092,44185566,2.7664666060668104
CML-T1,11404337,-1.4571467715346416
SET-2,3081361,2.3239444576412995
TE 617.T,23635314,-3.733388930400156
NCI-H1395,135398516,2.0913666591316216
Hs 683,46926350,-4.250334489293196
SNU-8,452548,0.8743559932335202
IST-Mes1,44491742,4.903550558956352
BT 328,12001922,1.7973322325176817
RPMI-7951,49850262,3.2718463669067916
BT 248,24797083,0.3482207661961916
AU565,54596558,3.073830584555768
KMS-20,44462760,0.735907586100602
MCAS,446155,3.4124965523550586
Hs 683,10113978,2.3708319863373
MCAS,navitoclax-pluripotin (1-1 mol-mol),0.5016754306809756
HMCB,60700,1.0606608504131512
CML-T1,selumetinib-piperlongumine (8-1 mol-mol),3.07705446138146
NCI-H2110,135411,0.5672279219720924
HEC-151,36314,-6.940972183869406
ML-1 [Human thyroid carcinoma],400769,0.4240275581269139
Hep-G2,11497983,4.251359027932584
LoVo,119182,-3.2827225124554804
PE/CA-PJ34 (clone C12),24180719,3.969047374225328
MCAS,119182,0.7383136380888948
NCI-H1092,decitabine-navitoclax (2-1 mol-mol),4.733361910852782
CA46,46199207,1.8825158344658808
NCI-H1092,11640390,3.833743684940511
OE21,9935249,1.7053577449970625
KYSE-410,5311,1.569986205030131
AU565,alisertib-navitoclax (2-1 mol-mol),2.3316727608646266
NCI-H2110,6917907,-5.621291047180246
EJM,6918878,1.483002003508878
YKG-1,5281321,0.1990106510793085
Ku812,5566,2.0197817582135604
BT 328,9926054,3.720062864226824
GOS-3,1242560,4.3763601819059526
TE-15,5287620,-3.110015038357965
AN3-CA,446155,1.829066428866823
KMS-20,23582824,0.2531987788293798
SEM,56649450,3.981802014132025
NCI-H2081,1566236,1.4725524820150873
IST-Mes1,9825149,1.824146809937508
CML-T1,selumetinib-JQ-1 (4-1 mol-mol),0.8733678884698052
NCI-H2110,9887053,6.172725359065793
NU-DHL-1,71466578,1.9656918552747795
CA46,25227462,-5.088225796968986
SNU-1272,445643,4.475083566650203
KMBC-2,8515,4.644578296093967
PE/CA-PJ34 (clone C12),24748573,1.6796934908276056
BT 248,57330099,3.914766288587865
MCAS,navitoclax-gemcitabine (1-1 mol-mol),-1.9981437035032432
SKM-1,60700,-2.303999469511284
BT 328,25227462,1.995910036473872
D283 Med,9803433,2.2263192458664767
AN3-CA,44543605,5.28797283911383
KMS-20,24951314,0.1651472976854425
KMS-27,135411,0.1575765990656979
KMRC-2,5746,3.1834045914700155
SET-2,1641662,3.568397606985167
IST-Mes1,11234052,4.921331368768723
HSC-4,erlotinib-PLX-4032 (2-1 mol-mol),2.314385393540324
NU-DHL-1,11257553,-0.7159264357065991
HCC2218,246676,3.234854854561146
HSC-4,2729026,2.4603123985812276
OE21,136227924,2.0991161235844404
KMBC-2,387447,-4.640187394922598
SKM-1,3025944,3.5406886531793225
HCC2218,3025944,4.040560692551885
NCI-H2172,66577038,3.596216662258609
SNU-308,969516,3.243815847086935
TE-15,441298,4.343362120875242
NCI-H2081,9933475,1.7869131663343656
EJM,136227924,2.8681258655198367
YKG-1,crizotinib-PLX-4032 (2-1 mol-mol),1.242537511199376
BT 330,tanespimycin-gemcitabine (1-1 mol-mol),-0.7395806919705037
KYSE-410,6438330,2.783614791976934
A4/Fukuda,10127622,0.8035335483112384
KMBC-2,JQ-1-MK-0752 (1-1 mol-mol),5.054925786618905
KMS-20,49793307,-3.879201058014154
NCI-H2110,5566,3.0568513878110712
GOS-3,carboplatin-UNC0638 (2-1 mol-mol),3.2409123088113194
Kasumi-2,6610355,3.4850778191475342
SNU-1214,JQ-1-MK-0752 (1-1 mol-mol),-3.5080834664420006
SNU-1214,5328940,0.1572716308190744
SNU-8,72376,-2.198548294992271
KMS-27,54649381,3.6361143349419898
HMCB,24180125,3.3063760805557054
NCI-H2110,285033,-2.9077531500214953
MCAS,49836020,4.94613909678053
BT 139,16725315,3.2723557113557105
SW1990,11494412,3.8548639457314184
ML-1 [Human thyroid carcinoma],66577038,3.490614785347513
RERF-LC-Ad2,25150857,2.115621654267039
CA46,71304818,1.9606514180280712
HEC-151,25150857,3.554215072236958
NU-DHL-1,navitoclax-birinapant (1-1 mol-mol),-2.6009930383173465
A4/Fukuda,6918638,-1.9449982869755031
KMS-27,135398516,-0.3174379343847421
A4/Fukuda,448949,1.1686862984883333
SNU-1272,44185566,3.1177568139661314
Hs 683,5278396,3.84823350271613
SNU-1272,9911463,4.2598402664697685
TE-15,4578,3.931578799636627
NCI-N87,2828334,6.0279909292271165
KMS-20,3025944,3.4740880117517974
Kasumi-2,24771867,-3.1023362721742607
PE/CA-PJ34 (clone C12),637858,1.319722583622998
SEM,6918328,-4.219248553628803
NCI-H1092,salermide-PLX-4032 (12-1 mol-mol),5.357754410384337
Kasumi-2,216239,2.0875832120118605
NCI-H2172,11485656,2.8163630892876212
NU-DHL-1,23582824,0.4052084507324015
AN3-CA,52912189,5.456100531842718
Raji,54619267,4.236071325253823
RPMI-7951,54613361,-0.7956260293060785
MCAS,2708,5.102956403259028
NCI-H1395,54678924,1.3168571915404212
Kasumi-2,UNC0638-navitoclax (1-1 mol-mol),-2.8195604802601197
HEC-151,9952709,2.93542691790346
CML-T1,1242560,3.0102013740079783
YKG-1,9926054,2.005416681797869
NCI-H2110,148198,-2.105563861688736
RPMI-7951,241158,3.4568590473726273
Ku812,5738263,2.3129138144842236
D283 Med,navitoclax-piperlongumine (1-1 mol-mol),0.4568546586164775
EJM,4261,0.9185867852984516
D283 Med,374536,-5.802881326036661
TE-15,11494412,-1.732621371792193
TE-15,9840324,5.5048533304021925
SW1990,tanespimycin-gemcitabine (1-1 mol-mol),-2.0275719671324577
PaTu 8988s,50905018,6.329104593069708
NCI-H2110,81146,4.4232530547981
BT 328,11955716,-1.056274858719932
SW1990,9915743,2.956888864284862
EJM,135984461,5.02990169097732
CML-T1,6252,-3.9112690302721265
BT 248,73707398,1.2475621750333084
NCI-H2172,11178236,-2.5566689408995593
SNU-1272,vorinostat-navitoclax (4-1 mol-mol),1.588620831694009
Hs 683,151289,0.7881286519354692
SNU-1272,navitoclax-gemcitabine (1-1 mol-mol),1.6228672225859768
SNU-1214,alisertib-navitoclax (2-1 mol-mol),-1.2524210364186528
Kasumi-2,71304818,2.3604520648914136
KMS-27,439501,-2.6111087383065597
HMCB,24797083,1.265825872563084
AN3-CA,16722836,2.609323427195484
BT 330,25126798,4.221457017188824
AN3-CA,6505803,-3.3327049528719312
BT 330,navitoclax-gemcitabine (1-1 mol-mol),-1.7742765886587748
SEM,119607,5.617200032788747
ML-1 [Human thyroid carcinoma],serdemetan-SCH-529074 (1-1 mol-mol),1.7858982688933729
BT 139,9887053,5.710056569748746
CML-T1,2874250,4.926765314452629
TE 617.T,71466380,4.669546530956131
NCI-H2081,67291369,3.286816150820097
BT 328,selumetinib-JQ-1 (4-1 mol-mol),3.8675980198640465
Ku812,44185566,0.7020078390558537
NCI-H1092,15983966,1.932051104008448
KMRC-2,11364421,2.112587869696082
CA46,2871966,-1.7971239931694716
BT 330,71466578,4.426885768144453
NU-DHL-1,5351362,0.683345885255648
LNCaP clone FGC,1641662,3.3792685969663716
RERF-LC-Ad1,selumetinib-vorinostat (8-1 mol-mol),4.734189741537759
CA46,alisertib-navitoclax (2-1 mol-mol),-0.3203128616100632
NCI-H2110,44462760,4.189023964938422
RPMI-7951,2841722,4.243352466432455
D283 Med,72193861,-0.1483015304434956
YKG-1,17755052,1.8826754774817915
SKM-1,11175137,1.89374364392194
SNU-1214,44589607,1.2011539365154311
Ku812,11485656,2.1573639541519474
Hep-G2,3038522,4.124890793702152
Hep-G2,42642645,0.7845833845237471
Hep-G2,135875424,4.631021258019282
SNU-1033,alisertib-navitoclax (2-1 mol-mol),1.8441105793255037
RPMI-7951,3854666,0.7955375468414883
D283 Med,123631,1.7488376783176118
HEC-151,2842253,4.840261523994017
HEC-151,2708,4.535952513422743
EJM,49793307,-4.860528919004407
D283 Med,5328940,1.7071399155082068
MM1.S,6918837,-5.0481223249904525
SNU-8,4521392,4.562248393821206
EJM,selumetinib-PLX-4032 (8-1 mol-mol),4.757753624463101
NCI-H2081,11317348,1.2192738417019382
IST-Mes1,262093,3.164571948045499
NU-DHL-1,7326481,2.7791277258100804
KMRC-2,67156097,4.44150811979282
RERF-LC-Ad2,9887053,4.334988147698079
SNU-1214,44632017,1.3603108487912077
BT 139,65064,5.271614365528748
CA46,vorinostat-navitoclax (4-1 mol-mol),0.373580583037546
KMS-20,71466380,4.301818086320641
SNU-1214,55283,4.343343098172006
KMBC-2,135398516,3.1820927081241392
TE 617.T,2858523,3.0924364714944192
NCI-H1092,5281672,3.7306069141641856
KMS-27,675434,4.061572812426806
BT 139,selumetinib-JQ-1 (4-1 mol-mol),2.342972128639262
NCI-N87,selumetinib-GDC-0941 (4-1 mol-mol),-0.1269197084307303
SNU-1214,1716436,5.314529066322949
Kasumi-2,16659841,3.619219766502468
KMBC-2,selumetinib-navitoclax (8-1 mol-mol),0.2839639839398448
KMS-20,675434,4.108652876132496
PaTu 8988s,613753,3.359242221886772
KMRC-2,11625818,5.255718414133251
EJM,navitoclax-sorafenib (1-1 mol-mol),1.3600415783658448
HMCB,984333,0.7502928259888776
CML-T1,2126,4.385584292912835
NU-DHL-1,2949965,1.9624818198288896
SNU-8,selumetinib-JQ-1 (4-1 mol-mol),-0.3445187438421354
SET-2,148198,-7.743060156944655
EJM,navitoclax-pluripotin (1-1 mol-mol),0.1382872848010396
KMS-27,400769,-1.4116934681425155
YKG-1,serdemetan-SCH-529074 (1-1 mol-mol),2.571956215465782
Raji,73707438,3.789338953981761
NCI-H2172,216345,4.0137667402470525
GOS-3,44137675,4.312209162350938
SEM,439501,-3.163159816591066
EJM,9866186,0.2932895588367603
AU565,9927531,4.912755977802547
HEC-151,71466380,5.72488815846615
KMS-20,53495165,-4.499917260073859
RERF-LC-Ad2,JQ-1-vorinostat (2-1 mol-mol),2.137541513249455
Hs 683,11707110,3.5249505522714553
HCC2218,53392493,1.6336256448398232
SNU-1272,vorinostat-carboplatin (1-1 mol-mol),4.458352308548227
Kasumi-2,25183872,-1.7482434423211834
IST-Mes1,decitabine-navitoclax (2-1 mol-mol),4.382542969117623
KMBC-2,44607530,2.1464142113547804
BT 328,25102847,3.596555529465503
AN3-CA,4788,5.292370025398028
CML-T1,676352,1.5222388602604249
KMS-20,44589607,0.4601335864045367
NCI-N87,10410894,1.83413876253328
HSC-4,208908,1.4999275809756432
NCI-H2081,navitoclax-pluripotin (1-1 mol-mol),1.3803711022863172
KMS-27,426756,4.187084446884802
NCI-N87,salermide-PLX-4032 (12-1 mol-mol),5.428528810612746
KMRC-2,selumetinib-piperlongumine (8-1 mol-mol),3.7705043206304496
SKM-1,11719255,2.1127493004030655
SEM,11213558,-1.899887205353697
CA46,135398516,0.7680931483587626
BT 330,11507802,1.5671604794200418
GOS-3,49836020,5.837697611269413
Ku812,5978,-3.250465069954706
PE/CA-PJ34 (clone C12),6918837,-2.593805851370388
BT 248,3038522,2.764297682711703
ML-1 [Human thyroid carcinoma],5329102,1.4103281602713895
SKM-1,49793307,-4.429104877934936
BT 248,selumetinib-MK-2206 (8-1 mol-mol),1.8493949286996905
A4/Fukuda,5329102,0.822909221294871
SEM,135999136,1.8493753189775255
KMRC-2,44819697,0.3716244404602152
LoVo,1641662,3.111662868893329
HSC-4,2130404,3.512147769522711
SNU-1272,216345,4.229036280799805
IST-Mes1,72376,0.3576615812024088
AU565,1750826,-0.6805778178680736
CML-T1,46907787,-0.5465083296094366
SW1990,107985,-4.22199587403486
RERF-LC-Ad2,400769,-0.9539605441189488
MM1.S,navitoclax-birinapant (1-1 mol-mol),0.4533704477118982
NU-DHL-1,11977753,-1.9405951450279333
NCI-H2110,9884685,0.5868574340900204
SET-2,2733487,3.345611630478478
LNCaP clone FGC,135421197,1.5055395740527522
TE 617.T,16725315,3.1542877991652656
NCI-H1092,10113978,3.439379415042978
SNU-1214,72734382,5.46139158929195
KMS-20,4259181,-0.0713242382704696
CML-T1,10322450,3.1347292789416934
CA46,135423438,1.6657304721140649
AU565,445455,4.9301368045011955
Kasumi-2,46398810,1.7112254413455064
KMS-20,selumetinib-UNC0638 (4-1 mol-mol),0.6726182150265286
AU565,1566236,1.7493429265082687
KMS-20,9929138,5.867169727564362
BT 320,9444,6.119535049609411
Ku812,219104,2.2435781346241743
KMBC-2,4917,3.3261464777108736
TE-15,25062766,1.200635335183344
ML-1 [Human thyroid carcinoma],100016,6.6260589736745015
Raji,409805,3.871069859266368
HEC-151,JQ-1-UNC0638 (2-1 mol-mol),1.268930454659871
SNU-1033,46398810,2.1751402205560972
PaTu 8988s,selumetinib-BRD-A02303741 (4-1 mol-mol),1.64163073342872
Hs 683,46398810,1.6710254432947709
SEM,3634881,2.315957933723583
Hs 683,56963564,0.3272394235462448
MM1.S,4259181,0.3083006728289762
Hs 683,11178236,-3.3483252874095837
EJM,1716436,2.8546888693070818
NCI-N87,6184667,4.346047693042568
CML-T1,17759555,3.491613035913433
NCI-H2172,5329102,2.0139014487546567
EJM,45279963,3.0633820554062345
SNU-8,carboplatin-UNC0638 (2-1 mol-mol),3.5048949040947512
SNU-1272,135423438,5.060183017948369
NCI-H2081,445455,4.231009644823477
NCI-H1092,11964036,2.0347322907537624
OE21,11494412,-0.1422694910703912
SET-2,11455910,-0.0425011411311434
A4/Fukuda,56963564,-0.5107551488404702
EJM,25105715,3.7124435653326984
LNCaP clone FGC,24772860,-1.3292601865972158
OE21,148198,-3.484738735179186
KMBC-2,11257553,1.2264195419995223
NCI-N87,1641662,2.907963520285112
RPMI-7951,crizotinib-PLX-4032 (2-1 mol-mol),1.5126241501158122
SKM-1,375860,-0.6747488513339966
SNU-8,ISOX-bortezomib (250-1 mol-mol),1.008571676159857
PaTu 8988s,252682,7.221235451439796
SNU-1033,44491742,3.84113608449774
NU-DHL-1,44507138,1.6307410381746317
D283 Med,81146,5.645785388190545
SKM-1,2708,3.277988117116173
LoVo,119607,4.4096130331744865
BT 330,25262965,1.1831066054977264
NCI-H2081,71466380,3.723063290723911
SET-2,68056272,3.2451496482148716
BT 248,11494412,3.557230805764516
SNU-1214,44202524,1.5276984250934775
RERF-LC-Ad1,selumetinib-PLX-4032 (8-1 mol-mol),4.111152215390761
GOS-3,11609586,2.254603724376055
TE 617.T,1716436,2.776815289007698
KYSE-410,5282054,4.0043320693852
SNU-1214,54619267,2.8943239784785817
Kasumi-2,445455,4.224989809831099
PE/CA-PJ34 (clone C12),71466380,4.94810327160088
HEC-151,9549297,4.0584666711622
Aska-SS,4261,1.667053994015884
D283 Med,5287620,-0.8821442485679016
LoVo,46398810,1.578557668618055
NCI-H1092,44137675,4.14698117829052
RERF-LC-Ad2,135984461,4.955680046889378
Hs 683,5311281,1.0766329567459891
Ku812,5284616,-4.419466580952263
HCC2218,46398810,2.1690925426260375
Kasumi-2,10385095,0.5473944457717855
D283 Med,9444,3.79519909230311
SNU-1272,6610216,4.610007140028073
HEC-151,11507802,1.3948793909557524
SNU-1033,216345,3.944827364524943
HARA [Human squamous cell lung carcinoma],5280436,4.238746998760762
AU565,decitabine-navitoclax (2-1 mol-mol),2.1782806047891095
SKM-1,3025986,-2.206806722856398
BT 139,44566777,1.379304994580189
A4/Fukuda,71466445,1.4546499284121797
KMS-27,25062766,1.8620246532604927
NU-DHL-1,5328940,1.0877052650240928
TE 617.T,24775005,3.008345052327752
RERF-LC-Ad2,11404337,1.0614824386793822
TE-15,613753,3.1421917783514273
HMCB,5738263,2.6270115747347993
HSC-4,24748573,1.230311327364621
CML-T1,11214940,-0.4703282723698588
BT 328,6436223,-4.925516012264063
SNU-1033,11707110,-1.6713761677122163
SNU-308,168313047,3.2453222840070324
BT 328,2949965,3.033023429372895
SET-2,42611257,3.1945148983849943
KMRC-2,24951314,2.6109807900606263
HEC-151,72376,-3.726090784979559
CML-T1,638278,3.0153915179905098
Aska-SS,46174525,4.195549448751143
HCC2218,119182,3.4186020256947076
BT 248,decitabine-navitoclax (2-1 mol-mol),1.3496925152518875
PE/CA-PJ34 (clone C12),1716436,3.718741146894734
LNCaP clone FGC,2749,1.1736843806937565
YKG-1,135875424,4.553579428376037
BT 330,1750826,-2.942167561904214
NU-DHL-1,10410894,0.6654652153011242
CML-T1,3543504,3.744639287704583
SW1990,selumetinib-piperlongumine (8-1 mol-mol),2.742013369961323
BT 320,crizotinib-PLX-4032 (2-1 mol-mol),2.9020632961686537
ML-1 [Human thyroid carcinoma],452548,-2.1962617612927375
PaTu 8988s,9927531,5.1297297992623605
Raji,46907787,-0.4930919590495862
HEC-151,44491742,3.809390131450424
SET-2,23725625,2.73090348890391
RERF-LC-Ad2,44137675,3.5131029762271564
Ku812,24771867,-1.2789053732108495
NCI-H2110,26596,-0.8689069076907829
RPMI-7951,119182,-2.106125598677035
SKM-1,9967941,3.3288322621426283
LNCaP clone FGC,53495165,-3.058468218132953
NCI-H2172,969516,3.534921805851224
KMBC-2,24180719,5.106392241669845
PE/CA-PJ34 (clone C12),selumetinib-BRD-A02303741 (4-1 mol-mol),2.3443290551447173
HSC-4,navitoclax-MST-312 (1-1 mol-mol),0.8559820038991849
SNU-1214,6918837,-2.7432806587125085
SNU-308,9936388,-0.5886369856263455
SNU-1272,16115403,-4.411665524606828
IST-Mes1,6610216,4.781215155625892
KMBC-2,421610,4.1276517367028545
KMBC-2,6505803,0.8249091565927539
NCI-H2172,54618771,2.767787208774524
RPMI-7951,7326481,3.2368064282682076
HSC-4,10127622,4.548794444843462
TE 617.T,JQ-1-vorinostat (2-1 mol-mol),1.0614147730739114
CA46,piperlongumine-MST-312 (1-1 mol-mol),1.0820043516957718
D283 Med,135984461,1.545115225409391
AU565,71466445,4.046585104708946
NCI-H1092,crizotinib-PLX-4032 (2-1 mol-mol),1.757742083775381
HEC-151,135423438,1.588330635557561
LNCaP clone FGC,54143018,0.4809008552653854
A4/Fukuda,9935249,-4.132944592984893
BT 139,52947716,1.016721134995223
HARA [Human squamous cell lung carcinoma],54613361,-1.6613115011598742
SNU-8,5351362,2.39465746218969
HCC2218,44241473,4.43561890592857
KMRC-2,2828334,5.998826671995852
SEM,54649381,3.0580730250658283
BT 330,72193861,1.6966256104912456
SKM-1,16720766,-1.9505812671776488
MM1.S,2113511,3.813209914161712
Kasumi-2,17755052,-2.6649013271346744
KMS-20,17755052,-0.5934612903297498
NCI-H2081,11497983,-3.5541578106955516
SEM,50905018,3.665116846876204
NCI-H2081,10302451,3.961972444166296
D283 Med,16725315,3.6263864453470993
KMBC-2,89928392,1.7581263697604317
KMS-27,56963564,-0.7436339869905211
AU565,24951314,-0.2220635763258615
AU565,navitoclax-piperlongumine (1-1 mol-mol),2.020927074963466
BT 330,2729026,1.1636644149412527
SET-2,12001922,1.3771697775776517
HMCB,54143018,0.6781529714604165
HMCB,1641662,3.3637139334178343
BT 330,3854666,1.6927657875958029
TE 617.T,675434,4.316914924358703
ML-1 [Human thyroid carcinoma],71304818,3.0426605111728517
HMCB,46398810,3.6730747784920226
LNCaP clone FGC,6918878,1.6855471667539077
NCI-H2110,11178236,-2.385448769325721
A4/Fukuda,JQ-1-vorinostat (2-1 mol-mol),-1.448511600529376
EJM,10026128,6.2528613872855
HEC-151,24775005,2.9454361304694805
Raji,168313200,3.851087858415495
Ku812,135423438,-2.2335088833738146
AU565,3825829,3.6732705699214105
SEM,409805,3.7048315559445575
BT 330,11396600,1.7759393171748088
KYSE-410,66577038,3.1075620073245624
SNU-8,54618771,-0.2346938322915562
SNU-1272,5278396,3.8944923273965113
Raji,46398810,2.4304525112151074
PaTu 8988s,erlotinib-PLX-4032 (2-1 mol-mol),4.531398986466389
D283 Med,5281321,-4.405439498584387
SNU-8,241158,1.5874400033719902
SNU-1214,71304818,2.138044493448437
TE 617.T,135398516,2.2575540165455052
OE21,piperlongumine-MST-312 (1-1 mol-mol),1.2426960927906567
D283 Med,24901704,2.1853171446916257
LoVo,erlotinib-PLX-4032 (2-1 mol-mol),1.656921727064621
RERF-LC-Ad2,16722836,3.0439182676210965
BT 248,24978538,0.997787879795877
MM1.S,5282054,2.5945944982730538
BT 328,9935249,3.0923830009934843
HEC-151,46191454,-0.1634405658392589
GOS-3,969516,3.7661148918393823
PaTu 8988s,327653,3.661431131961154
HSC-4,2842253,4.76622062087716
NCI-N87,219104,3.2437824126869415
NCI-H1092,11612883,3.1486493902012858
KYSE-410,753704,5.6578219631905435
KMS-27,23635314,-3.235668153489761
HCC2218,23725625,3.711729810486442
GOS-3,crizotinib-PLX-4032 (2-1 mol-mol),1.48580275068934
D283 Med,selumetinib-decitabine (4-1 mol-mol),-0.3297766379520341
RERF-LC-Ad2,71466445,6.028378172033726
TE 617.T,50905018,4.442001170768214
Ku812,613753,2.440420613478445
KMRC-2,3038522,2.4328384098536793
KMBC-2,71751553,4.649110275042704
KMS-20,2708,3.4127805917695095
ML-1 [Human thyroid carcinoma],135423438,1.332992654992983
SNU-1214,54618164,3.4998200252029257
KYSE-410,1716436,2.7110967894013847
NU-DHL-1,25262965,-2.025747961233056
A4/Fukuda,11626560,-1.03034976821798
BT 320,9926054,4.941319925063275
A4/Fukuda,46926350,-6.021657358635238
CML-T1,doxorubicin-navitoclax (2-1 mol-mol),-4.289526889070848
BT 248,serdemetan-SCH-529074 (1-1 mol-mol),1.089631188997332
NCI-H2110,5351362,1.1999288672979518
ML-1 [Human thyroid carcinoma],3062316,-4.511354956700351
LNCaP clone FGC,107985,-3.945098238572166
EJM,BRD-A02303741-navitoclax (2-1 mol-mol),2.6594376626213614
LNCaP clone FGC,16741245,4.9091514043929605
CA46,135659046,2.986085914123542
RPMI-7951,JQ-1-vorinostat (2-1 mol-mol),1.1154559644743227
BT 330,12003241,-0.9920089469814386
SNU-1272,3062316,3.6318670446165817
LoVo,11427553,2.604805449600099
MM1.S,119182,-3.364464438003169
HEC-151,107970,2.3284041079322497
NCI-H1092,71304818,2.0604821765755497
LoVo,6852167,1.8421975016001388
NCI-H2172,5746,2.735879314274068
Hs 683,36462,2.0938427707720786
KMRC-2,25102847,3.16009937811696
HEC-151,3025986,-2.169802753575252
A4/Fukuda,613000,-0.1954730319333323
KMS-20,119607,4.302564368851616
SNU-308,104842,-0.6964578064926701
CML-T1,salermide-PLX-4032 (12-1 mol-mol),4.618653772046038
PE/CA-PJ34 (clone C12),54596490,5.097353286236204
KMS-20,176870,2.605197587383483
EJM,5311,0.5955107958606237
Kasumi-2,135423438,1.5853456579896534
AN3-CA,2749,1.5883837990648886
KMS-20,19582717,1.3096306305639924
HEC-151,9825149,3.0210150218859018
KYSE-410,285033,-2.1152693669169924
Ku812,25195348,0.9000183512628003
RERF-LC-Ad2,2729026,3.074324067766426
PE/CA-PJ34 (clone C12),9911463,3.905990041696765
RERF-LC-Ad1,25102847,4.445433024758021
PaTu 8988s,135423438,2.605491208286135
KMS-27,23725625,4.667804380563468
KYSE-410,67156097,0.065853882181778
CML-T1,52912189,1.3905308136477008
NCI-H2081,UNC0638-navitoclax (1-1 mol-mol),0.8615686531760992
A4/Fukuda,24951314,0.2081517019188384
NCI-H1092,9884685,5.208907292159036
BT 248,285033,1.6288115150650024
SW1990,11625818,5.124392007984169
PE/CA-PJ34 (clone C12),753704,4.689094474093603
LNCaP clone FGC,676352,1.626838759048587
KMS-20,135440466,0.075801610820689
KMS-27,6252,0.0348439734292254
HEC-151,6918328,-0.3993843896261924
BT 248,24779724,5.957496049021181
RERF-LC-Ad2,168313200,4.3712795765743255
HARA [Human squamous cell lung carcinoma],5479543,3.520150804916199
YKG-1,6184667,4.226622972803886
MCAS,16725315,3.3168898128798676
Kasumi-2,176870,2.2683953361762166
NCI-H2172,5278396,3.8661280169478274
NU-DHL-1,67156097,-2.718460958664846
HSC-4,54626689,4.284935050666877
GOS-3,3825829,4.328758127334123
CA46,11175137,1.918070959510412
D283 Med,salermide-PLX-4032 (12-1 mol-mol),4.644943358179887
HARA [Human squamous cell lung carcinoma],168312962,2.6720428895447412
ML-1 [Human thyroid carcinoma],55508,1.8303716396385248
AU565,1641662,2.8108586385203234
AU565,24785538,3.4507965915778387
KMS-27,57519531,1.5676211644937377
BT 328,3062316,3.412447048158849
LNCaP clone FGC,5113032,4.377625008137422
KMS-27,4521392,4.241946733625076
HARA [Human squamous cell lung carcinoma],doxorubicin-navitoclax (2-1 mol-mol),-1.5170547368842298
HEC-151,55283,3.4756802706250154
Aska-SS,6610355,5.371993731345703
NCI-H1092,16722836,3.014278758354336
GOS-3,selumetinib-MK-2206 (8-1 mol-mol),3.670573645172849
SW1990,156414,1.6914107782596666
OE21,54613361,-0.5839103852924844
HARA [Human squamous cell lung carcinoma],9936388,-6.286258703982233
A4/Fukuda,984333,-0.4165614363108865
Aska-SS,52912189,1.2158641058153243
SNU-1033,BRD-K55473186,3.698407793853298
NCI-H2081,216468,0.1625451412214818
RPMI-7951,11683005,2.9377231655803526
KMS-27,44491742,4.7290458888071765
HCC2218,9884685,-1.464365341774582
SW1990,11234052,4.7904085138573445
OE21,60700,0.0279601434033075
Hs 683,119607,5.92215321701615
Ku812,126941,-4.2292627127122575
D283 Med,71466380,4.234415328805577
RERF-LC-Ad1,568763,-0.0216703206795301
SEM,3854666,0.6904434014299387
SNU-308,alisertib-navitoclax (2-1 mol-mol),0.6832132242815244
TE 617.T,409805,3.5642990209893024
SW1990,45279963,4.327475403633366
KYSE-410,4788,5.897202503975128
LNCaP clone FGC,445643,3.690270900500078
SNU-1214,4788,5.152440404862343
KMS-20,135875424,2.456374257858295
SNU-8,11626560,2.2205272197134835
KMBC-2,erlotinib-PLX-4032 (2-1 mol-mol),5.711685673840677
Aska-SS,11640390,3.6750430081547063
KMRC-2,10410894,3.9119211302015025
Aska-SS,5328940,1.7170196461113685
BT 330,11178236,-5.971414065790444
MM1.S,44185566,2.164095245238619
SET-2,446155,1.37850534523749
EJM,9884685,0.026997005394607
LNCaP clone FGC,10322450,2.7673995360058954
HCC2218,9926054,1.6047846197702569
SNU-1272,4261,0.7733171013559388
NU-DHL-1,11609586,2.2389796491819345
OE21,46398810,2.840841233000916
RERF-LC-Ad2,46215462,1.8550618153186036
TE-15,322968,4.717017848015086
A4/Fukuda,409805,3.596796639089143
ML-1 [Human thyroid carcinoma],6610355,5.061552725322464
BT 330,89928392,0.2679954207172777
PaTu 8988s,10231331,2.3383323035983787
GOS-3,25150857,1.9006273010690065
SNU-8,BRD-A02303741-navitoclax (2-1 mol-mol),4.867149955163663
SNU-308,24785538,3.8901431089761505
PaTu 8988s,6450551,3.88448828563756
A4/Fukuda,10184653,1.3612642262853822
SNU-308,3025986,-0.312085619689839
RERF-LC-Ad2,5566,3.316275965247943
KMS-20,53392493,1.7021821857252477
PaTu 8988s,16741245,5.057049957971029
SNU-8,44607531,1.6077512156664846
HSC-4,6914657,-3.070952064512468
Hep-G2,107985,-3.632879499618416
TE-15,25105715,3.688638378403114
AN3-CA,374536,2.9665572949501775
PE/CA-PJ34 (clone C12),44486219,4.215930684165307
MCAS,6917907,-8.091541669459648
MCAS,23582824,0.7882424561758696
RERF-LC-Ad1,446155,3.5948238619356676
MCAS,4259181,0.6276233805104566
D283 Med,24821094,1.9076821647913431
SNU-1272,124202324,3.3198251305185975
NU-DHL-1,2945648,1.372163089409248
KMS-27,11238147,1.891228711270113
KMBC-2,3552672,4.528759537704634
PaTu 8988s,6852167,3.1010868108448832
MCAS,135875424,3.596680652923431
Raji,65064,3.2905729648450643
A4/Fukuda,25126798,3.529395374343333
YKG-1,1750826,0.4616022986658529
HSC-4,11167602,1.6360881716966182
NU-DHL-1,54143018,-3.6528405777406743
KMS-27,ISOX-bortezomib (250-1 mol-mol),-0.0872942946358621
SET-2,252682,6.247375005107577
BT 328,9825149,2.1820811004987126
D283 Med,9823820,3.71007725808951
GOS-3,selumetinib-piperlongumine (8-1 mol-mol),4.534264258970437
HARA [Human squamous cell lung carcinoma],11625818,4.840804819194981
Hep-G2,4261,1.86720235378862
BT 330,9956119,4.409669867240458
CML-T1,11640390,3.08306987111381
BT 330,216345,1.3297376378121593
SNU-8,11497983,4.308002849653566
BT 248,24772860,-1.8114686790878316
HSC-4,15547703,3.6362413258054063
Kasumi-2,5311037,4.15499666746129
LNCaP clone FGC,54626689,4.472345767671783
PaTu 8988s,navitoclax-sorafenib (1-1 mol-mol),2.036825737456502
KMS-27,54618305,4.755877459713762
LNCaP clone FGC,2729026,3.004810986448101
D283 Med,24856436,-0.0403728829049674
MM1.S,46191454,-0.4947942037268417
SET-2,24180719,3.6007624988079696
HEC-151,969516,2.437486238076301
CA46,135411,0.0331424760277949
KYSE-410,675434,4.273259332206393
MM1.S,24964624,-1.3172140659784457
MM1.S,16065773,2.0312570616659125
Kasumi-2,2742550,3.256021563602066
EJM,12001922,1.7275636633087754
Aska-SS,11364421,-3.32672774799048
MM1.S,49836020,3.8296017324588942
SKM-1,16741245,1.8575385373814357
PE/CA-PJ34 (clone C12),11178236,-3.1085754379858175
SNU-1214,613753,2.649500579698431
NCI-H2110,54596558,4.350803568816045
MCAS,2749,1.4531198452067708
OE21,44487872,4.4115983844674185
LNCaP clone FGC,216239,1.7260872019236435
SNU-1272,322968,5.073692716750646
HARA [Human squamous cell lung carcinoma],16725315,4.551171651287005
NU-DHL-1,409805,5.5181498055430565
NCI-H1092,17755052,3.7440295863343342
NCI-H1395,72376,-0.6047916144496074
PaTu 8988s,9866186,2.7260374250505808
NCI-H2081,11396600,3.4950774921622174
NCI-H2172,6610216,4.169971132764112
Raji,3689413,-1.7827501217470076
A4/Fukuda,16038120,-3.113498344638628
SET-2,24821094,2.79989362054305
NU-DHL-1,56963564,-0.6352344971867577
LNCaP clone FGC,10385095,0.9687144663796518
Hs 683,327653,4.055715527758498
SW1990,387447,-5.224232089189946
RERF-LC-Ad2,5311281,2.9510769338472542
HARA [Human squamous cell lung carcinoma],20959075,-3.3968163713216657
Hs 683,46215462,1.5874451556641451
SNU-308,9915743,-2.1849760358615296
Raji,10296883,3.544688579045074
CA46,613000,1.1767209163070167
D283 Med,decitabine-navitoclax (2-1 mol-mol),-1.6592952462928667
Ku812,66577038,1.5928904454568968
SNU-1272,10074640,3.618892542136291
ML-1 [Human thyroid carcinoma],5280436,5.01828711367565
YKG-1,51037431,4.372919308418105
BT 139,219104,4.509107206389703
SEM,5284329,1.6736323396864567
CML-T1,984333,-1.4387494949343358
TE 617.T,72376,-3.1403158194387175
SW1990,11222830,2.726200871669508
NU-DHL-1,46191454,-0.6723674281273057
KMS-27,navitoclax-piperlongumine (1-1 mol-mol),-2.594469089968951
KYSE-410,135411,3.024507508048007
SNU-1033,SNX-2112-bortezomib (250-1 mol-mol),-2.69596565865477
TE-15,12001922,2.3177412223130496
LoVo,ISOX-bortezomib (250-1 mol-mol),0.9349202186753368
LoVo,9967941,3.621110602900207
KMS-27,6918837,-4.653515944209293
A4/Fukuda,3503,1.0521499831923595
SEM,sirolimus-bortezomib (250-1 mol-mol),-0.6909485025943941
Kasumi-2,3385,2.4314400955221576
Kasumi-2,5311281,1.4543587988632989
SKM-1,11178236,-3.008392774513597
NCI-H2172,9911830,3.117247767846657
MM1.S,54143018,0.2857202786050064
SNU-1214,5460769,-0.9519860634538546
MCAS,25062766,2.1662078190580085
HARA [Human squamous cell lung carcinoma],2733526,3.2699742840947414
AN3-CA,54618771,2.457771155909442
SW1990,49766530,-0.1486325613650474
NCI-H2081,5311,0.3244714847141396
Kasumi-2,49793307,-4.053216594075624
IST-Mes1,selumetinib-decitabine (4-1 mol-mol),6.500937496154089
TE 617.T,5335621,4.3358986748904655
AN3-CA,11214940,3.76725106540636
TE-15,24180125,5.117300850152298
MCAS,9911830,3.0082836124394214
NCI-H2110,753704,5.759547446476079
YKG-1,9911463,4.439291278473792
OE21,11152667,-1.518661040860189
KYSE-410,2733526,3.0552963215428286
HSC-4,sirolimus-bortezomib (250-1 mol-mol),1.2607817332731768
BT 330,3136844,4.335632368425244
Ku812,crizotinib-PLX-4032 (2-1 mol-mol),-1.188059714033302
NCI-H2081,45279963,2.492987124324476
IST-Mes1,carboplatin-etoposide (40-17 mol-mol),4.371414865626411
OE21,9866186,-0.2003776611728709
HSC-4,9840324,5.223554072523372
TE 617.T,1242560,3.2106509327260917
PE/CA-PJ34 (clone C12),71576739,4.786546039193674
LNCaP clone FGC,135999136,2.023158565172241
PaTu 8988s,42642645,0.9870759100571196
SNU-308,6852167,3.364672579284096
SET-2,107985,-4.483879722090849
HEC-151,100016,5.913951457428463
A4/Fukuda,11178236,-5.149024442366163
LNCaP clone FGC,navitoclax-PLX-4032 (1-1 mol-mol),3.229192012291585
KMS-27,4477,0.0382761833830738
Hs 683,53232,2.407041443710606
MM1.S,4521392,4.203260754264018
MM1.S,10410894,1.8770933860256032
SET-2,168312962,1.288351871230535
LoVo,8515,2.0502092932288543
D283 Med,9866186,-1.70229195873881
HARA [Human squamous cell lung carcinoma],7326481,3.3732570103291657
D283 Med,9935249,1.011376298828927
Ku812,445455,5.7620239049284505
RERF-LC-Ad2,71304818,2.712854683480008
LNCaP clone FGC,JQ-1-UNC0638 (2-1 mol-mol),-1.7433469805632364
SET-2,44202524,1.8632476825063649
OE21,5311,1.919322978011042
NCI-N87,54618771,0.8863121899707505
KMS-27,3815108,2.4440705350233856
Kasumi-2,11494412,-0.1140662522158316
SET-2,451668,-1.0979417928240258
LoVo,4259181,0.2045859597859785
PaTu 8988s,4096211,2.074974909140277
TE-15,BRD-A02303741-carboplatin (1-1 mol-mol),4.933510886872774
HARA [Human squamous cell lung carcinoma],4261,3.400371454492322
Aska-SS,3062316,2.173986451757374
PaTu 8988s,25105715,3.655682529941988
BT 248,5282054,3.4340814823816324
SEM,3011155,5.750051022389146
Hs 683,54143018,0.4338864337306197
AN3-CA,11455910,0.3745394880525272
PaTu 8988s,navitoclax-MST-312 (1-1 mol-mol),0.8903079843693547
HEC-151,alisertib-navitoclax (2-1 mol-mol),2.5924883600099236
BT 328,46398810,2.9413062884147014
Raji,6917907,-0.3162927321321608
NCI-N87,54143018,-0.5822633828546482
PaTu 8988s,3552672,2.0694229073359156
HARA [Human squamous cell lung carcinoma],15547703,3.5023955614710633
NU-DHL-1,31703,-3.2392931195383756
BT 248,15983966,1.8194061419836256
HMCB,11238147,1.8414836223135087
NCI-H2081,25150857,0.8996353500859205
KMRC-2,3503,3.1235286594556007
NU-DHL-1,73707398,-1.134131669743868
SKM-1,tanespimycin-gemcitabine (1-1 mol-mol),-1.8087612580761447
NCI-H2110,25062766,2.323703238743529
NU-DHL-1,5566,3.1581307498814923
BT 320,16038120,1.884341751706396
KMRC-2,25195348,4.278954150940016
NCI-H1092,44202524,3.663544570122555
HMCB,doxorubicin-navitoclax (2-1 mol-mol),-1.216514285353257
Hep-G2,12001922,1.7010359951064702
BT 139,4378219,1.2549106486924078
NCI-N87,73707398,0.9429301881187698
EJM,54596558,4.61440332017562
LNCaP clone FGC,3385,1.984048991307278
CML-T1,11717001,4.07494523492724
MM1.S,100016,6.180279624553647
SW1990,216345,4.764095840089945
CA46,3634881,2.7183374991781903
BT 328,serdemetan-SCH-529074 (1-1 mol-mol),2.5091917299328315
SNU-1033,12001922,1.3471825847750112
KYSE-410,44489675,4.9964303572855995
NCI-H2081,4788,5.364194014939799
AU565,JQ-1-carboplatin (1-1 mol-mol),2.695919157809604
Hs 683,selumetinib-piperlongumine (8-1 mol-mol),4.6915897012307735
NCI-N87,135411,0.0487965919912929
BT 328,5282054,4.480246853772489
HSC-4,3465537,2.7025414883497443
A4/Fukuda,135440466,-0.9873079875011114
NCI-N87,36314,2.766113993056904
LNCaP clone FGC,135659046,3.5330322853898957
Kasumi-2,135999136,3.771420948620172
BT 320,10184653,3.7290342309119686
TE 617.T,71304818,1.441601624929096
CML-T1,10077130,2.746402588915116
NU-DHL-1,44607531,1.8072861510407077
Ku812,25126798,3.6375519347650047
NCI-N87,322968,2.9452063604799417
OE21,selumetinib-UNC0638 (4-1 mol-mol),1.44688345450047
TE-15,selumetinib-decitabine (4-1 mol-mol),3.970444444773313
A4/Fukuda,9444,3.1818692272898423
Raji,119182,-4.8783079767530495
TE 617.T,2871966,-1.7687983505929656
Aska-SS,24797083,1.7745933427966527
HMCB,11640390,3.771072765277519
SW1990,73707398,1.200617797087527
Ku812,24772860,-3.654878232310525
AN3-CA,107985,-2.3733374503146414
D283 Med,JQ-1-vorinostat (2-1 mol-mol),0.6259651679916352
TE 617.T,11497983,3.60730452568753
D283 Med,24748573,1.2146097740205386
Hs 683,11228183,2.8143338222496666
PE/CA-PJ34 (clone C12),25195348,3.3119594159536874
LoVo,9926054,1.9069881185353632
TE 617.T,3825829,3.961501634657472
TE 617.T,9926054,1.7506239081922086
KMBC-2,11455910,1.9151529363040984
CML-T1,89928392,0.2335848320544615
KMBC-2,3854666,3.5091352093149455
ML-1 [Human thyroid carcinoma],11364421,-5.159158552339723
SNU-1272,2858523,2.5104124408417157
BT 328,107985,-2.461939045328001
HSC-4,BRD-K27188169-navitoclax (2-1 mol-mol),3.591026933435327
Ku812,72376,-3.225507267019729
KYSE-410,72376,-2.171020985776524
SEM,135421197,0.5141119166667375
MM1.S,107970,1.483055719195773
PE/CA-PJ34 (clone C12),16725315,5.214730305618214
Kasumi-2,23582824,0.0696466908969853
LoVo,3634881,2.800959668083557
LoVo,387447,-3.727342469020989
MCAS,44489675,3.667641612730395
Hep-G2,5278396,5.277054746379456
SNU-8,25126798,3.883778707085978
Hs 683,5282054,4.0736692861931205
TE-15,11640390,3.6556981227113634
Hep-G2,11178236,-2.211780590989946
Ku812,selumetinib-vorinostat (8-1 mol-mol),-1.7038187664037243
LoVo,400769,-0.9988261077541156
CML-T1,24771867,0.0964586614823225
NCI-N87,409805,4.5069551273823585
MM1.S,8515,6.088299107521539
NCI-H2172,9929138,5.835125788077067
AU565,89928392,2.1536851128845904
KMBC-2,36314,-0.0772216792920631
NCI-N87,selumetinib-tretinoin (2-1 mol-mol),6.374104250530425
HCC2218,52947716,-6.603303596955929
SET-2,135423438,1.6244153608303664
HSC-4,675434,4.235689784331333
MM1.S,15953870,5.481933437473156
SNU-1214,crizotinib-PLX-4032 (2-1 mol-mol),1.1503309085319278
AU565,54618795,2.974070020268914
CML-T1,25262965,-1.9815055926190612
LNCaP clone FGC,462382,0.5963170764169649
SW1990,54618305,4.718025842071016
LNCaP clone FGC,navitoclax-gemcitabine (1-1 mol-mol),-1.7581802216256437
BT 330,6918328,1.744082398516909
RPMI-7951,4917,2.3080292416300874
OE21,89928392,1.5103918625166863
Ku812,6918736,-3.1871453727372514
GOS-3,9933475,1.7482363497307876
YKG-1,72376,-2.105331743762953
PaTu 8988s,9911463,3.6809927178566855
A4/Fukuda,426756,4.168045276817785
Kasumi-2,9866186,-1.4043484015282397
BT 328,25062766,3.0045654818886507
BT 330,11317348,1.5954032915726168
PaTu 8988s,2949965,2.4899233213350085
GOS-3,6610216,4.739620593848468
KMS-27,16038120,-0.8539301751141739
SET-2,49793307,-5.300633765510322
IST-Mes1,6917907,-4.257425330675956
D283 Med,9927531,3.2144716566788745
KMS-20,5278396,2.5832332460860328
BT 139,2733526,2.8212973326719304
GOS-3,5113032,4.836446064307081
NCI-H2081,9935249,2.3780454134873263
SNU-308,984333,1.720970386122563
Kasumi-2,54613361,-0.9648217673530566
SKM-1,11455910,-0.0252675410510007
HMCB,11427553,2.900768435371354
EJM,4096211,1.0165645953400952
SEM,5566,3.255060505668301
RERF-LC-Ad2,5291,3.84133804155984
KMS-20,24901704,1.7542686332224908
NU-DHL-1,46943432,0.1764476025909112
KMS-20,123631,1.7522842668396212
LNCaP clone FGC,135398516,1.4914387819371897
HEC-151,3038522,3.9401881104716527
SKM-1,54454,1.9004592108781224
NCI-H2110,10302451,3.568351755533758
TE 617.T,tretinoin-carboplatin (2-1 mol-mol),4.888045737134101
LoVo,3025944,2.9449078290251256
SNU-8,71466445,3.518025690097915
SNU-8,10074640,3.140800903715358
LNCaP clone FGC,selumetinib-piperlongumine (8-1 mol-mol),4.580403937531623
IST-Mes1,66577038,2.5150906013236423
HMCB,676352,1.7835731305737277
KYSE-410,11175137,2.5904994526857994
SNU-308,selumetinib-GDC-0941 (4-1 mol-mol),1.3521020528190912
NCI-H2110,selumetinib-MK-2206 (8-1 mol-mol),2.3924644817565683
SET-2,4096211,2.089514790841445
RERF-LC-Ad2,4378219,2.030697080387384
BT 248,6914657,-2.576788872604972
HCC2218,2828334,5.476104905446887
NCI-H2172,10302451,4.417347550930714
SNU-1214,11656518,1.889614069943663
SEM,753704,2.726890937341564
TE-15,salermide-PLX-4032 (12-1 mol-mol),5.474506118716033
Kasumi-2,5335621,4.247176943532892
Raji,54143018,-0.8038928001043883
NCI-H2110,16065773,3.6504121328768937
YKG-1,5291,4.1211092927325526
PE/CA-PJ34 (clone C12),25183872,-0.4619037978479324
BT 248,44819697,-0.5101915766327456
KYSE-410,9840324,6.043585972673271
AU565,3634881,4.304518749556461
NU-DHL-1,serdemetan-SCH-529074 (1-1 mol-mol),1.6055293417204113
SEM,10184653,-0.2676312474090645
SEM,11178236,-5.071502076951621
Ku812,44819697,-2.8694764464804727
NCI-H1092,73707398,1.109051456829637
NCI-H2172,15983966,2.0038954044857227
OE21,46224516,1.3684984332825172
Hep-G2,262093,4.425755335049499
NU-DHL-1,5470400,3.3692959530783155
TE-15,126941,-2.159611946288151
TE 617.T,448949,1.7221444457220252
MM1.S,serdemetan-SCH-529074 (1-1 mol-mol),-0.1591683949873749
NCI-H1395,10127622,5.295029189605721
KMRC-2,9936388,3.0990467374612813
HCC2218,10113978,2.8653467839209448
NCI-H2081,23582824,1.3516004716610026
IST-Mes1,135398516,1.9830137838908624
SET-2,11609586,1.952463968520616
HEC-151,5291,4.223024984973082
Kasumi-2,2749,0.3805959448623131
NCI-H1395,11625818,4.225783797548463
ML-1 [Human thyroid carcinoma],6505803,-0.5261965004955029
BT 320,66577038,3.2847085574393557
YKG-1,46398810,2.968837802015958
KMS-20,BRD-K55473186,1.619659945853516
GOS-3,56649450,5.993657371981695
RERF-LC-Ad2,3689413,-2.3718681179327143
BT 139,selumetinib-piperlongumine (8-1 mol-mol),4.6640913830640445
NCI-H2110,selumetinib-BRD-A02303741 (4-1 mol-mol),4.4516534452427505
Raji,19582717,3.2823671659131244
Hs 683,3825829,4.070799794805118
CML-T1,BRD-A02303741-navitoclax (2-1 mol-mol),1.3394174355089614
NCI-H2172,168313200,3.683168062347926
PaTu 8988s,11485656,1.7881493862367523
IST-Mes1,5278396,4.120493778859633
Raji,25126798,3.979032960527878
PE/CA-PJ34 (clone C12),400769,-0.7071092107255599
A4/Fukuda,5281321,-4.090150251628595
HMCB,42642645,1.005103914323319
LoVo,JQ-1-vorinostat (2-1 mol-mol),0.1759239316074218
HMCB,56963564,0.3861475037431977
KYSE-410,49766530,0.2031131423748078
KMS-27,44486219,4.244516858504852
RERF-LC-Ad2,10074640,3.692209839516339
KMBC-2,2858523,3.042051698255358
KMS-20,71466445,3.065213582457146
SKM-1,25126798,2.9337562009187192
KMS-27,9911463,4.115013696687494
NCI-H1395,285033,-0.7222597352874329
CML-T1,navitoclax-birinapant (1-1 mol-mol),0.167080687914587
LNCaP clone FGC,3503,1.5902233641471553
BT 139,107985,-2.6737543341342316
TE 617.T,12001922,1.7952011808857071
MCAS,11222830,1.783415446127836
RPMI-7951,3384730,2.702292851333149
Hs 683,24772860,-1.8987479201847817
SEM,46224516,1.5959166317590987
HEC-151,124202324,2.4256348200617452
KMS-27,9967941,3.184631883228521
NCI-H2081,9911463,2.5760332235225016
KYSE-410,11404337,-0.5095483106694066
HSC-4,9952709,2.643320259436509
NCI-N87,65628,4.009039012864223
AU565,44489675,4.101715930322606
HEC-151,10385095,0.96058203758897
NCI-H1395,4788,5.899577984060707
KMRC-2,44607530,1.7376258849298154
KMRC-2,11609586,3.050903259712864
MM1.S,tanespimycin-bortezomib (250-1 mol-mol),-0.3747840615026737
OE21,16065773,2.7500210477660354
SW1990,5278396,4.36316707507952
Kasumi-2,navitoclax-gemcitabine (1-1 mol-mol),-5.447760787137567
KMBC-2,969516,3.745806938603398
KMS-27,6184667,2.930875862033721
SEM,60700,-4.28197010474707
LNCaP clone FGC,16065773,2.0959712633138423
KMS-27,107985,-3.725151900067263
YKG-1,3038522,1.877440168253775
RPMI-7951,5566,2.3477005519736083
AU565,tretinoin-carboplatin (2-1 mol-mol),5.430851550447548
KMRC-2,5291,3.728115184544096
TE-15,9826308,-0.7362911274714742
TE 617.T,carboplatin-etoposide (40-17 mol-mol),1.132049095306285
SEM,71680916,3.544265140998964
SNU-308,vorinostat-carboplatin (1-1 mol-mol),4.300379627893463
SNU-308,navitoclax-MST-312 (1-1 mol-mol),1.9474762449323673
HARA [Human squamous cell lung carcinoma],42611257,3.5357302300548716
NU-DHL-1,135999136,3.842512591140382
SEM,24978538,-3.458194735771583
NCI-H1092,44462760,4.232811059835202
SW1990,salermide-PLX-4032 (12-1 mol-mol),5.451252695389819
SNU-1033,24901704,3.4309079022670472
HCC2218,6438330,2.0468099735071865
NU-DHL-1,25102847,3.3147943558623916
KMRC-2,53392493,1.967193449511117
PaTu 8988s,5351362,1.2846781714572348
Kasumi-2,9444,3.998890232290453
HSC-4,9935249,3.700870290975298
SET-2,16219061,2.3262981001473912
LNCaP clone FGC,5284329,1.944960046338054
NCI-H1395,25161177,5.627463134287728
SNU-1033,148198,-5.122632724392466
NCI-H2081,53392493,1.9098873697280916
PaTu 8988s,3825829,4.7222594331906915
IST-Mes1,46199207,3.629760005921771
TE 617.T,126941,-4.418116621588743
HMCB,25126798,4.221661983457504
BT 330,444795,4.463557334125424
AU565,23582824,-0.1593812680979049
KYSE-410,2858523,3.007100667680198
SET-2,5291,3.646355415614293
HEC-151,navitoclax-birinapant (1-1 mol-mol),2.919110430192298
TE 617.T,24821094,-3.6157652796729094
NU-DHL-1,25183872,-1.6691954521805272
SW1990,selumetinib-PLX-4032 (8-1 mol-mol),2.638465998633568
HARA [Human squamous cell lung carcinoma],969516,2.3775549977258836
LNCaP clone FGC,44566777,0.2697402956754434
NCI-H2110,11427553,2.892862784296617
SNU-1272,5281672,5.145020952556211
LoVo,15953870,2.9352023189332703
PaTu 8988s,11396600,3.1820503715354276
TE-15,11719255,3.003827280691082
KMS-20,46199207,2.2005860320322532
NU-DHL-1,42611257,3.173167598663498
EJM,44543605,3.7217729651907825
PaTu 8988s,135398738,4.654350293354078
D283 Med,246676,4.416806480399498
OE21,11178236,-2.3861824388467676
Kasumi-2,11364421,-5.792134203695654
NCI-H2172,452548,3.3150482537276433
MCAS,126941,-2.2746618054427548
MCAS,44543605,3.819118149951799
SET-2,tretinoin-navitoclax (4-1 mol-mol),0.1055125541678496
KMBC-2,327653,3.602242571352684
KYSE-410,25195348,2.1737007538182973
CA46,9866186,-0.3275085520058725
SNU-1272,5351362,3.155646522066241
AN3-CA,24180719,3.691546686395667
NCI-H2110,navitoclax-birinapant (1-1 mol-mol),-4.382676347082387
KYSE-410,3081361,2.1077424153727535
KMBC-2,navitoclax-PLX-4032 (1-1 mol-mol),-0.2513103749729587
HEC-151,tretinoin-navitoclax (4-1 mol-mol),3.939553362858351
BT 139,44607530,0.8538745326791171
BT 328,9956119,4.461775202302022
GOS-3,6918328,0.9203199321907972
D283 Med,67291369,-1.3976379586601873
SEM,9823820,2.1841309858683866
BT 248,1714884,3.688077995610216
ML-1 [Human thyroid carcinoma],BRD-A02303741-navitoclax (2-1 mol-mol),3.3397252964004593
RERF-LC-Ad2,44185566,2.7611278525459872
SNU-1033,44507138,3.678827909971226
Hs 683,1716436,3.2273737363260286
PE/CA-PJ34 (clone C12),9967941,4.772694615178541
BT 320,46224516,3.0907007884048636
MCAS,24964624,2.6917475181600388
Raji,9935249,3.258166700499432
HEC-151,BRD-K99584050,4.400631541046007
MM1.S,322968,-0.5994478682175649
NCI-H1395,53232,3.2747143495441433
LNCaP clone FGC,5566,3.3009073934848496
Ku812,44137675,4.859064076132382
NCI-H2172,219104,5.178074654865666
LNCaP clone FGC,ISOX-bortezomib (250-1 mol-mol),0.3163092256046704
Kasumi-2,322968,1.3079365029289678
Hs 683,448949,1.593482361717585
SNU-1033,9915743,1.252454153580825
HMCB,selumetinib-piperlongumine (8-1 mol-mol),4.51678007909172
Ku812,2708,3.4695310575636262
Ku812,81146,4.292819669950478
SNU-1033,6438330,2.412682257725534
Ku812,12001922,1.5776657122495092
KMS-27,49850262,2.9709310853441524
HCC2218,8515,1.7075905965554727
SEM,53301938,6.1537936140173715
NU-DHL-1,11647372,-0.5414932497737441
SNU-308,25262965,-0.0197220188097323
SW1990,374536,2.916783298582251
TE-15,24772860,-1.8392832942259
SNU-1033,67291369,4.3431955493007175
A4/Fukuda,421610,2.9916322722523425
HEC-151,1750826,-0.7392796870326657
CA46,42611257,2.680269393096826
MM1.S,6917907,-7.99628431454436
SET-2,decitabine-navitoclax (2-1 mol-mol),-2.129700586239786
HCC2218,5311281,4.447969960603379
RPMI-7951,5291,3.179935187386984
GOS-3,sirolimus-bortezomib (250-1 mol-mol),0.3031881482046261
SEM,5287969,-1.544606693116113
MM1.S,227681,1.7327122613945027
Ku812,9929138,4.0796690015060095
Ku812,44607531,1.394726431566783
PE/CA-PJ34 (clone C12),72734382,5.58441698552576
SEM,49836020,0.2207243584754971
GOS-3,65064,3.2866798747983585
Ku812,6917907,-6.404390397127188
CML-T1,3825829,3.084807192466588
CML-T1,serdemetan-SCH-529074 (1-1 mol-mol),0.193373711840136
CML-T1,crizotinib-PLX-4032 (2-1 mol-mol),-0.082010794969092
NCI-H2081,24771867,-2.330318084024509
CML-T1,5470400,-2.3275269381266326
NU-DHL-1,1641662,2.8640618258666626
KMRC-2,11494412,6.4606307205450015
SW1990,24856436,-0.1901815995075366
SNU-1214,6918328,-0.2873228341432076
SNU-1272,16722836,2.182874461062422
HARA [Human squamous cell lung carcinoma],9911463,4.1556235611039405
KMS-27,89928392,0.4366769270858706
SNU-1033,4917,2.624881391157713
RERF-LC-Ad2,16736978,1.4486111986027184
HSC-4,2828334,6.111197262680893
HEC-151,tanespimycin-gemcitabine (1-1 mol-mol),-0.6306634684519514
BT 330,44632017,3.9619858214951726
KMRC-2,11485656,3.489579667056433
MM1.S,11152667,-1.9350060885580451
ML-1 [Human thyroid carcinoma],11626560,2.2482240841306123
KMS-27,49793307,-4.722985009136323
SW1990,5291,3.846713865326283
KMS-20,156422,3.444760878114978
Aska-SS,6918878,2.6155918137055973
SET-2,9911830,2.246088546927402
KYSE-410,24856436,0.3863800848702762
MCAS,23725625,4.4674153272431365
RPMI-7951,25102847,2.7186548604055725
SNU-1033,135398516,1.7537770421704515
YKG-1,12001922,2.2090036010272533
GOS-3,vorinostat-carboplatin (1-1 mol-mol),4.212232190110438
HMCB,navitoclax-sorafenib (1-1 mol-mol),1.4210675529122485
CA46,5311,-0.1889513685103653
RPMI-7951,10385095,1.3251666848544306
Ku812,2729026,1.365537555600546
Raji,159324,2.512472945563818
MCAS,2841722,3.7905480145249064
Kasumi-2,2949965,2.010544177145751
Kasumi-2,24901704,2.1856500624020994
Aska-SS,42642645,-6.050659008742591
Ku812,3503,1.4349303332326306
CA46,1239801,3.4142476342729817
MM1.S,637858,1.1030416488426389
ML-1 [Human thyroid carcinoma],55283,2.9349831464401936
HMCB,46191454,1.8598325801790512
SNU-1214,selumetinib-UNC0638 (4-1 mol-mol),2.031739596740135
EJM,9823820,4.691178108469771
KMRC-2,24889392,4.392694488278391
HSC-4,17755052,1.8179922614483863
HARA [Human squamous cell lung carcinoma],400769,-0.3643318812201842
SET-2,6610355,3.64487356976899
CML-T1,5113032,5.118103556540756
PaTu 8988s,45279963,3.4965151761067985
KMS-20,107985,-4.802194252756391
A4/Fukuda,5282054,2.418862118344995
NCI-H2110,53392493,3.635349980623696
Raji,11485656,1.8853842234896017
KMS-20,JQ-1-UNC0638 (2-1 mol-mol),-0.883173015839936
ML-1 [Human thyroid carcinoma],6184667,3.426764234055379
KMS-27,9926054,0.4648817543416692
NCI-H1395,9967941,3.3785918920686924
NCI-H2110,44566777,0.634528654722784
OE21,462382,0.6347226239367584
KMS-27,6610355,3.513461387639252
KMRC-2,11626560,1.6099167107882515
HARA [Human squamous cell lung carcinoma],135411,-0.5831763791629045
HSC-4,1566236,1.9723291328750472
Kasumi-2,3384730,0.4985599128931971
KMS-20,262093,1.6065117070445694
NCI-H2172,25126798,3.994275511302363
Ku812,54618164,2.681700331746246
CA46,5311281,1.0891225881142432
LNCaP clone FGC,104842,-4.4374315412875065
OE21,219104,4.351276400343982
D283 Med,4788,3.843501603973715
AN3-CA,11955716,-2.3983129306617808
LoVo,5281672,4.34355838965171
CA46,11228183,3.2150932794291975
KMS-20,11625818,3.818760510140028
Aska-SS,navitoclax-gemcitabine (1-1 mol-mol),0.2099132566273462
CA46,71466445,1.6737757590775906
AU565,135440466,3.093480574806016
NCI-H1092,49793307,-5.3090977764299145
SNU-1272,1750826,-1.393591916045707
ML-1 [Human thyroid carcinoma],439501,-1.5032891627146094
SKM-1,25195348,1.6929147684241908
RERF-LC-Ad1,409805,6.089650612893954
KMRC-2,carboplatin-UNC0638 (2-1 mol-mol),3.5447345065764937
Raji,60750,-3.9202655295609494
LNCaP clone FGC,11626560,2.371237682390705
NU-DHL-1,3062316,-0.3341948851357335
SEM,6505803,-1.7011482867291614
LoVo,56949517,2.258326270055845
A4/Fukuda,219104,2.2512696330904447
SNU-1033,6610355,4.276058849180123
D283 Med,11317348,2.3932264978402613
CA46,44137675,2.206940954689562
BT 139,5311,2.7929451938045355
D283 Med,148198,-7.782574988452476
BT 328,216239,3.5186612290950148
SNU-1033,11609586,2.722899451063462
Hep-G2,selumetinib-MK-2206 (8-1 mol-mol),-0.3910940132297484
LoVo,71680916,4.224958300762603
HARA [Human squamous cell lung carcinoma],3385,4.962584280578164
NCI-N87,656346,-0.0410900008101642
CML-T1,alisertib-navitoclax (2-1 mol-mol),-1.6309921665617133
Hs 683,9825149,1.7777217272553436
YKG-1,5311281,1.228854081788957
BT 330,53495165,-1.711062636200042
KMRC-2,navitoclax-piperlongumine (1-1 mol-mol),1.2623504539336696
HMCB,navitoclax-gemcitabine (1-1 mol-mol),-1.404873290232393
NU-DHL-1,selumetinib-PLX-4032 (8-1 mol-mol),3.261247948908544
Kasumi-2,1750826,-5.270023181988586
KMS-27,9936388,-7.881651109846528
NCI-H2110,24753719,4.19042786016423
KMRC-2,24748573,3.264041019770869
YKG-1,2126,5.813283713723567
KYSE-410,54143018,0.3314221651877773
SNU-308,11234052,4.284422221510759
HMCB,5746,1.3604590054330616
MM1.S,56946209,-4.843485824557046
KMBC-2,selumetinib-JQ-1 (4-1 mol-mol),1.4650712581947256
Aska-SS,9967941,3.6787786216313303
Kasumi-2,46224516,1.9043930771708657
KMS-20,25262965,-3.079526617825105
RERF-LC-Ad2,107985,-4.355232294484495
SNU-1272,19582717,3.9947115976130423
MM1.S,crizotinib-PLX-4032 (2-1 mol-mol),1.0198368521760113
SET-2,262093,0.9752595476876692
CA46,2746,0.9501634288999758
HSC-4,135659046,3.804399419736421
D283 Med,119182,-3.5504334050643314
SW1990,JQ-1-MK-0752 (1-1 mol-mol),3.1533696321662243
LoVo,23582824,-0.7966748622900964
PaTu 8988s,49793307,-4.962170953630436
SNU-1033,11626560,1.7306664010056585
SEM,25126798,3.9463817961224215
SNU-1033,6610216,4.08331616990365
Hep-G2,5311,0.6170411040071866
OE21,11625818,4.024138239241509
BT 139,decitabine-navitoclax (2-1 mol-mol),0.8812766124383217
KYSE-410,409805,4.5262440773568
NCI-H1092,11609586,2.567320203791852
KMS-27,11222830,0.7896621936309496
CA46,crizotinib-PLX-4032 (2-1 mol-mol),1.0865859048820203
Ku812,6918878,1.294263756548978
D283 Med,crizotinib-PLX-4032 (2-1 mol-mol),3.638694658116099
BT 248,676352,1.654368845250315
Hs 683,31703,-1.3519603121797323
D283 Med,2742550,3.5680258108109975
KMRC-2,1716436,3.689982087798527
SKM-1,44632017,0.051151225180369
TE-15,24748573,2.303795360135107
NCI-H2110,9907093,3.9192439301831734
NCI-H1092,tanespimycin-gemcitabine (1-1 mol-mol),0.9307316859155624
AU565,11234052,4.466615830851295
KMS-27,448949,2.041269365132705
TE 617.T,11977753,-2.378492704797965
TE 617.T,24180719,3.6567645960116497
NU-DHL-1,BRD9876-MK-1775 (4-1 mol-mol),0.6044264218877945
PE/CA-PJ34 (clone C12),11717001,4.9585803256068655
CA46,docetaxel-tanespimycin (2-1 mol-mol),-7.203765496579748
OE21,ISOX-bortezomib (250-1 mol-mol),0.2016252783580098
LNCaP clone FGC,decitabine-navitoclax (2-1 mol-mol),3.8356105754036025
NU-DHL-1,11707110,-4.149720194824857
AN3-CA,serdemetan-SCH-529074 (1-1 mol-mol),2.3645494916379532
Ku812,44507138,1.5251260017472812
NCI-H2110,selumetinib-tretinoin (2-1 mol-mol),4.2127406612871345
NU-DHL-1,3825829,3.145887822053552
KMBC-2,227681,3.9637269491798386
NCI-H2172,322968,4.774024266828323
HARA [Human squamous cell lung carcinoma],441298,0.3301976976056055
NU-DHL-1,49793307,-5.248785765365087
PE/CA-PJ34 (clone C12),3634881,3.34497371174834
Kasumi-2,navitoclax-piperlongumine (1-1 mol-mol),-3.156994425462095
SET-2,9826308,0.9008531739680242
NCI-H2172,17755052,2.9928260796165196
NU-DHL-1,9549297,1.597119849266011
RERF-LC-Ad1,126941,-1.292812823712893
SNU-1272,54618359,4.4674166850323624
KYSE-410,11507802,0.9736774052187488
AN3-CA,5351362,1.5175170648938876
NU-DHL-1,52947716,2.976276735024036
AU565,107970,1.9067452119355752
NCI-N87,11152667,-0.2953714197447944
RERF-LC-Ad2,5282054,2.499117900782071
Hs 683,15953870,3.706668121424788
MCAS,969516,1.3336911200408736
NCI-H2081,9884685,-0.1678318744759171
SNU-1272,25195348,5.361331640653284
MM1.S,5311,0.1972006182392905
SNU-1214,25126798,4.0560100491189575
NCI-H2110,24821094,3.684367762026687
SNU-8,docetaxel-tanespimycin (2-1 mol-mol),-4.581039340886612
SEM,3136844,3.235068436368959
SNU-1033,5282054,3.1260262048593246
NCI-N87,54619267,3.778794485594146
IST-Mes1,73707398,1.324483483158502
BT 330,3025986,-0.5037878900572669
SNU-1214,148198,-3.317197477709626
PE/CA-PJ34 (clone C12),selumetinib-navitoclax (8-1 mol-mol),1.660781192604045
Ku812,selumetinib-piperlongumine (8-1 mol-mol),-1.2433230226916236
BT 330,1716436,2.18293804812622
IST-Mes1,selumetinib-JQ-1 (4-1 mol-mol),0.7556363714344752
KMS-27,262093,2.820550232220946
SNU-1214,15983966,-3.997780013419944
NCI-H2081,327653,2.703400517065932
SNU-8,219104,4.134632076675879
SW1990,7326481,4.182711938657022
LNCaP clone FGC,123631,3.551253848409697
NCI-H2172,9911463,3.8994270098936745
SKM-1,9825149,0.9402099583911157
KMS-20,5311281,0.7208695610939495
HARA [Human squamous cell lung carcinoma],135421197,2.918907943246249
BT 320,44607530,2.9331646844346015
SET-2,31703,-1.4005504220650808
TE-15,11625818,4.172467616978408
Raji,3384730,0.7697959861519768
Kasumi-2,49867930,4.763867340262508
KMBC-2,25262965,0.9196876948223344
CML-T1,445455,4.626862894514658
Raji,451668,-0.235814270926015
LNCaP clone FGC,JQ-1-navitoclax (2-1 mol-mol),-1.107225810907736
SNU-308,5280436,4.624627017937284
KMS-27,44632017,0.8900196687878457
Ku812,54613361,-1.6579291545050676
KMS-27,135421197,2.249002810195298
NCI-H2172,3025944,4.329147396053403
BT 248,54649381,3.7327878949357394
MM1.S,49850262,1.6998908770625267
MM1.S,26596,-1.4234323398175248
SNU-8,JQ-1-MK-0752 (1-1 mol-mol),2.196982018923842
Kasumi-2,44202524,1.2131871054756846
IST-Mes1,9911830,1.5716425903239464
D283 Med,67156097,-2.9733455385355803
RERF-LC-Ad2,448949,1.713494552366947
Ku812,decitabine-navitoclax (2-1 mol-mol),-1.352567227704547
A4/Fukuda,2858523,2.415383768636832
LNCaP clone FGC,selumetinib-JQ-1 (4-1 mol-mol),0.1140146745231702
NU-DHL-1,11507802,0.1368599707509103
IST-Mes1,carboplatin-UNC0638 (2-1 mol-mol),3.3529895985097675
AU565,46191454,1.308540851634407
NU-DHL-1,10113978,2.330797013945373
SNU-8,51039095,3.4477657093502465
AN3-CA,9840324,5.532669136405244
SKM-1,60750,-2.55232212647046
TE-15,57519531,1.62599243838619
Ku812,11214940,0.086295431184551
Hep-G2,16736978,0.6632271469742936
BT 139,11152667,1.692404589023897
EJM,9840324,5.73899517118649
OE21,5460769,0.0529032243874579
PaTu 8988s,168313016,4.471656567537183
TE 617.T,11625818,4.430228460646322
SKM-1,374536,2.026505336627946
SET-2,9935249,0.876527985665801
KMRC-2,3634881,3.0472209218282407
HARA [Human squamous cell lung carcinoma],6184667,2.5882672266365128
Aska-SS,6252,2.0109053160371495
PE/CA-PJ34 (clone C12),2742550,3.898499868649933
A4/Fukuda,65064,3.1077716650538707
SNU-8,44507138,2.862034957014357
D283 Med,71466578,4.625574960038893
AU565,5287969,-1.6574542255158256
SKM-1,9868037,0.7505046314280106
LNCaP clone FGC,5738263,3.2803193382868745
NCI-N87,11507802,1.464328650743575
D283 Med,11507802,0.4939974977002742
KMBC-2,5282054,4.007403455924559
SNU-8,24951314,1.2731371289268598
OE21,25022340,4.370946816483807
NU-DHL-1,9926054,1.5745053582273782
NCI-H1092,53232,4.715701338222689
KMS-27,36462,-0.3122628984401899
BT 320,selumetinib-vorinostat (8-1 mol-mol),4.325017392219319
NCI-H2081,984333,-0.4217004435784025
RERF-LC-Ad1,3815108,3.6891446241117873
HMCB,51037431,1.7476286222602764
HEC-151,445455,5.064867513059979
AN3-CA,5287620,-3.0172646542127266
HMCB,45279963,3.8576212029181343
Hs 683,42611257,2.9373074107201167
TE 617.T,11175137,1.2522835808510424
D283 Med,445455,1.4902396217257328
LoVo,31703,-2.470313869470646
SNU-1214,24180719,2.9494589381604026
SEM,445643,-5.7878039164156725
HCC2218,3062316,3.0327849170125254
SNU-1272,12001922,1.7945381645240002
MCAS,4378219,2.0291292173835993
ML-1 [Human thyroid carcinoma],11507802,1.1504003941708354
MCAS,11612883,2.389047416071472
A4/Fukuda,15953870,2.701018205920996
KMBC-2,navitoclax-birinapant (1-1 mol-mol),-2.0894974372494612
Raji,68056272,3.875053228439545
KMBC-2,49836020,0.1766293750985906
HSC-4,123631,0.7882754974693414
Ku812,6914657,-6.377173707713946
EJM,11955716,-2.8070580374393073
SNU-8,44632017,1.3384899891643445
Ku812,10231331,-1.9439726513116764
KMS-20,16219061,1.4676215792149392
KYSE-410,3854666,3.296773212929304
TE-15,9823820,4.008583302696159
OE21,11609586,1.989609074462123
KYSE-410,44607530,1.8240121580330635
RPMI-7951,135421197,2.3107830834906324
SW1990,262093,3.247926984778252
PaTu 8988s,alisertib-navitoclax (2-1 mol-mol),-0.4124098932275182
KMS-20,2126,4.021349157282486
Aska-SS,2749,2.558429780989752
SET-2,7251185,1.3721361326487145
Hs 683,10322450,2.9588176453624766
SNU-1033,selumetinib-BRD-A02303741 (4-1 mol-mol),-1.3301681028325698
ML-1 [Human thyroid carcinoma],135659046,3.731165476589243
A4/Fukuda,selumetinib-BRD-A02303741 (4-1 mol-mol),0.8807124285351838
NCI-N87,5311,0.9556802173694716
MCAS,46907787,1.67067233253558
KMS-27,11656518,2.105180970638757
SNU-308,54454,2.6349591428314114
Kasumi-2,5281672,3.402650415017694
SNU-1214,15953870,3.760154168645951
ML-1 [Human thyroid carcinoma],carboplatin-UNC0638 (2-1 mol-mol),3.254418532258765
NU-DHL-1,56949517,4.418216826583101
SNU-308,9903786,2.008516122429012
NU-DHL-1,15547703,3.0121998321464805
RPMI-7951,17755052,0.7587041071085807
HMCB,10302451,4.070081150685941
Aska-SS,15983966,-2.33945991717623
LNCaP clone FGC,168313200,2.110708126530363
Hs 683,285033,-2.9773704601582636
CA46,9903786,1.650432742323398
SNU-1033,676352,1.6833566564961218
LNCaP clone FGC,148198,-3.4579469990265124
NCI-N87,5281672,5.2421020595736145
NCI-H2081,73707438,4.181676139303675
LoVo,6610355,3.962139785065475
SNU-8,11964036,0.9664399553551418
NCI-H2172,148198,-0.2534137859754289
HMCB,462382,0.5929109293335464
NCI-H2081,docetaxel-tanespimycin (2-1 mol-mol),-5.990158626012855
SW1990,navitoclax-birinapant (1-1 mol-mol),3.1067469492017232
GOS-3,16736978,3.431687375441577
A4/Fukuda,2708,3.0461577581065007
ML-1 [Human thyroid carcinoma],49846579,3.632639122540709
HSC-4,vorinostat-carboplatin (1-1 mol-mol),3.405772607796717
A4/Fukuda,24772860,-3.4983689572797307
SEM,23635314,-3.712591806997875
NCI-H1395,374536,5.636718886348253
RPMI-7951,6918837,-3.6765620040448783
MM1.S,5978,-3.473474877410116
MCAS,54626689,5.742619105162711
SEM,400769,-1.6212646015616712
SEM,11404337,-1.9668178292815095
SNU-308,44589607,4.7032544289207125
MM1.S,10113978,2.8208205912142597
CA46,9823820,1.6053302041689723
Hep-G2,637858,2.4710681435790747
KYSE-410,613753,3.317152261963387
GOS-3,24964624,2.7234427755560233
SNU-308,5113032,5.401232227004145
CML-T1,65628,2.7154825762494057
SNU-308,1750826,-0.3400503245695513
MCAS,selumetinib-GDC-0941 (4-1 mol-mol),0.6896207239253057
NCI-H2081,JQ-1-carboplatin (1-1 mol-mol),1.838328263048474
KMBC-2,216468,4.2660484739392714
HARA [Human squamous cell lung carcinoma],100016,5.315547253627084
LNCaP clone FGC,11404337,0.2192821981043099
ML-1 [Human thyroid carcinoma],9444,3.622178437751676
TE-15,5328940,0.2955762085250979
EJM,6918638,-1.326291213724497
KMS-20,613753,2.7781873523971687
OE21,16741245,4.961434938976918
MCAS,sirolimus-bortezomib (250-1 mol-mol),0.8032325328072784
LNCaP clone FGC,53481919,3.2974380827462633
KMS-20,5494449,2.3670693825128164
TE 617.T,46215462,1.4610108551553505
LoVo,5282054,3.3404837473565077
RERF-LC-Ad2,10302451,4.090867148457294
RERF-LC-Ad2,44607531,1.5056793765283658
NU-DHL-1,9907093,3.5839802480186713
SNU-1033,44607530,1.187440277371415
PaTu 8988s,selumetinib-MK-2206 (8-1 mol-mol),0.9064049603975098
MM1.S,65628,3.725915125304722
AU565,45279963,3.869118795762884
TE-15,JQ-1-vorinostat (2-1 mol-mol),-1.090745465541189
LoVo,selumetinib-JQ-1 (4-1 mol-mol),-1.8361098312254576
KMS-20,71751553,3.937106268474675
Hep-G2,4096211,2.329353731718805
RERF-LC-Ad1,44819697,0.2089459186593415
D283 Med,11427553,4.872458207858214
KYSE-410,SNX-2112-bortezomib (250-1 mol-mol),-2.4286427831534767
KMRC-2,17755052,2.40271888708834
SEM,216468,-1.0998833452832146
CML-T1,11396600,3.3654395371867425
TE-15,6505803,-1.869936847714552
KMS-27,60700,-3.1346357302250403
KMS-20,445091,4.2633800487131275
Hs 683,2749,1.5429350911360808
KMS-27,25126798,4.301851729139167
KMBC-2,3503,1.2413837341976814
BT 330,57330099,5.445552954780525
TE-15,11228183,3.3640474187882576
HCC2218,216239,1.3361151410076062
D283 Med,135398516,0.8377293343644862
CA46,71466578,1.7711352492213497
AU565,176870,1.580958212812136
KMS-27,10231331,-2.582639088661463
A4/Fukuda,tanespimycin-bortezomib (250-1 mol-mol),-0.1272603681833176
AU565,10385095,1.377392665812461
KMS-20,10127622,1.0951348794097868
CA46,6505803,0.7805822725654986
Raji,219104,3.2113175627591817
HEC-151,JQ-1-vorinostat (2-1 mol-mol),0.8892638871442682
MM1.S,36314,1.7843068012903331
SNU-1272,11364421,0.105074823044801
KYSE-410,11977753,-2.672714604263493
SET-2,375860,-0.3203156821570778
BT 248,44589607,2.2150317514642635
HCC2218,5284616,2.8874763223731805
BT 139,11455910,0.9756266505311688
SEM,1750826,-0.892835267111722
LoVo,selumetinib-MK-2206 (8-1 mol-mol),-1.1472378913456864
LNCaP clone FGC,tanespimycin-bortezomib (250-1 mol-mol),-2.6061183463030138
OE21,11647372,1.281241297693498
Kasumi-2,5460769,1.467216518279754
IST-Mes1,24753719,4.106786270688489
CML-T1,9823820,1.5491308586448294
Ku812,135875424,4.708872885868404
SET-2,salermide-PLX-4032 (12-1 mol-mol),5.224494931200647
Ku812,9926054,1.5145588468111315
TE-15,5746,-0.1886497101513132
LNCaP clone FGC,5278396,3.111775886688035
SET-2,11396600,3.171295781716927
Kasumi-2,6505803,-2.445084849944434
KMS-27,9866186,-0.3625285569835875
ML-1 [Human thyroid carcinoma],JQ-1-navitoclax (2-1 mol-mol),0.5559974390910295
BT 330,10427712,4.8242407419217095
BT 328,156414,4.0443464949872645
D283 Med,65064,2.891889878161975
HEC-151,3384730,1.630714045247598
LNCaP clone FGC,25154868,2.839691532506865
LoVo,54678924,0.9602640778132784
SEM,11612883,0.3199155998762981
KMS-27,11178236,-5.969829351072696
AU565,5281321,-1.6701173206544262
BT 320,72376,3.3397736941212433
EJM,31703,-1.6176826113818792
Hep-G2,400769,-0.0290927499508633
NCI-H2081,15547703,3.0939456177037945
KMBC-2,4477,1.229312067583003
HARA [Human squamous cell lung carcinoma],12001922,1.8002757111950325
TE 617.T,navitoclax-PLX-4032 (1-1 mol-mol),3.682311343585133
NU-DHL-1,8515,3.2734160853720105
Ku812,73707440,4.534867519967767
HEC-151,3854666,1.712269153838878
SNU-1033,24772860,-2.288475118116987
Raji,67156097,-2.169522461967466
HCC2218,2733487,6.357125769523036
LNCaP clone FGC,52912189,-0.9055719998181776
BT 328,1714884,3.4592731205549225
LNCaP clone FGC,6917907,-5.735621263633647
IST-Mes1,24964624,2.9505066533460464
SNU-1272,3038522,4.319393949707529
ML-1 [Human thyroid carcinoma],135875424,5.514442636506433
Aska-SS,107970,1.9510492684161391
SET-2,54596558,4.29557036905182
NCI-H2172,46199207,3.6599874133069337
KMS-20,15547703,2.6043322601948455
NCI-H2110,126941,0.8722085310593726
OE21,11719255,3.641646729629715
HCC2218,46926350,-3.897277890341576
Raji,6918328,-2.1612103654061516
TE 617.T,676352,1.4740706229451386
Hs 683,135875424,4.08610069423659
SNU-308,119607,5.862083488797092
NCI-H1395,135421197,1.2810683988074232
LoVo,6918837,-3.586713596901602
EJM,1566236,1.0332712944799087
SW1990,4096211,2.802021609981973
AN3-CA,16038120,1.3578591252446268
HSC-4,5479543,4.052409111099337
D283 Med,2874250,4.322597187496923
Aska-SS,322968,2.5996922122858286
NCI-H2172,23725625,6.323541290892874
Kasumi-2,54596558,4.023508952920703
NCI-H1395,1566236,2.7287407900944056
HSC-4,9926054,2.0278633205902468
HARA [Human squamous cell lung carcinoma],42642645,0.3266919515257925
HARA [Human squamous cell lung carcinoma],44589607,3.368220225067554
KMBC-2,10410894,2.9583144658422578
ML-1 [Human thyroid carcinoma],151289,2.136095657957592
HARA [Human squamous cell lung carcinoma],9549297,1.8946305959472185
TE 617.T,753704,4.601983889014857
SKM-1,9911830,2.174138233230932
Ku812,216239,0.9318176026438576
SNU-1214,19582717,3.35756148215671
PE/CA-PJ34 (clone C12),10296883,4.08655394492647
AN3-CA,6438330,1.0525165882785603
HEC-151,6623618,2.715792717872131
NCI-H1092,JQ-1-navitoclax (2-1 mol-mol),1.6253507016019415
RERF-LC-Ad1,676352,3.2240701362689204
SNU-1033,JQ-1-UNC0638 (2-1 mol-mol),0.3734309129675442
RPMI-7951,selumetinib-navitoclax (8-1 mol-mol),3.6622736037580506
NCI-N87,navitoclax-birinapant (1-1 mol-mol),2.0087616801931953
TE-15,2945648,2.9214028652347146
SW1990,docetaxel-tanespimycin (2-1 mol-mol),-4.562574826687001
HSC-4,selumetinib-piperlongumine (8-1 mol-mol),4.641326276625381
SEM,1716436,1.599764996763199
CML-T1,151289,0.34759640697574
NCI-H1092,docetaxel-tanespimycin (2-1 mol-mol),-2.441864918067417
OE21,637858,2.675555960290433
EJM,9915743,0.880814312418276
NCI-N87,452548,-1.772451424496647
OE21,107985,-4.136076680497118
NCI-H1395,11612883,3.2235820919891256
IST-Mes1,44607531,1.530053859314775
NCI-H2110,5328940,1.6135446259472608
EJM,24964624,2.1494935456800524
SNU-1033,374536,2.1253296894333595
OE21,11497983,4.210886829963034
Ku812,4917,2.1486710085794907
HMCB,16065773,1.8456110367577696
KMS-20,68056272,3.2246681172521083
Hep-G2,10113978,2.1536070556409252
NCI-H1092,5328940,2.2239525200024812
KMBC-2,11427553,3.346878465040894
OE21,6450551,3.896590607543263
BT 320,11178236,-2.5149680405736095
Ku812,10113978,1.4581505574303557
BT 330,11175137,2.2159250165553175
D283 Med,702558,2.919468662006613
D283 Med,1242560,3.0255302054486797
Hep-G2,6623618,1.7960151363036378
A4/Fukuda,3385,2.3595203579832553
NU-DHL-1,selumetinib-piperlongumine (8-1 mol-mol),1.0467236701826856
GOS-3,1750826,-2.070069963305823
BT 139,16038120,1.5236761382209176
NCI-N87,SNX-2112-bortezomib (250-1 mol-mol),-4.305728707352715
SNU-308,11640390,4.99720907789617
MM1.S,6918878,-0.530970823966065
A4/Fukuda,72967,3.695839205584607
PaTu 8988s,3634881,3.6338790992057417
AN3-CA,6610355,3.5783077725767853
PaTu 8988s,1716436,2.523682098033693
CML-T1,11497983,1.5281324652658594
HCC2218,675434,3.068178566954701
YKG-1,11167602,4.915993662125618
AN3-CA,11222830,1.3124942675480578
NU-DHL-1,10231331,-1.2748802736904843
PE/CA-PJ34 (clone C12),9444,4.358841089309469
ML-1 [Human thyroid carcinoma],navitoclax-gemcitabine (1-1 mol-mol),0.4874661343054459
RERF-LC-Ad2,54619267,4.920908972450122
D283 Med,135411,-1.9342059509823124
BT 320,9936388,1.7913306244505192
A4/Fukuda,9887053,3.945623871756388
SEM,10385095,0.8510184643991832
GOS-3,16038120,1.102104110747453
HEC-151,60750,-4.918286912586691
PaTu 8988s,11228183,1.465741521328901
Aska-SS,3038522,2.2994557551251864
PE/CA-PJ34 (clone C12),66577038,3.169631550973707
Hs 683,11404337,-0.8094527425397864
EJM,16013152,4.173303948908386
EJM,5287620,-2.617076608456458
SEM,5311281,0.7085042450698669
KMBC-2,6918878,5.016118473072515
SET-2,2729026,2.5950867985485813
Hs 683,375860,-0.6026673211862823
Aska-SS,4917,2.9830188607886856
RERF-LC-Ad2,11396600,4.594180065221676
NCI-N87,selumetinib-MK-2206 (8-1 mol-mol),0.3550893984048577
KMRC-2,135999136,5.684896477141993
GOS-3,374536,2.2437065899634843
PE/CA-PJ34 (clone C12),46191454,1.75087551478746
Kasumi-2,44137675,1.606596454570492
HSC-4,3081361,1.976322212956416
MM1.S,52912189,-0.6988954799800143
CA46,5329102,1.3169898780971163
AU565,5280436,3.6175977861549473
HARA [Human squamous cell lung carcinoma],6917907,-4.425737266076785
Hs 683,5460769,1.3545224877290158
CA46,11213558,2.4131379110887496
SEM,25062766,0.2261975735754109
GOS-3,24951314,2.597884619205853
MCAS,9926054,1.882674367902201
Hep-G2,322968,4.552458908145698
AU565,6505803,-0.7592801042803803
PE/CA-PJ34 (clone C12),sirolimus-bortezomib (250-1 mol-mol),0.9308222519351572
KYSE-410,1242560,3.117603457732663
KMBC-2,9926054,2.0094384239747294
TE 617.T,11228183,3.5711926571560593
RERF-LC-Ad1,2729026,3.1916819737077544
HEC-151,3136844,3.785721585050869
LNCaP clone FGC,135875424,3.855348592559951
D283 Med,135875424,3.0041212409823053
CML-T1,44202524,1.467740802576286
YKG-1,71751553,4.894394979371257
TE 617.T,44493528,4.329408184341151
EJM,6918837,-5.817810388992218
BT 330,11955716,-1.5122245117562267
Hep-G2,6914657,-1.7030868105501842
Raji,2828334,5.860428709895134
HCC2218,5311,0.3074156467085373
MCAS,1716436,3.309095084683311
CA46,11494412,-0.1540181126177876
BT 248,119607,5.038088774684491
MCAS,selumetinib-decitabine (4-1 mol-mol),2.306653637135641
Raji,387447,-4.438252130288484
BT 248,168312962,0.3799536225395565
KMS-20,navitoclax-birinapant (1-1 mol-mol),1.2609328237028008
HEC-151,serdemetan-SCH-529074 (1-1 mol-mol),2.434687006434136
EJM,9933475,2.243114584101206
IST-Mes1,168312962,2.5289389848934647
CA46,241158,1.6221144264981358
PE/CA-PJ34 (clone C12),439501,-1.4242244228812553
NCI-N87,11238147,1.7339284670687316
CA46,11234052,2.4794836109026077
KMS-20,36462,0.8301461091099265
CML-T1,5738263,2.8352523784169525
HEC-151,123631,3.074698137891114
D283 Med,216468,1.9230482030211824
PE/CA-PJ34 (clone C12),119182,-0.6317231418312041
BT 248,11404337,-1.3909400551472375
OE21,10113978,3.4201681643891413
TE 617.T,241158,3.7218678617090046
KYSE-410,6450551,3.839411878776235
BT 139,6610216,4.145166206340405
NCI-H2110,6918837,-3.807984438873097
MM1.S,JQ-1-carboplatin (1-1 mol-mol),-0.259196457141764
EJM,3689413,-2.394173462666658
CA46,5479543,2.004846411807367
KMBC-2,11964036,1.6060621816091996
Hep-G2,444795,7.091940765135057
KMRC-2,2871966,3.883506418529128
OE21,71680916,4.326553499160839
KMRC-2,9884685,0.9059778924037538
Hs 683,17755052,1.7713282136584354
PaTu 8988s,JQ-1-MK-0752 (1-1 mol-mol),2.5222168454811587
NCI-H2110,6852167,2.8025502977558165
GOS-3,46224516,1.1736861645065142
GOS-3,25183872,-0.8854682014750674
Aska-SS,262093,2.4925778805334975
KMS-27,2113511,3.9580514489410055
NCI-H2110,4096211,1.8204932319862264
PaTu 8988s,5291,3.600934363557586
Aska-SS,5287620,-1.825079293822929
MCAS,11717001,2.616335887582357
SNU-8,5978,-2.8991524915618454
TE 617.T,51037431,3.159720457999306
LNCaP clone FGC,46191454,1.9215643093708543
KMBC-2,3062316,2.6254409075794793
HEC-151,65064,4.514175261653523
SNU-8,selumetinib-BRD-A02303741 (4-1 mol-mol),1.2329010527569984
HMCB,53495165,0.9664452371473048
D283 Med,56973724,2.3235035869013703
NCI-N87,654092,-0.6954721735465327
Ku812,6450551,-2.2531779420040694
KMS-20,89183176,2.765105860834293
NCI-H1092,135411,1.4198261476430412
Hep-G2,11214940,1.620296702627768
YKG-1,3825829,4.427024688096871
KMS-27,9927531,4.171626738694902
TE 617.T,49836020,3.775264114601375
Raji,452548,-3.42803254084333
Raji,9840324,5.728026147182044
BT 139,5329102,2.274248668376467
HCC2218,44491742,3.8267338846087497
SW1990,23582824,0.8486087379824238
KMBC-2,11396600,3.805651469243142
HCC2218,71304818,0.9959138044887994
NCI-H1395,3062316,3.8693774304021433
PE/CA-PJ34 (clone C12),9952709,3.276837469660591
MCAS,44493528,4.628123206531076
PaTu 8988s,16659841,5.259060239450496
SNU-1272,5311,1.8395995002993613
RPMI-7951,11497983,3.9908718874763065
ML-1 [Human thyroid carcinoma],446155,2.0206180645356766
SNU-308,44241473,4.357724828152583
KYSE-410,5284329,3.558631935754952
SNU-1272,erlotinib-PLX-4032 (2-1 mol-mol),3.2570907164419025
Hep-G2,46199207,3.164086950692396
OE21,45279963,3.506365906002621
SNU-1214,12003241,-2.886982661469118
TE 617.T,72193861,0.4830435506885093
SW1990,6438330,2.378775688549145
KYSE-410,11497983,3.552400835840505
Ku812,3136844,4.770484958270985
TE-15,19582717,3.5124908558846353
OE21,71466445,1.981156974013709
Kasumi-2,2733526,2.6717950038671003
EJM,56946209,-6.334554937515429
NCI-H2081,9911830,1.4932773015429426
BT 139,24951314,1.6700082362111186
NCI-H2110,5978,-7.271449933003033
RPMI-7951,11612883,2.6435847430306696
SET-2,136227924,2.6175155289445646
KMRC-2,5311281,2.8027596223007136
A4/Fukuda,4705,2.104501352907832
RERF-LC-Ad2,9936388,1.1598877099292195
GOS-3,4917,3.642810744950485
NCI-H2081,11640390,3.2499982344751994
KMRC-2,56973724,4.033388480468852
Hs 683,5328940,1.5291062612291195
TE-15,46926350,-4.66402826584901
MM1.S,11612883,1.791748337852018
D283 Med,BRD-K55473186,4.203896885474867
SNU-1272,selumetinib-MK-2206 (8-1 mol-mol),4.6345162541062495
Kasumi-2,11964036,-0.3814812468505845
NCI-H2172,24797083,1.3731500491005717
KMBC-2,46398810,2.775956594355702
ML-1 [Human thyroid carcinoma],8515,2.907082200923046
HMCB,46174525,5.186938834845106
SW1990,65064,5.293704077887717
NCI-H1395,navitoclax-birinapant (1-1 mol-mol),3.789667753469327
NU-DHL-1,44566777,0.8504751325231436
EJM,2746,1.455612839065016
HARA [Human squamous cell lung carcinoma],navitoclax-pluripotin (1-1 mol-mol),-0.7875744304636512
LNCaP clone FGC,71466578,2.9422708697309377
YKG-1,31703,-1.4076263674107627
CML-T1,9907093,3.685523679081733
CA46,644241,2.374325583681648
PE/CA-PJ34 (clone C12),31703,-1.629082926616254
NCI-H2081,25126798,4.162268106632209
HARA [Human squamous cell lung carcinoma],6918736,-1.65788247009277
PaTu 8988s,11234052,4.024340086805705
RPMI-7951,25150857,1.9350032965663828
KMRC-2,65064,5.247444442299946
BT 330,52947716,-8.855474291024809
NCI-H2081,10322450,4.110472568642291
GOS-3,5282054,3.980081801292934
HSC-4,148198,-2.795908666323494
A4/Fukuda,11427553,0.0702382308883879
SNU-1272,441298,1.7337519477990695
HMCB,5278396,3.758401391477414
OE21,11228183,2.8752736860379504
EJM,25102847,3.2089639074549123
CML-T1,119182,-4.6073645657146285
BT 248,25262965,0.9142276489527752
HEC-151,6918736,-0.5117244940884614
CML-T1,54143018,-0.824314936779772
LoVo,3543504,4.109477120593384
MCAS,9967941,2.033273226216494
TE 617.T,6505803,-2.094273905964543
BT 248,crizotinib-PLX-4032 (2-1 mol-mol),2.0944776626354145
LoVo,3503,2.2987332704820016
CA46,25105715,3.628482142858773
LNCaP clone FGC,JQ-1-carboplatin (1-1 mol-mol),-0.8145893926012049
NCI-H1092,71466445,6.1929235006275585
NCI-H1092,11955716,0.959637304928072
SET-2,SNX-2112-bortezomib (250-1 mol-mol),-2.5339305074195804
BT 139,23582824,0.4442856742848364
SKM-1,216239,2.5216092374481716
KMBC-2,9935249,2.7698221479828726
Aska-SS,tanespimycin-bortezomib (250-1 mol-mol),-0.5241440221117086
KMBC-2,11228183,0.6800152041543918
TE 617.T,3634881,2.7724417169905937
RERF-LC-Ad2,24964624,2.450772716957221
OE21,5278396,3.185832182245697
Hep-G2,11404337,0.9907256098180968
IST-Mes1,216239,2.2087908746431517
BT 248,24748573,2.3039416185334556
LNCaP clone FGC,9915743,0.7205657109253502
TE-15,2733526,4.691356739445882
SNU-8,52912189,2.5544077359525525
Aska-SS,9926054,1.7306138768842658
PE/CA-PJ34 (clone C12),serdemetan-SCH-529074 (1-1 mol-mol),2.712414122638107
HARA [Human squamous cell lung carcinoma],11175137,1.814800704414418
BT 330,11485656,2.0154555749445486
Kasumi-2,9915743,-0.5759730647314978
SW1990,2749,1.9109779661146389
EJM,11497983,5.0496561241094895
NCI-H2081,71466445,4.38598643785932
Ku812,4788,3.899894541585596
LNCaP clone FGC,67291369,1.777562821585299
HCC2218,9549297,1.4476788481664282
OE21,3385,1.6130767225067393
SEM,10074640,2.905756912957373
SW1990,216239,3.0623929345543215
NCI-H2110,71751553,4.36348548213894
BT 328,2749,4.811351487491957
LoVo,4521392,4.145025799048703
BT 330,24753719,4.584303652526146
ML-1 [Human thyroid carcinoma],9887053,4.856845998315694
RERF-LC-Ad1,4259181,1.1969151495318886
KMRC-2,46907787,4.616997253710001
NCI-H1092,11719255,3.2848713677183334
A4/Fukuda,25262965,-4.823082336145625
SNU-308,51039095,3.440816334307095
NCI-H2172,56946209,2.15106765647146
BT 330,25183872,-1.681997867633064
PaTu 8988s,5460769,4.375147735669684
KMS-20,151289,1.001427412715124
LoVo,16065773,3.0239362353443195
MM1.S,656346,0.8966007785283742
KMBC-2,9952709,2.878804400852848
HARA [Human squamous cell lung carcinoma],208908,3.016531266929929
KMS-27,9952709,2.9518413251695477
ML-1 [Human thyroid carcinoma],11485656,3.567697107596816
KMS-20,135411,-0.1800034953276003
TE-15,3025986,-1.5294083137639527
CA46,24771867,-0.8036362931877258
CA46,135398738,2.145043320547598
Raji,969516,2.3459011615837677
KMBC-2,60700,0.1804497253264331
KMS-27,selumetinib-JQ-1 (4-1 mol-mol),-2.808360563321437
KYSE-410,9911830,2.598803177921042
SNU-1272,5284329,5.057648103020769
KMBC-2,53392493,3.27166937772612
TE 617.T,UNC0638-navitoclax (1-1 mol-mol),1.3072146472034474
AN3-CA,10427712,3.685891925367644
MM1.S,135398516,0.5060788410645305
NCI-H2110,11647372,1.4254628745095883
ML-1 [Human thyroid carcinoma],24901704,3.6288922396747743
KMRC-2,9933475,0.5684361183115326
Kasumi-2,135411,-1.6102115279025644
SET-2,36314,-4.420810932896412
PE/CA-PJ34 (clone C12),9866186,0.7220729418823932
SET-2,15983966,-4.296182260528854
KMBC-2,10074640,3.129680306387812
NCI-H2081,6252,0.369666564038939
SNU-1214,71466380,4.053214344929856
Hs 683,1566236,3.857796471842603
SET-2,208908,3.114087339668993
SNU-1214,9935249,2.745312094811984
SNU-1214,46191454,1.616623098413041
KYSE-410,56963564,1.1375859752415496
ML-1 [Human thyroid carcinoma],25062766,2.2645177949682775
RERF-LC-Ad2,10410894,5.556064790125131
PaTu 8988s,selumetinib-navitoclax (8-1 mol-mol),0.853510092858617
D283 Med,462382,-0.0438075540116339
HCC2218,serdemetan-SCH-529074 (1-1 mol-mol),1.544370866238826
NCI-H2110,4705,2.9559067422385494
D283 Med,11222830,1.8597449067047809
KMS-20,11707110,-4.269527722527802
BT 328,11257553,2.5148124289145217
KYSE-410,doxorubicin-navitoclax (2-1 mol-mol),-0.1636166485621063
SET-2,72199292,1.0742082962080146
BT 328,568763,1.8540976735744827
PaTu 8988s,445643,4.25778743866418
MCAS,216239,2.896051690918329
SET-2,44493528,4.2834335976641205
AN3-CA,2858523,2.9756329830987536
SKM-1,5328940,0.3112400146687634
Ku812,selumetinib-JQ-1 (4-1 mol-mol),-3.4448372792658857
KYSE-410,11152667,-0.1422079620328849
NCI-H2110,676352,2.552766155691823
HCC2218,54619267,3.644262219384105
LoVo,135928012,4.12079355273469
KMBC-2,4259181,1.3883022744442572
BT 139,11507802,3.556283958105639
MM1.S,11719255,2.0947187008170887
GOS-3,46398810,2.269718225041391
CML-T1,148198,-3.9003291277504526
AN3-CA,3384730,2.8247802599275618
Kasumi-2,46199207,3.5720995907025803
ML-1 [Human thyroid carcinoma],6918736,-3.4697519345619843
BT 320,52947716,3.1695176437652757
CML-T1,24785538,1.8797614633691848
HMCB,1566236,1.7394312384979265
AU565,10322450,3.206832643999438
BT 248,alisertib-navitoclax (2-1 mol-mol),-0.6283307077190651
KMRC-2,44137675,4.642823566259911
TE-15,445091,4.176775577912737
SET-2,702558,3.0142996947729848
BT 248,1750826,0.7778964775949998
AU565,4578,4.456552707084199
CML-T1,15953870,2.3626237456804025
LNCaP clone FGC,54639665,5.111125595868773
Raji,135398738,3.1562560071283907
SNU-1214,446155,1.554024884222307
TE 617.T,9927531,4.756324122053051
Kasumi-2,sirolimus-bortezomib (250-1 mol-mol),-0.078386775418122
TE 617.T,tretinoin-navitoclax (4-1 mol-mol),4.714029382854611
KMS-27,656346,-0.3984160294388325
PE/CA-PJ34 (clone C12),5470400,-0.1416170344108112
AN3-CA,23582824,-0.662849754096843
OE21,6505803,-1.9429365414296416
Kasumi-2,54618305,4.391643278203803
NCI-H1092,JQ-1-vorinostat (2-1 mol-mol),1.0867450445892073
KMS-27,crizotinib-PLX-4032 (2-1 mol-mol),2.7895791268037966
BT 328,54618771,1.300712581347958
NU-DHL-1,24856436,-1.132887458167272
BT 139,46224516,3.3567883234175406
SNU-8,crizotinib-PLX-4032 (2-1 mol-mol),2.308629614617598
SW1990,16038120,0.769493188570446
NCI-H1395,5978,1.0563157186154253
GOS-3,1566236,2.0611902912111013
Hs 683,135398516,3.188206567673989
KMS-20,568763,-0.7936979653536971
KMS-27,135984461,4.260058247162953
IST-Mes1,4917,3.386112443694605
SNU-1214,46907787,-0.1476900319760525
Hs 683,5311,1.7997560518290772
NCI-H1092,374536,2.5568939719400707
AU565,4261,1.5351844706992892
KMS-20,44819697,-0.2921256349223009
SNU-8,1716436,3.464795989893741
LoVo,vorinostat-carboplatin (1-1 mol-mol),2.43633518664014
NU-DHL-1,4578,4.105143209459994
SEM,44202524,1.290193172725863
AU565,119607,5.010456243294951
GOS-3,6505803,2.171469842265414
SEM,5743,-3.3598270412643347
A4/Fukuda,9840324,5.782088483619631
PaTu 8988s,1641662,3.5300797376584305
NCI-H2172,73707398,2.7683774259754914
A4/Fukuda,11485656,1.5130746228374388
SNU-8,49766530,-3.645853792041198
MCAS,25195348,2.845282760757658
NCI-H1092,navitoclax-MST-312 (1-1 mol-mol),0.5756040063373493
RERF-LC-Ad2,selumetinib-JQ-1 (4-1 mol-mol),5.304471125852225
SNU-1214,168313047,1.8606762103685877
OE21,445643,3.8717408037013703
SKM-1,57519531,1.204378273950668
NCI-H2110,44491742,4.139827167651669
SEM,SNX-2112-bortezomib (250-1 mol-mol),-3.272404633264421
AN3-CA,docetaxel-tanespimycin (2-1 mol-mol),-5.191099882644974
CA46,1566236,0.9666867201201066
NU-DHL-1,24180125,2.343403566122717
Aska-SS,9843750,4.126997970153608
SW1990,11178236,-3.6963335662856016
NCI-N87,119607,4.916125105909822
SW1990,46907787,4.845912107981417
BT 248,57519531,6.254880017804167
MCAS,4096211,1.525593887066156
BT 248,400769,-0.0166923245796401
LNCaP clone FGC,219104,4.612823227672206
LNCaP clone FGC,71466445,3.001006325551692
CA46,24775005,3.732581966598925
NCI-N87,25126798,3.678424158745535
LoVo,4261,-0.8211989197292223
BT 330,11625818,5.530530948719102
A4/Fukuda,24748573,1.3032837048402657
TE-15,67156097,-2.99459281057827
IST-Mes1,25183872,0.0748637978909832
Kasumi-2,tretinoin-carboplatin (2-1 mol-mol),2.8935059772434792
SET-2,5394,4.234029843739517
KYSE-410,3676137,3.886818634834923
ML-1 [Human thyroid carcinoma],11427553,2.643507576643823
KMS-27,3081361,3.484716209908866
KYSE-410,3815108,3.2500534674852743
EJM,72193861,-0.1961911914583163
NU-DHL-1,9933475,1.7184020266323787
AN3-CA,4096211,1.3018433501999591
NU-DHL-1,44589607,1.1355203141192094
KMRC-2,5351362,1.4627270802530556
CML-T1,42642645,-1.8637300463446456
AN3-CA,46843906,4.15372068511724
KMS-27,salermide-PLX-4032 (12-1 mol-mol),5.559658617499442
NCI-H1092,navitoclax-gemcitabine (1-1 mol-mol),-1.9058386314503173
NCI-H2110,3081361,2.457740426443218
Aska-SS,11494412,1.6723137258667875
SEM,4578,3.613772546494987
AN3-CA,9903786,1.5268103297033566
BT 328,1566236,2.4214904059930156
AU565,54678924,2.5293429329053763
KYSE-410,26596,0.1189340940832646
BT 248,53392493,1.7075191079379444
NCI-H2081,36314,-5.947411488726424
MM1.S,9911463,3.396498541948332
LNCaP clone FGC,navitoclax-MST-312 (1-1 mol-mol),0.9978593113162046
EJM,11455910,0.7170091081693915
Ku812,89928392,0.3085887086853859
BT 330,11238147,1.6995695818769838
SNU-1033,119607,5.415425235504449
HEC-151,11234052,3.9846011660902367
HSC-4,53495165,1.6708694504220498
BT 328,54678924,4.095049817388681
NCI-H2110,5287620,-2.255110543638233
HARA [Human squamous cell lung carcinoma],24748573,1.9169510591730587
KMS-20,selumetinib-GDC-0941 (4-1 mol-mol),-0.2221231396150395
EJM,sirolimus-bortezomib (250-1 mol-mol),0.0278018018083393
ML-1 [Human thyroid carcinoma],5328940,1.048806619411155
SEM,322968,1.9591491826764695
IST-Mes1,24856436,3.396810776549086
SET-2,4477,0.5083274914311526
NCI-H2081,4917,1.6033986047844857
NCI-H2081,76446078,4.17311881830217
A4/Fukuda,4578,3.815086457915261
KYSE-410,navitoclax-piperlongumine (1-1 mol-mol),2.0169443697094636
HSC-4,25154868,3.1331848354363063
KYSE-410,17755052,0.637998239137264
PE/CA-PJ34 (clone C12),selumetinib-JQ-1 (4-1 mol-mol),1.4884609912866928
HMCB,2708,5.151962818613397
OE21,JQ-1-UNC0638 (2-1 mol-mol),0.7092763534327602
YKG-1,46901937,4.239285052925771
Raji,11455910,3.338513112420112
Kasumi-2,doxorubicin-navitoclax (2-1 mol-mol),-4.049414259936193
SNU-308,JQ-1-carboplatin (1-1 mol-mol),5.335805605025179
Ku812,6918328,-1.271327436604222
TE 617.T,25227462,-3.549528235544154
YKG-1,135398516,1.8406212394581116
OE21,135398516,0.478939949697748
SNU-8,5287620,-2.974029721204148
BT 330,11612883,3.1615690662749083
MCAS,24779724,4.433406171067244
NCI-N87,15547703,1.070685995489879
SNU-1033,9935249,2.812235160690358
TE 617.T,23939,4.422369494200264
KMS-27,72193861,-0.2876549963756236
Aska-SS,24180125,2.481672199133219
BT 328,1242560,3.7217728648483552
SW1990,637858,2.6354229615266447
SNU-1214,54686904,4.412043989333209
NCI-H2110,4261,0.3587441913958428
BT 248,2708,3.971792549478314
BT 330,serdemetan-SCH-529074 (1-1 mol-mol),1.5699770652684284
RPMI-7951,60168763,3.264006929182048
KMS-27,52912189,0.3495473321033867
NCI-H1092,25262965,2.2331419117786617
TE 617.T,54618305,4.435147460279245
SW1990,10127622,2.690812065092725
HMCB,11626560,3.142721320668581
YKG-1,135440466,3.3595523458828582
SET-2,23635314,-3.981492201444291
PE/CA-PJ34 (clone C12),11317348,4.808081492985304
KMS-27,tretinoin-navitoclax (4-1 mol-mol),0.2143181167810407
OE21,5470400,-0.382943496610633
NCI-H1092,148198,-7.112179510843006
Hs 683,JQ-1-UNC0638 (2-1 mol-mol),1.243801160638627
EJM,5335621,4.269621462989024
NCI-H2081,17755052,2.5069462773108016
Hs 683,11427553,2.1811271780472983
D283 Med,5738263,2.4300934909040115
BT 330,49867930,4.445743606373579
NCI-H1092,107970,1.8386309101568237
D283 Med,9840324,6.111683507272441
NU-DHL-1,9915743,0.5782531397120328
LNCaP clone FGC,11612883,2.993446616877049
PaTu 8988s,119607,5.3348234532520875
KMRC-2,44607531,1.5632454082494247
NCI-H2081,1641662,3.083642159017046
KMRC-2,72193861,3.995820057929541
Ku812,421610,4.009209669697973
PE/CA-PJ34 (clone C12),446155,2.4621784911192317
TE 617.T,selumetinib-MK-2206 (8-1 mol-mol),1.3573740232103315
SNU-8,60750,1.7310690504443438
A4/Fukuda,9926054,1.7963505717751411
GOS-3,17755052,3.2453279413753147
SNU-1033,3503,1.5718890329009363
Kasumi-2,3038522,2.07744827479205
HARA [Human squamous cell lung carcinoma],5311,2.3146371221244184
Ku812,9825149,0.757991873961122
Aska-SS,3825829,4.613612651673856
KMBC-2,24978538,-1.3803333865803342
KMS-27,25150857,2.021589185938539
AU565,285033,-2.964869253470222
HSC-4,262093,2.780665409693215
AN3-CA,24797083,0.189199244931192
HEC-151,44185566,1.247652658298612
LNCaP clone FGC,89928392,1.3426249945041528
OE21,23635314,-4.652616263422308
Kasumi-2,9549297,1.4131024835139536
Hs 683,6914657,-2.788485470689341
TE-15,285033,-1.9345935977571684
A4/Fukuda,6450551,1.0528971846899622
CA46,3136844,3.7113001526336338
KYSE-410,124202324,2.809951119195219
Hep-G2,159324,2.69530902129888
HARA [Human squamous cell lung carcinoma],46191454,0.0255281814012309
CA46,67156097,-2.616833441535583
IST-Mes1,16659841,2.7339021092282527
SNU-308,3025944,4.421498495522431
BT 139,2126,3.939792833653474
CA46,10184653,1.13668363671425
Ku812,216345,2.75636919454375
PE/CA-PJ34 (clone C12),1239801,5.087439693870939
SNU-1272,2749,1.9740368038979512
TE 617.T,9823820,3.4486564121687695
LNCaP clone FGC,9927531,4.548275216558741
RPMI-7951,26596,-1.730558618097036
SEM,52947716,1.1671680401864422
MCAS,selumetinib-UNC0638 (4-1 mol-mol),1.217839285065653
SET-2,24785538,-0.3698408856768623
SNU-1033,2828334,6.270288536823683
HSC-4,16065773,3.311693132411482
LoVo,73707398,0.5951327141059009
MCAS,11455910,0.7655577193657753
NCI-H1092,11497983,4.878334634479546
PaTu 8988s,5282054,3.7753481211747824
BT 139,15953870,4.456672182655599
SNU-8,tanespimycin-gemcitabine (1-1 mol-mol),0.1281015518683249
KYSE-410,3062316,-1.640148197583731
SEM,9444,3.4451798115030705
KMBC-2,11657048,4.986417986707535
Aska-SS,5311,1.1143613375213084
SKM-1,5329102,1.247777123403785
AU565,135875424,4.732736146663846
Hs 683,5284373,2.937845283028805
KMBC-2,71466380,6.1487994263680354
AU565,374536,-0.7311314672583101
HEC-151,25105715,3.437309931066462
SNU-1033,65064,4.2871969578202735
SNU-1214,11404337,-1.0088442164692528
A4/Fukuda,60700,-1.3381290141173086
EJM,10385095,0.7131434808495797
NCI-H2110,46199207,3.4338454475007807
IST-Mes1,vorinostat-carboplatin (1-1 mol-mol),3.785712345618982
TE-15,tanespimycin-bortezomib (250-1 mol-mol),-0.6249388884216994
OE21,11955716,-2.430228405790455
MCAS,vorinostat-carboplatin (1-1 mol-mol),4.095044355949227
ML-1 [Human thyroid carcinoma],24771867,3.392643461506865
SNU-1214,216239,2.540927485180012
SNU-308,vorinostat-navitoclax (4-1 mol-mol),1.528170211925988
Kasumi-2,3689413,-2.6905586087263043
MM1.S,135421197,1.5136201913497214
GOS-3,JQ-1-UNC0638 (2-1 mol-mol),2.0742730655318233
GOS-3,45279963,4.315465934949481
BT 248,984333,1.3539050434846691
PE/CA-PJ34 (clone C12),6917907,-5.874012893273867
KYSE-410,6918736,-0.0092820973609371
PE/CA-PJ34 (clone C12),3503,2.1595052777982437
CML-T1,8515,3.304453494146528
ML-1 [Human thyroid carcinoma],1566236,3.1920996771286783
Aska-SS,16038120,1.63587187826233
NCI-H2081,148198,-5.584711698479823
CML-T1,9444,4.326131103147221
OE21,9823820,3.998720921326037
SNU-1214,4261,1.9825839440071136
Hs 683,421610,2.270321909677873
BT 330,54618795,3.387856446050376
HSC-4,5351362,1.6988999536887646
BT 248,5284373,1.9481267041892785
CA46,11640390,3.3312213559791397
SEM,55508,1.472940159532621
KMBC-2,65064,5.566156368628648
HCC2218,208908,-2.6201557122185544
OE21,702558,5.698291072797489
BT 328,73707398,2.390014521827579
MM1.S,vorinostat-navitoclax (4-1 mol-mol),0.234201323226823
TE-15,selumetinib-PLX-4032 (8-1 mol-mol),3.712944430775503
SNU-8,5566,3.274394982179717
EJM,24901704,4.248858299645136
KMS-20,5280436,3.104525764611907
SEM,carboplatin-UNC0638 (2-1 mol-mol),2.079018969490806
BT 139,5291,3.770783503503458
HMCB,44607531,1.498982144758814
NU-DHL-1,vorinostat-carboplatin (1-1 mol-mol),1.348913294016227
TE 617.T,selumetinib-piperlongumine (8-1 mol-mol),3.275728050255235
NCI-H1092,JQ-1-UNC0638 (2-1 mol-mol),3.1709081396689496
Hs 683,53481919,3.7353029255072783
NCI-N87,10231331,4.183605147658756
NCI-H2110,123631,2.3500505332428956
AU565,24748573,1.9131971710517224
KMRC-2,219104,4.226334553448108
RERF-LC-Ad1,2858523,3.2226795457282735
AU565,9915743,-3.6885201415408098
YKG-1,156422,4.407092102753243
YKG-1,67156097,0.6160547787763923
LoVo,100016,6.001395250082881
KYSE-410,25062766,2.1712810564055505
TE 617.T,46843906,2.8177440726942797
NCI-H2172,11427553,4.648186022805162
CA46,3825829,3.8503527939376583
KMS-27,11717001,3.99777903159406
NCI-H2172,650361,3.904571472219665
IST-Mes1,16038120,1.0913997834143612
KYSE-410,654092,0.1859492790790137
SET-2,135999136,1.840217367729006
HCC2218,navitoclax-sorafenib (1-1 mol-mol),1.2983575402034089
Hs 683,72193861,0.3699767996119639
Kasumi-2,15953870,2.7617758274096404
KYSE-410,10410894,3.2952841577918774
BT 330,107970,1.6746237285504426
BT 330,387447,-5.2185859135267405
SW1990,44185566,2.9867132370015037
LoVo,serdemetan-SCH-529074 (1-1 mol-mol),1.6319978332110785
GOS-3,SNX-2112-bortezomib (250-1 mol-mol),-0.0982198118702868
TE-15,6918837,-3.951124038573147
CA46,156414,1.2808873732328336
KMBC-2,54618164,4.620014952617177
AU565,322968,2.504214157528526
RPMI-7951,89928392,0.592794462037715
NU-DHL-1,navitoclax-gemcitabine (1-1 mol-mol),-5.825890673866902
ML-1 [Human thyroid carcinoma],46199207,3.5690585114534024
EJM,44632017,0.4808977509287103
ML-1 [Human thyroid carcinoma],3038522,3.665928761402901
BT 320,64971,4.224921006781723
HARA [Human squamous cell lung carcinoma],5287620,-1.762699468398793
KMS-27,409805,3.6220211323899782
RERF-LC-Ad2,6914657,-3.5206588239370946
CA46,702558,3.0016875761250383
YKG-1,36462,2.1375754999523915
BT 248,56963564,4.0439806336642175
CML-T1,3689413,-2.671933251411637
HMCB,JQ-1-navitoclax (2-1 mol-mol),1.0061070373244176
A4/Fukuda,45279963,1.9027034071047564
BT 328,5351362,3.058518390164376
BT 248,72199292,1.1105829108074048
BT 320,71751553,4.331550413851084
LNCaP clone FGC,10113978,2.438610206970959
NCI-H2110,55283,3.522352390292201
NU-DHL-1,445643,3.522779359362199
SET-2,67156097,-1.8675490835672344
SNU-8,55508,4.439953693077861
SKM-1,53301938,-5.946970566996532
KMS-27,327653,2.9836297632664905
KMS-27,16736978,-0.5913535811359448
HCC2218,252682,6.509393450799849
PE/CA-PJ34 (clone C12),5566,3.075370246500284
SEM,72734382,1.9390760938253868
SNU-1033,11455910,1.238389627301748
SNU-1033,219104,3.456953215141336
RPMI-7951,3552672,2.1891148728288363
SNU-8,19582717,3.8862122891629425
NCI-H2081,carboplatin-etoposide (40-17 mol-mol),0.0768376373319903
NU-DHL-1,1750826,-5.605759271082352
SEM,4261,-1.241514720735086
KMS-27,72734382,3.649380634189348
HCC2218,11494412,1.7192366491368396
SET-2,5978,-3.155154977585104
TE-15,10385095,0.8889950613802687
Ku812,navitoclax-MST-312 (1-1 mol-mol),0.7208208773965746
BT 248,123631,2.103805835203493
Hs 683,637858,2.5544628931589166
HSC-4,44137675,2.9134227764609735
KMS-27,selumetinib-GDC-0941 (4-1 mol-mol),-1.985163652094814
CML-T1,5278396,2.8291940129393054
Hep-G2,17759555,2.554294160836156
HEC-151,11364421,-4.903162292093641
KMBC-2,2871966,1.2658071123626833
Hep-G2,446155,4.188968045550805
HEC-151,navitoclax-MST-312 (1-1 mol-mol),1.3333991440572028
RERF-LC-Ad2,4917,5.168503342508482
LNCaP clone FGC,3634881,3.3768985687237683
SKM-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.830110061350853
Raji,6252,-4.099967470274552
Ku812,216468,0.540361244163346
BT 248,10302451,3.817813130063646
SW1990,9823820,4.425130211783221
Hs 683,168313200,1.8001064604931507
BT 248,46907787,3.027762940742573
RERF-LC-Ad2,24785538,2.4672547589811797
NCI-H1395,6610355,4.529724434844308
Kasumi-2,1242560,3.251932247793875
TE-15,52912189,0.9769039830004704
SET-2,5460769,3.4880653417656022
CA46,5287969,-2.5448622649608925
AN3-CA,3825829,3.633283861365007
BT 328,11455910,1.1431162062454217
LoVo,4788,4.577300245187766
HMCB,2874250,-4.802730295191432
KMBC-2,serdemetan-SCH-529074 (1-1 mol-mol),2.458567671710058
SW1990,4521392,5.488917399959202
SET-2,3038522,2.442853150165528
TE-15,5287969,-2.182793092465143
RPMI-7951,23725625,5.2145212739154205
HSC-4,10427712,3.709601221495256
NCI-N87,613753,3.043533794547513
SNU-8,638278,3.4785573806437036
SW1990,carboplatin-etoposide (40-17 mol-mol),2.808160331584739
TE-15,119607,5.472454895282724
Aska-SS,16722836,0.7336063119016827
PE/CA-PJ34 (clone C12),107985,-3.5683543961091138
IST-Mes1,3552672,2.081532957284865
ML-1 [Human thyroid carcinoma],387447,-2.817858817217488
GOS-3,46843906,3.599659815664158
A4/Fukuda,11507802,0.3746235533355334
PE/CA-PJ34 (clone C12),SNX-2112-bortezomib (250-1 mol-mol),-3.0590637711179745
RERF-LC-Ad2,17755052,2.119183120820772
BT 320,5978,5.361358451203573
SNU-8,65064,2.9443742563963555
MM1.S,9926054,1.5897504862532963
YKG-1,25154868,5.653220601909001
RPMI-7951,11214940,0.5707725902403461
HCC2218,9967941,1.8608671040934277
Ku812,alisertib-navitoclax (2-1 mol-mol),-1.9869824570436432
NCI-N87,176870,1.1060804163410003
HSC-4,navitoclax-sorafenib (1-1 mol-mol),2.0260640638250154
SW1990,9933475,2.2226971177902275
BT 330,73707438,1.741057691577743
YKG-1,65064,5.3416215480655875
NCI-H1092,11455910,0.2647471022018075
BT 320,448949,3.0267975144627894
CML-T1,docetaxel-tanespimycin (2-1 mol-mol),-5.351471523499181
Ku812,2858523,2.0099200401333563
KMBC-2,10302451,4.200978616748967
IST-Mes1,JQ-1-MK-0752 (1-1 mol-mol),2.655505520266403
AN3-CA,10184653,1.4748604510160417
IST-Mes1,969516,2.6899901133592103
HSC-4,11609586,5.018303752842559
NCI-H1395,11152667,2.8212920431399597
OE21,11964036,0.9502618768704822
LoVo,9911830,1.9062113768292104
EJM,5746,0.8997924429706388
RPMI-7951,5328940,1.4476277745678563
KMS-20,9823820,3.101769645887986
PaTu 8988s,46199207,3.3376100430192808
SNU-1214,448949,2.107335730874522
TE-15,9866186,-1.021801869424804
HEC-151,5479543,3.510315813920412
SNU-8,46191454,1.2400504834841688
NCI-N87,123631,-0.3933912143385343
SKM-1,5311,0.1549027361916286
D283 Med,2945648,2.7267209315034946
HMCB,219104,4.272733205803313
BT 330,45279963,4.220218850689366
HSC-4,445091,4.370395830414555
GOS-3,135421197,1.697146176044067
PE/CA-PJ34 (clone C12),10302451,1.6517506382371558
GOS-3,54596558,4.225745385987354
TE 617.T,322968,2.4970078464973255
KMS-20,9884685,-0.8480553066997102
SEM,54596558,4.142091338652408
BT 248,71751553,4.279070264679743
CML-T1,123631,1.8980514916470088
NCI-H2081,676352,1.7285025773311848
TE-15,11485656,1.960576997256463
NCI-N87,9967941,2.944195178928737
BT 320,3634881,4.591305105456608
LNCaP clone FGC,3384730,2.6704407926087783
NCI-H1395,327653,3.4863341416729847
SEM,65628,2.5869900174043647
NCI-H1092,10427712,4.783956203495579
Aska-SS,46943432,0.9231523980754076
NCI-H1092,151289,2.971736983161978
BT 320,2126,5.543243224179777
BT 320,71729975,3.655690084257896
SNU-1214,46943432,1.6748160233466023
BT 248,3025986,2.9298231166336297
KMBC-2,49793307,-1.842905492635861
KYSE-410,10184653,-0.7069417943968711
PaTu 8988s,11612883,1.4003047610740176
SNU-8,16722836,2.156858559437684
LNCaP clone FGC,46843906,2.034507662403873
SNU-1214,24951314,1.0660952993202617
SKM-1,176870,1.6834487076214133
KMS-27,11404337,-1.6812910673716006
HSC-4,selumetinib-UNC0638 (4-1 mol-mol),3.54677113858736
SNU-1272,676352,3.00667023527596
SNU-8,9936388,-5.172305126613517
CA46,44632017,0.5480853683486498
NCI-H2110,10231331,4.807632795755959
OE21,selumetinib-GDC-0941 (4-1 mol-mol),0.0714781013058572
PaTu 8988s,89928392,2.576588793876801
OE21,2113511,5.973000294010022
PE/CA-PJ34 (clone C12),3025986,-1.608443242420705
BT 139,15547703,3.8265236987304823
EJM,6438330,1.051199955575325
NCI-H1395,2858523,3.2706223313658445
IST-Mes1,71466578,4.723128098465521
Kasumi-2,10127622,5.115736544584973
SNU-1214,36314,0.8573482666662119
D283 Med,44489675,3.5231335030624855
CML-T1,selumetinib-MK-2206 (8-1 mol-mol),2.7460107356112644
TE-15,11214940,4.604212971840754
HMCB,54626689,5.696553588626368
NU-DHL-1,11317348,1.955778298078063
CML-T1,tanespimycin-bortezomib (250-1 mol-mol),-0.4350289295501254
NCI-H2081,613000,5.284324483502851
KMS-20,46174525,2.556560760455921
TE 617.T,26596,-3.5782456619220246
BT 139,6917907,3.169492285726481
AN3-CA,89928392,1.072961640369582
TE-15,53232,1.7812903569341405
CA46,54618771,1.203400154931592
GOS-3,409805,3.6304586799066967
SNU-1214,selumetinib-piperlongumine (8-1 mol-mol),2.3658233579142713
AN3-CA,246676,4.36497705352595
RERF-LC-Ad2,675434,4.722753673129772
RERF-LC-Ad2,409805,3.938022823911279
KMS-20,119182,-0.7060386970592318
OE21,9911830,2.128262086485743
Ku812,11656518,-1.0903190853859568
Hep-G2,4259181,-1.079856384384839
NCI-H2110,11640390,3.118244527452471
KYSE-410,docetaxel-tanespimycin (2-1 mol-mol),-4.488089598990408
RERF-LC-Ad2,66577038,3.292062541665056
A4/Fukuda,5291,3.6218734753047226
EJM,9929138,6.263891211273599
HARA [Human squamous cell lung carcinoma],49793307,-3.043253960744797
D283 Med,71751553,4.245405525851178
PaTu 8988s,17755052,-0.2693936600995607
BT 248,JQ-1-UNC0638 (2-1 mol-mol),2.2588808320886917
PE/CA-PJ34 (clone C12),5746,0.2373694033857969
AN3-CA,148198,-4.708662281337999
SNU-1214,selumetinib-JQ-1 (4-1 mol-mol),-0.4737134364925926
KMBC-2,vorinostat-carboplatin (1-1 mol-mol),3.723920308466531
GOS-3,60700,-0.2943345936745988
IST-Mes1,54454,3.4404607016766264
RERF-LC-Ad2,11626560,2.11718882124061
A4/Fukuda,445643,2.2110077600401996
NCI-H2081,JQ-1-vorinostat (2-1 mol-mol),-0.2017741262953333
SW1990,3385,3.92927023441494
SW1990,44137675,3.438362060135723
Hep-G2,6505803,-2.5933743398692894
Ku812,42642645,-2.294133807161646
BT 248,51037431,4.063284976838012
NCI-H2110,56949517,4.332039777651592
ML-1 [Human thyroid carcinoma],JQ-1-carboplatin (1-1 mol-mol),0.7562453345428342
RPMI-7951,9927531,5.17840544344631
NCI-H2172,2113511,6.262003489120703
BT 248,54596558,3.9995548839878503
PaTu 8988s,9933475,1.5392829753432309
MM1.S,4917,3.2531292975138033
KYSE-410,5291,3.7055428862452673
PE/CA-PJ34 (clone C12),9903786,2.211143495082886
NCI-N87,374536,0.3041613365805376
TE 617.T,9935249,2.123679604144266
MCAS,3634881,3.1690679925110357
CA46,44491742,3.801952242992866
TE 617.T,46901937,3.882810689943171
HARA [Human squamous cell lung carcinoma],54618771,1.4449475826214635
SNU-1033,9868037,4.1632978097237014
KMS-20,11964036,0.567950942976561
BT 139,11404337,0.9723364970795382
HEC-151,9826308,0.5114129980738326
LNCaP clone FGC,25126798,3.669964822378694
YKG-1,26596,0.9408189524000934
YKG-1,4261,2.958862922267848
RERF-LC-Ad2,15547703,3.0920288807988245
Hep-G2,49850262,3.2140640734627843
D283 Med,25195348,2.687944983140332
TE 617.T,73707438,3.845277218747361
HARA [Human squamous cell lung carcinoma],445643,3.755641736641804
BT 320,285033,5.611549861739741
BT 330,5282054,3.965299812309079
HSC-4,24856436,1.7831446753384608
Kasumi-2,navitoclax-birinapant (1-1 mol-mol),-3.1912080416511355
CA46,49867926,4.142181337076857
LoVo,5566,2.507145044552918
BT 330,9915743,0.5029117023680005
PE/CA-PJ34 (clone C12),285033,-2.1264465291275476
PaTu 8988s,67156097,-2.6078446731543754
KYSE-410,216468,2.8171143313107927
TE 617.T,11152667,-1.0765284818833325
KMBC-2,10296883,4.242347433736866
CML-T1,73707386,2.9358077283853974
HEC-151,25183872,-1.059402099425215
MM1.S,9903786,2.841249590923514
NU-DHL-1,10427712,3.994515346710207
KMBC-2,2874250,4.938053140379258
KMS-27,44819697,-2.444267674030988
HSC-4,24785538,3.772420906085344
CML-T1,5311,-0.0657355385312412
Hep-G2,1716436,2.124902478350978
NCI-H2110,135440466,1.5580785055019832
AN3-CA,3503,0.812908549205794
SET-2,25062766,-0.8634965177329965
RERF-LC-Ad2,322968,2.71312261755285
Hs 683,25102847,1.227616215801813
KMS-20,vorinostat-navitoclax (4-1 mol-mol),0.2184557123667096
SNU-1214,9826308,0.0838633230560196
OE21,salermide-PLX-4032 (12-1 mol-mol),4.851200282788362
NCI-H1395,51039095,3.804794716936721
NCI-H2110,16720766,0.4927290073632293
RPMI-7951,60700,-1.191819439472768
AN3-CA,navitoclax-piperlongumine (1-1 mol-mol),1.1185900597539058
KMBC-2,445091,4.27135106704316
NCI-H1092,serdemetan-SCH-529074 (1-1 mol-mol),2.0594961272701453
D283 Med,51037431,2.0998452060410484
CML-T1,11485656,1.9899616795432975
GOS-3,148198,-2.930015056129616
Ku812,10127622,-2.476292288821415
CML-T1,135984461,1.8956927240773784
NU-DHL-1,JQ-1-vorinostat (2-1 mol-mol),-1.099094096725154
LoVo,107970,2.0597080136849795
A4/Fukuda,selumetinib-JQ-1 (4-1 mol-mol),-0.1942413967070371
D283 Med,JQ-1-MK-0752 (1-1 mol-mol),0.6628276308701311
BT 139,tanespimycin-bortezomib (250-1 mol-mol),-4.226590067496966
KYSE-410,49846579,3.262799564425684
Kasumi-2,51039095,2.172369026283552
HARA [Human squamous cell lung carcinoma],11497983,-2.5330413808054333
KMS-27,5746,-0.3772523731080616
AN3-CA,11640390,3.6086639972683554
SNU-8,5280436,3.657328810288953
BT 330,carboplatin-UNC0638 (2-1 mol-mol),2.6250580335818228
CA46,15953870,3.0438117584706164
MCAS,135421197,1.955288267695935
SET-2,navitoclax-birinapant (1-1 mol-mol),-1.2703950962736938
HEC-151,387447,-4.537682357362599
Hep-G2,46224516,1.405645809008333
AN3-CA,9926054,1.8039265956503063
SEM,107985,-4.245084684067336
SET-2,navitoclax-sorafenib (1-1 mol-mol),0.424225685100551
CML-T1,5311281,3.0916675116608863
AN3-CA,11612883,1.455886821903922
GOS-3,72193861,3.4413196800383044
CA46,9549297,1.0960598621603344
BT 320,15547703,5.516273739658597
Aska-SS,9549297,1.144867094134784
OE21,navitoclax-MST-312 (1-1 mol-mol),0.9127482024320372
A4/Fukuda,11317348,1.1392337694005448
Kasumi-2,11396600,2.2579616248243495
Aska-SS,alisertib-navitoclax (2-1 mol-mol),-1.4792698488136429
TE 617.T,44632017,0.816965431655708
HEC-151,6610216,4.488226027984822
SNU-1033,135411,1.2023812389363322
CA46,1750826,-4.755590130007624
HSC-4,119607,3.948608575005578
AU565,3676137,4.605193047317769
HEC-151,156414,1.2927614693415013
SNU-308,9907093,4.131451183681241
TE 617.T,16065773,1.4641864926037722
NCI-H2172,25262965,2.237724096784882
HEC-151,11152667,0.2545196919023241
RERF-LC-Ad2,serdemetan-SCH-529074 (1-1 mol-mol),2.1261176554719525
NU-DHL-1,tretinoin-navitoclax (4-1 mol-mol),-1.9043556508131567
HEC-151,5738263,3.5405750813790373
RPMI-7951,4788,6.245294366048132
EJM,119182,0.4247713532004813
CA46,tanespimycin-bortezomib (250-1 mol-mol),0.4718837425399894
HEC-151,4259181,-0.935569196791714
Hs 683,10074640,2.88569633331329
SEM,6450551,0.3475016834415761
Hs 683,135440466,2.999728684300055
NCI-H2172,10074640,3.3243553400842516
KYSE-410,71466445,4.5751159315788055
AN3-CA,4259181,-0.2663396960548074
EJM,49867930,4.535292738275801
EJM,SNX-2112-bortezomib (250-1 mol-mol),-3.498117100633706
SET-2,72193861,1.1745173651273035
TE 617.T,9840324,5.809707926516217
NCI-N87,10184653,-5.297353828317573
KMS-27,216468,0.9091039339457488
HMCB,6918837,-1.783371825238031
KMS-20,11234052,3.409972208267674
HMCB,5287620,-2.490214484592024
KMS-20,66577038,2.524317684477447
AN3-CA,24748573,1.2496269403470617
TE 617.T,375860,-0.5164864785345091
HEC-151,9866186,1.196173458220247
OE21,navitoclax-piperlongumine (1-1 mol-mol),3.383148476178937
SKM-1,327653,2.256314826375049
BT 328,5738263,4.558527530025055
HCC2218,JQ-1-MK-0752 (1-1 mol-mol),5.949338502006685
PaTu 8988s,24964624,3.005673973446249
Raji,31703,-3.5148796323259446
KMS-27,65628,3.4273380344864233
NCI-H2081,navitoclax-MST-312 (1-1 mol-mol),0.8717360318084046
BT 328,5287969,-1.46849607666092
HSC-4,BRD-A02303741-navitoclax (2-1 mol-mol),3.4165254570204953
NCI-H1092,5278396,3.4693209388519137
Ku812,52947716,-6.670771231809934
SEM,135398738,-0.4705480766315878
Kasumi-2,11404337,-1.9658161518336
Ku812,24964624,1.8261107869601476
SW1990,52947716,2.9769085141275338
HCC2218,2708,4.7571446912258395
KYSE-410,53232,3.7629368703278208
HCC2218,448949,2.479128950709568
NCI-H1395,11656518,2.2687803518385365
KMS-20,11364421,0.7913102999239922
NCI-H2081,6914657,-5.6218862052201155
Kasumi-2,36314,4.106836250050073
SNU-1033,375860,2.3566426851273063
KMS-27,carboplatin-UNC0638 (2-1 mol-mol),2.884683789181856
A4/Fukuda,107970,1.5574682195612295
BT 248,11228183,2.0159399448324065
KMS-20,6914657,-2.6641551420146277
SKM-1,tretinoin-carboplatin (2-1 mol-mol),1.0065568323561174
TE-15,16219061,3.3101039470688125
HMCB,969516,2.786872605358725
SKM-1,24901704,2.156402770369734
SEM,675434,3.717379386242577
D283 Med,25062766,1.4055870376887964
SKM-1,44493528,3.979629908351757
D283 Med,9825149,0.299021869301145
TE 617.T,selumetinib-PLX-4032 (8-1 mol-mol),2.1990487798939764
RPMI-7951,selumetinib-piperlongumine (8-1 mol-mol),3.783430933117755
SET-2,8515,2.781692301096623
TE-15,5351362,0.7885319665169142
LNCaP clone FGC,54618305,4.126133237949938
PE/CA-PJ34 (clone C12),24771867,1.6845259930692984
PaTu 8988s,5328940,0.4052921421822181
CML-T1,SNX-2112-bortezomib (250-1 mol-mol),-2.787489120690278
YKG-1,123631,3.7325814546092873
BT 139,4705,1.2736947517063846
MM1.S,11964036,-0.3067716332960522
BT 330,262093,1.7469148441543585
NCI-H2110,24771867,3.185032011648231
MCAS,135411,0.3992258142971907
NCI-H1395,31703,-0.5933376727422321
NCI-N87,51039095,3.189774410902983
KMS-27,25105715,3.101679923324695
KMS-27,6852167,1.4833276189220757
SKM-1,71466445,1.6319589215508703
SNU-1033,6436223,-5.381153416381445
BT 139,11213558,5.051121416587095
SET-2,2858523,3.0609077413924175
NCI-H1092,navitoclax-pluripotin (1-1 mol-mol),0.8124337915703985
Hs 683,2858523,3.209008362776473
D283 Med,erlotinib-PLX-4032 (2-1 mol-mol),2.6364358466676627
NCI-H2110,2708,5.257811785679327
NCI-H2172,24753719,5.109863925049923
MCAS,11427553,3.4727199316582227
BT 330,71729975,0.6660991074128464
AN3-CA,1750826,-1.203263132000608
MM1.S,11507802,1.0778344524637908
TE-15,44493528,4.216402167585121
AN3-CA,675434,4.408623418183415
PaTu 8988s,25227462,-3.957838993193877
A4/Fukuda,1641662,2.3667755294261297
SNU-1272,25126798,4.058669238010608
Hs 683,50905018,4.377501260447325
SET-2,613753,2.542152072032537
NCI-H2110,72193861,1.5303088787695434
PaTu 8988s,285033,-3.9117222428012535
NCI-H2081,11175137,1.6715050081020637
SEM,3543504,3.2145269894533315
KMBC-2,56649450,2.455679969245251
D283 Med,4705,3.1008912872866325
TE-15,9903786,2.5325936452806723
BT 328,219104,4.206978092049304
PE/CA-PJ34 (clone C12),65064,5.4596992338484664
NCI-H2081,5329102,1.7214489652710063
PaTu 8988s,2749,1.4449513443083186
BT 328,135659046,3.8583019402961343
Hep-G2,9444,4.035145780865591
OE21,selumetinib-navitoclax (8-1 mol-mol),1.7269532854909095
EJM,selumetinib-MK-2206 (8-1 mol-mol),2.5520093937916144
TE 617.T,11234052,4.193590791426118
ML-1 [Human thyroid carcinoma],9911463,4.5829335325836436
SEM,36462,-2.7360640601525845
KMS-20,613000,1.1345541972303637
RERF-LC-Ad1,44202524,4.3484891149380696
Ku812,241158,2.509231607325934
AN3-CA,5738263,2.4424476879393193
SET-2,10077130,3.122391683197605
SNU-1214,452548,1.32611741110659
KMBC-2,637858,2.3795290977842014
Aska-SS,49836020,4.404663805549638
OE21,10184653,-4.387807743027572
SNU-1214,44137675,2.73058467391687
AU565,9444,3.6632568473184888
NCI-H1395,selumetinib-vorinostat (8-1 mol-mol),2.147255996625455
HARA [Human squamous cell lung carcinoma],107985,-4.031127583701494
PE/CA-PJ34 (clone C12),selumetinib-tretinoin (2-1 mol-mol),1.4850534564898672
KMS-27,2828334,5.834788512638451
BT 328,selumetinib-vorinostat (8-1 mol-mol),3.560914687145029
A4/Fukuda,9911830,0.8865121451383732
IST-Mes1,2828334,6.0384225929755555
LNCaP clone FGC,36462,0.9338803006106506
SEM,11625818,5.278130050580437
CA46,erlotinib-PLX-4032 (2-1 mol-mol),3.1947109713205033
HARA [Human squamous cell lung carcinoma],16722836,2.4020375260133595
NU-DHL-1,46907787,-1.3567156835247356
AU565,46926350,-5.126810871510528
OE21,5951923,5.242575680046821
HMCB,16722836,1.8505640461629969
SKM-1,46224516,2.679988010860087
TE-15,11626560,2.719456619678878
NCI-N87,4261,0.8200487533079858
SEM,9866186,-1.7113396105566032
BT 139,crizotinib-PLX-4032 (2-1 mol-mol),1.8615105842920296
HEC-151,67156097,-1.3315707739035665
YKG-1,2828334,6.412348563007059
CML-T1,57519531,1.0516100309241616
SNU-8,67291369,1.4328430830200354
SNU-8,selumetinib-decitabine (4-1 mol-mol),2.696466945642044
SNU-1033,15983966,1.6057150130260425
Hep-G2,11964036,2.846173129754555
SNU-1272,16720766,3.764344424348401
SNU-1033,60750,3.4861545004254597
RERF-LC-Ad2,3634881,3.586750457602715
HMCB,46215462,2.3614914052536062
HARA [Human squamous cell lung carcinoma],49766530,5.57937649881164
Raji,6438330,0.931764894842744
Kasumi-2,46943432,0.9724659287269805
Raji,5746,1.4113173154358156
KMBC-2,9868037,4.318288154925569
Ku812,5280436,2.864612594738688
RPMI-7951,387447,-4.73850592434981
MCAS,44632017,1.1533505396576618
BT 330,6436223,-4.427095413267329
TE-15,1716436,2.6611332853088316
HMCB,327653,2.816846205013027
TE 617.T,5479543,3.228503749183166
NCI-H1092,56649450,3.409643738416104
RPMI-7951,4096211,1.9647494652292783
NCI-H2081,9907093,4.181981134504412
CML-T1,15983966,-4.817800919639036
KMS-27,387447,-5.343247809144446
KMBC-2,6918328,-0.1114347675868699
KMS-20,3081361,1.7600848114221452
CA46,1641662,3.144498035259472
NCI-H1395,53392493,1.9985896329089852
HARA [Human squamous cell lung carcinoma],219104,4.732621852676119
KMBC-2,5494449,3.5619976172577967
KMBC-2,navitoclax-piperlongumine (1-1 mol-mol),-0.7575567643300402
PE/CA-PJ34 (clone C12),6610355,3.907121985476104
BT 328,11396600,3.7528560222461858
PaTu 8988s,2130404,3.505256394277455
Aska-SS,374536,3.2564720470478887
KMRC-2,25126798,4.178838935050268
LoVo,selumetinib-navitoclax (8-1 mol-mol),1.0965034655670265
SEM,JQ-1-vorinostat (2-1 mol-mol),-2.448022035749378
TE 617.T,navitoclax-pluripotin (1-1 mol-mol),-1.2596810773022633
HARA [Human squamous cell lung carcinoma],24856436,-1.2762108597510684
LNCaP clone FGC,3825829,3.9808343636151657
AN3-CA,11625818,3.589331976350389
NCI-H1395,11238147,4.343547830393109
Hs 683,262093,3.4514070525670295
MCAS,crizotinib-PLX-4032 (2-1 mol-mol),2.21255914817553
BT 330,docetaxel-tanespimycin (2-1 mol-mol),-2.1739850279343433
BT 320,969516,5.171798432399237
D283 Med,168313200,1.8321011656642825
TE-15,208908,-0.7821846792440665
LNCaP clone FGC,BRD-K55473186,4.308577924788359
BT 139,9911463,2.810742843963801
A4/Fukuda,46224516,1.3171235816864948
GOS-3,5281672,4.273337523665355
HEC-151,decitabine-navitoclax (2-1 mol-mol),3.101947586139779
NCI-H1092,135875424,3.039549904779009
PaTu 8988s,4378219,1.968690646273728
SNU-1214,16115403,-4.416699825861742
RPMI-7951,969516,2.1642782433531225
BT 328,selumetinib-PLX-4032 (8-1 mol-mol),4.625572383999939
CML-T1,6450551,-1.1017942434712815
HEC-151,4705,2.9357366805195735
EJM,10302451,3.688285722224437
HARA [Human squamous cell lung carcinoma],carboplatin-UNC0638 (2-1 mol-mol),4.127490867447662
CML-T1,5291,-1.725219795873105
OE21,445455,6.0645568713235845
NCI-H2081,7326481,2.574676844247029
RERF-LC-Ad2,7251185,1.8072338580113816
EJM,71466445,3.872070794685453
Hs 683,carboplatin-etoposide (40-17 mol-mol),2.425488807867045
SNU-1214,1750826,-1.2568858685348383
SNU-1033,969516,2.8339819827255326
SW1990,7251185,3.0840272669149384
SET-2,9866186,-1.6231732696202446
AU565,9936388,-7.122590364363415
Aska-SS,vorinostat-navitoclax (4-1 mol-mol),1.1942225208294903
HARA [Human squamous cell lung carcinoma],3854666,0.7328632401261175
HCC2218,6252,3.535836962146142
AU565,71466380,5.723316888337632
Hs 683,46907787,3.0982371748631325
SNU-308,216239,3.170566655617644
Aska-SS,44607531,1.822137800218542
HARA [Human squamous cell lung carcinoma],24951314,2.561199492034659
NCI-H1395,10074640,3.7402432932443137
SW1990,9927531,5.3345214594202695
CA46,44607530,1.320133740199814
OE21,53495165,-2.7243301708474603
Hs 683,5479543,5.525167734586747
BT 330,selumetinib-vorinostat (8-1 mol-mol),2.5092548953484184
KYSE-410,10427712,5.99349260924601
KYSE-410,54626689,4.470007741978822
SET-2,46907787,-2.0840425279846553
SW1990,6610216,4.556945274841773
KMRC-2,4578,5.1902183794487975
NCI-H1395,5746,0.9154814139320177
NCI-H2110,46398810,3.447174717347915
SNU-8,123631,2.432481388718517
HMCB,54619267,4.162576667162129
BT 320,24771867,4.382883452747231
HEC-151,16720766,-1.4304595515774003
CML-T1,JQ-1-MK-0752 (1-1 mol-mol),0.6034690158877323
SNU-1214,JQ-1-navitoclax (2-1 mol-mol),-0.2635916949837394
AU565,135398516,2.596290086865212
SW1990,252682,8.194560981520343
NCI-N87,3038522,3.5877635056945443
Ku812,54618771,-0.0049031848150657
HSC-4,5335621,5.235604448739508
CA46,3038522,1.2076902647573031
HARA [Human squamous cell lung carcinoma],alisertib-navitoclax (2-1 mol-mol),-2.092897901371494
PaTu 8988s,439501,-3.8776790772528864
BT 139,387447,-3.566401702341635
MCAS,24951314,1.5072363043467354
D283 Med,5291,3.8993292084473814
PaTu 8988s,53495165,1.8041587149483471
Ku812,36462,1.322759060978493
RPMI-7951,10184653,1.226360085792303
MCAS,BRD-A02303741-navitoclax (2-1 mol-mol),3.1168789876023117
RPMI-7951,navitoclax-PLX-4032 (1-1 mol-mol),2.4036000141339424
TE-15,3081361,0.3815937966647346
NCI-H1395,5281672,6.220750867773061
MM1.S,6918328,-1.8285057660481956
HCC2218,24797083,0.8276710015239062
SNU-1214,168312962,-0.9399527642901874
SW1990,44491742,4.13198674266079
Kasumi-2,3081361,2.7656675201923555
ML-1 [Human thyroid carcinoma],176870,3.163449715300446
NCI-H2081,11214940,0.770060608501173
PE/CA-PJ34 (clone C12),6852167,2.080023831418778
MCAS,24856436,0.2567380893611684
Ku812,5329102,0.560653568662338
NU-DHL-1,6914657,-3.9631462733451426
BT 139,71729975,2.9783826602427017
AN3-CA,984333,-0.6376607681335268
HARA [Human squamous cell lung carcinoma],9907093,5.03391680027973
AN3-CA,46907787,4.249089743528786
KMS-27,171352865,4.770366680942233
IST-Mes1,salermide-PLX-4032 (12-1 mol-mol),6.709164103992604
NCI-H1092,2733526,5.304612787284194
NCI-N87,71466578,5.1108247117444865
GOS-3,24753719,4.687766883023854
PE/CA-PJ34 (clone C12),erlotinib-PLX-4032 (2-1 mol-mol),0.5526794928208874
ML-1 [Human thyroid carcinoma],10410894,4.287937298613586
TE-15,46199207,2.907714368540411
AU565,5282054,3.2331302005717153
PE/CA-PJ34 (clone C12),6184667,2.6739231408415893
NCI-H2172,11640390,3.3047851454789536
BT 139,4096211,3.1155400909396973
MCAS,9826308,0.2385151370335357
KMRC-2,11964036,1.8487552887442
NCI-H2172,10385095,4.224975285900289
LoVo,969516,2.402995535890804
GOS-3,24785538,1.563454655561809
SNU-308,11626560,2.3164476710661983
HEC-151,9884685,0.5854860158758856
HARA [Human squamous cell lung carcinoma],5351362,1.123570314509272
SNU-1214,3634881,2.931050572657854
NU-DHL-1,241158,2.9356865238845313
LoVo,24753719,4.853832341629896
HARA [Human squamous cell lung carcinoma],176870,3.342277724847585
Ku812,11717001,2.262913045686641
HCC2218,262093,2.308676672701105
NCI-H2110,6610216,4.402528376622354
HSC-4,7326481,1.9301811465772087
BT 248,19582717,6.9976074882401464
D283 Med,9915743,1.368920834577302
Raji,decitabine-carboplatin (1-1 mol-mol),2.814088522434008
HSC-4,1750826,0.4564084690350189
BT 248,6505803,-0.8385222866943476
BT 139,44462760,4.266077088931013
BT 320,9935249,2.6939509810826294
BT 248,3825829,4.117903271720201
HCC2218,15953870,3.7305294656594623
RERF-LC-Ad2,23582824,1.2595931522328652
YKG-1,16038120,1.8317392999750344
PE/CA-PJ34 (clone C12),9887053,4.7354636419859935
SNU-308,17755052,0.6777282543616701
HEC-151,25126798,3.8095237719017048
NCI-H2172,2858523,3.5880883683386915
Ku812,navitoclax-gemcitabine (1-1 mol-mol),-4.518116419352301
Raji,24772860,-3.1428664616860615
SW1990,navitoclax-PLX-4032 (1-1 mol-mol),2.9594946441932573
OE21,5351362,1.3269520402296493
Kasumi-2,71466578,1.9217240593305729
KMS-20,89928392,-0.4430373670813298
EJM,11364421,-6.655313631459131
RERF-LC-Ad1,400769,0.0163383776885635
NCI-H2110,568763,1.7848846070854016
Hs 683,BRD-A02303741-navitoclax (2-1 mol-mol),3.3943725578287376
SNU-8,selumetinib-UNC0638 (4-1 mol-mol),1.307835764252158
SW1990,135984461,4.558882799669272
AN3-CA,2828334,6.144729082437511
SEM,6918878,-2.4366739995343196
BT 328,46199207,1.7290666248648392
AN3-CA,252682,7.06469427676738
Hs 683,135999136,4.01183659290713
Kasumi-2,387447,-5.322857892005912
HARA [Human squamous cell lung carcinoma],44607531,1.5873617953354324
Ku812,71680916,4.360628354999314
LoVo,JQ-1-MK-0752 (1-1 mol-mol),1.4055408884057283
SNU-1033,135440466,1.6329331691132638
Aska-SS,49793307,-2.549218823655417
NU-DHL-1,5746,-1.4660940923303851
NCI-H1092,568763,-0.3741146279376747
NCI-H2081,piperlongumine-MST-312 (1-1 mol-mol),0.9288913570617896
BT 248,15953870,3.6832035377423216
SEM,216345,1.9480472657729433
Aska-SS,navitoclax-birinapant (1-1 mol-mol),3.748625753251114
CA46,107985,-3.181693098398671
BT 328,123631,3.6473377820687847
AN3-CA,9823820,1.790343558291452
A4/Fukuda,ISOX-bortezomib (250-1 mol-mol),-0.2493422793699864
GOS-3,9866186,0.992376150226647
Hep-G2,10231331,-0.8368419788063003
PE/CA-PJ34 (clone C12),46215462,1.5577121166656367
EJM,9926054,1.7534790705740089
SNU-1272,24785538,2.381533689270871
Kasumi-2,42611257,3.9292605095902857
KYSE-410,2708,5.464005595955719
TE-15,1641662,2.6442257340275495
NCI-H2110,16013152,4.230924821724543
ML-1 [Human thyroid carcinoma],selumetinib-JQ-1 (4-1 mol-mol),1.6383064835611996
KMS-27,11396600,3.3340163467465573
SNU-1033,45279963,3.891384028776156
SNU-1033,71751553,4.333449645170772
A4/Fukuda,3038522,1.5780319148667876
BT 139,72967,3.761856387021038
HEC-151,11717001,4.773206045150148
NU-DHL-1,5335621,3.760222495124576
TE-15,selumetinib-JQ-1 (4-1 mol-mol),0.3530631195710951
SNU-1272,72193861,3.3833778859953294
SKM-1,54143018,-1.6863423462272775
KMBC-2,322968,4.513420316222048
HEC-151,2945648,2.9108937547424376
Kasumi-2,3136844,3.733604332390159
MCAS,176870,4.086443000813508
SNU-1033,104842,-3.0813929648763905
NCI-H2110,8515,3.3908091407293433
Kasumi-2,136227924,1.9658135956042504
YKG-1,46907787,4.9363681806831075
BT 328,6610216,4.43822058219873
NCI-H1092,53495165,1.5582645503568386
NCI-H2172,107970,2.7119922666869276
KYSE-410,16219061,3.535016267547529
GOS-3,60750,-1.363518575342279
SET-2,5335621,3.8169137961967534
SET-2,16065773,1.9278886667582409
SNU-8,5281321,-1.1560578240990744
MM1.S,46398810,1.896454943753355
BT 248,241158,3.909930885156875
HARA [Human squamous cell lung carcinoma],53232,3.05929528970331
A4/Fukuda,285033,-4.063528792592557
PaTu 8988s,6184667,2.9190065631966173
CA46,135440466,2.9995621349054007
EJM,60700,-2.1593175727596856
RERF-LC-Ad1,5566,3.2885825128552857
SW1990,11427553,2.629768269739627
SNU-1033,53495165,0.0808215902221362
SEM,67156097,-2.63166512459064
Raji,208908,1.6366125751195242
A4/Fukuda,9933475,1.717973727652582
IST-Mes1,11609586,2.670649923207088
RERF-LC-Ad1,10074640,3.528026148983471
KYSE-410,400769,-1.024882871497729
BT 139,9956119,4.207916626823982
GOS-3,9935249,3.5788705539521315
SEM,selumetinib-GDC-0941 (4-1 mol-mol),0.0721321703925677
NCI-H2081,25062766,3.110506006448837
HARA [Human squamous cell lung carcinoma],644241,2.250939574369427
A4/Fukuda,216468,0.7779788317268376
HSC-4,9911830,2.7717739782698563
SNU-1033,4705,2.6216736811916044
SEM,24748573,1.745245431773973
Kasumi-2,3062316,1.0772152233383698
SNU-308,2858523,3.05429804839885
GOS-3,322968,4.726179979484062
NCI-H2081,56963564,0.1641201817536982
Hs 683,UNC0638-navitoclax (1-1 mol-mol),1.040409655043311
PE/CA-PJ34 (clone C12),44202524,1.483466179088964
YKG-1,11955716,-0.8727721700650264
CA46,36462,0.0715644321871689
LoVo,11485656,1.8604760547282393
Aska-SS,44137675,1.3416422792711555
CA46,26596,-3.5845712744961324
GOS-3,16725315,5.248800956635294
NCI-H2110,10074640,3.26088943592308
OE21,46215462,1.559582352466536
A4/Fukuda,89183176,1.286008536767452
RERF-LC-Ad2,11152667,0.7033188335171204
LNCaP clone FGC,3552672,4.707114477173716
NCI-H2081,5287969,-2.131479495140116
SNU-1214,25195348,3.027248087174678
BT 330,16725315,3.2640281321348783
CA46,9926054,1.6892727173627182
LNCaP clone FGC,613000,2.5473993264791424
IST-Mes1,11964036,1.5284066254046933
BT 248,6438330,0.9229397913759128
MCAS,5329102,2.3259749403713372
RERF-LC-Ad2,erlotinib-PLX-4032 (2-1 mol-mol),4.9635698805638535
RERF-LC-Ad1,66577038,3.626450370462214
SKM-1,71466578,1.8721097081856155
NCI-H1395,9915743,5.704472879097531
NCI-H2110,selumetinib-JQ-1 (4-1 mol-mol),2.5540188828609907
KMBC-2,4261,1.386030908381011
D283 Med,11234052,3.767459494315311
HARA [Human squamous cell lung carcinoma],44632017,0.7187380309890276
NCI-H2110,42611257,3.389054989545232
LoVo,2708,4.2308362163689415
PaTu 8988s,24901704,4.07044278536804
SNU-1272,3384730,4.452220632140668
LoVo,44486219,3.9526381308541025
KYSE-410,9935249,4.016740976439891
Kasumi-2,241158,2.967162139629707
LNCaP clone FGC,JQ-1-vorinostat (2-1 mol-mol),-1.3563908691082545
PE/CA-PJ34 (clone C12),613753,3.1668131618299444
KMRC-2,6918328,1.5862321115038376
NCI-H1395,navitoclax-piperlongumine (1-1 mol-mol),2.9868041104516245
HEC-151,72193861,1.157153344552763
Hs 683,984333,1.5070108576246644
HARA [Human squamous cell lung carcinoma],445091,4.978549366904043
KMBC-2,navitoclax-gemcitabine (1-1 mol-mol),-0.4940632335872953
OE21,15983966,-4.016701447888591
KMS-20,5351362,0.6433164049464225
A4/Fukuda,11238147,1.0973923844128086
NCI-H1092,tanespimycin-bortezomib (250-1 mol-mol),0.328880127360426
RERF-LC-Ad1,6852167,4.2610431072057695
Aska-SS,3854666,3.7773042948558726
GOS-3,753704,4.989890215550621
SNU-8,446155,3.2136300084900493
CML-T1,9967941,3.2676581028704503
BT 328,selumetinib-UNC0638 (4-1 mol-mol),5.206465568197119
D283 Med,selumetinib-vorinostat (8-1 mol-mol),2.011575118738352
HARA [Human squamous cell lung carcinoma],156414,2.353598180094054
HARA [Human squamous cell lung carcinoma],19582717,3.08314824082211
TE 617.T,11222830,1.5585172004818777
RERF-LC-Ad1,54454,3.700489737063693
LNCaP clone FGC,11719255,3.490071444575551
Kasumi-2,3011155,3.05813684599445
SNU-8,42642645,1.5422938580488428
HARA [Human squamous cell lung carcinoma],9868037,3.8920643368101713
AN3-CA,10296883,3.730893077527662
MM1.S,159324,2.619931466693083
AN3-CA,81146,4.350886008377241
Ku812,docetaxel-tanespimycin (2-1 mol-mol),-7.546538272108434
A4/Fukuda,navitoclax-pluripotin (1-1 mol-mol),-2.9042967889462408
Kasumi-2,42642645,-0.9002721123779656
EJM,44607531,1.4254236431935456
AU565,135659046,3.967998335471068
NCI-N87,tretinoin-navitoclax (4-1 mol-mol),0.6005709555160592
KMS-27,selumetinib-PLX-4032 (8-1 mol-mol),-0.3903208707161197
Hep-G2,6918328,-0.5211746327374635
Ku812,4259181,-1.0914400455544095
NU-DHL-1,285033,-4.05787074586027
TE-15,46215462,1.4784607708053157
Ku812,46398810,0.5455073347084224
RPMI-7951,219104,3.3269736194785193
SW1990,123631,2.909312008041373
RPMI-7951,selumetinib-GDC-0941 (4-1 mol-mol),1.7374138302319462
PE/CA-PJ34 (clone C12),55283,4.2692019597898865
OE21,9908783,4.434588884510805
OE21,25105715,3.1274779018732213
A4/Fukuda,54619267,3.184419267966046
NCI-H1395,6917907,2.884455684924325
D283 Med,241158,3.4452599332241616
NCI-H2172,serdemetan-SCH-529074 (1-1 mol-mol),2.3503290461711424
SW1990,148124,-0.559061851738452
TE 617.T,11485656,1.686521614831033
LoVo,44241473,4.10673515965005
SKM-1,25262965,-1.3150053661970005
Kasumi-2,107970,1.3663131605888186
D283 Med,9911463,2.6227366888943986
IST-Mes1,7251185,3.206804970970884
TE 617.T,11964036,1.464476618126061
BT 328,selumetinib-piperlongumine (8-1 mol-mol),4.372590392700236
HCC2218,216345,3.0948922650331303
TE-15,5291,4.113420590945033
NCI-H1092,12001922,1.6370209009668415
Ku812,54649381,2.9639483445767087
PaTu 8988s,10410894,3.177464488854481
KMBC-2,11626560,2.4975919030328155
NU-DHL-1,9911463,3.294428726772871
KMBC-2,9911463,3.851747430991294
HSC-4,4477,1.1301199037714704
SNU-8,3634881,3.482703451635013
NCI-H1092,9927531,3.406213307022425
SKM-1,navitoclax-piperlongumine (1-1 mol-mol),0.8307338644583981
NCI-H2172,10127622,5.854674318699288
MCAS,19582717,5.177441348034704
KMS-27,9903786,2.0838522642379216
HSC-4,49793307,-1.7279713732228117
HSC-4,5470400,-1.775367561967962
TE 617.T,285033,-5.256321811666982
BT 330,54618305,6.276995186966791
HCC2218,6450551,2.46170463884505
EJM,6505803,0.0546883993617254
BT 320,6184667,3.5325258636094934
NCI-H1092,675434,3.921847980999154
LoVo,3815108,2.2685826541267615
RPMI-7951,alisertib-navitoclax (2-1 mol-mol),0.5274498370004379
KMS-27,vorinostat-carboplatin (1-1 mol-mol),1.7514374465473277
Kasumi-2,navitoclax-PLX-4032 (1-1 mol-mol),-2.139769926295153
Hs 683,6610355,4.617456613389187
NCI-H2110,54626689,4.627241982556493
YKG-1,11717001,4.560589494626805
A4/Fukuda,439501,-3.252400391503616
KMS-27,5329102,1.2754691026352412
Raji,6610355,4.317478015710172
HMCB,5328940,1.9903033853027137
TE-15,135421197,1.6096072932868513
OE21,7251185,3.300385841415819
BT 320,46843906,4.201274452576595
SEM,5460769,-1.0690415880949575
RERF-LC-Ad2,2708,5.54880563564346
CML-T1,26596,-2.14043660837674
BT 328,409805,5.840944403536212
CML-T1,piperlongumine-MST-312 (1-1 mol-mol),1.169857653831876
GOS-3,3503,2.7215232573825605
HCC2218,10410894,2.581995329678069
SET-2,tanespimycin-gemcitabine (1-1 mol-mol),-4.691670704779648
HCC2218,15983966,1.8414905081063295
IST-Mes1,71304818,2.7451890534908427
NCI-N87,6918837,-4.459129390963203
HARA [Human squamous cell lung carcinoma],119182,-1.5549760643936197
RERF-LC-Ad2,65064,5.3005897391207375
SNU-8,11152667,-0.943436801192986
KYSE-410,441298,2.439581525248614
A4/Fukuda,24821094,2.016569070962388
SEM,444795,1.9334021981472231
BT 248,8515,3.628450909279232
SNU-1214,24856436,-0.5176223298445978
SNU-1272,49793307,0.8482167940358369
NCI-H2110,5311,1.596719721323732
SET-2,selumetinib-navitoclax (8-1 mol-mol),-0.7080378803323621
BT 248,10074640,2.9402331094049265
SNU-1214,56946209,-3.438645101382296
A4/Fukuda,11396600,-8.215434514364686
EJM,54613361,-0.1468563757258991
HMCB,5566,3.160933533240533
RPMI-7951,JQ-1-carboplatin (1-1 mol-mol),3.054924141826928
YKG-1,25227462,2.1847299491854533
KMRC-2,24901704,3.4652957344934787
NU-DHL-1,4261,-0.9383444517557142
SKM-1,9936388,-5.746280121163761
SEM,9952709,2.504756008215234
KYSE-410,JQ-1-MK-0752 (1-1 mol-mol),2.863101776499217
AN3-CA,53495165,0.5423429810700756
BT 330,24821094,2.125553783080606
RPMI-7951,navitoclax-piperlongumine (1-1 mol-mol),1.5386843401965045
MM1.S,53495165,-2.546366748086311
HMCB,126941,-4.47992491137788
HSC-4,11612883,3.5946567658341197
SNU-1214,104842,-1.1109200217804778
GOS-3,11625818,5.199223686092666
NCI-H1092,2708,5.052405164442807
CA46,16722836,1.2778374610309875
CML-T1,4477,-0.6676342393752774
BT 248,vorinostat-navitoclax (4-1 mol-mol),1.3262626080799325
NCI-H2110,104842,-3.248883005108901
Ku812,2113511,4.022010912633414
SKM-1,123631,1.8909946005603888
SET-2,5702613,2.94601164461312
NCI-H1395,9907093,4.0773524584978285
LNCaP clone FGC,4521392,4.255573031439954
BT 330,2749,0.2806852407253283
IST-Mes1,2746,3.2096433183027604
NCI-H2172,11626560,2.2444184668426996
NCI-N87,9866186,-0.0362526715344146
NCI-H2081,4096211,1.423515993754231
CML-T1,navitoclax-gemcitabine (1-1 mol-mol),-3.0033720863451467
PaTu 8988s,9935249,3.279701271474824
NCI-H1092,11175137,2.874404641509256
NCI-H2110,5280436,2.8304700563547014
BT 248,89928392,0.7552276073317185
HARA [Human squamous cell lung carcinoma],36314,-5.79294260923826
HSC-4,ISOX-bortezomib (250-1 mol-mol),1.0749923378755126
BT 320,17755052,3.980908422662348
AN3-CA,4261,2.1641897406909285
EJM,56963564,0.0358307292912413
RERF-LC-Ad1,24951314,3.0210341675900736
PE/CA-PJ34 (clone C12),4096211,1.8873047656462525
HARA [Human squamous cell lung carcinoma],159324,3.9851922367796937
Kasumi-2,selumetinib-UNC0638 (4-1 mol-mol),3.1045685976717623
SEM,5394,4.006285802204493
CML-T1,53232,4.305570613336498
ML-1 [Human thyroid carcinoma],119607,6.010030667993389
HMCB,vorinostat-carboplatin (1-1 mol-mol),3.689100478232481
Hs 683,400769,-0.3737887426285373
D283 Med,60750,-5.2447634258495155
SNU-1033,25062766,2.0712439100177393
LoVo,613753,3.444351424595812
NCI-H1395,44819697,2.3149017923532607
Hep-G2,5281672,4.366631199734501
NCI-N87,navitoclax-sorafenib (1-1 mol-mol),-0.0367825564296656
TE-15,216468,4.462110868583238
HARA [Human squamous cell lung carcinoma],8515,3.1956320485149265
KMS-27,67156097,-2.33255133448615
NCI-H2081,25102847,1.5133964528442754
MM1.S,5311281,2.465283429832392
KMS-27,654092,-0.6433485810907916
NCI-H2110,5311037,4.07771587308812
MM1.S,67291369,-0.2087334312967911
CA46,25262965,-5.196703638661911
KMS-20,tanespimycin-bortezomib (250-1 mol-mol),-0.2140039466554119
OE21,vorinostat-navitoclax (4-1 mol-mol),1.0661063456279147
NCI-H2110,11485656,1.6105476919050796
PE/CA-PJ34 (clone C12),54618164,4.074052686035258
TE 617.T,568763,-0.1373542498055761
NCI-H2110,7326481,4.411470836489669
HMCB,11178236,-3.675827592873557
Raji,4259181,-0.4985032966889935
Kasumi-2,5738263,2.363328574896373
SW1990,10231331,2.104617413508516
RPMI-7951,9936388,-2.1957578683042205
NCI-H2110,107985,-2.7030092125020713
SNU-308,100016,6.582722131637771
SEM,11175137,1.2728559618828204
NCI-H2081,9866186,-0.1809494281387173
TE 617.T,5460769,-1.488012889612994
MCAS,navitoclax-birinapant (1-1 mol-mol),1.833168601601442
RERF-LC-Ad2,25227462,1.2556396259269138
OE21,9907093,3.967532299255402
SNU-1033,46191454,1.3939518639330748
Aska-SS,46191454,1.788346033353313
Aska-SS,56946209,-4.162847997331869
KYSE-410,24964624,2.5855367861983365
Kasumi-2,16065773,1.6844864290683614
TE-15,54143018,0.5513791553368855
IST-Mes1,doxorubicin-navitoclax (2-1 mol-mol),-0.5203692654605504
SEM,3689413,-0.1393923728957227
NCI-H2110,selumetinib-decitabine (4-1 mol-mol),5.0796744346099345
PaTu 8988s,15953870,3.81421509052964
KMS-20,148124,-6.52302823792501
LNCaP clone FGC,216468,3.3734920384995437
Ku812,9826308,-0.187387651853026
Aska-SS,9825149,2.2830097386925177
Hep-G2,46191454,0.5545112986492189
KMRC-2,alisertib-navitoclax (2-1 mol-mol),1.1298078497441686
HCC2218,navitoclax-pluripotin (1-1 mol-mol),-0.2294031857545135
EJM,11427553,2.2799246122967674
SNU-1272,11427553,3.4052745190282305
AU565,2746,2.9112036552039737
AU565,44819697,-0.774785052988496
Aska-SS,56649450,2.4139610587567115
MCAS,448949,2.981446658298907
NCI-H1092,9887053,3.38988914418067
YKG-1,637858,1.419948249294149
BT 330,3634881,2.0146150726773637
SKM-1,135421197,1.6359213938027426
A4/Fukuda,selumetinib-MK-2206 (8-1 mol-mol),0.2592073552888009
BT 328,9803433,4.554547423924098
CML-T1,24180125,2.207667320892802
EJM,9936388,-8.624056137584708
SNU-308,72193861,2.7866488099422693
PaTu 8988s,11625818,4.462633368005334
PaTu 8988s,navitoclax-pluripotin (1-1 mol-mol),-0.4799885460891017
PaTu 8988s,3503,2.76867417170209
HEC-151,24785538,3.133591967449538
NCI-H1092,selumetinib-navitoclax (8-1 mol-mol),4.937762967371625
KMS-20,24785538,-1.6506772000571488
LNCaP clone FGC,71466380,4.233263325075632
Aska-SS,119607,6.144068607625952
PE/CA-PJ34 (clone C12),11964036,1.19521304461458
IST-Mes1,53392493,1.914417087858707
SET-2,11964036,0.2316148322598224
BT 330,alisertib-navitoclax (2-1 mol-mol),-2.4408521522698767
SEM,82146,3.5358695310229704
PaTu 8988s,24772860,-3.347769561665238
IST-Mes1,51039095,1.641675506171098
BT 328,44484893,4.396363776297363
AU565,23725625,4.73732544358888
NCI-N87,107985,-3.2122311985508136
CML-T1,2733487,8.178067655910914
SNU-308,11178236,-0.1870535511193118
BT 330,11656518,2.0366659236710825
SKM-1,24821094,1.9211007905225637
Hs 683,10427712,4.853333023483971
CA46,4578,4.451375135730711
Hep-G2,439501,-0.8010222698535624
BT 330,104842,-0.5017629462874245
CA46,24901704,2.114836921018661
MM1.S,3825829,4.169189674904385
SNU-1272,salermide-PLX-4032 (12-1 mol-mol),6.075030129905205
PE/CA-PJ34 (clone C12),5351362,0.8158998641281501
NCI-N87,9952709,5.048469263792704
Hep-G2,23582824,2.7643164311321584
SKM-1,11238147,2.2552755658276875
KYSE-410,16720766,2.451225960087191
Kasumi-2,89183176,5.250973362639219
KYSE-410,25183872,-1.4094426192679763
SNU-1033,1716436,2.198719748586455
BT 139,44491742,4.209444035840443
CA46,doxorubicin-navitoclax (2-1 mol-mol),-1.6756299291036936
SEM,44632017,-0.1291219027701855
EJM,JQ-1-MK-0752 (1-1 mol-mol),0.8699252378567319
Aska-SS,6917907,-6.004886110594022
SNU-1214,44489675,3.6563084296485417
NCI-H1395,216345,3.4712022210886824
PaTu 8988s,25183872,-0.8462493694428076
BT 330,navitoclax-pluripotin (1-1 mol-mol),-1.4987783148891678
KMS-20,11494412,0.3854055603119042
AU565,262093,2.3992948308197093
HARA [Human squamous cell lung carcinoma],445455,6.075035505832661
NU-DHL-1,16013152,3.387087199942325
HSC-4,60700,-2.3901041148359
NCI-H2172,53392493,3.6625539807261656
TE-15,54618164,4.596489817745785
YKG-1,2729026,3.207992670398629
LoVo,44493528,4.114958638118981
OE21,44566777,0.5053272625116136
NCI-N87,24901704,2.2078626603453664
HARA [Human squamous cell lung carcinoma],navitoclax-MST-312 (1-1 mol-mol),0.8639589641874816
HEC-151,17759555,2.8737027606890875
KYSE-410,9927531,5.048506934315496
CML-T1,31703,-3.375342626899218
AU565,25062766,2.0331930756167234
SNU-1033,5281321,0.0827670253007856
SNU-1033,9936388,0.9211545103072076
LNCaP clone FGC,6918837,-4.306681175333808
KMS-20,446155,2.015814928352595
AN3-CA,151289,0.5319797330722529
Ku812,3815108,1.773113304227131
EJM,387447,-5.475320927013608
SNU-8,10127622,1.517621881090038
Ku812,navitoclax-piperlongumine (1-1 mol-mol),-0.4247050049516961
Ku812,9887053,2.4680731307119785
SNU-308,25102847,4.421541484548656
Hs 683,16065773,2.162457649302814
NCI-H1092,selumetinib-MK-2206 (8-1 mol-mol),4.303588531613232
CML-T1,969516,2.44416602520126
SET-2,11152667,-2.526707061700353
BT 248,54626689,4.44361910749143
SET-2,vorinostat-carboplatin (1-1 mol-mol),1.5706437227758208
SNU-1033,3062316,-0.0877910405089985
HSC-4,44202524,5.184990397771561
ML-1 [Human thyroid carcinoma],16722836,0.1571893320134409
Kasumi-2,11455910,-0.3707966959989963
TE-15,9915743,-3.4156269103241605
KMRC-2,navitoclax-PLX-4032 (1-1 mol-mol),2.3753142298233576
PE/CA-PJ34 (clone C12),6252,1.334555273604778
YKG-1,285033,-2.298749012962292
NU-DHL-1,11485656,2.738678590842112
OE21,25126798,3.6194882522456098
TE 617.T,salermide-PLX-4032 (12-1 mol-mol),4.973897299997077
SW1990,crizotinib-PLX-4032 (2-1 mol-mol),1.6329799636642304
PaTu 8988s,2871966,-0.1095165482463066
NU-DHL-1,11222830,0.1401036768079258
ML-1 [Human thyroid carcinoma],44491742,4.3341380025681175
Aska-SS,11609586,2.144286749456431
YKG-1,10427712,4.433579193557295
NCI-H2081,44185566,0.8061811733567802
ML-1 [Human thyroid carcinoma],11175137,2.0792526924223735
NCI-H1092,65628,3.8308798172666183
PaTu 8988s,168313200,2.2085646036836786
MCAS,65064,5.2677124531317245
KMS-27,1242560,2.2003071590723007
BT 320,11625818,5.9690326446968935
MCAS,44819697,-0.3897995387059051
HSC-4,JQ-1-navitoclax (2-1 mol-mol),3.2016872805134025
NU-DHL-1,451668,-1.5883202608860565
A4/Fukuda,56973724,1.7857996527787343
NCI-H2110,135659046,4.755266203031495
LoVo,16725315,3.2447595903434627
Hep-G2,24180125,3.881955939132959
GOS-3,51039095,2.831868271027857
EJM,tanespimycin-gemcitabine (1-1 mol-mol),-4.796041108961502
PaTu 8988s,12001922,1.9011418575580596
SNU-308,44259,1.4387037316410851
SEM,navitoclax-birinapant (1-1 mol-mol),-3.1404014425166777
Aska-SS,11427553,2.7743154007573287
Ku812,5335621,4.179509612142592
CA46,89183176,2.547561715641907
HEC-151,23582824,1.8104263678243615
TE 617.T,216468,4.057012823522719
SKM-1,9911463,3.5328203832136276
TE-15,5460769,-0.6910051691918724
AN3-CA,613753,3.2881872693616
Hs 683,11317348,3.009129007427486
HMCB,6438330,1.909471735352977
HSC-4,3854666,2.969420021692798
HARA [Human squamous cell lung carcinoma],65064,5.174523602274789
RPMI-7951,44607531,1.5066320786781766
KMS-20,5281672,3.173673228263361
NCI-N87,72193870,2.948099148236623
HARA [Human squamous cell lung carcinoma],54686904,4.432396143260886
MCAS,46398810,2.9404325213939364
CML-T1,5351362,1.0869507822739353
TE-15,2871966,-1.8816230451578544
BT 328,tanespimycin-gemcitabine (1-1 mol-mol),-0.0824560105444719
OE21,65064,5.246498479818922
KMS-27,2708,3.181722849238598
HSC-4,5281321,1.7816899121848235
YKG-1,613753,3.3129091754262827
EJM,doxorubicin-navitoclax (2-1 mol-mol),-1.6863315158060843
NCI-H2110,JQ-1-UNC0638 (2-1 mol-mol),2.777765951368402
CML-T1,4096211,0.5897034084412636
RERF-LC-Ad2,16659841,4.34581560235471
SKM-1,46215462,1.429596205296915
SKM-1,4477,0.924139002455618
KMRC-2,168312962,4.413019822762519
Kasumi-2,262093,1.7604912977671856
BT 328,6917907,3.783088770502935
CA46,5978,-7.34958411963843
Kasumi-2,tanespimycin-bortezomib (250-1 mol-mol),-1.599342036270796
HEC-151,89928392,1.5427367273356516
A4/Fukuda,107985,-4.34456564276242
LNCaP clone FGC,carboplatin-UNC0638 (2-1 mol-mol),3.3387312482974214
EJM,151289,0.6472385344760342
D283 Med,107985,-4.659724680199273
GOS-3,9936388,2.12022290506738
SNU-1272,4917,3.2346611590060608
RERF-LC-Ad2,24901704,2.869473134456323
NCI-H2172,2749,1.995653963491108
SET-2,400769,-1.0052037587602156
SEM,vorinostat-carboplatin (1-1 mol-mol),1.1477550395391434
SNU-1214,3385,4.1529729205972306
Ku812,637858,1.0891915977996414
RERF-LC-Ad2,6918837,-1.2883848481250342
SET-2,9825149,1.617033396612476
Hep-G2,25154868,4.6149046547070816
HSC-4,644241,2.6183127396598262
BT 328,984333,0.810991187703125
BT 139,46843906,3.701995296517631
NCI-N87,10113978,2.582247145825502
LNCaP clone FGC,9907093,1.5996607378578112
KYSE-410,ISOX-bortezomib (250-1 mol-mol),0.8932927534344921
SET-2,44486219,4.176423413472714
LNCaP clone FGC,3025944,3.856830453076277
Kasumi-2,5329102,1.6326140590430216
AU565,2871966,0.5985779022023225
BT 328,52947716,2.920977634750811
IST-Mes1,44566777,1.465871694296859
RPMI-7951,navitoclax-birinapant (1-1 mol-mol),1.0939904269343144
NCI-H2110,462382,1.2289410171017607
D283 Med,216239,2.1724575702857
Ku812,5460769,3.1615206717567608
MM1.S,52947716,-4.198321546878978
BT 330,54649381,3.7606030780580255
NCI-H1092,216239,1.663382184966008
RPMI-7951,erlotinib-PLX-4032 (2-1 mol-mol),2.7568128654498363
KMS-27,20959075,-3.466163882395625
KMBC-2,46926350,-3.492426009474656
SEM,25161177,4.0488319816215
NU-DHL-1,carboplatin-etoposide (40-17 mol-mol),0.2003297158995997
HEC-151,24748573,2.21609783337234
OE21,erlotinib-PLX-4032 (2-1 mol-mol),-1.4046764949857564
Kasumi-2,selumetinib-decitabine (4-1 mol-mol),-0.5593050771503721
GOS-3,119182,1.862888663663923
KMRC-2,12001922,2.386008364335044
SNU-1272,17755052,3.726908872062008
NCI-N87,16720766,-1.168414694473064
D283 Med,16736978,0.404071171344105
BT 248,42642645,1.464081071598135
IST-Mes1,25262965,-0.2533063216587133
BT 330,5329102,1.6954321581918674
TE 617.T,24964624,3.0326403472888988
PE/CA-PJ34 (clone C12),51037431,4.093871362794514
IST-Mes1,45279963,3.842534876522704
BT 330,16736978,2.4354691948516636
SEM,148124,-5.566475057371884
OE21,44137675,3.048058416075801
A4/Fukuda,241158,1.407426277414268
LoVo,135440466,2.5900307411888357
CA46,10127622,5.462644164632326
SNU-1033,11364421,-0.0634614398116834
CML-T1,56946209,-4.816302217893272
HEC-151,53392493,2.135168779555376
AN3-CA,71466445,5.096273299698095
SNU-8,44202524,1.4999626286569303
TE-15,16659841,2.5822649021931396
NU-DHL-1,135421197,0.761695548293036
HCC2218,6918837,-4.224202625927703
PE/CA-PJ34 (clone C12),46398810,2.398216250372749
Hep-G2,9956119,4.422188514955625
HEC-151,3081361,3.322855731838992
SNU-308,219104,5.365013057580392
SNU-1214,3038522,3.5904170903489585
KMBC-2,carboplatin-etoposide (40-17 mol-mol),4.395543758735
A4/Fukuda,676352,1.592410759121419
LNCaP clone FGC,4477,0.4038376941880343
TE 617.T,2874250,4.280917515238063
KMBC-2,selumetinib-GDC-0941 (4-1 mol-mol),-0.2152983894179389
TE 617.T,9967941,2.6679963163569647
SNU-1033,11955716,-0.1266857479332317
SNU-1214,1242560,3.2645993868330265
MM1.S,2858523,3.054704671957027
PE/CA-PJ34 (clone C12),969516,2.522946376643246
EJM,65064,5.323795448913802
NCI-H2081,73707398,0.6809572071185331
GOS-3,2749,1.7643517607481882
LoVo,20959075,-3.964629838563966
Kasumi-2,9907093,3.255145953057051
BT 139,selumetinib-vorinostat (8-1 mol-mol),4.048057418215767
KMRC-2,navitoclax-pluripotin (1-1 mol-mol),-0.9157954124950312
SW1990,81146,4.42209056734023
LNCaP clone FGC,16659841,3.8088119567527903
SNU-1033,11257553,0.3367229998318771
D283 Med,753704,2.8717556024543067
MM1.S,JQ-1-MK-0752 (1-1 mol-mol),-0.6005566068077197
SW1990,676352,1.910648708099832
HEC-151,73707398,0.6503268944686523
RERF-LC-Ad2,444795,4.5594337932678455
TE-15,135411,-0.3374771976719254
NCI-H2110,11657048,4.29195806881169
HMCB,11494412,1.1725416400884527
MM1.S,46224516,1.4824898133481414
KMS-20,445455,4.148068578484743
BT 330,439501,-3.680620250809701
KMS-20,9967941,3.626187423361352
SNU-8,11364421,0.2778138033460223
NCI-H2081,151289,0.7108361073513202
Hs 683,135984461,3.956952055268157
Hs 683,23582824,0.6802419635855828
KMRC-2,10427712,5.134156935709105
NU-DHL-1,5494449,-1.7833520753251897
KMRC-2,2729026,2.995912943656125
SEM,72199292,-0.295310917507193
SNU-1033,135984461,1.7836640453843908
SKM-1,159324,-1.3530804275700197
RERF-LC-Ad2,11167602,5.947765325830758
Raji,46215462,1.6816639746084328
SEM,11364421,-5.764014401440725
NU-DHL-1,445091,4.453700475457089
RERF-LC-Ad1,168313047,3.647095781351058
HEC-151,selumetinib-BRD-A02303741 (4-1 mol-mol),4.0698233593046735
GOS-3,9911463,4.370946765627494
NCI-H2110,12001922,2.34278570300224
KMS-27,3634881,2.704318622669992
NCI-H2172,119607,4.988984400900318
HSC-4,3062316,-0.6194675763886993
SET-2,JQ-1-carboplatin (1-1 mol-mol),-0.9059473366978348
SNU-1272,168313047,3.3416788102138995
A4/Fukuda,702558,5.147225783500614
NCI-H1092,23635314,1.8043090109267528
SKM-1,9956119,3.002044970915889
LoVo,44632017,0.6073588127957028
SET-2,24901704,2.3825305481978907
CML-T1,44632017,0.7838820876699769
AU565,613000,0.5241513608694668
PaTu 8988s,navitoclax-birinapant (1-1 mol-mol),1.2530315595122747
YKG-1,carboplatin-UNC0638 (2-1 mol-mol),3.500732763699647
PE/CA-PJ34 (clone C12),26596,-1.1037163261022582
NCI-H1395,3025986,0.7160390395986832
LoVo,25154868,3.829103546750207
HMCB,135999136,1.9344485879492248
SNU-1272,46901937,3.721598697481184
MCAS,44607530,2.813061724586131
SKM-1,11717001,-3.556230910849805
NCI-N87,4788,6.175336883845895
MM1.S,613753,2.867673919869975
RERF-LC-Ad1,11404337,1.7320849295693297
NCI-H1092,11178236,-2.084013708263219
NU-DHL-1,11152667,-2.1433741052472493
LoVo,11977753,-2.85765012298846
HMCB,piperlongumine-MST-312 (1-1 mol-mol),1.358280026891677
SKM-1,54618164,3.978394394327194
HSC-4,285033,-0.8602386046724618
IST-Mes1,6505803,0.837907313306775
BT 248,4259181,0.8166391520482507
D283 Med,72734382,2.7546451144628756
EJM,11612883,2.7547358243223368
CA46,carboplatin-UNC0638 (2-1 mol-mol),3.486985389348746
NCI-H2081,navitoclax-sorafenib (1-1 mol-mol),1.2084558654866828
KMBC-2,156414,2.2596369338990976
HEC-151,53232,3.7500563191364193
PE/CA-PJ34 (clone C12),49793307,-5.119931749998305
D283 Med,44607530,0.9211029721085632
BT 248,11455910,-0.0312737668402554
NCI-N87,49793307,-2.95740399691262
RPMI-7951,3081361,2.390832718109946
NCI-H2110,322968,4.098165258163528
KMRC-2,54596490,5.045398582154487
TE 617.T,piperlongumine-MST-312 (1-1 mol-mol),1.050582795400428
SNU-1033,44607531,1.915061497650475
NCI-H1395,168313016,6.368341181188219
Aska-SS,2729026,2.2940081648522246
RERF-LC-Ad2,100016,6.703705933143471
Raji,11626560,2.140916450876962
CA46,71751553,4.222934016329145
IST-Mes1,24180719,3.838804357743771
KMS-20,4521392,3.4103323634767775
NCI-N87,5278396,3.196450874168962
CML-T1,vorinostat-carboplatin (1-1 mol-mol),1.2674452804454217
HCC2218,24753719,4.203747077764167
SEM,375860,-0.9031870337732496
CA46,25126798,3.582571225160254
KMBC-2,72193861,3.090412546181339
SW1990,navitoclax-piperlongumine (1-1 mol-mol),3.4843269276509883
NCI-H1395,216239,1.7586314171989954
A4/Fukuda,54143018,0.5698360241890451
KMS-20,4261,-1.121015461502452
KMBC-2,400769,-0.6422603462472702
PE/CA-PJ34 (clone C12),119607,5.593400059439999
AN3-CA,44607530,0.9977206657387836
OE21,57519531,2.944377743454458
MM1.S,10427712,3.559662100834844
AU565,2858523,2.8415967437488443
A4/Fukuda,6918878,-0.3411937140873722
SNU-1214,54619238,4.665437411925521
NCI-H2081,16065773,2.352319766762804
SEM,241158,3.04470395214072
PE/CA-PJ34 (clone C12),3689413,1.240876822848384
HARA [Human squamous cell lung carcinoma],11238147,2.905443405294126
EJM,4705,3.167336091742425
BT 320,2949965,3.703585539882772
RPMI-7951,11167602,2.502155495655697
PaTu 8988s,1566236,3.825164305906747
LoVo,1750826,-1.736017877496402
NU-DHL-1,24180719,3.951276464233685
EJM,vorinostat-carboplatin (1-1 mol-mol),2.441111900525166
Raji,5284616,-3.4327724662437853
BT 328,piperlongumine-MST-312 (1-1 mol-mol),1.83335233808469
LNCaP clone FGC,10231331,4.305884734347832
NCI-H2081,44462760,3.7666296085166375
SKM-1,4521392,4.8540748740064705
NCI-H1092,16065773,1.6948884921799936
HARA [Human squamous cell lung carcinoma],44137675,4.310894105428011
Hep-G2,24951314,0.9482365858167474
NCI-H2172,11625818,5.408752687191274
HSC-4,3815108,3.178044313970192
NCI-H2081,462382,-0.5652785498949985
Raji,25150857,2.2556333838390388
SNU-8,5278396,3.766037951677824
SNU-8,JQ-1-carboplatin (1-1 mol-mol),1.6259891864743636
AN3-CA,5566,3.1575267125293793
KMS-20,46907787,-1.3444114814530854
BT 320,5311,2.686412240878293
KYSE-410,2828334,6.400513638299557
SNU-1214,68056272,3.695101742442541
KYSE-410,2126,4.711224213364265
Hs 683,123631,1.7758111782879298
HMCB,246676,5.779204987667754
CML-T1,JQ-1-vorinostat (2-1 mol-mol),-0.0778878507242399
Kasumi-2,6438330,0.3381981879114322
NCI-N87,4259181,-0.3128226187706996
SNU-1033,5311037,5.480663471936506
PE/CA-PJ34 (clone C12),11707110,-0.098789156222797
CA46,11612883,1.866301185217262
BT 328,17755052,2.7457916392526247
KMS-20,135984461,4.215331371407202
PE/CA-PJ34 (clone C12),selumetinib-PLX-4032 (8-1 mol-mol),2.847954484086583
EJM,5328940,0.8607847045793436
BT 248,135411,2.4646623802818577
EJM,5566,2.9848804377366545
SNU-8,107985,-2.480678817312735
BT 330,44607530,0.8480949545139396
SKM-1,44589607,2.983642754360158
SET-2,676352,1.571456304153482
MM1.S,9967941,3.082231496587742
Ku812,1750826,-2.479099984818899
SNU-1033,24797083,2.041031359710837
Kasumi-2,156414,1.0465549823430256
A4/Fukuda,4915,4.811112690158961
NCI-H1395,vorinostat-navitoclax (4-1 mol-mol),3.530315000383913
SNU-1214,46199207,2.239067133840438
BT 248,11317348,2.524808263877468
KMS-27,navitoclax-sorafenib (1-1 mol-mol),-1.216948658463341
OE21,44202524,1.341863747335709
OE21,9840324,7.130440725429134
KYSE-410,135398516,1.6469122862912091
NCI-H2110,36314,-7.893561115183718
KMBC-2,selumetinib-MK-2206 (8-1 mol-mol),1.3312821672012836
Ku812,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.5255380430209794
SNU-8,168312962,2.7450687253779025
SNU-1214,11178236,-3.3009861540973024
SEM,176870,1.5033295083802505
AN3-CA,107970,2.2532094276604115
Kasumi-2,navitoclax-sorafenib (1-1 mol-mol),-1.696804912117395
NCI-H2110,51039095,3.0637434644856283
KMS-27,374536,1.0390671300660683
KMRC-2,23582824,0.4728362426959734
HCC2218,10302451,2.366058376925374
HEC-151,445643,3.872369343454908
KMS-20,40482356,4.999111533237927
HMCB,168312962,-2.518156127893363
BT 248,docetaxel-tanespimycin (2-1 mol-mol),-0.0329319446366538
OE21,JQ-1-vorinostat (2-1 mol-mol),-0.1835803700202176
MM1.S,89928392,0.1055731132110887
BT 248,11427553,3.5134734510694687
BT 328,5281321,2.1998966981580073
KMS-20,216468,1.0997828740051716
CA46,439501,-3.521132637790176
SNU-8,6918837,-2.3006259406352023
RPMI-7951,44632017,0.9234981216419595
Kasumi-2,11214940,0.2886545067447796
SET-2,44566777,-1.033546336439595
NCI-H2081,JQ-1-UNC0638 (2-1 mol-mol),0.2107025154126548
HMCB,23725625,4.742834994685236
SNU-1214,702558,4.805377717438986
OE21,2733526,4.086815697024987
OE21,selumetinib-decitabine (4-1 mol-mol),1.7352766036003722
PE/CA-PJ34 (clone C12),3552672,5.59200043016104
BT 139,10385095,0.5327849644676411
MCAS,1750826,-3.484933557510254
RERF-LC-Ad2,11977753,-1.321500951988714
Hs 683,56946209,-4.267470222354378
HSC-4,9956119,3.775946121479013
SNU-1214,100016,6.334633199659308
NU-DHL-1,53232,2.540653358624638
SKM-1,46843906,1.3113663495190937
PE/CA-PJ34 (clone C12),46199207,3.406755484984745
Aska-SS,carboplatin-etoposide (40-17 mol-mol),4.007794441531432
PE/CA-PJ34 (clone C12),11494412,-0.047975107536018
NCI-H1395,49766530,-2.8850236043305792
Hs 683,44566777,1.5079586204281026
TE 617.T,11960529,3.773275701050975
Hs 683,11396600,3.438921740314131
MCAS,71466445,2.5533694020857163
SW1990,1566236,1.8608127009436903
BT 328,71304818,3.21596633578744
PaTu 8988s,10385095,1.7438856573412385
BT 139,5278396,3.8835862216023194
SKM-1,107970,2.3266449159028735
D283 Med,selumetinib-piperlongumine (8-1 mol-mol),2.4396148018972585
EJM,10296883,2.9448984253361057
Ku812,16736978,-0.4990163142068329
CML-T1,11626560,-0.8907703496754931
KMS-20,56963564,-0.3718578032159711
PaTu 8988s,10113978,5.272463308546891
HMCB,selumetinib-JQ-1 (4-1 mol-mol),1.6185777798994516
PaTu 8988s,2828334,6.366685519056066
YKG-1,24951314,2.313291828558588
HEC-151,12003241,-1.83751972949174
CA46,navitoclax-PLX-4032 (1-1 mol-mol),3.7945066500570057
Kasumi-2,tanespimycin-gemcitabine (1-1 mol-mol),-5.446919177897971
MCAS,72376,-3.5735765785817373
LNCaP clone FGC,11485656,1.8681426570872277
EJM,2742550,4.0665181922374805
AN3-CA,46901937,3.742113645268159
SKM-1,89928392,0.546592586318215
IST-Mes1,6918328,0.8508470020259952
SNU-1272,doxorubicin-navitoclax (2-1 mol-mol),1.2550263816124974
OE21,12001922,1.590204471841314
AU565,5738263,3.0246848768630334
SNU-8,409805,5.0276813202923325
PE/CA-PJ34 (clone C12),702558,5.513865527518569
NCI-H2081,3543504,2.734133783068638
NCI-N87,selumetinib-decitabine (4-1 mol-mol),3.433626364692319
TE-15,ISOX-bortezomib (250-1 mol-mol),0.2495596410464286
BT 248,9549297,1.6274014594604191
Ku812,5291,-2.2328806497489437
KMBC-2,5278396,3.553356906982777
NCI-H1395,16725315,5.329149992697811
A4/Fukuda,15983966,4.102938700353478
GOS-3,25227462,1.8095270845710951
D283 Med,navitoclax-pluripotin (1-1 mol-mol),-1.8329751159945813
BT 139,46398810,1.8221701592535624
CML-T1,241158,2.0968023336421227
BT 248,9866186,3.3997152825838515
SET-2,374536,-5.775259114630841
Hs 683,11964036,1.2536165923644558
KMRC-2,6852167,1.9056104142520949
YKG-1,89928392,2.561295118158604
NCI-N87,446155,3.321702095578996
CA46,selumetinib-BRD-A02303741 (4-1 mol-mol),5.304542005494123
HSC-4,135999136,1.7584955345229645
SEM,erlotinib-PLX-4032 (2-1 mol-mol),2.337772510139529
KMBC-2,5470400,-2.1674218484821446
MCAS,409805,5.6817502143710685
TE 617.T,46199207,2.701675473879776
IST-Mes1,11222830,1.7720886037954378
Kasumi-2,71466380,3.646549475683979
HEC-151,10231331,4.832109833959945
D283 Med,11497983,0.3282977330400873
TE 617.T,3136844,3.7181899767171607
SW1990,2945648,2.974467829952507
KMBC-2,16065773,2.994561730317731
HMCB,135423438,4.419625220654583
NCI-H2110,54613361,-0.3026858846945739
Raji,17759555,4.490622135010783
OE21,9927531,4.992848693668257
MM1.S,5743,-3.388771568562768
MM1.S,9907093,3.622673002337576
SET-2,selumetinib-MK-2206 (8-1 mol-mol),1.7607206315112338
EJM,60750,-5.8267895844580515
HSC-4,JQ-1-UNC0638 (2-1 mol-mol),5.303785757115223
TE-15,11178236,-2.699061593629313
HCC2218,46907787,2.570368749578335
KMRC-2,54765302,3.811296252656916
HMCB,4259181,-1.3658440890199388
TE-15,462382,1.115995338445578
PaTu 8988s,322968,4.793369541663368
D283 Med,71304818,2.1992785048974577
HARA [Human squamous cell lung carcinoma],216239,2.4828561148565256
PaTu 8988s,136227924,2.43354349220747
CA46,4788,4.772802977698259
CA46,selumetinib-MK-2206 (8-1 mol-mol),2.416379770776117
KYSE-410,5280436,3.0983343367538447
TE 617.T,462382,-0.1040217351692691
NU-DHL-1,44486219,3.982254697079296
LoVo,73707386,4.416344333605744
PaTu 8988s,46224516,1.391714663581103
NCI-H1395,navitoclax-PLX-4032 (1-1 mol-mol),3.577675870608842
MCAS,52912189,1.8684628256786515
IST-Mes1,crizotinib-PLX-4032 (2-1 mol-mol),1.4798286107475835
AN3-CA,11234052,3.789167280312416
NCI-N87,11485656,1.873926788766734
AU565,46398810,1.9802808058059196
HSC-4,11178236,-3.2670379451965164
Aska-SS,53232,-5.775078503604418
BT 330,4378219,1.6055397762494217
PE/CA-PJ34 (clone C12),10385095,0.6586777190246488
RERF-LC-Ad2,3825829,4.845421431972124
HEC-151,9967941,3.6318712214056705
SNU-1033,25227462,-2.9576169404781947
A4/Fukuda,46191454,-2.2780561859524457
ML-1 [Human thyroid carcinoma],11683005,4.957719989216769
SNU-8,navitoclax-PLX-4032 (1-1 mol-mol),4.548524240325165
KMS-27,46199207,2.868672970964164
GOS-3,123631,3.414822398468875
TE 617.T,11507802,1.0822738369190534
AU565,637858,2.0174799842455364
RERF-LC-Ad2,56649450,3.379867439418164
KYSE-410,11612883,2.6710093722065875
SNU-308,6914657,-1.649213598148654
NCI-H2081,44632017,0.6530598645266015
SW1990,107970,2.5044307368694687
SEM,262093,0.379936046646312
Kasumi-2,53495165,-3.989635350263354
SEM,445091,4.25698967514786
BT 328,24180719,4.750415959710981
KMBC-2,selumetinib-PLX-4032 (8-1 mol-mol),3.916029133492093
NU-DHL-1,46398810,1.6641868117973977
SNU-1214,JQ-1-carboplatin (1-1 mol-mol),3.0225618728899675
LoVo,51037431,2.9518330914759043
CA46,44566777,-1.0409480025289963
YKG-1,11977753,-3.046563007641072
LNCaP clone FGC,navitoclax-piperlongumine (1-1 mol-mol),2.2980400101036045
HCC2218,BRD-A02303741-navitoclax (2-1 mol-mol),3.8967353048757394
CML-T1,322968,2.5082577681036473
NCI-H1395,25154868,5.12981371240632
SEM,serdemetan-SCH-529074 (1-1 mol-mol),1.7105647593027902
TE-15,7326481,3.653309357321709
OE21,53232,2.5328108907893734
D283 Med,56649450,1.3695223630329627
PE/CA-PJ34 (clone C12),11507802,0.6950078471538325
PaTu 8988s,122327,4.239534425754978
BT 248,11238147,1.7431248737974965
LNCaP clone FGC,piperlongumine-MST-312 (1-1 mol-mol),-0.3549600707438295
MCAS,2828334,5.7041828884392345
NCI-H2081,53232,2.211955699015755
SNU-8,44185566,2.3653389321238354
NCI-N87,navitoclax-piperlongumine (1-1 mol-mol),-1.185093256857405
NCI-H2172,24180719,4.347081195006066
CML-T1,9911463,2.5893115421622737
BT 330,56946209,-4.733206514470745
A4/Fukuda,71466578,0.6387062903604859
IST-Mes1,49867930,4.491137344342606
NU-DHL-1,2828334,5.350284710579576
RERF-LC-Ad1,9936388,2.559895364863056
HSC-4,24753719,5.996217074466553
BT 320,sirolimus-bortezomib (250-1 mol-mol),1.2360663463766004
PE/CA-PJ34 (clone C12),49766530,5.059286998332617
SET-2,3011155,5.360962728041406
KYSE-410,54454,3.984562652045316
MCAS,60700,0.1584567285823285
D283 Med,44566777,0.6704743507952735
KMS-27,3136844,4.048697620753124
BT 330,8515,4.407994026323292
AN3-CA,123631,2.4895292563964584
EJM,2828334,5.892634980488002
Ku812,8515,2.860455557749638
Aska-SS,60750,0.2520411068674127
KMRC-2,1239801,5.8496258004918245
Kasumi-2,54626689,4.779746030866953
SNU-1272,3854666,4.252561459564198
NCI-H1395,serdemetan-SCH-529074 (1-1 mol-mol),2.764228376704601
KYSE-410,sirolimus-bortezomib (250-1 mol-mol),0.4997693160347982
SEM,5494449,-4.399827227621216
BT 320,73707438,3.918904444875683
OE21,5335621,5.192479733807399
HCC2218,11175137,2.387225353328728
OE21,2708,5.840495936667117
MCAS,selumetinib-navitoclax (8-1 mol-mol),1.918251839366345
KMS-20,5566,2.852625231328134
KMS-27,241158,2.104620669820106
KMS-20,72199292,0.0792134976648957
SW1990,carboplatin-UNC0638 (2-1 mol-mol),3.853887350525919
EJM,44607530,2.5070049311277423
BT 139,73707398,1.451350595417811
RERF-LC-Ad2,11955716,-2.482304442016354
Kasumi-2,54678924,1.0609274738962189
Kasumi-2,5284616,2.846557055185116
Ku812,55283,1.038914433795577
SW1990,9967941,3.0043140523429512
BT 139,5470400,0.7333090079769623
SNU-308,4259181,0.5010319397561465
SNU-8,3038522,3.557349026871971
AU565,53232,3.892352285865555
SW1990,126941,-4.292570667373939
BT 330,11626560,1.856341325054047
LNCaP clone FGC,10184653,1.6496146664208813
SKM-1,26596,-4.237929506963809
KYSE-410,11234052,4.03136586306223
IST-Mes1,9935249,3.876611894197404
KYSE-410,11364421,-2.2224816076543132
SEM,11707110,1.3401031193099515
Aska-SS,136227924,2.71481465035111
A4/Fukuda,9884685,-2.10728676228506
TE 617.T,6610355,3.955537249205886
KYSE-410,6918837,-2.3211819523697947
YKG-1,5328940,2.878150949986743
SET-2,3825829,4.044328892203194
LNCaP clone FGC,5460769,1.4769173176739367
BT 139,31703,-0.7978827356055225
NCI-H2081,4477,0.6401046576729016
MM1.S,16038120,-1.5361112717361085
LoVo,72193861,-0.0557430791680942
EJM,44185566,2.4578466315948013
LoVo,60700,-0.3967380120150421
KYSE-410,24951314,1.1788192496872791
BT 248,54618771,0.8718785044821341
SNU-1272,4788,6.041801756981533
SNU-1214,12001922,1.6320434938041075
HSC-4,1242560,3.572222416741055
NU-DHL-1,44137675,1.8440314002595644
MCAS,51037431,1.5804023066668025
NCI-H2081,7251185,1.1327722028105756
CA46,9911463,2.565133854881976
PaTu 8988s,11178236,-3.993619119148662
BT 330,sirolimus-bortezomib (250-1 mol-mol),0.7092263662862476
Kasumi-2,52912189,-0.393622705419007
NCI-H2172,44202524,4.914031503934329
NCI-N87,72734382,4.464771871646434
PE/CA-PJ34 (clone C12),54618771,0.3330928840466188
CA46,JQ-1-vorinostat (2-1 mol-mol),-0.7880767442206768
HSC-4,446155,4.1145986724492865
SKM-1,46174525,2.564354179427139
BT 328,24797083,3.187781247629872
BT 248,4788,5.6007343352714605
SKM-1,4261,-0.5534245942964136
CML-T1,2708,2.830885116766648
SEM,5278396,2.924280160734611
CML-T1,55283,-0.0221984323925449
HARA [Human squamous cell lung carcinoma],navitoclax-PLX-4032 (1-1 mol-mol),1.441529788664552
MCAS,400769,-0.8505604420726267
D283 Med,46398810,1.668520426721307
NU-DHL-1,5311,-0.0484251150139828
MM1.S,24753719,4.473744821146246
MM1.S,3062316,1.4627062032317144
SEM,selumetinib-BRD-A02303741 (4-1 mol-mol),2.811165590219853
HSC-4,445643,4.123722857917103
LNCaP clone FGC,10410894,3.366093772051826
SNU-308,3081361,2.4730065598640247
CML-T1,10385095,0.9719029483379856
RPMI-7951,9825149,2.2495460787888866
AN3-CA,439501,-3.229124904343767
KMBC-2,doxorubicin-navitoclax (2-1 mol-mol),0.0494170582755545
SNU-1033,crizotinib-PLX-4032 (2-1 mol-mol),1.9066763754153624
Aska-SS,445643,4.692347461031462
SNU-1214,serdemetan-SCH-529074 (1-1 mol-mol),2.0689906007106376
NCI-H2081,753704,4.35902455138568
A4/Fukuda,24771867,-3.7385177445932585
SET-2,285033,-4.01065883021271
PE/CA-PJ34 (clone C12),5287969,-2.1859806545337888
MCAS,119607,3.997130409644658
Hs 683,54613361,-1.1051240356391956
NU-DHL-1,tanespimycin-gemcitabine (1-1 mol-mol),-5.858735676299637
HEC-151,9929138,7.082890356746388
Hs 683,11977753,-2.3238360318004747
OE21,54619267,3.756831032565462
YKG-1,4578,4.349355625393761
HEC-151,637858,1.4744237971842309
SKM-1,1750826,-4.975588841995149
HARA [Human squamous cell lung carcinoma],6852167,2.790696024551457
A4/Fukuda,9866186,-0.2462641713744652
Hep-G2,24964624,2.457583201626236
ML-1 [Human thyroid carcinoma],alisertib-navitoclax (2-1 mol-mol),-1.2100779480376045
PE/CA-PJ34 (clone C12),vorinostat-carboplatin (1-1 mol-mol),4.08253378532113
AU565,10296883,3.47614106437246
LNCaP clone FGC,5284616,-5.194516474442037
MCAS,selumetinib-BRD-A02303741 (4-1 mol-mol),1.302698878227716
HSC-4,53392493,2.986961827224748
EJM,52912189,-1.0770989556153556
RERF-LC-Ad1,JQ-1-vorinostat (2-1 mol-mol),2.719518134337945
NCI-H1092,104842,-3.256755572593022
Raji,9803433,5.319356572768684
GOS-3,11175137,2.721300894926601
Ku812,44487061,4.391820137967094
A4/Fukuda,10385095,0.4549399411675465
MCAS,23635314,-2.30522753278216
EJM,676352,1.4630125029054086
KMRC-2,119607,5.905550906408889
CA46,24797083,-0.1839530161688024
CA46,2126,3.4622152695614767
PaTu 8988s,2858523,3.066235891558281
NU-DHL-1,24964624,0.3458888815745198
HEC-151,56946209,-4.508348377915924
LNCaP clone FGC,60750,-2.9424370829616056
BT 248,156422,4.367304785746438
NCI-H2110,387447,-4.13995118678638
SET-2,5284616,3.130528148118791
A4/Fukuda,tanespimycin-gemcitabine (1-1 mol-mol),-4.973874531854187
MM1.S,5278396,3.253514832421593
NCI-H1092,54596490,4.303629834820445
SNU-1033,JQ-1-navitoclax (2-1 mol-mol),0.4519309992600058
MM1.S,piperlongumine-MST-312 (1-1 mol-mol),1.4350664876301185
EJM,selumetinib-vorinostat (8-1 mol-mol),1.9565276246961512
MCAS,46943432,2.7452690797646553
Hs 683,3136844,4.024059328221529
ML-1 [Human thyroid carcinoma],25126798,4.037868296097697
KMBC-2,BRD9876-MK-1775 (4-1 mol-mol),1.3624664038852188
BT 328,285033,-0.2548275745662432
BT 328,3503,3.047903158140159
RPMI-7951,44137675,2.7666009410901284
SNU-308,73707398,3.5686803185694327
SEM,17755052,1.610064105024121
CML-T1,6610355,4.414519429527798
BT 139,969516,2.3517673922237003
KMRC-2,12003241,-1.7913952791170802
A4/Fukuda,2746,1.0000278581130588
NCI-H1092,5281321,0.8486024687815589
SEM,24856436,-2.546648725851104
LNCaP clone FGC,serdemetan-SCH-529074 (1-1 mol-mol),1.845658775945097
MM1.S,9887053,3.7557116412340568
SNU-308,6918328,0.4613782583679794
LoVo,216345,1.1599721320761718
CA46,9915743,0.7447060154867644
EJM,9927531,5.060130602494636
NCI-H1395,11317348,4.623534055604914
HCC2218,2729026,2.847632009198406
KMBC-2,44491742,4.484748547607026
NU-DHL-1,24772860,-2.0670136915752395
NCI-H2110,44202524,1.5427817116056417
RERF-LC-Ad2,5328940,1.9140374587439275
KMS-20,25154868,4.103093703114607
NCI-H2081,439501,-4.570953887500971
BT 139,1716436,2.2745354204675667
BT 139,navitoclax-MST-312 (1-1 mol-mol),0.7116034048397698
HCC2218,vorinostat-carboplatin (1-1 mol-mol),2.0355750419233107
SNU-1033,navitoclax-pluripotin (1-1 mol-mol),0.0916869526510523
ML-1 [Human thyroid carcinoma],44607531,1.8496707927685447
AN3-CA,285033,-3.4589248343725503
LoVo,docetaxel-tanespimycin (2-1 mol-mol),-4.329942307031701
SKM-1,10385095,0.5930890296191716
HSC-4,24779724,5.454925638847944
HSC-4,11626560,2.5873766751252436
CML-T1,23635314,-1.5423479854884166
BT 320,selumetinib-PLX-4032 (8-1 mol-mol),4.7621521702079175
NU-DHL-1,11175137,1.9777455594143565
Kasumi-2,11647372,-1.94314797775666
NCI-H2110,piperlongumine-MST-312 (1-1 mol-mol),1.820600105428923
NCI-H2081,2871966,0.7006851296353342
BT 248,navitoclax-gemcitabine (1-1 mol-mol),0.2474795408705132
SKM-1,selumetinib-JQ-1 (4-1 mol-mol),-3.5716961442559496
NCI-H2110,11494412,1.0397098548542971
Kasumi-2,10074640,2.978792769082284
LoVo,11455910,2.8170443999319574
CML-T1,9840324,5.6593047828259495
HARA [Human squamous cell lung carcinoma],104842,-3.702627319243614
YKG-1,9956119,4.349400441756489
NU-DHL-1,54618795,3.1409617958317613
KMS-27,445091,4.415439646433754
KMS-20,5328940,1.431090406795279
A4/Fukuda,44589607,1.1710928843495056
NCI-H2081,12003241,2.480414390654569
IST-Mes1,navitoclax-piperlongumine (1-1 mol-mol),2.2991023643561115
SNU-1272,46199207,3.241167347577687
LNCaP clone FGC,25227462,-2.764949583578387
PaTu 8988s,123631,3.038734585993763
SNU-8,2733526,4.815147828958365
NCI-H2110,11222830,1.6504638716126514
HCC2218,JQ-1-carboplatin (1-1 mol-mol),4.076746377800596
NCI-H2081,56649450,3.184734939652862
EJM,25150857,1.0881005690844914
AN3-CA,5280436,-0.2236746703993007
BT 248,55508,3.993579478299883
EJM,24771867,4.483722434089688
OE21,446155,2.477997855575094
BT 320,3503,3.052625173384868
HSC-4,3676137,3.997252050059137
NCI-H1092,36314,4.877889816324306
NCI-H1395,5470400,-0.4743897093415642
NCI-N87,400769,-1.2757727144105298
Ku812,54619238,3.9506340253533834
SKM-1,36462,-0.9664350566951958
BT 248,selumetinib-BRD-A02303741 (4-1 mol-mol),5.279106159978606
BT 320,71304818,2.914725517037444
TE-15,156422,4.158605403638828
CML-T1,11507802,-0.1369004319183971
D283 Med,65628,4.590969471061447
Ku812,5311,0.5445817614844265
NCI-H2110,44819697,0.5938285996585121
Raji,4096211,1.4072280963801722
HARA [Human squamous cell lung carcinoma],26596,-2.1080424946580245
KYSE-410,navitoclax-MST-312 (1-1 mol-mol),1.5349956003218148
ML-1 [Human thyroid carcinoma],171352865,2.7298814774275435
HEC-151,441298,2.008915484481665
IST-Mes1,3854666,2.0681561223579075
D283 Med,25161177,4.21580762062299
NCI-H1395,448949,2.6579762505133915
NCI-H2172,11364421,1.11334494051812
A4/Fukuda,6505803,0.0348674492980193
KMRC-2,4705,3.2105980144700004
EJM,5470400,-0.5536603917301139
OE21,3081361,0.1199830515991339
KMRC-2,56649450,3.7925860379336576
CA46,11485656,1.2289823963881294
KMBC-2,5284616,2.9519587458655057
HMCB,25154868,4.752941970603395
SW1990,6918638,1.2411625887645945
AU565,3552672,1.7684242008913282
BT 328,9903786,4.817171686681598
RERF-LC-Ad1,9444,4.3231726239662045
SET-2,568763,-0.7021275174916793
CA46,100016,3.773189878640827
NU-DHL-1,216239,2.6087015234421056
Aska-SS,135875424,5.860449274469886
NCI-H1092,11977753,0.4568762986768944
NCI-H1092,3081361,3.870512478612
GOS-3,168313016,4.456848917287458
AU565,54143018,-0.7127893506095456
Aska-SS,65064,5.347065069795541
Hs 683,24856436,-0.2136505281073007
ML-1 [Human thyroid carcinoma],3384730,3.994618489141425
PE/CA-PJ34 (clone C12),5282054,3.496383978879579
SET-2,168313307,4.480873522233062
MCAS,6914657,-2.7470677358412714
HARA [Human squamous cell lung carcinoma],11640390,3.0925981241806983
ML-1 [Human thyroid carcinoma],135398516,0.6909808613935852
PaTu 8988s,52947716,2.8130648859444523
BT 248,31703,-0.7981868387763399
SW1990,24821094,3.800095262517989
CML-T1,2841722,3.5416474270082796
KMS-27,docetaxel-tanespimycin (2-1 mol-mol),-5.169430287476713
TE 617.T,135398738,3.966056675742529
NCI-H2110,11656518,2.991078235347568
A4/Fukuda,JQ-1-carboplatin (1-1 mol-mol),-0.863856573463552
AU565,11152667,-0.8659767610796402
IST-Mes1,11213558,3.9887472477266215
CML-T1,11222830,0.9922056813064216
KMRC-2,11396600,3.609897485717139
IST-Mes1,sirolimus-bortezomib (250-1 mol-mol),2.2264590257726704
RERF-LC-Ad2,374536,3.127585092037682
HARA [Human squamous cell lung carcinoma],322968,4.828098936758316
PE/CA-PJ34 (clone C12),54626689,4.8339545787356215
Aska-SS,984333,0.5743102703142339
OE21,67291369,1.9144842745200683
AU565,selumetinib-PLX-4032 (8-1 mol-mol),5.080870453516365
IST-Mes1,25150857,2.301198962208278
SEM,doxorubicin-navitoclax (2-1 mol-mol),-4.027940922325109
ML-1 [Human thyroid carcinoma],675434,4.374805668496918
SNU-1214,11626560,1.3344620508576424
BT 330,60700,-0.8929467454140042
PaTu 8988s,44819697,0.2776197966694109
TE-15,26596,-3.7197158754991615
NCI-H2110,613000,2.499144712249598
PE/CA-PJ34 (clone C12),5280436,1.7888326138899853
Kasumi-2,11625818,2.3070585930223477
LoVo,89183176,4.107889784939482
SEM,selumetinib-MK-2206 (8-1 mol-mol),0.6180470677405737
NU-DHL-1,navitoclax-piperlongumine (1-1 mol-mol),-2.603408624311022
LNCaP clone FGC,erlotinib-PLX-4032 (2-1 mol-mol),2.8127712400378737
KMRC-2,11647372,1.1574311998836746
KMBC-2,25022340,2.3366821677333114
SET-2,135398516,1.449792598541135
SKM-1,2749,1.349204961084549
PE/CA-PJ34 (clone C12),15953870,4.1853998040231595
SW1990,3025986,-1.519374574742827
GOS-3,107970,2.255442380434802
TE 617.T,navitoclax-birinapant (1-1 mol-mol),2.46391001326416
Ku812,638278,2.0428029041013387
SNU-308,176870,1.056241712459876
SNU-1272,alisertib-navitoclax (2-1 mol-mol),1.6439535972099484
OE21,SNX-2112-bortezomib (250-1 mol-mol),-2.31253131529281
KMRC-2,5287620,-2.766433271422092
KMBC-2,119607,5.19926943709357
LoVo,JQ-1-carboplatin (1-1 mol-mol),1.9010825713651585
CML-T1,400769,-1.2523952078832103
KMRC-2,3025944,4.8383382704693405
PaTu 8988s,JQ-1-navitoclax (2-1 mol-mol),0.4387961323167006
CML-T1,selumetinib-navitoclax (8-1 mol-mol),1.8946920670328231
SEM,44486219,4.180288188212984
SEM,54143018,-0.980630372208269
LoVo,5280436,3.7935840263164984
KMBC-2,navitoclax-sorafenib (1-1 mol-mol),0.8722120803993443
KMRC-2,54618771,2.1629104463678335
RPMI-7951,51039095,2.6069304996363964
GOS-3,4788,6.125814579723799
HMCB,67156097,-0.9353963085848984
NCI-H2110,72734382,3.9204916905436953
SNU-1214,44259,0.5042401155612436
Hs 683,erlotinib-PLX-4032 (2-1 mol-mol),3.209711945439973
PaTu 8988s,54619267,3.798156483041669
Hs 683,1474550,4.474380523645793
NCI-N87,navitoclax-pluripotin (1-1 mol-mol),-2.6023370603895337
SNU-308,5329102,2.481111150286444
OE21,984333,1.2352091637058848
KMS-27,navitoclax-birinapant (1-1 mol-mol),-2.0662648148507596
TE-15,4261,1.1705616568389658
Kasumi-2,selumetinib-piperlongumine (8-1 mol-mol),1.718006716449046
LoVo,168313047,1.791039731088859
KYSE-410,54618164,4.094546226578619
HMCB,51039095,2.359958278264178
NCI-H1092,439501,-3.60207444945155
ML-1 [Human thyroid carcinoma],56649450,4.029501942502391
HCC2218,44197249,3.83159054202454
SEM,44507138,-0.6979596604838103
KMRC-2,selumetinib-BRD-A02303741 (4-1 mol-mol),4.480458444032737
BT 328,89928392,1.451353651421501
HARA [Human squamous cell lung carcinoma],45100309,5.833200435543825
NU-DHL-1,3025944,4.128998199561555
TE 617.T,327653,3.0456722347172738
SET-2,9956119,1.6747796641968389
NCI-H2110,54596490,5.001361284562202
LNCaP clone FGC,11977753,-4.293415372510932
A4/Fukuda,72734382,2.815137004147321
LNCaP clone FGC,10074640,3.1868639923318516
MM1.S,753704,4.513964984168999
RERF-LC-Ad1,322968,3.2350252408465843
SNU-1272,JQ-1-vorinostat (2-1 mol-mol),1.5021778679128583
Aska-SS,51039095,3.6384675258199857
RPMI-7951,57519531,2.017467458096007
NU-DHL-1,439501,-3.591448694271343
Hs 683,navitoclax-birinapant (1-1 mol-mol),2.3623030418922566
OE21,5291,3.3087584466891813
D283 Med,68056272,-6.774567480474886
NCI-N87,11964036,0.5275056986755973
HCC2218,19582717,2.3590342236199464
BT 248,2742550,4.585670765822412
BT 330,5351362,1.3923603742420232
NCI-H2172,3825829,4.682162679328668
SKM-1,151289,-0.219296204228563
AU565,56649450,1.7738933823843377
AN3-CA,10302451,3.617635565971862
CA46,252682,5.8821335535914905
D283 Med,25126798,4.439280321419275
LoVo,24821094,2.523288695365458
NCI-N87,selumetinib-vorinostat (8-1 mol-mol),2.348461304209469
NCI-H1395,49793307,-1.2890393548834251
KMS-20,46398810,1.6452638403183906
HEC-151,2828334,5.830320904671621
A4/Fukuda,3025944,3.254701794903189
EJM,navitoclax-piperlongumine (1-1 mol-mol),0.8895676752169835
LoVo,54454,2.7172548619434025
KMS-20,42611257,2.1874354470841366
LoVo,46191454,2.275591949439888
RERF-LC-Ad2,136227924,3.207411157267862
GOS-3,11222830,1.7526889108260606
ML-1 [Human thyroid carcinoma],2708,2.4589573831191633
NCI-H2172,1716436,2.3088273241910686
LNCaP clone FGC,46224516,2.2037418982015784
YKG-1,7326481,5.641592853625606
SNU-1214,doxorubicin-navitoclax (2-1 mol-mol),0.3140477617848352
KYSE-410,erlotinib-PLX-4032 (2-1 mol-mol),1.7965080867279632
SKM-1,148198,-3.315233928127138
TE-15,9926054,1.8189889434505215
NCI-N87,72193861,-0.2047514956394879
NU-DHL-1,36462,-1.7187718695601946
A4/Fukuda,8515,2.244185004641864
HCC2218,vorinostat-navitoclax (4-1 mol-mol),0.8970155470733918
RERF-LC-Ad2,462382,1.275402371905796
SNU-308,44185566,2.4594712559167204
BT 328,100016,6.778172011931934
MM1.S,10127622,5.107569305905412
HARA [Human squamous cell lung carcinoma],11364421,-4.71423157944935
CA46,11955716,-2.7152267118714204
KYSE-410,135875424,4.192963545953549
SNU-1214,54613361,-1.50350179537693
Hep-G2,1750826,0.4131687532811144
GOS-3,3025944,4.406147026305863
EJM,1750826,-2.1256322025072323
PE/CA-PJ34 (clone C12),9926054,1.748247929323894
Kasumi-2,24779724,5.733659143451784
SW1990,241158,4.5746267223156085
TE-15,selumetinib-MK-2206 (8-1 mol-mol),2.8531290134214093
Hep-G2,72193861,3.225479457080403
AN3-CA,56963564,0.0711443344118292
LoVo,24856436,-0.7244956111709783
NCI-H1395,6450551,6.187307607667542
MCAS,5746,2.7138823307916335
AN3-CA,135440466,1.9764681400731403
HMCB,637858,1.3431818902192771
YKG-1,969516,4.834181385446052
KYSE-410,676352,2.3264223438557847
BT 330,7251185,1.8500952657054732
SET-2,89928392,0.7137402814992264
Raji,5351362,1.8284566296891975
KMRC-2,23725625,7.2890345118236
LNCaP clone FGC,387447,-4.3744425710670685
NCI-H2081,46926350,-4.428589866932994
AU565,9933475,1.5968241540352486
Hs 683,25062766,2.2319076725821714
Kasumi-2,11719255,0.7919357371697194
HARA [Human squamous cell lung carcinoma],9823820,4.297752192216693
HCC2218,25150857,2.4817306828124313
KMS-20,5291,3.4295110430475204
PE/CA-PJ34 (clone C12),11396600,3.27217842552133
KMS-20,46224516,1.6732996169077097
HMCB,4917,3.7036802766341266
ML-1 [Human thyroid carcinoma],6918289,2.565001109569917
KMRC-2,salermide-PLX-4032 (12-1 mol-mol),6.473934379742123
AN3-CA,5311,1.952423788364144
D283 Med,11977753,-2.8972996135138565
NU-DHL-1,46224516,2.2701616013146655
KYSE-410,613000,3.5449915972816575
KYSE-410,selumetinib-tretinoin (2-1 mol-mol),5.436574012517174
EJM,66577038,3.002566519429357
NCI-H2172,44543605,3.7462839501403256
NCI-H2081,44566777,0.9156481361850354
KYSE-410,15983966,-1.007567423181931
EJM,426756,4.346205416348047
IST-Mes1,10302451,1.9071808976959603
GOS-3,126941,-1.2183252312090715
Kasumi-2,selumetinib-PLX-4032 (8-1 mol-mol),4.8744745414665145
GOS-3,89928392,1.6340555670682608
OE21,44486219,3.8380849815177616
NCI-H2110,446155,3.203285885476125
HARA [Human squamous cell lung carcinoma],24772860,-1.3203429479269333
NCI-N87,11609586,1.5678533381622328
EJM,135421197,1.4211538659692204
MM1.S,JQ-1-UNC0638 (2-1 mol-mol),0.1865642255881416
Ku812,11396600,2.326776145026828
NCI-H2110,4788,5.467246455417277
Kasumi-2,4096211,1.078024917290252
HCC2218,16725315,2.471471872055809
CML-T1,11228183,0.9343365693589996
KMBC-2,2749,1.7206137145305835
BT 139,44589607,2.7431100811702227
A4/Fukuda,25150857,1.0832866246256998
LoVo,6918878,0.5506920931363443
AU565,107985,-3.572249289009051
BT 328,24821094,3.7290564258342904
AU565,24775005,3.4802015368768657
ML-1 [Human thyroid carcinoma],selumetinib-vorinostat (8-1 mol-mol),1.7610539005616883
CML-T1,54686904,3.622967709931094
BT 320,5328940,3.389766935980773
SKM-1,54618771,0.6725959366795358
D283 Med,44493528,4.1397828788754465
SNU-1272,637858,3.0444768805463465
AU565,11507802,1.2242731086346843
KYSE-410,51039095,3.0078200287209165
HARA [Human squamous cell lung carcinoma],25105715,3.4880191589222966
SNU-308,24772860,-1.8975415647068492
HEC-151,66577038,3.228211368838608
IST-Mes1,9926054,1.778703370274458
AN3-CA,11404337,1.5621280335523782
AU565,46199207,2.977397460043432
Kasumi-2,72376,-3.459838502439841
OE21,17755052,1.0095449688943243
ML-1 [Human thyroid carcinoma],52947716,-0.2471601623530622
KYSE-410,vorinostat-carboplatin (1-1 mol-mol),3.364608717554743
NU-DHL-1,45279963,-1.229232320472187
EJM,JQ-1-UNC0638 (2-1 mol-mol),-0.7989999630217455
KMBC-2,11178236,-2.9069382083568733
BT 139,25102847,3.0960881456640954
Kasumi-2,2842253,5.767696299842194
IST-Mes1,6852167,3.791716512628995
HCC2218,56946209,-1.8093732345555749
HARA [Human squamous cell lung carcinoma],52947716,4.13690029570622
KMS-20,5329102,1.4165548971793418
Hs 683,24821094,3.6507321764392806
TE 617.T,49793307,-4.415420925878237
TE 617.T,7326481,2.496151388001922
BT 139,107970,1.8298356347130915
LNCaP clone FGC,24797083,1.6504551610378324
NCI-H2110,44507138,3.030476898815104
HARA [Human squamous cell lung carcinoma],11228183,1.9492387662676105
RPMI-7951,675434,4.528835067595089
CML-T1,selumetinib-tretinoin (2-1 mol-mol),2.254120654073675
BT 330,SNX-2112-bortezomib (250-1 mol-mol),-2.8993198862024205
SNU-1214,3384730,2.1855301864131422
BT 328,66577038,3.3966345058951974
PaTu 8988s,selumetinib-GDC-0941 (4-1 mol-mol),-0.6255434999404949
SNU-1214,23725625,3.932415720321906
KMRC-2,322968,3.4299636827157003
SW1990,42642645,0.6858937551923172
HCC2218,25183872,0.3170535790676645
KYSE-410,5287620,-2.2725432544483426
PE/CA-PJ34 (clone C12),445091,4.329153580227635
Kasumi-2,9956119,1.4541571674658873
Aska-SS,216468,2.623048745293118
Raji,52912189,0.0180017052979321
SNU-1214,selumetinib-tretinoin (2-1 mol-mol),0.5457033843008748
MCAS,25183872,-2.415818615558872
HMCB,25227462,1.4267273911688456
CML-T1,119607,4.0157878157192375
NCI-H2081,11455910,0.9023670010212674
HMCB,JQ-1-UNC0638 (2-1 mol-mol),1.877058831391371
LNCaP clone FGC,135411,1.269325429429485
NCI-H2081,9903786,1.5566694513779922
PE/CA-PJ34 (clone C12),44507138,2.9484181855986704
RPMI-7951,656346,-0.3467317873475116
NCI-H2172,60700,2.910113972841169
KMRC-2,3689413,-1.0505298927618916
HCC2218,9911463,3.007199101123831
SNU-1214,135875424,3.75117609732274
Hs 683,9956119,2.9988441581599967
TE 617.T,17755052,1.8954392302041911
BT 139,2729026,2.333147558824636
OE21,439501,-2.897438407377833
TE-15,12003241,-1.6215722433150963
CA46,25183872,-1.226882585953409
CML-T1,19582717,1.9595186711365948
RPMI-7951,4521392,5.160488379575089
NCI-H2110,445091,4.470444523586047
NCI-N87,56946209,-4.157058230951839
SEM,JQ-1-carboplatin (1-1 mol-mol),-2.3661872454189634
CA46,6610355,3.575030613446337
YKG-1,676352,1.798762675179312
HEC-151,6918837,-2.8647570458184433
IST-Mes1,613753,3.190229377917506
OE21,71466380,5.2862149479921205
SNU-8,4917,3.3493519367479396
HMCB,selumetinib-GDC-0941 (4-1 mol-mol),1.81562386250498
HSC-4,2733526,3.5101027459294425
SW1990,2871966,0.595244082749687
A4/Fukuda,31703,-2.1013190360416147
NCI-H2110,24748573,2.8560245780031255
BT 330,vorinostat-navitoclax (4-1 mol-mol),1.1563637796794242
BT 320,25183872,-0.2453721787274933
SET-2,9967941,2.243909136307081
SEM,tretinoin-carboplatin (2-1 mol-mol),1.6069371738870424
SEM,4259181,-0.7975863762048068
KMRC-2,3552672,1.8363190955361777
Aska-SS,11404337,-0.8839501993376483
HCC2218,176870,2.47397725704118
NCI-H2110,9825149,2.4425512538743672
D283 Med,984333,-2.902754645088125
MCAS,JQ-1-navitoclax (2-1 mol-mol),0.8322559592301813
BT 248,46224516,2.5816980785990875
AU565,73707398,1.1644887368044523
KMS-20,36314,4.071326540312212
LoVo,16741245,3.141864677583783
Hs 683,439501,-3.4221859538690467
HSC-4,tretinoin-navitoclax (4-1 mol-mol),4.058213789004076
Hs 683,4261,1.6182911270348386
KMS-27,navitoclax-gemcitabine (1-1 mol-mol),-3.3144752374157007
LNCaP clone FGC,9956119,4.171775479590179
EJM,navitoclax-MST-312 (1-1 mol-mol),0.9135656796063774
LNCaP clone FGC,426756,4.29389408705882
HCC2218,6610216,3.6192910247057113
YKG-1,6610216,4.705494965359816
SEM,6252,-2.7487715463047926
TE 617.T,54639665,4.38998607843506
LNCaP clone FGC,12001922,2.092576995336353
BT 320,44819697,2.9489346663339187
Kasumi-2,65628,2.2018759133614987
NCI-H1395,9911830,2.6279117929683142
NCI-N87,49850262,3.22497182450996
NCI-H1395,44486219,4.094426397743146
Raji,49793307,-4.3030150703266505
BT 139,10296883,4.347610797549644
SET-2,54619267,3.644282553207176
SNU-1033,1566236,1.8581490134242764
D283 Med,73707398,0.757498039182734
NCI-H2110,2871966,1.1507738299242007
NCI-H2081,10296883,3.746053952557345
Aska-SS,327653,3.2557442863738033
NCI-H1395,5284373,3.990100299544354
TE 617.T,119182,-1.0028967690047823
MM1.S,25262965,-3.9211538227137432
D283 Med,46215462,1.5827854676989337
D283 Med,16722836,1.0096131047253871
Hep-G2,2828334,6.110325188036079
NCI-N87,1242560,3.6090545678814983
CML-T1,46174525,3.020182372643586
RPMI-7951,44259,0.2296299118102286
NCI-H2110,navitoclax-piperlongumine (1-1 mol-mol),2.9971394291703675
YKG-1,erlotinib-PLX-4032 (2-1 mol-mol),4.830623769808739
OE21,5281321,-2.5477026104814726
EJM,54626689,4.594595753018125
A4/Fukuda,doxorubicin-navitoclax (2-1 mol-mol),-2.572338922039687
SKM-1,decitabine-carboplatin (1-1 mol-mol),-0.2461784142024601
SNU-1033,54613361,2.637775236449954
TE 617.T,JQ-1-navitoclax (2-1 mol-mol),1.0175639846758282
D283 Med,6450551,2.1323753590226686
KMRC-2,216345,4.240105942298959
SNU-1214,52912189,1.010183035410781
MCAS,JQ-1-carboplatin (1-1 mol-mol),0.8866425431722468
Kasumi-2,10296883,1.6134498936175832
A4/Fukuda,25183872,-2.565081518812491
Kasumi-2,navitoclax-pluripotin (1-1 mol-mol),-2.9755028456871866
TE 617.T,44566777,0.1553719189995731
CML-T1,54613361,-1.4794949633252166
IST-Mes1,135999136,4.360333625305844
EJM,piperlongumine-MST-312 (1-1 mol-mol),0.9890593099361664
KMS-20,5287620,-2.1955252828905745
Kasumi-2,crizotinib-PLX-4032 (2-1 mol-mol),1.093787578488076
SNU-1272,11683005,3.754967611266652
KMRC-2,5329102,1.5816589334413396
SW1990,11455910,1.2583427289615488
NCI-H2110,5278396,3.9686122668770416
OE21,54143018,0.6332765597065765
SW1990,9884685,1.028509429358882
BT 139,9952709,2.4160089059178107
EJM,51037431,2.8000590273437274
LoVo,219104,3.1119995266948237
RPMI-7951,151289,0.7115875874342479
ML-1 [Human thyroid carcinoma],46215462,1.6577528274030604
CML-T1,9936388,-6.3994005254305995
Kasumi-2,2828334,5.794074438385768
Kasumi-2,702558,4.897760229735286
BT 248,tanespimycin-gemcitabine (1-1 mol-mol),-1.6636234476811602
NCI-H1092,23582824,0.4041583076972229
D283 Med,23939,4.340055640528423
SNU-308,selumetinib-UNC0638 (4-1 mol-mol),3.862265734158656
NCI-H2081,9927531,2.933726437844289
BT 139,44185566,2.413248885611864
SNU-1033,54619267,4.351275427505696
CML-T1,9868037,1.2045012402986977
Hs 683,tanespimycin-gemcitabine (1-1 mol-mol),-0.667566647901776
SET-2,1716436,3.333075721211582
NCI-H2172,135440466,3.920075838881322
TE-15,4259181,-0.9180245906878618
KYSE-410,11317348,4.323305036717103
NU-DHL-1,ISOX-bortezomib (250-1 mol-mol),-0.6058420278393776
MM1.S,24180125,2.972534828152793
SEM,89928392,-0.8606001711517224
KMS-20,selumetinib-piperlongumine (8-1 mol-mol),1.0367675116667423
MM1.S,54613361,-0.4658763422564649
BT 248,44185566,1.9117845458549376
KYSE-410,11964036,1.1280393858063724
Raji,3815108,1.348726927410812
SNU-1033,navitoclax-birinapant (1-1 mol-mol),0.0075865215090206
AN3-CA,12001922,1.6874605479132982
BT 139,445643,3.8282789867787104
NCI-H1092,24901704,2.360617916449716
SNU-8,11178236,-4.432412759173127
SET-2,docetaxel-tanespimycin (2-1 mol-mol),-5.191672273029725
SKM-1,46199207,3.0713623583857257
Aska-SS,15953870,4.084404755513187
PaTu 8988s,5280436,1.929961763742872
BT 248,9956119,4.3886748820117925
TE 617.T,11955716,-2.720710291099432
RPMI-7951,16736978,1.3640230791983192
KMBC-2,tanespimycin-gemcitabine (1-1 mol-mol),1.4795294977237738
TE 617.T,9911830,2.045260681155165
MM1.S,654092,-1.4935807523777964
YKG-1,53232,1.050815302448319
AU565,4788,5.691461260554478
HARA [Human squamous cell lung carcinoma],3081361,3.3764732224556533
IST-Mes1,selumetinib-UNC0638 (4-1 mol-mol),3.472834598034016
NCI-N87,12003241,-2.470820657410725
LoVo,439501,-1.7683171506776545
KMBC-2,6918638,1.17976161020614
CA46,148198,-5.7845042531785
GOS-3,135411,0.9391696009475228
AN3-CA,4578,4.32429882400022
SNU-8,159324,3.7143577321129393
NCI-H2110,54143018,1.0459653529397772
SNU-308,6917907,-4.778384146649152
LNCaP clone FGC,2858523,3.0735622516163175
OE21,3062316,-1.8002534504736254
BT 320,45279963,4.337631582225757
NCI-H2110,60750,-4.5848595647563695
RPMI-7951,375860,-1.2606970188300772
NCI-H1395,24951314,2.24574697242026
KMBC-2,71466578,4.853263312097692
SEM,10322450,3.0556839954997685
OE21,135984461,4.867121216346128
TE-15,148124,-8.056509685609365
PaTu 8988s,44486219,4.497877862030564
RERF-LC-Ad2,vorinostat-carboplatin (1-1 mol-mol),4.276623561794826
CML-T1,637858,1.454745710944211
SW1990,16736978,1.235642463151611
NU-DHL-1,9952709,2.663459796321655
LoVo,159324,-0.9516179858777442
LNCaP clone FGC,navitoclax-pluripotin (1-1 mol-mol),-1.5517628792513285
NCI-H1092,6438330,0.9695610451657
KMRC-2,135440466,2.172644324172392
EJM,11178236,-6.131326848580391
OE21,9952709,2.641418469624622
TE-15,10322450,3.2140192626835313
NU-DHL-1,3011155,4.64596997294592
SKM-1,16722836,0.5905694358336332
SKM-1,10231331,-2.5704839701228117
A4/Fukuda,6610216,3.4719570509087445
LoVo,54613361,-1.4267659732177436
Hep-G2,676352,2.2206143636349287
KMBC-2,11175137,3.4182731043572847
SNU-8,124202324,2.521017615962926
MCAS,53232,1.2719461381962025
NCI-H2110,selumetinib-UNC0638 (4-1 mol-mol),5.261547030595486
Kasumi-2,5746,-4.326746041624573
KMS-27,25154868,4.068393562898578
CML-T1,100016,5.302267949835527
Aska-SS,carboplatin-UNC0638 (2-1 mol-mol),1.782130723144459
LoVo,241158,4.012317425862525
CML-T1,675434,3.803383794807122
CML-T1,7326481,2.1414014754107735
SNU-1214,51037431,3.8670550149268146
Ku812,156422,3.166038236669379
Hep-G2,tanespimycin-gemcitabine (1-1 mol-mol),-1.7096270961562854
D283 Med,400769,-1.1931139995593163
TE 617.T,10302451,0.2926739718102283
NCI-H2081,11609586,0.9464908978048564
SW1990,SNX-2112-bortezomib (250-1 mol-mol),-2.6554849763111807
BT 139,selumetinib-GDC-0941 (4-1 mol-mol),0.4945119496988254
NCI-H2081,24951314,0.5279638616093859
SNU-1033,25183872,-1.222439470478559
AU565,421610,2.258686960610045
CML-T1,4788,4.608482830288328
RPMI-7951,54626689,4.364725309097019
YKG-1,25183872,-1.2785338987258574
RPMI-7951,156414,1.6471654307541064
SW1990,ISOX-bortezomib (250-1 mol-mol),0.2814121129638218
Ku812,16722836,-0.2272484724796736
EJM,10074640,3.565491607836162
SNU-1033,24951314,1.0911642280306344
ML-1 [Human thyroid carcinoma],119182,-2.1546594526399647
EJM,46398810,2.702595853434399
SNU-308,216468,4.097191393615079
TE 617.T,5329102,1.5061058549942548
HEC-151,2729026,2.502599167536784
AU565,72376,-1.9935205494525805
LoVo,3136844,3.7568853791466608
HSC-4,441298,2.8371907900438535
MCAS,BRD-K27188169-navitoclax (2-1 mol-mol),3.9772772002243353
Hep-G2,5978,6.393090792335967
Ku812,16038120,-0.3334823664980552
KMS-20,selumetinib-navitoclax (8-1 mol-mol),-1.8022181228536576
YKG-1,24901704,4.300110329432471
AN3-CA,46199207,3.4912031216021906
SNU-1272,107985,-3.786570861641408
KMS-27,25183872,-2.068864908594192
KMRC-2,11213558,0.8524914998044264
BT 328,4917,3.0980779681660375
D283 Med,SNX-2112-bortezomib (250-1 mol-mol),-3.2108691902220317
AU565,6918736,-3.127988177088939
HEC-151,tretinoin-carboplatin (2-1 mol-mol),4.7632496996236044
SKM-1,10074640,3.0692754490442975
BT 330,selumetinib-MK-2206 (8-1 mol-mol),2.398235060247757
MCAS,5311281,4.0403014636627805
SNU-308,124202324,2.379759434386111
SNU-308,54618164,4.492572736691696
OE21,11707110,-4.185918719413557
EJM,11213558,2.5134733614994778
BT 320,54618795,3.6611780989616514
SEM,navitoclax-gemcitabine (1-1 mol-mol),-6.263167217210504
LNCaP clone FGC,25105715,3.6102542432221703
SKM-1,3689413,-2.418262014134033
BT 139,selumetinib-navitoclax (8-1 mol-mol),2.4007286553519833
Kasumi-2,66577038,2.680052495523132
RERF-LC-Ad2,6505803,1.9541445598040723
OE21,2871966,-1.4442396602428826
MCAS,3503,2.6496028272402756
HCC2218,1750826,-2.5526345061979208
OE21,11717001,4.412432147312286
BT 330,135421197,3.0606427160011433
AU565,1239801,6.39587237663574
EJM,15953870,3.026448270110203
HCC2218,51039095,3.70801925853649
SNU-1272,6918837,-2.3331308300912332
GOS-3,navitoclax-pluripotin (1-1 mol-mol),1.020256272208372
RPMI-7951,216345,3.31559127630656
BT 139,11257553,1.1662278460307622
D283 Med,54618164,3.747562396348618
Ku812,10090485,4.033633081547376
TE 617.T,navitoclax-piperlongumine (1-1 mol-mol),1.3861842012788683
NU-DHL-1,3465537,0.9340526955418934
HMCB,409805,5.980176460908731
BT 328,5113032,4.3388133731022585
A4/Fukuda,72193861,-0.8043632874402014
SNU-1033,46907787,1.4215977745383968
CML-T1,60750,-4.308471121020489
YKG-1,3062316,3.550628439107019
NCI-H2081,decitabine-navitoclax (2-1 mol-mol),1.4988648347854454
SNU-1033,carboplatin-UNC0638 (2-1 mol-mol),3.4423158884964664
HMCB,9936388,-4.997946026418023
Hep-G2,selumetinib-BRD-A02303741 (4-1 mol-mol),0.1901606503524278
D283 Med,46943432,1.9673056187100668
Raji,24180719,5.292771843313121
RERF-LC-Ad1,3062316,2.885097567128067
HARA [Human squamous cell lung carcinoma],5566,3.127581032716584
A4/Fukuda,5328940,-0.5379688872377596
EJM,16065773,1.9015047473462103
PE/CA-PJ34 (clone C12),9884685,0.3333327844016708
BT 328,44185566,3.0844866112877916
HEC-151,3062316,-0.2172135639655068
NCI-H2081,135411,-0.7766989256852646
SKM-1,67156097,-2.558709086141829
LNCaP clone FGC,4096211,1.3967324251081952
BT 139,11626560,2.3775074493494284
HARA [Human squamous cell lung carcinoma],24180125,3.640570848683534
NCI-H2110,53495165,1.2696599250691445
KYSE-410,10026128,4.447643449479421
NCI-H2110,5746,0.0974100097723131
HARA [Human squamous cell lung carcinoma],3503,1.5305596721968624
SKM-1,56946209,-5.085207204294124
KMS-27,53232,2.4317447026544254
NCI-H2110,448949,2.5547306967217605
KMRC-2,JQ-1-vorinostat (2-1 mol-mol),1.361951420268354
AU565,11317348,4.006750700524709
NU-DHL-1,selumetinib-MK-2206 (8-1 mol-mol),-0.0840641688117376
Hep-G2,3854666,3.2360339128212554
TE 617.T,alisertib-navitoclax (2-1 mol-mol),0.7236825350281212
NCI-H2172,44607530,2.4860384239384605
D283 Med,119607,5.46522088170326
OE21,44607530,0.5174164350757162
SNU-1214,5351362,0.7905695196735173
HCC2218,6505803,-2.0723621071637788
BT 248,JQ-1-navitoclax (2-1 mol-mol),0.658869929233474
NCI-H2110,25126798,3.7228045991020817
KMRC-2,11228183,2.3872134310173103
KMS-27,8515,4.078018494843081
NU-DHL-1,50905018,3.2450154850069093
Kasumi-2,56963564,-0.3250682085247875
AN3-CA,216345,4.244798528220181
SET-2,5282054,2.570839430401872
SNU-1033,10410894,4.578281873924552
SEM,216239,-0.7466305411957983
SNU-1272,25154868,3.807572464361502
NU-DHL-1,969516,2.257710289132893
NU-DHL-1,selumetinib-tretinoin (2-1 mol-mol),1.2606436334910045
BT 330,219104,3.3915993444029047
EJM,6610216,4.116260512201503
BT 328,10385095,1.6482003129933624
RPMI-7951,5335621,4.393846950764213
NCI-H2081,136227924,2.7498424735477913
KMS-20,285033,-4.372488793803924
Ku812,11497983,0.3868240418152458
GOS-3,44185566,2.676138755124573
IST-Mes1,16725315,5.212250641781058
HMCB,selumetinib-vorinostat (8-1 mol-mol),3.744114804484371
PaTu 8988s,25126798,3.8731761859174
HSC-4,5280436,3.1415705358429884
SNU-1214,135398516,2.563377227960364
LNCaP clone FGC,126941,-2.139687278750632
HARA [Human squamous cell lung carcinoma],10113978,3.460603354098383
Hep-G2,46907787,3.3643071732848
YKG-1,9927531,5.706988241233545
OE21,vorinostat-carboplatin (1-1 mol-mol),2.300312192247963
NCI-H1092,216345,3.5494296383445105
Hep-G2,2858523,3.0476821102731977
HSC-4,25183872,-0.8460464512297751
HSC-4,BRD-A02303741-carboplatin (1-1 mol-mol),4.481505642686289
NCI-N87,3385,5.19418058853999
ML-1 [Human thyroid carcinoma],156414,1.0547615836858202
Aska-SS,53392493,1.884177786668172
KMBC-2,9825149,2.796829820387343
AN3-CA,JQ-1-carboplatin (1-1 mol-mol),4.617910971387189
D283 Med,ISOX-bortezomib (250-1 mol-mol),-0.293421488526388
NCI-N87,6917907,-5.514556019160177
A4/Fukuda,753704,3.7176461109746897
MM1.S,11455910,0.7825849388460823
LNCaP clone FGC,5470400,-1.212361408528563
NCI-N87,9903786,2.403456427338335
KMS-27,46224516,2.4008723262948353
SNU-308,44486219,4.355116140168268
SEM,23725625,1.850131021404486
Hs 683,4259181,-0.0189213214010426
MM1.S,54618164,3.790511096311708
KMS-20,42642645,0.7493716009663114
SEM,100016,5.238818929389881
AN3-CA,24180125,3.116324501416526
TE-15,439501,-2.48025284068881
RERF-LC-Ad1,10385095,3.535917584536634
Raji,25195348,4.486887099265514
Hep-G2,5287620,-1.53536683394514
NCI-H1395,16741245,6.143335067349052
PE/CA-PJ34 (clone C12),25262965,-2.594783363003755
Hep-G2,51037431,2.134327625147545
KMRC-2,16736978,2.3097236282239413
HSC-4,11964036,1.64347500999081
MM1.S,6252,-0.7116460334368461
Hep-G2,11960529,4.314757049098683
Hs 683,JQ-1-vorinostat (2-1 mol-mol),1.2290552326293391
NCI-H2081,119607,5.212257732916615
MCAS,9908783,6.190374698999782
SNU-1033,216239,2.417211779255053
SNU-1272,11485656,2.6947903691441795
Aska-SS,11717001,4.629967554850357
OE21,176870,-1.551021133678407
TE 617.T,135659046,3.676706194159886
GOS-3,5329102,1.5794439698416267
NU-DHL-1,119182,-3.6416118406759863
IST-Mes1,24797083,1.4429650511590184
LNCaP clone FGC,3676137,4.985186216409979
NCI-H2081,selumetinib-PLX-4032 (8-1 mol-mol),4.306569856872656
NCI-H1092,3825829,4.014845832677727
HCC2218,docetaxel-tanespimycin (2-1 mol-mol),-2.41898448454828
TE-15,51037431,4.673386377362048
RPMI-7951,6917907,-4.326801206648588
Kasumi-2,55508,1.5459922299360274
Ku812,44486219,3.768405676871863
SEM,9929138,6.8273209917060145
BT 330,16722836,1.958946864061731
AN3-CA,168313307,4.649989431692814
KMBC-2,24772860,-1.3622286012164393
SKM-1,3384730,1.003819632931897
Kasumi-2,3503,1.0805615825532868
SNU-308,216345,4.441885405176313
Kasumi-2,16736978,0.2987482410922295
KMRC-2,10296883,4.145802538683136
SEM,676352,1.684382877039761
AN3-CA,selumetinib-UNC0638 (4-1 mol-mol),3.959828908489292
NU-DHL-1,4521392,3.4601800103971474
NCI-H2172,409805,5.805224348451236
SET-2,2126,3.918228348888737
KMS-20,49867930,4.214222642380502
ML-1 [Human thyroid carcinoma],49793307,-2.0238665574613024
SEM,15547703,1.7172948756521211
Raji,107985,-3.425855595457866
Hep-G2,89183176,5.542677270745169
HMCB,262093,2.6900614407313355
KMBC-2,46907787,3.4975434896929674
BT 328,9444,4.598160630608248
YKG-1,19582717,5.492201151442481
PaTu 8988s,55283,2.9199595680280455
MCAS,46843906,3.427852323124774
NCI-H1395,675434,4.314501346602578
RPMI-7951,24748573,2.4053931326402114
Kasumi-2,JQ-1-UNC0638 (2-1 mol-mol),-0.8323708292538591
SW1990,10184653,1.79028114395006
BT 328,613753,3.4687194971891184
Kasumi-2,5351362,0.8391907710572402
SET-2,doxorubicin-navitoclax (2-1 mol-mol),-1.5394953542498078
RERF-LC-Ad2,6917907,-5.643167163740422
SET-2,25102847,3.1923802096251648
BT 320,53392493,4.061896393500848
SET-2,ISOX-bortezomib (250-1 mol-mol),-0.1710867295006007
PE/CA-PJ34 (clone C12),56963564,0.4073431502200141
SNU-1214,984333,-0.2882399666487046
RERF-LC-Ad1,5329102,2.5838260577458754
MM1.S,selumetinib-JQ-1 (4-1 mol-mol),-0.6106024148084398
NCI-H2110,637858,3.1754566169961005
A4/Fukuda,46215462,1.453707580765341
BT 330,9933475,1.5908629116386517
NU-DHL-1,5329102,1.5398804917088604
SET-2,25183872,-1.8828048567516271
BT 248,navitoclax-sorafenib (1-1 mol-mol),1.2094722993885498
MM1.S,17755052,-0.7145946453467518
CML-T1,carboplatin-etoposide (40-17 mol-mol),-0.8203492199596885
KMRC-2,5280436,2.5305591566490504
HCC2218,9935249,-1.250761387060799
SKM-1,675434,4.4448031338395655
TE 617.T,5287620,-2.8248047974089188
KMS-27,selumetinib-MK-2206 (8-1 mol-mol),-1.32719530265033
NCI-N87,5351362,0.9196567139345124
NCI-H2081,6917907,-5.960779404992594
EJM,25183872,-1.9531773899114209
KMS-20,4705,2.611307391977677
HSC-4,168312962,-1.5337410071263893
Ku812,68056272,1.369253541918081
HSC-4,46191454,1.405754738797376
HMCB,25262965,-1.6581729760544606
Ku812,9444,3.739860815114633
BT 248,46215462,2.381699206499341
Ku812,136227924,2.6493599225721742
HMCB,ISOX-bortezomib (250-1 mol-mol),0.174785181826403
SNU-308,23725625,7.126867792374974
NCI-N87,60750,-4.457686499395666
BT 139,10302451,2.4564119741984785
SNU-1033,16659841,4.758000486381672
MCAS,6450551,3.1349872094378815
TE 617.T,49766530,0.7219936029633269
KMBC-2,46199207,3.631177458951401
NCI-H1395,66577038,3.726458763342507
SW1990,selumetinib-navitoclax (8-1 mol-mol),1.0683829293373002
CML-T1,JQ-1-carboplatin (1-1 mol-mol),0.6334590834009667
KMS-20,54619267,3.8128952871152046
MM1.S,44241473,4.365495360199436
HSC-4,navitoclax-gemcitabine (1-1 mol-mol),-4.75214371637746
SNU-308,tanespimycin-gemcitabine (1-1 mol-mol),-0.7443975463839722
SKM-1,10296883,3.074274434558128
Kasumi-2,19582717,2.3340571924025326
SET-2,vorinostat-navitoclax (4-1 mol-mol),-1.0463472428768836
KMS-27,19582717,2.129982519189229
SW1990,25126798,3.59446918054184
NCI-N87,19582717,3.5520999296373437
SEM,3038522,-0.4118927159500882
AN3-CA,5329102,1.5296424840231522
KYSE-410,168313047,2.9642256553070796
LoVo,53495165,-1.2075385636979648
Ku812,selumetinib-GDC-0941 (4-1 mol-mol),-2.0259411915786294
D283 Med,vorinostat-carboplatin (1-1 mol-mol),1.5123175007523422
ML-1 [Human thyroid carcinoma],122327,4.584045367066115
NCI-H2081,702558,5.114835001496795
PaTu 8988s,9825149,-0.4385958210811754
LNCaP clone FGC,10296883,3.861229612453215
PE/CA-PJ34 (clone C12),6914657,-4.423290668811461
HSC-4,19582717,4.479728463380205
SW1990,322968,4.796232412021376
A4/Fukuda,675434,3.712142385749843
SNU-1272,51039095,3.39193895302749
HMCB,9866186,-0.3805378738701598
SNU-8,151289,1.199400027159569
NCI-H1092,SNX-2112-bortezomib (250-1 mol-mol),0.0447588085081416
LNCaP clone FGC,4259181,1.1537445787746927
SEM,selumetinib-vorinostat (8-1 mol-mol),0.5449202862000408
NCI-H1395,JQ-1-UNC0638 (2-1 mol-mol),2.0863626902926065
PaTu 8988s,6918328,-0.474247394227878
Hep-G2,3081361,2.5045314139497723
EJM,24180719,3.679957283710777
NCI-H1395,11707110,3.0530004675688964
SEM,docetaxel-tanespimycin (2-1 mol-mol),-4.77446001640726
CA46,6918328,-3.721989268042841
D283 Med,25227462,-4.9287589290971905
D283 Med,JQ-1-UNC0638 (2-1 mol-mol),3.413583109357789
YKG-1,selumetinib-GDC-0941 (4-1 mol-mol),1.6719516399203749
SNU-1272,72376,1.3199699316246591
HSC-4,24821094,3.2038955653523713
CA46,17755052,1.7120394846678155
BT 330,448949,2.2489092778248856
SNU-8,selumetinib-GDC-0941 (4-1 mol-mol),0.1167274542532347
LoVo,446155,3.732759169917468
SW1990,serdemetan-SCH-529074 (1-1 mol-mol),2.760960145814768
SW1990,9936388,2.7870062891486613
SNU-8,322968,3.931908512694919
Ku812,3384730,0.3528763049585885
SW1990,426756,4.883420539625358
NCI-H2172,11404337,1.861894071580906
SKM-1,568763,-0.8159483316937144
NCI-H2172,44137675,4.33723657992909
Kasumi-2,439501,-3.441659601561783
EJM,2871966,-0.3879200189788208
RPMI-7951,5351362,0.7294605148676923
CML-T1,10231331,3.71504818577299
CML-T1,6610216,3.6071739537574863
BT 248,piperlongumine-MST-312 (1-1 mol-mol),1.560142448953329
BT 248,439501,-2.3411963573363104
Aska-SS,54649381,3.801699572591553
RERF-LC-Ad2,9911463,4.319203395941844
BT 139,salermide-PLX-4032 (12-1 mol-mol),3.718587641626584
Kasumi-2,1714884,3.668347649937234
MCAS,676352,2.173847245928757
D283 Med,44607531,2.0088553908095954
HEC-151,5278396,3.3762180058910936
Raji,11396600,3.2888358336472496
Kasumi-2,46191454,0.4638336944386738
SNU-1272,44486219,5.3170939881808605
RPMI-7951,426756,3.7939477986224786
HCC2218,11364421,1.1672869749146255
AN3-CA,navitoclax-sorafenib (1-1 mol-mol),1.2865520246226765
SEM,4378219,1.9889519046071171
Hs 683,54596558,3.756343230742294
PaTu 8988s,5329102,1.5064447610423493
HMCB,25183872,-1.6540878742670562
AN3-CA,135411,1.991464550187558
BT 248,5738263,3.817096252163507
Aska-SS,969516,3.631447738748967
BT 248,216239,2.185733710507839
CML-T1,73707440,4.384977554594534
BT 328,24771867,5.867133384354764
HARA [Human squamous cell lung carcinoma],selumetinib-piperlongumine (8-1 mol-mol),4.925037100159097
NCI-N87,6918328,-0.6140119948836108
HCC2218,9908783,4.405293589440005
GOS-3,5311,2.439895727975568
KMS-20,11719255,0.9257373719636144
KYSE-410,5470400,-1.5495007517242574
SET-2,50905018,4.146383712792895
SNU-1033,navitoclax-sorafenib (1-1 mol-mol),2.074211206681648
A4/Fukuda,vorinostat-carboplatin (1-1 mol-mol),1.5546210220419645
HCC2218,24964624,1.465719307350961
LNCaP clone FGC,10302451,3.7109646115457418
MCAS,124202324,3.0914896284438225
HEC-151,5280436,3.043419102339868
SEM,25150857,1.6285052261344466
RPMI-7951,5281672,4.014017945800659
TE-15,1566236,3.006173949892504
SNU-308,56946209,-3.292515746238392
CML-T1,60168763,3.1201048573104395
GOS-3,216239,2.237593713178657
A4/Fukuda,3384730,1.825152720179272
KYSE-410,16722836,1.4110627130753524
NCI-H1395,219104,2.9305329834901768
KMS-27,9825149,1.9092185850085857
Kasumi-2,44819697,-2.5261102007933154
SEM,421610,2.11087969336726
KMRC-2,navitoclax-birinapant (1-1 mol-mol),0.645706108158614
KMS-20,11152667,-1.0661904813825076
NCI-H2110,46191454,1.7891309559503268
NU-DHL-1,66577038,2.8657572180523823
HCC2218,2749,0.2260672738818868
TE 617.T,sirolimus-bortezomib (250-1 mol-mol),0.0331781036900695
NCI-H1395,11977753,-2.444387577547746
HSC-4,10322450,4.749470049467763
AN3-CA,44566777,-1.0212204802664189
RPMI-7951,3543504,4.334732090077199
LoVo,11507802,0.9778049572121082
A4/Fukuda,67291369,-0.3870993856905487
OE21,6914657,-3.0452398561654057
SET-2,1242560,2.568331435299952
SKM-1,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.9272317692561286
HEC-151,53495165,-0.7067966609618063
PE/CA-PJ34 (clone C12),JQ-1-vorinostat (2-1 mol-mol),0.3742706792458093
BT 330,16659841,3.5039239914317255
AU565,44137675,3.533476650788096
MM1.S,44819697,-1.023018126505823
RPMI-7951,25126798,3.405375688978992
SEM,2749,0.1715728235618304
D283 Med,36462,-0.7003958685437419
NCI-H1092,9823820,4.957338648627321
KMS-20,sirolimus-bortezomib (250-1 mol-mol),-0.3833823463346493
TE-15,1750826,0.9215180524945688
RERF-LC-Ad2,10184653,1.8467582375287743
KMBC-2,73707438,4.383844764052632
NCI-N87,54618164,3.997308077582706
KMS-27,72193870,3.4384796192922877
AU565,11222830,1.6780695218323665
BT 139,262093,2.8481987129285256
BT 328,216345,4.606684867794206
SNU-8,25195348,3.807920536715813
PaTu 8988s,11317348,4.902981978815887
HEC-151,6438330,1.1738977407400153
TE-15,16720766,1.0189208524673423
BT 139,4578,3.0697168430814874
TE 617.T,24753719,3.744070928960869
D283 Med,46191454,0.4881415464041219
AU565,67156097,-2.287523284177128
IST-Mes1,67291369,1.9412797776758044
KMS-27,4096211,0.8812731296424201
Kasumi-2,5281321,-3.5035572972621916
GOS-3,54619267,4.509336729831847
A4/Fukuda,25195348,0.8993846970771071
SNU-308,49850262,4.866731965414422
KMS-20,5311,0.5424141236542899
Raji,sirolimus-bortezomib (250-1 mol-mol),0.8276284938593903
LoVo,2729026,2.166128688763036
NCI-H2110,9823820,4.01768744149593
HSC-4,46843906,4.814917111969106
Kasumi-2,54649381,3.5158481033233593
NCI-H1092,4917,2.811199240132262
RPMI-7951,71466445,5.865470046063986
BT 328,3689413,2.3836323832860673
SET-2,JQ-1-navitoclax (2-1 mol-mol),-2.289388904955715
KYSE-410,969516,2.9293638368777417
HSC-4,44819697,-1.3561318696958864
MM1.S,46943432,0.8040935349772499
RERF-LC-Ad1,6623618,2.970461552664049
GOS-3,44486219,4.351702661257634
PaTu 8988s,56949517,4.226883317513966
KMS-20,3038522,2.067228476552794
HEC-151,9907093,4.173038055291299
BT 328,carboplatin-etoposide (40-17 mol-mol),5.134403751038302
AU565,57330099,4.7929461834362606
SKM-1,3136844,3.4979321802253356
CA46,89928392,0.0283947615438792
SKM-1,400769,-3.7567993571091063
Aska-SS,46398810,1.7944329951404463
BT 139,11396600,2.700615833267889
KMRC-2,navitoclax-MST-312 (1-1 mol-mol),0.8384543480139683
AN3-CA,11427553,1.8420889337174475
SNU-308,16038120,2.1179451909693445
A4/Fukuda,135999136,4.178898868342667
BT 248,208908,1.7719462620560902
BT 139,51039095,2.2391406183743605
SEM,54618164,3.8944596685913138
BT 330,11152667,1.4109610692427392
AN3-CA,10074640,3.604671853947176
SNU-1214,123631,-0.2014867970711348
CA46,5328940,1.1838617633473132
CA46,56949517,4.303265452215328
Kasumi-2,11612883,1.7782552978814286
LNCaP clone FGC,4705,3.099970805518314
NCI-N87,100016,7.118039999797619
BT 330,navitoclax-sorafenib (1-1 mol-mol),1.5761874727240903
CML-T1,71680916,4.411758468982172
HSC-4,72193861,2.788231918333871
KMS-27,44259,0.2014836924539016
KMS-20,vorinostat-carboplatin (1-1 mol-mol),1.9283897088416788
SW1990,9926054,1.8053433824091036
PaTu 8988s,7251185,3.0647906499377964
NCI-H1092,107985,-3.3152950865622564
BT 248,2729026,1.163283415080523
BT 139,24797083,0.871050037747606
BT 328,24856436,4.552904501266461
AN3-CA,104842,0.1693347049630243
HCC2218,53495165,1.287439615302038
NCI-N87,44486219,4.180509732108111
NCI-H1395,navitoclax-pluripotin (1-1 mol-mol),0.5678965327909137
MCAS,53392493,2.955916127146427
Kasumi-2,5291,3.833785516332381
SKM-1,25183872,-3.4899394684902947
Raji,3385,2.7756153582112133
KYSE-410,107970,2.1635571527834676
TE 617.T,11640390,3.011974342366218
HSC-4,9911463,3.832706037448295
LoVo,3854666,1.417426416420887
NCI-H1395,46926350,-3.2144597586965515
SNU-8,5746,1.6714509344644508
BT 328,46224516,3.135960011776331
KMS-27,135875424,3.062949478876591
HMCB,sirolimus-bortezomib (250-1 mol-mol),0.2910880989689153
KMS-27,676352,1.6977067639732282
SEM,9911463,3.141152403249145
Kasumi-2,10322450,3.5434418993684114
PE/CA-PJ34 (clone C12),168312962,3.0603880546719537
Hep-G2,6852167,3.060489701170588
NCI-H2081,2729026,2.0154063962132676
NCI-H1395,71304818,2.2994001148699414
LoVo,1242560,3.2639930925900305
A4/Fukuda,2729026,2.569130626356953
TE 617.T,4259181,-1.3173271639424509
CA46,49793307,-4.01311922110524
SW1990,5351362,1.1543206548626652
BT 320,375860,4.032556785404055
SNU-1033,984333,0.2399038951060862
HMCB,23635314,-3.4339046991489743
NCI-N87,erlotinib-PLX-4032 (2-1 mol-mol),3.0192784761472
Hs 683,11625818,3.859187506214817
MCAS,24753719,3.982586102388834
PaTu 8988s,46398810,1.9991090660302973
CA46,4096211,0.9281979530192106
SNU-1272,11964036,3.162546122356154
SEM,8515,3.1734533469366064
NCI-H2110,24901704,3.0781208675388028
A4/Fukuda,148198,-4.99238512913244
HSC-4,25102847,2.881629074853979
Kasumi-2,10410894,1.8135964606255892
Hep-G2,124202324,1.2953785205676314
TE-15,23635314,-5.216893508037696
KMS-20,12003241,-1.6984779188581272
MM1.S,9956119,2.8192181838045354
OE21,16038120,0.6992947070479802
HSC-4,12003241,-0.0373048915881231
KMS-27,107970,2.0805071505254107
CML-T1,6918878,-0.7643857619236708
NCI-H2110,3854666,1.2202267080403588
BT 139,24964624,1.9176050283121209
LoVo,5460769,-2.1468642890382412
A4/Fukuda,44486219,1.5854911698245977
Hep-G2,387447,-2.9195151512018427
D283 Med,327653,2.8736593168933786
SET-2,11640390,2.674485343113428
Hep-G2,vorinostat-navitoclax (4-1 mol-mol),1.3069749829657018
NCI-H2081,36462,-1.2215520528836945
D283 Med,135659046,3.420100505846104
KMS-27,638278,2.799419886682137
OE21,tretinoin-navitoclax (4-1 mol-mol),-2.1805876439959433
Hep-G2,11175137,2.5182853193143813
HEC-151,piperlongumine-MST-312 (1-1 mol-mol),1.456707300994177
NCI-H2081,6918638,-1.1409095287475362
Kasumi-2,9935249,-0.6704419087402653
SEM,2828334,4.508628490160364
SW1990,6505803,-2.4928933936476048
CML-T1,36314,-5.131510797683319
EJM,135411,0.4460244130907568
Aska-SS,16736978,2.0956913570631976
NCI-H2110,11612883,2.552146272408435
SEM,11167602,1.6764895293096356
HEC-151,444795,4.8159070538718245
SEM,327653,3.0255719016474605
IST-Mes1,3503,2.9550990055374413
BT 320,56963564,5.490825870792066
SET-2,71751553,3.975724095102093
ML-1 [Human thyroid carcinoma],2746,-1.478438692576885
KMBC-2,UNC0638-navitoclax (1-1 mol-mol),-0.2443441372437479
CML-T1,656346,-0.3506831167953311
HCC2218,navitoclax-birinapant (1-1 mol-mol),2.2134337805756985
AN3-CA,3543504,4.592926404158275
RPMI-7951,decitabine-navitoclax (2-1 mol-mol),1.2781145153350604
EJM,JQ-1-navitoclax (2-1 mol-mol),0.2111319026515788
SEM,BRD-A02303741-carboplatin (1-1 mol-mol),3.6880829932604247
RERF-LC-Ad2,46191454,2.0010974670681083
SNU-1033,46224516,2.2546354693256165
CA46,107970,1.651382626144423
YKG-1,doxorubicin-navitoclax (2-1 mol-mol),-1.1717417104097605
SNU-8,400769,-0.7541255884015454
KMS-20,carboplatin-etoposide (40-17 mol-mol),1.5141675555174716
NCI-H2081,3825829,4.196645416863087
KMS-20,24180719,3.3038292759957404
SNU-1214,49793307,-3.442501742996358
LNCaP clone FGC,15547703,2.930829356369123
NU-DHL-1,446155,2.7819424460824274
TE-15,637858,1.9944393508197875
LoVo,2749,2.494181165729376
PaTu 8988s,2945648,3.478517867509888
RPMI-7951,11964036,0.1825580846818816
OE21,11507802,1.2439926105697752
AU565,9549297,3.94244046983191
NCI-H2172,9907093,5.645738343072073
TE 617.T,135999136,4.164047799222283
KYSE-410,25105715,3.37078451111397
KYSE-410,5746,2.8569470687695184
Aska-SS,25183872,0.6675184537647518
BT 328,168312962,4.074485851514308
KMS-27,135999136,1.9595465875821207
PE/CA-PJ34 (clone C12),JQ-1-navitoclax (2-1 mol-mol),1.827928126908855
SKM-1,24856436,-0.4445096015127717
PaTu 8988s,9952709,4.520443732339643
EJM,53245473,3.7165309146021417
CML-T1,448949,0.9677195275785144
SNU-1033,2729026,2.996817399923943
SNU-1272,49766530,0.1675221070029884
CA46,5291,2.960224941202677
LoVo,17759555,2.3197484044750905
HEC-151,25262965,-1.7922976694301076
CML-T1,9956119,2.073633266475815
SNU-8,10427712,5.587961063746706
Ku812,15953870,2.600365830737877
SNU-1214,9825149,1.427253874883519
NCI-H1092,54613361,1.771000250382894
Kasumi-2,selumetinib-vorinostat (8-1 mol-mol),0.9890334474484956
IST-Mes1,9936388,2.2275468363886763
Hep-G2,6917907,5.1054062498915025
KYSE-410,tretinoin-navitoclax (4-1 mol-mol),3.820486237274089
AU565,6610355,3.967539400054512
CA46,23582824,0.075225101675958
D283 Med,6914657,-8.666743136315109
SNU-1214,25262965,0.0915990021409113
KMRC-2,decitabine-navitoclax (2-1 mol-mol),1.6162271998356526
HEC-151,3503,2.00593361013826
SKM-1,44185566,1.2087289104491263
HEC-151,16013152,4.101963115676647
Raji,16722836,1.1339708179404666
NU-DHL-1,72376,-4.025213511339456
BT 320,6438330,2.745053768259143
SET-2,navitoclax-pluripotin (1-1 mol-mol),-1.6885811961175636
BT 330,11640390,1.9167810634257632
SNU-8,11455910,1.7503640063904615
Aska-SS,19582717,3.474703226130623
NCI-N87,54686904,4.2918164398278815
RPMI-7951,409805,3.607253520959431
ML-1 [Human thyroid carcinoma],JQ-1-UNC0638 (2-1 mol-mol),2.6444298637243167
AU565,6436223,-4.706952881213825
D283 Med,168313016,4.168522701530026
AN3-CA,11175137,1.6731689264439218
NCI-H1395,119607,5.849828221842235
GOS-3,26596,5.630360863540023
SKM-1,656346,0.2148623299853773
AU565,11977753,-1.5018138963846497
PE/CA-PJ34 (clone C12),44566777,1.0686416610033969
BT 330,3025944,4.419674295508754
AU565,JQ-1-MK-0752 (1-1 mol-mol),3.9179209493370175
KMRC-2,44185566,2.9985969521540805
KMS-20,60700,-2.172769530417687
Raji,9825149,2.621015556442004
HMCB,26596,-1.2966092010554455
YKG-1,44607531,1.7314965452309146
SNU-1033,2858523,2.909769226528934
OE21,23582824,0.2325595193496268
SNU-1033,5287620,-4.078658633318351
NCI-H2081,4259181,0.351932807704407
IST-Mes1,9933475,1.3564169932051346
RPMI-7951,3634881,2.27691218047639
NCI-N87,crizotinib-PLX-4032 (2-1 mol-mol),2.5035050425609673
SNU-1033,15953870,4.135823998081224
BT 330,44241473,4.196358562733664
KMS-20,439501,-3.5751856752548985
NCI-H2081,11152667,0.3314648978290519
LNCaP clone FGC,selumetinib-GDC-0941 (4-1 mol-mol),1.7020146925511015
YKG-1,3136844,4.395647151601772
EJM,1641662,2.9948072583311567
NCI-H2172,doxorubicin-navitoclax (2-1 mol-mol),1.5806613828001743
IST-Mes1,5978,0.1624820602578698
SNU-8,navitoclax-MST-312 (1-1 mol-mol),1.2469420286948325
TE-15,25126798,3.521201926251703
HCC2218,11507802,2.2692790947966617
HARA [Human squamous cell lung carcinoma],119607,5.240910567943734
KMRC-2,53232,5.206621782747443
TE-15,2113511,5.968719681321621
CA46,navitoclax-birinapant (1-1 mol-mol),3.397408717118992
MCAS,100016,6.4909883414165135
Ku812,9908783,4.70753642591378
AN3-CA,71304818,2.4203683950062493
KMS-20,135928012,3.091470628632976
HCC2218,25227462,0.9757651959327488
SKM-1,9926054,1.2950133266657913
D283 Med,5287969,-2.6386701555560466
KMRC-2,10074640,3.080783314535937
NCI-H1395,25150857,3.355605487128081
SNU-1214,262093,2.99372726902227
NU-DHL-1,6918736,-3.063185007693412
SNU-1214,60750,2.067077163111611
KYSE-410,637858,1.774325597801251
Raji,11175137,2.7969423133493025
BT 139,6852167,2.565632709988516
SNU-308,2729026,3.0372932862375692
PE/CA-PJ34 (clone C12),9907093,4.32490374707387
AU565,5291,4.2478378741719105
LNCaP clone FGC,285033,-4.262367843729107
SNU-1033,12003241,-0.6294445516416565
PE/CA-PJ34 (clone C12),135928012,3.818108144360031
RPMI-7951,JQ-1-navitoclax (2-1 mol-mol),1.5648934807647052
BT 328,25150857,3.2556687678990612
Ku812,11175137,1.3138431643712536
CML-T1,54454,4.932328921432074
Hs 683,11364421,-5.723594219866352
BT 320,135411,3.5003751238841887
KMBC-2,445643,3.749158738502044
LoVo,54618164,3.038824107117225
SET-2,46191454,2.4902419082362677
LNCaP clone FGC,44137675,-0.0914155631340202
RPMI-7951,9887053,3.65793605994431
TE 617.T,400769,-0.3997612253478387
SNU-1272,52947716,-5.180719901739396
GOS-3,3689413,-2.185831490776692
CA46,46926350,-5.311040218420036
NCI-H1395,46191454,1.8704386563260864
BT 248,25227462,1.1845227545958306
TE 617.T,135440466,2.798852052515524
BT 330,4261,3.0560809505668365
HSC-4,73707371,4.771220465805862
KMBC-2,1566236,2.626882312986064
NU-DHL-1,46926350,-4.283271721572929
AN3-CA,46398810,2.836151148830735
D283 Med,5460769,1.125938178392905
KYSE-410,9907093,4.226995518045274
AU565,49793307,-1.974878634968376
NCI-H1092,navitoclax-sorafenib (1-1 mol-mol),1.0021052217425306
SNU-8,24771867,0.819050595072537
BT 320,11152667,2.8584362453350427
PaTu 8988s,12003241,-0.9111494781164662
KYSE-410,44632017,4.131355537094701
BT 248,53495165,3.0905684330313803
MCAS,46224516,4.169683625614388
SNU-1033,168312962,3.0466986481809406
NCI-N87,5335621,4.88881532131479
ML-1 [Human thyroid carcinoma],71466380,5.169213277707957
BT 139,5746,0.3581690049929101
A4/Fukuda,52912189,-0.8285591911559074
PE/CA-PJ34 (clone C12),73707398,0.9457530769963428
ML-1 [Human thyroid carcinoma],54619267,4.278122085164484
SEM,11494412,-0.8044371012013913
BT 328,11178236,-3.1111942702784092
SNU-1033,11494412,3.797369316086489
KMRC-2,10231331,3.7445529235865895
NCI-N87,136227924,3.040461203265333
NCI-H2081,135984461,4.3718384438901285
Hs 683,25227462,0.9336514298487568
KMS-27,119182,-1.6421871247609852
AN3-CA,24951314,1.3705311595438758
KYSE-410,5329102,1.9540391850066523
EJM,168313016,4.883313185195125
NCI-H2110,71466380,5.718855140716474
SEM,44489675,3.2608943672828827
TE 617.T,6610216,4.021742193250995
LNCaP clone FGC,selumetinib-decitabine (4-1 mol-mol),5.4258848699301225
MCAS,72734382,4.82541753834805
Kasumi-2,54618795,2.2160859361178624
EJM,36462,0.7713020046102423
OE21,carboplatin-etoposide (40-17 mol-mol),4.891272299916478
NU-DHL-1,702558,5.1708042133042875
HCC2218,60700,0.1059889943667532
HEC-151,9926054,1.821769205783168
HSC-4,44486219,5.375029781512573
D283 Med,322968,2.541378119684702
CML-T1,3384730,0.9879066704986152
TE 617.T,2113511,5.005683090438257
Hs 683,9926054,1.7064216062537565
EJM,16736978,1.1744995972918135
SNU-8,selumetinib-vorinostat (8-1 mol-mol),1.098702489226645
Ku812,9927531,3.686533687467188
NCI-H2110,136227924,4.625762146403413
MCAS,10296883,3.979435703813419
BT 248,119182,0.6885021238666414
KMRC-2,5282054,5.119210462309406
NCI-H2081,446155,1.804477819432441
SW1990,2874250,4.4866341652918145
GOS-3,984333,1.7865923354783255
Hs 683,45100481,4.462551987037815
ML-1 [Human thyroid carcinoma],2126,5.801287401499987
KMS-20,11178236,-2.952639968854244
Ku812,4261,0.3259044550005565
PaTu 8988s,168312962,3.50119634211369
BT 330,5311,1.7603481679347692
CA46,23725625,5.582899861703026
KMS-20,135421197,1.5361253797366796
SET-2,selumetinib-piperlongumine (8-1 mol-mol),2.3759886885841293
A4/Fukuda,5460769,3.0365194168079572
NCI-H1395,3503,1.633865651752571
SNU-8,serdemetan-SCH-529074 (1-1 mol-mol),2.5370176550442705
CA46,135875424,2.985562686352135
RERF-LC-Ad1,3854666,3.753707482876592
PaTu 8988s,73707398,1.72539191163247
A4/Fukuda,637858,0.8198578842358093
AU565,56963564,-0.3705062094323867
SEM,10427712,3.915195829350839
BT 248,445091,5.158109648340294
SNU-308,4788,6.043537780465283
A4/Fukuda,262093,3.0357368226896178
D283 Med,tretinoin-navitoclax (4-1 mol-mol),6.584931144825414
OE21,9915743,-2.7713034399639
Kasumi-2,16722836,0.3444985018145829
SNU-308,sirolimus-bortezomib (250-1 mol-mol),1.6825510481181765
OE21,46191454,0.5707756581247114
NCI-H1092,3038522,3.1295884700931182
BT 248,24951314,2.138284126904765
LoVo,49793307,-4.412709808216002
AU565,5351362,0.5336942302969934
LNCaP clone FGC,11494412,0.5135445267768279
GOS-3,5278396,3.876962723891849
A4/Fukuda,216345,2.739557201577506
TE 617.T,4578,4.427740747516631
NU-DHL-1,24951314,-0.7364467941633237
ML-1 [Human thyroid carcinoma],49766530,-1.1158595986885904
RPMI-7951,148198,-2.190615440736015
BT 248,327653,3.4402013175237394
BT 139,136227924,3.476406727957654
Hs 683,24901704,3.2629232057843467
LNCaP clone FGC,vorinostat-carboplatin (1-1 mol-mol),2.985187583085351
NCI-N87,11647372,-1.5140697510658656
KMBC-2,46843906,4.6430675158298715
SNU-1214,sirolimus-bortezomib (250-1 mol-mol),0.3499333667052599
NCI-H2081,25262965,-3.276528067385419
RPMI-7951,44491742,3.876790810560562
YKG-1,9887053,4.276479175493701
SKM-1,44202524,0.4961794817988646
Kasumi-2,2126,3.96137914347523
TE-15,44185566,2.9529174101649796
KMS-20,JQ-1-navitoclax (2-1 mol-mol),-1.501822959559956
SNU-308,selumetinib-BRD-A02303741 (4-1 mol-mol),5.178063267003013
Ku812,20959075,-3.7806985906685298
TE-15,53495165,0.1275569462567273
RERF-LC-Ad1,51039095,3.4667294063138407
SNU-1272,11626560,2.412334917468919
Kasumi-2,3025944,3.902952987709838
SKM-1,56963564,-1.6088992179098347
MCAS,637858,2.160945503625874
RPMI-7951,71304818,2.808506833737362
SNU-1214,selumetinib-PLX-4032 (8-1 mol-mol),2.398477274128209
TE 617.T,4917,2.465000151468364
PE/CA-PJ34 (clone C12),36462,2.153519991196826
KMRC-2,navitoclax-gemcitabine (1-1 mol-mol),0.8388920791058432
HSC-4,5311,1.8002123285320597
AU565,7251185,1.9736319172199277
LoVo,10231331,-0.6826574775964468
SKM-1,9826308,-1.0931344277451622
SKM-1,11626560,0.5030232412556168
TE 617.T,969516,2.4231589401294027
TE-15,24797083,2.028256767173618
AN3-CA,25150857,3.292765254129613
RPMI-7951,72193861,-0.4754821102951712
Hep-G2,1242560,4.268302796379108
SET-2,24951314,0.2183359263596641
MM1.S,25102847,1.6569670603022522
Ku812,327653,2.6105949863285436
BT 248,9927531,4.7076279917818225
D283 Med,5311,-0.2786348864571751
NCI-H2110,24180719,4.287105919201185
KMS-20,JQ-1-vorinostat (2-1 mol-mol),-0.6306779482230097
NCI-N87,44486093,4.414725106733636
TE-15,15953870,1.748445900477018
AN3-CA,219104,2.4655837884379626
Hep-G2,navitoclax-gemcitabine (1-1 mol-mol),1.7377855458966929
GOS-3,6852167,4.136996914293619
TE-15,2828334,6.064569260089426
BT 139,5280436,3.140631305966164
NU-DHL-1,16659841,3.4914634927740456
CA46,151289,0.6780663351050565
SET-2,6610216,4.10264033472901
EJM,53392493,1.8417186959189336
SET-2,44819697,-4.543529613323342
SW1990,46191454,3.835132075792151
CML-T1,16741245,3.55536863016822
KMBC-2,409805,6.016015175624214
CML-T1,3025944,4.207605674746215
KMS-27,3385,3.2431788484740993
SNU-1033,54618771,0.4334411730243536
LNCaP clone FGC,sirolimus-bortezomib (250-1 mol-mol),-6.240208819655782
AN3-CA,4521392,6.410981335600101
HSC-4,JQ-1-vorinostat (2-1 mol-mol),2.1995872566354864
TE 617.T,11364421,-5.700379248879762
NCI-H1092,135928012,3.192957596716536
BT 328,374536,4.943552861027733
A4/Fukuda,44185566,1.3030950937163224
YKG-1,24753719,4.608335607306647
HCC2218,11214940,1.0598485229259995
LNCaP clone FGC,82146,3.546858803484303
LNCaP clone FGC,54618164,3.473617920574014
BT 248,9825149,2.247604687491298
D283 Med,24753719,3.1316348069328357
HMCB,52912189,1.846008318835607
YKG-1,72734382,5.141211314394623
HEC-151,11647372,1.208008316206568
SEM,11647372,1.226548693223236
BT 320,322968,4.418694945814317
Hep-G2,10184653,1.7532809843488162
BT 248,54454,4.901618168416747
MCAS,72193861,0.5600268291929783
SEM,71751553,4.239243086655999
MM1.S,12001922,1.2922454576478266
RPMI-7951,11647372,-0.0231097705626451
HCC2218,46191454,1.332680934532818
MCAS,selumetinib-JQ-1 (4-1 mol-mol),0.5693027943347815
Aska-SS,6610216,4.460274887229386
KYSE-410,16013152,4.977584509485277
NCI-H2110,1239801,4.6745645972191685
NCI-N87,11427553,2.9770783714757005
CA46,2842253,3.7037662444842696
GOS-3,4578,4.471088168951713
KMRC-2,11175137,2.6874128471774865
SNU-1033,54143018,3.812965937787427
EJM,5113032,5.279570802403047
AN3-CA,56649450,1.7999761644788916
KMS-27,6918328,-1.1796709912308914
PaTu 8988s,5311,1.267782379432991
SNU-1272,crizotinib-PLX-4032 (2-1 mol-mol),2.5958559456556025
KYSE-410,6505803,-1.395116732641888
NCI-H2081,6438330,1.5625660396683954
SET-2,1239801,3.802011225535514
SET-2,6252,-3.154531220963429
SEM,navitoclax-MST-312 (1-1 mol-mol),-2.7304049147303764
SET-2,10074640,2.793690603615292
D283 Med,23582824,-0.1827482787925018
NCI-H2110,44486219,4.2907180414461195
RPMI-7951,4378219,1.8029418546764064
PE/CA-PJ34 (clone C12),7326481,3.1862405320000606
HSC-4,216468,2.5769925673594227
OE21,49793307,-5.20007789952048
HMCB,24785538,2.1780409626739177
PaTu 8988s,72376,-1.5914481946696195
IST-Mes1,44487872,4.402175961022997
NCI-H1092,54596558,4.902565947797631
SKM-1,navitoclax-pluripotin (1-1 mol-mol),-0.780320881442614
SKM-1,JQ-1-MK-0752 (1-1 mol-mol),-0.3579798637205856
SNU-1214,72193861,0.8767959746030513
NCI-H2081,11612883,1.5585709489952069
PE/CA-PJ34 (clone C12),1641662,3.2339299238694066
SEM,6610216,3.5318840364079302
OE21,54765302,4.254324559348036
NCI-H2110,10385095,0.9459448618339928
PaTu 8988s,selumetinib-tretinoin (2-1 mol-mol),2.1087968884942057
KMBC-2,6917907,-6.447748478018451
NCI-H2110,31703,-2.3083076582256083
PaTu 8988s,46215462,1.30654538565013
NCI-H1092,19582717,5.304024438034291
KYSE-410,11427553,3.390914778571702
NU-DHL-1,44462760,1.663932260819044
KMS-27,46191454,-0.9265013604002822
OE21,4259181,-0.2444735464140802
RERF-LC-Ad2,25126798,4.1724068761038104
AU565,148124,-5.63717967948206
BT 330,51039095,2.347210430351482
NCI-H2110,crizotinib-PLX-4032 (2-1 mol-mol),1.801559524212287
HEC-151,6450551,3.129732127763604
YKG-1,11178236,-5.715271869049359
PaTu 8988s,42611257,3.954270823860523
NU-DHL-1,6436223,-6.457204193178952
SNU-308,5282054,5.076445837500988
HSC-4,409805,5.399675964474335
SNU-1272,452548,2.9795464172377923
RERF-LC-Ad2,216239,1.8867785835820676
KMS-20,44607530,1.038063034852437
Raji,44185566,3.214102845082995
KYSE-410,9936388,-3.552366403662026
KMS-27,54626689,4.411427785332684
SNU-308,12003241,0.0879961923245038
MM1.S,5280436,3.932437851404913
IST-Mes1,11717001,4.337000636344965
NCI-H2081,57330099,4.306968967458579
TE-15,42642645,0.6450047304037199
KMS-27,10322450,3.3921429038631707
KYSE-410,375860,0.3539761529169563
KMS-20,445643,3.538778449687995
SNU-1214,53232,1.694141933876363
Hs 683,11507802,1.064006368361757
KMBC-2,SNX-2112-bortezomib (250-1 mol-mol),-0.6016200424782262
BT 248,25150857,2.3784591591930635
CML-T1,6918328,-2.287128701752201
Ku812,5281672,3.8217692077235
CA46,3689413,-3.563387503989764
EJM,25062766,1.6809786410493317
KMRC-2,9927531,6.175340087469203
SEM,54618305,4.259603919662889
HCC2218,11609586,2.605015214107852
BT 330,16038120,0.5396247487924652
AN3-CA,11507802,0.6411944159694901
NCI-N87,637858,1.7879892218708664
TE 617.T,11396600,3.161779711193339
SEM,3062316,2.096847795011344
MCAS,25126798,3.8264410165946336
Hs 683,426756,5.100809290243355
BT 328,702558,5.711275260817638
HMCB,44620216,3.75907635673166
Raji,2708,4.369088535017227
ML-1 [Human thyroid carcinoma],107985,-3.3059977696559204
SKM-1,53392493,1.9339863901276448
TE 617.T,9908783,5.790109793451864
Ku812,168312962,-3.0210187912028075
CML-T1,126941,-3.100237153288417
PaTu 8988s,6610216,4.229616892314871
SW1990,5738263,4.0408382975361965
HEC-151,4378219,2.401235967325108
SKM-1,11964036,0.1293394770460754
Aska-SS,1750826,-0.901544414457822
BT 139,selumetinib-decitabine (4-1 mol-mol),7.21511875028252
MCAS,11404337,-0.3191442981427469
OE21,4788,5.877941677977921
NCI-H2110,52947716,3.0612107252591634
EJM,24748573,1.377291094457539
BT 320,navitoclax-sorafenib (1-1 mol-mol),2.857010837113841
BT 320,439501,-1.927418392306892
HCC2218,25102847,3.5244982698311396
PaTu 8988s,25062766,1.061864368687882
NCI-N87,5460769,3.352422042402732
NU-DHL-1,56973724,1.6300802460905772
KMS-27,6505803,-0.687237988201334
NCI-H1092,44491742,3.604656167614849
NCI-H1092,25150857,2.120015833074409
Hep-G2,44607531,2.793402038765765
D283 Med,285033,-3.580408991915884
NCI-H1092,76446078,4.704982368459853
NCI-H2081,5282054,2.482146692013313
RERF-LC-Ad2,3503,2.250409262953343
KMBC-2,11625818,5.816213773261342
SKM-1,24771867,-3.0651139758567068
LoVo,71466445,2.646256567071358
EJM,11228183,2.3693057708406005
HSC-4,3689413,2.5472025828962055
Ku812,36314,-5.058801255345217
Hs 683,crizotinib-PLX-4032 (2-1 mol-mol),1.208716890495358
SW1990,168313016,4.40739187693859
TE-15,568763,1.5416541843675535
BT 248,24180125,1.9773901044414168
SNU-8,49850262,3.672071843328665
SET-2,6505803,0.5122894661821437
LoVo,168312962,0.7059894109575258
BT 330,23582824,1.1075472955671075
RERF-LC-Ad1,71304818,3.4677724486162753
NCI-H2081,8515,3.558797146048482
CA46,3854666,0.2733202158609283
EJM,11234052,4.536788140349876
LoVo,753704,4.37626239298451
TE-15,56946209,-4.477662549081909
HMCB,2871966,0.8621861028027487
HARA [Human squamous cell lung carcinoma],11152667,-1.8717886502550631
RERF-LC-Ad2,11175137,3.7973989123571665
SEM,11238147,1.513546731102789
KMBC-2,10385095,2.342587870752789
HMCB,10427712,4.183996317253481
MM1.S,navitoclax-MST-312 (1-1 mol-mol),0.8830386124411814
Kasumi-2,71729975,0.1244547207122276
TE 617.T,5738263,3.651421569462811
AU565,44486219,4.217962962304986
GOS-3,10410894,4.409774071454934
SNU-8,1242560,3.383210455618013
PaTu 8988s,10184653,1.0549683128731666
Hep-G2,3062316,2.0384050526370454
Kasumi-2,637858,0.3812755763700117
NCI-H2081,selumetinib-GDC-0941 (4-1 mol-mol),2.2419889571626146
BT 328,31703,-0.2898094024615853
NCI-H2110,16659841,3.1191566994365147
ML-1 [Human thyroid carcinoma],selumetinib-MK-2206 (8-1 mol-mol),-0.7620404937141786
HSC-4,122327,4.034102983304833
BT 328,SNX-2112-bortezomib (250-1 mol-mol),-2.692646777339037
TE-15,71466578,4.537975566322263
NU-DHL-1,5978,-4.279769734598632
CML-T1,24180719,2.7823494948279373
CML-T1,135421197,0.9317392273651705
Hs 683,1641662,3.565270683929052
Hs 683,selumetinib-BRD-A02303741 (4-1 mol-mol),4.926542916228776
PE/CA-PJ34 (clone C12),9927531,5.274687585125943
NCI-H2110,9903786,2.318107893964858
KMS-27,65064,3.02992990636513
NCI-N87,25262965,-2.609521679715104
NCI-H1092,46191454,1.930270640932621
LoVo,53232,3.084407514553567
HMCB,6914657,-4.177401359592738
RPMI-7951,vorinostat-navitoclax (4-1 mol-mol),1.0109262347877594
GOS-3,ISOX-bortezomib (250-1 mol-mol),0.1639381713704753
BT 139,2742550,2.665128125190364
NU-DHL-1,135875424,2.8057790902603665
CML-T1,JQ-1-navitoclax (2-1 mol-mol),-0.3838204075177596
NCI-H1395,selumetinib-MK-2206 (8-1 mol-mol),2.294517762393479
Ku812,25262965,-2.692215385678303
Hs 683,9935249,2.3161488384728575
PaTu 8988s,4259181,0.1562419703255739
HARA [Human squamous cell lung carcinoma],10427712,4.036967432982734
EJM,126941,1.4597619440351868
SW1990,446155,2.0061093369202285
BT 248,421610,3.3246840566564484
Ku812,tanespimycin-bortezomib (250-1 mol-mol),-1.4793309547353497
TE-15,375860,-0.9577501669745316
LNCaP clone FGC,4917,3.636523890997274
SNU-1214,5280436,3.8026602944252184
Hs 683,selumetinib-tretinoin (2-1 mol-mol),6.040363001093622
SEM,11955716,-2.9812698149685626
NCI-H1395,4917,3.698580311776931
NCI-H2081,BRD-A02303741-navitoclax (2-1 mol-mol),1.572790594213783
IST-Mes1,135411,1.0362911335756892
D283 Med,11485656,1.7629558217294734
KMRC-2,3136844,4.810057568138529
KMS-20,136227924,2.296093636743899
KMS-27,11485656,2.096815262793708
Aska-SS,11625818,3.428731184802555
MCAS,44202524,1.49697239773081
AU565,11228183,3.2105327090314133
NCI-H2081,375860,-0.0986689884250349
HMCB,10184653,1.7690843609902929
PaTu 8988s,11964036,1.6421369085466544
NCI-H1092,25126798,3.974673346500284
KMS-27,73707386,3.821733041812712
HCC2218,65628,6.436563943794135
AU565,selumetinib-UNC0638 (4-1 mol-mol),4.121266553774429
HEC-151,446155,4.059621209738735
MCAS,9907093,4.1861639948310785
YKG-1,439501,-3.197548465236136
GOS-3,71304818,3.432284958440276
KMRC-2,6450551,2.739677229756094
RERF-LC-Ad2,12001922,1.5702211119337048
KYSE-410,11647372,0.147715793237346
NCI-H1395,6852167,3.4323108551980748
Kasumi-2,675434,3.537694279705698
HSC-4,15983966,0.1445652725334258
D283 Med,11213558,0.9641513863181852
BT 328,11404337,1.5843001055688009
RPMI-7951,9907093,4.278738901234216
SET-2,5287620,-2.9581433175203315
AU565,25154868,3.4836730381065424
SET-2,445643,3.8553582166731415
ML-1 [Human thyroid carcinoma],44632017,3.256506939906626
BT 139,docetaxel-tanespimycin (2-1 mol-mol),-4.169767352390419
SNU-8,104842,-1.0653176876921144
SKM-1,5460769,2.732858525958475
KMS-20,72734382,2.4480499103893707
PE/CA-PJ34 (clone C12),navitoclax-birinapant (1-1 mol-mol),3.3511739424223457
NU-DHL-1,5284329,2.6170218668943632
NCI-H2110,60700,-0.2930949286274902
D283 Med,71680916,4.275278855129835
SET-2,5479543,3.7570504136940346
OE21,24856436,0.030233909527142
Raji,322968,2.716304325933968
YKG-1,11152667,0.85211892000732
RERF-LC-Ad2,135398744,6.529632870190649
AN3-CA,216468,2.584012324066889
RERF-LC-Ad1,selumetinib-UNC0638 (4-1 mol-mol),4.185176714709013
Kasumi-2,16038120,1.393585308421038
KMRC-2,444795,5.142588115774172
Raji,46191454,-0.7209725963204677
A4/Fukuda,387447,-5.631039688913266
LoVo,selumetinib-decitabine (4-1 mol-mol),1.6918156459461149
KMS-20,11427553,1.7901611501195382
LoVo,44589607,1.625549992230134
KMS-20,5311037,3.3328695016599132
AN3-CA,11238147,2.9794087759771664
KYSE-410,5702613,2.208254881931662
SNU-1033,11427553,3.174584917196522
RPMI-7951,4261,1.656871275640203
LoVo,10296883,3.831816674357036
HARA [Human squamous cell lung carcinoma],72376,-2.3262904878865083
SNU-1214,17759555,2.7745156093905043
Ku812,654092,-1.4885664585268723
SKM-1,216468,0.4318372825903644
KMS-27,16725315,0.8036221388012417
BT 320,25227462,3.0496366497602025
BT 139,54618771,0.6654274606551459
ML-1 [Human thyroid carcinoma],9926054,2.0491703403306056
IST-Mes1,25154868,5.0412707783574735
A4/Fukuda,44819697,-1.7397384839387715
HEC-151,JQ-1-MK-0752 (1-1 mol-mol),1.1160938672676726
BT 320,9911463,3.706038906545982
SNU-308,9911463,4.030831002886429
RERF-LC-Ad2,carboplatin-etoposide (40-17 mol-mol),4.970817395675663
SEM,73707398,-1.1402705015945305
LNCaP clone FGC,71576739,5.072405718386329
TE-15,11222830,1.763810814771804
SNU-8,89183176,3.903990016446917
PaTu 8988s,54626689,4.835984760777768
Raji,11234052,1.9952907949513128
KMS-20,decitabine-carboplatin (1-1 mol-mol),3.602021094753337
SEM,11657048,5.137852973890356
MCAS,89928392,1.6246065994897545
Hep-G2,3815108,3.2270973506014182
Ku812,sirolimus-bortezomib (250-1 mol-mol),-4.706863759104448
Ku812,1242560,2.376914084475441
SNU-308,5566,3.3108470564797225
PE/CA-PJ34 (clone C12),176870,0.680065557462293
HMCB,3025986,0.04435044447406
Hs 683,4096211,1.660669341815773
Hep-G2,3825829,5.065822708326793
GOS-3,107985,-2.049266528770901
EJM,3038522,1.9147262325597951
Kasumi-2,54143018,-2.3900299530010405
BT 330,10231331,3.9874659396467793
NCI-N87,6852167,1.8373876080574163
HCC2218,9927531,0.7764965952119703
IST-Mes1,448949,2.0697752718967677
NCI-H2081,2828334,5.70400376605512
Ku812,serdemetan-SCH-529074 (1-1 mol-mol),1.0312018024481138
BT 330,9825149,1.038089152704002
NU-DHL-1,71729975,0.4748567113914174
MCAS,151289,1.3537471569868331
SET-2,42642645,1.5716650325889971
NCI-H2172,11175137,1.9843888690025844
HMCB,44819697,-1.3294210375282771
NCI-H2110,49836020,-1.7351781152481929
YKG-1,46215462,1.7714075060920065
MCAS,selumetinib-vorinostat (8-1 mol-mol),1.2956109897166193
Hep-G2,56946209,4.656180413694649
IST-Mes1,JQ-1-UNC0638 (2-1 mol-mol),0.9628638270224468
PaTu 8988s,44462760,3.684376374134235
LoVo,6623618,1.7195113979524326
Ku812,54618305,3.744773275517672
KMBC-2,2729026,3.016115186069628
KMBC-2,24753719,5.4446471977662245
SNU-1214,11455910,3.3877834337363124
NCI-H1395,24964624,3.1015144047697367
MM1.S,56649450,0.693428636347353
Aska-SS,selumetinib-navitoclax (8-1 mol-mol),5.320747711873069
Raji,12003241,2.533123505917396
SET-2,11175137,2.2694521768309976
NU-DHL-1,2742550,3.0949121408680886
HEC-151,54686904,4.134628252363428
HEC-151,24797083,1.0438718877064863
SEM,UNC0638-navitoclax (1-1 mol-mol),-2.575766799282578
KMBC-2,5329102,2.8485011824708133
TE-15,135875424,3.16520710682736
CML-T1,3011155,1.2837041284349135
Raji,11964036,1.1423265876219442
HEC-151,11609586,3.2288944152185515
HARA [Human squamous cell lung carcinoma],25062766,2.285935640348263
Kasumi-2,6918638,-1.1951505869280743
SET-2,54596490,4.331118205930631
SNU-8,656346,1.5871868754593337
KMS-20,3136844,4.071065919144672
NCI-H1395,25262965,-4.1064506045953095
HEC-151,5311,1.3919062885565148
CA46,216468,1.7849524837603168
SET-2,168313200,1.9017333660597997
KMS-27,4917,2.986896806012511
KYSE-410,104842,-1.9558924274335232
SKM-1,11507802,0.9251203923511582
HSC-4,44507138,3.308450875381542
SEM,3552672,5.542055720565402
Aska-SS,5282054,2.790443973979982
KMS-27,decitabine-navitoclax (2-1 mol-mol),-1.799686527598198
A4/Fukuda,9826308,-1.4955537783248567
SNU-1033,6450551,4.4287775672397345
IST-Mes1,3081361,1.9096346363157353
TE-15,168312962,5.254824497149209
BT 139,2842253,7.121896255124089
SET-2,24856436,-1.7721570824148565
RPMI-7951,6505803,-3.4302306957343434
BT 248,702558,5.9883095131036495
EJM,vorinostat-navitoclax (4-1 mol-mol),0.2535752664026445
NU-DHL-1,12001922,1.2463642245780415
AU565,15953870,2.093538779145719
PaTu 8988s,969516,3.9630929777783663
LoVo,16720766,-0.1141862087465287
LNCaP clone FGC,9444,4.43168901353623
BT 139,selumetinib-MK-2206 (8-1 mol-mol),2.0878690107327555
KYSE-410,9967941,5.8848991583197385
Hep-G2,24797083,1.3035755936637026
KMS-20,44489675,3.4055865865697283
AN3-CA,216239,1.4123950124016178
HARA [Human squamous cell lung carcinoma],9935249,3.837366541191349
YKG-1,241158,4.094206621053088
GOS-3,44607531,1.5266968302788424
HSC-4,11222830,1.068056053085511
BT 139,53392493,1.7683203487497317
PE/CA-PJ34 (clone C12),16065773,2.5490560227958436
CML-T1,11612883,2.4336919382311253
D283 Med,11178236,-4.81725298730488
BT 248,25195348,5.391578709053811
SEM,46943432,-1.9096552724661455
SKM-1,66577038,3.0728529943968153
ML-1 [Human thyroid carcinoma],16065773,2.2629168527060117
NCI-H2081,107970,1.5324597930931985
SET-2,selumetinib-JQ-1 (4-1 mol-mol),-0.4291738156644369
HCC2218,44607530,-1.0450440399880232
NCI-N87,104842,-4.261750557946528
PE/CA-PJ34 (clone C12),568763,0.9098247878075588
SNU-8,4261,0.9369229460712624
NCI-H1395,5287620,-5.195854195125387
RPMI-7951,5738263,2.8494549417989035
NCI-H2081,216345,3.6466668059147054
D283 Med,451668,-1.57029447939279
TE-15,168313200,2.769784502897391
BT 139,piperlongumine-MST-312 (1-1 mol-mol),0.9398262944577864
BT 248,25126798,4.2564362718884965
BT 330,selumetinib-tretinoin (2-1 mol-mol),5.330829076137418
NCI-H1092,11234052,4.115847054230737
TE 617.T,9866186,0.80054695295052
AU565,16722836,1.9939850778221897
SEM,9887053,1.384456155351722
HARA [Human squamous cell lung carcinoma],568763,1.3363257274557196
SW1990,148198,-3.981392088661051
RPMI-7951,1750826,-2.4322694777109453
SET-2,241158,3.0184145193600807
OE21,54618164,3.767482528775002
EJM,25161177,4.274116422039874
Hs 683,24748573,2.9434046596633068
HCC2218,16736978,3.2618573796089834
LoVo,3062316,-2.119304437973892
HEC-151,9903786,2.765131251863377
ML-1 [Human thyroid carcinoma],11214940,1.6315509593699482
KMS-27,441298,2.670154019123105
NCI-H1395,60750,-2.362742731537794
LNCaP clone FGC,11178236,-2.8738158193146575
CA46,168313200,1.9493207867170304
SNU-1214,10385095,1.848528700998056
NU-DHL-1,65064,2.7159461046068545
Aska-SS,2949965,2.3817646321620938
HCC2218,89183176,2.3867110966376464
D283 Med,5280436,0.4701684330621582
ML-1 [Human thyroid carcinoma],1716436,2.512454049061402
SKM-1,54678924,0.9652165480263206
HARA [Human squamous cell lung carcinoma],54454,2.560964814308564
Aska-SS,9868037,4.2121131114727435
CML-T1,11964036,0.6626338262041811
GOS-3,219104,4.122096403169316
SNU-1033,71729975,1.596048380525692
RERF-LC-Ad2,16725315,5.240836708334476
MM1.S,168313016,2.515366642859788
TE 617.T,44137675,3.915947346314195
BT 139,9926054,3.0317650629280717
HARA [Human squamous cell lung carcinoma],9840324,5.741888919857564
NCI-H2172,241158,6.148791775116968
AN3-CA,tanespimycin-gemcitabine (1-1 mol-mol),-1.213429357847596
SKM-1,10302451,3.713731670018531
YKG-1,5566,3.213592507672074
SEM,52912189,-3.2555480793236713
BT 139,3552672,1.636250898601629
SEM,426756,3.493351005002034
NCI-H2110,135398738,4.827884640911211
AU565,16065773,1.4318565791423328
SNU-1033,568763,-0.247393300871531
KMBC-2,11647372,4.281314262736034
CML-T1,208908,1.88775844056814
TE-15,11507802,0.98779179602805
KYSE-410,56946209,-4.266724774825525
SEM,119182,-4.118292279963464
GOS-3,16722836,1.9168472063673057
NU-DHL-1,BRD-K55473186,1.794195588089048
KMRC-2,4096211,2.549532275475938
NCI-N87,11213558,1.0018400483751706
BT 330,9549297,1.684631895780215
CA46,19582717,2.2741322004032716
Raji,9866186,0.6262664347859852
BT 330,135999136,1.458475788495572
RERF-LC-Ad2,24180719,5.168983190689386
SKM-1,44507138,-0.8724707362135841
NCI-H1395,11222830,1.7032197933937347
SNU-1272,11612883,3.2902813327971936
NCI-H1092,15547703,3.51736308964877
SKM-1,6610216,3.825535401377457
CA46,6438330,0.8057128440407828
HCC2218,4705,1.2825749224447869
TE 617.T,387447,-4.6885019632323255
SEM,448949,-1.6287077587171075
HSC-4,24771867,2.9499855440491243
PE/CA-PJ34 (clone C12),5281321,-0.3897758283892497
Aska-SS,100016,5.454856815374324
PE/CA-PJ34 (clone C12),24964624,2.1602822275221354
AU565,navitoclax-pluripotin (1-1 mol-mol),-0.1402455429535511
Hs 683,24964624,2.490055513295311
A4/Fukuda,1242560,1.4412010240031818
SKM-1,JQ-1-vorinostat (2-1 mol-mol),-0.4999254314738021
BT 248,erlotinib-PLX-4032 (2-1 mol-mol),2.9999117563905497
D283 Med,54678924,1.845714700786355
NCI-H2172,24785538,3.3212479615271366
KMS-27,24753719,3.911687472760716
MCAS,654092,-1.435173669526354
SNU-1214,9926054,3.9057313084396656
HMCB,9887053,4.4985851609275995
BT 328,11626560,2.3893583978213617
SNU-1214,5311,1.4424355919167942
EJM,tretinoin-navitoclax (4-1 mol-mol),2.7267851224914854
TE 617.T,5287969,-2.246039947920682
HSC-4,46174525,4.818915916273074
BT 248,44241473,4.372252470027867
NU-DHL-1,9840324,6.681797282677095
HSC-4,241158,3.797905223062241
NCI-H2110,10410894,3.887521181440491
NCI-H1092,46174525,3.656769194454104
KMRC-2,19582717,5.701776985219262
RPMI-7951,2729026,0.4139461540992614
NCI-H2081,5351362,0.7138229961516296
SNU-1033,66577038,2.1226133896065815
CML-T1,72734382,3.1811123479261276
CML-T1,11427553,0.3447104584156399
KMS-20,16725315,3.260760916795047
LNCaP clone FGC,72376,-1.8461779553879152
EJM,1242560,2.98578545305507
NCI-H1395,46843906,3.1516076694809994
D283 Med,444795,-3.2845998018022775
HEC-151,262093,2.667137080366997
SNU-1033,409805,7.650675265058521
SEM,66577038,2.939382481525851
D283 Med,72376,-2.8932553569848385
BT 328,25183872,0.4527606216465452
CML-T1,15547703,2.6642294109203823
GOS-3,44819697,0.5869793417455883
SNU-308,25183872,-0.4312596852258337
OE21,5329102,1.6646243395280815
GOS-3,selumetinib-GDC-0941 (4-1 mol-mol),2.3911305512377217
LoVo,15983966,-3.091518031584947
NCI-H1092,selumetinib-PLX-4032 (8-1 mol-mol),4.373059758392111
KMS-27,navitoclax-MST-312 (1-1 mol-mol),-1.901648609736443
HCC2218,6610355,4.312691214632914
OE21,54626689,4.586584726224223
BT 248,25183872,-1.6442953183353304
NCI-H2081,2858523,3.0254216671755114
SNU-8,44259,1.3502886518318586
NCI-H2110,selumetinib-GDC-0941 (4-1 mol-mol),1.414956690857524
Aska-SS,1566236,2.835493117782545
PaTu 8988s,984333,1.020213634750089
ML-1 [Human thyroid carcinoma],selumetinib-piperlongumine (8-1 mol-mol),2.412069402111766
SET-2,54613361,-0.3766377840861687
NU-DHL-1,5280436,2.443749482827121
OE21,16725315,4.952658677155423
CA46,46191454,-0.333651418813281
SET-2,11625818,3.966078974132002
HEC-151,285033,-2.1318823022506184
SNU-1272,89928392,2.766641438672422
HSC-4,2749,1.8453067540575636
NCI-H1092,702558,4.580378170457022
SNU-1214,44241473,4.767389445416476
TE 617.T,10296883,3.758267174754907
KYSE-410,11485656,2.2435649092934775
RPMI-7951,322968,2.854105958499618
SET-2,10113978,3.44756755844501
ML-1 [Human thyroid carcinoma],53392493,2.260380394132801
ML-1 [Human thyroid carcinoma],24797083,1.931228349809168
SW1990,erlotinib-PLX-4032 (2-1 mol-mol),3.1505138932188994
NCI-H2172,675434,4.445738285070077
TE 617.T,613753,3.0355308718279304
MCAS,135398516,-0.2900633713122362
HSC-4,12001922,2.169357927696289
CA46,9935249,0.2545497442771542
A4/Fukuda,11222830,1.361211164053787
KMS-27,2733526,3.3995560375076663
TE 617.T,7251185,1.6615053823648038
NCI-H2081,3385,5.204021808998722
SNU-308,11152667,0.4634525960285107
NCI-H1395,107970,2.4345825548290265
BT 139,9868037,3.9588523345635376
HMCB,89928392,1.1617926857836482
Hep-G2,selumetinib-JQ-1 (4-1 mol-mol),-0.7772498513580158
HARA [Human squamous cell lung carcinoma],6918328,1.494996835192892
BT 248,navitoclax-piperlongumine (1-1 mol-mol),1.2015082500214636
SNU-1214,72376,-2.4971526141185043
NCI-H2081,2113511,5.887523874573183
NU-DHL-1,71680916,3.5275093347477795
MCAS,9866186,0.5994154394418661
Ku812,9868037,1.2688072678140785
NCI-H2110,11228183,3.5598870695262215
Kasumi-2,10113978,2.7713645825563153
KMS-20,73707438,0.304623121226347
BT 330,65064,5.135566827612043
HCC2218,6918638,-0.2279728548913661
NCI-H2172,24821094,4.093523635745637
PaTu 8988s,135659046,3.7225208809385073
HARA [Human squamous cell lung carcinoma],9926054,1.843677597683555
MM1.S,5284616,-5.860014911973016
SNU-308,ISOX-bortezomib (250-1 mol-mol),0.4354606210952242
NU-DHL-1,6505803,0.0102011938996583
BT 139,BRD-A02303741-navitoclax (2-1 mol-mol),1.9732620235846352
NCI-H2172,24951314,2.272328238210006
SNU-1214,10074640,2.7352407476720084
EJM,9444,4.350025057986223
BT 320,53301938,4.424260786877386
AN3-CA,637858,1.3761527435149865
KYSE-410,656346,1.720425099616191
SW1990,56649450,3.67691256278054
OE21,969516,2.6445480444615375
SNU-8,54613361,-0.0435743875336692
YKG-1,salermide-PLX-4032 (12-1 mol-mol),5.716825477266549
EJM,123631,3.178477510788884
EJM,2733487,6.457690507426682
RERF-LC-Ad2,tanespimycin-bortezomib (250-1 mol-mol),0.3910876035437155
HEC-151,31703,-2.2895750216205832
TE 617.T,erlotinib-PLX-4032 (2-1 mol-mol),0.933535349864826
D283 Med,15547703,2.9787798550877476
HCC2218,135411,2.314880593616264
SNU-8,9915743,2.7412552085538326
AU565,46215462,1.837951563203271
CML-T1,124202324,0.7419542279604492
PaTu 8988s,vorinostat-navitoclax (4-1 mol-mol),1.0724018274153246
ML-1 [Human thyroid carcinoma],56963564,0.9868520726565888
NCI-H2172,16725315,5.920732263272158
SW1990,24785538,-0.3480071895354156
OE21,24180719,4.795188480973195
EJM,crizotinib-PLX-4032 (2-1 mol-mol),1.5260381375566714
KYSE-410,49867926,3.884487882273441
Hep-G2,6610216,4.162282260552703
AN3-CA,44607531,1.3300471520029256
LoVo,1566236,1.5203890875485482
NU-DHL-1,148198,-4.718908672184396
OE21,5738263,2.69040689736045
NCI-H2110,1716436,3.4022042263381675
OE21,375860,-0.7347528974131474
MCAS,3689413,-1.1400919247426515
Hs 683,2828334,6.124701184526488
IST-Mes1,51037431,5.172794571797409
KYSE-410,3038522,3.5021634739591088
GOS-3,6917907,-5.627090987822961
MCAS,4917,3.1194785232106503
BT 139,5566,2.9967310450121816
NU-DHL-1,5278396,3.036483105356944
YKG-1,44185566,3.0761735678069884
BT 248,16219061,2.5057647005845354
BT 330,3552672,1.5304127335233928
HMCB,71304818,2.4359376321219046
HMCB,4477,0.1906220265974898
LoVo,46224516,4.94892102130723
CML-T1,25195348,1.1650045100950834
NCI-H2110,25195348,2.492831292074008
IST-Mes1,5746,2.704326416379231
MM1.S,219104,2.0959225509633552
BT 328,ISOX-bortezomib (250-1 mol-mol),1.5922800813403362
HCC2218,5460769,-0.600250204778271
D283 Med,10127622,5.31032518886127
D283 Med,3136844,3.2984572039507274
Hs 683,252682,6.537137149473829
HSC-4,9936388,2.361545024779824
SNU-1033,89928392,1.43326577549897
YKG-1,1716436,3.7130114389790982
BT 248,navitoclax-MST-312 (1-1 mol-mol),0.9766831627739164
Raji,54649381,3.576842683556631
TE-15,426756,4.053189655465964
HARA [Human squamous cell lung carcinoma],11485656,2.214748392282881
Aska-SS,25227462,1.0052150561481492
SW1990,11396600,4.084870548965884
LNCaP clone FGC,11455910,0.1396389722474823
LNCaP clone FGC,53392493,2.7107691255841457
YKG-1,tretinoin-carboplatin (2-1 mol-mol),6.38208471298272
Hs 683,9952709,3.6516209267387914
NCI-N87,5566,2.8110881508350567
LoVo,11364421,-3.7348040522268624
Raji,5566,2.9720798314318477
AN3-CA,44486219,4.4449329254105105
SNU-308,navitoclax-piperlongumine (1-1 mol-mol),2.161495777411906
HMCB,12001922,1.7530973363803413
Ku812,BRD-A02303741-navitoclax (2-1 mol-mol),1.860548372203261
SNU-8,15983966,2.284009944123205
SNU-8,262093,2.9266150824116877
SW1990,4705,4.395682074596428
SEM,72376,-3.684920591192524
YKG-1,56973724,4.73671500707
OE21,3854666,0.7782353690934734
KYSE-410,24785538,1.121475010860572
YKG-1,decitabine-navitoclax (2-1 mol-mol),4.796036772567169
SET-2,55283,3.9035205221786664
SNU-1033,25150857,2.130511087959952
HEC-151,navitoclax-gemcitabine (1-1 mol-mol),-2.2394249546056972
MM1.S,11640390,-0.5885267923488479
NCI-H2110,11455910,0.8455410267883708
HARA [Human squamous cell lung carcinoma],16720766,-0.0810608938508249
PaTu 8988s,3136844,4.247292724797891
BT 248,76446078,4.2307608716074565
PaTu 8988s,3689413,2.020164099747706
KMS-27,54618771,0.0520641396166809
HEC-151,erlotinib-PLX-4032 (2-1 mol-mol),3.187674900849174
NCI-H2110,24772860,-1.5922871326648207
BT 330,119182,-0.5764948998791074
TE 617.T,53495165,-2.1817272104035537
LNCaP clone FGC,11964036,0.9277079727850748
SNU-1214,5702613,4.390712346710364
BT 330,2130404,4.448251197584531
KMS-20,375860,-0.5673020428522673
Ku812,56963564,-0.7269120722317722
KMS-27,9823820,3.714575222743397
HEC-151,71304818,2.2040931123668357
TE 617.T,2828334,5.85541447916693
LNCaP clone FGC,5328940,2.0473459597054258
EJM,409805,3.072892420926549
NU-DHL-1,54678924,1.1302571335689575
PaTu 8988s,53232,5.199955962685543
CML-T1,17755052,2.353347963272661
HARA [Human squamous cell lung carcinoma],439501,-2.358364257130844
HMCB,10113978,4.0112336544376435
NCI-H1092,navitoclax-PLX-4032 (1-1 mol-mol),1.5069536319364394
RPMI-7951,BRD-K13185470,4.283548482725321
SEM,54678924,1.6439221988057715
PE/CA-PJ34 (clone C12),9823820,3.875484528440309
AU565,2842253,5.995707097044385
KMRC-2,25262965,-2.17943777957922
HEC-151,9911463,4.0043305736729105
CA46,4261,-0.8863355705331979
HSC-4,11625818,4.485436042124793
PaTu 8988s,5284616,5.504271391115589
Hs 683,6917907,-5.495645682266978
BT 328,135875424,3.085389187382682
SET-2,322968,2.0480585516644014
RERF-LC-Ad1,11427553,3.528122025886616
NU-DHL-1,decitabine-navitoclax (2-1 mol-mol),-3.2385891621120786
BT 328,16725315,5.116957818378766
D283 Med,44185566,1.0704577587111352
OE21,46926350,-5.252070355990055
PE/CA-PJ34 (clone C12),216239,3.0316915626145726
Hs 683,6438330,3.1088945001228945
PaTu 8988s,44185566,2.1261231703862324
NCI-H1092,BRD-A02303741-navitoclax (2-1 mol-mol),2.482084229088134
NCI-H1092,25105715,3.7576457289964416
NU-DHL-1,57519531,1.3873329303321325
Raji,10184653,4.239843890669247
NCI-H2081,44197249,1.2499480792075393
NCI-H1092,BRD-K55473186,3.7509315405702224
YKG-1,24180125,3.6126357196897496
BT 139,BRD-K55473186,3.20697937041343
Ku812,51037431,1.3532968628760291
LNCaP clone FGC,71304818,1.9992076453215637
SW1990,25105715,3.6419570585511063
TE-15,2858523,3.0581585072874313
A4/Fukuda,23635314,-5.004930640559638
PE/CA-PJ34 (clone C12),25227462,0.7769258738291116
Aska-SS,11977753,-0.7258583648361356
NCI-H2172,446155,4.098751908168383
NU-DHL-1,53392493,1.5644562418702903
NU-DHL-1,9887053,0.6312128826435269
NCI-H1395,2708,5.386847702037966
LoVo,11222830,1.6500045227885836
MM1.S,2828334,5.0723954602187735
AN3-CA,42642645,-0.9169147434440384
RERF-LC-Ad1,11222830,1.8540425304510488
AN3-CA,25262965,-4.540862032837182
RERF-LC-Ad2,11222830,1.7233775029483531
OE21,3038522,1.96217261831384
KYSE-410,24978538,2.729267614475142
PaTu 8988s,6610355,3.7428320904728607
SNU-1033,135421197,1.1443309651958211
SNU-1033,71680916,4.277496611581877
CML-T1,44489367,4.494553632990814
KYSE-410,4917,3.010113303817647
Hs 683,25183872,-0.3449669069687002
HSC-4,54143018,5.46718478704898
OE21,322968,4.800040293873742
Hs 683,445643,3.970374608486991
RPMI-7951,16038120,0.7557486439637527
RERF-LC-Ad1,54618771,3.6047591405088673
A4/Fukuda,10074640,2.009206402328629
EJM,25154868,4.2554852921408415
YKG-1,56649450,3.459902550410693
HCC2218,9915743,-6.199285187365854
BT 248,6918638,2.3802175448525844
BT 330,421610,2.3539293685640357
OE21,1641662,3.2639680960542012
ML-1 [Human thyroid carcinoma],54618164,4.279062995535924
NCI-N87,387447,-5.408237770865747
HMCB,tanespimycin-gemcitabine (1-1 mol-mol),0.8879400812338334
CML-T1,6918736,-1.6116924986143133
NCI-H2081,9549297,1.131692292209531
MCAS,11626560,1.9624316490643523
RERF-LC-Ad2,54618771,1.6045253072760792
SNU-1272,16725315,4.676116134552396
BT 248,navitoclax-birinapant (1-1 mol-mol),0.9680614151724524
SW1990,16725315,3.443689747487624
RERF-LC-Ad1,15983966,3.1811444894910896
SNU-1214,navitoclax-MST-312 (1-1 mol-mol),0.6097742809788183
KYSE-410,16736978,1.1524112302725302
GOS-3,6914657,-2.554831261851343
GOS-3,doxorubicin-navitoclax (2-1 mol-mol),-1.4068563769280584
LoVo,11214940,1.900565531770479
HSC-4,6852167,2.6632521076475446
PaTu 8988s,10302451,4.079091129858146
Hs 683,16219061,3.2988722475842303
SNU-1033,tanespimycin-bortezomib (250-1 mol-mol),-1.1601474483832803
CML-T1,3025986,-2.237853890359125
EJM,11175137,3.135182491748147
KMBC-2,3081361,3.23383852332178
SET-2,5311037,4.060144880616426
SNU-1033,637858,1.4383513056323138
CA46,56649450,3.397645307363617
KMS-27,36314,-5.123625139779761
AU565,44462760,4.31661778136252
LoVo,89928392,0.5944678691764933
HARA [Human squamous cell lung carcinoma],navitoclax-birinapant (1-1 mol-mol),1.3986072497708624
SEM,54618795,1.733111871979466
BT 139,selumetinib-UNC0638 (4-1 mol-mol),5.570827080630345
OE21,1750826,1.9997604925130417
SNU-1033,54618795,3.158688402051182
NCI-H2081,135440466,3.0899746157429173
SEM,carboplatin-etoposide (40-17 mol-mol),-1.5762350099115583
Hep-G2,285033,2.524821694424631
PaTu 8988s,11640390,0.9509340120197388
RERF-LC-Ad2,5329102,2.745960476689009
SKM-1,8515,1.7539525603020008
SEM,2945648,0.1615373734566605
SNU-1033,10385095,1.019137651596638
LNCaP clone FGC,44491742,3.7255423914895776
BT 248,445643,3.6752138638176057
Ku812,451668,-0.4735095751840026
ML-1 [Human thyroid carcinoma],24748573,2.352453339172467
HMCB,25062766,3.4032091718136543
Kasumi-2,SNX-2112-bortezomib (250-1 mol-mol),-2.9653989283259805
YKG-1,2733526,4.337499984532551
Kasumi-2,3025986,-2.1480582997040325
Hs 683,5738263,2.557969884365718
SEM,4917,2.902637653661685
NCI-N87,156414,-4.435299577962505
MCAS,387447,-5.167136486263057
Ku812,72193861,-0.3622836093760774
NCI-N87,11228183,1.1576925814137384
BT 328,5566,3.1707222601804803
KMS-20,67156097,-1.6945401630297232
IST-Mes1,5328940,2.5729000547912397
SW1990,selumetinib-JQ-1 (4-1 mol-mol),1.814683670817831
KMS-27,selumetinib-vorinostat (8-1 mol-mol),-1.5585431850605205
ML-1 [Human thyroid carcinoma],5287620,-1.9113881956575816
Raji,5278396,3.201743093215407
NCI-N87,11656518,1.4544081811160725
Ku812,135411,-0.2793980307615341
NCI-H2172,10296883,3.8919469305692256
HSC-4,64971,1.7199562834608897
KMS-20,3025986,-0.9941815226128248
CA46,60700,-1.6899904219212585
KYSE-410,126941,-0.1479111087820589
Kasumi-2,25126798,3.908076551751955
Hs 683,15547703,3.207902462535534
EJM,10184653,1.0173463538393004
SW1990,6450551,3.4368390730521203
NCI-H2110,54618305,4.481600360500252
BT 330,9967941,3.1248823788428
SNU-8,969516,2.7797463612145017
SNU-308,selumetinib-navitoclax (8-1 mol-mol),2.9333493766077
KMS-20,11222830,0.8671541561907014
Ku812,3062316,-6.759416676198835
CA46,285033,-4.358161131916293
KMS-20,54596558,3.850002617797552
PE/CA-PJ34 (clone C12),23582824,0.3149365494632303
LNCaP clone FGC,2874250,4.6479769678530385
Hs 683,piperlongumine-MST-312 (1-1 mol-mol),1.8550922989500056
HSC-4,6918878,5.2813290465493505
SEM,1317464,3.839801567359689
HMCB,24821094,3.404555238372124
KYSE-410,123631,1.1616708404794314
PaTu 8988s,decitabine-navitoclax (2-1 mol-mol),1.4226472466211717
SKM-1,3062316,1.7707772464859106
NU-DHL-1,3081361,1.944566373471897
PaTu 8988s,6914657,-2.9857558603888124
YKG-1,54454,1.2493986655314475
OE21,45100481,5.232894765925204
AN3-CA,44137675,1.4304677853789944
SNU-1033,44589607,3.2892143664644142
PE/CA-PJ34 (clone C12),3081361,0.8218652425695582
NU-DHL-1,4096211,0.6464919825454908
LoVo,carboplatin-etoposide (40-17 mol-mol),1.7816353489464614
BT 139,44137675,3.208547495705803
BT 328,135398744,6.520469371663204
MCAS,40482356,5.123729097421837
KMS-27,216239,2.2357433386354613
CA46,11238147,1.5462987380530164
LoVo,selumetinib-BRD-A02303741 (4-1 mol-mol),1.3489379302549531
ML-1 [Human thyroid carcinoma],136227331,5.904689393841422
RERF-LC-Ad2,51037431,5.373275241569261
CA46,123631,1.9024335998312112
SNU-8,6852167,2.9028412896879856
NCI-H2110,216345,4.506742036788765
TE 617.T,23725625,4.689900861752102
ML-1 [Human thyroid carcinoma],19582717,3.041392892734857
MM1.S,23635314,-2.389508847734426
ML-1 [Human thyroid carcinoma],9825149,3.1128843906344117
Kasumi-2,44486219,4.4104720165674145
OE21,4477,0.4795387541776513
TE 617.T,252682,6.17928013673487
KMRC-2,54618305,4.826508920504646
YKG-1,10231331,5.270675851444794
D283 Med,11494412,-0.6782080211757803
Aska-SS,5566,2.9883753994933335
CML-T1,2742550,2.9758871773228366
RERF-LC-Ad2,15983966,2.6001101676234644
AN3-CA,51039095,-0.7477898547965632
RERF-LC-Ad2,11964036,2.3866453788190034
IST-Mes1,24180125,3.710624760267412
RPMI-7951,8515,4.057754260895621
YKG-1,71466578,5.303115926973424
KMS-27,6917907,-6.097066724901309
HARA [Human squamous cell lung carcinoma],448949,2.536052822584039
MM1.S,16720766,-1.4015692069091197
AU565,71751553,3.982904849419344
Hep-G2,JQ-1-UNC0638 (2-1 mol-mol),2.605795560708836
D283 Med,89928392,0.7177145922675237
LNCaP clone FGC,51037431,3.363500928465347
Hep-G2,11427553,2.5788240600315686
NCI-H2172,5351362,3.0006177485677044
BT 330,11364421,1.7373568839489189
A4/Fukuda,decitabine-navitoclax (2-1 mol-mol),-0.552282956789893
NCI-H2110,19582717,3.427888450014282
RPMI-7951,4477,0.5653184124970599
Ku812,11228183,0.9929327430500092
BT 139,216345,2.003802202628343
RPMI-7951,82146,4.419432545694383
CA46,tretinoin-navitoclax (4-1 mol-mol),4.197829514755647
IST-Mes1,6918837,-3.247555275823077
TE-15,135398516,2.5916064538875188
EJM,6917907,-6.067792190523033
AN3-CA,11964036,1.072172858204418
HARA [Human squamous cell lung carcinoma],11222830,1.4006503885864872
TE 617.T,156414,-2.5018662250676713
HEC-151,15983966,-2.399363351088112
NCI-H2110,241158,3.1912359933366465
OE21,2749,1.218654717399713
AN3-CA,25126798,3.0603028688799077
LNCaP clone FGC,136227924,2.6855023326383387
LNCaP clone FGC,9840324,4.693814425253386
SNU-8,10231331,0.8787847787611084
SKM-1,446155,3.079957129001659
CA46,46843906,1.200591966763502
SNU-308,53232,3.288372850050381
CML-T1,5335621,4.035243944386916
Kasumi-2,5278396,3.160923329427041
YKG-1,5951923,5.422075002317939
RPMI-7951,3038522,3.102178458058184
HMCB,serdemetan-SCH-529074 (1-1 mol-mol),2.4925748009554938
KYSE-410,82146,4.878809212200983
SEM,2871966,-1.3459801337867392
NCI-H1395,54618305,4.493399620925908
LoVo,SNX-2112-bortezomib (250-1 mol-mol),-2.7337701225380786
SNU-1272,5746,2.042902676289699
NCI-H2081,3136844,3.846689018483167
HSC-4,65628,3.12205826618997
HMCB,2749,2.739693517527312
SNU-1033,448949,2.2538788240200724
CML-T1,71466578,2.784294880886227
ML-1 [Human thyroid carcinoma],65064,4.907366569161651
LNCaP clone FGC,53325874,5.102870442920095
SNU-308,selumetinib-piperlongumine (8-1 mol-mol),6.364021070075463
YKG-1,3634881,3.332049721322664
SET-2,6918328,-2.5220109859531497
BT 248,53232,4.253838861384023
SET-2,11955716,-2.510198617741863
OE21,10302451,0.4947890408637831
NU-DHL-1,6610355,3.4648292160050373
RERF-LC-Ad2,5311,3.206144053941421
AN3-CA,44241473,5.120578762393663
PaTu 8988s,15983966,3.43832073761555
SNU-8,3025986,-0.8610390713696733
OE21,selumetinib-JQ-1 (4-1 mol-mol),-0.1930020472631329
SET-2,5278396,3.705713194683595
SKM-1,3825829,2.28297195030611
AU565,6918328,-1.0169109160359904
Kasumi-2,9927531,4.453654232617923
NCI-H1395,10113978,4.152681883448846
SW1990,6914657,-2.9873541347075774
SW1990,12001922,2.3012891946870866
D283 Med,3503,1.294693501027344
BT 248,53481919,4.127258509947241
OE21,5287620,-2.6065865417872205
RERF-LC-Ad2,5287620,-2.1666968362828274
KMS-27,9868037,2.1445614612253614
KMRC-2,16725315,5.308613938847766
AU565,erlotinib-PLX-4032 (2-1 mol-mol),2.347179893247943
SEM,71576739,-1.1799480290235729
SET-2,3384730,2.0546342840453216
BT 330,2126,5.626411128120884
SNU-308,24951314,1.7440964726968256
KYSE-410,10074640,2.973181094557615
PE/CA-PJ34 (clone C12),72193861,0.4823673810594518
IST-Mes1,126941,-2.6873860553959754
CA46,JQ-1-navitoclax (2-1 mol-mol),-0.4595467452216603
D283 Med,135398738,4.108910630376311
LoVo,25183872,-1.0423877479811554
OE21,46907787,0.1329558963792394
HARA [Human squamous cell lung carcinoma],11317348,1.2268055094863417
MCAS,44185566,2.861754795019825
HEC-151,54618771,1.151174886462992
SKM-1,15953870,2.3750866132882305
NCI-H2110,tanespimycin-bortezomib (250-1 mol-mol),-2.8330652513678274
SNU-1214,11507802,1.140140670038604
BT 330,54618164,3.911280393833352
RPMI-7951,54454,1.921047833616469
SW1990,3136844,6.37521146697811
SW1990,568763,-0.2089680591537602
KMS-20,51039095,1.9722708258577504
A4/Fukuda,3825829,2.918538307685252
SW1990,984333,1.0677771030068235
BT 248,3062316,2.7315660903773606
Hs 683,6918328,0.6076463522681637
SW1990,12003241,-1.6004272332343192
HSC-4,selumetinib-PLX-4032 (8-1 mol-mol),3.794219924107932
SW1990,45100481,5.275366410533853
D283 Med,3634881,2.480961702066835
KYSE-410,JQ-1-vorinostat (2-1 mol-mol),1.3768131521604037
SNU-8,44589607,2.595559159087893
EJM,11494412,-0.937899289743814
SET-2,445455,4.086945585806047
BT 248,16725315,3.27587483179283
NCI-N87,selumetinib-UNC0638 (4-1 mol-mol),3.172064031081815
TE 617.T,6852167,3.448270243983474
SW1990,6918328,1.0030891487677016
NU-DHL-1,24821094,1.4406945146133665
BT 248,54618795,3.2071840181570477
BT 328,42642645,1.526904383487112
Hep-G2,3025944,3.632600142557463
NCI-H1092,vorinostat-navitoclax (4-1 mol-mol),0.5832215278438359
BT 139,3634881,2.542487141086037
AN3-CA,54678924,1.6198465889937177
NU-DHL-1,10322450,3.582925513183909
SNU-1033,49836020,1.7840304926095434
LNCaP clone FGC,374536,-0.7618428530873494
SNU-8,9911463,4.350153434001515
Hs 683,6450551,2.938905151489075
SNU-8,piperlongumine-MST-312 (1-1 mol-mol),1.6623284799155622
NU-DHL-1,3634881,1.5922727518374944
PE/CA-PJ34 (clone C12),168313200,2.559397227720179
SNU-8,6438330,2.278299075946909
KMRC-2,vorinostat-navitoclax (4-1 mol-mol),1.1989801526794588
HMCB,tanespimycin-bortezomib (250-1 mol-mol),1.0972296557807748
NU-DHL-1,151289,0.4356808259590597
SEM,3384730,-0.188183167842947
BT 330,selumetinib-UNC0638 (4-1 mol-mol),4.0092554620462835
SNU-1033,387447,-4.464166548944418
NCI-H2081,19582717,3.032200893690187
Ku812,71466445,2.9617943038056858
EJM,16038120,0.4172376538699918
SET-2,54618305,3.97030944643435
HMCB,54618771,0.8772324111806863
SET-2,448949,1.065059148438568
Hs 683,5281321,-2.3150031498918495
IST-Mes1,tanespimycin-gemcitabine (1-1 mol-mol),1.7121373731851923
TE 617.T,56946209,-5.04642023755872
LNCaP clone FGC,9903786,4.486079979714403
TE 617.T,54618771,-2.3163435045847436
HMCB,25102847,1.6678693363559989
BT 328,16038120,0.9793977548017024
TE 617.T,9907093,4.051637713465443
YKG-1,5746,3.4716356966928927
AN3-CA,9911830,-0.0740885579254531
MCAS,10302451,3.470287420983729
HCC2218,9803433,5.3162447416903005
SEM,54626689,4.433727990073252
RPMI-7951,72376,-2.0795055355089533
KYSE-410,4521392,4.26682708750012
SET-2,6917907,-5.85452555473126
PE/CA-PJ34 (clone C12),2746,3.651379195242312
YKG-1,3552672,2.1988515508502764
Kasumi-2,73707398,-0.974822208153436
Ku812,44543605,3.7520401009891504
RERF-LC-Ad2,9915743,1.500109019763864
IST-Mes1,2858523,3.245314531932087
YKG-1,46199207,3.7186268028334
Ku812,11455910,-0.1088527514294285
MCAS,3825829,3.968162894586803
HARA [Human squamous cell lung carcinoma],3025986,-0.8541128463962537
BT 330,135928012,3.687683575459301
KMBC-2,4705,2.3520992205272395
EJM,71466380,4.304951400979373
PaTu 8988s,44607531,1.582037029265366
PE/CA-PJ34 (clone C12),24753719,4.157355819781257
SKM-1,3815108,3.188772071922917
TE 617.T,25154868,2.46272579601567
NCI-H2172,2949965,5.543762898620983
HSC-4,10385095,0.4573663196580717
BT 328,148198,-4.14614868661324
SKM-1,11497983,2.969155076814477
KMBC-2,3543504,4.210942018618952
RPMI-7951,441298,2.363553637102318
SNU-8,5281672,3.454491420991977
MM1.S,66577038,3.082546058901061
OE21,4578,4.816064750618817
SEM,71466578,1.2445916775629704
TE 617.T,11238147,1.8250112009941364
BT 330,2871966,0.8536485035302345
BT 139,135875424,2.659641868559938
BT 139,19582717,5.798754830706931
BT 330,11719255,3.5995815229972488
PaTu 8988s,44589607,1.86453426836221
HSC-4,5566,3.1631957469062684
BT 248,3081361,2.663958705985954
NCI-N87,5282054,3.4882884399441125
KMRC-2,66577038,2.988810152223179
HMCB,2113511,5.752921913122264
CA46,15547703,2.518572103836232
OE21,400769,-1.1322682679141538
PE/CA-PJ34 (clone C12),3384730,4.479323787915653
YKG-1,60700,3.1326853541806603
SW1990,54618164,4.162528357630221
LNCaP clone FGC,2733526,4.4157191232054736
CML-T1,24978538,-0.5146505107576096
KMS-20,2749,1.3693937739963689
SET-2,4705,3.0557910229077554
RPMI-7951,71466380,3.6712055122760665
AN3-CA,11609586,3.731629186042926
Raji,135421197,1.3656726509446273
SNU-8,107970,2.3224728440298814
CML-T1,navitoclax-PLX-4032 (1-1 mol-mol),0.956704604832818
RPMI-7951,5287620,-3.1537111028341527
SNU-1272,carboplatin-UNC0638 (2-1 mol-mol),5.070275489272453
HCC2218,16065773,1.4581065516563485
SET-2,9927531,4.801393694643548
Kasumi-2,24856436,-1.5154163657154227
HEC-151,54618305,4.2925699084671525
BT 320,3854666,3.86904800273952
ML-1 [Human thyroid carcinoma],4261,2.09291450929782
Kasumi-2,426756,1.7072417198911318
NCI-N87,76446078,4.157863043796239
A4/Fukuda,9908783,4.281950187885367
ML-1 [Human thyroid carcinoma],3025944,4.339456842576773
CML-T1,107970,1.8137988275945616
LNCaP clone FGC,56963564,-0.1269898531988885
RPMI-7951,123631,2.176055459854137
RERF-LC-Ad2,1641662,4.420593940976066
NU-DHL-1,navitoclax-pluripotin (1-1 mol-mol),-2.727717397237378
ML-1 [Human thyroid carcinoma],25105715,3.821272786179671
NCI-N87,46224516,3.4075734240800624
NCI-H2081,JQ-1-MK-0752 (1-1 mol-mol),1.5845874170404597
AN3-CA,135398516,0.9039138069149286
IST-Mes1,4521392,4.383284740471391
BT 328,navitoclax-MST-312 (1-1 mol-mol),1.0481188204981575
CML-T1,3634881,2.472630922180769
TE-15,6918638,-0.5881050446638335
KYSE-410,2729026,2.3808934175081378
NU-DHL-1,56946209,-8.095759228151296
TE-15,56649450,2.5668764192074898
SNU-8,100016,6.375529183181613
RPMI-7951,126941,-2.8571002343127354
NU-DHL-1,11404337,-3.826325924415509
KMS-20,148198,-4.371887061655697
SEM,25195348,3.192775666849986
AN3-CA,44185566,2.983350323486881
KMBC-2,2828334,6.082053545971173
ML-1 [Human thyroid carcinoma],9911830,3.383108057822615
HSC-4,selumetinib-GDC-0941 (4-1 mol-mol),1.9348378913345816
SNU-8,24901704,4.345339239210362
SNU-1033,53392493,1.6848356880137518
HCC2218,11455910,0.1685104412294276
GOS-3,11214940,1.8063167684007233
EJM,11507802,0.5924902988751046
KMS-20,selumetinib-BRD-A02303741 (4-1 mol-mol),1.4575031822908706
BT 320,16065773,4.123538520669632
NCI-H1092,60700,-0.3122141816941802
NCI-N87,54454,3.669804409798402
GOS-3,24821094,3.805948767285243
NCI-H2081,5281321,-4.529040765604765
Kasumi-2,31703,-3.912318367279324
ML-1 [Human thyroid carcinoma],25262965,-1.8922435286727564
TE-15,16013152,5.11463322397938
D283 Med,10184653,1.6755426612344793
Kasumi-2,11317348,0.9834435800612674
SNU-8,11404337,-0.4750422228003279
CML-T1,6438330,0.4811462042672619
KMRC-2,9952709,4.468026604525415
Ku812,400769,-1.4290125405795582
Aska-SS,227681,3.9388192472577175
LNCaP clone FGC,6918736,-2.2970648149141475
ML-1 [Human thyroid carcinoma],vorinostat-carboplatin (1-1 mol-mol),2.0705525470951587
OE21,11234052,4.474728947098881
SW1990,219104,4.210148447482214
SNU-308,15983966,2.358099109597309
HCC2218,10322450,3.115665598848324
HCC2218,9868037,3.0911136075501253
EJM,6450551,3.4833257379535967
PaTu 8988s,11222830,1.69695662081358
NCI-H2110,400769,-0.3675284283858097
PaTu 8988s,2729026,2.6444658169673914
KMBC-2,24964624,3.269942985008608
RPMI-7951,5746,-1.3005105178038452
D283 Med,9884685,0.4652080192462777
HARA [Human squamous cell lung carcinoma],BRD-K27188169-navitoclax (2-1 mol-mol),2.401020533417727
TE-15,selumetinib-GDC-0941 (4-1 mol-mol),1.395228567811366
KMS-27,12003241,-0.3161890721272481
PaTu 8988s,56963564,0.8100228770040716
NCI-H1092,11404337,-0.107357005094737
SNU-8,6623618,2.2752999138216103
PE/CA-PJ34 (clone C12),67156097,-1.858213748948673
RERF-LC-Ad1,17759555,3.957571120556156
CML-T1,51037431,4.458839280310569
KMS-20,54618164,3.4319678497850705
YKG-1,25062766,3.484547068129602
IST-Mes1,JQ-1-carboplatin (1-1 mol-mol),0.3758398512274805
NCI-N87,241158,3.56045646229574
CML-T1,445643,3.3065494006722327
SNU-8,2113511,5.362037141803559
BT 330,9887053,2.636361390531868
ML-1 [Human thyroid carcinoma],72193861,1.5092085092070135
NU-DHL-1,6852167,1.5672236440525231
IST-Mes1,5329102,1.6787488330100182
LNCaP clone FGC,44543605,4.499692025996323
CA46,53495165,-3.0280125025934495
Aska-SS,219104,2.9804042619186433
Ku812,2945648,2.863676297745722
SNU-1214,89928392,0.5360423871118476
SET-2,135659046,3.4006834919950006
SEM,57519531,1.3518150272189275
SW1990,sirolimus-bortezomib (250-1 mol-mol),0.2169201029218291
AU565,11647372,-0.7623159020318493
SEM,24821094,2.5010829781969774
KMS-20,11647372,-0.2518820801437051
Hs 683,46224516,1.0817542389140755
SEM,9903786,1.5227669871926164
CML-T1,12001922,1.44047939392769
KMS-20,168313016,2.502907983030332
EJM,252682,5.970760325898544
CML-T1,6918837,-4.73728443815153
TE-15,16065773,3.2085213823347094
CML-T1,decitabine-carboplatin (1-1 mol-mol),-0.978509690631207
Hs 683,navitoclax-gemcitabine (1-1 mol-mol),-1.976153895418953
ML-1 [Human thyroid carcinoma],124202324,2.283804161098842
EJM,serdemetan-SCH-529074 (1-1 mol-mol),2.152068500257776
MCAS,24889392,4.880860270636762
HMCB,19582717,4.963972584535481
HEC-151,54143018,-0.0525941697067482
Hs 683,7326481,2.8848658644574803
A4/Fukuda,24180719,2.900503133545593
AU565,12003241,-0.6235660341918571
GOS-3,135999136,4.682109520485855
NCI-H2081,54639701,4.415769472543696
BT 139,3038522,2.270920869321994
Hs 683,2130404,3.573514599351806
NCI-H1092,11494412,2.17753949415027
NCI-H2081,vorinostat-navitoclax (4-1 mol-mol),0.2731238832512092
NCI-N87,148198,-3.7864178683693774
KMRC-2,25105715,3.6980162207420126
NCI-H2081,24856436,-0.1244268039061882
MM1.S,3503,2.4888642007911175
TE 617.T,6918736,-0.5588786583625035
MM1.S,16722836,0.4655451922698376
KMS-20,selumetinib-PLX-4032 (8-1 mol-mol),2.2500774116215196
YKG-1,25126798,4.0055488213659185
A4/Fukuda,6852167,0.513003696591474
TE 617.T,3503,2.650146151665676
NCI-H2110,sirolimus-bortezomib (250-1 mol-mol),0.8725557491519701
LNCaP clone FGC,44202524,1.406144438084138
A4/Fukuda,selumetinib-tretinoin (2-1 mol-mol),0.1306282538246569
PE/CA-PJ34 (clone C12),selumetinib-MK-2206 (8-1 mol-mol),1.6855089164633987
AU565,11955716,1.5670888997114951
HEC-151,46943432,3.433057061661308
TE 617.T,selumetinib-vorinostat (8-1 mol-mol),2.763602035928325
SNU-1272,10184653,2.951340324734288
EJM,73707398,0.7642029358076543
HSC-4,navitoclax-pluripotin (1-1 mol-mol),0.2476370471109345
SNU-1214,9903786,2.1258190574569955
PE/CA-PJ34 (clone C12),89928392,1.3443265924415142
KMS-20,15983966,1.6874259889880727
A4/Fukuda,9907093,3.513986602103764
NCI-H2081,107985,-4.4331361775732905
HARA [Human squamous cell lung carcinoma],89928392,1.691456490518517
RERF-LC-Ad2,119607,5.953581699586958
MM1.S,15547703,2.467235317270649
OE21,5282054,3.887024213871436
IST-Mes1,10127622,4.960728342788448
SNU-308,UNC0638-navitoclax (1-1 mol-mol),1.6647275742348495
RERF-LC-Ad2,2746,5.029161088145208
NCI-H2110,56649450,2.75917742246227
TE 617.T,71751553,3.9067894428896928
LoVo,9903786,0.6551100591729495
Ku812,24901704,-0.4203026454288152
TE-15,25150857,2.8317844054679977
RPMI-7951,702558,5.239771710086362
NCI-H2110,969516,2.600500497982865
HARA [Human squamous cell lung carcinoma],5113032,5.077717215414557
KYSE-410,9926054,2.1669765108653483
BT 248,753704,4.567621051188063
BT 328,136227331,5.061934875267611
KYSE-410,2949965,3.144048608876155
NU-DHL-1,168312962,2.5247820941481183
Raji,44589607,2.4455053114760084
Hs 683,9911463,3.853379830397607
Raji,6610216,4.035753851614817
CA46,56963564,-0.0544830399645368
KMS-20,16065773,1.6920071988630498
RPMI-7951,439501,-2.4869379045692313
CML-T1,89183176,3.024950752568636
A4/Fukuda,322968,1.909418940393303
AU565,26596,-1.0644098452654434
Raji,11404337,2.5048803156599586
BT 139,5394,4.451617966192458
HSC-4,docetaxel-tanespimycin (2-1 mol-mol),1.367923691324148
RERF-LC-Ad2,753704,5.049271110646248
CA46,10322450,2.6264913036213606
Hep-G2,11625818,5.989869211242665
Aska-SS,5460769,3.7674682150871552
KYSE-410,5278396,3.492812084650607
BT 328,448949,2.700509720099411
SW1990,31703,-0.7858843712781126
NCI-H1092,72193861,1.411805795615286
HSC-4,56949517,4.34052816497715
EJM,2858523,3.0050440424582554
SW1990,BRD-A02303741-navitoclax (2-1 mol-mol),5.14877156626653
LoVo,44137675,-1.419079349485425
NU-DHL-1,2842253,5.839459621103588
KYSE-410,159324,2.9190840710884385
PE/CA-PJ34 (clone C12),4917,3.437342838485429
SW1990,9825149,2.486018157354109
KMS-27,2858523,2.831836362446579
OE21,16013152,5.5838435912248015
Hs 683,navitoclax-pluripotin (1-1 mol-mol),0.0441092724696649
AN3-CA,26596,-3.5868272426759584
NCI-H1092,44489675,3.6172638586076937
BT 139,JQ-1-vorinostat (2-1 mol-mol),1.3408990308759607
PaTu 8988s,24951314,1.7139060752195443
PE/CA-PJ34 (clone C12),navitoclax-pluripotin (1-1 mol-mol),-0.3375022038968858
D283 Med,44137675,1.6630116690363648
NCI-N87,46199207,2.9512504868324565
SET-2,15953870,2.8793590754908926
KMS-27,decitabine-carboplatin (1-1 mol-mol),3.5592603787119472
CML-T1,BRD-K03911514,3.1384749532861234
MCAS,44491742,4.8173197109659
Hs 683,tanespimycin-bortezomib (250-1 mol-mol),-2.2425112205370388
RERF-LC-Ad2,89928392,1.2500542472683187
OE21,11626560,1.5106981785877758
Ku812,selumetinib-navitoclax (8-1 mol-mol),-2.189866116629726
BT 330,46224516,1.677739394435492
KMS-27,168312962,-1.5157440270086788
HSC-4,navitoclax-piperlongumine (1-1 mol-mol),2.6552743905338905
BT 320,9933475,3.009143992406663
NCI-H2081,46199207,1.540391568515102
CA46,53481919,3.755788894439918
LNCaP clone FGC,2746,2.220031738697338
PaTu 8988s,46191454,6.477602463627896
Ku812,10074640,-0.7535750701578889
TE-15,445643,3.9755663234454
Hs 683,65064,5.005451582048715
TE 617.T,16736978,1.1800461581216122
RERF-LC-Ad2,selumetinib-UNC0638 (4-1 mol-mol),4.427730153317547
BT 330,24964624,1.4419629083261656
HCC2218,135421197,0.9685735875874713
LNCaP clone FGC,1566236,3.496775804541155
LNCaP clone FGC,24821094,3.724025510090393
KMS-20,53393127,3.681479767939244
SEM,23582824,0.9375364224327816
D283 Med,4477,-0.1925528209177479
Kasumi-2,vorinostat-navitoclax (4-1 mol-mol),-2.345570206946048
HSC-4,124202324,2.961748327308983
CML-T1,3854666,0.73725489161191
RERF-LC-Ad2,262093,2.9385372389092197
TE 617.T,25183872,-1.615385706309996
HSC-4,2746,3.845189406581069
TE-15,44607531,0.6290395295712479
HCC2218,9887053,4.291749578436511
YKG-1,6917907,-5.4818958682637975
Ku812,11964036,0.5319973253616799
SNU-1033,19582717,3.722098743560197
CML-T1,6914657,-6.7918120052462685
SNU-1214,3854666,1.2717797575016767
OE21,10074640,2.6390698783302025
TE 617.T,168312962,2.958125582565616
EJM,46224516,1.5336479152215143
BT 248,2871966,0.7814721484275546
SKM-1,65064,4.990027609519168
PE/CA-PJ34 (clone C12),89183176,5.81670990965372
YKG-1,11719255,4.471587264464231
CA46,24785538,1.2011715151517115
NCI-H1395,6918328,1.6549046673815768
OE21,selumetinib-tretinoin (2-1 mol-mol),0.421110586770226
LNCaP clone FGC,4261,0.6571905831455885
SET-2,11507802,0.9446717198166472
KMRC-2,1750826,-1.9203371760077488
NU-DHL-1,11625818,2.715961384338104
LoVo,11152667,-3.1828514843907967
HMCB,crizotinib-PLX-4032 (2-1 mol-mol),2.393956445339111
Aska-SS,17755052,-1.6126335800222398
IST-Mes1,31703,-0.6384703159849433
RPMI-7951,46398810,2.059588562452404
ML-1 [Human thyroid carcinoma],selumetinib-decitabine (4-1 mol-mol),4.367801531941202
HEC-151,16736978,1.2843209009698278
KYSE-410,54649381,4.165413744231657
SNU-1214,3825829,4.190729041400542
NCI-H2081,60700,-2.8603020139497115
SET-2,selumetinib-UNC0638 (4-1 mol-mol),2.5429931364421603
KYSE-410,156414,-0.3480069289117364
Hs 683,11222830,1.737895244343142
AN3-CA,11396600,4.58709626361668
TE-15,72376,-1.582377580745315
SNU-8,5329102,2.2855954751690692
IST-Mes1,72193861,3.6955595837075137
RPMI-7951,5280436,3.8526287980581264
SKM-1,15547703,2.340856724788066
Hep-G2,10427712,4.820719836314107
NCI-H1092,5287620,-3.3437578986524517
NCI-N87,9926054,1.7069639615174013
LoVo,navitoclax-piperlongumine (1-1 mol-mol),1.788433807521411
OE21,16722836,1.695900510061296
SKM-1,navitoclax-MST-312 (1-1 mol-mol),0.2103824065609011
Hs 683,135411,0.700670072035792
EJM,71751553,6.47545049455161
SNU-1214,107985,-3.75427796779674
A4/Fukuda,12001922,1.2276815023009988
BT 248,4378219,1.4454405763629643
NCI-H2110,3136844,5.069664376003593
HSC-4,11234052,4.4583786214563865
KMRC-2,445643,4.176265931710495
HSC-4,72199292,2.0552941548988506
MM1.S,241158,2.058054746242757
MM1.S,tretinoin-navitoclax (4-1 mol-mol),4.414459370094276
AU565,3854666,0.9438607721687704
Hs 683,26596,-1.91567083647516
SET-2,selumetinib-vorinostat (8-1 mol-mol),0.6611589487965128
CML-T1,11656518,-0.3565307280161567
TE 617.T,46398810,1.6357636391747654
BT 139,1750826,1.464250627384646
Hs 683,3025986,-1.4982466986527858
ML-1 [Human thyroid carcinoma],285033,-2.470992399828971
PE/CA-PJ34 (clone C12),126941,-0.8332093183770951
KMS-20,4096211,1.0816474439893842
KMS-27,10184653,1.6525430220853072
PaTu 8988s,tanespimycin-gemcitabine (1-1 mol-mol),-1.822995270028692
NCI-H2081,44607531,1.066204155267354
YKG-1,9933475,2.2328524578213007
HEC-151,168313047,2.403687455264255
BT 139,11485656,3.131336333287838
NU-DHL-1,9803433,4.595964480668706
TE 617.T,11612883,2.497162119511236
PaTu 8988s,44607530,2.1258058161075226
TE-15,9884685,1.0908801329755264
SW1990,16720766,0.6444202452308027
MM1.S,11626560,0.5945750260073711
MM1.S,46199207,3.245764113166512
Hs 683,135423438,3.058302675128977
IST-Mes1,JQ-1-navitoclax (2-1 mol-mol),-0.6205173891711487
OE21,6917907,-6.174409961475981
GOS-3,637858,2.327239346274226
RERF-LC-Ad1,doxorubicin-navitoclax (2-1 mol-mol),0.6040282925735914
HEC-151,613753,3.2816732653219636
NCI-H1395,54626689,4.483963070109989
HCC2218,445455,5.240101293913752
CML-T1,71466380,3.6658800118854673
Aska-SS,135398516,1.3915584627152666
EJM,17755052,2.369354031148252
NCI-H2172,54618305,4.356498397814067
CML-T1,4259181,-0.9247208790621684
SEM,JQ-1-MK-0752 (1-1 mol-mol),-2.5626704583038276
HEC-151,44607531,1.801754904846464
TE-15,176870,0.8443195231211779
SNU-308,16720766,0.3051642754670216
CML-T1,11152667,-2.6898641024331584
HSC-4,56946209,-4.10163917558625
LoVo,25062766,1.8850615394111836
MM1.S,4788,5.213003022570621
D283 Med,135999136,3.641764348590375
BT 248,JQ-1-vorinostat (2-1 mol-mol),2.5830463890167064
PE/CA-PJ34 (clone C12),crizotinib-PLX-4032 (2-1 mol-mol),2.0573857462256124
SET-2,25105715,3.703330817780227
NCI-H2081,25183872,-2.502554706433877
NCI-H1395,11228183,4.844045820829891
NCI-H2110,SNX-2112-bortezomib (250-1 mol-mol),-2.488327500904662
TE 617.T,9887053,1.3952225168172891
HEC-151,148198,-1.7915860378087891
OE21,24180125,3.3854112835406625
SNU-1214,2858523,2.9431030962515132
HSC-4,24775005,4.677905847548428
SNU-308,3062316,0.6997417325646793
TE 617.T,10322450,3.863383234066746
RPMI-7951,11485656,2.1770384312644246
LNCaP clone FGC,445455,4.814735127711645
MM1.S,25154868,3.9012655265230127
BT 328,selumetinib-navitoclax (8-1 mol-mol),1.1111417470564258
BT 328,6450551,3.790902491385394
OE21,44185566,1.237363329886175
KMS-27,4788,5.2861405054010975
NCI-H2110,5291,3.663817127631551
NCI-H1092,3854666,1.7831562708521254
Hep-G2,44819697,0.0700800273928934
NCI-H1395,53495165,1.995718788623105
MCAS,46199207,3.5595414630698152
TE-15,25227462,-1.6172386739041076
A4/Fukuda,3552672,1.9607713184754867
Aska-SS,49766530,-1.4586728518943333
BT 248,46398810,1.9244684206215508
KYSE-410,6918328,-0.1647605185632367
KMRC-2,24180125,1.140997225837335
HCC2218,400769,-0.8822322308261966
Ku812,426756,5.933292752952192
HEC-151,135875424,3.433906350348657
OE21,36462,4.517672973298236
NCI-H1395,72199292,3.1887982930787575
OE21,10296883,3.8232218432120058
NU-DHL-1,4788,5.7470913378244
SEM,53392493,1.476252706272148
Kasumi-2,11152667,-1.6921100461719016
HSC-4,66577038,3.591157601556467
KMRC-2,16038120,1.2280873757091175
SNU-1214,6852167,3.35319741255355
MM1.S,11364421,-5.91278520312213
ML-1 [Human thyroid carcinoma],5311281,2.103239185945236
NU-DHL-1,6918878,-0.9557667101081658
HCC2218,439501,-2.1463275405716495
SNU-8,637858,2.315225412035183
RPMI-7951,136227924,2.219680452566263
OE21,10127622,2.1709622508475657
SNU-1214,46398810,2.1577623807495745
NCI-H2081,54618164,3.631207373775394
HCC2218,72734382,3.781656999997794
YKG-1,11404337,0.7038073229533129
SW1990,11485656,1.987828191145096
LoVo,135398516,0.8347424818537327
SNU-308,3825829,4.765268226018265
ML-1 [Human thyroid carcinoma],4521392,4.335063435629941
OE21,11175137,1.6816702571856903
HSC-4,2949965,3.8536489984175097
IST-Mes1,5287620,-1.7840398419727848
BT 328,selumetinib-GDC-0941 (4-1 mol-mol),2.0917542081125067
OE21,tanespimycin-gemcitabine (1-1 mol-mol),-1.4888613002009743
KMS-20,11640390,0.2250858855689749
Ku812,6438330,1.0615071756734653
LNCaP clone FGC,11955716,-2.71802058727311
SNU-8,208908,3.1333693959692033
ML-1 [Human thyroid carcinoma],72376,-3.175400377997246
HMCB,9926054,1.939305093595803
LoVo,54619267,3.1603381625719
ML-1 [Human thyroid carcinoma],3676137,5.53606210778591
Kasumi-2,16725315,3.214174294489856
SET-2,25150857,1.6478785174653998
KMS-27,216345,4.13074054952734
SW1990,11238147,2.1916804245922217
RPMI-7951,135398516,2.029284125204852
CML-T1,16115403,-5.689263243746957
IST-Mes1,tanespimycin-bortezomib (250-1 mol-mol),0.5343992581220592
PaTu 8988s,135999136,4.429569126789119
D283 Med,3543504,2.346861617384035
NCI-H1092,10296883,3.8260798051213376
NCI-N87,doxorubicin-navitoclax (2-1 mol-mol),-2.375472287210564
HARA [Human squamous cell lung carcinoma],4096211,1.410240196225579
NCI-H2081,51039095,1.7581275368381517
OE21,2729026,3.0182002409216606
NCI-H2081,10127622,5.641065202822249
SW1990,24180719,3.37776868647363
BT 248,3503,0.874016545693445
HARA [Human squamous cell lung carcinoma],2828334,6.6956020196427115
KYSE-410,55283,1.8179347719355985
ML-1 [Human thyroid carcinoma],24856436,-1.6469735215058778
SEM,10302451,1.800985187016429
EJM,11717001,5.2726365511414475
BT 139,2828334,6.284593174469785
CML-T1,135999136,1.353337094400064
GOS-3,8515,4.692167574261379
KMS-27,613753,2.615432098108357
RPMI-7951,navitoclax-MST-312 (1-1 mol-mol),1.3595666482877595
D283 Med,3385,1.9589527474544168
KMBC-2,5738263,3.5623230616489647
OE21,44607531,0.2159575767547405
PE/CA-PJ34 (clone C12),11657048,5.70613373367465
LNCaP clone FGC,446155,3.719256081694015
LNCaP clone FGC,1716436,2.823622083342099
SET-2,439501,-3.519167585481613
TE-15,151289,-0.165043524143007
A4/Fukuda,3062316,0.4248767517614322
HSC-4,6610216,4.241818899552939
SKM-1,969516,2.2754030412406774
GOS-3,3634881,3.062788872748443
NCI-H1092,alisertib-navitoclax (2-1 mol-mol),0.2122885178318103
OE21,doxorubicin-navitoclax (2-1 mol-mol),-0.7978006740829118
GOS-3,54618164,5.027817061073729
Kasumi-2,4261,-0.415942894249068
SEM,15953870,2.946140214563167
NCI-H1395,10302451,4.201114377039751
HCC2218,erlotinib-PLX-4032 (2-1 mol-mol),2.4789964468615735
LNCaP clone FGC,5329102,2.7055412464817823
SW1990,60750,-3.7468579464707448
ML-1 [Human thyroid carcinoma],135411,-0.343606028350642
SNU-308,676352,2.958164070149424
KYSE-410,6918878,3.650985342430235
A4/Fukuda,71680916,4.641498651595925
BT 320,11175137,3.303235141929386
HMCB,374536,3.816146263296923
MM1.S,6918289,-3.2114710937619635
CML-T1,46191454,-1.3100798451488396
SNU-8,navitoclax-piperlongumine (1-1 mol-mol),2.452305783836848
EJM,24889392,5.896592144374216
NU-DHL-1,135411,-1.8300926299415428
Hep-G2,5329102,1.3159700162106798
SNU-308,11404337,1.2327957985917497
AN3-CA,9908783,6.235828315125512
RPMI-7951,24951314,1.154817681866478
MCAS,ISOX-bortezomib (250-1 mol-mol),1.124686826511184
HEC-151,1716436,2.3472897882552934
LNCaP clone FGC,9952709,2.4492721163211333
KMRC-2,2126,5.828846038780047
SNU-1033,65628,4.326862310201289
MCAS,451668,-1.085007175694647
CML-T1,25102847,0.4234360383549997
SKM-1,637858,0.6023395164344832
D283 Med,6917907,-6.043720587150759
ML-1 [Human thyroid carcinoma],6917907,-7.443362541349426
NCI-H2172,5566,3.083299737650171
A4/Fukuda,119607,3.918640768426122
SNU-8,2874250,4.080390541790942
IST-Mes1,49836020,4.276541253138442
NCI-H2110,23582824,0.7863788867419214
BT 248,BRD-A02303741-navitoclax (2-1 mol-mol),1.4606318161646668
HEC-151,selumetinib-decitabine (4-1 mol-mol),4.407861516510348
SET-2,2742550,3.6204915074122814
TE-15,decitabine-navitoclax (2-1 mol-mol),4.29792572523416
IST-Mes1,navitoclax-gemcitabine (1-1 mol-mol),-2.5828122357465144
PaTu 8988s,52912189,-0.4293595588527679
BT 139,76446078,5.753374932108957
CA46,5284616,-8.167802056045408
HMCB,3854666,0.4980905922324143
SNU-1272,24951314,2.1913708545239543
RPMI-7951,6450551,3.1050149829691787
TE-15,carboplatin-UNC0638 (2-1 mol-mol),4.72041849195812
AU565,135999136,4.178255303593246
AU565,156422,4.303267692822867
HARA [Human squamous cell lung carcinoma],4788,5.847017929418924
SW1990,16065773,1.719871366206884
D283 Med,5351362,0.7934624245547425
NCI-H2081,54618771,1.045855982244366
D283 Med,70680404,3.701093742955501
BT 328,3384730,1.2152683647278577
Aska-SS,11396600,4.186494523446212
CA46,25150857,1.719157108492683
MM1.S,6852167,1.3787685421812157
Raji,446155,3.9594959965174543
Ku812,49850262,3.2075768806895324
HMCB,71680916,4.934494068760343
A4/Fukuda,11647372,-0.68075141177871
CML-T1,10127622,3.755726914771393
BT 330,246676,6.180038418715505
OE21,2858523,3.0662483175538444
SNU-1033,6852167,3.058956873768391
SKM-1,168313047,1.823669024693072
MCAS,5281321,-0.2583959641541334
RPMI-7951,46191454,0.3810355763539577
KYSE-410,25262965,-2.4471071962998683
HEC-151,219104,3.6842983437818058
PE/CA-PJ34 (clone C12),675434,4.380294227135041
SNU-1272,1641662,4.135361121218487
TE-15,24785538,-0.3031970560139655
SNU-1272,241158,4.382370259171122
HEC-151,selumetinib-PLX-4032 (8-1 mol-mol),3.4450740625580956
Ku812,73707438,3.988741413659523
SET-2,54765302,3.648671672605155
SET-2,613000,2.447046938208336
HSC-4,31703,-2.446577735650292
BT 248,2949965,2.620236046838219
IST-Mes1,6450551,1.123519877762822
GOS-3,54618771,2.751038853336045
NCI-H1395,11175137,3.230418109330353
SNU-308,54618305,4.365090105355177
SEM,9825149,0.5680322280051573
PE/CA-PJ34 (clone C12),219104,4.13429787847428
NCI-H1395,6918837,-1.563832795621605
HARA [Human squamous cell lung carcinoma],9911830,2.811378702432749
KMRC-2,selumetinib-decitabine (4-1 mol-mol),3.5803480958076315
HCC2218,49766530,-1.6679502221604972
CML-T1,5328940,-0.6883003462747955
Hs 683,4477,0.8459227550326421
SNU-8,11228183,3.906973897476982
OE21,5978,-4.237509886719093
NCI-H2081,4705,3.121794828383862
OE21,613753,3.266280413729653
LNCaP clone FGC,65064,5.307201363412214
EJM,208908,2.014256342304326
KMBC-2,208908,2.0987626264881696
HARA [Human squamous cell lung carcinoma],56946209,-3.7436646215458182
KMS-27,54619267,3.510252942114814
EJM,16725315,4.889333996088531
KYSE-410,44137675,3.6487631222802337
BT 330,10410894,4.0887660018271905
BT 248,5311,3.0798190942417363
BT 330,613753,3.615021864677912
KMBC-2,24771867,3.814811761513654
A4/Fukuda,navitoclax-sorafenib (1-1 mol-mol),1.3354427361603598
OE21,25150857,1.931299408890093
BT 139,676352,1.9837722344026232
MM1.S,44543605,5.063671171274212
A4/Fukuda,16065773,1.900447949816596
KMRC-2,49867926,5.18700499218569
BT 330,46907787,5.374973233157415
NCI-N87,25183872,-2.1426120555107824
NCI-H2172,ISOX-bortezomib (250-1 mol-mol),1.8546920872964217
Hep-G2,10296883,3.682570839684776
Ku812,67156097,-2.3155423886631117
D283 Med,6918328,-4.962430098316081
IST-Mes1,4788,5.898872389352922
HMCB,46199207,3.64794084151039
RPMI-7951,BRD-K27188169-navitoclax (2-1 mol-mol),3.4218571512591915
A4/Fukuda,3634881,2.7004024711225596
AN3-CA,262093,3.1058426937478036
KMS-20,2945648,2.3119596630463657
SEM,135398516,2.1523456379103028
BT 330,426756,3.999579288506848
TE 617.T,25262965,-3.4538880737625814
KMBC-2,12001922,2.090180788791515
Hs 683,9826308,0.3200109255128864
KMRC-2,6914657,-1.6241038444290086
SNU-8,387447,-4.803741501160462
CML-T1,44589607,0.9502853682806348
HCC2218,46843906,4.781522984776227
Kasumi-2,25161177,3.916701757551495
Kasumi-2,984333,-0.6107639841292208
AN3-CA,156414,1.36110068717594
RPMI-7951,984333,0.6667231329572814
Hs 683,salermide-PLX-4032 (12-1 mol-mol),5.2498039837805734
PE/CA-PJ34 (clone C12),2729026,3.095265123820331
SNU-1214,176870,0.0461730328895412
NCI-H2110,44632017,1.4132924038310986
LoVo,24797083,1.0858534416002044
TE-15,JQ-1-UNC0638 (2-1 mol-mol),-0.5241568674316489
NCI-H2110,9956119,4.294829796278382
CML-T1,644241,-4.543158274485358
CA46,11507802,0.4399982092061076
CML-T1,4521392,4.044943461780163
AU565,54649381,3.996593912741648
LNCaP clone FGC,44185566,2.784372312754108
TE 617.T,5278396,3.459688739570118
SET-2,219104,2.1406118345364877
Hs 683,9903786,4.056971165383086
SET-2,216468,-1.8966500344526072
SKM-1,49850262,2.605889729576421
LoVo,452548,-1.7762082467733018
SW1990,24964624,2.8456248953182137
HMCB,3689413,1.1423939419443525
SNU-308,selumetinib-tretinoin (2-1 mol-mol),4.936945882415517
IST-Mes1,71751553,5.350652566949457
PE/CA-PJ34 (clone C12),53232,2.457629300419982
PE/CA-PJ34 (clone C12),navitoclax-gemcitabine (1-1 mol-mol),-0.7545233222413882
SET-2,24797083,1.3463282154315572
TE-15,10184653,-1.8330433827490031
BT 328,9952709,3.885158695523131
Raji,16741245,3.933598107386241
Hs 683,5287620,-3.309313653276712
EJM,11396600,3.800195279839431
BT 330,4578,6.009740129400711
NU-DHL-1,68056272,3.3268540806967493
SKM-1,17759555,3.1390325960457264
BT 248,salermide-PLX-4032 (12-1 mol-mol),3.4628856053275623
SEM,9549297,0.9674551206649342
TE 617.T,374536,1.0085284501370833
SNU-1272,JQ-1-navitoclax (2-1 mol-mol),0.2802121909183701
KMS-20,135999136,4.473937191041351
PaTu 8988s,serdemetan-SCH-529074 (1-1 mol-mol),1.9776411306305544
HEC-151,11626927,4.237303713859301
LoVo,16722836,0.1488668556579147
BT 330,327653,3.419413627791973
SNU-1033,285033,-5.400641169333858
BT 320,54143018,4.726719249085395
NCI-N87,3062316,-1.4174361948917271
KMBC-2,107970,2.196231544396115
BT 330,637858,2.906999129152924
PE/CA-PJ34 (clone C12),45279963,3.8312353498990785
BT 328,1750826,2.2772741974811637
CA46,24951314,-0.0442972386064399
Ku812,11152667,-2.1041122356576127
NCI-N87,selumetinib-piperlongumine (8-1 mol-mol),3.3316492796689112
SNU-8,54143018,-0.3270913068576444
HEC-151,54678924,1.55404668159995
MM1.S,BRD-K27188169-navitoclax (2-1 mol-mol),4.93691832790379
KMS-27,44137675,3.9560542315733738
SET-2,24772860,-2.44164092451758
SEM,6438330,0.6807940195950141
NCI-N87,216239,2.2423368269273753
MCAS,216345,4.8670475281089045
HEC-151,64971,3.070504643309202
HARA [Human squamous cell lung carcinoma],3825829,3.0637384073868787
ML-1 [Human thyroid carcinoma],9823820,3.655965927562111
HMCB,15953870,5.102048815758539
HMCB,136227924,3.0347930044007643
HCC2218,selumetinib-MK-2206 (8-1 mol-mol),1.7074362554421436
BT 320,5280436,4.79134990721052
PE/CA-PJ34 (clone C12),123631,-0.1749534582660772
NU-DHL-1,25161177,3.575744569500696
SET-2,107970,1.5950786133470078
NCI-H2081,selumetinib-piperlongumine (8-1 mol-mol),2.382828726466422
HCC2218,216468,2.074728004381242
BT 248,11955716,-0.8129800870812356
EJM,23582824,0.4180774571431987
Aska-SS,16720766,-0.4517051678184295
RERF-LC-Ad1,1750826,-2.353785617747723
NU-DHL-1,selumetinib-vorinostat (8-1 mol-mol),0.3575264561509241
RERF-LC-Ad2,tanespimycin-gemcitabine (1-1 mol-mol),1.644525077585294
NCI-H2081,selumetinib-navitoclax (8-1 mol-mol),3.86740666902644
Hep-G2,17755052,0.5179186148477235
TE 617.T,24772860,-3.1791034277666164
NCI-H1395,BRD-A02303741-navitoclax (2-1 mol-mol),5.774765873736903
ML-1 [Human thyroid carcinoma],24964624,3.117302997790913
TE 617.T,vorinostat-navitoclax (4-1 mol-mol),1.1998993642927214
Raji,doxorubicin-navitoclax (2-1 mol-mol),-1.4888855783591863
RERF-LC-Ad1,219104,4.500436139497514
NCI-H2081,44486219,4.417324221540856
BT 328,439501,-3.1360046964577983
SNU-1272,54618164,4.215546778710406
BT 330,5328940,2.377605998635507
Hep-G2,11152667,-0.2869645192447481
HMCB,carboplatin-UNC0638 (2-1 mol-mol),4.229494663747289
KYSE-410,selumetinib-MK-2206 (8-1 mol-mol),2.2155459155232182
D283 Med,5335621,3.872227054379363
A4/Fukuda,72376,-3.4342601152101473
SNU-1033,25161177,3.7481241199091953
CML-T1,6505803,-0.3633146304142068
AN3-CA,25183872,-1.1882282616586746
HMCB,44632017,0.9230813407361356
SET-2,UNC0638-navitoclax (1-1 mol-mol),-0.0926361698206657
OE21,7326481,2.85473988539988
AN3-CA,selumetinib-navitoclax (8-1 mol-mol),2.227792232631343
D283 Med,10302451,2.6795990859409695
CML-T1,46224516,0.9570028124056976
BT 328,637858,2.786285777963434
NU-DHL-1,89183176,4.0895744389875155
OE21,9825149,2.195531408914893
HSC-4,2945648,2.59041604505869
AU565,3038522,2.241670788617941
GOS-3,11626560,1.8119824279577827
HSC-4,selumetinib-MK-2206 (8-1 mol-mol),1.8625647516668664
KYSE-410,216239,2.2242703671059405
BT 328,11609586,3.6463226315951225
ML-1 [Human thyroid carcinoma],navitoclax-pluripotin (1-1 mol-mol),-1.2739160400163367
SW1990,selumetinib-MK-2206 (8-1 mol-mol),1.7059513810078966
SNU-8,JQ-1-vorinostat (2-1 mol-mol),0.5470628080695262
NCI-H2172,16720766,4.787872984188638
SET-2,54618164,3.897456065397519
KMRC-2,11640390,3.840288818498483
EJM,9911830,2.3498846254734267
D283 Med,tanespimycin-bortezomib (250-1 mol-mol),-0.3446270457541043
HCC2218,11404337,1.2593455770198374
Hs 683,24180719,3.5923230228392953
KMS-20,10296883,2.054648014794474
LoVo,5335621,4.644708398315867
SKM-1,5281321,-0.4705948424838158
D283 Med,selumetinib-tretinoin (2-1 mol-mol),-0.135437445848875
HCC2218,44137675,3.038492049158943
A4/Fukuda,2749,1.141581020051295
Aska-SS,119182,-2.681734240555131
HSC-4,2874250,5.810325396532396
Kasumi-2,753704,4.42700120937948
KMRC-2,285033,0.3199202745946036
KMS-20,44566777,-0.0659077616958368
CA46,9887053,1.048475441216289
Hs 683,53495165,0.4818655856082811
Aska-SS,9936388,1.048322458845263
ML-1 [Human thyroid carcinoma],UNC0638-navitoclax (1-1 mol-mol),2.518264645027629
MM1.S,119607,4.277227419584953
BT 320,409805,6.1406982436622
SNU-1272,11234052,4.3028185789263045
NCI-H1092,9933475,2.1569011395664934
AN3-CA,135875424,2.655467292479818
BT 248,selumetinib-vorinostat (8-1 mol-mol),3.707211778635912
OE21,9826308,0.6399815117118636
Aska-SS,navitoclax-sorafenib (1-1 mol-mol),3.529033353230181
MCAS,49793307,-3.621287740472224
HCC2218,11626560,2.6153990580460396
HCC2218,44507138,1.661210096504924
LNCaP clone FGC,3081361,3.1605102026982363
BT 330,24772860,-2.5000585413753815
ML-1 [Human thyroid carcinoma],11238147,1.6119243998814434
BT 248,9967941,3.931710866923424
SNU-1033,16065773,2.5318700618978007
AN3-CA,56946209,-4.582764500182781
BT 328,53495165,1.3387140928137258
NCI-N87,6914657,-3.795056001746233
PaTu 8988s,4788,6.041968744796845
MM1.S,9884685,-0.9027319630033926
OE21,10322450,4.259055597018236
MCAS,11964036,1.9381780562903528
HSC-4,984333,1.2474358256824072
PE/CA-PJ34 (clone C12),1566236,1.827252089315036
Hs 683,11214940,1.610301401893697
Kasumi-2,9868037,2.67651294484719
Hs 683,25150857,1.0448555959679475
SW1990,1474550,4.493069593499753
SEM,148198,-7.106649826649242
LNCaP clone FGC,9825149,3.2345733372350463
YKG-1,107970,2.756113266406284
TE-15,24753719,4.009686025079942
RERF-LC-Ad1,selumetinib-JQ-1 (4-1 mol-mol),3.573516405475977
ML-1 [Human thyroid carcinoma],44607530,1.6401891623478355
MM1.S,168313047,1.9214959854165885
Aska-SS,285033,-3.0886143623039146
SET-2,12003241,-1.37504024910663
KMBC-2,2708,4.865695204708852
SEM,1239801,2.628378122820145
SET-2,piperlongumine-MST-312 (1-1 mol-mol),1.1695579595502636
HMCB,216345,4.536008903536929
TE-15,6438330,2.635469606386231
SNU-1214,16722836,0.6993060369104132
PE/CA-PJ34 (clone C12),alisertib-navitoclax (2-1 mol-mol),-0.593506063139588
Hep-G2,135398516,2.8835237684961483
SNU-8,44486219,6.2061810000984465
CA46,6918878,-0.7300256707111569
OE21,24797083,1.6133510569110745
KYSE-410,navitoclax-birinapant (1-1 mol-mol),3.0273545148034664
KMS-20,72376,-2.953076031643005
AU565,vorinostat-navitoclax (4-1 mol-mol),1.0795272840825962
D283 Med,3081361,2.432626618810537
SET-2,36462,0.7834835963268753
SW1990,9866186,-0.356042877423586
SNU-1214,selumetinib-navitoclax (8-1 mol-mol),0.7432927168918613
SNU-8,5335621,4.415032779411775
NCI-H1092,24951314,0.6671727176626792
KMRC-2,637858,2.4993405738331216
NCI-H2081,3854666,0.2078847774714705
SET-2,3465537,3.762273356710905
SNU-1033,135875424,3.081818614002125
PaTu 8988s,2746,3.571987596167747
NCI-N87,3025944,4.18610508240951
SEM,374536,-3.4278771787335107
Ku812,25105715,2.5153812758141902
EJM,24821094,3.662751413369248
KMS-27,135398738,6.313619028269227
Hep-G2,selumetinib-navitoclax (8-1 mol-mol),0.9270338424772362
HEC-151,24772860,-1.663502215408852
CA46,71680916,4.255070441315874
NCI-H1092,23725625,4.586662466959233
SEM,26596,-3.506968001766276
SEM,11626560,-0.667786957756766
HMCB,5329102,2.553440838947416
TE-15,11234052,4.285608247306556
LNCaP clone FGC,11228183,3.180943323557888
Ku812,selumetinib-tretinoin (2-1 mol-mol),-1.3123873210444326
CML-T1,1716436,3.108020123675437
BT 330,3503,1.007043340813608
TE-15,3136844,3.713291500695178
NCI-H2110,navitoclax-pluripotin (1-1 mol-mol),0.1078154634516552
TE-15,6918328,-0.394350388862967
Kasumi-2,4705,3.579279614719375
Kasumi-2,57519531,1.2182883326717542
RERF-LC-Ad2,11640390,3.4027791820615665
Hs 683,5702613,1.9234532000360829
TE 617.T,637858,1.1275370402381546
NU-DHL-1,984333,0.6343201948214459
LNCaP clone FGC,57330099,4.343062431668908
EJM,selumetinib-GDC-0941 (4-1 mol-mol),1.950719382616822
NCI-H2110,71466445,4.525976755285506
KMRC-2,6918638,2.530608433892335
BT 248,24889392,1.8419989874192408
MCAS,2729026,3.0980354631151883
Hep-G2,25183872,0.2185171281580754
HSC-4,16722836,1.7684769334825834
Kasumi-2,7251185,0.9050560163252253
Kasumi-2,serdemetan-SCH-529074 (1-1 mol-mol),0.2929627524168506
PE/CA-PJ34 (clone C12),11955716,-2.415491990969517
ML-1 [Human thyroid carcinoma],168313047,1.965548883908303
HEC-151,tanespimycin-bortezomib (250-1 mol-mol),0.2767790074283919
SW1990,9908783,5.688653533069491
IST-Mes1,16736978,2.528104664048346
RPMI-7951,5978,-4.041450293577184
BT 320,navitoclax-gemcitabine (1-1 mol-mol),3.195871969497656
Hep-G2,9911463,3.8113421260686735
HSC-4,16725315,4.164866459292326
AU565,753704,4.59624742359194
HCC2218,selumetinib-decitabine (4-1 mol-mol),6.205354195390442
KMBC-2,1641662,3.704374614283828
YKG-1,44486219,4.265701062085959
BT 330,12001922,1.1352898980242132
ML-1 [Human thyroid carcinoma],decitabine-carboplatin (1-1 mol-mol),4.481069697343496
Aska-SS,11497983,4.298236057631577
HCC2218,3689413,-1.7582350299108729
KMRC-2,49766530,0.0425057620545657
Hep-G2,5311281,3.757916922752933
KYSE-410,54613361,0.8741468052843427
A4/Fukuda,16725315,3.095723533871789
Raji,16065773,3.8590792328782095
AU565,42642645,1.544546710659079
D283 Med,57519531,1.3990443657534628
OE21,alisertib-navitoclax (2-1 mol-mol),1.9539668690079708
NCI-N87,44202524,1.5092428544055756
SKM-1,46191454,-1.3563386144764775
HMCB,11222830,1.7352561808770213
Raji,10127622,5.596219893755101
AU565,2945648,3.081352201841014
HEC-151,5566,3.259333295747091
BT 248,54613361,5.122685224165604
SEM,12001922,1.121071645665963
SNU-1272,9926054,2.4790221898932283
SNU-1214,44620216,4.405337924710413
LoVo,5311,0.3380696500116906
BT 320,11485656,3.3413754154715796
AN3-CA,24771867,0.3006367782170145
HEC-151,46843906,4.015581502156025
OE21,6610216,4.168001578531245
Hs 683,selumetinib-decitabine (4-1 mol-mol),5.275083439030192
KMRC-2,462382,1.077906580919196
PaTu 8988s,219104,4.155059926230293
SNU-308,9926054,1.9749915644839853
Kasumi-2,9911463,3.4999156831259524
YKG-1,11625818,4.5202694072392715
NCI-N87,5311281,2.449994968111211
CML-T1,20959075,-3.2800173274392983
BT 139,54618164,4.290643622410761
NU-DHL-1,11178236,-4.241745516668476
PaTu 8988s,148124,-0.8669711950509935
NCI-H1395,46907787,2.4653160178838354
MCAS,5978,-2.806072841189786
D283 Med,3384730,1.3777916079396086
KMRC-2,702558,5.806055725230924
A4/Fukuda,5284616,3.229953451024844
HSC-4,71466380,3.6804948915169784
SNU-8,5470400,-2.564132685735376
HARA [Human squamous cell lung carcinoma],2708,4.268843127757034
RERF-LC-Ad2,11625818,4.943642256275433
D283 Med,5479543,3.66909557584616
NCI-H1395,100016,6.569605836811141
SKM-1,24180719,1.95578575443114
SNU-8,23635314,-1.998431310162353
SNU-1214,56963564,0.6024580482919216
RPMI-7951,3815108,2.5391159267765144
Ku812,5281321,-2.365774247469062
RPMI-7951,44202524,0.9827362400760508
SKM-1,24753719,3.966974937988049
BT 320,60700,5.739551872199599
YKG-1,54618771,1.607640245193468
SET-2,10127622,3.4186773553125827
HMCB,6918328,1.0614857704066594
RERF-LC-Ad1,crizotinib-PLX-4032 (2-1 mol-mol),2.9408300097194013
Ku812,445091,4.27375620690436
Aska-SS,5351362,1.185018098934001
BT 330,2949965,2.2304640179968827
BT 320,53495165,1.9791180905331631
TE 617.T,11213558,1.2171494320369085
SET-2,984333,-2.9081310934556868
CML-T1,56973724,1.0958106846759064
LoVo,444795,4.8141558651213145
PE/CA-PJ34 (clone C12),ISOX-bortezomib (250-1 mol-mol),1.4521008685739432
NCI-H2172,72376,1.185130981132838
KYSE-410,216345,4.526779821165723
NCI-H1395,107985,-3.679096931387758
NCI-H2081,5978,-4.744970810463312
HMCB,alisertib-navitoclax (2-1 mol-mol),1.9380444383575808
AN3-CA,72193861,0.4572966127744896
TE-15,71466445,3.5922640502663077
MCAS,441298,4.221459009048935
Ku812,56973724,1.3677236281972405
LNCaP clone FGC,11167602,1.6735547882241617
BT 328,9933475,2.2718026120514216
BT 330,44491742,4.367748851083318
SET-2,11647372,1.3402152078110998
SNU-1033,262093,2.351645391909522
PE/CA-PJ34 (clone C12),3825829,4.057915478742878
NCI-H1395,9903786,3.8864807174358984
KYSE-410,148198,-1.166924431681682
RERF-LC-Ad1,10184653,2.5913648583184905
NCI-H2110,122327,5.56586564748931
OE21,208908,-0.200539873809521
MM1.S,9825149,-1.0079549399990844
NCI-H1092,6918328,-0.0864293010170715
NU-DHL-1,53495165,-3.4420511548934973
BT 330,445091,4.429056044070297
KMBC-2,11485656,2.7390953396220588
SNU-1214,docetaxel-tanespimycin (2-1 mol-mol),-4.931471584468297
EJM,445643,4.021541307883637
BT 139,60700,1.6721898683127974
BT 139,5287969,-1.5925638100844708
SNU-308,tanespimycin-bortezomib (250-1 mol-mol),-1.0172716653448413
KMS-27,11507802,0.7171665546072066
MCAS,6438330,2.7548820430881653
HSC-4,72376,-2.108784759313747
BT 330,135875424,2.80821579250056
NCI-H2110,375860,0.2017557628381111
YKG-1,126941,-4.127185813066353
AU565,5335621,4.583819394214033
SNU-8,654092,-2.3977544496906624
Hs 683,2742550,3.2253237968684134
BT 248,5280436,3.4551701194558935
LNCaP clone FGC,57519531,1.9149339462743336
YKG-1,25105715,3.7815729862100578
RPMI-7951,107985,-3.3094239868135467
NCI-H2081,135659046,2.9715500062667455
ML-1 [Human thyroid carcinoma],6918328,-0.1732040518011542
KMS-27,9907093,4.633224131705679
KMBC-2,11238147,3.862409359846617
HCC2218,5566,-1.3857884624884214
LNCaP clone FGC,6852167,3.159871073492599
OE21,54596490,5.298200205444942
HARA [Human squamous cell lung carcinoma],676352,2.7556636695973515
NCI-N87,448949,2.160730221150561
HARA [Human squamous cell lung carcinoma],60700,-1.6734694813518207
SNU-1033,11175137,3.157480409419269
SNU-8,57519531,3.1479992665124623
IST-Mes1,8515,4.272788297141445
D283 Med,53232,2.450854354928572
NU-DHL-1,49766530,-4.7275009055236445
RERF-LC-Ad2,2828334,6.229076280366517
NCI-N87,11396600,3.282772907192936
YKG-1,409805,3.8056431996277578
RERF-LC-Ad1,navitoclax-gemcitabine (1-1 mol-mol),2.5531217714066177
YKG-1,10385095,1.6490747273170454
PE/CA-PJ34 (clone C12),445643,3.973961211408011
PE/CA-PJ34 (clone C12),387447,-4.003769145095816
SNU-308,6610216,4.383994283569161
LoVo,46907787,0.5340804086119918
RPMI-7951,36314,-5.69556054736906
NCI-N87,sirolimus-bortezomib (250-1 mol-mol),-1.2024587113239409
SNU-308,3543504,4.589142587467719
RERF-LC-Ad1,374536,2.042610785182273
LoVo,10302451,1.0215583424111876
MCAS,44137675,2.939638990664671
MM1.S,44137675,2.286622980046456
YKG-1,24785538,1.7282682094095363
CML-T1,5280436,4.11670865979611
SNU-8,9907093,4.701426357025219
KMBC-2,9866186,-0.8646710770131696
NCI-H1092,400769,-0.5957387539071202
HSC-4,25195348,4.125902627491381
Hs 683,44632017,0.8900941738880314
MCAS,17755052,1.3855879628381012
BT 328,6914657,-4.350943519439018
Raji,5311281,3.438768621179428
Hep-G2,71466578,4.87571024377078
PaTu 8988s,selumetinib-JQ-1 (4-1 mol-mol),0.3498739449396179
HMCB,carboplatin-etoposide (40-17 mol-mol),3.2976351954293324
BT 328,400769,0.7243238216549931
KMS-20,5746,-0.3166262639193328
SEM,2746,-0.0565030951113346
CA46,2130404,5.640885888744477
BT 139,10074640,2.997567621853052
TE 617.T,5280436,2.065282864017122
Hs 683,10410894,3.5223252226939312
HEC-151,46199207,3.1847539015673307
KYSE-410,16741245,5.350523076249508
SET-2,53495165,-2.0941219446387347
KMS-27,24785538,0.2071067325135329
BT 248,135875424,2.546043839111523
NCI-H2172,4259181,0.413697798920579
HCC2218,5113032,5.565941219612929
SW1990,36462,1.719748778334474
AU565,2949965,1.8156290557963255
D283 Med,135928012,2.2283751237398906
AU565,24753719,4.632017214490639
CA46,46398810,1.9636985074186508
YKG-1,16720766,0.8883100647238013
KMRC-2,24785538,1.9810416518294935
MCAS,9956119,4.084833721760423
TE-15,navitoclax-piperlongumine (1-1 mol-mol),2.8674602106602527
HMCB,JQ-1-carboplatin (1-1 mol-mol),2.516859123575671
Ku812,11234052,3.043132602643913
KYSE-410,11656518,2.307112216885876
HEC-151,3689413,0.5850952885102259
Hs 683,216239,2.6289304351017595
BT 330,9840324,5.89658505539565
A4/Fukuda,4378219,1.9024946719152895
A4/Fukuda,46943432,-0.0927442133672991
SNU-1214,25150857,2.4299746363214125
KYSE-410,5284373,3.250370291088375
HSC-4,171352865,4.360447231593142
NCI-H2081,67156097,-1.7291479863882548
Hep-G2,ISOX-bortezomib (250-1 mol-mol),0.639259182735851
HMCB,4578,4.2642752613227435
PE/CA-PJ34 (clone C12),selumetinib-vorinostat (8-1 mol-mol),2.6799974676882883
SNU-1033,445643,4.458031896103707
SEM,44185566,0.8758222102990114
EJM,57519531,2.975105121216571
NCI-H2110,119182,-1.092135789483473
NCI-N87,327653,3.392428289503534
KMS-20,9549297,1.1298438503478845
BT 328,53392493,3.725538863996033
AU565,54613361,-1.6068695222158444
SEM,6918736,-2.5690877985953566
PE/CA-PJ34 (clone C12),JQ-1-MK-0752 (1-1 mol-mol),5.182119120511875
HCC2218,5278396,3.6856174156136374
KMS-27,100016,3.811410813700335
SNU-1214,216345,3.6404445587750383
SW1990,11497983,4.192407052388532
Aska-SS,72193861,0.8225136305229684
OE21,JQ-1-MK-0752 (1-1 mol-mol),0.8288579789909071
BT 320,vorinostat-carboplatin (1-1 mol-mol),4.235025979591699
SKM-1,6852167,1.599440768743568
RERF-LC-Ad1,16722836,2.166524022697494
IST-Mes1,3062316,-4.79181247277669
SEM,25102847,-1.3835697041248178
SNU-308,322968,4.604014460202124
SET-2,3025986,0.9668569869400652
Kasumi-2,44462760,0.6612462691358557
KMS-27,57330099,4.453875165878117
Hs 683,11152667,-1.390521313969312
SW1990,selumetinib-tretinoin (2-1 mol-mol),2.9707045736448707
PE/CA-PJ34 (clone C12),11612883,2.848187742516691
RERF-LC-Ad2,72193861,4.063600666642819
HARA [Human squamous cell lung carcinoma],6505803,-0.6058988133854029
LoVo,51039095,1.8047028032602028
SNU-1214,6610355,4.339610066840723
OE21,10410894,3.4125906572250027
KMS-20,246676,4.441835225578849
CML-T1,2733526,2.616681149896765
MCAS,navitoclax-MST-312 (1-1 mol-mol),0.7888327520655
NCI-H2110,119607,5.439167297599681
NCI-N87,31703,-2.5850470675010175
SKM-1,50905018,4.354316940379774
CML-T1,9927531,3.1672020542525674
OE21,73707398,1.45276102032063
NCI-N87,26596,-0.8687464208841552
SNU-308,656346,3.271973298432795
HEC-151,24771867,2.9837344862982
Hs 683,89183176,4.93147502343302
HCC2218,44185566,2.40017687659303
NCI-H2110,navitoclax-MST-312 (1-1 mol-mol),0.9913337300457437
ML-1 [Human thyroid carcinoma],15983966,-5.2151360937473
TE-15,16722836,1.2676445254840203
SEM,54613361,-1.7157995235006995
D283 Med,9956119,3.549058379846889
EJM,72734382,3.5540919183880733
PaTu 8988s,5278396,3.9928047507799698
KMBC-2,54649381,3.86367738798119
NCI-H2081,24785538,-0.1890476398389944
SNU-8,tretinoin-navitoclax (4-1 mol-mol),4.661127606592348
AU565,17755052,-0.9729531204394496
SET-2,6852167,2.1824189534016556
SNU-8,6610216,4.841964372920672
MCAS,7326481,2.333692391827008
YKG-1,16736978,1.5030984389697135
RPMI-7951,46907787,2.690496694685834
MM1.S,JQ-1-vorinostat (2-1 mol-mol),-1.2519551841274497
NCI-H2172,44241473,5.356586155091817
Ku812,46907787,-1.7178287271779615
YKG-1,5311,2.0355380974233928
HEC-151,10113978,2.960493097461511
KMS-27,10385095,0.2784313447424752
ML-1 [Human thyroid carcinoma],navitoclax-MST-312 (1-1 mol-mol),1.8932386957075495
HMCB,446155,0.6240619426088403
Aska-SS,24901704,0.9689987170877432
EJM,285033,-3.245893351127227
IST-Mes1,JQ-1-vorinostat (2-1 mol-mol),0.3770936853030046
NCI-H2081,6852167,2.954622232439069
AN3-CA,16736978,1.2131559252663011
NCI-N87,1750826,1.3506728687975464
SNU-8,navitoclax-pluripotin (1-1 mol-mol),-0.2823616495473457
NCI-H2110,11955716,-2.3591682548088273
SKM-1,5291,3.5671310197846267
BT 248,16038120,1.7409517230791791
RPMI-7951,168313047,1.8853313482329883
PE/CA-PJ34 (clone C12),tanespimycin-bortezomib (250-1 mol-mol),-1.982258316980141
SET-2,135875424,3.0388135878797833
PaTu 8988s,9903786,1.8009975173036927
PE/CA-PJ34 (clone C12),24797083,1.4819806490602767
HEC-151,2742550,3.8773994743488966
SEM,49766530,0.1216347460182048
MCAS,56946209,-4.611204773415356
HARA [Human squamous cell lung carcinoma],1242560,4.08747373250943
NCI-H1092,5351362,1.059712602120236
Aska-SS,44507138,3.8617946638708545
KYSE-410,73707398,1.149006405026039
Raji,26596,-2.574302974428465
D283 Med,56946209,-6.610135638072429
PaTu 8988s,3384730,2.8335076266627386
A4/Fukuda,11707110,-3.666992219196893
D283 Med,24180719,4.216892125950757
SET-2,135440466,0.3849463595907619
TE-15,serdemetan-SCH-529074 (1-1 mol-mol),2.490682124349896
Kasumi-2,2945648,2.1908336830751436
LoVo,9907093,0.4604974674369004
Kasumi-2,selumetinib-navitoclax (8-1 mol-mol),-1.4155555334459644
SNU-1214,31703,0.2327477554999883
TE-15,51039095,1.9253122960428968
A4/Fukuda,168313200,2.9572494196719723
RPMI-7951,135984461,1.8350083594586524
NCI-H1395,135999136,4.46612092216275
CML-T1,104842,-6.467154894462458
HCC2218,5746,1.2598379525306076
Raji,25262965,-2.39728180513871
Hs 683,67156097,-2.670852292829107
Aska-SS,5494449,2.854188753025021
HARA [Human squamous cell lung carcinoma],decitabine-navitoclax (2-1 mol-mol),1.7884131125603568
HSC-4,5328940,0.4436918358674775
YKG-1,44137675,3.325068196687256
A4/Fukuda,216239,1.5760740052804734
KYSE-410,navitoclax-gemcitabine (1-1 mol-mol),1.688863056737806
MCAS,1641662,3.2767625761066643
BT 328,5311,4.9120281347164525
RPMI-7951,42642645,1.1114872828283802
NU-DHL-1,12003241,-2.4677988287748915
SET-2,387447,-5.133141904857513
AU565,BRD9876-MK-1775 (4-1 mol-mol),-0.166226177958293
KMRC-2,969516,2.9883028529807083
Kasumi-2,15983966,-4.769110499873103
Kasumi-2,decitabine-carboplatin (1-1 mol-mol),-0.2922568730993647
HEC-151,2949965,3.303774381727868
BT 139,5460769,4.859801196456228
NCI-H1395,5566,3.555593017937037
OE21,sirolimus-bortezomib (250-1 mol-mol),-0.2095744240897051
Kasumi-2,44489675,3.5763019986617106
BT 139,71466578,5.495328241613025
NCI-N87,208908,-2.7799590207113014
A4/Fukuda,selumetinib-PLX-4032 (8-1 mol-mol),2.453113132843287
CML-T1,613753,3.0468922998366357
BT 330,46843906,3.7826602279254895
ML-1 [Human thyroid carcinoma],3854666,0.5957604923029644
KYSE-410,25154868,4.70403816905794
BT 248,5284616,2.1714532824885473
BT 328,72193861,3.7422212299852946
SEM,24771867,-2.7357477254631744
HMCB,15547703,2.756722106244236
HARA [Human squamous cell lung carcinoma],71304818,2.9544117211144147
HEC-151,15953870,3.67347109220223
Kasumi-2,1716436,2.2552230484948477
NCI-H1395,4378219,4.7590684323615635
A4/Fukuda,11404337,-2.650657466190433
MM1.S,11234052,4.653102386091589
KMS-20,BRD-A02303741-carboplatin (1-1 mol-mol),5.179174708590503
TE-15,44632017,0.1469612223098825
OE21,26596,-3.6158126221637823
Hs 683,25154868,5.327126206185975
SET-2,3503,1.2013280353182436
BT 248,11609586,2.7692010936053064
HEC-151,16722836,1.6765297492906277
IST-Mes1,5738263,4.045528078129119
TE-15,5282054,3.1485256365752914
EJM,650361,3.796410138993618
MCAS,6918837,-1.9488611085333296
SEM,2742550,2.6060865780770293
Aska-SS,53495165,-0.2600081026021872
SEM,53393127,4.163322375685533
SET-2,168313016,3.716090786123575
RERF-LC-Ad1,119607,5.958194091123051
PaTu 8988s,135421197,1.1460063606701134
Ku812,31703,-2.031411479408016
KMBC-2,613753,3.2512958056393195
RPMI-7951,selumetinib-decitabine (4-1 mol-mol),5.604258441807631
A4/Fukuda,9825149,-2.050748608979426
MM1.S,6610216,4.132453161575956
RERF-LC-Ad2,9907093,4.485338642207398
RERF-LC-Ad2,216345,4.614438011082231
LoVo,6505803,-0.2027234925460443
HMCB,71576739,-3.3278802588106955
BT 248,72193861,2.013908806167315
TE-15,448949,1.444286373082681
SNU-308,11485656,2.7823829895443657
PaTu 8988s,100016,6.475282567189534
ML-1 [Human thyroid carcinoma],16038120,1.3266996549374028
SNU-1214,11964036,0.7123256395160985
KMS-20,10113978,2.317809443763058
NCI-H2110,65064,5.718221272891953
MCAS,24772860,-3.031835508256121
AU565,136227924,2.2371309282915184
NCI-H2110,439501,-2.2349143195011583
YKG-1,66577038,3.063547577829753
TE-15,5284616,3.380011015586448
PE/CA-PJ34 (clone C12),409805,3.8621146596524087
KYSE-410,selumetinib-navitoclax (8-1 mol-mol),3.3378568723711286
NCI-H1395,5329102,2.4714501130754294
NU-DHL-1,JQ-1-MK-0752 (1-1 mol-mol),-1.024409939497564
RPMI-7951,2742550,3.350018850838408
SET-2,53301938,4.205096030806661
CML-T1,tretinoin-carboplatin (2-1 mol-mol),3.366911214203907
OE21,3689413,1.0863405783683666
BT 248,selumetinib-PLX-4032 (8-1 mol-mol),4.4451180166492765
KMS-20,9915743,0.2569666585707142
ML-1 [Human thyroid carcinoma],24772860,0.5673209260643837
PE/CA-PJ34 (clone C12),10427712,4.368954658182041
NCI-H1395,JQ-1-vorinostat (2-1 mol-mol),1.5410924011287808
NCI-H2081,65064,5.195192489742978
NCI-H2172,24964624,2.6919837814589926
SNU-8,66577038,3.195926950502157
Ku812,568763,-0.5026436454206128
TE-15,100016,6.263488161224716
Hs 683,11955716,-2.7747078575525905
RERF-LC-Ad2,3025944,4.191488625541467
KMBC-2,52912189,4.619437750179636
ML-1 [Human thyroid carcinoma],selumetinib-UNC0638 (4-1 mol-mol),-2.912510210684258
LNCaP clone FGC,107970,2.7706506032666067
SNU-308,1641662,4.06307518178202
Aska-SS,25161177,4.387383753124496
NCI-H2110,1566236,3.9517659227404263
SNU-1214,11427553,2.9043841340969494
CA46,5738263,2.2696720462337456
SEM,3825829,3.0657110006972026
KMS-20,11609586,1.7506096338547088
RPMI-7951,selumetinib-JQ-1 (4-1 mol-mol),1.1039196671614755
KMBC-2,6184667,2.7972954567946737
KMRC-2,11427553,2.2676638482656313
BT 330,11404337,-0.3310722205999429
PE/CA-PJ34 (clone C12),11228183,3.283497353043469
HARA [Human squamous cell lung carcinoma],5311281,2.4258881489706217
Hs 683,135659046,3.747937151940255
Kasumi-2,5479543,2.6831620827512004
YKG-1,375860,0.0929787084961373
MM1.S,135999136,4.602725766791159
MCAS,67156097,-1.87014679044215
KMS-27,11612883,2.155507394778575
SNU-1214,54143018,-0.2365789293950507
GOS-3,72376,-1.137393114335449
HMCB,56649450,4.482181356100994
TE-15,SNX-2112-bortezomib (250-1 mol-mol),-1.9782645389742703
SNU-308,439501,-2.437759024379206
NU-DHL-1,216468,0.3012450032871305
CA46,6610216,4.017162804005507
LNCaP clone FGC,25262965,-4.44239132451972
KYSE-410,JQ-1-UNC0638 (2-1 mol-mol),2.635802003886042
AN3-CA,6918837,-2.3890611994888293
NU-DHL-1,11396600,1.7686570539993816
NCI-H2081,72734382,3.7264145222957
MM1.S,452548,-3.3591080388586816
Aska-SS,BRD9876-MK-1775 (4-1 mol-mol),1.635899844987541
CML-T1,navitoclax-pluripotin (1-1 mol-mol),-4.409543307902375
HEC-151,19582717,3.794727124654104
NU-DHL-1,54618771,-0.7819429035186433
BT 330,23635314,-1.0389926397651292
KMRC-2,6438330,3.135955348186537
RPMI-7951,decitabine-carboplatin (1-1 mol-mol),3.5510906298045937
OE21,25183872,-1.0362554321418709
SNU-8,17755052,1.701415000241573
Hs 683,2842253,5.180053846927469
MCAS,52947716,-6.74647882054788
EJM,2749,0.9568555282188456
HCC2218,46199207,3.4003371329104475
PE/CA-PJ34 (clone C12),122327,5.619503436222374
Raji,5287620,-1.5524953820622165
RPMI-7951,44819697,-0.9414715677570764
ML-1 [Human thyroid carcinoma],11152667,-4.726499990059393
AN3-CA,16065773,1.8864857102144683
LNCaP clone FGC,25102847,2.2619247724264695
PaTu 8988s,25102847,3.091699775507105
HMCB,11507802,1.157749348598854
LoVo,676352,2.5317553470156646
SKM-1,vorinostat-carboplatin (1-1 mol-mol),1.9252377672335388
BT 320,5738263,4.511639431207419
BT 248,568763,0.252168352363544
SW1990,5287969,-2.232579195364531
D283 Med,448949,1.5195328538607995
RERF-LC-Ad2,24951314,2.804595086569925
SEM,44607530,0.9041857053195362
KMS-20,navitoclax-sorafenib (1-1 mol-mol),1.3745359370236474
Kasumi-2,53392493,1.5560274267449214
TE-15,135440466,2.1391462006279216
PE/CA-PJ34 (clone C12),24856436,0.073315127978312
SEM,123631,1.8586141248102523
Hep-G2,16722836,1.3885604192453562
EJM,374536,1.880245992175634
TE 617.T,3552672,4.636158960130362
SNU-1033,5311,1.072248134793335
NCI-H1092,erlotinib-PLX-4032 (2-1 mol-mol),3.728956989705323
SNU-1272,73707398,1.7046938678660917
TE 617.T,3025944,3.9487310185301534
HEC-151,676352,2.204105817499985
HMCB,11609586,3.5550453810468094
KMS-27,11455910,0.2864489394234576
YKG-1,JQ-1-UNC0638 (2-1 mol-mol),2.7051806168218153
HEC-151,135411,-0.0260657506821276
HMCB,66577038,3.152546562192711
EJM,135440466,1.184398396955965
SNU-308,4917,2.9791418397771485
SEM,4705,3.2789499070594816
Hep-G2,81146,5.451523711608541
BT 248,11396600,1.9236183524788075
BT 320,3552672,1.9342456765414169
KYSE-410,15953870,3.289472194998764
Ku812,24753719,3.51384685300995
NCI-N87,12001922,1.750767235665954
TE 617.T,3465537,1.2174694198208424
LNCaP clone FGC,9908783,4.491876694058294
AU565,46907787,3.197599854412173
CML-T1,753704,4.085313154725238
IST-Mes1,1242560,3.612096070768593
SEM,135411,-1.7060706905647656
CA46,56946209,-5.9555571874685755
HCC2218,24951314,0.6107555519957106
NCI-H2110,135398516,2.6738042917327385
EJM,44487872,4.364141533871357
Hs 683,6610216,4.167851340670154
RPMI-7951,6918289,2.8870775780311924
KMS-20,6852167,1.0361135786452058
NCI-H2081,53495165,-2.055173508699106
NCI-H2172,9903786,4.970438346504575
BT 330,36314,3.842656257622534
CML-T1,16725315,3.685793664289718
AN3-CA,54618164,3.8831604834020688
RERF-LC-Ad2,65628,4.3888994667995815
EJM,12003241,0.5402616975347148
Kasumi-2,3543504,3.4583921680412413
HCC2218,1641662,5.2445396499203865
MCAS,49850262,3.7303738254171046
HCC2218,2949965,2.5969904614047485
KYSE-410,44543605,4.220068383699119
AU565,16725315,3.19394291041594
KMS-27,5281321,-2.6329785941906367
Hs 683,46191454,1.864722809202389
SKM-1,44819697,-2.7532924214144727
HEC-151,BRD-A02303741-navitoclax (2-1 mol-mol),3.754080908993735
RPMI-7951,vorinostat-carboplatin (1-1 mol-mol),0.9974437990960702
SW1990,9907093,4.562381279872213
KMBC-2,2949965,2.9085438857268313
NCI-H2081,11404337,-2.077246389622244
KMBC-2,3384730,3.00741450377378
IST-Mes1,89928392,1.562289834411229
BT 328,9908783,5.49619417239086
CA46,72193861,0.1338517787347367
ML-1 [Human thyroid carcinoma],49850262,3.5297334075235245
LoVo,46199207,2.62459096292295
BT 248,73707438,3.693804860778579
KMRC-2,JQ-1-UNC0638 (2-1 mol-mol),2.613983630437413
RERF-LC-Ad1,46398810,3.150870182853183
AU565,11455910,2.266336610800082
Ku812,2749,1.0031884353437008
EJM,5951923,6.145734491390667
OE21,107970,2.067715024549662
SNU-1214,11612883,2.1855017074755874
TE 617.T,decitabine-navitoclax (2-1 mol-mol),3.662981442194223
RPMI-7951,9911463,4.017661136446782
Hep-G2,10074640,2.639791541844783
ML-1 [Human thyroid carcinoma],44819697,3.711954604060423
KMS-20,10184653,1.4307527517519167
HARA [Human squamous cell lung carcinoma],piperlongumine-MST-312 (1-1 mol-mol),1.5629845870291592
AU565,11257553,-0.514738811981399
SEM,44566777,-0.7801941037699254
NCI-H2081,44137675,3.995852216137384
SNU-1214,6610216,3.72445074492986
Raji,119607,5.398499611687464
Hs 683,135421197,1.945110581550152
KMS-27,10074640,2.787372900594659
NCI-H1395,5291,4.092601973794721
SEM,24797083,0.5724609501787771
SET-2,11214940,1.520131237216913
SW1990,66577038,3.4185516807761847
RERF-LC-Ad1,969516,3.975761175318136
NCI-H2081,11485656,1.3595446454141742
LoVo,5351362,1.2957137522113673
TE-15,3689413,0.9912236496957668
AN3-CA,65064,5.356494247928247
D283 Med,44632017,0.7172381887934464
HEC-151,46398810,2.8206847831158166
Hs 683,445091,4.264347039677046
AU565,44566777,1.2994228207825576
SNU-1033,10074640,3.1442232102828407
CA46,4477,-0.2706834990523855
AN3-CA,17755052,-0.2934004434039564
NU-DHL-1,6252,-2.10817374162043
KYSE-410,selumetinib-GDC-0941 (4-1 mol-mol),1.4678317054050969
PaTu 8988s,9887053,3.932226470782735
HARA [Human squamous cell lung carcinoma],navitoclax-sorafenib (1-1 mol-mol),1.2625473684238606
Kasumi-2,44507138,0.9761318750595236
SKM-1,11427553,1.4023933333008194
OE21,11977753,-4.142897881576489
AN3-CA,51037431,3.642744967178951
RERF-LC-Ad2,148198,-4.2716837580451825
SW1990,46199207,3.658278833189125
KMS-27,568763,1.003046085220826
Hep-G2,54618771,-1.2901934533941846
AN3-CA,44632017,0.5090157762596916
HARA [Human squamous cell lung carcinoma],5470400,2.3733756266777037
EJM,9935249,2.9209217117855903
ML-1 [Human thyroid carcinoma],11404337,0.3501599152959295
KMS-27,4261,0.5113923676120534
PaTu 8988s,216345,2.7185919890283525
NCI-H2110,11977753,-0.363959983784443
Kasumi-2,56649450,1.224051068091054
KMS-20,216345,3.908471127762827
AU565,6610216,3.647426232490327
NCI-N87,24772860,-4.531203546207334
CA46,409805,3.3808362620175187
SNU-8,54454,1.9724642800889125
MM1.S,262093,0.96316485237803
KMRC-2,7251185,3.015442118932741
D283 Med,44462760,4.193275636143645
A4/Fukuda,4096211,1.2598455852625392
MM1.S,46907787,-0.8682718758201811
AN3-CA,25227462,0.2372085595528866
YKG-1,11228183,3.6918030107166784
AN3-CA,57519531,4.872501979365299
LoVo,44185566,1.1715497148164364
NCI-H2081,9887053,1.079075391336974
Ku812,9911463,3.2535027234043428
HEC-151,16065773,3.119237421704228
KYSE-410,65064,4.338133496704831
KYSE-410,44491742,3.6208474241241473
OE21,4096211,1.2391392667305623
PaTu 8988s,53392493,2.9230199935224213
Aska-SS,168312962,3.7841820579012864
KMRC-2,9915743,0.8631489276658242
HSC-4,54678924,3.092091974621669
TE 617.T,10385095,0.7381710373926665
SNU-1272,11507802,4.459274197083698
D283 Med,72199292,-0.0739367415470992
LNCaP clone FGC,24771867,3.412877398053759
BT 330,1641662,4.904949234649615
KMS-20,11175137,2.2632484557969152
NCI-H1395,doxorubicin-navitoclax (2-1 mol-mol),0.3327602651018742
ML-1 [Human thyroid carcinoma],9952709,4.669340472029816
RPMI-7951,25154868,4.817276169138943
SEM,11317348,-1.664715379633235
BT 328,tanespimycin-bortezomib (250-1 mol-mol),-1.4953584261079875
SKM-1,753704,3.832130750350089
SW1990,11717001,5.72522940053554
OE21,54618771,-0.7908986466721764
BT 139,6610355,5.0488800183599825
NCI-H2110,11626560,1.8725648928578935
NCI-H2081,44607530,1.5089413575069657
NCI-H2110,11609586,2.483630448963632
NCI-H1395,9933475,2.0762479324148435
OE21,285033,-4.639504259676399
SEM,71729975,0.1111350195233953
NU-DHL-1,selumetinib-UNC0638 (4-1 mol-mol),1.2848172177454842
HARA [Human squamous cell lung carcinoma],25183872,-0.077265330214196
ML-1 [Human thyroid carcinoma],2113511,5.6174346670931286
KMS-20,3543504,3.2520128843169096
PaTu 8988s,25154868,5.292132269319359
A4/Fukuda,selumetinib-piperlongumine (8-1 mol-mol),1.1723483513994604
A4/Fukuda,23582824,-0.7377224087572002
MCAS,51039095,3.4523930786190937
MCAS,107985,-3.860765706660282
HARA [Human squamous cell lung carcinoma],73707398,1.6371281450925783
HEC-151,11455910,-0.546024976491568
HSC-4,5284616,2.67117659303102
MM1.S,selumetinib-GDC-0941 (4-1 mol-mol),0.5513447190034949
PaTu 8988s,11494412,1.3671050203889736
SET-2,25262965,-2.0268431974032013
NU-DHL-1,1566236,-0.7944323454419335
SNU-1033,4096211,2.270906667975924
EJM,44491742,4.208016925641279
Ku812,5351362,0.738272453823816
SNU-1214,25183872,-1.2283957727376138
ML-1 [Human thyroid carcinoma],441298,2.939924630100921
NU-DHL-1,4378219,5.179201062544345
NCI-H2110,9911830,2.0378965069300112
SKM-1,227681,3.1077347467323224
NU-DHL-1,11455910,-0.2130419418137634
SEM,613000,-0.3108787408101454
GOS-3,16659841,4.90242511664039
LoVo,10074640,2.9851259451828476
HEC-151,46215462,3.299053185970681
KMRC-2,156422,4.661743193371779
KMS-27,135440466,1.8359860014950335
KMBC-2,45279963,3.9581668191157706
SET-2,24748573,2.5163254367643515
LoVo,11396600,2.965288622606591
PE/CA-PJ34 (clone C12),42611257,3.7997794760186654
BT 330,107985,-2.041993977074398
GOS-3,216345,3.7028655718770502
RERF-LC-Ad2,3062316,0.3390724872590722
SNU-1214,10231331,0.2722984048431807
RERF-LC-Ad1,alisertib-navitoclax (2-1 mol-mol),3.5290493102127045
HCC2218,17755052,-0.3435339731300795
PaTu 8988s,selumetinib-UNC0638 (4-1 mol-mol),1.5979017868409875
Hs 683,57519531,2.6846964890948875
NU-DHL-1,9823820,3.2683941347540704
TE 617.T,selumetinib-GDC-0941 (4-1 mol-mol),0.2172055936678418
AN3-CA,36462,2.7690899161359774
LoVo,5329102,1.3429054297502294
ML-1 [Human thyroid carcinoma],53481919,4.335778865313171
AU565,11626560,1.628517095800036
MM1.S,107985,-4.097612409872881
TE 617.T,65064,3.122907491233594
NCI-H1092,11214940,3.734775459591196
D283 Med,12003241,-3.4539176227720794
HSC-4,54618164,4.183236352259565
OE21,15953870,1.724082394316485
KMS-27,44241473,4.927559459703403
NCI-H2172,44507138,4.736094102762083
PaTu 8988s,sirolimus-bortezomib (250-1 mol-mol),0.5300595749454592
EJM,3062316,1.2217642247890057
IST-Mes1,10184653,1.5276072056435492
SET-2,1566236,1.327292849582041
HSC-4,44607530,1.7156299328297433
TE-15,49793307,-3.104697903925981
BT 320,11626560,2.4160208902080713
LNCaP clone FGC,6252,0.2782127642477334
NCI-N87,24753719,4.36387060101307
A4/Fukuda,5978,-3.163562671527086
HCC2218,6852167,2.7413890151562543
TE 617.T,11707110,-2.0138618331633564
KMBC-2,11640390,3.92986275287967
KMS-20,54454,4.411646924173224
AN3-CA,16725315,2.970185923367207
HCC2218,2733526,3.8936387665194423
HARA [Human squamous cell lung carcinoma],11609586,3.326388879496588
Kasumi-2,227681,1.7835466743963533
HSC-4,10410894,2.7401570440851155
RPMI-7951,216239,2.699311777327497
HEC-151,171352865,4.287251049554932
PaTu 8988s,10074640,3.467954722409322
SNU-8,25183872,-1.2856044424153128
AN3-CA,selumetinib-PLX-4032 (8-1 mol-mol),3.6699680325080615
SKM-1,654092,-1.7907532685480716
Kasumi-2,54618164,3.8625919459899833
Hs 683,11719255,3.697399434664443
A4/Fukuda,89928392,-0.3543848103605003
NCI-H2172,16722836,1.8466753686021025
IST-Mes1,136227924,2.313131576565863
KMS-20,8515,3.454893590517526
Ku812,piperlongumine-MST-312 (1-1 mol-mol),1.051865706808779
RPMI-7951,2708,3.6014757516050113
Hs 683,6918638,0.9726484186750864
Hs 683,4378219,5.423312148170216
A4/Fukuda,1750826,-3.1003590099134284
SNU-1214,9907093,4.1629772242299365
MM1.S,11222830,1.7404282204181818
LoVo,44819697,3.398153390084315
AN3-CA,49793307,-2.78420396185601
OE21,carboplatin-UNC0638 (2-1 mol-mol),3.28101335426984
TE 617.T,72734382,4.397534859865898
EJM,26596,-3.57565028157041
SET-2,135411,-1.5084865108910783
LNCaP clone FGC,12003241,-1.977151768552247
ML-1 [Human thyroid carcinoma],crizotinib-PLX-4032 (2-1 mol-mol),2.9053104812744186
AU565,6852167,0.824199435407992
AN3-CA,24856436,0.4687169072066183
NCI-H2081,241158,4.1289817617864575
MM1.S,1641662,3.76159788149762
KYSE-410,42642645,0.880387648201634
RPMI-7951,3825829,3.4221940030653903
KMS-20,16720766,-0.6400494103311998
HSC-4,carboplatin-etoposide (40-17 mol-mol),1.986163410800157
NU-DHL-1,327653,2.351197542951544
NCI-H1092,11485656,1.8493866648869597
CML-T1,159324,0.3275039904336689
TE-15,451668,4.643080759774818
PaTu 8988s,selumetinib-decitabine (4-1 mol-mol),2.721971536386784
RPMI-7951,66577038,2.619905734292419
BT 330,15547703,3.0125474836751756
PaTu 8988s,5746,2.3512258375405235
D283 Med,6438330,1.0407570094657193
Ku812,6852167,2.7508092991832016
KMS-27,446155,1.6717794193167046
IST-Mes1,11214940,2.2228722379077857
KYSE-410,60700,0.1592027393358413
KMRC-2,2945648,3.792915068350856
A4/Fukuda,11175137,1.0544671313881684
CML-T1,2113511,4.359369559056824
SET-2,135398738,4.079297463223511
SNU-1272,675434,6.21056389373631
RERF-LC-Ad2,5460769,6.029186520623905
EJM,65628,4.064740748344536
TE 617.T,10113978,3.7033253194318054
NCI-H2110,2858523,3.1162710583015416
CML-T1,1641662,2.8295390269831464
KMS-27,11964036,0.90121658773837
Hs 683,322968,4.8398669271169705
Hs 683,5978,-5.5766481174172675
NCI-H1395,637858,2.3715473340173774
SKM-1,451668,-2.063833274943064
Kasumi-2,carboplatin-UNC0638 (2-1 mol-mol),1.808252059410855
CA46,tretinoin-carboplatin (2-1 mol-mol),4.700900152183415
Kasumi-2,5282054,2.4598760030877553
LNCaP clone FGC,25195348,3.417298777907315
OE21,2828334,6.183173525602709
SEM,11717001,4.301730945883233
SET-2,9926054,1.6776501813643687
KMS-20,2729026,2.385777395539285
SNU-1033,49766530,-1.347246040659949
HEC-151,3465537,1.222208329394757
YKG-1,3025944,4.339643197163568
SNU-1033,11404337,-1.419235655385228
NCI-H1092,2113511,4.75362905375034
KYSE-410,56649450,1.649053942309861
NCI-H2081,11977753,-1.86082433815017
Kasumi-2,46926350,-4.426429724391801
EJM,decitabine-navitoclax (2-1 mol-mol),0.2249299573101983
Raji,24797083,0.986652540468224
BT 330,25154868,5.299931833551549
ML-1 [Human thyroid carcinoma],16720766,0.621696324806819
BT 330,2842253,6.3702274717066105
HARA [Human squamous cell lung carcinoma],46199207,3.289640650109998
NCI-H2110,44607531,1.2211196147146048
NCI-N87,5470400,-1.6354434063399317
SNU-308,JQ-1-navitoclax (2-1 mol-mol),0.7322557838250645
KMRC-2,9956119,4.342871750577885
CML-T1,73707398,-0.0310412376393591
HSC-4,23725625,4.12890848458229
NU-DHL-1,3136844,3.805099216127406
RERF-LC-Ad1,136227924,3.427007002266959
PE/CA-PJ34 (clone C12),46907787,4.066257221145479
LNCaP clone FGC,5282054,2.507461271717801
Kasumi-2,9967941,2.996370075692804
SEM,3385,2.486221343421728
KYSE-410,2113511,6.262812466706523
HEC-151,3825829,3.2794548774754384
SET-2,16038120,0.992903996663106
KMS-27,1750826,-0.889143246867569
KMRC-2,9911463,4.365671191059928
GOS-3,57519531,1.810044257027968
TE-15,6852167,2.5993041449635794
RERF-LC-Ad1,ISOX-bortezomib (250-1 mol-mol),1.1789049180677365
ML-1 [Human thyroid carcinoma],2858523,3.273643216387516
NU-DHL-1,25227462,-4.640207660582911
LNCaP clone FGC,25062766,1.6324812543548115
EJM,selumetinib-tretinoin (2-1 mol-mol),5.075808196107974
TE 617.T,208908,-0.8702085838150805
MM1.S,409805,4.03743481309792
CML-T1,439501,-2.361432010025089
HEC-151,49850262,3.872671430576316
SNU-8,72193861,0.8736863386386848
MM1.S,24856436,-0.1487659765377816
KMS-20,448949,1.7182131870831587
LoVo,54626689,4.759845357486115
AU565,11960529,4.91307375329511
SEM,135440466,0.4390195175312653
PE/CA-PJ34 (clone C12),375860,-0.361568415532625
RPMI-7951,5282054,3.73037875419875
YKG-1,2113511,6.330776905666784
NCI-H1092,148124,4.484868615111272
Aska-SS,25062766,3.8645676552270865
PE/CA-PJ34 (clone C12),445455,5.711009055392974
OE21,5113032,4.566089749491281
BT 139,53232,4.606115897907571
NCI-H2081,52912189,1.203290286041043
AN3-CA,3854666,0.7881289812333258
EJM,selumetinib-decitabine (4-1 mol-mol),1.790992102358079
NCI-H1395,5282054,4.370285426965396
Ku812,446155,2.2243145788030496
ML-1 [Human thyroid carcinoma],7251185,4.28899372473645
NCI-H2110,11404337,1.6337523371229576
HMCB,10127622,5.814733445969234
KMS-20,44620216,3.7048661868251536
Kasumi-2,6252,-4.69021119640851
HMCB,44589607,2.914653389177592
SKM-1,71466380,3.1609741047778965
EJM,753704,3.6448847004253055
HARA [Human squamous cell lung carcinoma],2858523,2.980861882613042
ML-1 [Human thyroid carcinoma],24951314,0.9772476096511332
CML-T1,sirolimus-bortezomib (250-1 mol-mol),-2.349010287951753
CA46,25161177,3.91788686206549
AU565,3136844,3.8072298284959385
NU-DHL-1,46199207,3.5516049097640243
NCI-N87,56963564,-0.4773091963101655
ML-1 [Human thyroid carcinoma],2949965,3.680012286367402
HEC-151,374536,2.760377421474409
SW1990,136227924,4.2742525725591864
SNU-1214,5978,-1.5940747604494143
A4/Fukuda,25227462,-5.883792654516593
PE/CA-PJ34 (clone C12),11152667,0.0112826586729411
SW1990,1750826,-1.720199004206297
Kasumi-2,25062766,0.6905738640208902
Kasumi-2,44607530,0.8991199704837235
BT 139,9866186,3.845827958746893
SNU-1272,6917907,-2.5782962145708295
BT 320,89928392,3.842726131224359
HARA [Human squamous cell lung carcinoma],9444,4.21141613858085
LNCaP clone FGC,11427553,3.334144293197662
TE 617.T,67156097,-2.0932175014499244
SW1990,3854666,4.405402240089115
Raji,23582824,3.0012319575717092
TE 617.T,9826308,1.164230071049112
HMCB,72193861,1.1610146616364858
BT 330,676352,2.486537166636609
D283 Med,11964036,0.8770173052283631
SKM-1,5746,0.5128586399928746
NU-DHL-1,selumetinib-BRD-A02303741 (4-1 mol-mol),1.320938208731918
RERF-LC-Ad1,25183872,4.290443599779795
NU-DHL-1,60700,-4.437717551634179
SNU-1214,51039095,2.453803390320648
SW1990,445643,3.875026525774262
BT 139,119607,5.955834117102029
LoVo,selumetinib-GDC-0941 (4-1 mol-mol),0.7605582392782264
CML-T1,44819697,-2.8753334506591504
A4/Fukuda,sirolimus-bortezomib (250-1 mol-mol),-5.340339704000633
HEC-151,6917907,-8.293051303885992
NCI-H1092,227681,1.9884114901843049
KMS-27,24951314,0.3454296251372741
SET-2,637858,1.0371530211435662
PE/CA-PJ34 (clone C12),44607530,0.8156299641770444
Ku812,65064,2.9938168255221234
Raji,4788,5.107202303225676
Kasumi-2,15547703,3.1022786704275394
CML-T1,176870,2.5950096151434345
NCI-H2081,54626689,4.922665584817983
NU-DHL-1,9927531,5.134600574788464
EJM,24797083,0.92088604751269
PE/CA-PJ34 (clone C12),107970,2.3192518543827476
KMS-27,4259181,-1.1469286160575058
CML-T1,135440466,1.4712310181015782
MM1.S,60700,-1.118985990176223
NCI-H2110,72376,-1.2241994360828286
TE-15,5311,1.424175872597402
RERF-LC-Ad1,52912189,6.211834521603204
KMRC-2,5328940,2.384373805479353
LoVo,4096211,0.5868958804653562
OE21,15547703,2.5365503437817263
SEM,168312962,2.860671737666069
BT 248,5278396,3.9189937549477545
SNU-8,3384730,2.821449347547462
AU565,387447,-4.131425766006191
BT 248,11222830,0.9088188698521174
HEC-151,327653,2.9802978395573123
HEC-151,49766530,-0.2709325293810298
IST-Mes1,3689413,0.9013533734229402
Hs 683,71466380,4.422250293269032
BT 320,24797083,3.954904976663047
SEM,navitoclax-sorafenib (1-1 mol-mol),-3.0874607200488975
A4/Fukuda,4261,-0.9007526332595048
KMRC-2,2749,6.275179909532919
Hs 683,alisertib-navitoclax (2-1 mol-mol),-1.5712729640696714
Ku812,navitoclax-pluripotin (1-1 mol-mol),-5.237528282763509
SW1990,25161177,4.580361629509595
KYSE-410,64971,2.2623618573953035
SKM-1,6438330,1.742877849242422
NCI-H2110,2733526,4.313644509385281
Raji,135875424,2.0989109294233264
PE/CA-PJ34 (clone C12),1750826,1.4658207982474565
SW1990,selumetinib-UNC0638 (4-1 mol-mol),2.944809271766447
TE 617.T,11609586,0.4827523694476935
MCAS,11175137,3.0218199031977324
GOS-3,9926054,2.0544356724695776
OE21,crizotinib-PLX-4032 (2-1 mol-mol),1.31959608862987
BT 248,2858523,2.3138600326756436
SEM,136227924,1.2424830449991908
HCC2218,89928392,0.2292477103613163
AU565,tanespimycin-gemcitabine (1-1 mol-mol),-2.222908317148695
IST-Mes1,1566236,1.9315527075511711
SNU-1214,6914657,-4.451170657925107
SNU-1214,24772860,-2.6292403304682197
CA46,9927531,3.0223750820915978
SNU-1214,327653,3.7315085171271742
PE/CA-PJ34 (clone C12),4261,2.8870037717787307
Raji,16720766,-0.0176101372134706
NCI-H1395,52912189,3.2257776206607205
SW1990,25062766,1.7290899582352826
MM1.S,9915743,0.5251517896588939
Ku812,16725315,3.503963255457298
TE 617.T,44620216,3.671019031819898
KMS-20,54618795,2.973934546624762
NCI-N87,11175137,1.8903805503335804
LNCaP clone FGC,3543504,3.746355174755062
Hs 683,10302451,3.704535359284315
KYSE-410,4261,2.0189298285374724
NU-DHL-1,11717001,3.5993200450588634
BT 320,6610216,4.229919303269505
Kasumi-2,erlotinib-PLX-4032 (2-1 mol-mol),2.6918027963335827
KYSE-410,135984461,4.6292418393207235
SNU-8,46224516,2.6221554593886935
SW1990,104842,-4.21160579314145
SKM-1,72734382,3.266871379316779
BT 248,444795,4.817055384579841
KMS-27,10113978,3.1128677638338274
SEM,446155,3.622162137038395
Raji,107970,1.9902567284357284
AN3-CA,5328940,2.159766358768341
NU-DHL-1,6918638,-1.28362156468715
NCI-H1395,1716436,2.423237318066945
TE-15,4096211,1.1922951600653937
NCI-N87,11364421,-4.7214998150919065
SEM,navitoclax-pluripotin (1-1 mol-mol),-2.998871592273369
Raji,44493528,4.013963979075194
SET-2,67291369,1.628396214067084
A4/Fukuda,25105715,3.290295740743095
RPMI-7951,56963564,-0.4899477969524511
IST-Mes1,alisertib-navitoclax (2-1 mol-mol),2.2852376454563896
HSC-4,3543504,3.922868331711394
RERF-LC-Ad2,11427553,3.2032799731483355
KMS-27,JQ-1-vorinostat (2-1 mol-mol),-1.434696398320996
NCI-H1092,46843906,3.6069684847393666
RPMI-7951,122327,4.401671664381031
CML-T1,54618164,3.634689828068523
IST-Mes1,2113511,6.40207592921409
NU-DHL-1,JQ-1-UNC0638 (2-1 mol-mol),-1.1533967446161832
LoVo,11626560,0.8234069861143318
NCI-H1395,400769,0.1156241429574924
SNU-1214,16038120,-0.3379155033922369
BT 139,322968,3.0519168490050377
KMBC-2,24856436,1.133565283278238
NCI-H2110,16725315,5.265709205943982
Hep-G2,5470400,-2.8506942607066943
NCI-N87,44137675,2.149558923433186
KMBC-2,25227462,1.5498003806223235
RPMI-7951,3025944,4.282884400108956
LoVo,9936388,-7.372990206557469
KMS-27,tanespimycin-gemcitabine (1-1 mol-mol),-4.329009308752247
HEC-151,176870,3.1650788397927014
NU-DHL-1,9935249,0.0276338554577939
GOS-3,piperlongumine-MST-312 (1-1 mol-mol),1.994862701912013
KMRC-2,selumetinib-navitoclax (8-1 mol-mol),2.5033979772822934
CML-T1,6852167,0.9836314645814764
PaTu 8988s,216239,1.879765133929404
TE-15,36462,0.8303129579402212
RERF-LC-Ad2,selumetinib-tretinoin (2-1 mol-mol),5.38502918958907
ML-1 [Human thyroid carcinoma],11612883,2.523942692100722
SET-2,11213558,-0.1598016097823202
KMBC-2,44462760,4.169877786786469
Ku812,navitoclax-sorafenib (1-1 mol-mol),0.8229949370688716
PaTu 8988s,11404337,-0.6739371473320328
KYSE-410,151289,3.1282412096438477
AN3-CA,1566236,1.2128002285671464
Kasumi-2,3465537,0.5812514796989715
OE21,44493528,4.16320367055504
Kasumi-2,52947716,-3.704060756771708
D283 Med,2113511,4.840177237246556
NCI-N87,46398810,2.1002609832839187
HMCB,54678924,1.6823171066105604
AU565,445643,3.872431437053606
AU565,2729026,2.5804084357046033
SET-2,3634881,2.666088197706586
D283 Med,9933475,1.5513206335845269
RPMI-7951,9956119,1.9401474518949864
LoVo,3385,1.4948122184820352
LNCaP clone FGC,46943432,1.061880867154241
CA46,227681,1.829365253324193
TE-15,11404337,-0.7391616924820064
A4/Fukuda,252682,6.117343290485243
EJM,6852167,1.8935710220557025
LNCaP clone FGC,11364421,-5.720348695353833
HEC-151,11175137,1.9694841907666147
SNU-1033,piperlongumine-MST-312 (1-1 mol-mol),1.4896523298912026
PaTu 8988s,9967941,1.4650396579971054
TE 617.T,44486219,4.035845763911834
YKG-1,216239,3.3317563893959377
HARA [Human squamous cell lung carcinoma],16736978,1.7495486591528322
LNCaP clone FGC,1750826,0.7741819365239112
SET-2,104842,-5.7974789199415655
BT 330,11222830,1.4594926246246218
NCI-H2110,24785538,0.2009701166765833
Kasumi-2,46215462,1.2219116069395664
SW1990,selumetinib-vorinostat (8-1 mol-mol),3.2800234723001016
TE-15,374536,3.2802674358624926
BT 330,409805,3.8422840862788386
HEC-151,docetaxel-tanespimycin (2-1 mol-mol),-4.438217342936677
LoVo,6610216,4.332472846182503
HCC2218,4917,2.6450259941081535
ML-1 [Human thyroid carcinoma],10184653,1.3933805894109417
NCI-H2110,5282054,4.116451043017715
ML-1 [Human thyroid carcinoma],54613361,1.1529799235720395
ML-1 [Human thyroid carcinoma],67156097,-0.9782117982072136
Ku812,46199207,2.6759001741675372
NU-DHL-1,5738263,2.6843790569826536
D283 Med,11228183,0.836865512138477
HEC-151,3385,3.772390411553772
SNU-1272,JQ-1-UNC0638 (2-1 mol-mol),2.22691909239422
MM1.S,969516,2.341213349507295
HSC-4,9825149,2.985341504866837
A4/Fukuda,51037431,0.9928208538339424
KMBC-2,24951314,1.4260955032902127
TE 617.T,54143018,0.9097668622902736
SEM,984333,-2.6792255714981295
Raji,17755052,2.273004041581242
SNU-8,selumetinib-MK-2206 (8-1 mol-mol),0.7228558487827623
SKM-1,23939,4.408683246884893
BT 320,2858523,3.05792743854883
IST-Mes1,5351362,3.046296530947078
SW1990,11175137,2.8268727027301557
TE-15,navitoclax-pluripotin (1-1 mol-mol),-0.7527292133388892
GOS-3,100016,7.242262816552233
NCI-H1092,753704,4.364704525984801
NU-DHL-1,246676,5.479524719053534
SKM-1,9915743,-0.8868720134451151
Kasumi-2,6914657,-5.1533998646952925
PaTu 8988s,11626560,1.379807477109151
PE/CA-PJ34 (clone C12),BRD-A02303741-navitoclax (2-1 mol-mol),3.842627181356933
AN3-CA,5281321,-1.191778330255899
ML-1 [Human thyroid carcinoma],doxorubicin-navitoclax (2-1 mol-mol),-2.7240522304333763
RPMI-7951,navitoclax-gemcitabine (1-1 mol-mol),-1.9936108856149684
LoVo,5281321,-2.272723057934536
SNU-1033,227681,3.718667619088726
Hep-G2,71466380,3.1584053277092696
NCI-H2110,JQ-1-vorinostat (2-1 mol-mol),1.1663353184581713
NU-DHL-1,2749,0.1316403537643747
SNU-1272,5470400,5.593661886100306
KMRC-2,9911830,1.0904583461694266
CA46,11977753,-4.21997551918338
PE/CA-PJ34 (clone C12),135659046,3.607473265136562
IST-Mes1,4261,1.7623274186426838
HARA [Human squamous cell lung carcinoma],erlotinib-PLX-4032 (2-1 mol-mol),3.6972893846800545
KMBC-2,crizotinib-PLX-4032 (2-1 mol-mol),2.655410383048939
TE 617.T,9884685,-0.3777668305269445
EJM,9826308,-0.8928202360474983
NCI-H2110,5460769,2.6451142093153326
Aska-SS,10427712,3.984050891681042
SNU-1033,docetaxel-tanespimycin (2-1 mol-mol),0.7558284849800709
BT 248,67156097,4.587573075901519
EJM,613753,3.047876123022861
LoVo,navitoclax-pluripotin (1-1 mol-mol),-2.104287475086767
NCI-H2110,9935249,3.1608776626158432
AU565,9935249,2.085801217703038
SW1990,46215462,1.636650619537341
PE/CA-PJ34 (clone C12),11626560,2.4969016411570117
BT 248,9884685,-0.279602051509792
KMS-20,5470400,3.66095099823791
Hs 683,4788,6.010266672743516
CML-T1,46943432,2.522264418529326
MCAS,5311,1.443638775726388
SEM,5470400,1.0027675108194032
BT 330,4705,1.8638133419743137
NCI-H2081,1716436,2.350567267109174
Kasumi-2,216468,0.9994844042695143
Hep-G2,168313016,5.1281820641860545
RPMI-7951,JQ-1-UNC0638 (2-1 mol-mol),1.9085754129843169
SKM-1,SNX-2112-bortezomib (250-1 mol-mol),-3.517071278236208
PaTu 8988s,421610,3.586133279881709
KMS-27,doxorubicin-navitoclax (2-1 mol-mol),-3.301354518616035
A4/Fukuda,3081361,1.810117399969756
Ku812,25062766,1.6116262467918423
D283 Med,11955716,-2.6841002299683336
ML-1 [Human thyroid carcinoma],56946209,-4.214217670545523
YKG-1,sirolimus-bortezomib (250-1 mol-mol),0.0311399701967428
PaTu 8988s,9929138,5.293231117903689
HEC-151,656346,0.6910223701420927
NCI-H1092,navitoclax-birinapant (1-1 mol-mol),1.7535361576658914
D283 Med,45279963,2.3359358447892093
OE21,3025944,4.106709914382062
AN3-CA,6914657,-5.228653700421252
TE 617.T,25126798,3.397946475866573
PE/CA-PJ34 (clone C12),262093,3.186494210920842
NCI-N87,44607531,-2.3963447234482196
PE/CA-PJ34 (clone C12),JQ-1-UNC0638 (2-1 mol-mol),1.4419134854320173
Hep-G2,5566,2.9766368191633545
KMS-20,71729975,0.4297208720314417
A4/Fukuda,71304818,1.5363144884487692
A4/Fukuda,selumetinib-decitabine (4-1 mol-mol),-0.8212818207724355
SNU-8,327653,3.195636469676862
Hs 683,71751553,4.288998179151866
BT 320,24951314,2.328206990278251
Hep-G2,vorinostat-carboplatin (1-1 mol-mol),2.5677353378270453
Kasumi-2,10184653,1.2356790109659648
Hep-G2,3025986,-0.5782752651876217
D283 Med,6252,-2.3531201064109526
NCI-H2110,262093,4.10340668622513
MM1.S,42642645,-0.2096887803746246
SW1990,tanespimycin-bortezomib (250-1 mol-mol),-3.036947159692904
NCI-N87,3081361,1.4568926260691408
Hep-G2,44507138,3.1613379759015845
AN3-CA,3136844,5.019620857220237
NCI-H2110,36462,0.5226581571760742
PE/CA-PJ34 (clone C12),selumetinib-GDC-0941 (4-1 mol-mol),0.7203053018358525
A4/Fukuda,16722836,0.6102638619225811
ML-1 [Human thyroid carcinoma],46398810,2.1486791434985344
Ku812,387447,-5.271865105209625
MCAS,2746,3.159271623653468
D283 Med,11238147,1.1761560661302457
LNCaP clone FGC,6610216,3.917804193778173
BT 330,9884685,0.2489393167095227
SNU-1214,3689413,-0.7711373431609502
KYSE-410,122327,4.394987930415306
CA46,11167602,1.6890466560929325
HCC2218,5291,3.9239941781881216
CML-T1,216468,0.1350088901202253
MM1.S,9908783,5.963347561700224
SW1990,9911463,4.278474352365717
SNU-308,1242560,3.771174309636351
HCC2218,46174525,3.5633372392386224
YKG-1,51039095,2.966618349513072
ML-1 [Human thyroid carcinoma],6918837,-4.218663166819277
SKM-1,selumetinib-PLX-4032 (8-1 mol-mol),-3.711046707808481
A4/Fukuda,54454,2.014078017992857
AU565,3465537,1.0667310492419344
NCI-H1395,6610216,4.652818435628847
AN3-CA,6610216,4.1751650141546826
OE21,2949965,2.11775663365824
AU565,25227462,0.9575642046813388
HSC-4,6918328,0.4827098957230251
SNU-308,9877608,6.965514964870985
SKM-1,19582717,2.678138329760968
PaTu 8988s,176870,3.825949689559086
KYSE-410,9952709,3.3732272384526265
Ku812,168313016,4.091505378923506
SNU-8,5328940,1.340184233172612
MCAS,613753,4.7352169808443305
Hs 683,1242560,3.640721837691029
Ku812,3025986,-0.7700675438788807
BT 139,10113978,3.580002932334986
CML-T1,441298,0.5187670078326817
SNU-1033,23582824,0.7558818085524805
LoVo,327653,2.9108064375514604
CA46,11214940,-0.2735426892992921
HCC2218,445643,3.270243804562818
NCI-N87,168312962,2.346349065468924
AU565,52947716,0.8422274137680903
SNU-1272,71304818,2.26244025747745
SET-2,4259181,0.1167213945949705
Kasumi-2,400769,-1.337956311995758
MM1.S,9840324,5.541225191096644
HMCB,448949,2.7592399466934516
YKG-1,8515,4.7576372381485
SNU-8,carboplatin-etoposide (40-17 mol-mol),3.8322598256715543
SET-2,3025944,3.2400035641971514
PE/CA-PJ34 (clone C12),16219061,2.427956187970103
BT 328,44819697,-1.602072753607262
Hep-G2,9911830,2.4259359362723147
NCI-H1395,tanespimycin-gemcitabine (1-1 mol-mol),4.210954263258385
RERF-LC-Ad2,tretinoin-carboplatin (2-1 mol-mol),5.31055335503166
HEC-151,46907787,1.109021567995486
SET-2,11228183,-0.1721778083662545
OE21,44632017,0.6503868556767491
TE 617.T,6450551,3.191526585759877
EJM,44462760,3.937355169319973
D283 Med,151289,0.5549046196657793
NCI-H2081,24964624,2.0878863741822395
SNU-8,445455,4.353348054039297
LNCaP clone FGC,8515,4.149767079879017
RERF-LC-Ad2,4578,5.041786487447376
NCI-N87,3634881,3.127468365851455
SNU-308,65064,5.346277065283632
BT 139,ISOX-bortezomib (250-1 mol-mol),0.8371078463924151
TE-15,156414,-3.941980071268382
SNU-308,11964036,0.9815562264956836
MCAS,49766530,-0.3094916991443784
AN3-CA,crizotinib-PLX-4032 (2-1 mol-mol),1.4874439223623748
D283 Med,675434,4.226898122057941
RPMI-7951,docetaxel-tanespimycin (2-1 mol-mol),-5.319642676447243
NCI-N87,11404337,-0.8803091706648726
MCAS,selumetinib-tretinoin (2-1 mol-mol),3.7245773647682503
SET-2,135421197,1.735218850040683
Hs 683,71304818,2.49706068927472
KMBC-2,5328940,2.0515381672179305
HARA [Human squamous cell lung carcinoma],salermide-PLX-4032 (12-1 mol-mol),5.233652502193764
ML-1 [Human thyroid carcinoma],126941,-2.044263255039902
HEC-151,159324,2.248651561242496
RERF-LC-Ad2,53495165,-0.0238297802129515
BT 320,6917907,3.364777316338114
SNU-1033,3689413,-2.6391429266703015
RERF-LC-Ad2,60700,1.5764321460020152
SNU-308,4261,2.7469296008750845
NU-DHL-1,9903786,2.0090459538270298
NCI-N87,11683005,3.6426598339920297
PE/CA-PJ34 (clone C12),5281672,4.445747577315385
NCI-H1092,444795,4.269979452389004
SNU-308,5287620,-2.917824809068675
LNCaP clone FGC,71751553,4.050545611826545
HEC-151,216345,3.2233459330078316
A4/Fukuda,445455,4.756694709293823
SW1990,16219061,3.467469065240219
D283 Med,46843906,0.2520687270302775
LoVo,53392493,2.4765619401689154
Ku812,doxorubicin-navitoclax (2-1 mol-mol),-2.802907461854501
MM1.S,73707398,0.3713750235386087
LNCaP clone FGC,11175137,1.5358821473222088
MM1.S,24797083,1.1984729512209644
SW1990,19582717,5.28624367684453
BT 330,15953870,3.8560811614803696
SKM-1,6918328,-1.5551778635865745
SNU-1272,31703,1.4762999099427376
KMBC-2,7251185,2.346374978663141
HARA [Human squamous cell lung carcinoma],24964624,2.781169175627229
NU-DHL-1,60750,-6.327200330067859
Raji,135411,0.5014739051384897
PE/CA-PJ34 (clone C12),25154868,5.263511922776674
SW1990,11977753,-2.174403412887458
NCI-H2110,168313016,5.8271641700116215
NCI-H2110,selumetinib-piperlongumine (8-1 mol-mol),4.320159489938801
ML-1 [Human thyroid carcinoma],322968,3.685498672876688
SNU-8,4259181,-0.24228140638784
OE21,100016,6.577886119924336
TE-15,11647372,1.9040962473693783
Ku812,carboplatin-etoposide (40-17 mol-mol),2.1492601350964606
KMS-20,erlotinib-PLX-4032 (2-1 mol-mol),2.78905431504454
SEM,702558,2.631789406831085
Kasumi-2,5328940,0.1344355450802072
KYSE-410,5311281,2.9358960951405817
HCC2218,12003241,-0.1021817446699859
HARA [Human squamous cell lung carcinoma],55508,3.1590088041564752
SNU-8,135440466,2.5469173905619
BT 320,46398810,3.263265417740268
A4/Fukuda,119182,-4.160589878424858
A4/Fukuda,9915743,-0.3554458205966057
YKG-1,16725315,5.438032591098022
RERF-LC-Ad2,31703,1.0316481375838702
A4/Fukuda,tretinoin-carboplatin (2-1 mol-mol),3.3716994915899945
NCI-H1092,2746,3.1114505923007583
HEC-151,44137675,3.543841403432853
MM1.S,11238147,1.6949017998059208
Hep-G2,71466445,2.837099504530813
BT 320,4261,3.457041279765096
SNU-1214,73707398,0.3322136890505088
HEC-151,2749,0.6701627119421153
MCAS,4477,1.7344664635493
SNU-308,docetaxel-tanespimycin (2-1 mol-mol),-2.0146386685461692
KYSE-410,46215462,2.1860497248848074
SNU-1033,31703,0.0483483778174432
KMS-20,26596,-2.568893435013116
SNU-1214,9929138,6.834852342367116
SNU-8,5282054,3.706785624209938
D283 Med,15983966,-4.384389226245483
PE/CA-PJ34 (clone C12),11719255,3.7761142192038353
SW1990,9840324,6.0153251354755914
Ku812,11404337,-0.6784609129861706
PaTu 8988s,9840324,5.988728279946886
BT 248,82146,3.895792146901818
AU565,11178236,-4.26632575473861
HSC-4,23582824,-0.585849233367442
NU-DHL-1,72193861,-0.4414983831950781
NCI-H2081,135999136,1.634974352928294
SNU-8,25150857,2.244462666981657
PE/CA-PJ34 (clone C12),5291,4.131665147466615
SW1990,2828334,6.278483653876946
SNU-1272,44489675,3.6917039980316297
GOS-3,6918638,1.663921744527482
BT 320,7251185,3.9998923472411008
MM1.S,10385095,0.5772741744912003
NCI-H2081,11222830,0.8960915766388172
BT 320,400769,-0.2737977451215982
RPMI-7951,11152667,-2.388321573678012
SEM,tanespimycin-gemcitabine (1-1 mol-mol),-6.855613835545683
PE/CA-PJ34 (clone C12),9933475,1.703658812980445
Kasumi-2,23725625,0.6917734152233637
HEC-151,135398738,3.56789949879182
KMS-20,54618771,0.3177440488164709
BT 320,2828334,6.462824713587457
CML-T1,219104,2.3392357294314055
SEM,11214940,0.7713690657909067
A4/Fukuda,126941,-4.18863393868508
BT 139,56649450,2.9826205065713745
KMRC-2,selumetinib-MK-2206 (8-1 mol-mol),3.0125560396841786
D283 Med,5746,-2.9158663455035434
Hs 683,10127622,4.848321205774742
EJM,11404337,-0.4702991542329423
SW1990,9903786,3.346032701157222
BT 330,4521392,4.71297125211208
CA46,2733526,4.193969711090682
Raji,serdemetan-SCH-529074 (1-1 mol-mol),2.061630355858183
NCI-H2110,135928012,4.809338380726518
SKM-1,2113511,5.805612167808562
TE-15,tanespimycin-gemcitabine (1-1 mol-mol),-0.1853120012449584
A4/Fukuda,5281672,3.917758560865086
NCI-H1092,4705,2.99261822421246
MM1.S,SNX-2112-bortezomib (250-1 mol-mol),-2.3785977719805595
IST-Mes1,49867926,4.44564652397053
AN3-CA,15983966,-4.416614083786217
YKG-1,16722836,2.573532003620113
NCI-H1092,11427553,2.7182169046328837
BT 330,56963564,0.9178396039866584
Aska-SS,9915743,4.6132993472825765
RERF-LC-Ad2,126941,-4.128221669961258
TE-15,136227924,4.530652264188515
SW1990,6918837,-2.228569736722479
KYSE-410,BRD-K27188169-navitoclax (2-1 mol-mol),3.7266510041041463
Ku812,60750,-5.176437907735511
HEC-151,selumetinib-GDC-0941 (4-1 mol-mol),1.9023911399430904
NCI-H2081,11238147,1.888813561617346
Kasumi-2,44185566,0.8464196954941686
TE 617.T,5311281,1.5821805256738954
KMBC-2,49766530,0.6316468025143787
CA46,11656518,1.817934601803022
MCAS,piperlongumine-MST-312 (1-1 mol-mol),1.212907637048482
HSC-4,613753,3.3632883902358715
PaTu 8988s,66577038,3.044910362978071
SNU-8,46398810,2.415375163446902
KMBC-2,53393127,4.084787929931407
HSC-4,216345,4.5807127841732775
LoVo,135411,-0.4629764704945864
SKM-1,crizotinib-PLX-4032 (2-1 mol-mol),0.9277132426054632
SEM,24775005,3.6246781660471794
NCI-N87,24180719,3.957157119616887
EJM,5291,3.786529645155132
SNU-1033,49793307,-3.819770558923537
NCI-H2172,9825149,2.304858157045072
NCI-H1395,11626560,2.322318216024447
Ku812,17755052,2.1126549747307535
BT 330,46199207,1.6849129944487666
KMS-20,24821094,3.078317328475283
HCC2218,11964036,1.3824566955772797
RPMI-7951,25183872,-1.0536451007514205
GOS-3,12001922,1.73057519179838
LNCaP clone FGC,208908,1.9496007840678085
SET-2,crizotinib-PLX-4032 (2-1 mol-mol),0.7395547134989802
Kasumi-2,12003241,-2.245419673861097
CML-T1,5281321,-0.1268784610637486
SET-2,5284329,2.750889251948025
RERF-LC-Ad1,107970,2.434538597740863
PE/CA-PJ34 (clone C12),135984461,4.299717419292052
NCI-H2081,168313200,2.364564714683474
SET-2,3062316,1.708959853761753
SEM,46174525,1.2921885913164932
OE21,374536,3.562547341164509
OE21,71304818,1.669793656395023
RPMI-7951,doxorubicin-navitoclax (2-1 mol-mol),-2.741205682713804
SW1990,vorinostat-carboplatin (1-1 mol-mol),4.185330295794131
BT 330,2708,4.477643165741568
KMS-27,5280436,3.782674761872888
Hs 683,selumetinib-MK-2206 (8-1 mol-mol),3.2513983070328805
SEM,16720766,-0.2754839165177884
NCI-H2081,16720766,0.6801529058840203
KMBC-2,122327,5.100342441776212
NU-DHL-1,5479543,3.232300897170713
SEM,68056272,3.037181097799154
HCC2218,9952709,2.8174958163995427
MM1.S,44607531,1.436632189629932
MCAS,11640390,3.637750239974848
KMS-20,5113032,5.7855573183073785
BT 330,44589607,2.8465871158327265
NCI-H2110,11152667,-0.5579192362236717
KMS-20,6918736,-1.6214038389500036
NCI-N87,72376,-2.7230406051655676
TE 617.T,25102847,2.403945205063307
BT 248,2828334,5.879853395133371
PE/CA-PJ34 (clone C12),5738263,2.3523932159562144
SEM,16038120,-1.4644891288976194
SNU-8,135984461,1.5881449503105405
KMS-20,11626560,1.153431092647739
RERF-LC-Ad2,12003241,0.07971757119013
LNCaP clone FGC,selumetinib-MK-2206 (8-1 mol-mol),2.0330759913309437
SNU-1214,135984461,4.331180195663339
SW1990,4917,3.708163725655013
NCI-H1092,6914657,-5.953361692198434
CML-T1,ISOX-bortezomib (250-1 mol-mol),-0.7676441178316211
SNU-1214,10127622,1.5590297578060857
SKM-1,5311281,1.1395980087167572
MM1.S,24901704,2.7745891166557786
IST-Mes1,44185566,3.025290337876495
BT 320,123631,3.381923883037432
NCI-H2081,55508,1.4698718095491496
BT 330,25062766,3.0536121535083587
TE 617.T,11656518,1.2463696913193645
CA46,208908,1.4900061271350116
KMRC-2,25154868,5.42308156728812
BT 320,5566,3.007077893151021
SKM-1,10113978,1.631549527430136
TE-15,24964624,2.6946677854492367
Kasumi-2,3634881,1.9476495169521624
AU565,11497983,3.5183187315924185
D283 Med,navitoclax-birinapant (1-1 mol-mol),0.5906558429150628
NCI-H2110,erlotinib-PLX-4032 (2-1 mol-mol),2.7310792101368175
HEC-151,JQ-1-carboplatin (1-1 mol-mol),1.2344499659819954
Hs 683,navitoclax-sorafenib (1-1 mol-mol),2.3387746809474823
NCI-H1395,65064,5.358143004384587
NCI-H1395,9926054,1.836702615994444
A4/Fukuda,36462,-0.7730347482869518
IST-Mes1,11507802,2.196367921071978
NU-DHL-1,11964036,-0.3211090677795742
Aska-SS,9935249,3.1640243411747666
KMS-20,44491742,3.719914001289463
LNCaP clone FGC,60700,-1.3738906500494386
NCI-H2081,24748573,1.609194979965708
SET-2,122327,4.075304929861821
RPMI-7951,carboplatin-etoposide (40-17 mol-mol),2.086794328183726
BT 139,216239,2.0237892251606513
AN3-CA,148124,-1.73779448723161
HSC-4,crizotinib-PLX-4032 (2-1 mol-mol),2.8141472051881076
BT 330,5287969,-1.4719993323531353
LoVo,selumetinib-UNC0638 (4-1 mol-mol),1.1151231376311057
Hs 683,24978538,3.02239694191792
A4/Fukuda,135398738,0.2588260022635366
CA46,122327,3.963727711050333
SET-2,5281321,-3.932606276737236
MCAS,104842,-2.5817593322889625
KMS-20,9952709,2.6593366876189717
KYSE-410,11396600,3.754375595740645
MCAS,6918878,0.9071397786754258
NU-DHL-1,11719255,1.476075031302051
TE 617.T,9915743,-4.6063841978227
HARA [Human squamous cell lung carcinoma],5281321,-1.682952924947167
Kasumi-2,11175137,1.5162390215690418
NCI-N87,6918878,2.817621762559668
AN3-CA,54613361,0.6928239140558707
NCI-N87,216345,3.97830172236079
HCC2218,doxorubicin-navitoclax (2-1 mol-mol),0.3064126907990808
NCI-H2110,6450551,1.873911800645245
LoVo,1716436,2.86184708699294
ML-1 [Human thyroid carcinoma],25150857,2.4072078224567486
KYSE-410,3825829,3.948132670947577
AU565,11214940,0.9865925706012508
KMS-27,1641662,3.015780749094616
AU565,31703,-1.2264921928318224
SNU-1214,439501,-2.3459859921965793
Hep-G2,3503,2.878453369176515
SET-2,5566,3.01113622374019
BT 248,6852167,2.795606288509473
NU-DHL-1,17755052,-0.6529178657406193
KMS-20,crizotinib-PLX-4032 (2-1 mol-mol),1.622375633570859
LoVo,sirolimus-bortezomib (250-1 mol-mol),0.1095810263563626
IST-Mes1,selumetinib-GDC-0941 (4-1 mol-mol),2.032921854049634
SET-2,2871966,-0.0579957240311698
CA46,7251185,0.9564015595877396
BT 330,24748573,2.0465375235525176
LNCaP clone FGC,1242560,3.3033179259269887
KYSE-410,16725315,3.3139770396099943
SNU-1272,3689413,0.1489687776606243
BT 139,54626689,5.014806632611532
SNU-1272,1716436,3.918709850381952
Hs 683,81146,4.863086263601974
SET-2,216239,1.8893520946498368
SNU-8,selumetinib-PLX-4032 (8-1 mol-mol),2.081334250605702
KMBC-2,107985,-4.329865422149039
EJM,9907093,4.11164993118498
SNU-1033,10184653,1.4967757543250255
TE-15,3011155,4.33060770882189
RPMI-7951,56946209,-3.4543929986035717
KMS-27,44507138,1.0396730145947588
SET-2,462382,0.4973532947572526
PE/CA-PJ34 (clone C12),16722836,1.614238744479456
RERF-LC-Ad1,selumetinib-decitabine (4-1 mol-mol),6.00514087254069
PE/CA-PJ34 (clone C12),5278396,3.888828333623774
AN3-CA,selumetinib-decitabine (4-1 mol-mol),5.583042753450803
AU565,9967941,3.769081839228565
SNU-308,107985,-2.764112061523982
NU-DHL-1,decitabine-carboplatin (1-1 mol-mol),-0.9080396977162584
YKG-1,148124,-3.4477323343219637
SEM,24753719,1.9867479465315392
NCI-H2110,46926350,-4.246677806016688
IST-Mes1,46843906,1.738626305357275
BT 320,136227331,4.5584663350036605
BT 248,11647372,0.9807519416972552
Ku812,54454,3.828644257456088
BT 139,25161177,3.287797573016262
KYSE-410,72193861,2.3574856526220076
PE/CA-PJ34 (clone C12),241158,3.3825380068249276
NCI-H2110,613753,3.1736011398703226
OE21,11427553,2.458070036132566
NCI-H2172,11396600,4.171717068415809
NCI-H2110,54618771,2.4596551535175504
SKM-1,2946601,6.482572504848425
BT 330,68056272,3.791659523244117
KYSE-410,36314,-5.691724228748092
SKM-1,15983966,-6.231443096361553
SNU-1272,445091,5.878277369278403
Kasumi-2,119607,5.143919911790516
EJM,46191454,0.9178079006601862
SNU-1033,1750826,-3.4063740524017785
KMS-20,44543605,3.8968998395353784
NCI-H2081,6918328,-1.921531809564582
SET-2,44632017,1.0717539740379156
EJM,navitoclax-gemcitabine (1-1 mol-mol),-5.027748230090614
NU-DHL-1,vorinostat-navitoclax (4-1 mol-mol),-1.7668259453714923
SNU-1214,navitoclax-birinapant (1-1 mol-mol),1.6796123920432815
KMRC-2,ISOX-bortezomib (250-1 mol-mol),0.1988664338872188
Hs 683,2729026,2.6302099584377534
KMBC-2,1716436,2.8982733087308095
SET-2,11977753,-1.6200324397994894
ML-1 [Human thyroid carcinoma],11719255,2.5461185366109453
KMRC-2,984333,1.7771942339470834
D283 Med,sirolimus-bortezomib (250-1 mol-mol),0.1311503224086672
BT 328,alisertib-navitoclax (2-1 mol-mol),0.3590132286260764
OE21,9933475,1.3312258090067837
SEM,salermide-PLX-4032 (12-1 mol-mol),4.3063302243904085
HARA [Human squamous cell lung carcinoma],25262965,-0.7160848382234604
KMS-20,208908,1.6387060547766314
HSC-4,15953870,4.269670192757531
HEC-151,3815108,2.591309919436277
ML-1 [Human thyroid carcinoma],969516,2.8184901812435923
SNU-8,168313016,4.339041813764209
OE21,24964624,1.4326186271800114
KMS-27,148198,-3.735247787675698
NU-DHL-1,2746,0.9771874808438498
EJM,3543504,5.026142247155409
Hep-G2,73707398,1.4703050959367814
Hep-G2,46843906,2.934188713214244
NCI-H2172,10184653,4.232620517792368
MCAS,5291,3.577669160991793
HSC-4,11404337,-0.2351979780524762
HARA [Human squamous cell lung carcinoma],selumetinib-UNC0638 (4-1 mol-mol),6.072288250407716
SNU-1033,42642645,0.3333795520512672
SNU-1214,135411,0.9910284163381392
NCI-H2110,52912189,2.774816177157098
PE/CA-PJ34 (clone C12),984333,0.8782712724781023
SNU-8,vorinostat-navitoclax (4-1 mol-mol),1.1947638066550503
ML-1 [Human thyroid carcinoma],10074640,3.5607250325369812
MM1.S,selumetinib-MK-2206 (8-1 mol-mol),-0.3870286118827264
TE 617.T,36462,-0.1303372273364364
PaTu 8988s,44491742,3.6400918872033343
PE/CA-PJ34 (clone C12),6438330,2.354249023140132
NCI-N87,11178236,-2.6087498623354977
KMS-27,151289,0.3978275019277482
KYSE-410,44202524,1.688546222164906
TE-15,selumetinib-BRD-A02303741 (4-1 mol-mol),4.531240951960659
SNU-308,6505803,-0.8731800664163156
TE 617.T,6917907,-5.978561156381877
SET-2,52912189,-0.82180039451398
HEC-151,3025944,3.722964755387822
HCC2218,selumetinib-piperlongumine (8-1 mol-mol),3.6814989837566183
SET-2,54626689,4.509616884336031
HEC-151,122327,4.377570322773753
BT 330,10184653,1.5334712264974883
NCI-N87,15983966,-4.100894125332804
LoVo,24964624,-0.96112559187181
Hep-G2,53392493,3.106454846806137
D283 Med,9826308,-0.3808520436039156
KMRC-2,89928392,1.7780290135771808
AN3-CA,71680916,4.563365541904402
Aska-SS,JQ-1-carboplatin (1-1 mol-mol),-0.8718657257645913
AN3-CA,5978,-3.3545327463272256
Hs 683,sirolimus-bortezomib (250-1 mol-mol),1.0884212532476678
NCI-H1395,409805,5.969168563416671
HSC-4,44491742,4.173988284907792
A4/Fukuda,15547703,2.4441609561923547
OE21,9884685,-0.6560236160170761
HSC-4,navitoclax-birinapant (1-1 mol-mol),2.9615241748083907
Kasumi-2,BRD-A02303741-navitoclax (2-1 mol-mol),-1.941760845574772
BT 328,2708,7.776890663910961
AU565,tretinoin-navitoclax (4-1 mol-mol),4.550367433205839
KMS-20,JQ-1-MK-0752 (1-1 mol-mol),-0.7766502176752437
HCC2218,piperlongumine-MST-312 (1-1 mol-mol),1.2280946622585671
HEC-151,1239801,4.069177380185276
Hep-G2,SNX-2112-bortezomib (250-1 mol-mol),-2.874949452723731
OE21,445091,4.160069232896354
LNCaP clone FGC,vorinostat-navitoclax (4-1 mol-mol),1.1003389364553935
HCC2218,navitoclax-gemcitabine (1-1 mol-mol),1.3997049625477047
HSC-4,46398810,3.0881815243810897
CML-T1,tretinoin-navitoclax (4-1 mol-mol),0.9331911225781374
RPMI-7951,676352,1.7068328683549538
KMS-20,tanespimycin-gemcitabine (1-1 mol-mol),-4.135890410106922
HSC-4,24964624,2.5086826728272538
TE-15,969516,2.4646441907015464
HEC-151,9868037,0.6566472366149405
LoVo,selumetinib-tretinoin (2-1 mol-mol),0.1717915474841797
SW1990,135421197,2.4673652362446887
CML-T1,11625818,4.307055863962681
EJM,erlotinib-PLX-4032 (2-1 mol-mol),3.5502108693148973
SKM-1,448949,1.85245067746411
KYSE-410,11222830,1.660607012947518
TE-15,6610355,3.622853234209338
SNU-308,9444,4.413415053457932
EJM,11647372,1.0355727686672764
SNU-8,selumetinib-tretinoin (2-1 mol-mol),1.3577737463468764
LNCaP clone FGC,151289,1.132388420767888
PaTu 8988s,11167602,2.4534499550927653
HSC-4,568763,1.3764913265299208
KYSE-410,9911463,3.4542799068802696
RERF-LC-Ad1,44589607,3.7662280805427097
A4/Fukuda,10113978,1.900139268592958
MM1.S,65064,3.292120648020702
SW1990,16659841,3.7468858961477833
BT 139,3503,1.158588418080293
HCC2218,carboplatin-UNC0638 (2-1 mol-mol),3.781070783372361
SNU-308,5328940,1.5292174648752217
ML-1 [Human thyroid carcinoma],53232,3.218931075380609
OE21,5566,2.95647125808646
D283 Med,53245473,4.5476493386622625
Hs 683,54618164,4.101275609218899
SW1990,9952709,3.369520781827838
NCI-H1395,navitoclax-gemcitabine (1-1 mol-mol),2.205005883298022
KMS-20,12001922,1.070822318900554
Kasumi-2,6450551,0.5816635943537883
HCC2218,613753,1.639284692925763
KMBC-2,16722836,1.9787417702056784
LNCaP clone FGC,72734382,4.201277780294119
Kasumi-2,11238147,1.8873340406507049
HEC-151,11626560,2.4585377057566613
SNU-1033,60700,0.4874108250457245
SW1990,54596490,5.639139126471044
NCI-H1092,24856436,2.3450141967184233
ML-1 [Human thyroid carcinoma],9915743,-0.6180546405493912
LoVo,54618771,0.7060685526757626
D283 Med,445643,3.9929703650481914
YKG-1,25195348,4.74888442973518
SNU-8,3689413,-3.353074674655615
SKM-1,BRD-A02303741-carboplatin (1-1 mol-mol),3.2500648097928524
NU-DHL-1,erlotinib-PLX-4032 (2-1 mol-mol),2.559491717642415
NCI-N87,navitoclax-PLX-4032 (1-1 mol-mol),1.558715689605079
BT 330,168312962,3.1827136044568087
NCI-H2081,25154868,4.423306661705061
RERF-LC-Ad2,1716436,3.755030175494451
NCI-H1395,15547703,3.241893522159582
Hs 683,44607531,1.496524141296035
NCI-H1092,6918638,-0.0011423595466388
PE/CA-PJ34 (clone C12),252682,7.281153515089364
HARA [Human squamous cell lung carcinoma],15953870,3.428154571209005
HMCB,3062316,2.903029383335688
SKM-1,53495165,-0.711725561210763
NCI-H1092,9907093,4.298683896140943
BT 139,568763,-0.0093893552495712
A4/Fukuda,1566236,1.4071330472860828
D283 Med,1716436,2.988422279265608
HMCB,24901704,3.7054734278526986
KYSE-410,53495165,1.4811388636079783
KMRC-2,2708,5.508421118967876
KMS-20,4917,2.7295029836090565
NCI-H2081,637858,0.9384843122739523
SW1990,89928392,2.811800306716961
HMCB,24964624,3.0929732847658613
BT 248,9868037,3.916296675967623
BT 330,11455910,-0.0355958099114693
OE21,676352,1.691810166684416
SNU-8,12003241,-0.8120802877527198
NCI-N87,24951314,0.3588892807295563
Kasumi-2,676352,0.386616578071509
KMBC-2,44819697,2.777025588666699
LNCaP clone FGC,375860,-0.5963987861231773
BT 330,6914657,-4.9495639860890535
Aska-SS,46224516,1.5509268521183468
SNU-1214,11222830,1.6691423584498886
PaTu 8988s,tretinoin-carboplatin (2-1 mol-mol),4.870625870132988
KMS-20,57519531,0.5319259109001735
IST-Mes1,serdemetan-SCH-529074 (1-1 mol-mol),2.635765253356215
SET-2,2733526,4.122359576354569
HCC2218,49793307,-3.7920850700069857
BT 139,135999136,1.5889963250911243
Ku812,navitoclax-birinapant (1-1 mol-mol),0.1805704585034357
NCI-N87,5281321,-1.2852273423113845
MM1.S,23725625,4.074862026328633
SNU-8,selumetinib-navitoclax (8-1 mol-mol),0.997902568577224
SNU-1033,53232,2.540520147394444
SNU-1033,11640390,3.12906001854956
SEM,9907093,3.7735778111244698
LNCaP clone FGC,24180125,4.5156786529947714
Hep-G2,54618164,4.2874336189086115
BT 248,5566,1.2795658146577915
Hs 683,46199207,2.9953123395602703
LoVo,67291369,1.4516021942624118
HMCB,17755052,3.106416097908083
HEC-151,54626689,4.464334654686751
HCC2218,44607531,-1.2799819817909714
BT 328,57519531,5.35390801053985
SET-2,60700,-2.9666676909447496
SNU-308,66577038,3.0438550827272457
D283 Med,216345,1.9831386358290584
RERF-LC-Ad2,168312962,3.944293822864603
AN3-CA,176870,2.4166207171941214
HEC-151,72734382,4.52120073933795
LoVo,16038120,0.8839921956645777
SNU-8,16725315,4.537611285821178
BT 330,24785538,-0.5573762170833948
LoVo,2828334,5.515630519838643
LNCaP clone FGC,5280436,1.7775351222193678
NCI-H1395,2729026,3.1697601093173136
TE-15,9887053,4.0849522615234735
PaTu 8988s,2742550,4.064177152940504
HSC-4,46224516,3.389129888163455
AU565,selumetinib-BRD-A02303741 (4-1 mol-mol),5.383276880115408
SKM-1,31703,-4.0248884095114965
HCC2218,11152667,3.74490271643498
KMS-27,3025944,4.260679999843123
SNU-1272,9936388,1.7321766128233604
Aska-SS,6914657,-4.988458799040991
SET-2,24753719,3.747338164648229
CA46,46907787,-0.8110179268567884
BT 328,12003241,0.43959296828198
HEC-151,409805,5.612668913895041
Hs 683,119182,2.9030188000592947
AN3-CA,5287969,-2.418502797890807
ML-1 [Human thyroid carcinoma],26596,-0.6105391992480588
SNU-1272,25150857,3.4753548117910853
HMCB,11717001,6.037652275918416
SNU-308,159324,3.7188145940777617
RERF-LC-Ad1,5311,3.464534219485875
SET-2,11494412,0.7084758030554381
Kasumi-2,71466445,1.815897736576068
YKG-1,11222830,2.3027831380451342
EJM,decitabine-carboplatin (1-1 mol-mol),2.2378968674639363
PE/CA-PJ34 (clone C12),11485656,1.7983954039931191
MM1.S,23582824,0.1697868743152248
NCI-H2081,3038522,1.7557154711324474
A4/Fukuda,11609586,0.4485915276425587
LoVo,6438330,1.2087527750724023
SET-2,6918638,-1.854101300935
PaTu 8988s,15547703,3.1329587275782935
NCI-H1092,54618164,3.7504442983527104
YKG-1,15953870,4.202012318992034
SEM,285033,-4.419553075317265
Raji,3825829,3.3082858479955557
CA46,72376,-3.3789820311778764
NCI-H1395,135875424,3.644181585171065
KYSE-410,11167602,2.662008040827567
PE/CA-PJ34 (clone C12),10322450,3.5530253232214664
CA46,24821094,1.9467424475066963
A4/Fukuda,5311037,4.577970147235868
MM1.S,20959075,-2.7728358796049
HCC2218,31703,-0.3143133536876616
BT 330,5738263,3.980318493089423
OE21,6918328,-0.8017876191186217
HARA [Human squamous cell lung carcinoma],selumetinib-MK-2206 (8-1 mol-mol),2.6906074312139676
KYSE-410,11238147,4.798531583653568
ML-1 [Human thyroid carcinoma],11964036,2.920411614995081
MCAS,54454,1.6754872426458818
NU-DHL-1,54596490,5.416894183216897
HMCB,6505803,-1.40903466994972
SNU-1272,15983966,2.6541351995098545
SNU-1033,3854666,3.138218307419996
EJM,24180125,2.4307327863044215
SNU-8,216345,4.58176579196645
CA46,2742550,3.5037926309603944
AN3-CA,375860,-0.4575105157706771
CA46,5470400,3.727677755196873
SNU-8,36314,-4.300047746226618
BT 330,374536,3.220978821427871
SNU-8,3815108,0.8679959369818034
PaTu 8988s,16065773,2.5223841177009083
SET-2,5280436,1.6179366010145249
KMS-20,navitoclax-PLX-4032 (1-1 mol-mol),2.7801553034248543
EJM,44486219,4.513652355820563
SW1990,53392493,2.7839355508070773
NCI-H1395,36314,2.584917869739777
SNU-8,168313047,1.8430166286557448
SKM-1,46907787,-1.5658410471483666
Hs 683,241158,4.572594529470727
NCI-H2110,44543605,3.9595151388935226
AN3-CA,selumetinib-JQ-1 (4-1 mol-mol),3.4953796840918763
TE 617.T,23582824,1.0106934298284411
KMS-27,42642645,1.0749697510061529
NCI-N87,124202324,1.1856737577999816
LoVo,10410894,2.092646303934145
NCI-H2110,66577038,3.0197995654494076
NCI-N87,135421197,1.227136310912881
BT 330,6505803,-1.6088860696930485
SET-2,45279963,3.9995800028102
PaTu 8988s,11977753,-2.9446150832886815
SNU-1272,9840324,5.6851374422445335
KYSE-410,4705,2.1516675380518953
MCAS,3038522,3.685183083956727
HCC2218,crizotinib-PLX-4032 (2-1 mol-mol),2.9875837963122427
PaTu 8988s,9926054,1.8956430403525124
HARA [Human squamous cell lung carcinoma],25150857,2.860855820493058
MM1.S,4261,-0.3517097479501856
BT 248,BRD-K55473186,1.6909762369263868
KMS-20,7326481,3.962170132504471
SNU-1033,9967941,3.6129070478106367
Aska-SS,11152667,-1.72297256980761
HCC2218,73707398,1.2835282527544178
BT 328,11656518,4.018032711371447
NCI-H1092,54618771,1.961811722948082
AN3-CA,72376,-2.2485185205059985
AN3-CA,9911463,3.862780684019093
AU565,11964036,0.1505437081667179
HARA [Human squamous cell lung carcinoma],24901704,2.881552784728447
ML-1 [Human thyroid carcinoma],5291,4.042812106600411
GOS-3,4477,0.980296597324464
SNU-308,25126798,3.9253752381206346
ML-1 [Human thyroid carcinoma],60750,0.2716917716617745
NCI-H2172,71304818,2.48630822535131
SNU-8,erlotinib-PLX-4032 (2-1 mol-mol),3.5567070048816367
RERF-LC-Ad2,3854666,2.675858231607706
Aska-SS,216239,3.237488227144498
HEC-151,44589607,2.8063930431223465
Aska-SS,44185566,1.9962460513423377
NCI-H2081,219104,2.665049667127658
HCC2218,6918878,2.7353588630987686
HARA [Human squamous cell lung carcinoma],54618305,5.079823174852019
SNU-8,20959075,-3.095305417381531
BT 320,25102847,3.622666729654605
HARA [Human squamous cell lung carcinoma],5284616,3.060508834181737
SET-2,11656518,-0.7512695953696935
NCI-H1092,9936388,1.337118908669493
NCI-H2110,176870,4.703150335420955
TE-15,60700,-0.2470975087472006
TE 617.T,55508,2.646830647843717
Ku812,6918837,-4.505214094305032
LoVo,23725625,5.102020281972671
KMS-27,46907787,-0.4980850656291734
ML-1 [Human thyroid carcinoma],3465537,2.728802739434878
HCC2218,44589607,2.315850455563168
SNU-308,3503,2.890100962673665
OE21,135421197,1.5054570422138
D283 Med,252682,6.563125255029891
EJM,9825149,1.9985799603893497
Ku812,441298,2.016526434026497
A4/Fukuda,16741245,4.963846947143099
BT 139,675434,4.372766341294952
Hs 683,44489675,3.7743974579303465
KYSE-410,9903786,4.00816844948711
PE/CA-PJ34 (clone C12),2858523,2.9495363309542126
TE 617.T,49867926,4.093517719231764
KMBC-2,5287969,-1.6235944200251051
BT 328,44607530,2.310615312338521
YKG-1,49793307,-1.8928162197489815
KMBC-2,675434,4.8268210565645076
NCI-H2110,24856436,-0.06908715109082
EJM,9967941,2.872620425548139
BT 139,11175137,3.339566250291237
SNU-1272,135421197,2.338787330458388
BT 328,navitoclax-piperlongumine (1-1 mol-mol),2.639428516957035
MCAS,9884685,0.0580097672331096
KMRC-2,262093,3.029643780288338
TE-15,53392493,3.2221529579805983
RPMI-7951,selumetinib-BRD-A02303741 (4-1 mol-mol),5.015404158676352
LoVo,10184653,-0.0525672628767589
HSC-4,135440466,2.2202939224472655
Aska-SS,25262965,-1.93819336627009
KMS-20,60750,-4.802924293659105
NCI-H2110,44137675,2.993470299595554
A4/Fukuda,7326481,2.3355820774301206
HARA [Human squamous cell lung carcinoma],54619238,4.4726064543510144
SW1990,71751553,4.1573307972574485
TE-15,123631,0.6559553869726535
SNU-8,984333,1.7075817084324745
SKM-1,3552672,1.0574054456056317
NCI-H2081,46843906,1.767144018608114
IST-Mes1,5311281,1.4883568311904505
RPMI-7951,637858,1.6619998861158691
NU-DHL-1,613000,1.3520499940785358
KYSE-410,navitoclax-PLX-4032 (1-1 mol-mol),1.8859543476529048
NCI-H1395,11485656,1.9214345391656065
PE/CA-PJ34 (clone C12),322968,4.7320744640732775
Kasumi-2,1566236,1.00471674851072
BT 248,9936388,1.117792201973615
SET-2,11612883,1.412102181509034
MM1.S,5329102,1.1303790251840526
SNU-308,89928392,3.511225244541038
A4/Fukuda,67156097,-3.3575882698535526
BT 330,208908,1.7217981038647123
A4/Fukuda,53495165,-3.058270414187161
TE 617.T,carboplatin-UNC0638 (2-1 mol-mol),2.951137803819235
SNU-308,135875424,4.501679724510711
AU565,selumetinib-piperlongumine (8-1 mol-mol),3.265854364361565
LoVo,36314,1.7018910931264415
BT 248,1641662,4.808188715890419
NCI-H2172,159324,3.4766300457250416
GOS-3,vorinostat-navitoclax (4-1 mol-mol),3.0226897716285905
NU-DHL-1,11234052,4.39505697792573
HSC-4,10184653,-0.7296444895073179
BT 328,24951314,3.0926880274607753
HEC-151,selumetinib-piperlongumine (8-1 mol-mol),2.3699584185565836
MM1.S,JQ-1-navitoclax (2-1 mol-mol),-0.6640240653642139
BT 330,49793307,-4.038045129216892
OE21,53481919,3.671898939631697
ML-1 [Human thyroid carcinoma],107970,2.5074769228196025
YKG-1,selumetinib-PLX-4032 (8-1 mol-mol),3.9991996258306384
HSC-4,5287620,-1.917371788332746
D283 Med,1239801,3.514118708957111
A4/Fukuda,24856436,-2.105951383298443
ML-1 [Human thyroid carcinoma],168313016,5.516575315061805
NCI-N87,9911830,2.159086109533926
NCI-H1395,12003241,1.698262392733821
SKM-1,9908783,4.725135976054751
IST-Mes1,4096211,2.0722665154973052
TE 617.T,JQ-1-UNC0638 (2-1 mol-mol),0.3306309340053746
KMRC-2,11497983,5.325556261162262
BT 248,selumetinib-piperlongumine (8-1 mol-mol),3.781064018131383
A4/Fukuda,135928012,2.23734461349398
Hs 683,10296883,3.967060059444981
YKG-1,5738263,3.956639283215739
LNCaP clone FGC,46174525,4.178946718976701
MCAS,3025944,4.53185196548215
SEM,71304818,2.4443931751083254
SNU-1272,selumetinib-piperlongumine (8-1 mol-mol),5.23378922409154
IST-Mes1,11404337,-0.5180157624887997
KMS-20,54678924,1.6750524513499827
NCI-H2110,3689413,0.5131338822863976
HEC-151,24951314,1.163377873037901
BT 330,selumetinib-PLX-4032 (8-1 mol-mol),4.410131517671973
PE/CA-PJ34 (clone C12),46843906,2.5839561879544775
Hs 683,3503,2.6166989682892483
Hs 683,serdemetan-SCH-529074 (1-1 mol-mol),1.0183404300099244
ML-1 [Human thyroid carcinoma],5566,3.147714437598846
BT 320,6918638,3.210777195522013
NCI-H1395,10296883,4.692616973111803
Ku812,11609586,1.4051049600539705
PE/CA-PJ34 (clone C12),11497983,5.068239933837802
IST-Mes1,5281321,-0.504099135222913
TE 617.T,5328940,-0.5240714161974301
CA46,12003241,-2.799565618947511
KMS-20,72193861,0.4494795381256313
HSC-4,9967941,3.0274642479334215
GOS-3,42642645,0.8540004409462456
RPMI-7951,46224516,1.6628846173712368
MM1.S,60750,-5.284473024198937
MCAS,285033,-1.470619911744651
HEC-151,104842,-2.1594012391460735
SET-2,24775005,3.2774971851311516
OE21,5280436,1.8081382274823423
GOS-3,11178236,0.4111622236569117
A4/Fukuda,613753,2.966875582154842
NCI-N87,439501,-2.2970478950560715
Hs 683,7251185,3.0057343513623036
AN3-CA,11977753,-5.169213467666737
Kasumi-2,445643,3.712609595977314
AN3-CA,9967941,2.1371429863242692
BT 320,ISOX-bortezomib (250-1 mol-mol),1.4901983753773511
MM1.S,9936388,-7.097218801181761
NCI-N87,57519531,1.4365599080949227
NCI-H2110,12003241,-0.2811614102315782
SNU-8,11485656,2.474151094807621
LoVo,10113978,1.9718639606113115
AU565,53495165,0.1395352595616783
NCI-H1092,31703,-0.4568076370772141
D283 Med,426756,3.908529404251969
NCI-H2110,3552672,2.1088574672384435
OE21,52947716,1.6020082935985775
PaTu 8988s,11152667,-2.740642733850453
ML-1 [Human thyroid carcinoma],10231331,4.187669502210677
Raji,5281672,3.9689768271377592
KMBC-2,44566777,-1.4027522495205034
BT 330,JQ-1-UNC0638 (2-1 mol-mol),3.496932096076456
SET-2,89183176,2.321946976910911
Aska-SS,52947716,3.0851875163999067
A4/Fukuda,151289,0.1986917338936865
BT 139,66577038,2.708472891460834
KMBC-2,54618795,4.253399568860813
BT 248,262093,2.0571072545208926
PE/CA-PJ34 (clone C12),5479543,3.749651315015809
RERF-LC-Ad2,135398738,6.149274102093841
OE21,9926054,1.7334869398194368
D283 Med,tanespimycin-gemcitabine (1-1 mol-mol),-4.72619951673043
MCAS,10385095,0.5712472701663329
Hs 683,5291,3.518739684260069
CA46,46943432,1.2105530921386296
KMS-20,2746,0.7437630311682376
LoVo,11238147,1.4038592423826672
HARA [Human squamous cell lung carcinoma],656346,-0.3153592740671193
SEM,tretinoin-navitoclax (4-1 mol-mol),-1.6039122831909487
LNCaP clone FGC,navitoclax-birinapant (1-1 mol-mol),2.777103449634557
RPMI-7951,11175137,0.94409588176426
Hs 683,444795,5.839973604661916
SEM,637858,0.6523373975707702
IST-Mes1,24901704,2.6411672165981965
TE-15,navitoclax-birinapant (1-1 mol-mol),0.1032456902871259
OE21,24753719,4.068797621390331
KMS-27,2841722,4.033827389929099
EJM,216239,1.8380778507015632
OE21,31703,-0.5136116587785329
IST-Mes1,SNX-2112-bortezomib (250-1 mol-mol),1.249422428379272
YKG-1,11238147,1.8492898998590992
AN3-CA,462382,0.8052159492645975
SNU-1214,9915743,-3.00050567913294
EJM,969516,2.0507913702378886
PaTu 8988s,16219061,4.781688826460346
PE/CA-PJ34 (clone C12),3038522,3.0123071564783777
HEC-151,5329102,2.7051876594578887
MCAS,168313200,3.057905648422764
D283 Med,3062316,1.834992436946839
SET-2,2945648,2.8777449925198924
KMS-20,11612883,1.7611738578766285
NCI-N87,4917,2.911504588829893
SNU-8,tanespimycin-bortezomib (250-1 mol-mol),1.1303799126997314
Aska-SS,3025986,-1.1269382472860745
GOS-3,73707398,2.285638026393688
AN3-CA,11494412,0.238688631284878
ML-1 [Human thyroid carcinoma],20959075,-2.269435131540743
NCI-H2081,3552672,1.4004455642024622
KMS-27,46398810,2.309866347447312
Kasumi-2,72193861,0.1525951303543335
NCI-H1092,54619267,3.872554434622377
RPMI-7951,24856436,0.185198824753273
TE-15,52947716,3.120902835565105
ML-1 [Human thyroid carcinoma],6852167,2.7131700239928316
SKM-1,11960529,3.62763439473286
HEC-151,6184667,3.0163898402014597
RERF-LC-Ad2,439501,-3.088259445062755
SET-2,16741245,4.779685324729375
CML-T1,168313047,1.9633067789473095
YKG-1,4259181,0.3868166013965885
IST-Mes1,11485656,3.5408910362273835
SNU-8,135411,1.0950293066595111
PE/CA-PJ34 (clone C12),374536,3.765928674441179
HEC-151,6852167,1.7550927798186455
RPMI-7951,10113978,3.377189439622248
PaTu 8988s,448949,1.7496601969177892
BT 328,6505803,-1.1568571975604598
HMCB,5287969,-1.832915880429025
LNCaP clone FGC,23582824,1.140271679671597
TE 617.T,2708,3.9220927277029505
RPMI-7951,6438330,2.3921336529099357
KMS-27,24856436,0.2038546195429807
KYSE-410,46907787,2.6604064739007804
BT 328,969516,3.8664962726625416
NCI-H2110,10113978,3.4332805714710157
BT 330,3384730,0.3611580582543141
Aska-SS,4259181,1.378146825762795
KYSE-410,5566,3.1176802766209772
A4/Fukuda,451668,-0.3897468918932548
YKG-1,2742550,5.856053185506653
SNU-1033,11396600,3.651423781511848
SNU-1214,16741245,4.00897301492853
TE-15,25195348,3.308076464846487
LoVo,49850262,2.4887252685350227
ML-1 [Human thyroid carcinoma],15547703,3.133536230544004
SNU-1033,439501,-2.7458935942411085
MCAS,54618771,1.3372810495752594
CA46,54765302,3.694944477545822
AN3-CA,15547703,2.8402798062083496
NU-DHL-1,navitoclax-MST-312 (1-1 mol-mol),-2.4981273247607696
TE-15,16038120,0.1842728168046561
HARA [Human squamous cell lung carcinoma],11507802,1.3937860028408913
TE-15,135659046,3.5275305939343884
HEC-151,selumetinib-tretinoin (2-1 mol-mol),3.175453438392023
TE-15,25183872,-0.3952031615517913
KMS-27,54618164,3.8128826777039047
SET-2,151289,0.8976963811504413
NCI-H2110,carboplatin-UNC0638 (2-1 mol-mol),5.586200860655614
KMS-20,11977753,-3.0017304932885525
HEC-151,6252,-0.631577765285913
NCI-H1092,327653,2.585630282314354
PE/CA-PJ34 (clone C12),4259181,0.3767954059641493
Hs 683,45279963,3.956345863658136
SNU-1214,11238147,1.933777148058132
AN3-CA,selumetinib-GDC-0941 (4-1 mol-mol),1.0170906897464025
A4/Fukuda,24785538,-4.18833617701787
KMS-20,selumetinib-JQ-1 (4-1 mol-mol),-2.1329666207384124
TE 617.T,89183176,5.544457080682588
PaTu 8988s,SNX-2112-bortezomib (250-1 mol-mol),-3.3618432014620323
IST-Mes1,375860,0.4088289358172842
HARA [Human squamous cell lung carcinoma],46398810,2.9743064800682912
GOS-3,676352,1.7019961079374837
OE21,4917,1.8464114079840808
MM1.S,702558,5.540826177817469
SNU-8,44491742,5.735879763811486
KMRC-2,selumetinib-JQ-1 (4-1 mol-mol),3.693514223055559
EJM,11238147,1.5865276508772588
KMRC-2,16065773,3.0434544081000636
KMS-20,44137675,3.5747690218783075
IST-Mes1,46398810,2.0674819997592406
SEM,5335621,4.131642173212617
BT 328,135440466,1.9729468656409803
PE/CA-PJ34 (clone C12),208908,0.4778342169619697
A4/Fukuda,54618771,0.259551202975953
HMCB,135440466,2.2236465110977988
BT 330,25227462,1.0613604603878093
LoVo,navitoclax-sorafenib (1-1 mol-mol),2.5511515051305893
ML-1 [Human thyroid carcinoma],selumetinib-GDC-0941 (4-1 mol-mol),2.142388159439524
KYSE-410,46224516,3.135861836382126
NCI-H1092,navitoclax-piperlongumine (1-1 mol-mol),0.63980848570381
SW1990,17755052,2.187799447368803
CML-T1,654092,-1.9909155078044125
CML-T1,9915743,1.9836361869709076
A4/Fukuda,6918837,-6.1208599704470865
KYSE-410,89928392,1.6242803203582832
SET-2,45100481,4.393455446981079
HSC-4,tanespimycin-gemcitabine (1-1 mol-mol),-4.488052486534361
CML-T1,387447,-5.712019248069361
NCI-H1395,44589607,3.310256586301432
TE-15,24951314,1.3185945015140828
HSC-4,6505803,0.688410933428746
HMCB,2828334,6.16899162002209
AN3-CA,10113978,0.3124355863019905
NCI-H1395,2828334,6.054247002865052
BT 248,44491742,4.160095989296475
NCI-H2110,54619267,3.929199476042736
KMS-20,53232,2.383010797318735
AU565,navitoclax-birinapant (1-1 mol-mol),2.4267027556232836
A4/Fukuda,navitoclax-gemcitabine (1-1 mol-mol),-5.146642660406073
NCI-H2081,71466578,5.057643127393127
SW1990,119182,0.7225456675209282
HMCB,73707398,1.3368186639169768
NCI-H2110,3503,1.6749548080811365
TE 617.T,44607531,-0.797135035283961
NCI-H2172,135421197,1.3346129669572484
AU565,135421197,1.4743648854968991
LNCaP clone FGC,24901704,3.287653019708383
SW1990,72376,-1.0379449828245817
BT 328,11427553,3.9535129095984054
NCI-H2110,168313200,2.986185729607549
A4/Fukuda,25154868,2.544294393199085
SKM-1,5278396,2.594174785730779
ML-1 [Human thyroid carcinoma],656346,1.1399678324227185
KMS-27,11497983,-3.919978981960082
KYSE-410,24821094,1.0715044163214813
Kasumi-2,6436223,-4.213376684231403
TE-15,54613361,-1.0416432703799845
SNU-1214,5287620,-2.0712575071030326
SNU-308,156414,-0.0512353312380724
SNU-1033,5978,2.257122010870001
HCC2218,11955716,-1.901873274308428
AN3-CA,3025986,-1.5680744465077654
HSC-4,71466445,6.061667629347064
BT 330,9803433,6.095354123290605
Hs 683,5280436,2.3398809988130287
ML-1 [Human thyroid carcinoma],selumetinib-navitoclax (8-1 mol-mol),2.127776457092234
SKM-1,2858523,3.0530773935068836
NCI-H1395,selumetinib-GDC-0941 (4-1 mol-mol),2.3368578075304463
IST-Mes1,54596558,4.6034089904468125
Aska-SS,JQ-1-MK-0752 (1-1 mol-mol),-0.7931575716583488
EJM,5281321,-4.177995468364573
KYSE-410,selumetinib-piperlongumine (8-1 mol-mol),4.297006093363548
NU-DHL-1,49867930,4.548635442109189
CML-T1,5284616,-2.6047133462283276
OE21,navitoclax-pluripotin (1-1 mol-mol),-1.4136373161087934
Raji,753704,4.744566564298066
SNU-308,25154868,5.193874635622483
BT 248,11640390,5.783520002908773
RPMI-7951,6184667,3.432679630495054
EJM,71304818,1.7741690400196457
NCI-H2110,25154868,5.090581289250825
D283 Med,24951314,-0.1478123596184988
CML-T1,44486219,3.9826752825954306
Hs 683,11717001,5.284697015762219
EJM,11977753,-2.8981828943560255
ML-1 [Human thyroid carcinoma],12003241,-1.866080903179476
AN3-CA,568763,0.8013749082806687
EJM,11152667,-2.5425383772209393
LoVo,9956119,3.291456775833892
BT 248,135440466,3.298497559431859
A4/Fukuda,44137675,1.307300702935143
RERF-LC-Ad2,135999136,4.345961129852593
KMS-20,54143018,-0.774941821803654
HCC2218,navitoclax-piperlongumine (1-1 mol-mol),2.0551255289167893
TE 617.T,navitoclax-sorafenib (1-1 mol-mol),2.2031906036417883
NCI-H1395,104842,-0.629937294678588
AN3-CA,9907093,3.670524814087886
NU-DHL-1,selumetinib-GDC-0941 (4-1 mol-mol),-1.8169816306561488
RPMI-7951,31703,-2.081328284525375
SET-2,4521392,4.244272466851802
AU565,439501,-2.8703859168743384
PE/CA-PJ34 (clone C12),426756,4.422998932397389
Aska-SS,7251185,1.843675489494185
Hep-G2,selumetinib-UNC0638 (4-1 mol-mol),0.8728537208894
HMCB,4261,2.182520846929022
AN3-CA,11626560,1.578975476242315
MM1.S,51037431,1.8715826956664352
BT 328,2858523,3.1475044170181996
Kasumi-2,9911830,1.88551459110434
NCI-N87,2708,3.9537199090854673
YKG-1,9884685,-0.1545508204895388
RPMI-7951,9911830,3.3922230843192778
KMRC-2,15953870,4.6713206769498585
IST-Mes1,2871966,0.3614602719279896
KMS-20,16722836,0.7293384571450807
CML-T1,9887053,1.7753443459725933
SKM-1,5282054,2.595149696397153
SEM,219104,1.121871934400501
CML-T1,11317348,-0.5508465073970409
SET-2,409805,5.152205992309063
NCI-H2110,135875424,4.423682476800295
SNU-1214,208908,0.2392860714899357
A4/Fukuda,135875424,2.943838777845953
TE 617.T,44543605,4.234759992226973
Ku812,644241,-5.729959790836442
SKM-1,6610355,3.573663853963525
CML-T1,11175137,2.223157836501134
Aska-SS,docetaxel-tanespimycin (2-1 mol-mol),-1.5084400255004682
Aska-SS,57519531,2.1807971197736946
AU565,4259181,-0.781957409712965
HMCB,11152667,-0.8228544828189237
KMS-27,11647372,0.3312333587119215
PaTu 8988s,56946209,-6.332681007571092
KMS-27,9929138,5.026853283311406
SEM,5282054,2.754283213849225
KMRC-2,24856436,2.923913597668444
BT 328,25195348,5.638362277561031
LoVo,71466578,1.8530080227063717
CML-T1,2828334,5.888296080725352
SET-2,51037431,3.918390185213242
NCI-H2110,5738263,3.5819945608358053
GOS-3,9825149,2.947863727591062
SEM,73707438,3.837123399224833
NCI-H1092,285033,-2.138341448649312
BT 320,644241,3.936570500455286
SNU-1214,25102847,1.6586626773857935
Hs 683,2113511,6.229191209412549
NCI-H1092,462382,0.0075448360840851
SNU-1272,15953870,3.4362338657153835
HARA [Human squamous cell lung carcinoma],selumetinib-JQ-1 (4-1 mol-mol),3.6659251122276015
EJM,24951314,0.9397817217373432
A4/Fukuda,44202524,1.0259860145116777
Hs 683,72376,-1.5249898832053124
TE 617.T,227681,2.8564980043830515
SW1990,9935249,3.469784483732877
MCAS,JQ-1-vorinostat (2-1 mol-mol),1.0555725464616676
YKG-1,11485656,3.6397536658143865
NCI-H1395,23582824,0.9688847884522048
KMBC-2,16720766,1.1424969689441744
HARA [Human squamous cell lung carcinoma],168313047,3.4416690801744574
TE-15,10296883,4.422841947508094
NCI-H2110,3062316,1.6416396765359922
AU565,7326481,2.6950900258123256
TE-15,49836020,0.684840592082847
NCI-H2172,44489675,4.773557971551537
SEM,BRD9876-MK-1775 (4-1 mol-mol),-0.9190635288333102
Ku812,selumetinib-PLX-4032 (8-1 mol-mol),-1.0900745107339422
PE/CA-PJ34 (clone C12),11238147,2.027181576861032
Hs 683,216345,3.130540481909432
OE21,135875424,4.2322811376256
KMRC-2,selumetinib-GDC-0941 (4-1 mol-mol),1.6802426748833608
RERF-LC-Ad1,73707398,2.698751964761458
Raji,168313047,1.9706216654470443
AN3-CA,135999136,1.6085173592108284
KMBC-2,5351362,2.0199902229891356
PE/CA-PJ34 (clone C12),56646779,4.7380779869722565
Ku812,3385,4.251256683389901
Raji,2729026,2.2038396204117503
NCI-H2110,56963564,0.3870789119863705
GOS-3,24797083,1.855899364684227
SNU-1214,JQ-1-vorinostat (2-1 mol-mol),-1.44187466676985
CML-T1,71304818,1.5782846307483736
D283 Med,446155,1.3640842146375642
TE-15,selumetinib-UNC0638 (4-1 mol-mol),4.91335463818381
NCI-H2081,navitoclax-birinapant (1-1 mol-mol),2.3090613202793473
D283 Med,9936388,-6.8022099816120605
SW1990,445091,4.416962817156631
OE21,216345,4.272499716080272
A4/Fukuda,6252,-3.645065834912594
RERF-LC-Ad1,4788,6.277207203808431
BT 139,6436223,-4.846164479138538
BT 248,156414,1.4948422332158926
KYSE-410,568763,1.7432246593970837
NCI-H1092,UNC0638-navitoclax (1-1 mol-mol),0.7964927017699627
BT 248,4917,1.8494335305709009
HEC-151,56963564,-1.301366231241759
SET-2,44507138,2.8272213268552218
AN3-CA,navitoclax-pluripotin (1-1 mol-mol),-1.6190260246598227
RERF-LC-Ad1,5282054,4.000708411224595
Hep-G2,9915743,2.3547256655946542
RERF-LC-Ad2,doxorubicin-navitoclax (2-1 mol-mol),0.6418385821919341
KYSE-410,salermide-PLX-4032 (12-1 mol-mol),5.1075765861504
HARA [Human squamous cell lung carcinoma],24785538,-0.0579889747329333
Ku812,11238147,1.619388725534285
EJM,3384730,2.079765680312452
NCI-H1092,24772860,3.2138830329080563
NCI-H2110,5287969,-1.8120859549958457
MCAS,4788,5.287180776673087
YKG-1,1239801,4.465183015374798
TE-15,6184667,1.875027670900844
TE-15,4788,5.841864344946093
MM1.S,10074640,2.540679060778685
NCI-H2172,67156097,4.441497505181189
LoVo,71466380,3.017013363980257
KMS-27,31703,-3.2755995749362214
TE 617.T,5311,1.3477335510320705
ML-1 [Human thyroid carcinoma],11222830,1.0897337620982457
NCI-H2172,52912189,3.576299193055669
Hs 683,12001922,1.3488364585339865
NCI-H2110,51037431,3.847304773627672
SNU-1272,navitoclax-MST-312 (1-1 mol-mol),2.3385631446874897
AU565,9952709,2.716124716701941
BT 248,selumetinib-GDC-0941 (4-1 mol-mol),1.214957443871495
SKM-1,2828334,5.763127700268427
BT 330,42642645,0.9623973470262224
BT 320,SNX-2112-bortezomib (250-1 mol-mol),1.4191259031936097
BT 330,3689413,-2.329423623315505
SW1990,119607,5.501984818830774
OE21,135398738,5.932843920060456
YKG-1,11707110,2.3974603193605275
RPMI-7951,5311,1.014545329666132
NCI-H2110,9926054,1.839297705521365
CML-T1,375860,-0.8039918924580166
SEM,11485656,1.8495119352561953
D283 Med,409805,5.788391613893814
LoVo,9911463,2.8816718818913176
RPMI-7951,JQ-1-MK-0752 (1-1 mol-mol),5.357089232557581
YKG-1,6610355,5.888296552052047
NCI-H1395,crizotinib-PLX-4032 (2-1 mol-mol),2.536780809037994
HCC2218,11427553,3.731500730274806
SNU-308,5351362,1.2731127244632512
NU-DHL-1,67291369,-1.3620718957318685
HEC-151,9956119,3.45656253081276
NCI-H1395,168312962,2.594728459229535
KYSE-410,25126798,3.4955563392448203
AN3-CA,71751553,3.9967289000483097
HCC2218,107970,1.4999859497279118
CA46,1716436,3.005257864158129
PaTu 8988s,24785538,-0.1319104813604629
PaTu 8988s,54618164,4.048235772282788
NU-DHL-1,BRD-A02303741-carboplatin (1-1 mol-mol),3.0745710267326545
Kasumi-2,5280436,2.9235164089126884
BT 330,4259181,0.5985885076364172
BT 328,BRD-K55473186,3.4747994390176027
CA46,2113511,3.5674790523720317
HCC2218,67291369,2.875814700305801
NCI-H2172,44185566,3.129392327597959
SW1990,327653,3.573318417462307
Ku812,9907093,3.786730640592808
NCI-H2081,24797083,0.7037810965891612
Kasumi-2,216345,1.8251746878221435
RPMI-7951,11228183,2.9012784360869492
NCI-H2081,5746,-1.1331646162653188
NCI-N87,44589607,2.3758044537421026
SNU-1033,15547703,0.9378221532753946
Aska-SS,44589607,3.03884653856261
SW1990,5460769,2.4608974418371017
EJM,selumetinib-navitoclax (8-1 mol-mol),3.474694147708575
BT 330,753704,4.468894642288355
NCI-N87,9444,3.5890718830627923
Hs 683,24785538,1.2142111239768636
BT 139,11427553,3.113347058526198
NU-DHL-1,100016,6.7557445252971355
NU-DHL-1,44819697,-0.6868539952356948
LNCaP clone FGC,16013152,2.5423309014724076
TE 617.T,selumetinib-navitoclax (8-1 mol-mol),2.626941630887623
Ku812,2126,4.384485550053496
SNU-308,3384730,3.959298768658411
KMS-27,11427553,1.1582692146360252
A4/Fukuda,57519531,1.5811593813701257
RERF-LC-Ad2,46843906,4.812156389581379
ML-1 [Human thyroid carcinoma],9903786,1.6234934744716731
A4/Fukuda,2113511,3.845432548996496
HARA [Human squamous cell lung carcinoma],375860,-0.967052520231088
BT 139,5351362,1.0294081440467506
NU-DHL-1,54765302,3.7764075919835984
BT 248,216345,4.501699374414374
RERF-LC-Ad2,44819697,-0.974294728440346
NCI-H2110,327653,3.7242823172188815
Ku812,107985,-3.8161281001358778
GOS-3,4259181,0.7347951046145877
PaTu 8988s,19582717,4.619699148190798
IST-Mes1,9840324,6.735519666210419
PaTu 8988s,3081361,-0.9003151729601504
KYSE-410,54618305,4.463720756901811
PaTu 8988s,56973724,3.426395169348298
SNU-1033,11178236,-4.360978702778772
PaTu 8988s,5470400,-0.4207196157643424
TE-15,11238147,1.9681475739859464
LoVo,208908,1.8298234127328137
YKG-1,5978,-2.4789766194906857
KMBC-2,11977753,-0.8687302027295553
KMBC-2,285033,-0.4300275194695732
BT 330,selumetinib-GDC-0941 (4-1 mol-mol),1.903493951226084
NCI-H2110,16736978,1.6836733571257971
RERF-LC-Ad1,9911463,4.614184078770455
YKG-1,4705,3.5798209595137247
CML-T1,44137675,3.6793288779986377
NCI-H2110,445455,4.560590235855628
BT 248,16736978,2.1942612442020484
Kasumi-2,89928392,-0.7212883806223124
SEM,56949517,5.249537038012084
HARA [Human squamous cell lung carcinoma],446155,2.5576922800664006
AN3-CA,BRD-A02303741-navitoclax (2-1 mol-mol),4.701391126937182
TE-15,46191454,1.606865712982689
KMRC-2,148198,-2.5062257311600753
SEM,25022340,5.24487165377703
KMBC-2,446155,4.099966375118705
TE-15,navitoclax-gemcitabine (1-1 mol-mol),-0.4700203817880856
HMCB,24856436,0.4140973737290317
Aska-SS,9933475,1.583955769626178
AN3-CA,3081361,1.150999325724236
NCI-H1395,5351362,2.8626857880223757
HMCB,36462,1.7096647665785494
SNU-8,6914657,-3.408955584236779
HMCB,44202524,1.5502685423041775
HSC-4,135411,-0.261300177061483
EJM,11625818,4.5052460488071935
SNU-308,44507138,2.844975712866042
IST-Mes1,44632017,4.619480314320218
SNU-1272,216468,5.738566915129053
NCI-H2110,3825829,4.046505267673778
ML-1 [Human thyroid carcinoma],selumetinib-tretinoin (2-1 mol-mol),1.8296865613090936
Raji,327653,2.879098254460797
AU565,navitoclax-MST-312 (1-1 mol-mol),1.5837862455188414
NCI-N87,11626560,1.9254713694635637
BT 320,387447,-3.873135040539017
CA46,44462760,4.878030903037556
TE-15,11609586,3.241700650449008
SKM-1,54613361,-1.1301405501278758
NCI-H2081,9823820,3.6115894739916414
OE21,25195348,1.239334280919703
SET-2,71466445,1.5490156865471134
YKG-1,44566777,0.971285441188688
Ku812,123631,1.6677708488644187
RERF-LC-Ad1,12003241,-0.821513059069255
D283 Med,BRD-A02303741-carboplatin (1-1 mol-mol),4.587928026591079
GOS-3,2858523,3.344991232469259
D283 Med,44491742,3.738153910971064
Kasumi-2,decitabine-navitoclax (2-1 mol-mol),-3.2819175731867927
Kasumi-2,11960529,3.120745126362072
LoVo,675434,4.114717976727459
NU-DHL-1,11228183,-3.596114572397512
CML-T1,49850262,2.3003389318393404
OE21,11222830,1.596711740965295
EJM,42642645,0.830143723901443
RERF-LC-Ad2,6918638,1.8472690467547748
SNU-1272,selumetinib-GDC-0941 (4-1 mol-mol),3.373247687277942
SNU-8,5311,1.0961338625008177
BT 330,44819697,-2.7674730539604453
HEC-151,selumetinib-vorinostat (8-1 mol-mol),2.0752491992861537
Hep-G2,44185566,1.2927959850835242
NCI-H2081,44819697,-2.617512109063003
BT 320,11494412,4.421767883618589
NCI-H1092,5978,-1.8741882782335129
TE-15,104842,-4.310031309104666
KMS-20,3384730,1.352817423261366
CML-T1,4261,-0.2906672064872484
TE 617.T,3062316,-0.9321506482338564
HEC-151,23725625,4.932869099588327
Kasumi-2,selumetinib-GDC-0941 (4-1 mol-mol),-0.6309006264211411
TE 617.T,53232,0.6252760379465637
SKM-1,serdemetan-SCH-529074 (1-1 mol-mol),2.2169498527480664
Aska-SS,54619267,4.321796866323048
BT 139,serdemetan-SCH-529074 (1-1 mol-mol),1.800882656670933
MM1.S,2729026,2.344981820167116
TE 617.T,24978538,3.3206422008385403
KMBC-2,11955716,1.186326617820705
SEM,135984461,1.5883939694151252
Raji,2749,0.6023054030818428
HARA [Human squamous cell lung carcinoma],SNX-2112-bortezomib (250-1 mol-mol),-1.7614271905544292
RERF-LC-Ad2,navitoclax-pluripotin (1-1 mol-mol),0.2360218345452729
IST-Mes1,11178236,-2.2337214332221023
SET-2,56963564,0.295658155824717
SET-2,6918837,-6.044596893115915
SNU-8,9903786,3.356408381726989
CA46,24772860,-2.6679944090404035
Kasumi-2,JQ-1-carboplatin (1-1 mol-mol),-0.6879782047787374
BT 139,42642645,1.0499068063196206
LNCaP clone FGC,2871966,-0.8616364754610153
SNU-1272,56946209,0.3273283438568876
CA46,11609586,1.0102139081655188
SKM-1,54619267,4.249968374064052
HEC-151,2841722,4.53693591236262
Hs 683,675434,4.367936233685233
KMBC-2,25154868,4.277573934530614
Hs 683,11494412,0.4021600423895013
BT 139,208908,1.2301436422365457
SNU-1033,navitoclax-piperlongumine (1-1 mol-mol),1.3513123030743783
SNU-308,3815108,4.426401095088581
BT 248,409805,5.374494739188799
SNU-1033,72376,-2.494714641053571
NU-DHL-1,10302451,2.2542174061675055
Raji,15983966,-4.617791465019002
HSC-4,50905018,4.462883747891921
KMRC-2,2742550,3.727908257312414
Hs 683,4705,2.6530339386806476
RPMI-7951,9903786,2.3675771120862485
D283 Med,2708,2.7389036189058156
SKM-1,100016,4.336407790429152
MCAS,11977753,-2.438590361715294
NCI-H2081,alisertib-navitoclax (2-1 mol-mol),-2.14822930035513
NU-DHL-1,9866186,-1.5869624207218205
D283 Med,11625818,3.5261927376586626
SNU-308,5470400,-1.2304202061174676
CML-T1,72193861,-0.1877801569331633
GOS-3,alisertib-navitoclax (2-1 mol-mol),5.122405699516746
Hep-G2,136227924,2.2133800896817304
BT 330,400769,0.3388217199631021
NCI-H1395,4477,0.6354024043517065
AU565,11494412,-0.7938994603064
RERF-LC-Ad2,6852167,2.3505226801926686
BT 328,3543504,5.231432946006072
SEM,46215462,-0.5146100993456324
A4/Fukuda,44543605,3.1271044447490235
PaTu 8988s,24797083,1.7671088655864275
Ku812,9903786,1.763683139425592
HEC-151,448949,2.014658447928665
KMS-20,2842253,5.9707742385710825
Aska-SS,71304818,3.0417210051705417
TE-15,675434,4.749290653711745
LNCaP clone FGC,6610355,3.563130598931258
BT 139,46199207,1.7979142661010763
SW1990,409805,4.048741151107136
SET-2,644241,4.42349249378709
EJM,100016,6.634092198961092
SET-2,82146,3.921079503064887
AU565,selumetinib-GDC-0941 (4-1 mol-mol),0.6894235176740465
KMS-20,65064,3.1315037554409466
BT 139,44507138,3.6612045892844303
Hs 683,568763,1.3884888776313176
SNU-1214,107970,2.341829699130604
GOS-3,11152667,0.5000513857969126
BT 320,53393127,4.811652436573408
TE 617.T,16013152,3.960391652735795
Ku812,6252,-2.9657002300116924
Hep-G2,25262965,-2.000044227384341
BT 248,5479543,3.7849708026150406
HCC2218,135875424,1.4940742692763715
BT 248,448949,1.935087924253196
SEM,11455910,-0.3463344343386808
SEM,46398810,0.2793522314631458
SKM-1,selumetinib-UNC0638 (4-1 mol-mol),-0.1462150618543426
MM1.S,11625818,2.94126991090669
TE-15,676352,1.8572191068197632
SNU-8,6505803,0.4041272460627742
HSC-4,42642645,1.8060847122685193
LNCaP clone FGC,56949517,2.4559029214773824
SKM-1,4096211,0.188033132168566
RERF-LC-Ad2,selumetinib-BRD-A02303741 (4-1 mol-mol),5.235970238895281
SNU-8,44819697,-0.5709611370205837
ML-1 [Human thyroid carcinoma],25183872,1.7816002858265556
Kasumi-2,36462,-1.2000537391874553
MCAS,25105715,3.2707078341625837
IST-Mes1,25126798,3.982374188902535
KYSE-410,52947716,2.8858360152094695
TE-15,3854666,-0.2434846174212646
LoVo,65064,4.389937632551182
Ku812,753704,4.676427896259273
HEC-151,107985,-5.149498087919081
EJM,6252,2.286416731528207
Aska-SS,10302451,3.2025437422649796
Aska-SS,46907787,-0.8953027920417477
AU565,46943432,5.0196372017891555
TE 617.T,1641662,3.175023016974929
MM1.S,36462,-0.6145210813224762
MCAS,17759555,4.691620378552776
RERF-LC-Ad1,carboplatin-UNC0638 (2-1 mol-mol),3.9915096293079912
Hs 683,4917,2.526590822315022
BT 320,11214940,4.494237160276683
Kasumi-2,613753,2.4327594137588235
BT 139,156414,0.911612783306993
Kasumi-2,54454,5.727506476700654
TE 617.T,selumetinib-UNC0638 (4-1 mol-mol),1.935672721822544
YKG-1,151289,1.726340360462664
KMRC-2,6610355,3.6681341689584928
HSC-4,9884685,0.6492053944574516
SNU-8,5460769,4.64495536055113
RPMI-7951,3465537,-0.2413225331247042
D283 Med,44589607,0.7733689758035397
SEM,JQ-1-navitoclax (2-1 mol-mol),-3.2274870101256306
NU-DHL-1,65628,2.3268847474457317
KMRC-2,6918837,-1.7199510522110808
HARA [Human squamous cell lung carcinoma],9825149,2.481612932411
HARA [Human squamous cell lung carcinoma],navitoclax-piperlongumine (1-1 mol-mol),2.215632811452015
KMBC-2,6852167,2.897354350199853
SNU-1272,3503,2.878382710922879
SKM-1,452548,-4.875448432121974
KYSE-410,24748573,1.6083529001862935
Raji,BRD-K55473186,3.4562594687437733
MCAS,46191454,-0.6520538534336672
SET-2,5281672,4.329689350067033
NCI-N87,702558,5.013224249903468
SW1990,4788,5.859060109553269
EJM,10127622,6.4367680304352675
SET-2,969516,2.6708400521609788
ML-1 [Human thyroid carcinoma],135440466,2.0685655954708824
KYSE-410,16038120,0.9720900860952146
SNU-8,54649381,3.860275528998684
SEM,5479543,1.9736510753778953
TE 617.T,54619267,3.894645588668696
SET-2,9933475,1.8182440705609093
PaTu 8988s,82146,4.315487161713906
RPMI-7951,119607,5.588441079801166
TE-15,decitabine-carboplatin (1-1 mol-mol),5.90574027638704
SET-2,17755052,1.2918452501265123
BT 248,tretinoin-carboplatin (2-1 mol-mol),4.674619984359253
NCI-H1395,969516,2.7506221381545823
YKG-1,navitoclax-MST-312 (1-1 mol-mol),1.1745049441725737
KMRC-2,57519531,3.768608069014823
SET-2,11485656,1.7886595096067897
A4/Fukuda,9549297,1.6255879909683784
RERF-LC-Ad1,selumetinib-tretinoin (2-1 mol-mol),4.153167483660677
Kasumi-2,9825149,1.9223862209950433
NCI-H2172,3689413,0.3383001060602208
MCAS,984333,1.2733066723150994
BT 330,23725625,5.635337028270855
IST-Mes1,387447,-3.626604128124616
BT 328,2126,6.023692748820712
CML-T1,3038522,2.3382153755761372
KYSE-410,9444,3.8448275957909983
D283 Med,387447,-5.573112310264525
TE 617.T,71466578,5.5404489464924165
RERF-LC-Ad2,53392493,1.8485928216397516
CA46,65628,4.372814936384242
KYSE-410,71466578,5.354766099813538
BT 139,11656518,1.698271601966726
LoVo,124202324,1.6089295836770297
NCI-H2081,2749,0.7188111553916358
TE-15,25102847,1.8663159044636977
PaTu 8988s,selumetinib-piperlongumine (8-1 mol-mol),2.380469190147341
SEM,6436223,-5.97261058273431
NCI-N87,11222830,1.733835072175261
HSC-4,alisertib-navitoclax (2-1 mol-mol),1.936953944798388
ML-1 [Human thyroid carcinoma],42642645,0.1882919364816784
HARA [Human squamous cell lung carcinoma],135398516,1.8495805389969304
GOS-3,10074640,3.609406723020456
NCI-H2110,100016,6.079052375839209
NCI-H2172,46224516,4.4094176842523245
SNU-1033,10127622,1.9510135134483133
NCI-H2081,42642645,-0.9606541390632763
KMS-27,selumetinib-decitabine (4-1 mol-mol),-1.1457589946421645
HSC-4,219104,4.150323587810277
MM1.S,vorinostat-carboplatin (1-1 mol-mol),1.8626350946674588
HARA [Human squamous cell lung carcinoma],16741245,4.4624437574750955
HARA [Human squamous cell lung carcinoma],122327,4.478573115200279
SET-2,6918878,0.2720159878545329
SW1990,25183872,-1.894552114448352
IST-Mes1,409805,5.880779442140838
Raji,9444,3.612558099704484
Ku812,44259,0.671540597620678
AU565,568763,-0.2996152351915113
TE 617.T,2733526,4.048872059257863
HSC-4,9887053,4.087399127765092
Hep-G2,2729026,2.3048811631927344
Kasumi-2,135875424,2.5938758238859494
PaTu 8988s,374536,0.6964721820737422
KYSE-410,7326481,3.59147835328922
LoVo,9840324,5.061772266378942
SKM-1,387447,-5.418764341651642
BT 330,BRD-A02303741-carboplatin (1-1 mol-mol),5.354371330024741
BT 330,568763,0.0623204630185717
Aska-SS,ISOX-bortezomib (250-1 mol-mol),0.9403464673165612
SKM-1,9866186,0.3816129775524117
SEM,45279963,3.71935630000701
PaTu 8988s,JQ-1-vorinostat (2-1 mol-mol),1.1000553998885545
Hep-G2,docetaxel-tanespimycin (2-1 mol-mol),-1.6535454004195396
HSC-4,25062766,1.8609848482730849
SNU-1214,3062316,-2.6139765207076064
Raji,11719255,3.479182830951447
NCI-H2110,10322450,4.394668434370401
ML-1 [Human thyroid carcinoma],54143018,-0.4485048931823356
KMBC-2,53232,2.737414991179705
NU-DHL-1,SNX-2112-bortezomib (250-1 mol-mol),-2.810384781380506
HCC2218,salermide-PLX-4032 (12-1 mol-mol),3.4023873677480343
NCI-H1092,2749,2.105029797010796
HMCB,53232,1.5068869536074645
NCI-H2110,73707371,5.04412555046355
NCI-H2081,11626560,1.2362543076571495
HSC-4,11214940,4.953530718305131
HMCB,148198,-4.3449695976370055
SNU-1272,11404337,1.107901220459772
RPMI-7951,16725315,3.4897623746856308
BT 320,4378219,1.7610425663146678
HARA [Human squamous cell lung carcinoma],11455910,0.2072973533181662
ML-1 [Human thyroid carcinoma],24180719,3.042356764984187
HCC2218,25161177,4.153006406170549
HARA [Human squamous cell lung carcinoma],9927531,4.552330692797245
BT 248,ISOX-bortezomib (250-1 mol-mol),0.8192035269806958
SNU-1033,11625818,4.277044008333248
RERF-LC-Ad1,selumetinib-GDC-0941 (4-1 mol-mol),2.261809192633126
BT 328,9884685,2.9316032553217166
Raji,72734382,4.449789381323658
Ku812,73707386,3.1917387110464666
PE/CA-PJ34 (clone C12),16659841,3.7885969371213704
Kasumi-2,72199292,0.0568572050486096
EJM,11214940,4.2208595782990965
NCI-H1092,44237094,3.0131214117675835
NCI-H2110,55508,3.902465685482405
HEC-151,10296883,3.675956149700743
SNU-1272,16038120,1.164758471385012
Aska-SS,25150857,1.346839871610819
BT 328,5328940,3.187680057709996
HEC-151,54619267,3.743184211293532
NCI-H1395,10385095,0.8966814857932361
NCI-H1092,5282054,2.5552812504046742
Hs 683,10184653,1.5587127969041623
NU-DHL-1,227681,1.656422659669183
SNU-1272,selumetinib-UNC0638 (4-1 mol-mol),4.820393329674523
SKM-1,126941,-2.265408392302096
SEM,2126,4.2087863854026
LNCaP clone FGC,11152667,0.3595402317003787
HEC-151,24964624,2.1072074781623207
KMRC-2,11707110,1.2359243165534883
AN3-CA,sirolimus-bortezomib (250-1 mol-mol),0.0528830702221854
SNU-8,6918289,2.2992452702949495
SW1990,3062316,-3.500086973246357
TE 617.T,11455910,0.3917461009813664
HARA [Human squamous cell lung carcinoma],44507138,3.9193587835112
AN3-CA,1716436,2.9241172946515963
LNCaP clone FGC,6914657,-3.0837607942450553
BT 330,6917907,-6.368853634848569
SW1990,60700,-0.8541147195402934
A4/Fukuda,24964624,-0.76967256635286
RERF-LC-Ad2,71466578,4.353163131989011
CA46,44486219,3.6158388001945463
LNCaP clone FGC,54613361,0.3300056652080663
NCI-H2110,1750826,0.5855780260076004
NCI-H1395,24901704,3.973165668688871
BT 248,51039095,3.103752706938284
KYSE-410,53301938,-5.993806788421289
NCI-H2110,3634881,3.6380485446132194
YKG-1,3854666,1.2272418792594904
AU565,salermide-PLX-4032 (12-1 mol-mol),3.909685759147712
NCI-N87,alisertib-navitoclax (2-1 mol-mol),-1.7331970522410185
HMCB,navitoclax-pluripotin (1-1 mol-mol),-1.6437751572745434
HMCB,702558,5.238794075302357
PE/CA-PJ34 (clone C12),136227924,2.74058031223244
KMBC-2,71304818,2.1221045201066935
LNCaP clone FGC,3038522,2.1505332840631413
NCI-H1092,2871966,-0.9629545155853874
A4/Fukuda,salermide-PLX-4032 (12-1 mol-mol),4.8455357298985655
EJM,168312962,1.0850962961178168
SKM-1,10127622,-2.6973341706863567
BT 328,2729026,2.3236347104871924
D283 Med,24772860,-2.7962047950668345
AN3-CA,4917,3.684782782332227
KMRC-2,44566777,2.916165299357533
Hs 683,doxorubicin-navitoclax (2-1 mol-mol),-1.8748809062125371
SW1990,2708,4.958099509571108
NCI-N87,6505803,-6.101345662019038
LNCaP clone FGC,11717001,4.310122679605935
Hep-G2,135421197,1.3335693407455125
NCI-H2172,9936388,1.8105409817982183
KMS-20,6505803,-0.2025622916563878
Ku812,44489367,4.131127961346879
Hs 683,selumetinib-GDC-0941 (4-1 mol-mol),2.318747786701251
HSC-4,156414,0.4374127066870092
HEC-151,11238147,1.8644347040117784
IST-Mes1,navitoclax-pluripotin (1-1 mol-mol),-0.6633970571557571
HSC-4,5291,4.568554891244716
CML-T1,24856436,-1.6072060020086385
KMS-20,2733526,2.652352860912795
Kasumi-2,5494449,-3.67008601278043
Ku812,208908,2.1856881030512043
PE/CA-PJ34 (clone C12),navitoclax-piperlongumine (1-1 mol-mol),2.16883584787438
YKG-1,135421197,3.1079510852519343
SNU-1272,969516,3.722830166507094
TE 617.T,216239,1.6591385885716896
SW1990,5281321,-2.022256600799693
SNU-1272,44507138,4.148225527043363
BT 330,BRD-K55473186,1.816667001967137
HCC2218,4378219,3.99128981890596
MCAS,36462,1.655496509759999
KMRC-2,51039095,2.899193634556031
BT 328,11175137,3.2083588182965705
LNCaP clone FGC,119182,-0.8257267598050168
CA46,6918638,-2.155597959241919
Kasumi-2,24772860,-3.0702303943568197
Kasumi-2,BRD-A02303741-carboplatin (1-1 mol-mol),3.1733704189118894
NU-DHL-1,44185566,1.0271500895351358
SNU-8,9884685,1.4758258715385455
A4/Fukuda,alisertib-navitoclax (2-1 mol-mol),-3.158247130795727
LNCaP clone FGC,119607,4.062147707063417
SEM,9911830,1.1725597754210613
BT 248,UNC0638-navitoclax (1-1 mol-mol),1.1596436088492943
BT 320,119607,6.086126545734404
KMRC-2,54626689,4.800851370562855
AU565,JQ-1-UNC0638 (2-1 mol-mol),2.17780253884304
SW1990,4259181,-0.3516567866303933
TE 617.T,5746,-1.809843384603936
D283 Med,16741245,4.294298413876073
BT 330,54678924,1.905713263173462
IST-Mes1,1641662,3.7606227939030528
Hs 683,23635314,-4.006388146865234
EJM,3136844,3.6340399610084537
SET-2,327653,2.598960189681515
Kasumi-2,25150857,1.3589874253765015
PE/CA-PJ34 (clone C12),9935249,1.3468495063678572
HEC-151,322968,3.0831168321133147
SET-2,11234052,4.522742685815237
NCI-H2110,168312962,3.2702691603373437
CA46,676352,1.5563040092860552
A4/Fukuda,66577038,2.118562328013949
KMS-20,25195348,3.35080522486854
Hs 683,2945648,3.084046242394678
RPMI-7951,57330099,4.153180907590616
Kasumi-2,67291369,1.3044869974839717
NCI-H2110,5284616,3.413803921011568
HARA [Human squamous cell lung carcinoma],2126,5.112984415511083
Aska-SS,4521392,4.288945960666941
SEM,10410894,0.6852786057514013
BT 139,3062316,2.4169193568594474
BT 330,54143018,0.7587246341312203
Ku812,5278396,2.880964948790695
D283 Med,9903786,1.479416225891386
KMBC-2,16725315,3.826236477379129
MCAS,25262965,-2.666466085626817
NCI-H1395,135411,0.822890110332085
KMRC-2,241158,4.767496150813131
Raji,54678924,0.89459864851051
TE 617.T,54678924,4.605608720275873
MM1.S,49793307,-4.457847663527619
SNU-308,71304818,2.6626259183515706
SNU-1272,5329102,2.930087391403409
HSC-4,23635314,4.118860430098142
AN3-CA,46215462,1.512809957192001
BT 139,11178236,-1.4908860807124438
OE21,56963564,0.5882361592475003
SET-2,3385,1.651824905688349
A4/Fukuda,12003241,-4.192136354440014
NCI-H2110,3025986,-1.015275725568356
TE-15,168313016,4.315144290531877
TE 617.T,10410894,2.186198503761745
AU565,25161177,3.67389505129512
CA46,16065773,1.8844207098737984
PE/CA-PJ34 (clone C12),148198,-4.8428586798807265
D283 Med,24964624,0.6925287192814263
HSC-4,16013152,3.4985623845199956
LoVo,9887053,2.8676927346989265
D283 Med,JQ-1-navitoclax (2-1 mol-mol),-0.3504935844901085
NCI-H2110,3011155,5.273512703845773
Hep-G2,4788,5.9429406045428586
ML-1 [Human thyroid carcinoma],421610,2.367130129227347
IST-Mes1,135421197,1.925463420817299
HARA [Human squamous cell lung carcinoma],3062316,1.9438846554207736
PaTu 8988s,67291369,4.90609121399087
HCC2218,676352,1.7082186018348895
PE/CA-PJ34 (clone C12),9911830,2.0683867467094657
RERF-LC-Ad2,46926350,-4.2991338588257815
TE 617.T,3038522,1.9677439515706376
SKM-1,carboplatin-etoposide (40-17 mol-mol),-0.1005652278487919
A4/Fukuda,53392493,1.8640822641046917
Hs 683,2871966,1.6246107590680972
RERF-LC-Ad2,5281672,4.4185435462263625
SW1990,4261,2.5081676502355985
BT 248,46199207,1.879415157386071
OE21,tanespimycin-bortezomib (250-1 mol-mol),-1.6225844369747413
BT 139,89928392,1.7039273106387889
MCAS,15983966,-5.308386091607527
KMBC-2,25102847,2.042822848975917
HEC-151,24753719,4.229390718265724
OE21,448949,1.634533405585945
CA46,16736978,0.453820731366511
ML-1 [Human thyroid carcinoma],89928392,0.0943028098974214
BT 328,24748573,3.666462316296569
KMS-20,3634881,2.563355579370569
SNU-1272,24779724,4.452113053156204
KYSE-410,BRD-A02303741-navitoclax (2-1 mol-mol),3.215352374876829
SEM,122327,5.062595568788216
KMS-20,44632017,0.8974421618736498
SEM,208908,2.0616953187944835
KYSE-410,selumetinib-JQ-1 (4-1 mol-mol),1.899201390217913
SNU-1214,135999136,5.40108770784267
HSC-4,2858523,3.1192513569149245
SNU-1272,6918328,1.7738060965296416
Aska-SS,6918638,1.1582390446838242
YKG-1,25262965,-2.8273978219835416
HARA [Human squamous cell lung carcinoma],49867926,4.231294833351195
ML-1 [Human thyroid carcinoma],5311,0.3887425314777955
KMS-20,1750826,-2.803513511799702
LNCaP clone FGC,25150857,2.3178859166041126
SNU-1033,3634881,3.607045840169791
KMS-20,374536,-2.9179307309900553
PaTu 8988s,7326481,2.917044511474032
NCI-H2110,67156097,-1.093207704220165
D283 Med,16065773,1.947977492056464
PE/CA-PJ34 (clone C12),6450551,2.8483436332661873
AU565,25195348,3.492226581515367
SKM-1,1641662,2.105508221547458
PaTu 8988s,UNC0638-navitoclax (1-1 mol-mol),1.233216645790841
Hs 683,100016,6.526692615081327
Aska-SS,24964624,0.7459195537143974
MM1.S,72734382,3.2405632872404233
HSC-4,6438330,1.0116267584860468
OE21,3634881,3.2741606130174357
YKG-1,selumetinib-UNC0638 (4-1 mol-mol),5.486260238223351
KMS-20,carboplatin-UNC0638 (2-1 mol-mol),2.6820630100068197
ML-1 [Human thyroid carcinoma],568763,0.2556406277244685
LoVo,9915743,-0.8819018227786422
SKM-1,25150857,2.131946056717962
LNCaP clone FGC,675434,3.938004078494452
D283 Med,2126,1.5971545854650095
KYSE-410,7251185,4.107605175954228
NCI-H1092,5335621,4.115542911112419
KMBC-2,5566,4.423461642371862
NCI-H2081,3384730,2.313537319887304
MCAS,148198,-2.0312221156390717
NU-DHL-1,375860,-1.1724229979544771
NU-DHL-1,JQ-1-carboplatin (1-1 mol-mol),-1.21461572309572
HEC-151,4521392,4.2001313231876205
SKM-1,9907093,3.8598781273482983
TE 617.T,135411,1.06145621929179
A4/Fukuda,decitabine-carboplatin (1-1 mol-mol),0.1179398036962416
AN3-CA,2746,4.007834108220286
Ku812,10385095,1.0609410330256543
MM1.S,selumetinib-BRD-A02303741 (4-1 mol-mol),3.755901339608387
HEC-151,SNX-2112-bortezomib (250-1 mol-mol),-1.2486822284520165
SW1990,24951314,2.394074405536706
SW1990,5287620,-2.5079972796899295
SNU-8,2708,5.486542141379691
RERF-LC-Ad1,637858,2.9001668968564953
NCI-H2110,10127622,4.572029064946556
RPMI-7951,65064,3.1043550872304495
Raji,15953870,3.353900819495554
RERF-LC-Ad2,selumetinib-piperlongumine (8-1 mol-mol),1.7514629313981869
NCI-H1395,3025944,4.281266699042143
YKG-1,148198,-3.345136621371903
LoVo,12001922,1.64420677630862
LoVo,44607531,1.302221694572025
D283 Med,9952709,1.9575920153591797
SW1990,44493528,4.327134813333531
Kasumi-2,445091,5.553993217061133
Ku812,24856436,-0.802197411924791
HARA [Human squamous cell lung carcinoma],JQ-1-navitoclax (2-1 mol-mol),2.200588179814963
SNU-308,12001922,2.139310360120992
LNCaP clone FGC,56946209,-6.055306214745871
SNU-1214,1641662,3.48771227860231
Aska-SS,44566777,0.3208847613888042
D283 Med,carboplatin-UNC0638 (2-1 mol-mol),3.6189692606648016
AU565,56946209,-4.483098881483793
SNU-1214,11640390,2.9297550209160343
OE21,9444,3.8449200329038846
Ku812,984333,-1.8126254994765352
BT 248,11175137,2.43855252671782
ML-1 [Human thyroid carcinoma],2828334,6.601742138030732
TE-15,89928392,1.3476165657557055
LNCaP clone FGC,5287620,-2.246789776562607
SNU-308,445091,4.634958976950105
ML-1 [Human thyroid carcinoma],89183176,4.271882086089193
SET-2,11238147,1.9393035585687608
CML-T1,9911830,-1.528510322337235
BT 320,11222830,2.3629400148118354
SEM,24901704,-0.5071793762146407
HEC-151,10074640,3.1058867670982924
Hs 683,55508,3.511539870113758
RERF-LC-Ad2,6610216,4.489268569667584
KMRC-2,16741245,6.502208850196386
KMRC-2,9903786,3.847767222952075
NCI-N87,44819697,-2.3159908553894932
EJM,219104,2.2100971150413264
Raji,71466445,2.2613596218999295
Aska-SS,serdemetan-SCH-529074 (1-1 mol-mol),2.1099409470519777
D283 Med,44486219,3.429631651942111
KMBC-2,10184653,1.7602800183814515
D283 Med,3689413,-5.066385831563446
KMS-27,6914657,-3.8444502413551658
HSC-4,11719255,4.924721636143113
NCI-H1092,1566236,1.754245151236072
SNU-1272,446155,4.168307414617033
HEC-151,BRD-K27188169-navitoclax (2-1 mol-mol),2.581586549309544
KMBC-2,56946209,-4.199826885472946
SNU-1214,9967941,3.4599845144853916
CA46,4259181,0.0375174782651609
NCI-H2081,46191454,1.7931363741805633
SNU-1214,navitoclax-piperlongumine (1-1 mol-mol),1.9032666953627455
KMS-20,49836020,5.970121389426133
HCC2218,3825829,3.8059808455027704
SW1990,54626689,4.474747694138227
PE/CA-PJ34 (clone C12),11625818,4.760944363107288
BT 328,JQ-1-vorinostat (2-1 mol-mol),3.553838421661415
BT 248,65628,4.438815715072134
TE-15,46907787,0.2449943729998491
MM1.S,11485656,1.9684027845110144
KMRC-2,123631,3.03467045210905
CA46,JQ-1-UNC0638 (2-1 mol-mol),-0.7861923396287928
KYSE-410,5978,-3.3770169672228416
MM1.S,135984461,3.1063926235928703
RPMI-7951,3503,3.303373344392616
A4/Fukuda,56946209,-6.395954164738885
KMS-20,46943432,0.2963080368709872
KMS-27,375860,-1.142960082705596
Aska-SS,6436223,-4.489938965385282
LoVo,10127622,2.21220618035224
NU-DHL-1,5281321,-2.700321539992985
BT 248,11178236,-4.1971988945266965
MCAS,10184653,2.7840829057514753
TE 617.T,serdemetan-SCH-529074 (1-1 mol-mol),0.9612641436619076
IST-Mes1,12001922,2.6228240364869113
SNU-1272,46398810,3.303753409066687
SNU-1033,56649450,2.0286705758027144
BT 139,3854666,3.266069647715192
SNU-8,6918878,1.8134579719269337
IST-Mes1,46907787,2.643041583848796
ML-1 [Human thyroid carcinoma],36462,0.3533243941090192
KMBC-2,alisertib-navitoclax (2-1 mol-mol),-0.3408409494439297
HSC-4,1716436,3.018983829466311
LNCaP clone FGC,24785538,2.385782397443259
KMBC-2,66577038,3.542721508364004
SW1990,46843906,3.690159048824788
RERF-LC-Ad2,44566777,0.7222536941065739
KMS-20,65628,3.828249966077918
CA46,selumetinib-UNC0638 (4-1 mol-mol),4.090188755292698
PE/CA-PJ34 (clone C12),25126798,3.781683390757729
KMBC-2,44507138,2.985904055733976
RERF-LC-Ad2,5746,3.2227004681968174
SW1990,44202524,5.184894737297559
D283 Med,54765302,3.826457537496404
EJM,46843906,2.2065096868149294
RERF-LC-Ad2,1242560,3.853205903260469
SEM,1242560,2.9052555910824025
OE21,66577038,2.109411516197842
MM1.S,5287620,-1.6558303438795536
AN3-CA,54596558,4.225678688908697
HMCB,9907093,4.430209797884857
MCAS,6918328,0.5035344277026522
TE 617.T,439501,-4.266247423790402
HCC2218,445091,4.1052384856024515
LNCaP clone FGC,crizotinib-PLX-4032 (2-1 mol-mol),2.1211203614787912
MM1.S,208908,2.7600413341345225
BT 139,10127622,4.956470394935132
RERF-LC-Ad2,5351362,2.9757711645344105
BT 330,53481919,5.743905569728565
Aska-SS,45279963,4.287982423003227
AU565,15983966,1.7541662071439053
SKM-1,10427712,3.615808474028536
PE/CA-PJ34 (clone C12),216468,0.8117185056100308
KMS-20,2874250,3.851287435238237
Ku812,44589607,1.98424939843821
NCI-H2081,73707371,5.9412545737381075
LoVo,10385095,1.3603816893768768
Hs 683,11656518,2.657909620235412
HMCB,46926350,-4.187449030083668
Hep-G2,5328940,1.8827970950468589
NU-DHL-1,262093,0.667372891927881
NCI-H2110,navitoclax-PLX-4032 (1-1 mol-mol),3.5351266692450256
NCI-H2081,JQ-1-navitoclax (2-1 mol-mol),0.0671859130804495
BT 139,selumetinib-PLX-4032 (8-1 mol-mol),3.878194147055926
PE/CA-PJ34 (clone C12),72376,-1.7240853207922306
SET-2,5311281,5.420440730186175
SNU-1272,65064,5.250850515288352
NCI-N87,151289,0.0450530603050232
PaTu 8988s,navitoclax-PLX-4032 (1-1 mol-mol),3.0937800000641493
BT 139,613753,3.3719914419642376
PE/CA-PJ34 (clone C12),5328940,0.4121607573919046
ML-1 [Human thyroid carcinoma],5335621,2.3456257872682933
NCI-H2081,3689413,-0.989992552174664
YKG-1,carboplatin-etoposide (40-17 mol-mol),2.9316391165537943
SET-2,46398810,-1.245906502267527
ML-1 [Human thyroid carcinoma],168312962,4.623396193395582
KMS-20,9903786,1.7377090782754483
SNU-1033,44185566,1.7669218302114065
A4/Fukuda,navitoclax-MST-312 (1-1 mol-mol),0.8742444067839383
BT 139,4477,0.6839306905009712
HSC-4,11228183,2.0585180361700313
Raji,71466380,3.4025085363686376
BT 330,3543504,4.802620749525746
MM1.S,439501,-1.8322200924082088
D283 Med,7251185,1.5816987638690432
NU-DHL-1,9826308,0.2321848028640403
D283 Med,docetaxel-tanespimycin (2-1 mol-mol),-4.966560181844395
HCC2218,7251185,1.522693086843718
SEM,selumetinib-decitabine (4-1 mol-mol),-1.996234931247303
SNU-1214,vorinostat-carboplatin (1-1 mol-mol),2.9413523332998315
EJM,24753719,3.944145631978448
NCI-H2110,11364421,-5.382703147813924
AU565,16736978,1.4090353018278403
PE/CA-PJ34 (clone C12),10184653,-3.1495831813545165
HARA [Human squamous cell lung carcinoma],68056272,4.667757023830857
SKM-1,44137675,2.6593794287267127
KMBC-2,decitabine-navitoclax (2-1 mol-mol),0.1268287752394686
NCI-H1395,89928392,1.518159514357362
ML-1 [Human thyroid carcinoma],51039095,1.326261900002616
SNU-8,24856436,0.3445950257327131
LoVo,168313016,4.599216339831628
HARA [Human squamous cell lung carcinoma],5329102,2.385019760073336
SNU-308,6918837,-2.0367306099029587
Ku812,tanespimycin-gemcitabine (1-1 mol-mol),-4.681338743201834
LoVo,42642645,0.0146125142547242
BT 139,9936388,1.6173516252245872
Ku812,439501,-2.3195298765386587
BT 328,15983966,3.6622955294931865
HEC-151,26596,-1.920762353069635
KMS-27,11609586,0.8561260403457472
RPMI-7951,54649381,3.585382450251425
NCI-H1395,54618771,3.4411900765558125
PaTu 8988s,5281321,-0.5973180568257009
PaTu 8988s,9936388,0.6570193749634515
AN3-CA,23725625,6.041812493780868
SET-2,19582717,2.274143567405833
LoVo,107985,-3.583734032756361
Hs 683,82146,4.206888158378674
NCI-H2172,676352,2.4225571956967804
AU565,11612883,2.0019521527087982
KMBC-2,25161177,4.427519408575105
BT 330,135440466,2.4249688767909383
HEC-151,vorinostat-navitoclax (4-1 mol-mol),2.0027819292472193
NCI-H2110,151289,0.7148300319898179
SW1990,10296883,4.2503704087411025
AN3-CA,6918638,0.8350174262489668
IST-Mes1,11364421,-1.7965673619245748
HARA [Human squamous cell lung carcinoma],navitoclax-gemcitabine (1-1 mol-mol),-0.596107332987684
NCI-H1395,5281321,-3.249479550606142
NU-DHL-1,11656518,1.0275988085654195
MM1.S,3689413,-0.3922685663675629
OE21,11612883,2.14911442236508
PE/CA-PJ34 (clone C12),54143018,0.7240710800326328
BT 139,7251185,1.9571958886017575
SEM,5351362,0.4245704934919823
PE/CA-PJ34 (clone C12),carboplatin-etoposide (40-17 mol-mol),3.8374450875844297
Ku812,25150857,2.8984825229110207
KMS-27,JQ-1-navitoclax (2-1 mol-mol),-1.2384478741336744
LoVo,227681,3.064150517180394
EJM,16720766,0.882880765643151
NCI-H2081,9926054,1.7325996665522785
KMS-27,56946209,-4.916734128569137
NCI-H2172,216468,5.592406085337583
OE21,11404337,-3.0833954848691234
SEM,selumetinib-tretinoin (2-1 mol-mol),0.5709175371364448
SNU-1214,9911463,3.639683247778992
Aska-SS,675434,4.382693996612232
SW1990,JQ-1-vorinostat (2-1 mol-mol),1.8788348022946737
SNU-1214,17755052,0.132624780404394
KMRC-2,serdemetan-SCH-529074 (1-1 mol-mol),2.3285498447862287
TE 617.T,11404337,-2.8418150062947487
A4/Fukuda,374536,-1.0311095755670416
KMS-20,24772860,-2.355954669463017
CA46,9884685,-1.0270691788705264
TE 617.T,11719255,3.3427190655840526
Hep-G2,25150857,1.869528617252537
AN3-CA,24772860,-3.14166980026705
HCC2218,26596,-0.1880453521462128
NU-DHL-1,11494412,-1.1621345375437304
PaTu 8988s,46843906,2.1796914916961865
ML-1 [Human thyroid carcinoma],24889392,3.5627585346619712
LNCaP clone FGC,9887053,1.6596295171491997
RERF-LC-Ad1,navitoclax-piperlongumine (1-1 mol-mol),2.3229899285484352
SNU-1033,156414,1.6354285292334745
MCAS,6505803,-1.4160035963714128
NCI-H2110,4917,3.7009084145755216
HEC-151,5470400,-2.6727104085641376
D283 Med,5282054,2.5822291305993064
NU-DHL-1,400769,-1.0687598831956515
SEM,46907787,-3.1211446232519178
KMRC-2,400769,0.9397643729925782
NCI-H2081,285033,-4.017735387470941
TE 617.T,71466445,3.56672644929392
BT 248,6610216,3.912037893092857
Hs 683,60700,-0.414224895156259
Raji,100016,6.465762715187829
KMS-20,969516,2.5083831299130233
NCI-H1092,3689413,-0.2231155414175143
SEM,6852167,1.184676073870636
BT 320,44566777,1.538730078733798
AU565,60700,-0.684074891390158
Kasumi-2,60700,-3.733340750045026
SNU-1033,9866186,1.161302246288351
Raji,10113978,1.8720249970674376
SW1990,10074640,3.349164976711024
PaTu 8988s,56649450,1.242344926252794
Hs 683,168312962,3.719183345738996
KYSE-410,176870,1.6923860408993845
HARA [Human squamous cell lung carcinoma],17759555,3.7036804092868847
KMRC-2,vorinostat-carboplatin (1-1 mol-mol),4.622831077205028
KMS-20,67291369,0.8651776622015213
SNU-8,10184653,1.6550353804349267
CML-T1,44259,0.1754844857900887
HARA [Human squamous cell lung carcinoma],11626560,1.1307601374566012
RPMI-7951,6918736,-2.0199101963947608
BT 139,11612883,3.441320456022431
NCI-H1395,16722836,3.221617987091192
CML-T1,44491742,2.876043803936746
NCI-H2081,12001922,1.0080325544819035
HEC-151,9915743,1.4580340601681427
BT 139,11640390,3.588853002664297
CA46,49766530,-5.499020578204802
NCI-H2172,11964036,2.255348451727483
PE/CA-PJ34 (clone C12),carboplatin-UNC0638 (2-1 mol-mol),3.7033637644797217
HARA [Human squamous cell lung carcinoma],5278396,3.775794457804869
RPMI-7951,2733526,3.292724930535778
SNU-1033,46926350,-3.712986003015726
AN3-CA,selumetinib-vorinostat (8-1 mol-mol),3.509818575986226
SNU-1033,46843906,2.8992746692094795
HEC-151,36462,3.471634124285656
EJM,54619267,3.875367584336116
RERF-LC-Ad2,crizotinib-PLX-4032 (2-1 mol-mol),1.9189852963092824
HARA [Human squamous cell lung carcinoma],126941,-2.554285063423382
KYSE-410,4096211,2.054863080467891
PE/CA-PJ34 (clone C12),56649450,1.6238624024089472
NCI-H2110,alisertib-navitoclax (2-1 mol-mol),2.8711325454482988
A4/Fukuda,53232,1.4709221708336295
NU-DHL-1,6918837,-5.004297563636696
D283 Med,11364421,-5.590051926548293
BT 330,15983966,1.8406845073782188
YKG-1,10302451,4.0412794748223835
SEM,9915743,-2.2587042117517284
IST-Mes1,374536,3.187270781803884
LoVo,68056272,4.365145786196869
HSC-4,9908783,6.127900398037499
KMRC-2,2858523,3.2070058966935115
AN3-CA,5746,2.1305977985768085
D283 Med,26596,-3.592310964496019
BT 320,4788,6.027753085231011
NCI-N87,11455910,1.6652699053284308
Hs 683,11647372,1.1270075140835378
NCI-H2081,16038120,0.2763554915628486
SET-2,49867926,3.721151379814877
SET-2,72734382,2.7143918769890543
KMS-20,23725625,4.884759798123119
NCI-H2110,15547703,2.9800613541020633
SNU-1214,136227924,2.9720785133706213
TE 617.T,71680916,4.955345580180031
AN3-CA,445091,5.023008436415508
SW1990,11364421,-1.7327127591081195
NCI-H2081,6184667,2.212797142714644
AU565,24180125,2.1910645714042634
SEM,51039095,0.5318115856558748
SNU-1214,65064,4.148568727564404
Aska-SS,11964036,-0.6557208412964481
NU-DHL-1,56646779,5.05824342116676
HMCB,285033,-1.7820394591449478
RPMI-7951,452548,-0.2922706234765502
SNU-1214,54454,1.0965137828709777
Aska-SS,9911463,4.275261976243402
KYSE-410,54619267,4.169541955466141
PE/CA-PJ34 (clone C12),16038120,0.98561045029006
NCI-H2081,24180719,4.062007967057392
LNCaP clone FGC,44486219,4.025087195486354
SNU-1214,selumetinib-MK-2206 (8-1 mol-mol),1.1524923685822592
BT 330,navitoclax-piperlongumine (1-1 mol-mol),1.7947014353724977
RPMI-7951,selumetinib-vorinostat (8-1 mol-mol),2.1108488039083775
SEM,72193861,-0.1864351946405744
Aska-SS,446155,3.3770877945361444
SEM,56963564,-0.810126734608135
BT 248,387447,-5.028656036950466
MCAS,71304818,1.9599377919200471
NCI-H2110,42642645,1.3057236795101204
LNCaP clone FGC,26596,-2.187376252798695
Hep-G2,753704,5.097151878686146
AN3-CA,54626689,5.185402039214214
SKM-1,9444,4.064416967836726
CA46,4917,3.2539126844885757
NU-DHL-1,selumetinib-navitoclax (8-1 mol-mol),-0.984371811473836
PE/CA-PJ34 (clone C12),156414,-2.3095911483351004
BT 328,676352,2.591297575109724
KMBC-2,25062766,2.4834909036700203
AU565,9884685,0.3686008824574254
SEM,387447,-5.877720306537758
HMCB,252682,6.031465547355209
CA46,25154868,4.248651634430963
NU-DHL-1,44491742,4.098367852004394
D283 Med,73707438,3.9956281889573697
Kasumi-2,374536,-0.2175337956908027
BT 320,5282054,5.407913205549652
SET-2,10410894,1.7754039173574685
SNU-8,25062766,1.5846373572086123
SNU-308,5978,-1.1640731069355073
KMBC-2,36462,2.9079010396533302
BT 139,navitoclax-birinapant (1-1 mol-mol),0.9139278911158232
IST-Mes1,52912189,1.1075207421426316
NCI-H2081,49793307,-4.448015018456752
MCAS,67291369,1.7014951656107709
HMCB,10296883,4.337758420607625
IST-Mes1,11640390,3.2581579646920966
AU565,4705,1.275846161151896
SW1990,9911830,1.8136131351030251
D283 Med,5329102,2.0804491951462323
HARA [Human squamous cell lung carcinoma],2130404,2.6459509712703246
TE-15,4917,3.684614793750609
SNU-308,10385095,3.412893840135653
SNU-1214,656346,0.878147723418443
NCI-H1395,11364421,1.3628820394407153
NCI-H1092,11152667,0.3392565176972865
KMS-20,6436223,-4.921746279888799
SEM,441298,2.8242609372288485
SNU-1214,2749,1.7868446846610977
NCI-H2110,5329102,2.106537605857881
PaTu 8988s,11707110,-3.690877241312631
SKM-1,208908,3.3298351666258763
SNU-308,637858,3.38776683487698
CA46,11222830,0.90552754986452
Ku812,176870,1.7235761174633464
AU565,5470400,-3.0594075513818995
NCI-H2172,46215462,1.890508970942278
NCI-H2172,24856436,1.5621419745636402
LoVo,24785538,0.3940436885335026
PE/CA-PJ34 (clone C12),16741245,6.228519168048979
KYSE-410,9823820,4.309422676682165
RPMI-7951,36462,0.7881901219926554
NCI-H2172,51037431,3.879120282151884
HMCB,65064,5.473995129472351
KMRC-2,448949,3.3117772729308728
PE/CA-PJ34 (clone C12),5335621,5.154193572953575
KYSE-410,46199207,3.362816327601518
SNU-1033,2746,3.071869125008986
SNU-8,2841722,2.136956824320515
HSC-4,36462,0.7755986988683452
BT 139,135411,3.1054244698858566
LoVo,1317464,3.6287749925486743
KMS-20,BRD-A02303741-navitoclax (2-1 mol-mol),1.210365618273724
TE-15,11427553,2.4729252663942685
Ku812,151289,0.0229500128579697
SNU-8,sirolimus-bortezomib (250-1 mol-mol),0.5784576721065883
TE 617.T,421610,1.5744665942554643
EJM,227681,2.671980927947041
TE-15,11612883,2.028874235885918
HSC-4,322968,4.636798889333657
Kasumi-2,44607531,1.0542160339181526
HSC-4,400769,-0.948607557046086
Kasumi-2,BRD-K55473186,1.9287541942318225
RPMI-7951,54686904,4.071763535806967
CML-T1,409805,3.5817002644537683
SNU-1214,4521392,3.48771925693952
SET-2,54678924,1.2764107286462951
Hs 683,644241,2.1182711597047277
ML-1 [Human thyroid carcinoma],46191454,1.5014607148772898
IST-Mes1,16720766,0.7299606902549882
NCI-H1395,5280436,0.4598531683399105
RERF-LC-Ad2,25183872,-0.4436700906623944
NCI-H2081,10074640,2.3874549358623756
PE/CA-PJ34 (clone C12),3062316,-0.5825484419455179
CML-T1,decitabine-navitoclax (2-1 mol-mol),-1.9117963719087396
NCI-H1395,462382,1.900499609260616
TE 617.T,8515,3.600809985804118
IST-Mes1,9911463,4.127098730346426
ML-1 [Human thyroid carcinoma],327653,3.144384021244803
KMS-20,alisertib-navitoclax (2-1 mol-mol),-2.6675858557663825
Raji,44137675,4.0530836304331475
EJM,JQ-1-carboplatin (1-1 mol-mol),0.7172378388996342
TE-15,6917907,-5.750854284737166
SEM,16659841,1.8965739479385648
BT 330,6610355,5.532780791196112
AU565,54626689,4.66017141288812
HMCB,navitoclax-MST-312 (1-1 mol-mol),0.7821438430480089
NCI-H1395,25195348,3.618629950214112
GOS-3,10184653,2.042716455984749
RERF-LC-Ad1,135440466,4.040059542632656
NU-DHL-1,46215462,1.671878123602452
ML-1 [Human thyroid carcinoma],10127622,2.646237824428173
SNU-308,24964624,2.3333426495769567
A4/Fukuda,serdemetan-SCH-529074 (1-1 mol-mol),0.8122212024039632
NCI-H1395,5460769,5.87662281780079
NU-DHL-1,2729026,2.5099936780211674
SNU-1272,2828334,5.899475603043714
Kasumi-2,12001922,1.274437651383908
KYSE-410,5328940,1.0709504499455504
KYSE-410,24772860,-3.1334090173521156
OE21,25062766,1.2859206682836428
ML-1 [Human thyroid carcinoma],piperlongumine-MST-312 (1-1 mol-mol),2.022291985496103
Hep-G2,12003241,-0.7040118985216451
NCI-H1092,4477,0.1803011714935916
HARA [Human squamous cell lung carcinoma],11647372,1.8404588933860024
OE21,72376,-3.060607188572333
HSC-4,44589607,3.345116081225748
TE 617.T,6918878,1.9615768244510037
KMRC-2,3062316,-0.0725608563984309
TE-15,219104,4.3944003343810705
BT 248,11960529,3.73553983344596
Hs 683,ISOX-bortezomib (250-1 mol-mol),0.1836379152412065
KMS-27,11364421,-5.15529881457266
HMCB,387447,-4.760692258076148
ML-1 [Human thyroid carcinoma],1285940,4.2577484489413004
NCI-N87,52912189,1.61892272115858
HEC-151,3543504,4.035104451563593
PE/CA-PJ34 (clone C12),53392493,1.8170083800399903
GOS-3,10296883,4.354871301885758
TE-15,56646779,4.168404632635053
MCAS,73707398,1.1782781305000984
IST-Mes1,1750826,2.0701004204652778
HEC-151,753704,4.907356002546064
TE 617.T,426756,4.479031808281675
NCI-H2110,6184667,3.212045367006698
MM1.S,4096211,2.0079042529830673
HCC2218,156414,-3.7494092331236497
CA46,10385095,0.6992054873225039
AN3-CA,73707398,0.9328233137559012
Hep-G2,piperlongumine-MST-312 (1-1 mol-mol),2.8906524908682143
RPMI-7951,11427553,2.3286341602705596
Kasumi-2,123631,2.0188728462797885
NU-DHL-1,9868037,1.5827566273106026
NU-DHL-1,9444,2.485842478800355
KMRC-2,72376,2.0798917005863617
YKG-1,25102847,1.9293075860384323
Raji,44632017,1.4331486298315164
EJM,4259181,-0.0332233948997356
Hs 683,44620216,3.795198661592088
HARA [Human squamous cell lung carcinoma],5738263,3.6004475982525825
ML-1 [Human thyroid carcinoma],9868037,3.639883526106939
SKM-1,409805,3.7093603817382337
SNU-8,12001922,1.7857478253759511
ML-1 [Human thyroid carcinoma],10385095,1.881738472046862
SNU-308,8515,4.888482056700149
Ku812,57519531,1.8933058292523095
CML-T1,5329102,0.8946748960608596
BT 320,44607531,2.095455849416377
HSC-4,3384730,1.6775009570022803
Hs 683,11167602,3.3707679458067195
NU-DHL-1,374536,0.7676256966435839
CA46,2729026,2.6315261399645755
SW1990,46926350,-4.013688074453093
SKM-1,4788,4.719822695202535
MM1.S,136227924,2.5395832269167027
Ku812,46191454,1.1353148896243908
Ku812,73707398,0.2962870044778456
PaTu 8988s,4705,3.38811272412219
GOS-3,6438330,5.388884852572475
CA46,44819697,-3.819793103454841
RERF-LC-Ad2,1566236,1.925261747039256
BT 330,984333,-0.0959079494022657
TE 617.T,navitoclax-MST-312 (1-1 mol-mol),0.8185651463211672
SNU-1214,676352,1.8003199215115635
TE-15,60750,-0.4335181627273449
KMS-27,3503,1.5005311551351748
KYSE-410,644241,2.1966590431724
HSC-4,24951314,1.4348411807415282
D283 Med,selumetinib-GDC-0941 (4-1 mol-mol),1.1541990578163812
OE21,71466578,4.389757659452917
NCI-H1092,3025986,-1.5280995504056256
NCI-H2172,4788,5.873949794280354
Hs 683,16659841,2.9598539767719507
CML-T1,24772860,-2.9357343941167713
MM1.S,135440466,-0.9043223941603596
D283 Med,11626560,0.0898695348441468
SNU-308,654092,2.765487663234044
RPMI-7951,2113511,4.6851966794067925
AN3-CA,navitoclax-MST-312 (1-1 mol-mol),0.2700125726217607
SET-2,126941,-5.930398504442238
SET-2,24771867,3.532138745646488
BT 330,148198,-5.294661964865024
RPMI-7951,25262965,-1.858765534488669
KMS-20,24748573,1.7452169384063008
AN3-CA,25102847,0.707734828928581
SNU-1214,2828334,5.794331402319802
SNU-1214,5746,1.6489281214471312
EJM,6610355,4.327559225261186
NCI-H2081,445643,4.277637250227414
BT 328,15953870,4.378443753461669
SET-2,753704,4.217890366544489
A4/Fukuda,BRD-K55473186,4.020373973875239
MM1.S,285033,-2.3858654705971
MCAS,24821094,3.5818395784670076
RPMI-7951,44589607,2.5685754653743724
LNCaP clone FGC,3062316,2.5314062575910383
SKM-1,135875424,3.1648969740603095
SEM,16065773,1.5866010830455777
KMS-27,11228183,-4.318717214987111
AU565,6918638,0.3564513775218086
LoVo,3825829,3.571391318080427
Kasumi-2,327653,2.4977161394914953
HEC-151,11977753,-1.2526892648552814
OE21,753704,4.973993702825942
EJM,46907787,1.3360205419537388
LNCaP clone FGC,BRD-A02303741-navitoclax (2-1 mol-mol),3.7065262118724114
BT 139,5494449,2.762901803316331
NU-DHL-1,208908,2.2448533414134864
YKG-1,9935249,4.562558251006297
NCI-N87,24180125,2.059368273959215
TE-15,25154868,5.0854480005148694
NCI-H2081,445091,4.108892916064877
KMS-20,54626689,3.7959086868633016
LNCaP clone FGC,16722836,2.225690900484634
HCC2218,2742550,3.114607696672168
Aska-SS,selumetinib-BRD-A02303741 (4-1 mol-mol),5.7728850622560755
SKM-1,168312962,0.8747361111835986
SNU-8,71466380,3.799489012925572
KMS-20,241158,1.964058176771948
Ku812,46174525,2.0497895392537133
ML-1 [Human thyroid carcinoma],46907787,2.3673247902218804
CA46,10296883,3.259152671675197
Hep-G2,16720766,4.874988016159793
AU565,serdemetan-SCH-529074 (1-1 mol-mol),1.652601677572969
SNU-1272,3025944,5.229392036537965
AN3-CA,2708,5.218139570683085
NU-DHL-1,44607530,2.2321185489089026
Ku812,23725625,3.808154058237452
Ku812,11317348,-1.076361726967916
SEM,19582717,2.6237313520594996
KMS-20,9936388,-8.248983770505305
MCAS,6610216,4.229351733917807
CA46,navitoclax-MST-312 (1-1 mol-mol),1.8648125815203176
TE 617.T,44819697,-1.9200443333950732
Ku812,25102847,-0.2981237407146331
CML-T1,702558,3.0833664933254235
PE/CA-PJ34 (clone C12),salermide-PLX-4032 (12-1 mol-mol),5.538851904722065
YKG-1,400769,0.2933301417342049
BT 330,selumetinib-navitoclax (8-1 mol-mol),1.8958449254541392
SKM-1,71304818,2.6002187783001154
NCI-H2110,9444,4.512884732727542
SET-2,6450551,2.11700475180411
NCI-N87,15953870,2.623738434863841
RPMI-7951,49766530,-2.0352614049405178
SNU-8,73707398,1.2983083910911808
GOS-3,81146,4.428248018506032
Hs 683,2746,3.210764654839646
AN3-CA,3385,5.79126133100466
SET-2,10322450,3.4472789227229925
HEC-151,81146,5.455769476076874
SW1990,54454,0.8815842407729143
SKM-1,23635314,-2.3855466073838913
PE/CA-PJ34 (clone C12),9826308,-1.235624594971424
SNU-8,4477,0.155555271951445
HEC-151,9823820,4.10807898967116
Ku812,322968,2.754974105795659
BT 328,5470400,1.931366636892646
NCI-N87,135398516,0.1780104282584799
NCI-H2081,navitoclax-piperlongumine (1-1 mol-mol),0.7242013058592781
TE-15,56963564,-0.9589446957937114
KMS-20,46926350,-4.252708447125384
HSC-4,11977753,4.574500022269399
AU565,168313200,1.787588028354966
HSC-4,salermide-PLX-4032 (12-1 mol-mol),5.175495928614886
A4/Fukuda,49793307,-5.572580515048152
BT 139,15983966,1.4948166481511225
HARA [Human squamous cell lung carcinoma],ISOX-bortezomib (250-1 mol-mol),0.5382016887520487
BT 248,3384730,2.3830241448741987
Hs 683,10385095,1.154404132181591
HEC-151,452548,0.8844863829622529
KMS-20,6918638,-0.8366604804869239
LoVo,36462,0.97058855741136
KMRC-2,3081361,1.5624883528172209
SET-2,JQ-1-MK-0752 (1-1 mol-mol),-1.2343828589073973
SKM-1,16038120,-0.2538482343739291
RERF-LC-Ad2,navitoclax-piperlongumine (1-1 mol-mol),2.1145246572038565
NU-DHL-1,44202524,1.452274997974498
MCAS,3025986,-1.0760873319224546
PaTu 8988s,68056272,3.766790890647225
IST-Mes1,11626560,1.5280230569409714
CML-T1,9935249,2.5956918222650507
SNU-1033,25154868,4.9583601903631855
KYSE-410,3385,5.3788897343124376
BT 139,53495165,1.1666373701090846
GOS-3,2871966,0.5648988653696159
LoVo,67156097,-2.753278115102512
Hs 683,5287969,-2.018977265327553
HMCB,613753,3.1872639599039188
KYSE-410,alisertib-navitoclax (2-1 mol-mol),1.3779189641202882
KMS-27,piperlongumine-MST-312 (1-1 mol-mol),3.135425545454246
Ku812,6505803,-1.520866948509506
NCI-H1395,445643,4.969337372862375
Raji,46224516,3.459730704149693
Hs 683,54454,3.167936412491247
AU565,12001922,1.255153902569356
KMS-27,46174525,3.4749969625152604
OE21,104842,-2.9568269236985416
SW1990,49793307,-5.12969398647881
SW1990,462382,0.8888111274221407
NU-DHL-1,6438330,0.0083524547313942
OE21,25262965,-4.357084277861301
SNU-1272,72734382,5.027303621851128
TE 617.T,1239801,3.896236456079403
EJM,11222830,0.9008763267177864
NCI-H2110,5113032,4.667236952685056
AU565,JQ-1-vorinostat (2-1 mol-mol),0.9003268678800701
CA46,5282054,2.3254868404716755
KYSE-410,448949,2.4860337699563906
HEC-151,5311281,4.406904152868016
Aska-SS,44607530,3.7629974782079674
CML-T1,1750826,-4.284831191139796
Aska-SS,1714884,3.5797361691775427
NCI-H2081,5311281,1.3336176865333822
NCI-H1395,piperlongumine-MST-312 (1-1 mol-mol),1.204552153931692
KMBC-2,vorinostat-navitoclax (4-1 mol-mol),-0.0695917806099074
TE 617.T,123631,-0.2963807875359265
TE-15,10113978,3.8378245924643184
A4/Fukuda,72199292,-0.4044306818473915
KMS-20,56649450,1.446370800321743
NCI-H2172,2729026,2.5458261586186013
KMBC-2,selumetinib-vorinostat (8-1 mol-mol),1.67831087866627
HARA [Human squamous cell lung carcinoma],crizotinib-PLX-4032 (2-1 mol-mol),1.0458249521104828
BT 328,navitoclax-pluripotin (1-1 mol-mol),-1.2977497604117467
EJM,3634881,2.858173041625091
SNU-1214,BRD-A02303741-navitoclax (2-1 mol-mol),-0.2601448097331313
NU-DHL-1,15953870,2.3700996174311095
BT 328,11612883,4.649689158242477
SEM,54618771,-1.6874791122177024
HSC-4,135875424,3.4627713632233537
PE/CA-PJ34 (clone C12),5113032,5.000018786320908
BT 248,23582824,0.3842375588836932
HMCB,9935249,3.1054191675254064
IST-Mes1,119182,0.8525106306178227
IST-Mes1,9903786,2.7623614356082458
Hs 683,selumetinib-UNC0638 (4-1 mol-mol),2.56808468223834
NCI-H2110,selumetinib-PLX-4032 (8-1 mol-mol),4.399430073640621
SNU-308,11427553,3.899753909319736
LNCaP clone FGC,54619267,3.520399318672114
SNU-1272,400769,-0.1796926060476786
KMBC-2,9927531,4.40438479738659
PaTu 8988s,36462,3.2992976849858593
HMCB,5351362,3.123131663123805
KMS-20,ISOX-bortezomib (250-1 mol-mol),0.1513994172758227
Hs 683,54765302,3.844319739814382
Ku812,10427712,4.412501870743701
ML-1 [Human thyroid carcinoma],46174525,4.296155307906125
NCI-N87,3825829,3.9513849877108207
SKM-1,168313200,4.186901063511942
RPMI-7951,104842,-2.886076741729941
SNU-8,439501,-2.494664293068585
KMS-20,6450551,1.8183077034001904
KMBC-2,9903786,2.1846129600819353
NCI-H1395,5278396,4.323134607051869
Hep-G2,4477,1.6560348387058257
D283 Med,11647372,0.822685670820016
SW1990,piperlongumine-MST-312 (1-1 mol-mol),1.0885797655495495
Kasumi-2,25102847,1.9985292692576584
IST-Mes1,46224516,1.3511239581863117
AN3-CA,444795,3.791626271347074
SEM,46926350,-4.492601003803031
NCI-H2081,57519531,0.9438571598062376
RERF-LC-Ad2,5335621,4.374608507204801
BT 139,11964036,2.0973433466968587
KMBC-2,6438330,1.6296124635179827
LoVo,46943432,3.050109964187685
SNU-1033,4521392,4.048046804000424
BT 248,selumetinib-UNC0638 (4-1 mol-mol),4.192258549840557
KYSE-410,UNC0638-navitoclax (1-1 mol-mol),2.9728532369388425
A4/Fukuda,5278396,2.678829799859676
BT 328,selumetinib-BRD-A02303741 (4-1 mol-mol),6.07719627140778
CA46,3062316,1.4079672687586804
SKM-1,5280436,3.132311342282295
Kasumi-2,4788,5.288898541322949
NCI-H2110,57330099,5.373662696434695
NCI-H1092,4259181,1.0265302606919988
MCAS,57519531,3.520827392578698
IST-Mes1,5566,2.9881744281003373
SNU-1272,10385095,3.7094210277095274
BT 330,2828334,6.027702866230108
BT 139,navitoclax-pluripotin (1-1 mol-mol),-1.6784448507193144
MCAS,159324,3.426184358584357
PaTu 8988s,54618771,-1.1165982816182902
KYSE-410,selumetinib-PLX-4032 (8-1 mol-mol),2.7618648700335213
IST-Mes1,322968,3.0930404941453933
PE/CA-PJ34 (clone C12),54596558,4.3489795544634315
D283 Med,23635314,-3.5786484067215545
NCI-H1092,168313200,1.6747772833697747
SNU-308,54649381,3.890823095113657
BT 139,10322450,4.915425697373417
SET-2,123631,1.6700754945891212
CML-T1,11167602,0.5863351465273275
TE 617.T,56963564,0.1382790284756134
SW1990,BRD-A02303741-carboplatin (1-1 mol-mol),4.5101495763826245
A4/Fukuda,54618305,3.964460418875751
LoVo,vorinostat-navitoclax (4-1 mol-mol),1.8172554757062631
AU565,selumetinib-JQ-1 (4-1 mol-mol),3.812986745391109
OE21,4705,-2.1528136210817324
KMS-27,9884685,-0.4174100202309531
KMS-20,navitoclax-MST-312 (1-1 mol-mol),0.8684749204516451
HEC-151,9840324,5.659644401752755
LoVo,445455,4.556737788306169
BT 139,9825149,2.03233190699606
SKM-1,168313016,3.949913306453134
OE21,6184667,1.691212727819629
NCI-H1395,9884685,-0.0679636269907438
HARA [Human squamous cell lung carcinoma],2945648,3.3865607820212316
KMS-20,24856436,0.4598512604017683
HMCB,JQ-1-vorinostat (2-1 mol-mol),1.2235343393627285
HEC-151,168313016,4.881545929029312
Hep-G2,71680916,5.349288664380335
NCI-H1395,568763,0.9321190773221452
HEC-151,11228183,2.0673314322119984
NCI-H2081,6610216,3.784534117796005
NU-DHL-1,2858523,3.2387233611606945
Hs 683,54649381,3.1065100499344034
BT 330,6450551,1.8703937125350776
CA46,11625818,3.63093624941088
SNU-8,26596,-0.6710039843025739
Hs 683,107970,1.9317129294379751
TE 617.T,2729026,1.8529578734685528
HCC2218,3854666,2.216625580917516
SNU-1033,11222830,1.785225605711629
SNU-1214,navitoclax-gemcitabine (1-1 mol-mol),-0.6659452983720491
Hs 683,136227331,4.5546400151434066
Kasumi-2,11609586,-0.6223010091545076
A4/Fukuda,25161177,3.5710974046751804
AN3-CA,241158,3.592519055568355
CML-T1,11178236,-2.7580162479970634
BT 320,9952709,2.926036005886834
NCI-H2172,65064,5.016684921609816
NCI-H2110,salermide-PLX-4032 (12-1 mol-mol),5.468211494078165
GOS-3,11364421,2.246503341599216
SNU-8,4096211,2.394279422586692
D283 Med,54618305,4.176148849074149
KMBC-2,BRD-A02303741-navitoclax (2-1 mol-mol),-0.0859203707063457
NCI-N87,6918736,-4.217256713101777
NCI-N87,119182,-3.621619524843969
NCI-N87,16736978,0.698711777805788
SW1990,2858523,3.108665147059129
BT 139,5281321,0.9957709719611229
LoVo,216468,2.992200557668688
Ku812,11626560,-1.6024532092090518
OE21,5311281,1.796992451946629
BT 330,1566236,2.4105147195149694
Ku812,135440466,1.6128490007977765
NCI-H1395,54618164,4.0783729987601225
SEM,5281321,-3.2823659838346697
SNU-308,9911830,3.1003297251909845
KMS-27,5978,-4.633882828191892
SW1990,448949,1.3238938068231705
CML-T1,68056272,2.531220488236934
Ku812,4521392,4.096251186969024
NCI-H2172,16038120,1.3227343075096445
Hs 683,156414,1.79593868877012
SET-2,9840324,5.675754316118916
EJM,53495165,-2.1869464879132963
AU565,44632017,0.8977842888684593
NU-DHL-1,navitoclax-PLX-4032 (1-1 mol-mol),-1.9945668257516072
SNU-8,54619267,3.9617652458857777
Kasumi-2,piperlongumine-MST-312 (1-1 mol-mol),0.99360798269259
NU-DHL-1,49846579,4.101611336723351
KMS-27,15983966,-4.691446519193063
AU565,216345,2.670108206329082
LNCaP clone FGC,67156097,-2.4913542577132146
PaTu 8988s,71304818,2.815056412385755
Kasumi-2,44589607,0.7324041454669186
MCAS,25102847,3.243219999349448
BT 320,9549297,2.275077325933936
EJM,135999136,1.6782155584907743
BT 328,11152667,1.7027658226426858
SNU-308,25062766,3.067179561733296
HARA [Human squamous cell lung carcinoma],25102847,2.0322740825170555
KMS-27,10410894,2.595057582613953
YKG-1,119607,6.023388476770122
LNCaP clone FGC,54678924,0.8118061161726199
TE 617.T,16720766,0.6194685193213763
NCI-H2081,9444,4.107001529584513
NU-DHL-1,tretinoin-carboplatin (2-1 mol-mol),1.578778354574034
KMRC-2,11717001,4.303274746092272
KMS-20,16736978,-0.5263513628668083
TE-15,5280436,1.6052639817547756
HMCB,5281321,-2.1554910502862046
NU-DHL-1,135984461,1.11873859248707
BT 248,54618164,4.1848059637542585
Hep-G2,409805,4.627773602187177
SW1990,53325874,4.767228471561693
IST-Mes1,44607530,1.064599314990069
LNCaP clone FGC,45279963,3.0791910503127533
BT 139,10231331,4.592628649226856
HMCB,24753719,4.311459213197197
OE21,JQ-1-navitoclax (2-1 mol-mol),0.2592566821270753
LNCaP clone FGC,44607530,2.55645338869262
Hs 683,11609586,2.3962325200102317
KMBC-2,tanespimycin-bortezomib (250-1 mol-mol),0.8255558863308646
PaTu 8988s,11427553,1.984096358783623
SET-2,selumetinib-PLX-4032 (8-1 mol-mol),3.6485530309859406
Kasumi-2,JQ-1-vorinostat (2-1 mol-mol),-0.9081345169636283
KMRC-2,6610216,4.281887950309424
RERF-LC-Ad2,327653,2.6151456371110404
Kasumi-2,168312962,2.3104598884340515
HEC-151,54649381,3.9974164574496824
SKM-1,5287620,-2.0310276882381633
SNU-1272,448949,3.345262663923222
HSC-4,3011155,4.427149856421904
NCI-H1092,11626560,1.887558219337559
Raji,9911463,2.729188500459454
NCI-H1395,11178236,-3.24243996776791
Ku812,2828334,5.359664398174482
KMBC-2,25195348,3.3424120098205643
SNU-1033,5470400,-4.183042746355976
YKG-1,11427553,2.5425746736996735
SEM,4096211,0.9150772033108496
CA46,11497983,3.715862022418827
Hep-G2,selumetinib-GDC-0941 (4-1 mol-mol),-0.4461378228189951
EJM,262093,1.353461350978494
SNU-1272,25183872,3.9601685379854583
SKM-1,426756,6.104096040981277
PE/CA-PJ34 (clone C12),4788,5.839985662068601
OE21,216239,2.081942890669219
BT 328,25154868,6.16063190444204
MCAS,9929138,6.918248380879042
Kasumi-2,409805,3.7279902229812114
NCI-H1395,25126798,4.167853501092747
IST-Mes1,piperlongumine-MST-312 (1-1 mol-mol),2.506000344733661
SET-2,10302451,3.517530060309579
KMS-27,11625818,1.7619850217742694
PE/CA-PJ34 (clone C12),5311,2.204084588588605
HARA [Human squamous cell lung carcinoma],2841722,4.596341456340547
NU-DHL-1,568763,-0.5697749505348572
TE 617.T,107985,-4.218073473743226
MM1.S,6918736,-2.225977964273826
HARA [Human squamous cell lung carcinoma],6918837,-1.4537868658939308
Hs 683,19582717,3.1827290375005997
HSC-4,136227924,4.2199200707906845
LNCaP clone FGC,doxorubicin-navitoclax (2-1 mol-mol),-2.264651644205161
KMS-27,16722836,0.7458247417063953
NCI-N87,444795,4.906796024963376
BT 248,969516,3.2750512548532136
Aska-SS,11626560,-3.0218589475675226
SNU-8,36462,2.8022982828339957
NCI-H2172,selumetinib-GDC-0941 (4-1 mol-mol),3.58741960121688
KYSE-410,5738263,3.814535171181479
CA46,10427712,3.800630662833656
SW1990,24748573,2.78159398278425
Ku812,JQ-1-UNC0638 (2-1 mol-mol),-1.3299079938073646
YKG-1,15547703,3.315188658721057
Ku812,5746,-0.7811708469290007
CML-T1,2130404,3.1458672398900425
GOS-3,19582717,5.639915925254865
RERF-LC-Ad1,selumetinib-piperlongumine (8-1 mol-mol),4.22277875723884
YKG-1,6450551,3.4208466602547833
Kasumi-2,5566,3.0024962406609874
Ku812,11364421,-4.941394755779054
Kasumi-2,11507802,0.0513516992758086
TE-15,15983966,-0.6041186145494649
YKG-1,11507802,1.2532518288313863
TE 617.T,12003241,-2.151805000440827
HEC-151,4477,1.2372126866923474
KMRC-2,BRD-A02303741-navitoclax (2-1 mol-mol),3.3429469235932494
NU-DHL-1,11640390,3.61397071522667
AN3-CA,387447,-4.801616318597083
NCI-H2110,5281321,-2.7282695734042473
TE-15,3384730,5.002634362664369
BT 248,3689413,-0.3734654016267222
Hep-G2,168313047,1.9779091798447304
MM1.S,71466578,0.9736156366581122
HMCB,439501,-1.1140754693945072
KMS-20,16741245,4.955396324130607
Hs 683,46174525,4.3348734308118715
KMBC-2,11234052,4.545716332187808
SET-2,10427712,3.7228965704476233
HARA [Human squamous cell lung carcinoma],1641662,3.0207416829742058
AN3-CA,5278396,3.224746709449046
HCC2218,3384730,3.481352808748772
AU565,156414,-1.7188953203880928
BT 248,9911830,3.0671224453630326
SNU-308,1716436,5.086826833735244
Hs 683,44137675,2.697665290818916
AN3-CA,73707371,5.974433333213384
HSC-4,71304818,1.898043557267106
PE/CA-PJ34 (clone C12),135411,0.6306768615973338
LNCaP clone FGC,5978,-3.7743504448066583
KYSE-410,crizotinib-PLX-4032 (2-1 mol-mol),1.8110357932791312
PE/CA-PJ34 (clone C12),24772860,-2.582582767798194
SNU-308,BRD-A02303741-carboplatin (1-1 mol-mol),1.672049819506349
Hs 683,9915743,1.4986187440690526
NCI-H1092,24964624,2.2870226351654637
KYSE-410,10385095,1.3109396001615272
HEC-151,selumetinib-UNC0638 (4-1 mol-mol),5.224989415390747
KMBC-2,9936388,2.279378439007598
PaTu 8988s,24748573,3.6833420319814487
YKG-1,4477,1.5489937349359375
ML-1 [Human thyroid carcinoma],11609586,2.006327876020203
PE/CA-PJ34 (clone C12),44607531,-0.1890255077191596
RERF-LC-Ad2,42642645,1.4647501272846788
AN3-CA,6852167,1.7401945713297349
D283 Med,11717001,4.89268752114943
TE 617.T,selumetinib-tretinoin (2-1 mol-mol),2.362320733514288
SNU-1214,10113978,3.0914953155633964
HSC-4,54619267,4.093335991980471
CML-T1,374536,2.401691970017444
AU565,sirolimus-bortezomib (250-1 mol-mol),0.9370118878253954
NCI-H1395,60700,0.9119898603788574
BT 248,675434,4.340673839490162
LoVo,123631,1.2882244486240189
SET-2,44491742,3.5989743077742387
Kasumi-2,135984461,1.6284116850001094
CML-T1,11455910,-0.3388293365451558
MCAS,3543504,4.5617609044392955
KMRC-2,SNX-2112-bortezomib (250-1 mol-mol),0.782253631071063
AN3-CA,60700,1.9216907704274913
AN3-CA,11719255,3.633331051172675
TE-15,107985,-3.356146031116269
NCI-H1395,3689413,-2.5246792207692073
SW1990,168313200,2.994110056013303
AN3-CA,SNX-2112-bortezomib (250-1 mol-mol),-3.588743722591154
SW1990,11647372,1.9027324676319584
SNU-1033,123631,2.4204782637043616
AU565,216239,2.683840039589205
MCAS,selumetinib-MK-2206 (8-1 mol-mol),0.565829170882376
RPMI-7951,54143018,-0.6464494976945091
SW1990,71466445,5.525497338974383
PE/CA-PJ34 (clone C12),12001922,2.3473594689504687
GOS-3,168312962,3.853513662902144
ML-1 [Human thyroid carcinoma],16219061,3.525142786131821
PE/CA-PJ34 (clone C12),135440466,2.5835124352915084
AN3-CA,322968,2.7400100761512967
MM1.S,54618771,0.954891721558104
D283 Med,71466445,1.8844109066317911
MM1.S,24951314,0.1961256505054842
RERF-LC-Ad2,135440466,2.5121012258931295
SNU-1033,BRD9876-MK-1775 (4-1 mol-mol),1.5655773369442785
BT 248,54678924,1.5069949057557903
KYSE-410,25150857,3.210005156084859
Kasumi-2,9887053,0.7760357688642865
SET-2,3543504,3.7201819667077176
EJM,ISOX-bortezomib (250-1 mol-mol),0.254764569122289
CML-T1,10113978,1.6264516706818362
LoVo,46174525,4.300656487428364
BT 320,65064,6.551398782521052
NU-DHL-1,24797083,0.8543647878457378
SET-2,9915743,0.156310507538352
NCI-H2081,vorinostat-carboplatin (1-1 mol-mol),1.7925408533831422
AU565,carboplatin-UNC0638 (2-1 mol-mol),2.4152389485219503
IST-Mes1,12003241,-1.7187710036837192
SEM,3465537,0.8371255640679629
Ku812,vorinostat-carboplatin (1-1 mol-mol),2.0345642738218386
NCI-H2110,24964624,2.4930185559615947
HMCB,11175137,3.661072098195176
BT 328,crizotinib-PLX-4032 (2-1 mol-mol),2.7816896231682886
NCI-N87,23725625,5.7035859672182125
Hs 683,71466578,5.36710853249766
HSC-4,9444,4.231424733159592
HARA [Human squamous cell lung carcinoma],6252,0.9917938801151434
HSC-4,46199207,3.2853086951025197
Ku812,969516,1.9833816835003693
NU-DHL-1,445455,3.2773220789700397
HCC2218,tanespimycin-gemcitabine (1-1 mol-mol),-2.850540092805532
RPMI-7951,3690,3.5557452100063123
HEC-151,60700,-0.0125711606129759
TE-15,119182,-1.6418031467147085
KYSE-410,2842253,4.506572282444764
SNU-1272,44607531,2.5999559202839384
SEM,6610355,4.764894277791875
HARA [Human squamous cell lung carcinoma],10302451,4.803964333247322
CML-T1,11238147,1.550777100551064
EJM,5329102,1.5761634875262642
PaTu 8988s,4917,3.2992563846024128
EJM,51039095,2.802911331082466
Kasumi-2,BRD9876-MK-1775 (4-1 mol-mol),0.2372012332768771
SW1990,122327,5.6524077873763385
D283 Med,52912189,0.6805327994585112
LNCaP clone FGC,2708,4.692892865043915
NCI-H2081,10385095,0.3312851708861742
OE21,44489675,3.6391121100343247
CML-T1,216239,1.5759445467703133
SNU-1214,54649381,3.4023462512727516
Kasumi-2,46843906,1.3893397569967554
SET-2,9823820,3.5307586058920397
Kasumi-2,148124,-6.270957848916609
NU-DHL-1,156414,1.5243299906287209
SKM-1,12003241,-1.1629643414911237
NCI-N87,135440466,2.814988966864087
CML-T1,71466445,2.0221424049362033
Kasumi-2,selumetinib-MK-2206 (8-1 mol-mol),1.1378728727000402
SET-2,4261,-0.6443084099324052
KMBC-2,11364421,2.175132064190205
MM1.S,selumetinib-navitoclax (8-1 mol-mol),2.538303509958093
HEC-151,71466578,3.9461658446284753
SNU-8,24775005,3.6289506087302015
MM1.S,3385,3.993221582004266
ML-1 [Human thyroid carcinoma],5281321,-2.300928121678764
AU565,9840324,5.90463961449661
PE/CA-PJ34 (clone C12),52912189,3.061596603136192
OE21,2746,3.2562317048816363
CML-T1,3385,2.6066574492649184
NCI-H2081,sirolimus-bortezomib (250-1 mol-mol),-0.0413699313219798
HARA [Human squamous cell lung carcinoma],67156097,-1.978765302962937
SET-2,serdemetan-SCH-529074 (1-1 mol-mol),1.260779700034802
CA46,10113978,2.0547387812543425
HCC2218,44819697,2.205591212815753
SNU-1214,10302451,0.3178594253094901
HEC-151,10427712,4.368252042828018
HEC-151,5284616,2.6847657376009484
HMCB,16725315,3.1918238782276274
IST-Mes1,11494412,3.57589790392084
CML-T1,5460769,1.000954417912476
Hs 683,44589607,3.229038489255208
PaTu 8988s,409805,3.706044847536148
NCI-H1395,3136844,4.616978313876093
MM1.S,73707438,4.7017263774156
HSC-4,11455910,0.337268703123225
BT 330,crizotinib-PLX-4032 (2-1 mol-mol),1.6276794707330204
Hs 683,3062316,0.7713399730021859
OE21,navitoclax-birinapant (1-1 mol-mol),1.1957116946433446
LoVo,637858,1.5179613366947162
SNU-1272,16741245,3.8765356368768566
NCI-N87,ISOX-bortezomib (250-1 mol-mol),-0.226060851576525
KMRC-2,60700,1.5834227754610717
TE 617.T,57519531,1.7478555944414165
SNU-308,56963564,3.1096793012002615
MCAS,54678924,2.1250047909510013
OE21,25227462,-4.320449849945017
HARA [Human squamous cell lung carcinoma],17755052,1.9898088824831797
MCAS,135440466,2.9955528767437234
SEM,vorinostat-navitoclax (4-1 mol-mol),-1.6904002163702885
HEC-151,654092,0.4022245307281385
ML-1 [Human thyroid carcinoma],3689413,0.6725245747839163
SKM-1,9840324,5.371011979568873
KMBC-2,216239,2.9233965853231587
YKG-1,46843906,3.149273077560738
HCC2218,16659841,4.361072089276897
GOS-3,3011155,4.288572340636914
HCC2218,44566777,-0.7932095979791006
Raji,6918837,-4.178794520867055
NCI-H2081,9956119,4.1032174456876485
Hep-G2,613753,3.545634028634973
NCI-H2081,613753,3.0014003602908392
NCI-H2172,46191454,4.392012035479809
BT 139,168312962,3.392986151792307
AN3-CA,46191454,1.6354260060942205
NCI-H2172,400769,-0.2846387856986963
ML-1 [Human thyroid carcinoma],6450551,2.5869852554462622
NU-DHL-1,10385095,-0.0540424655836512
HSC-4,439501,-1.7709622187792924
OE21,24901704,3.8910537982527673
PaTu 8988s,24753719,4.178289167008363
PE/CA-PJ34 (clone C12),9915743,-2.2300833448892985
NCI-N87,46191454,1.700307220457573
NCI-H1395,44185566,2.9760824770163756
HCC2218,119607,3.922202464613258
MCAS,6852167,1.7021529696000626
Aska-SS,11955716,-1.6455074883452614
RPMI-7951,445091,5.789041246929377
KMBC-2,3038522,3.0239147751029
CA46,decitabine-navitoclax (2-1 mol-mol),3.2544479904294383
SNU-1272,107970,2.7088030141342383
SNU-308,11222830,2.6372387279798706
SET-2,53481919,3.738136134081667
Kasumi-2,148198,-6.27183434225638
NCI-H1395,42642645,1.8763678628327745
PaTu 8988s,doxorubicin-navitoclax (2-1 mol-mol),-1.420841461356717
OE21,2945648,3.0380681902240254
BT 320,selumetinib-UNC0638 (4-1 mol-mol),5.097773746306877
AU565,9926054,0.9817648939808896
BT 248,11612883,3.485439835170839
NCI-H2081,selumetinib-tretinoin (2-1 mol-mol),6.041656888825654
D283 Med,49793307,-5.548587928279458
OE21,46843906,2.363538949964924
EJM,salermide-PLX-4032 (12-1 mol-mol),5.466360284353834
NU-DHL-1,9825149,2.2287917110137445
TE-15,3385,3.4864316011439844
RERF-LC-Ad2,5287969,-1.5613987175817166
SET-2,9444,4.37195818926585
LNCaP clone FGC,11222830,1.7946004031282303
MM1.S,24772860,-3.323759307224156
HSC-4,6252,1.1187983220422375
EJM,11626560,1.3808062425150147
KMS-27,46943432,1.1908434425451844
OE21,4521392,4.107626345506232
PE/CA-PJ34 (clone C12),selumetinib-piperlongumine (8-1 mol-mol),3.000431938444702
RPMI-7951,56973724,2.888823682314247
AU565,3503,2.743681155949089
SNU-308,36462,4.516059663616316
MCAS,12003241,0.5308085719616568
SNU-1214,selumetinib-GDC-0941 (4-1 mol-mol),-0.7739258064747034
ML-1 [Human thyroid carcinoma],vorinostat-navitoclax (4-1 mol-mol),0.5480043604957033
KMS-20,9868037,2.1280335543005293
CA46,11178236,-6.883102305003874
Hs 683,3038522,2.242318808618233
NU-DHL-1,6610216,3.849394820990355
Ku812,452548,-0.7948570640360005
SEM,44607531,0.7149871957090602
BT 139,16722836,1.5591777456407394
Aska-SS,23582824,0.9314351370865972
MCAS,135398744,6.37399282177603
Ku812,JQ-1-carboplatin (1-1 mol-mol),-1.5108430449944463
PaTu 8988s,107985,-3.719022802572999
HEC-151,6505803,0.2052514279790806
Kasumi-2,65064,2.9473106091456467
KMBC-2,46224516,3.7476992828736737
SNU-1272,24964624,2.8014320140467124
HARA [Human squamous cell lung carcinoma],31703,-1.5277652674394486
HMCB,44486219,4.542033268900389
NCI-H2081,227681,2.433511689406021
BT 330,71304818,2.8134783689342235
CML-T1,5978,-4.3443825686600785
OE21,135440466,1.3796180177518549
RPMI-7951,selumetinib-MK-2206 (8-1 mol-mol),3.2832065602787712
SNU-1033,erlotinib-PLX-4032 (2-1 mol-mol),3.2989071401635344
Aska-SS,5329102,2.307959348285351
SKM-1,36314,2.437591695433872
PE/CA-PJ34 (clone C12),60700,-0.5177392228311933
IST-Mes1,25102847,1.8280194065910471
SET-2,selumetinib-BRD-A02303741 (4-1 mol-mol),3.5961531213512834
TE-15,crizotinib-PLX-4032 (2-1 mol-mol),1.7250862743662545
Raji,11497983,3.8774717564884416
KYSE-410,19582717,4.791336864447624
RPMI-7951,5329102,1.587417345703683
HCC2218,1716436,1.618358710169954
SEM,613753,2.3547167164197247
HSC-4,126941,-2.3076253927529127
KYSE-410,71304818,2.5026339556272994
YKG-1,selumetinib-JQ-1 (4-1 mol-mol),2.6528510984038864
MM1.S,16725315,3.2712240196505165
ML-1 [Human thyroid carcinoma],60700,-3.146668380067059
SNU-1033,54596558,4.298942732542006
IST-Mes1,42642645,0.3467837133172653
BT 328,docetaxel-tanespimycin (2-1 mol-mol),-0.9357205348249352
Hs 683,6918837,-3.551122123117506
MM1.S,9866186,0.3210827277460168
LoVo,151289,0.7390860710542093
KMS-27,60750,-4.266224763393727
KMS-20,73707398,-1.0592725192615595
SW1990,168312962,3.681678065961884
D283 Med,136227924,2.613464686393682
KMS-20,3062316,-0.0467041684401502
KMS-20,4788,3.707173211304455
BT 139,erlotinib-PLX-4032 (2-1 mol-mol),1.3072437000876354
IST-Mes1,446155,1.803889787209672
GOS-3,1641662,3.7460543636412535
SNU-1214,5566,2.3887972000624296
KMS-20,54618305,3.8048007259852543
A4/Fukuda,9927531,3.7257201794253776
NCI-H1092,445091,4.147919416996549
KYSE-410,49793307,-2.0140322893035867
PE/CA-PJ34 (clone C12),2749,1.5513879621362283
LNCaP clone FGC,969516,2.7285158421956677
RPMI-7951,42611257,2.919657953778153
BT 330,2746,4.080308483434876
A4/Fukuda,26596,-3.7061252239164553
NCI-H1092,sirolimus-bortezomib (250-1 mol-mol),0.4958114346992872
NCI-H2110,45279963,4.041141728653127
SET-2,72376,-3.832573157030871
AN3-CA,168313200,3.821120909855463
TE 617.T,6438330,2.7353087025620377
YKG-1,168313200,2.942374611054984
HEC-151,156422,4.178129409325859
TE 617.T,2742550,3.402468402026986
CML-T1,49766530,-2.849769761760908
HMCB,135421197,2.011360494635396
D283 Med,24978538,0.887710634714784
NCI-H2172,55283,3.100636399415034
HEC-151,119607,4.186956957695685
Kasumi-2,4477,0.978376283081578
HSC-4,6184667,2.683776581109496
HEC-151,56649450,3.3632660336882436
TE 617.T,66577038,2.256585489002928
SEM,135398744,6.34358667151958
NCI-H1395,selumetinib-JQ-1 (4-1 mol-mol),2.8235760807369177
KMS-27,219104,3.484553686975267
Ku812,49766530,-2.390671573618507
TE 617.T,24180125,2.0821537489988544
NCI-H1395,119182,1.588983658397695
SNU-8,15547703,3.2095801021704142
KMS-27,3543504,3.911589713227349
KMBC-2,24821094,3.5283056158301997
NCI-H2081,11234052,3.237478562823228
Ku812,374536,1.5029739319713498
Ku812,135421197,1.6654017400601815
MM1.S,126941,-0.9459288946859304
AN3-CA,67156097,-2.7467711936339394
A4/Fukuda,6438330,0.8804707138455458
SEM,5281672,3.3448340158126055
AN3-CA,9884685,-1.0076208994656373
Hs 683,6918878,3.497965846629707
D283 Med,46907787,-0.0797634926932206
SNU-308,10074640,3.162888533136693
SW1990,5281672,4.431148411532364
KYSE-410,46843906,2.989071360754789
BT 139,sirolimus-bortezomib (250-1 mol-mol),1.2497154154601016
PaTu 8988s,6918837,-3.581272315150156
EJM,4477,0.4259147068963801
TE 617.T,54765302,3.214416792318029
NCI-H1092,11228183,0.9840040358909228
TE-15,72193861,-1.1257441377745852
NCI-H2110,JQ-1-navitoclax (2-1 mol-mol),2.104417955521832
BT 139,24180719,5.457784024295298
KMS-20,selumetinib-decitabine (4-1 mol-mol),0.7829332375750434
SKM-1,219104,2.5131596943012053
KMS-20,216239,1.7632685828356174
D283 Med,11396600,2.9109671183024983
TE 617.T,168313200,1.7162313923101786
IST-Mes1,67156097,2.0129233452386095
SW1990,3825829,4.305269855808273
HCC2218,10427712,4.297430574502978
SNU-308,selumetinib-PLX-4032 (8-1 mol-mol),4.004313994841309
Hep-G2,5351362,2.6024956401093684
KMS-20,4378219,1.896511565907232
Hep-G2,navitoclax-piperlongumine (1-1 mol-mol),2.9586079970104984
NCI-H2110,89183176,5.1726369191381165
HEC-151,11640390,3.665486165588669
KMS-20,11257553,0.1864785625212487
PE/CA-PJ34 (clone C12),16720766,1.060904595920648
MM1.S,25183872,-3.313227348504023
KMBC-2,135875424,3.177506278142116
D283 Med,10427712,4.834864727067545
HEC-151,8515,4.452182396163437
HCC2218,3503,1.2267358647117403
Raji,216345,3.9745931055166257
KYSE-410,5479543,3.752161213938342
MCAS,decitabine-navitoclax (2-1 mol-mol),1.3286044996274589
RERF-LC-Ad1,11626560,2.342625482561719
HARA [Human squamous cell lung carcinoma],56963564,-0.1933628562955875
PaTu 8988s,54596558,4.4628427535713895
KMS-27,11626560,0.5459873226362797
LNCaP clone FGC,24951314,1.1304514947758728
SNU-308,3038522,4.08288745774994
PE/CA-PJ34 (clone C12),4521392,4.437675700379316
PE/CA-PJ34 (clone C12),5426,4.4355205896905225
A4/Fukuda,4788,3.9402862208503753
LoVo,11964036,-0.4950100771581299
KMS-20,421610,2.181473098974352
SNU-8,2828334,6.367919006563491
CA46,66577038,2.896384523521911
AU565,16720766,2.906162391657848
KMS-20,10322450,3.2597318465423353
SNU-1214,675434,4.01196725824336
SNU-308,15953870,3.462040803535903
SNU-1033,11977753,-3.95491254834697
Hs 683,11485656,3.0003726107919437
Ku812,19582717,3.1020544900029297
A4/Fukuda,16736978,-0.5754825114210159
Kasumi-2,6918328,-2.1918789082401355
HARA [Human squamous cell lung carcinoma],selumetinib-GDC-0941 (4-1 mol-mol),2.088944743887487
LNCaP clone FGC,44489675,3.4266240607626397
SKM-1,439501,-2.678240610691138
BT 330,selumetinib-JQ-1 (4-1 mol-mol),4.150840661532534
NCI-N87,24856436,-1.0645338149753525
MCAS,56963564,0.4121061980618511
PE/CA-PJ34 (clone C12),tanespimycin-gemcitabine (1-1 mol-mol),-1.6336664164478074
BT 320,11257553,3.955696091315844
KMS-27,16720766,-1.503343187948689
ML-1 [Human thyroid carcinoma],JQ-1-vorinostat (2-1 mol-mol),1.0159563388217403
HCC2218,969516,2.8110779148383616
CML-T1,52947716,-5.195799479557534
KMS-27,104842,-6.162149674211061
MCAS,9444,3.993377815466736
HMCB,135411,0.3409472589453896
NCI-H1395,6252,1.808154322431175
BT 139,54618795,3.673895729151394
CML-T1,66577038,2.0285847507138017
NCI-H1092,119607,5.038336546670844
TE 617.T,11494412,-0.0865540584067903
SNU-8,89928392,1.721753144093074
A4/Fukuda,168313016,2.0147776130358253
ML-1 [Human thyroid carcinoma],tretinoin-navitoclax (4-1 mol-mol),3.335416129341979
SNU-1033,6918878,2.3543358775294845
IST-Mes1,9915743,1.0557522455188102
Kasumi-2,46174525,2.7896977924424218
BT 320,12001922,1.695610420399754
RPMI-7951,2842253,5.693868632906147
SNU-8,3854666,0.7475509647190202
BT 330,9952709,2.8069341569894304
SET-2,49846579,1.764293772248107
BT 320,9825149,2.6279121601862676
SW1990,6917907,-5.702121739351915
Ku812,JQ-1-vorinostat (2-1 mol-mol),-1.169942743430711
Kasumi-2,10302451,2.501538159290375
NCI-H1395,2945648,2.6727068131011285
SKM-1,71680916,4.070179784204398
YKG-1,4378219,2.059610902750737
OE21,10385095,0.8074841582682157
TE 617.T,navitoclax-gemcitabine (1-1 mol-mol),-4.956703675225032
HARA [Human squamous cell lung carcinoma],82146,4.619283658647928
SNU-1033,3025986,-0.1134743810645725
NCI-H1395,25102847,3.3934069433864953
LNCaP clone FGC,17755052,0.9231030927826008
PaTu 8988s,148198,-4.140903608928441
BT 328,73707438,3.7767552618386087
NU-DHL-1,3503,1.1771125091152093
MCAS,25154868,4.061191249717254
HARA [Human squamous cell lung carcinoma],60750,0.0702005032300629
RERF-LC-Ad2,49793307,-3.0853357906020125
EJM,445091,4.2359621817187225
KMBC-2,135421197,1.90199423292403
SW1990,135411,0.6325357507232034
Aska-SS,3025944,4.227311720651848
KMS-20,71466578,2.1821979344467537
SEM,9868037,2.0923686689232137
HCC2218,219104,2.9510043871026643
Kasumi-2,67156097,-2.3799018148926363
GOS-3,613753,3.227220710192061
PE/CA-PJ34 (clone C12),5284616,3.3084044044013017
Hs 683,9907093,3.927023043212742
BT 139,44197249,5.019770619603963
HSC-4,23939,4.494005895197972
TE 617.T,135875424,2.9015039808938483
D283 Med,doxorubicin-navitoclax (2-1 mol-mol),-2.991531954647572
PaTu 8988s,carboplatin-UNC0638 (2-1 mol-mol),2.6893749166795047
RPMI-7951,9826308,0.480723158605391
NCI-H2172,387447,-2.372723736293485
PaTu 8988s,11955716,-2.6399696193516164
IST-Mes1,11427553,1.720147340773497
SNU-1214,carboplatin-UNC0638 (2-1 mol-mol),3.0570508968305488
D283 Med,10113978,2.100289947071623
HSC-4,4788,5.270141450772874
RERF-LC-Ad2,5113032,4.576998956244217
NU-DHL-1,16038120,1.471185196159862
MCAS,16736978,0.5390207570846622
HSC-4,44185566,3.0805483382503844
CML-T1,selumetinib-PLX-4032 (8-1 mol-mol),3.463736211464864
HSC-4,650361,3.951915492066197
TE 617.T,3025986,-2.9533377775399376
BT 330,5280436,5.191650160397472
OE21,selumetinib-vorinostat (8-1 mol-mol),1.753596194788317
BT 320,1566236,4.371560124605876
CA46,71466380,3.212448709653588
RERF-LC-Ad1,72193861,4.30689015133483
HSC-4,vorinostat-navitoclax (4-1 mol-mol),1.9548576859286355
D283 Med,serdemetan-SCH-529074 (1-1 mol-mol),1.078221364588871
A4/Fukuda,9911463,2.417745886609146
CML-T1,54618305,-5.881736901302383
HCC2218,5282054,2.4788530599446656
Hs 683,73707371,5.528718161611099
SNU-1033,322968,2.479712039507349
TE 617.T,2945648,2.283999025187704
IST-Mes1,3384730,4.026476803757859
KMS-27,51039095,2.4502408780185903
PE/CA-PJ34 (clone C12),71466578,5.659709650891852
KMRC-2,24964624,3.0030349135178884
PaTu 8988s,60700,-0.3114042731507669
TE 617.T,54454,1.1275583619704346
HSC-4,452548,-1.2537746146037845
HARA [Human squamous cell lung carcinoma],3136844,4.042885024123848
TE-15,2708,3.2297865949089024
TE 617.T,16038120,0.6774481293525906
Ku812,10184653,0.6444023558931821
MCAS,4261,1.8522605558000784
NCI-H2081,carboplatin-UNC0638 (2-1 mol-mol),2.641355380173533
LoVo,176870,1.1282563754131285
KMS-20,3854666,0.6836854926820529
PaTu 8988s,54765302,3.5413529163500383
D283 Med,10410894,2.0006248450880912
BT 139,25126798,4.1512134868113435
SNU-8,9926054,2.0095672828148636
OE21,11213558,0.6907970625707129
SKM-1,46943432,0.4553858331231263
SEM,16219061,1.294188336335581
TE-15,navitoclax-MST-312 (1-1 mol-mol),1.0157748808045457
BT 248,5329102,2.143317374155595
KMS-27,alisertib-navitoclax (2-1 mol-mol),-3.3119680885741314
NCI-H2081,24753719,4.037731991107883
CA46,2749,1.009648399882346
PaTu 8988s,44566777,2.3336781645980573
A4/Fukuda,11719255,2.014724282446697
PaTu 8988s,107970,1.550826733385026
HEC-151,68056272,4.055262002994441
TE-15,11656518,2.447571109654658
GOS-3,44589607,2.926429501470136
KMBC-2,44607531,1.206215949573423
TE-15,67291369,1.930417695564843
Hs 683,65628,4.4952708080724495
KMBC-2,5280436,3.963085231477196
Hs 683,11612883,3.874361817357709
GOS-3,119607,5.92961228058127
SKM-1,3038522,3.769689867373741
CA46,54619267,3.4754479185856604
NU-DHL-1,71466380,3.774747568676896
NU-DHL-1,carboplatin-UNC0638 (2-1 mol-mol),3.3161247745153277
HARA [Human squamous cell lung carcinoma],107970,2.425047737070786
MCAS,26596,-1.466898780296629
SET-2,2113511,5.707178743986511
PaTu 8988s,51037431,3.954345324731351
OE21,42642645,1.345400530545778
BT 320,selumetinib-GDC-0941 (4-1 mol-mol),2.4654879652784447
A4/Fukuda,11497983,-1.0595923666648657
D283 Med,55508,1.738146449836156
D283 Med,107970,1.5899675113879286
YKG-1,navitoclax-PLX-4032 (1-1 mol-mol),5.471845288851878
KMS-20,4477,-0.4884463728422688
CML-T1,46398810,1.457844995716712
LoVo,322968,3.2361743048313536
SNU-1214,11175137,3.3781853792916787
PE/CA-PJ34 (clone C12),25105715,3.6718860986285975
NU-DHL-1,1716436,2.341384326057666
HARA [Human squamous cell lung carcinoma],6450551,1.1333007709837388
TE 617.T,11626560,1.8832957884579664
BT 248,322968,2.9090533378149535
MM1.S,89183176,2.023432778974028
EJM,5282054,2.6284954887881784
NCI-H2081,71304818,1.874241739609375
A4/Fukuda,25102847,0.4372365282678318
HSC-4,16720766,-1.6245250648624636
GOS-3,4261,3.5553215793215185
RPMI-7951,2945648,3.164942400305847
BT 328,2828334,7.045901610155557
HEC-151,doxorubicin-navitoclax (2-1 mol-mol),-1.3612556233539408
HARA [Human squamous cell lung carcinoma],216468,1.0737616041415703
SEM,12003241,-3.075217153076431
MM1.S,12003241,-0.8577985614667851
KMS-20,5335621,4.346191921531872
NU-DHL-1,387447,-5.01713614563577
KMS-27,5291,3.6501433744509177
CA46,126941,-4.174426911659592
TE 617.T,16741245,4.1592195625423845
RERF-LC-Ad2,11609586,3.457016103236202
NCI-H1395,44137675,3.7508448726513737
HEC-151,136227924,2.850288220591168
SKM-1,5351362,1.5652480308403496
BT 330,216239,1.743255722435545
HARA [Human squamous cell lung carcinoma],tanespimycin-gemcitabine (1-1 mol-mol),0.469334809183726
BT 320,44507138,4.949888097685237
AU565,24772860,3.3222909323637455
BT 139,2708,5.853118570413443
AU565,piperlongumine-MST-312 (1-1 mol-mol),1.980808732390433
D283 Med,alisertib-navitoclax (2-1 mol-mol),-3.1585358120838825
PE/CA-PJ34 (clone C12),16013152,4.240449393705453
KMS-20,10074640,2.509346004952602
HSC-4,25150857,3.233332545340528
SET-2,26596,-1.642607786787168
HCC2218,navitoclax-MST-312 (1-1 mol-mol),0.956940950080559
PaTu 8988s,9444,3.623021044997965
SNU-1272,216239,2.083500892876492
SET-2,9549297,1.5914218230891424
SNU-1214,4477,0.8623778747742765
AU565,72193861,-0.1764123403705666
HARA [Human squamous cell lung carcinoma],24889392,3.022552356394008
Kasumi-2,11228183,-3.3606954683588057
CA46,BRD-A02303741-navitoclax (2-1 mol-mol),3.6671520767068095
NCI-N87,navitoclax-gemcitabine (1-1 mol-mol),-3.6490042770502815
BT 328,71729975,3.0990455270892365
KMS-20,11214940,3.272421487084948
SNU-1033,53393127,-1.534783790658787
KMRC-2,676352,1.733053022246691
RERF-LC-Ad2,4477,2.027795326183103
A4/Fukuda,6914657,-5.308594861321554
Aska-SS,1716436,2.2467196259646114
Kasumi-2,168313200,3.5619242662151342
LNCaP clone FGC,66577038,3.107164223519453
D283 Med,11404337,-0.900512184015852
LNCaP clone FGC,753704,4.7408710893467525
LoVo,60750,-4.161283305326802
AU565,5566,3.0303294385930584
KMRC-2,5113032,5.093384649259218
HCC2218,selumetinib-JQ-1 (4-1 mol-mol),1.4456076234612698
SW1990,selumetinib-decitabine (4-1 mol-mol),2.063456443553195
NCI-N87,piperlongumine-MST-312 (1-1 mol-mol),3.209921452990857
KYSE-410,24901704,3.119564924115497
HMCB,49793307,0.2477875655449162
LNCaP clone FGC,168312962,1.214226575768129
HEC-151,135659046,3.7740160846468
TE 617.T,24785538,1.222197390283284
NCI-H2110,9933475,2.2594309830350054
HCC2218,136227924,2.978872567688762
LNCaP clone FGC,984333,2.4697165737254516
LoVo,11719255,3.552916809155198
KMS-27,54613361,-1.5890909260641095
AN3-CA,11317348,1.5853926508405654
GOS-3,5746,1.4150119127186604
GOS-3,tanespimycin-gemcitabine (1-1 mol-mol),3.128044986938021
BT 139,6450551,2.676401003884647
IST-Mes1,216345,3.619183672475448
HCC2218,2746,2.1275689170875847
HARA [Human squamous cell lung carcinoma],6918289,2.581505632245523
AU565,5113032,4.518377698044194
KMBC-2,3689413,-0.0193871140642154
EJM,5738263,3.5762426266629617
NCI-N87,2841722,4.410495760007658
SW1990,135440466,2.3978591257913218
BT 139,6918328,2.0359102713275528
Kasumi-2,68056272,3.4308739954935867
TE-15,10302451,0.955725633878595
BT 139,984333,5.086302666222492
A4/Fukuda,208908,1.6750686900112284
RPMI-7951,tanespimycin-bortezomib (250-1 mol-mol),-3.2107041108384524
SEM,4521392,4.258271706242731
HEC-151,sirolimus-bortezomib (250-1 mol-mol),0.8769904812641561
SET-2,11626560,-0.1084885136053665
SKM-1,5978,-3.867045594927121
KMS-20,3825829,3.171752203706611
SNU-308,44489367,4.856356872192214
SKM-1,9929138,6.747336348801134
MM1.S,2708,4.3305699285872095
SNU-1033,decitabine-navitoclax (2-1 mol-mol),1.6958517813828735
TE-15,65628,4.191504747725539
NCI-H1092,9967941,1.8935629998367884
OE21,navitoclax-gemcitabine (1-1 mol-mol),-2.221611192043541
PE/CA-PJ34 (clone C12),doxorubicin-navitoclax (2-1 mol-mol),-1.5110947353726836
SNU-1272,2733487,6.387054792356426
LoVo,tretinoin-carboplatin (2-1 mol-mol),5.63935886980119
HARA [Human squamous cell lung carcinoma],4477,-0.0807211341972061
PaTu 8988s,262093,3.243938357884203
KMBC-2,25183872,-1.1751157821952534
TE-15,7251185,3.1886736649035656
ML-1 [Human thyroid carcinoma],72199292,2.652505906746634
LoVo,12003241,-2.8621949377385465
NU-DHL-1,71304818,2.6808989156503467
MCAS,656346,0.9240137968686226
Hs 683,89928392,1.5985619722358693
LoVo,24180719,2.381979820549913
KMBC-2,15983966,3.0423394947967526
OE21,67156097,-2.1300652740102963
HSC-4,159324,3.192829599869501
NCI-H1092,ISOX-bortezomib (250-1 mol-mol),0.1294529339414141
LNCaP clone FGC,selumetinib-navitoclax (8-1 mol-mol),4.604637822418501
NCI-H1395,selumetinib-piperlongumine (8-1 mol-mol),3.796978991433947
NCI-H2110,11625818,4.775751943194114
CML-T1,BRD-K27188169-navitoclax (2-1 mol-mol),1.24494098413804
LNCaP clone FGC,10127622,5.349418794723568
RPMI-7951,644241,2.388085399534529
SNU-8,16736978,2.3395746599285214
KMRC-2,25183872,-0.2670953829983857
NCI-H2110,6914657,-2.218161327784245
Kasumi-2,24951314,-0.5780068322267972
SNU-1033,4259181,1.0677542833514009
Ku812,11612883,2.6120187815621128
MCAS,5566,3.352816905659856
TE 617.T,16659841,3.927285951195876
SNU-308,46199207,3.55488110741621
NCI-H2110,11964036,1.9928973384702835
SNU-1033,25262965,-0.5666439209435467
NCI-N87,969516,2.8189934287936733
Ku812,3825829,2.937255635905749
KMS-27,444795,4.486378633657878
A4/Fukuda,3011155,4.269088750580724
ML-1 [Human thyroid carcinoma],2841722,5.015074505803474
HEC-151,675434,4.287380101646617
CA46,9967941,3.699441503938977
HEC-151,54613361,-0.1055371916059164
TE-15,doxorubicin-navitoclax (2-1 mol-mol),-2.2072480277972355
RERF-LC-Ad2,SNX-2112-bortezomib (250-1 mol-mol),-1.0932359303566324
OE21,selumetinib-piperlongumine (8-1 mol-mol),2.027180738703513
SKM-1,3503,1.2893215840676688
Ku812,9549297,1.3276484644733737
HCC2218,23635314,1.9160689040832388
KMS-20,45279963,3.236905004417033
NU-DHL-1,2733526,3.27744677089757
KMRC-2,tretinoin-navitoclax (4-1 mol-mol),2.3072936502607884
EJM,375860,-0.4454409247993169
KMBC-2,1750826,-0.4794415324441379
Aska-SS,6852167,0.8511531756898867
NCI-H2110,9840324,5.768286236692181
YKG-1,216345,4.618368772629755
YKG-1,11609586,3.3937959596704523
Ku812,71466380,3.9178457046107704
HEC-151,9911830,2.8637422134890342
NU-DHL-1,23635314,-3.800545586452872
NCI-H2110,16038120,0.9199508274522638
PaTu 8988s,tanespimycin-bortezomib (250-1 mol-mol),-2.9825646134003825
BT 248,10410894,2.478264779428893
KYSE-410,421610,3.494907211126446
NCI-H1092,carboplatin-etoposide (40-17 mol-mol),2.1846305146298852
IST-Mes1,44589607,3.0309009389458605
CA46,navitoclax-piperlongumine (1-1 mol-mol),1.4441341288477034
TE-15,JQ-1-MK-0752 (1-1 mol-mol),0.2653870098950329
NCI-H2172,107985,-3.1793632305275836
Kasumi-2,568763,-0.985189730983464
EJM,637858,1.0127573104049012
MCAS,9549297,1.7154224156023905
NCI-H1395,9803433,5.44811246769085
BT 248,6450551,3.394353011187604
HEC-151,15547703,3.1775490487943148
TE 617.T,9933475,1.4725788991352122
Aska-SS,vorinostat-carboplatin (1-1 mol-mol),2.719460579822469
A4/Fukuda,11717001,3.8123333180630103
TE 617.T,5284373,2.9344966923010047
TE-15,9911463,3.694434531668693
OE21,5328940,-0.4875133080521308
Hep-G2,67291369,4.476639132471762
ML-1 [Human thyroid carcinoma],5470400,0.2567315670041485
SNU-1214,selumetinib-BRD-A02303741 (4-1 mol-mol),2.175511889017324
NCI-H1092,25227462,1.0244248968881735
BT 328,selumetinib-MK-2206 (8-1 mol-mol),3.5375003025596596
HEC-151,644241,2.1605297615214716
KYSE-410,10302451,1.6161895544560456
SNU-8,3825829,4.279062116005913
HMCB,151289,0.8924062734288687
HSC-4,2841722,4.578140166849417
NCI-H2081,11494412,-0.0076516448343769
HSC-4,51039095,3.5449735354798
EJM,2708,5.071772468532641
SNU-1214,3465537,5.236709132299774
KMRC-2,44589607,3.5490328249670164
Ku812,23635314,-2.972505773411878
CML-T1,5284329,2.20205002414717
SNU-1214,selumetinib-vorinostat (8-1 mol-mol),1.1139893258531253
AN3-CA,445643,5.011387684987895
HSC-4,3825829,4.330540788358233
HCC2218,10074640,2.6631017803382604
KMS-20,135398516,0.4779911076393339
CML-T1,5566,2.203374574789853
SEM,11222830,0.5269269081978375
Raji,148198,-3.0979012911214077
BT 248,25154868,4.640538278810453
MCAS,navitoclax-sorafenib (1-1 mol-mol),2.154813083369075
KMRC-2,446155,4.179289387738745
A4/Fukuda,16659841,2.2699989015311437
OE21,46174525,4.431848508923809
KMS-20,tretinoin-carboplatin (2-1 mol-mol),3.6685354299569486
RPMI-7951,19582717,3.949815378259687
PE/CA-PJ34 (clone C12),25150857,2.980955844336646
RPMI-7951,6918328,-0.3826949167276244
NU-DHL-1,56649450,3.732895044014296
SET-2,2749,1.5247234859739272
NCI-N87,17755052,-1.4521000328048816
KYSE-410,11625818,4.768458424942497
NU-DHL-1,44632017,-0.251527549613568
NCI-H2081,409805,3.646579192169883
EJM,5351362,0.5946464682501855
LoVo,448949,1.89047161937067
KMS-20,25102847,2.4151614593065687
GOS-3,11964036,2.3854684921529525
SNU-308,24901704,5.163894321909123
BT 320,navitoclax-MST-312 (1-1 mol-mol),1.1316480984239057
NCI-H2110,4521392,4.271379132375328
IST-Mes1,11175137,3.00105789094782
BT 139,3689413,1.1435542954681734
Ku812,135984461,1.927355885078453
NCI-H1092,57519531,1.6858418046030903
SNU-1214,5278396,3.4697021692694325
SEM,BRD-A02303741-navitoclax (2-1 mol-mol),-2.0492341390598368
LNCaP clone FGC,11609586,0.8127524529146487
Hs 683,navitoclax-MST-312 (1-1 mol-mol),0.9161458061573864
Raji,11152667,-1.6469558196734089
CML-T1,3081361,0.8904525598046117
Ku812,3038522,2.027577923639431
KMBC-2,9884685,1.520589448798377
MM1.S,135411,0.4705097492243096
D283 Med,11214940,-0.7958287739094837
CA46,426756,4.77193452473935
SNU-1033,5287969,-1.852663004526358
KMBC-2,44489675,4.815586661350087
BT 139,9903786,4.553274987644657
KMS-27,11152667,-0.6309596217329284
LNCaP clone FGC,400769,-1.0721127446992365
MCAS,9840324,5.2050043041150245
Kasumi-2,24964624,-0.4292953548999766
RERF-LC-Ad2,selumetinib-MK-2206 (8-1 mol-mol),1.6130132483311332
HSC-4,6450551,4.030000721690881
SEM,24889392,-0.6485372818048298
KYSE-410,135999136,4.574182902915764
BT 328,11364421,2.7356800342957777
BT 248,122327,5.08009478305936
HARA [Human squamous cell lung carcinoma],638278,3.613202989039307
MCAS,31703,-0.84361495393889
AU565,68056272,3.4490660549666425
NU-DHL-1,4259181,-0.8877351143250455
A4/Fukuda,10302451,3.353566161735505
A4/Fukuda,2871966,-1.2628046939905593
MCAS,25150857,3.0365638700183424
MCAS,1242560,3.9777332019119385
Ku812,49836020,4.574644913995472
SEM,31703,-4.117081497210504
NCI-H2110,10427712,6.255261988959236
KMBC-2,11152667,1.3012621029988305
SKM-1,5394,3.370864501723167
KYSE-410,24797083,1.7449948464454093
Kasumi-2,alisertib-navitoclax (2-1 mol-mol),-2.881127323252466
OE21,168313200,2.14822822620211
KYSE-410,5284616,2.743882210150552
NCI-H1395,72193861,3.743948008436619
KMRC-2,24797083,1.3154639139008475
MM1.S,navitoclax-pluripotin (1-1 mol-mol),-0.4741986975069364
Kasumi-2,24180125,1.6711646659047346
TE 617.T,10427712,3.9181007930072855
BT 320,44241473,4.3699389688619945
CML-T1,446155,3.2304119453056632
Hep-G2,31703,-1.2144454026470897
BT 328,51039095,3.5315864754377735
A4/Fukuda,375860,-1.1918610484687095
KMRC-2,46199207,3.1948404300914555
NU-DHL-1,119607,5.442587797739693
MCAS,3062316,-0.1716556504853732
BT 248,9933475,1.8575466823142976
HCC2218,9825149,2.6814610531710223
SET-2,53232,1.7911172891332965
BT 328,10074640,3.6733046849863986
MM1.S,navitoclax-sorafenib (1-1 mol-mol),3.1642933402407705
PE/CA-PJ34 (clone C12),44819697,-1.5115898426437493
NU-DHL-1,3854666,0.0415857497138207
NCI-H2081,10113978,3.1143213489087755
SET-2,16722836,-0.1774401414878187
MCAS,10074640,3.1296292298776716
NU-DHL-1,2126,4.057777482675548
KMRC-2,71304818,3.686445866652109
RERF-LC-Ad1,6918837,-0.1903099145343919
CML-T1,10302451,-1.0288409878116755
RPMI-7951,6852167,2.0077345898162675
NCI-H1395,navitoclax-MST-312 (1-1 mol-mol),0.8378237881754972
SET-2,119607,4.996784507856945
HEC-151,984333,1.4845970451786328
HSC-4,navitoclax-PLX-4032 (1-1 mol-mol),2.8756909366575023
Hs 683,9884685,-0.0613437771219763
Kasumi-2,6918878,1.1877992835952844
NCI-H2081,216239,1.3066578972225331
SW1990,71304818,2.4151211840042563
Hs 683,16038120,1.3403020790788895
ML-1 [Human thyroid carcinoma],4096211,3.147888642031647
Hs 683,6505803,-1.9207933299910505
PaTu 8988s,crizotinib-PLX-4032 (2-1 mol-mol),1.415044616335074
Hs 683,72199292,1.8937209912313913
Ku812,9911830,-2.227591069329418
BT 328,sirolimus-bortezomib (250-1 mol-mol),2.117607620911863
YKG-1,6914657,-2.9791287497746186
NCI-H1092,89928392,0.7576351526304943
SNU-1214,71466578,5.469763615942432
SNU-1033,serdemetan-SCH-529074 (1-1 mol-mol),1.6630124827493464
D283 Med,selumetinib-JQ-1 (4-1 mol-mol),1.653180962560337
SKM-1,11640390,1.3825660672186588
NCI-H2081,doxorubicin-navitoclax (2-1 mol-mol),-3.331282092417488
MM1.S,5113032,5.133627737640779
NCI-N87,3025986,-2.1031012904407818
IST-Mes1,3025944,4.475795844293571
MCAS,6918736,-1.7437988275136789
A4/Fukuda,6917907,-6.123586781218294
KMRC-2,122327,4.0267787578359835
Kasumi-2,54619267,3.817493003311882
Hs 683,15983966,4.053767211388769
NCI-H2110,73707398,1.6375647309525496
OE21,72193861,0.4570614689766386
BT 139,12001922,1.0025758835184926
AN3-CA,selumetinib-MK-2206 (8-1 mol-mol),2.0426489986894265
A4/Fukuda,6918328,-3.9252329494253586
ML-1 [Human thyroid carcinoma],216345,4.790115930225849
NCI-N87,6252,-1.400414082532842
SET-2,JQ-1-vorinostat (2-1 mol-mol),-1.920843385058424
NCI-H2110,4578,4.455232001542883
LoVo,285033,-2.045623665035502
NCI-H2081,25105715,3.7171475325174703
LoVo,2746,2.3133613771451524
KMRC-2,25150857,2.328256139477392
SET-2,5328940,1.259459223371511
IST-Mes1,49793307,1.120791830462594
NCI-H2172,6610355,5.133393026581665
RPMI-7951,BRD-A02303741-carboplatin (1-1 mol-mol),4.1288937818997695
TE-15,5470400,-2.757197006714044
SNU-1033,24753719,4.01001604133428
HARA [Human squamous cell lung carcinoma],12003241,-0.2443339656532688
HARA [Human squamous cell lung carcinoma],2729026,2.992927693558788
SW1990,25154868,5.078344865125208
NCI-H2172,25150857,2.903675927541502
BT 330,5566,2.621258469673252
BT 328,5494449,3.740729289137561
A4/Fukuda,25062766,1.3929374396347198
EJM,67291369,1.7499501988378825
SNU-308,10302451,1.9995275040024083
SNU-1033,54618164,4.351406762339218
SKM-1,135398516,2.107945219475692
SNU-308,168312962,3.315997972235471
MM1.S,5351362,1.350784459153801
A4/Fukuda,135398516,0.099848878431286
SW1990,246676,4.838396695986544
NCI-H2081,10410894,3.3787731123867464
BT 330,5460769,2.587250000288721
IST-Mes1,10385095,2.3784865098232255
LNCaP clone FGC,46398810,3.373306144767874
TE 617.T,11647372,2.975388477244594
RPMI-7951,11507802,1.523521389260421
HSC-4,11427553,3.1625220487182193
BT 139,11364421,1.3257085435205094
PaTu 8988s,675434,4.44028682039976
AU565,44620216,3.755834453350393
SNU-1033,702558,5.237655466937512
HARA [Human squamous cell lung carcinoma],387447,-4.146769649621688
BT 139,11494412,3.8637696290948815
Kasumi-2,docetaxel-tanespimycin (2-1 mol-mol),-5.507046356769771
Ku812,656346,0.2651161677447766
D283 Med,11640390,0.8547144759523356
KMS-20,31703,-1.639291403660424
SNU-1214,219104,3.8192671033642105
EJM,5278396,3.1726685526501357
EJM,54618164,3.6862835131456455
HMCB,10385095,1.0131649772543003
A4/Fukuda,168312962,0.589698091471745
CA46,24753719,4.040239779097469
KMRC-2,675434,5.987792180737955
MM1.S,11404337,0.2422934532029092
NU-DHL-1,docetaxel-tanespimycin (2-1 mol-mol),-4.786935307033958
KMRC-2,31703,0.7673744318667989
LNCaP clone FGC,73707398,1.3422598428306614
Ku812,9803433,4.326144725372532
KYSE-410,3025944,4.432706614143299
SW1990,11626560,2.077334834203954
NU-DHL-1,7251185,0.290516417532148
HSC-4,54686904,4.85379149564711
RPMI-7951,135411,0.7923410936868759
HMCB,107970,2.4632765451158356
MM1.S,selumetinib-piperlongumine (8-1 mol-mol),2.4141492547305243
YKG-1,10322450,5.46076367923885
BT 139,25150857,2.51891884617669
SEM,selumetinib-piperlongumine (8-1 mol-mol),1.0176958248446395
KMBC-2,441298,2.4144420207612094
SET-2,73707398,0.747643412090769
RPMI-7951,tanespimycin-gemcitabine (1-1 mol-mol),-4.333052092080868
KMS-27,16115403,-5.455837565599094
Hs 683,3025944,4.195696476989441
Raji,54618771,-0.1378575615243227
TE 617.T,6918328,0.5232426228966834
EJM,241158,2.554123806651753
SEM,11507802,-0.3844502911192904
RERF-LC-Ad2,1750826,-3.0175803273525004
HEC-151,vorinostat-carboplatin (1-1 mol-mol),3.4535763483208313
RPMI-7951,11364421,-4.7201296636782795
D283 Med,44202524,1.228437692555833
SNU-1033,2749,1.0851493879986265
KMBC-2,71729975,0.876835648832875
SNU-1214,tanespimycin-gemcitabine (1-1 mol-mol),-2.56698732074714
HSC-4,9915743,0.765957034876682
SET-2,4788,5.639545717723676
LoVo,49836020,1.6927786584323
PaTu 8988s,57519531,4.239533170435924
CML-T1,selumetinib-vorinostat (8-1 mol-mol),2.04753807538672
BT 328,5329102,2.931007183375298
RPMI-7951,46199207,3.018080532945558
SNU-1272,selumetinib-navitoclax (8-1 mol-mol),2.1860356940542087
NCI-H1092,16038120,0.7864664240058443
TE-15,216345,4.377731510791297
SEM,168313200,1.52373638401344
KMS-27,24771867,-2.8070025091368054
SEM,5287620,-2.250994542245304
YKG-1,54618305,4.389332697073838
SKM-1,11222830,1.186229333087779
OE21,19582717,3.6173239158070674
SET-2,16659841,0.156050821805508
IST-Mes1,9866186,0.9671533169607398
NCI-H1092,4261,0.9195387417672236
SW1990,selumetinib-GDC-0941 (4-1 mol-mol),1.2183464614228592
KMBC-2,5460769,1.880103554481412
CML-T1,9908783,6.154706718384333
BT 328,1716436,3.653949071950038
BT 248,10184653,1.5665149744328004
PE/CA-PJ34 (clone C12),4705,1.0597990978306746
EJM,4788,5.350018534970788
YKG-1,45279963,4.304411410062701
EJM,49836020,4.362565190709962
Raji,ISOX-bortezomib (250-1 mol-mol),0.7576291321089732
OE21,56949517,4.209689564616798
SEM,135875424,2.4848737039506426
SNU-308,11625818,3.828888868418273
KMS-20,6252,-0.1616795629584481
BT 248,135421197,1.5349499708791383
TE 617.T,44202524,1.3944067361692245
Hs 683,24753719,4.249788601430605
YKG-1,24821094,3.8775145827770703
NCI-H1395,25062766,3.463916813883382
HMCB,24951314,2.2278273113758083
KMBC-2,2742550,4.819576117265504
MM1.S,3025986,-1.7222159842477116
TE 617.T,56973724,2.843269444748679
NCI-H2081,208908,1.5488690353253576
GOS-3,24180125,3.35218152246705
NCI-H2081,15953870,2.893627667573686
KMBC-2,17755052,1.0782212674471028
RPMI-7951,2949965,2.7750243079239016
KYSE-410,135440466,2.1527835463527834
NU-DHL-1,136227924,1.2519389073848997
TE-15,11396600,3.8567248680954056
IST-Mes1,11955716,-2.3343063309165095
OE21,156414,-3.0417448997848857
KMS-20,11455910,0.7957422642794928
KMS-27,25195348,3.2487462992442437
OE21,123631,-1.0243580930173388
SNU-1272,24856436,1.090216568071402
LNCaP clone FGC,44819697,-0.1546779845051894
TE-15,11977753,-0.2031072822871913
Kasumi-2,4521392,4.1748849427500625
LNCaP clone FGC,42642645,0.6379836145749267
SNU-1214,25154868,4.088629107850921
EJM,54143018,0.5914638722228845
RPMI-7951,44507138,1.9104854997841585
SKM-1,JQ-1-navitoclax (2-1 mol-mol),-0.3773904973177986
MCAS,46215462,2.85395044792557
KMS-27,5460769,1.7009983096984826
HCC2218,322968,2.14614660643138
SKM-1,73707398,0.3700517012219515
KMS-20,10410894,2.165253537613353
KMBC-2,ISOX-bortezomib (250-1 mol-mol),0.6592727050482347
HSC-4,73707398,0.9895931551524366
SNU-308,6918736,-1.7889919897338664
KMS-20,2949965,1.3339775316337088
NCI-H1395,73707398,1.4482642438908118
KMS-27,SNX-2112-bortezomib (250-1 mol-mol),-3.169114693760398
LoVo,16736978,-0.2277330125842315
LNCaP clone FGC,11647372,0.1561825282558437
NCI-H2110,71466578,5.140572162086394
TE-15,216239,2.79028848933855
LNCaP clone FGC,SNX-2112-bortezomib (250-1 mol-mol),-2.9814353159230778
KMRC-2,409805,5.9581282148190855
NU-DHL-1,24775005,3.519869888834562
TE 617.T,11167602,1.5922008252868003
NCI-H2172,11152667,1.0620592795126853
NCI-H1092,55508,4.291309194674307
TE-15,24821094,-0.055231882311639
TE 617.T,11214940,1.9376192277077016
IST-Mes1,vorinostat-navitoclax (4-1 mol-mol),2.4210379040593972
HEC-151,24901704,3.5854197233536382
HEC-151,4788,4.697494958927593
SNU-1272,44137675,4.576444163035884
GOS-3,285033,-3.584870880949546
SKM-1,23582824,1.1838260126790126
Hep-G2,25062766,1.9430883989406535
NCI-H2110,11175137,3.0426764679724383
AU565,5328940,1.3384832652905083
HSC-4,11175137,3.5997845208099797
RERF-LC-Ad1,44185566,3.2196778571318356
HSC-4,6918837,-1.8301723200742368
KMS-27,3025986,-2.2531201014218376
KYSE-410,46191454,2.564213585612182
SNU-8,44137675,3.738684584786805
BT 330,erlotinib-PLX-4032 (2-1 mol-mol),3.1729998083866784
KMS-20,3689413,-1.644811207648459
SNU-1214,54639024,4.425030534008987
CA46,4705,3.1649236354970154
KMRC-2,5281672,4.440039611161242
YKG-1,9907093,5.058925928948357
LoVo,374536,3.1459286411718055
Hs 683,676352,1.7883450519966615
MCAS,54649381,4.395413097110276
AN3-CA,selumetinib-tretinoin (2-1 mol-mol),4.656553495981066
PE/CA-PJ34 (clone C12),2945648,3.1110047210534533
NCI-H2110,4477,0.6632295370187135
CA46,11152667,-1.1506421067609531
AU565,4477,0.8975719043136093
KMBC-2,241158,4.749872704815576
BT 328,9868037,5.326885818831123
SNU-1214,erlotinib-PLX-4032 (2-1 mol-mol),0.9511109417824108
SEM,151289,0.5470981042649448
SNU-1214,ISOX-bortezomib (250-1 mol-mol),-0.0324388048428389
HEC-151,44607530,2.2664323505361987
GOS-3,135875424,4.516628943420056
BT 330,285033,0.8091924542559932
HCC2218,53245473,4.390880482928817
KMS-27,5281672,6.396603390578461
KMS-20,1242560,1.3747443997814042
RPMI-7951,446155,0.7290278361931649
MM1.S,54619267,4.994237455053685
HARA [Human squamous cell lung carcinoma],11178236,-2.833191042701781
Kasumi-2,24821094,1.7820431474601306
NCI-H1395,11494412,4.0372714005300026
BT 330,675434,4.00898726797857
KMS-20,6438330,0.8417749626453567
NU-DHL-1,5460769,0.1990382783266381
PaTu 8988s,53481919,3.618361431835983
Raji,24753719,3.12822311930087
LNCaP clone FGC,6438330,2.9794054600880013
BT 330,6918736,-1.8375752033286947
SKM-1,9935249,2.0831236560196147
HSC-4,654092,0.2566378579351391
TE 617.T,5291,3.75733559146497
RPMI-7951,67291369,2.8154779502053016
RPMI-7951,168312962,2.348138858924481
AN3-CA,45279963,3.097251207724971
BT 139,9907093,5.793430367876926
Aska-SS,24779724,-1.025302849370559
BT 328,9936388,2.1535847087745386
HARA [Human squamous cell lung carcinoma],1750826,2.2891380116234616
BT 328,24964624,2.9431698803975324
SW1990,56946209,-5.150132867799484
AU565,104842,-3.8153307910583014
A4/Fukuda,5394,2.6676913787283305
NU-DHL-1,16219061,1.476487728041343
PaTu 8988s,ISOX-bortezomib (250-1 mol-mol),0.2755393634191515
HEC-151,5460769,2.7656616945667
A4/Fukuda,selumetinib-vorinostat (8-1 mol-mol),0.52731023294293
Kasumi-2,ISOX-bortezomib (250-1 mol-mol),-0.8608455854799354
PaTu 8988s,702558,6.597763482628467
NCI-H1092,60750,0.6504249492062534
SW1990,135398738,4.6011979379855665
BT 328,24775005,3.5424710463828624
PE/CA-PJ34 (clone C12),6918638,1.3328388585954094
PaTu 8988s,441298,3.298421994041664
LoVo,25126798,3.7423562181337338
NCI-H1395,selumetinib-PLX-4032 (8-1 mol-mol),5.142160466217897
SNU-308,54613361,1.3783530680753424
NU-DHL-1,613753,2.5066251808010716
PE/CA-PJ34 (clone C12),11222830,1.6303913144002309
TE 617.T,136227924,1.63601430884803
PE/CA-PJ34 (clone C12),11455910,0.5657744918990928
AN3-CA,24901704,1.906570785391895
Aska-SS,11222830,1.885220624165585
Raji,44607530,2.3705151094198387
Raji,3543504,2.7811348432985032
Kasumi-2,49836020,6.151495097204233
YKG-1,9915743,1.478165176900873
NCI-H1092,tretinoin-navitoclax (4-1 mol-mol),3.4593364841450085
SNU-308,10184653,0.2436604548829367
Kasumi-2,375860,-0.7090394918812726
A4/Fukuda,navitoclax-piperlongumine (1-1 mol-mol),0.9145762959476356
TE 617.T,25062766,1.6641802399549648
KMS-20,46215462,1.529319856062388
NCI-N87,3854666,1.2679317332294615
HMCB,9911463,4.262652850494811
SEM,11656518,-0.9335747644896384
BT 139,285033,-0.1387265291417826
EJM,JQ-1-vorinostat (2-1 mol-mol),-0.3009892531248522
SEM,1566236,0.4832736150587708
HCC2218,51037431,1.0791921367059885
NCI-H2110,23635314,-3.755634787992258
BT 320,24821094,3.905918214519909
NU-DHL-1,4917,3.040548897529803
SNU-308,44819697,2.1321699487878245
RPMI-7951,53232,2.1899974119602352
LNCaP clone FGC,1239801,4.741594223771951
SKM-1,51039095,1.6344221890369603
Hep-G2,51039095,2.027774881018878
Aska-SS,navitoclax-MST-312 (1-1 mol-mol),1.6298710816433473
BT 248,2749,1.3146464590197295
KMBC-2,44237094,3.0834774593122924
NU-DHL-1,176870,2.457037183526244
A4/Fukuda,5738263,2.3624425097256676
ML-1 [Human thyroid carcinoma],409805,4.766723032315811
BT 330,2858523,3.0506576949933844
Hep-G2,452548,1.6597392394544144
KMBC-2,JQ-1-navitoclax (2-1 mol-mol),0.1634433459310504
SNU-1214,2113511,7.01646304826078
SEM,25262965,1.0326177265018786
TE-15,5738263,2.473444471017114
OE21,53392493,3.130106350947806
HMCB,11612883,2.765209617636502
BT 139,72376,0.534950921160439
TE-15,selumetinib-vorinostat (8-1 mol-mol),2.423276654507223
NU-DHL-1,1242560,3.5143861800076652
BT 139,navitoclax-gemcitabine (1-1 mol-mol),-0.6679699098523508
Raji,1242560,3.207248077218254
NCI-H1395,44566777,1.012205213932494
CML-T1,49793307,-4.188413118061572
Hs 683,5284616,3.1798422053690394
LoVo,72734382,4.052668353480041
LNCaP clone FGC,637858,2.004669804836901
EJM,54618771,0.5366367501744294
SNU-308,11612883,3.4519110604801875
NCI-H2081,5287620,-2.511505650083613
TE 617.T,vorinostat-carboplatin (1-1 mol-mol),2.8187064409728806
CA46,5746,0.6077367646083516
SNU-8,vorinostat-carboplatin (1-1 mol-mol),2.8875335842096077
PE/CA-PJ34 (clone C12),11175137,2.637065754924562
Aska-SS,navitoclax-piperlongumine (1-1 mol-mol),2.115176063293757
D283 Med,9967941,4.476390135887204
Raji,73707398,0.7917635742848352
NU-DHL-1,alisertib-navitoclax (2-1 mol-mol),-2.593164821561062
NU-DHL-1,11427553,2.3101556642862575
D283 Med,6918837,-6.563523505293122
PaTu 8988s,6505803,-2.1809975101024417
TE-15,54626689,5.678962222931802
CML-T1,168312962,-0.7219792388324245
PaTu 8988s,11214940,1.9051514433442307
Kasumi-2,285033,-4.713748931161676
CA46,613753,2.777360120502711
Aska-SS,3503,3.4369193911145732
SNU-1214,67156097,-1.7976268412329377
Hs 683,navitoclax-PLX-4032 (1-1 mol-mol),2.4517865371866163
CML-T1,navitoclax-sorafenib (1-1 mol-mol),0.8856526530243491
SNU-1272,navitoclax-sorafenib (1-1 mol-mol),0.9627190131227148
KMS-27,3384730,0.3724984048412317
KMS-20,9444,4.5404933780509635
Hep-G2,107970,2.033740391106035
BT 320,107970,2.3152930812829497
RPMI-7951,16115403,-4.771621646391644
SKM-1,11404337,-1.0204518416697923
MCAS,5287620,-1.9007294396044043
YKG-1,53495165,0.7600331159064647
SNU-308,44137675,3.0382663195493382
SNU-1033,107985,-3.3872017086874924
CA46,11707110,2.876405562319207
D283 Med,441298,3.3392911841728767
YKG-1,vorinostat-navitoclax (4-1 mol-mol),2.284483308866315
BT 248,44607531,1.181861447118321
KMS-20,24180125,1.3264637419284662
Kasumi-2,219104,1.7742372806275355
AU565,54618305,4.305835133395234
BT 330,tanespimycin-bortezomib (250-1 mol-mol),-1.5657589280340811
NCI-H2081,135398516,2.933732637162879
AN3-CA,11364421,-5.734422820985375
CML-T1,vorinostat-navitoclax (4-1 mol-mol),0.0862805898320609
PE/CA-PJ34 (clone C12),56946209,-4.043732138060434
PE/CA-PJ34 (clone C12),11977753,0.3576222008658177
HSC-4,selumetinib-decitabine (4-1 mol-mol),5.3885261906416275
Kasumi-2,451668,-1.101171086852316
GOS-3,10385095,1.261141423395055
SNU-1033,446155,4.017329310578931
AU565,5978,-4.241011158819041
NCI-H2081,6918878,1.3213602453376416
PaTu 8988s,carboplatin-etoposide (40-17 mol-mol),4.348077475366244
Aska-SS,31703,-1.1205597197123982
NCI-N87,44620216,3.650574309449747
NCI-H2081,5278396,2.9598770747140435
PE/CA-PJ34 (clone C12),44491742,3.733326745267952
KMS-20,44507138,1.4113768398696636
KMS-27,44202524,0.9115909799659608
SET-2,56973724,3.3542907589691913
CA46,3543504,2.8823298921776717
TE-15,409805,5.7286558076606955
MCAS,9903786,3.9207216019302007
SNU-8,56946209,-3.769670510670666
YKG-1,72193861,1.638693395639398
Hs 683,44185566,2.9251167986243347
KMBC-2,54678924,1.7845836529906036
NU-DHL-1,135440466,3.3716397656308827
KYSE-410,44819697,0.9782497759883692
NCI-N87,159324,0.0331676951949142
Raji,53232,3.544478932485298
BT 330,decitabine-carboplatin (1-1 mol-mol),4.09556937223759
BT 139,51037431,6.1063918018057555
AU565,219104,2.449004695507307
KMRC-2,2746,4.010185211314044
Hs 683,44819697,0.4352103232561417
BT 330,46174525,4.328901662443132
KMS-27,6610216,4.611195004957726
Raji,24856436,0.5760631088144806
NCI-H2081,10026128,5.597175491927259
D283 Med,17755052,0.4087785710021853
A4/Fukuda,65628,3.8428022223998366
MM1.S,5281321,-2.4935203757499997
SET-2,176870,1.8171058168649483
TE-15,piperlongumine-MST-312 (1-1 mol-mol),1.329292927903699
CA46,49867930,4.292641096024632
SEM,tanespimycin-bortezomib (250-1 mol-mol),-2.121594680168012
MCAS,16722836,2.5171913283956613
SNU-8,doxorubicin-navitoclax (2-1 mol-mol),0.6886100127038397
OE21,613000,2.5457180338251533
NU-DHL-1,4705,3.159533609841756
SNU-1214,124202324,2.007945459844625
KMS-27,carboplatin-etoposide (40-17 mol-mol),0.9248762236277256
PaTu 8988s,10127622,2.65847651383055
Hep-G2,5282054,4.608034876508238
Aska-SS,piperlongumine-MST-312 (1-1 mol-mol),2.035630717741488
NCI-H2081,46174525,2.628990819300419
PaTu 8988s,3062316,1.0456910406995648
NCI-H1395,216468,5.017239605699041
TE-15,71680916,5.234367240209889
D283 Med,3825829,1.8555624568055975
NU-DHL-1,9956119,0.6553979418631676
HCC2218,5351362,1.9073731200214807
GOS-3,462382,0.0265721167554945
HSC-4,49846579,1.975916395804951
AN3-CA,702558,5.277719355843632
TE 617.T,tanespimycin-bortezomib (250-1 mol-mol),-1.7403863885968738
D283 Med,3854666,0.4329488785955893
NCI-H1092,10184653,1.2833708133715205
BT 248,5351362,1.0725587198101878
BT 320,11396600,4.5560356349666
KMRC-2,6184667,3.661056720524383
CA46,25102847,1.8345278315547784
YKG-1,4917,3.898835828558946
NU-DHL-1,219104,1.8536267097184471
BT 320,3025944,4.750339696858045
BT 320,57519531,6.301542560729613
HEC-151,49793307,-2.295287882760735
SEM,3503,1.134942375896238
NCI-H2172,46398810,3.0587069990018865
HSC-4,decitabine-navitoclax (2-1 mol-mol),3.5629592535507557
PaTu 8988s,24180125,3.4136901052211246
BT 139,3101542,5.0506373944633
Kasumi-2,24748573,1.468920481488018
CA46,637858,0.8997823848237061
MCAS,navitoclax-piperlongumine (1-1 mol-mol),2.2326615000605066
TE 617.T,25161177,3.228800177382168
SNU-8,16038120,1.656867017929408
TE 617.T,54613361,0.91605087523289
KYSE-410,BRD-A02303741-carboplatin (1-1 mol-mol),3.200574814178471
Raji,227681,3.8191821490012807
SW1990,72193861,3.365835430501514
HARA [Human squamous cell lung carcinoma],10074640,3.2082861236873814
SNU-308,46191454,3.85812081805359
SNU-308,5278396,3.621291065796055
SET-2,71466380,3.2876551416058337
NCI-H1092,3503,1.0568837915666558
Aska-SS,JQ-1-navitoclax (2-1 mol-mol),-0.8890863860184747
IST-Mes1,2874250,4.337377448058327
ML-1 [Human thyroid carcinoma],9936388,-4.434207119356507
NCI-H1395,56946209,-3.045135926894346
KMRC-2,selumetinib-PLX-4032 (8-1 mol-mol),3.8526523658363248
NU-DHL-1,11167602,2.239253055046329
SEM,49793307,-5.17285060705878
YKG-1,44589607,3.192854738782174
LoVo,3081361,0.9226789940369008
BT 330,6918638,2.094290704712354
KYSE-410,4259181,0.334687441755604
KMS-27,vorinostat-navitoclax (4-1 mol-mol),-1.848445503822888
NCI-H2110,2113511,5.920003848385286
BT 248,637858,2.256250159493538
NCI-H2110,25262965,-3.5486036305483752
ML-1 [Human thyroid carcinoma],5282054,2.990899024296238
SET-2,44607531,0.4466369484576992
AU565,119182,0.402305157716339
ML-1 [Human thyroid carcinoma],73707398,0.9772448893034968
CA46,44493528,3.81061502276679
BT 320,42642645,3.0201339489728563
Aska-SS,11214940,1.7313506139966672
KMS-27,73707438,4.94205625351234
MCAS,2945648,2.573954473525045
BT 328,60700,3.9480451882670424
SNU-1214,11152667,-0.0787501334473708
OE21,4261,1.6765399274629706
BT 139,2858523,3.519149173207282
HCC2218,327653,1.357600314803345
RERF-LC-Ad2,676352,1.8513721102027352
CA46,375860,-0.5712781411665353
RPMI-7951,2130404,3.231380778195222
BT 139,vorinostat-navitoclax (4-1 mol-mol),2.3090973995678232
NCI-H1092,3136844,4.087353218769457
LNCaP clone FGC,4788,4.966129065472295
MM1.S,10296883,3.0108141042121246
YKG-1,1641662,3.864636587440989
NCI-H1395,24180719,5.770511312321668
SET-2,5470400,-1.759000400814145
Ku812,6610355,4.836489952876677
NCI-H1395,11964036,2.245588880269689
SNU-1214,5281321,-2.431599106885235
HSC-4,4917,3.66079963002401
HSC-4,168313047,3.0036663016787015
KMS-20,100016,6.235059528000449
CML-T1,135398738,1.6792363237461696
SEM,9884685,1.4949119152013906
HEC-151,5351362,1.6437904555870773
NCI-H1395,3825829,4.5765318321652355
HMCB,4096211,2.0391547918713626
SNU-1272,51037431,3.3764674616808734
NCI-H2110,navitoclax-gemcitabine (1-1 mol-mol),-4.243546622798395
TE-15,9911830,2.3751205563534064
LoVo,25150857,3.1045912764862056
Aska-SS,135411,1.2728425883633323
SNU-8,375860,-0.8346021123643971
BT 328,3634881,2.884291919608293
SNU-1033,46215462,1.934389008047672
TE 617.T,3384730,2.113266542955424
HMCB,72376,-0.5022720815558697
HCC2218,25062766,2.21521740758537
IST-Mes1,25022340,4.432743731061051
HCC2218,10077130,4.346327682406917
MM1.S,5460769,2.129502129742311
MCAS,9825149,2.8412530080010874
PaTu 8988s,5287969,-2.4599396728047176
MM1.S,navitoclax-piperlongumine (1-1 mol-mol),0.7235910010394726
PaTu 8988s,16725315,5.295606501066723
CA46,400769,-1.5476292313826252
Hs 683,3854666,0.633440254190545
HARA [Human squamous cell lung carcinoma],613753,4.606319217012033
RERF-LC-Ad1,124202324,3.7772146428282385
LNCaP clone FGC,24180719,3.4893851088457266
RERF-LC-Ad2,piperlongumine-MST-312 (1-1 mol-mol),2.0244589143138763
Kasumi-2,11222830,0.4757152299010318
RPMI-7951,10074640,2.626377299406927
NCI-H2110,ISOX-bortezomib (250-1 mol-mol),1.2567543792582585
SEM,44620216,4.3298868043431975
SKM-1,285033,-2.3553922545886796
MM1.S,sirolimus-bortezomib (250-1 mol-mol),-3.4112466986615475
ML-1 [Human thyroid carcinoma],136227924,2.8741817701449506
A4/Fukuda,54596558,4.022693113590735
SKM-1,10184653,1.0746342455202622
KMS-27,124202324,1.1714757425485065
TE-15,navitoclax-sorafenib (1-1 mol-mol),3.1467908177063686
HARA [Human squamous cell lung carcinoma],44185566,2.9912273208606552
Hs 683,54626689,4.697975786794028
SNU-308,piperlongumine-MST-312 (1-1 mol-mol),3.701215910216338
KMS-27,JQ-1-carboplatin (1-1 mol-mol),2.20932469874721
SNU-1272,168313016,6.45685474572034
SW1990,44819697,-0.3435815177199327
RPMI-7951,12001922,1.647334289946116
A4/Fukuda,46398810,1.5683404384737003
NCI-H1092,613753,3.151391695683802
CA46,11427553,1.0834968953052575
KYSE-410,5281672,5.403053592840652
NCI-H2081,selumetinib-MK-2206 (8-1 mol-mol),3.504748246371747
LNCaP clone FGC,4378219,3.8557648266649704
KMRC-2,46224516,1.0513672467692918
AN3-CA,49766530,0.9400447576922468
SKM-1,6918878,-0.8378415751208989
KYSE-410,11626560,1.963091480584616
PE/CA-PJ34 (clone C12),6610216,4.323795888758034
IST-Mes1,60700,-0.0817355864677207
KMRC-2,5978,6.823148875955023
Hs 683,24775005,3.4836460982496633
HEC-151,241158,3.682505125351082
SW1990,44566777,-0.1581198274864337
SEM,168313016,1.967017226052083
SET-2,3854666,1.160822920042355
SEM,11427553,-0.9142896779989294
EJM,9911463,3.809334952263978
SNU-308,navitoclax-birinapant (1-1 mol-mol),2.87220330029568
AU565,9956119,3.3766215860348368
NCI-H1092,5311,1.4107579527755432
NCI-N87,54613361,-1.4178620324204825
A4/Fukuda,71466380,2.851115718652883
NCI-H1395,4261,3.7287687859459377
SW1990,5284616,3.332802592112085
HEC-151,11222830,1.1889668864862717
NCI-H2172,16065773,3.3027567277795513
SW1990,5280436,2.285966065927425
IST-Mes1,selumetinib-MK-2206 (8-1 mol-mol),3.5229121932796423
SKM-1,11214940,2.1069577398563415
RERF-LC-Ad1,54618164,4.2675139031657325
NU-DHL-1,123631,1.9528798329340396
HSC-4,46907787,5.727789952108257
HCC2218,selumetinib-vorinostat (8-1 mol-mol),2.1332099474977455
AN3-CA,53232,2.110237276491864
HSC-4,44607531,1.5153971496977892
SNU-308,54619267,4.081885658033266
HEC-151,10410894,2.649584895586281
NCI-H1092,6918837,-4.303898755117286
SNU-1214,5335621,6.2577168024968675
SNU-8,73707386,4.786793714978147
BT 330,135659046,3.618868703955065
Ku812,5311281,1.497944921969674
KMS-20,9840324,7.129228187943907
Kasumi-2,24753719,3.2877720740856815
NCI-H1092,44819697,-2.585083012775511
LNCaP clone FGC,216345,2.061788892653963
PE/CA-PJ34 (clone C12),135875424,2.9771289784544934
ML-1 [Human thyroid carcinoma],54618771,2.3801125351223105
NCI-N87,carboplatin-UNC0638 (2-1 mol-mol),3.4159981227624394
TE 617.T,5311037,3.706459212786118
BT 139,5978,4.457671126786022
CML-T1,9866186,-1.0355523545849354
Kasumi-2,25154868,4.0151171723744765
KMRC-2,52947716,3.2403383849187195
IST-Mes1,123631,3.330483874726673
SKM-1,2945648,2.351982295686625
LoVo,11175137,1.7419612548831422
EJM,36314,-6.683540661368917
PE/CA-PJ34 (clone C12),24951314,2.349740240636077
NCI-H1395,2742550,4.633125791317317
HEC-151,11485656,2.368331048173754
KMRC-2,9926054,2.0216271093968263
Ku812,9967941,3.019856322262854
CML-T1,216345,1.8584843601432488
BT 330,10302451,3.8668829581904944
KMS-27,49766530,0.6819698946698491
MCAS,11214940,1.0484190061593228
SKM-1,52912189,-0.3265905862540428
GOS-3,5351362,2.3365334015432686
MCAS,44589607,3.464520884676177
SNU-8,176870,3.005143293310265
A4/Fukuda,piperlongumine-MST-312 (1-1 mol-mol),1.0662246579823889
NU-DHL-1,tanespimycin-bortezomib (250-1 mol-mol),-0.2455773179911887
SNU-308,16722836,1.6160846911951356
HMCB,11625818,4.609137962647994
TE-15,5329102,1.929411101964923
SNU-8,5738263,3.0569282263832935
AU565,vorinostat-carboplatin (1-1 mol-mol),2.4881642304307463
TE-15,5566,3.0500751380182396
NCI-H2081,119182,0.5857992910725418
AN3-CA,9933475,-1.822781591064649
BT 139,439501,-2.1565169223075062
BT 248,71729975,1.811306833980593
SET-2,sirolimus-bortezomib (250-1 mol-mol),0.175715922868153
NCI-H1395,11640390,4.861591383833504
RERF-LC-Ad1,49766530,-0.8755533009144216
OE21,2742550,3.7946471320286568
Ku812,SNX-2112-bortezomib (250-1 mol-mol),-3.5302001962831846
Hep-G2,11612883,2.6533620783645935
HARA [Human squamous cell lung carcinoma],3689413,3.203435099189031
BT 330,72376,-2.2798402595654643
PaTu 8988s,637858,2.70031319298971
Aska-SS,439501,-3.4608963825976686
NCI-H1092,6917907,2.9110687137698443
KMRC-2,439501,-1.138228475309333
PE/CA-PJ34 (clone C12),navitoclax-MST-312 (1-1 mol-mol),0.8797788073810391
KMRC-2,613753,3.2501406467499536
SNU-1214,60700,1.0859962451574008
TE 617.T,176870,1.0236396280936095
OE21,44462760,4.2487562361155335
NCI-N87,tanespimycin-gemcitabine (1-1 mol-mol),-4.9778446176040845
KMBC-2,51037431,2.8141584353563736
MM1.S,68056272,3.565537338229292
Hs 683,decitabine-navitoclax (2-1 mol-mol),3.1967251504262943
KMS-20,9933475,1.7150335171182485
Raji,46843906,1.86954144818753
SEM,15983966,-4.919276038332578
CML-T1,135398516,1.062716502546658
NCI-N87,25150857,2.476373943211786
BT 139,SNX-2112-bortezomib (250-1 mol-mol),-3.0018202826250033
NCI-H1395,5287969,-1.6108462512694277
NCI-H1395,10322450,2.951434286433811
CML-T1,67291369,-1.213032955096986
SKM-1,6918837,-4.5219646789618455
SEM,decitabine-carboplatin (1-1 mol-mol),-2.5558539092772947
Ku812,119182,-3.854816046340745
BT 328,3825829,4.625111565622426
LoVo,5278396,2.046108484267772
ML-1 [Human thyroid carcinoma],54454,2.7684179569761422
BT 320,46199207,1.7709687668778378
HSC-4,9826308,3.3704185574061456
TE 617.T,73707398,0.9549107621752264
SNU-308,decitabine-navitoclax (2-1 mol-mol),1.4439981820169328
Ku812,10410894,1.977948047331864
BT 248,11656518,0.6524098808252552
BT 330,10074640,3.124160063926403
BT 320,15983966,3.4202708205912087
TE 617.T,25150857,1.1400030971124389
OE21,46199207,3.110625169720766
GOS-3,46199207,3.558565735467231
MCAS,445091,5.5986001063773365
HARA [Human squamous cell lung carcinoma],JQ-1-vorinostat (2-1 mol-mol),2.5839829159057848
CML-T1,3815108,1.7472513397157303
KMS-27,5351362,0.4742016355596101
MCAS,5282054,3.321833855503111
CML-T1,44543605,3.785822858271075
HARA [Human squamous cell lung carcinoma],selumetinib-navitoclax (8-1 mol-mol),2.8572824243778725
KYSE-410,132971,2.959826431509786
SNU-1214,46901937,3.826869108468287
HSC-4,selumetinib-navitoclax (8-1 mol-mol),1.957846901945355
TE 617.T,219104,2.7498102062256464
HSC-4,9866186,0.7177643600632182
LoVo,135999136,5.7154474843469565
CA46,11396600,2.515122226404857
KMS-20,23635314,-2.706306797828618
SNU-1214,piperlongumine-MST-312 (1-1 mol-mol),3.1129983440518294
HEC-151,11427553,3.4373448447885098
AN3-CA,11152667,-0.493921351954846
HSC-4,11656518,1.5757846986297326
Kasumi-2,54618771,-0.6876381814105375
NCI-N87,984333,0.3233765721021273
HMCB,2858523,3.340163049950989
BT 139,navitoclax-sorafenib (1-1 mol-mol),0.7413129484728741
SNU-1272,UNC0638-navitoclax (1-1 mol-mol),1.3009701153803632
PE/CA-PJ34 (clone C12),25102847,1.9967626307461543
Kasumi-2,selumetinib-BRD-A02303741 (4-1 mol-mol),4.464770515691229
NU-DHL-1,426756,2.782423692029965
MM1.S,216345,1.7407707889539985
EJM,46926350,-5.52167397488298
Kasumi-2,8515,3.2781378887974775
KMBC-2,9549297,4.127496683757197
BT 248,148198,-3.920391313180545
CA46,42642645,0.1424242949920916
CML-T1,60700,-4.046906202956944
LNCaP clone FGC,5311281,2.449942426153834
Ku812,11167602,0.0017995666708742
SNU-308,44607531,0.5379458517759286
Hep-G2,selumetinib-decitabine (4-1 mol-mol),0.775371272875809
SET-2,444795,4.329364706689898
LNCaP clone FGC,439501,-2.4937134944398176
NCI-H1092,5287969,-2.1818617821183457
KYSE-410,decitabine-navitoclax (2-1 mol-mol),3.6389678139101065
NCI-H2110,24951314,1.7833745955098474
TE 617.T,5281321,-3.562368647699087
KMS-27,6918878,3.015060659774869
EJM,3825829,3.923583211439946
HARA [Human squamous cell lung carcinoma],44819697,3.9048868362328264
A4/Fukuda,11964036,-0.0142982917472374
HSC-4,SNX-2112-bortezomib (250-1 mol-mol),-1.2345732834782526
Hs 683,56973724,3.747322559671367
HSC-4,10302451,2.384078053411002
BT 248,6918837,-0.6138774965830072
TE-15,135928012,3.6935983275775537
TE-15,23725625,5.9431267639026375
RERF-LC-Ad2,ISOX-bortezomib (250-1 mol-mol),1.6620551731965916
HARA [Human squamous cell lung carcinoma],51039095,3.2872110498619573
YKG-1,49766530,1.555111020821771
BT 330,53392493,1.8521619405922451
SKM-1,42642645,1.502866726077564
NCI-H2110,25183872,0.2482276686998807
EJM,44566777,-0.1727976349601711
KMS-20,9926054,1.4765400556600523
HSC-4,11152667,-1.532358108136572
KMRC-2,168313016,5.0095238893407315
BT 330,ISOX-bortezomib (250-1 mol-mol),-0.1691367130870625
BT 139,6505803,-5.215267056081471
HMCB,4521392,4.730786278370015
RPMI-7951,67156097,-1.9803086890967103
Raji,1714884,4.147818206483101
RERF-LC-Ad2,5281321,-1.005629212662992
LNCaP clone FGC,3689413,0.5325071990753445
SET-2,4917,3.2769010357827
HSC-4,17759555,2.4253306074953978
PaTu 8988s,4521392,4.128256043423252
Aska-SS,JQ-1-vorinostat (2-1 mol-mol),0.3568016982520641
HMCB,SNX-2112-bortezomib (250-1 mol-mol),-0.8165650702209287
A4/Fukuda,11977753,-3.131569873612884
YKG-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.005827491367844
SEM,6918638,-1.2521894984782256
HMCB,vorinostat-navitoclax (4-1 mol-mol),1.320679048022774
SNU-8,25262965,-1.972301864506803
AN3-CA,24785538,1.050781031507658
HARA [Human squamous cell lung carcinoma],10184653,0.92256613856931
PE/CA-PJ34 (clone C12),53495165,-1.0427588967994468
Hs 683,tretinoin-navitoclax (4-1 mol-mol),4.212339797785814
SNU-1033,56946209,-4.811007379199089
BT 328,11485656,2.729036955069127
MM1.S,5328940,1.2024233811688534
NU-DHL-1,637858,-0.1721952663561851
HEC-151,439501,-1.7100799573978192
Kasumi-2,4578,4.103424218787652
NU-DHL-1,3543504,4.940281677285891
GOS-3,53392493,2.045340494319027
EJM,15547703,3.175300844457044
CA46,5351362,0.7524287969492447
LNCaP clone FGC,54618771,1.2210181091381391
AN3-CA,445455,4.730408681611543
NCI-N87,selumetinib-BRD-A02303741 (4-1 mol-mol),3.924319992587928
BT 248,4477,0.1181412005602309
LNCaP clone FGC,9935249,1.606284127709269
LoVo,11612883,2.4190290931093954
Ku812,445643,2.6180665518205046
A4/Fukuda,erlotinib-PLX-4032 (2-1 mol-mol),1.6869811830916113
BT 248,5328940,2.875094995002875
PE/CA-PJ34 (clone C12),piperlongumine-MST-312 (1-1 mol-mol),1.2365607449836908
RERF-LC-Ad2,4261,3.541910546022979
KYSE-410,6184667,2.8740805650715404
BT 139,9915743,2.3473723766604833
SNU-1272,6610355,5.209635935326743
LoVo,5328940,0.1711764774474706
A4/Fukuda,10231331,-0.0070700765814584
NCI-H1092,5951923,4.507769777348797
RERF-LC-Ad1,25126798,4.287589780864176
LNCaP clone FGC,168313016,4.233748238876194
KYSE-410,439501,-2.4284024166032365
CA46,2874250,4.668483912698598
MM1.S,24785538,-3.291318943306552
EJM,107985,-4.84255557894517
SW1990,4578,4.588770076265956
KMBC-2,piperlongumine-MST-312 (1-1 mol-mol),2.5373712464665767
CA46,246676,4.699933053014099
MM1.S,3384730,0.9083087021644016
SNU-1214,selumetinib-decitabine (4-1 mol-mol),1.9441376366653231
NCI-H2110,navitoclax-sorafenib (1-1 mol-mol),3.278080215599179
NU-DHL-1,3676137,5.3250743483320395
SEM,49867930,5.348327492184154
CML-T1,4917,2.5218741140394476
TE 617.T,5978,-5.158536368271862
GOS-3,31703,-1.1173409595108883
CML-T1,54618771,0.285641515878807
SET-2,156414,0.9354500438685124
HCC2218,9933475,1.682361828234478
BT 248,selumetinib-JQ-1 (4-1 mol-mol),2.943393356661563
LNCaP clone FGC,24964624,0.1008168217168594
GOS-3,docetaxel-tanespimycin (2-1 mol-mol),-1.4336653490933862
LoVo,25022340,4.929882293123705
TE 617.T,docetaxel-tanespimycin (2-1 mol-mol),-7.03188292749413
KMRC-2,crizotinib-PLX-4032 (2-1 mol-mol),1.931069342582774
KMS-20,9956119,3.554120536013074
TE 617.T,9952709,5.0574728387335695
AN3-CA,36314,3.30264317359827
RPMI-7951,66890843,4.6499131615758635
YKG-1,6918638,1.332910318202703
NU-DHL-1,72734382,3.1751450889524593
NCI-H2081,6918837,-5.022444332992493
TE 617.T,10127622,2.9715092422586324
BT 248,3543504,4.235039119755324
SNU-1272,5282054,4.2528231243793755
Raji,15547703,3.0439493228256183
Aska-SS,11175137,1.8524433581649336
ML-1 [Human thyroid carcinoma],3025986,-0.9166044093803444
Raji,241158,1.7953871388242486
CML-T1,327653,2.5732071532781866
Hs 683,10077130,6.330426980372672
RPMI-7951,12003241,-0.9511728924240472
HEC-151,navitoclax-pluripotin (1-1 mol-mol),-0.5891321923863233
BT 139,selumetinib-BRD-A02303741 (4-1 mol-mol),7.331254221783839
Hs 683,11455910,0.4733989942514576
NU-DHL-1,salermide-PLX-4032 (12-1 mol-mol),3.6957030880466544
SNU-1214,3081361,0.6983035837467504
BT 330,17755052,1.654973830147732
TE 617.T,65628,4.20520230930191
A4/Fukuda,JQ-1-navitoclax (2-1 mol-mol),-1.310646692558982
HEC-151,375860,-0.8046156329798803
NCI-H1395,56649450,3.261892320114533
NCI-H2110,10184653,1.1943735267322029
KMS-20,49766530,-1.2962307066769267
A4/Fukuda,44489675,3.3968348796203003
NCI-H2172,11455910,3.487096997214958
LNCaP clone FGC,carboplatin-etoposide (40-17 mol-mol),1.692445189331318
EJM,2945648,1.6647438664441567
CA46,5281321,-3.5082232289526663
SNU-1214,11625818,2.8882147103355043
EJM,11485656,1.52616093441074
KMRC-2,doxorubicin-navitoclax (2-1 mol-mol),0.532546220972544
BT 330,16219061,2.713050419726025
OE21,23725625,5.730307601781646
BT 328,9549297,2.748428048509406
NCI-H2110,3025944,4.089971841145756
RERF-LC-Ad2,4521392,4.328503056699229
TE 617.T,24856436,-0.0598938558590973
Raji,10302451,3.856690135156121
AU565,navitoclax-gemcitabine (1-1 mol-mol),-2.716980570642507
GOS-3,11404337,1.2142789078350222
RPMI-7951,3689413,-1.832371720912868
SET-2,BRD-A02303741-navitoclax (2-1 mol-mol),0.0634881941295692
PE/CA-PJ34 (clone C12),3385,1.9835594525471536
BT 139,135440466,2.831424659347837
NCI-H2081,tanespimycin-gemcitabine (1-1 mol-mol),-4.020630878954612
NCI-N87,10074640,2.8038201142488504
SKM-1,4259181,-0.1122232838107409
CML-T1,5281672,4.316508820409711
HSC-4,89928392,1.9678897287961257
GOS-3,navitoclax-gemcitabine (1-1 mol-mol),-2.24576809498804
YKG-1,5278396,4.162705739282169
RPMI-7951,15953870,2.308533676595083
D283 Med,tretinoin-carboplatin (2-1 mol-mol),0.0098310122185737
IST-Mes1,676352,1.6027795070012942
KMRC-2,3854666,3.8888485200781377
Raji,54626689,5.170364825272944
Aska-SS,11257553,-0.3673169428608714
ML-1 [Human thyroid carcinoma],25102847,2.935986325205898
TE 617.T,JQ-1-carboplatin (1-1 mol-mol),1.6979959142929375
Hs 683,16736978,1.840534683645933
HCC2218,568763,-0.2339231027865239
KMRC-2,42642645,1.3665066587462662
Kasumi-2,56946209,-4.865772879743349
SKM-1,2729026,2.7681439157014753
PaTu 8988s,24978538,1.7094830128151086
KMS-20,984333,0.9930989474187464
KMS-27,5278396,3.716466097320167
SET-2,4578,3.7108744301164305
NCI-H2081,65628,3.78371199726488
NCI-H1092,5291,3.938438464985971
SNU-1033,71304818,2.203127671736772
SNU-8,119607,5.799968666397276
HEC-151,400769,-0.8964791777115502
HEC-151,25195348,3.5295436007133323
KMS-20,9935249,1.026705986562312
KMBC-2,sirolimus-bortezomib (250-1 mol-mol),0.4292158066242218
SKM-1,9903786,0.91314187591027
HMCB,1750826,1.2340633069907747
NCI-H1395,54649381,3.0165140825256884
Hs 683,49793307,-2.867673541770698
EJM,439501,-2.5591027297640565
NCI-H2081,6918736,-2.652468008724762
OE21,71751553,4.442993146906493
ML-1 [Human thyroid carcinoma],42611257,2.85876832372032
ML-1 [Human thyroid carcinoma],445643,4.241689590807037
HARA [Human squamous cell lung carcinoma],44202524,1.300312464104863
TE-15,400769,-0.4103749264039792
SNU-8,9956119,2.4121257943102496
TE 617.T,4477,0.7099747137468548
NCI-H2081,9952709,2.2305361453905284
Kasumi-2,9903786,1.7296917357536032
AU565,3689413,0.8257687517728082
AU565,9911463,3.1332064122278687
TE 617.T,crizotinib-PLX-4032 (2-1 mol-mol),0.7930399968582251
AN3-CA,67291369,4.137326776444439
SNU-308,60700,1.6377484625650067
HMCB,navitoclax-piperlongumine (1-1 mol-mol),1.137064859390896
HEC-151,crizotinib-PLX-4032 (2-1 mol-mol),2.750322812792129
SET-2,55508,1.782724659965198
Kasumi-2,5743,-2.32743694805066
NCI-N87,54649381,3.6397596564561487
OE21,216468,0.7894672125707919
Ku812,selumetinib-UNC0638 (4-1 mol-mol),-0.6885180767604759
GOS-3,49793307,-1.7592424650384757
CA46,selumetinib-GDC-0941 (4-1 mol-mol),2.557872196645032
HEC-151,25154868,3.9891461634357657
SNU-1272,5566,3.0890958358012064
HSC-4,9823820,4.434899642824078
SNU-1272,71466445,5.534293199033029
KMS-27,156414,1.1434862066422389
PaTu 8988s,4261,3.2609853730369323
KMS-27,984333,-0.7104374674124097
SNU-1272,11222830,2.080284552032401
HSC-4,4521392,4.744801099229743
BT 330,selumetinib-piperlongumine (8-1 mol-mol),3.896837261696385
LoVo,5978,-0.9838296745754056
BT 248,24964624,0.9785580517881716
CML-T1,44493528,3.9716542826771297
OE21,3025986,-1.6199199531853583
NU-DHL-1,42642645,1.3661891975131202
PE/CA-PJ34 (clone C12),65628,4.231511653332105
MCAS,8515,4.589748627719716
KMS-20,135398744,7.132407790781497
SNU-8,10302451,3.487044127075749
LNCaP clone FGC,11625818,1.7203183902552397
RERF-LC-Ad2,selumetinib-GDC-0941 (4-1 mol-mol),0.4804595733416271
RPMI-7951,100016,4.945357769827656
SET-2,24978538,-1.67699540287414
MM1.S,135928012,3.410124861289675
RERF-LC-Ad2,24856436,4.538529090428389
MM1.S,3543504,4.234419040105733
BT 248,25105715,2.686391114115495
SEM,5284373,0.4038831266174929
MCAS,5328940,1.99827020232334
Hs 683,44202524,1.2205424042821535
ML-1 [Human thyroid carcinoma],5746,-1.0436745341015816
SEM,46843906,-1.2667030420519347
SNU-1033,6918328,-0.3254583453090335
SKM-1,107985,-4.676728901872281
D283 Med,60700,-2.552297119661109
AU565,11719255,4.218610599596327
HMCB,3503,1.423228329049259
HCC2218,72967,3.841314233742601
NCI-H2081,387447,-5.408009728713125
NCI-H1092,1716436,2.458293295551776
PE/CA-PJ34 (clone C12),135999136,4.2559270335643955
BT 139,9935249,2.9068190210975975
EJM,23939,4.39619028953138
PE/CA-PJ34 (clone C12),448949,2.311723632816614
PaTu 8988s,104842,-0.666004861540946
A4/Fukuda,11228183,1.827405863351363
HARA [Human squamous cell lung carcinoma],23635314,-1.642514653884031
GOS-3,241158,4.584939515140501
CA46,BRD-A02303741-carboplatin (1-1 mol-mol),6.48045136918117
SW1990,54618771,1.819696432191247
TE 617.T,19582717,4.16014564583822
BT 320,67291369,4.380585752028441
NU-DHL-1,23725625,1.761495354377978
CML-T1,54649381,3.615747973120369
KMBC-2,72376,-0.7788588244541385
RERF-LC-Ad1,42642645,1.4403465890046834
KYSE-410,135659046,3.770855239455897
Aska-SS,24785538,0.938194107656888
TE 617.T,10231331,2.9787791726298183
NU-DHL-1,selumetinib-decitabine (4-1 mol-mol),-0.5267480512116699
KMS-20,6610216,3.669058069013872
LNCaP clone FGC,5335621,4.370259556780433
A4/Fukuda,17755052,-0.6813796549781841
PaTu 8988s,676352,1.727843425986356
Hep-G2,JQ-1-vorinostat (2-1 mol-mol),1.308980455848885
D283 Med,52947716,0.9658281246971616
KMS-20,25126798,3.810031241179322
PaTu 8988s,1750826,1.0085664751094332
TE-15,44137675,2.7760233846096845
RPMI-7951,10302451,2.662563983337758
EJM,44202524,0.907560202578118
NCI-H2081,52947716,1.970928272197099
EJM,46174525,3.426446737452036
Ku812,10077130,3.943478130533959
SW1990,53495165,-0.9290580990156484
HARA [Human squamous cell lung carcinoma],1716436,3.773793106717324
SNU-308,25195348,4.257440412888309
BT 330,46398810,2.0838726617109575
BT 328,44566777,0.5494237323450607
PaTu 8988s,54678924,4.2231984066275015
GOS-3,11497983,4.172510051232983
Aska-SS,selumetinib-MK-2206 (8-1 mol-mol),1.267914479489374
TE-15,46398810,2.257588086332498
SEM,107970,1.646444978651256
EJM,10113978,3.070208700221595
SNU-308,3854666,3.849126427296356
BT 328,227681,3.8990040378810544
D283 Med,168312962,2.205429971467616
NCI-N87,20959075,-3.4539866912118784
MCAS,54613361,0.0059907932342909
Hs 683,9823820,5.340119686592485
CA46,44185566,1.786162700750641
HCC2218,3025986,-1.6636604941868665
HEC-151,ISOX-bortezomib (250-1 mol-mol),1.0155875831574754
EJM,67156097,-2.836977847319536
TE-15,241158,3.84144022719984
KMS-27,11175137,1.4645453009817528
SET-2,53325874,4.5663395365380355
KMBC-2,9803433,4.330600463833804
SNU-308,navitoclax-gemcitabine (1-1 mol-mol),-0.158413006757676
HARA [Human squamous cell lung carcinoma],374536,3.8012573814376567
SNU-1214,409805,4.003952928265266
SEM,6184667,1.572697662015749
KYSE-410,23635314,-1.9771165162186872
SEM,9926054,1.3281424685311425
NCI-H2081,1750826,-1.4408995085202256
LoVo,4705,1.5085236639058903
KMRC-2,10385095,2.7581688365802917
ML-1 [Human thyroid carcinoma],44185566,2.5450411112530475
EJM,72376,-2.674765470406556
BT 328,72376,0.5320465754189707
TE-15,72734382,4.282308713316559
KMS-27,6438330,1.5142340540628925
KMS-20,15953870,2.7543869132459378
Kasumi-2,11977753,-3.013388327331023
LoVo,375860,-0.1162329718395109
MCAS,alisertib-navitoclax (2-1 mol-mol),1.883780422351886
NCI-H1092,7251185,1.5138496531623726
NU-DHL-1,11657048,4.264544687406424
BT 320,44486219,4.486546687955142
KMS-20,25183872,-1.3231637510750665
LNCaP clone FGC,navitoclax-sorafenib (1-1 mol-mol),0.830072177871062
MM1.S,31703,-4.019307858079406
KMBC-2,tretinoin-navitoclax (4-1 mol-mol),1.1343859495127468
ML-1 [Human thyroid carcinoma],11167602,2.9640815113410923
AU565,11656518,2.4577765871660353
AU565,52912189,3.2475583793468994
SKM-1,selumetinib-decitabine (4-1 mol-mol),-0.7515820525024105
KMBC-2,44543605,3.691802605477142
NCI-H1092,10385095,0.6716651912361483
YKG-1,24180719,3.9983429760657265
SEM,67291369,-2.94711830511694
NU-DHL-1,54596558,4.252396729652346
SW1990,6610355,4.5884758329623825
KMS-20,24964624,0.3956961700125998
PaTu 8988s,BRD-A02303741-navitoclax (2-1 mol-mol),1.8909548429371676
Hs 683,9933475,1.6882466578728266
AU565,11175137,1.8234152921093247
NCI-H1395,11234052,4.314713395827009
HEC-151,11612883,2.187289533777292
KMS-20,decitabine-navitoclax (2-1 mol-mol),-0.178300212626614
HARA [Human squamous cell lung carcinoma],11612883,2.0711773248440783
Ku812,89183176,4.102616384722936
YKG-1,vorinostat-carboplatin (1-1 mol-mol),4.05575271660812
SET-2,10184653,0.8254197833466991
Ku812,carboplatin-UNC0638 (2-1 mol-mol),2.607088734610279
KMS-20,7251185,1.0924387988239983
NCI-H2110,156422,4.257541093107017
PaTu 8988s,JQ-1-UNC0638 (2-1 mol-mol),1.1829021924496204
OE21,1566236,3.330797910783387
IST-Mes1,107985,-3.865584471784785
HEC-151,navitoclax-piperlongumine (1-1 mol-mol),2.1681324903190147
BT 330,67156097,3.647776091251183
KMBC-2,2945648,2.6298767117226256
OE21,135659046,3.360946677017383
RPMI-7951,60750,-3.7488570048538254
KMS-20,10385095,0.7360105255887816
A4/Fukuda,5287620,-3.30087759062066
LNCaP clone FGC,9926054,1.750086860049474
SET-2,11178236,-0.8349720594026627
HMCB,selumetinib-MK-2206 (8-1 mol-mol),3.305781399088849
Kasumi-2,100016,5.973936097539331
HEC-151,17755052,1.492406720227873
KMS-27,3465537,3.890176803896576
SNU-8,4378219,2.1792585601727468
TE-15,11152667,-0.8942963388788865
BT 328,16219061,3.835550220565251
HEC-151,4096211,1.0893719310707468
LNCaP clone FGC,15953870,2.830210193885845
TE 617.T,45279963,3.525595804474129
SNU-1033,5329102,1.9595624260675009
LoVo,148198,-1.1147075342847712
EJM,46199207,3.0615007754696095
HMCB,2746,4.319833835287885
NCI-H1092,25102847,3.2602491068155572
KMBC-2,selumetinib-UNC0638 (4-1 mol-mol),5.043544295314639
LoVo,2858523,2.923658201852042
HARA [Human squamous cell lung carcinoma],216345,4.215325728716343
TE 617.T,1750826,-0.8446628594544829
Kasumi-2,44566777,1.2078773885517011
LoVo,6918328,-0.3156299102516719
NCI-N87,docetaxel-tanespimycin (2-1 mol-mol),-6.128008635109833
AN3-CA,3634881,3.1259393094548065
KMS-27,5287620,-2.957381061466462
CML-T1,136227924,1.8923919385229255
SKM-1,JQ-1-carboplatin (1-1 mol-mol),-0.9064446956996236
NCI-N87,5287620,-2.9994225662437928
SNU-308,452548,3.317512043570676
Kasumi-2,vorinostat-carboplatin (1-1 mol-mol),1.2501182531177977
SNU-8,11214940,-1.3549016918821504
NU-DHL-1,navitoclax-sorafenib (1-1 mol-mol),-1.6614414384749498
NU-DHL-1,54626689,4.007312828770784
Aska-SS,89928392,1.1550841986309472
RPMI-7951,piperlongumine-MST-312 (1-1 mol-mol),1.6179236321332118
D283 Med,4259181,-0.2806940214967063
YKG-1,23582824,0.6705184906158483
Hs 683,JQ-1-navitoclax (2-1 mol-mol),1.5815341723355376
D283 Med,53495165,-4.057226120074279
PE/CA-PJ34 (clone C12),71751553,4.188621560003168
MCAS,675434,4.4613170524920465
HMCB,644241,4.490422282614611
SNU-1033,5351362,1.310104845288504
NCI-N87,73707386,2.4106113659233723
SNU-308,72376,-1.526423190812565
BT 139,16065773,1.9490897684890804
LNCaP clone FGC,salermide-PLX-4032 (12-1 mol-mol),5.148679103489374
RERF-LC-Ad2,11497983,4.777328214496428
KMRC-2,11612883,3.017077992042704
SEM,451668,-2.438792361971123
HCC2218,10184653,-4.3566068193330505
BT 139,5328940,1.1830416254021676
SW1990,5311,2.4410720341542977
AU565,123631,0.0519428975879534
CA46,52912189,-0.9978651387823436
HARA [Human squamous cell lung carcinoma],136227924,3.047223136335837
NCI-H1395,8515,4.661084548760473
KMS-20,24889392,-0.8715030564449404
HEC-151,5328940,1.5925494123023634
NCI-H2081,16741245,4.790981336180039
HEC-151,3676137,4.107793982328588
HEC-151,52912189,0.2381447663588256
MCAS,2874250,5.406237635191556
HEC-151,11167602,1.902436852174608
KMRC-2,selumetinib-vorinostat (8-1 mol-mol),3.246916366131707
HEC-151,selumetinib-MK-2206 (8-1 mol-mol),2.7056336497933295
AU565,5311,0.7700744364318666
SKM-1,1716436,1.3420802961199974
RERF-LC-Ad2,984333,1.0605681508803593
YKG-1,44491742,4.005192115909779
IST-Mes1,54618164,4.8538718291352945
RPMI-7951,24978538,2.2131570624667978
NCI-H1092,5746,1.1584970745481975
Kasumi-2,208908,2.161160996454662
PaTu 8988s,25262965,-5.220063752579666
SET-2,66577038,2.976908237906438
BT 320,6918837,0.518825985636162
SNU-308,49793307,-1.790706563652843
CA46,53232,2.437328600755792
HEC-151,5978,-5.356059517955617
PaTu 8988s,2733526,4.194013495733503
NCI-H1395,7251185,2.615518868498986
ML-1 [Human thyroid carcinoma],73707386,3.645367416812384
HEC-151,24856436,0.1538040410841821
TE-15,6918878,1.5398675408353943
Hep-G2,24901704,2.3159858819340817
Ku812,1716436,3.2496939057778738
YKG-1,11494412,2.049778246411874
KMRC-2,387447,-4.643727787787694
SEM,24951314,-1.2286603360441832
NU-DHL-1,9911830,2.5877421671517578
HARA [Human squamous cell lung carcinoma],135999136,4.433628677785179
NCI-H1092,46926350,-4.274443636172462
AN3-CA,9915743,2.510213815091878
BT 330,71680916,4.818271109302731
NCI-H2110,16219061,3.166955045757715
OE21,9911463,3.2233291636106727
BT 330,JQ-1-vorinostat (2-1 mol-mol),2.3888509552963773
Raji,60700,-1.0505645112477118
BT 139,1566236,2.5894214641501345
SET-2,10385095,0.921007815514528
A4/Fukuda,11214940,3.3298423014633585
IST-Mes1,4259181,1.4706848514509867
SNU-8,676352,2.994743080679249
HARA [Human squamous cell lung carcinoma],3025944,5.227932597847333
NCI-H2081,72193861,0.0859869526456893
YKG-1,25161177,5.080655083918658
A4/Fukuda,11364421,-5.769651092108399
TE 617.T,89928392,0.9742163708877738
BT 139,6918638,0.9412017663716644
NU-DHL-1,135398744,6.409233084142903
BT 139,6438330,1.030727178191843
SKM-1,54649381,3.9349803004412496
LNCaP clone FGC,11507802,2.5099467265832915
MCAS,24748573,-1.0691794347023724
NCI-H2081,24821094,3.1641844707183417
IST-Mes1,9884685,0.6527999920478087
AN3-CA,5335621,4.80855208441781
AU565,24856436,-0.2368560911374172
HCC2218,44462760,4.0308527913259615
RPMI-7951,24753719,4.344653463611892
KMS-20,11507802,0.6395655511000325
SEM,25154868,5.025601551325329
CA46,6184667,1.8666466805539537
ML-1 [Human thyroid carcinoma],5351362,1.4214743835970418
RERF-LC-Ad2,56946209,-4.743349890760071
BT 330,6438330,0.9073034139929264
HSC-4,135928012,4.241462346184107
AU565,selumetinib-MK-2206 (8-1 mol-mol),1.4284909775011103
KMRC-2,25227462,1.115220732551639
MM1.S,5281672,3.0676410234065745
NCI-H1395,16065773,1.699191956744155
NCI-H2172,5311,2.4884362345426045
TE-15,446155,1.2346950535383283
HMCB,16736978,1.7637750571409103
RERF-LC-Ad1,12001922,2.2096549629967424
EJM,156414,1.801807158025587
SNU-1033,208908,1.8154583109832951
OE21,1239801,3.897845306753703
CML-T1,25154868,3.739287072403725
BT 320,4259181,1.858689674297262
RERF-LC-Ad1,11364421,2.25691448448964
RPMI-7951,6252,4.663548083399878
PaTu 8988s,24821094,3.32561092177269
SET-2,54618771,0.9858111819135928
KMRC-2,135875424,4.786513298485674
RERF-LC-Ad2,16038120,1.0723160205223616
NCI-H1092,3552672,1.5396506423580394
HEC-151,72199292,1.439503600932236
NCI-H2081,54619267,3.7296456534329097
KMBC-2,219104,4.201311649898133
PaTu 8988s,241158,4.442566432866993
Hs 683,25105715,3.2975436946067407
MM1.S,1750826,-2.8354438151746972
NCI-H2081,31703,-2.720849472293294
RERF-LC-Ad1,16038120,1.845587377613844
Raji,5282054,3.374507062958241
TE 617.T,10074640,3.37516320161221
A4/Fukuda,46907787,-1.6446005772830188
Hs 683,12003241,0.8693905406704602
KMS-20,753704,4.324043656881392
SNU-8,15953870,4.687237129335348
Ku812,5287620,-1.7974758930014358
CML-T1,54619267,3.062776009775362
NCI-H1395,375860,1.7808246881173873
NCI-H1395,JQ-1-carboplatin (1-1 mol-mol),2.36945639284839
HARA [Human squamous cell lung carcinoma],54626689,4.600126869473187
BT 330,322968,2.4204114649278092
BT 330,11427553,2.521211397546692
SET-2,5329102,1.4152351029185346
SET-2,4378219,5.019702964288066
KMBC-2,25105715,3.761881827065379
BT 320,2729026,2.399631543883215
BT 328,107970,2.1571810870296333
D283 Med,49766530,-3.2280701678526853
TE-15,66577038,3.2233581304715053
NCI-N87,11625818,1.9405356473547937
OE21,168312962,2.0349973268808
KMS-20,126941,3.518118662895743
SW1990,10302451,2.528677635613451
NCI-H2110,25150857,3.0611564298156315
NCI-H1092,56946209,-3.79263403316681
HEC-151,2746,2.893075641123897
HSC-4,426756,6.131320111521982
KMS-20,56946209,-4.641611942860024
KMBC-2,11222830,1.8438762755647733
BT 330,3465537,1.066825715550645
NCI-H2110,tretinoin-navitoclax (4-1 mol-mol),5.524341634711108
KMRC-2,71466380,5.319728082628547
Aska-SS,crizotinib-PLX-4032 (2-1 mol-mol),-1.4096716043895037
GOS-3,56946209,-4.9562360028209795
EJM,24856436,-1.4562249201698472
NCI-H1092,selumetinib-GDC-0941 (4-1 mol-mol),3.727074735978538
NCI-H2081,46398810,2.7782565224728537
KMS-27,9911830,2.432969269856635
SEM,46191454,0.071038860902165
CA46,10302451,0.2515382956842912
NCI-H2172,5291,3.961077690922126
Kasumi-2,9826308,-0.3836015857314186
NCI-H2110,9927531,4.774812830583443
RPMI-7951,11404337,-1.491748801484046
YKG-1,3465537,3.622087306802616
RPMI-7951,4259181,-0.293226545536714
NU-DHL-1,322968,1.8618584947977044
SNU-1214,9803433,4.368496616834253
EJM,52947716,-8.188732553251715
KMS-20,9866186,-0.9814068490558976
KMBC-2,104842,-3.307712782526657
YKG-1,3689413,0.6324676509110861
KMS-20,3465537,0.9285591790497558
HCC2218,11612883,3.5699235112121466
A4/Fukuda,49766530,-0.1813275565198268
TE 617.T,441298,4.204811776771992
SKM-1,11612883,1.510436976347248
KMRC-2,72734382,5.924709157089256
MCAS,15953870,3.8672859313011614
KMS-27,51037431,3.195812814283898
MCAS,3552672,2.2795897691619538
NCI-H2110,11238147,1.9999305345415608
KYSE-410,6852167,1.749610623919313
NCI-N87,serdemetan-SCH-529074 (1-1 mol-mol),1.7996053995650736
HMCB,12003241,-2.4987094510650834
NCI-N87,3503,2.784967297602414
A4/Fukuda,100016,4.8831896191852096
LNCaP clone FGC,9843750,5.190823020080022
LNCaP clone FGC,5746,-0.0567096076106954
SNU-8,136227924,2.992589463119238
PaTu 8988s,selumetinib-vorinostat (8-1 mol-mol),2.3854275000826592
Ku812,11222830,0.9056809830950744
HMCB,7251185,3.03450552612139
SNU-1033,24821094,3.577851437010747
MM1.S,15983966,1.9540047876230984
BT 248,4705,2.6318547262793386
SW1990,46398810,2.5994928983733847
LNCaP clone FGC,5291,3.697238645744427
RERF-LC-Ad2,2858523,3.25558003658132
BT 328,44589607,2.897724961441205
SNU-8,56963564,0.0574253000889037
OE21,3384730,3.1797767333044136
PE/CA-PJ34 (clone C12),decitabine-navitoclax (2-1 mol-mol),5.825207158072148
Kasumi-2,135398516,1.3882982648798712
MCAS,24901704,3.384328232240074
Ku812,54143018,-0.9918104054999368
HEC-151,216239,1.8200014424297823
RPMI-7951,124202324,2.0500814967899355
TE 617.T,46224516,0.8374598863695136
HSC-4,24772860,-3.179601965562413
SNU-308,107970,2.9327058246303483
Raji,72193861,0.4918514187287914
Ku812,11507802,0.7053087419669674
KYSE-410,44185566,2.6133836189946344
PaTu 8988s,24771867,5.513171941040546
HSC-4,65064,5.180183799352401
TE 617.T,24951314,1.788416561198006
KMBC-2,navitoclax-pluripotin (1-1 mol-mol),-0.7787416964266355
NCI-N87,568763,-0.5346616138078667
NCI-H2110,53232,4.104445138935315
KMBC-2,19582717,5.005649239927271
KMS-27,24901704,2.134456940081379
NCI-H2081,24901704,2.205959847838861
NCI-H2110,216239,3.010643148225552
YKG-1,JQ-1-vorinostat (2-1 mol-mol),1.103772140957631
Raji,44507138,1.1959829987130275
PE/CA-PJ34 (clone C12),23635314,-4.428756055244555
OE21,24772860,-2.401866774595391
NU-DHL-1,5281672,2.8333763139746813
EJM,56649450,2.621369128509505
HEC-151,navitoclax-sorafenib (1-1 mol-mol),2.5394801706733237
AU565,702558,5.325524002647016
Hs 683,16722836,1.639377356168815
HARA [Human squamous cell lung carcinoma],44259,0.8184068416156438
PE/CA-PJ34 (clone C12),6505803,-2.153335195822847
MCAS,123631,2.0688356997390884
PaTu 8988s,10296883,3.673245902839484
NCI-H2081,3634881,3.1906450882675785
HEC-151,44202524,1.4448897283808455
RERF-LC-Ad2,104842,0.4265236360414571
BT 328,5287620,-1.6650936654034112
Ku812,25154868,3.035500592962472
LNCaP clone FGC,5351362,1.275923514869112
D283 Med,89183176,3.347036918603312
CA46,51039095,1.651262767418978
HMCB,57519531,4.328338374820244
NCI-H2110,46907787,2.692877404772462
AU565,36314,-7.774521242942876
BT 320,135875424,3.1120862947515255
Ku812,168313047,1.6186365472773052
SNU-1214,navitoclax-pluripotin (1-1 mol-mol),-3.219384330131526
SET-2,5284373,2.6486368029968377
SNU-1033,51039095,2.869483479494676
NCI-H1092,10302451,4.171918094429464
NCI-H1092,3384730,3.333041277553113
LoVo,24951314,0.8531724175888866
PaTu 8988s,9915743,-0.0886276947358788
SNU-308,11175137,3.154524014075145
SEM,44137675,3.2773016295912445
A4/Fukuda,56649450,0.8497740308893211
LoVo,15547703,1.4569683263207862
SNU-1272,serdemetan-SCH-529074 (1-1 mol-mol),2.457882821768218
BT 248,9911463,2.7908107916357436
SEM,11964036,-0.8070570708115667
AN3-CA,7251185,2.1715897853653168
TE 617.T,5282054,2.832126943240028
MM1.S,327653,2.336208515323047
KMS-27,5311,0.4888181345330854
MM1.S,5566,3.0863542301618905
NCI-H2081,16725315,3.0839899254921095
KMS-20,46843906,1.2536393237633636
BT 248,107970,1.564508535325896
TE 617.T,15953870,3.1067145457473906
SNU-1033,navitoclax-MST-312 (1-1 mol-mol),1.0077386216365567
AU565,16038120,1.417918520815656
LoVo,52912189,0.3784309245329977
Aska-SS,54596558,3.9801722385312694
NU-DHL-1,6918328,-1.9544594496437568
TE 617.T,SNX-2112-bortezomib (250-1 mol-mol),-3.542024974050954
RERF-LC-Ad2,4259181,0.9500738030007112
AU565,36462,0.154728470238132
SNU-8,3552672,5.071932913496887
SNU-1214,24964624,2.2699672227084435
NCI-H2110,135999136,4.378229186440323
ML-1 [Human thyroid carcinoma],3081361,2.035617561629102
KMS-20,10302451,2.7224697614535662
NCI-H1092,2945648,2.0700638140292256
KMS-20,25105715,2.3755676458508277
PE/CA-PJ34 (clone C12),151289,0.5971679831137401
CML-T1,3503,1.2439697949752524
NCI-H1395,3854666,3.0219534193280637
IST-Mes1,docetaxel-tanespimycin (2-1 mol-mol),2.3952937403433685
IST-Mes1,65064,5.185430309398801
IST-Mes1,25227462,1.492895446731939
Kasumi-2,1641662,2.7685254402742183
SEM,selumetinib-JQ-1 (4-1 mol-mol),-1.6081049960911422
MM1.S,446155,2.5979306804829463
SKM-1,44607530,1.4032430904738862
SNU-1214,44607531,-0.2478501514076817
Ku812,60700,0.4505355107695148
TE-15,3062316,-2.853969144385318
HMCB,44185566,3.1081163889895107
KMS-27,168313016,5.514189836939729
AN3-CA,carboplatin-UNC0638 (2-1 mol-mol),3.453409834733988
SEM,5311,-0.7681925912074375
A4/Fukuda,46199207,1.9027513858957976
YKG-1,46224516,1.3693431765841828
EJM,25126798,3.659135720159963
NCI-H2110,9803433,6.043701280949829
KMBC-2,44137675,3.7082057495512095
BT 248,56649450,1.4607260014057133
A4/Fukuda,11494412,-1.359408079628026
PaTu 8988s,24856436,-1.8823090138598328
EJM,5287969,-2.456057382836623
KMS-20,54649381,1.58560475565201
NCI-H1092,JQ-1-MK-0752 (1-1 mol-mol),3.999675305705296
TE-15,17755052,1.65002415158768
OE21,3543504,4.324385832552226
RPMI-7951,52947716,3.0759598541034796
HCC2218,5328940,1.3666058898247246
NCI-H2110,4259181,-0.2511035825060961
CML-T1,JQ-1-UNC0638 (2-1 mol-mol),0.1970824478028413
SNU-308,252682,6.464226744000865
SW1990,11964036,1.893921505809902
IST-Mes1,10113978,3.525341044523829
KMBC-2,51039095,3.65813416171897
HARA [Human squamous cell lung carcinoma],46907787,3.600628557962214
HSC-4,216239,1.6239220207771676
BT 248,9935249,2.246614582121965
YKG-1,11497983,4.151175156243401
Ku812,135999136,1.6073024160366625
HCC2218,72193861,2.2032780830216483
EJM,89928392,0.7789703373466773
OE21,9903786,3.8183922804943298
KMBC-2,9956119,4.710694162970388
Raji,9915743,1.7375595717981451
OE21,serdemetan-SCH-529074 (1-1 mol-mol),0.8779139743327479
PE/CA-PJ34 (clone C12),676352,1.767200093931116
LNCaP clone FGC,262093,3.5120752927452803
IST-Mes1,135875424,5.039969018342982
NU-DHL-1,3385,1.8377112991123596
NU-DHL-1,448949,-1.77397684546658
CA46,156422,3.7635879578153126
SEM,7326481,2.7655671912091933
D283 Med,227681,2.8388924362301378
LNCaP clone FGC,322968,4.5137290252550955
HEC-151,42642645,2.0154759097446875
GOS-3,navitoclax-MST-312 (1-1 mol-mol),2.0809346375553877
Aska-SS,54618771,0.6758112733038071
D283 Med,2858523,2.945286331512549
HSC-4,9903786,4.262681016067309
Aska-SS,5287969,-1.6668619193384573
NCI-H1395,1242560,3.324194967981579
OE21,44819697,0.3428124471506664
YKG-1,docetaxel-tanespimycin (2-1 mol-mol),-4.349420995381951
SNU-8,navitoclax-gemcitabine (1-1 mol-mol),1.4326989909967949
SET-2,421610,1.9981144134483724
SNU-308,9866186,2.6206872366175302
SEM,25105715,2.97048574375964
NU-DHL-1,6184667,2.420250013348629
LNCaP clone FGC,46907787,-0.4203114771143783
Raji,3062316,2.8888075900479007
MCAS,54619267,3.7434418919533656
KMS-20,44607531,1.4954007749288158
KMRC-2,53495165,1.7829529769899184
SEM,4477,0.916929513987914
AN3-CA,4477,-0.0945656012999716
NCI-H2110,409805,5.766269272797009
NCI-H2172,54618164,4.006615708933043
NCI-H2081,11178236,-4.898241631670769
TE-15,3825829,1.985318153826467
TE 617.T,135928012,3.262303401406854
HEC-151,25062766,1.949383068165884
Hs 683,4578,4.4950914970661175
MM1.S,1242560,2.8271935424204786
KMS-27,5566,2.9589346041205995
BT 328,selumetinib-tretinoin (2-1 mol-mol),5.411953573942954
SEM,5280436,2.6493290705242636
PaTu 8988s,156414,1.7268071269453409
RPMI-7951,15983966,-4.254718362973844
PaTu 8988s,462382,0.5447337070478522
MCAS,SNX-2112-bortezomib (250-1 mol-mol),-2.5445813038175222
NCI-N87,9825149,1.7110175659097178
TE 617.T,46191454,0.1498319013060245
KYSE-410,24771867,2.1573021034498705
SNU-308,10427712,4.3610615678797595
BT 328,3552672,2.1088972193148146
KMS-27,3689413,0.1610585283674763
NCI-H2110,6918328,-0.2547690999366837
AN3-CA,12003241,-2.637522524679412
Hs 683,613753,3.2727608242534827
SKM-1,decitabine-navitoclax (2-1 mol-mol),-1.0300252512758497
Hep-G2,969516,2.730535591005145
BT 320,168313200,3.0477072720221936
CA46,60750,-0.9269398092944348
NCI-H2110,carboplatin-etoposide (40-17 mol-mol),1.3774072251808476
KMS-27,9549297,2.0072526603834464
Hep-G2,241158,4.703758837360285
OE21,JQ-1-carboplatin (1-1 mol-mol),0.5069290847889931
KMRC-2,45279963,3.8727204027924103
Kasumi-2,72734382,3.1758679904650715
NU-DHL-1,135398738,5.717285469146395
A4/Fukuda,selumetinib-navitoclax (8-1 mol-mol),1.1983954877584069
YKG-1,49867926,5.593368072360718
SNU-1214,26596,-1.0463524319184982
HEC-151,6610355,3.6251776557221542
RPMI-7951,16722836,1.3566033726121791
BT 139,4917,2.8777452549817086
KMRC-2,25062766,1.716878433118612
AU565,54618164,4.092787142183454
BT 139,135421197,2.718205377140928
HSC-4,25262965,-0.4495508061813805
Kasumi-2,salermide-PLX-4032 (12-1 mol-mol),2.944713771170232
RPMI-7951,24180125,2.9670273769283506
NCI-H2081,selumetinib-UNC0638 (4-1 mol-mol),2.5188590507358177
RERF-LC-Ad2,5280436,1.929463914653169
NCI-H2110,15983966,-4.372575735276371
MCAS,16013152,4.123178903224857
NCI-N87,135999136,4.294797881105147
EJM,selumetinib-piperlongumine (8-1 mol-mol),3.077035642814966
NCI-N87,71304818,2.1951958800989133
NCI-H1395,613753,3.1434817827730126
SEM,11626927,4.390660689868242
NCI-H2081,9967941,3.827989580994779
D283 Med,6918878,0.6524959368526162
NU-DHL-1,11238147,1.5129277124969711
MM1.S,11977753,-3.342519732711574
MM1.S,675434,3.752127211451784
HCC2218,73707438,1.7281107307453174
Ku812,selumetinib-decitabine (4-1 mol-mol),-3.2860234073960126
SET-2,6438330,0.4596866663258824
OE21,11485656,1.707456262972337
NCI-H2081,56946209,-6.444502083933019
NCI-H1395,JQ-1-MK-0752 (1-1 mol-mol),2.3863379692228976
NCI-H2081,60750,-4.420786299204752
SW1990,selumetinib-BRD-A02303741 (4-1 mol-mol),3.2981500130451753
GOS-3,568763,1.0345737986601573
Aska-SS,2828334,6.296749924229201
SNU-1214,168313016,6.364459074383153
KMS-20,426756,4.256968107104022
BT 248,3634881,2.1213928087500413
KYSE-410,72199292,2.115453552605538
MCAS,5738263,3.7529999834247545
Hep-G2,135440466,2.0493223992937653
RPMI-7951,5311281,1.1032843350695771
PaTu 8988s,11647372,1.5690311428117751
AN3-CA,66577038,3.203903428846991
AN3-CA,2733487,6.345501913037738
SET-2,60750,-4.586930142507914
LNCaP clone FGC,54596490,4.35808730811733
NU-DHL-1,JQ-1-navitoclax (2-1 mol-mol),-1.983484883677281
BT 330,66577038,2.74568444462768
D283 Med,439501,-4.70695325279779
KYSE-410,BRD-K99584050,4.270959972469134
YKG-1,25150857,2.66438292717209
RPMI-7951,54618771,0.8844591471525661
HEC-151,53481919,3.609306129178792
KYSE-410,16065773,3.1689596022377136
KMS-20,637858,0.4496747428654858
OE21,24748573,1.791064623837087
RPMI-7951,16219061,3.1411295377528297
KMS-27,44185566,2.2798928208944287
NCI-H2081,3503,1.8029989394083912
SNU-8,11222830,1.589804664349569
OE21,54678924,1.4309083952693855
MCAS,1566236,2.0523817086491296
KYSE-410,6610216,4.091315961018864
SW1990,3634881,3.9244954734122217
CA46,31703,-2.2435350155349023
Raji,5281321,-0.7829578369432236
KMBC-2,9907093,5.425782821141152
GOS-3,10302451,4.10350760632464
ML-1 [Human thyroid carcinoma],17755052,4.154119256233629
MM1.S,navitoclax-gemcitabine (1-1 mol-mol),-5.407415705446715
SW1990,6852167,2.6280721153803843
BT 139,5738263,3.7831987912460505
A4/Fukuda,selumetinib-UNC0638 (4-1 mol-mol),0.1859137838774149
PaTu 8988s,selumetinib-PLX-4032 (8-1 mol-mol),2.527572283068169
KMBC-2,4578,5.794411776152561
Kasumi-2,9823820,3.05022407511669
HEC-151,42611257,2.939259263914983
RERF-LC-Ad2,51039095,3.0886162133744173
NU-DHL-1,135398516,0.2609599699484601
PaTu 8988s,11719255,3.3536118584296086
BT 330,7326481,4.958680714168664
Hs 683,2733526,4.306174797129774
SET-2,6914657,-8.835137306174536
SNU-1214,9444,4.604017653648716
RPMI-7951,44185566,2.293538209282658
Hep-G2,4705,3.661377424610174
TE-15,54678924,2.061678703135273
Kasumi-2,446155,3.789762475260846
Kasumi-2,11178236,-5.568204380320254
Kasumi-2,3825829,3.3479634665685167
HSC-4,doxorubicin-navitoclax (2-1 mol-mol),-1.2623488821486932
HEC-151,25102847,3.323993310168594
NCI-H1092,selumetinib-piperlongumine (8-1 mol-mol),4.34690656876425
SNU-8,6918328,-0.0298959396904497
KMBC-2,53495165,1.1717790124128142
TE 617.T,3689413,-0.0312016851133043
MCAS,serdemetan-SCH-529074 (1-1 mol-mol),2.3575545697640043
TE-15,45279963,3.13807888384382
CA46,navitoclax-pluripotin (1-1 mol-mol),-1.6931023620468224
OE21,11364421,-5.654768870517808
BT 139,441298,3.6889162663460406
NCI-N87,25102847,3.5806366762623645
KYSE-410,5351362,1.4338379223432771
NCI-H2081,54143018,0.6248059952712489
Ku812,676352,0.8509371863711478
NCI-H1092,7326481,2.520886584471623
NCI-H1395,24771867,4.164021178387528
HEC-151,135984461,3.687449100902744
AN3-CA,46174525,4.153257771053101
HEC-151,5282054,3.4640113624850435
BT 139,4259181,1.714008353576017
NCI-H1395,25227462,2.331405873777041
KMS-20,SNX-2112-bortezomib (250-1 mol-mol),-2.8206001469797974
OE21,selumetinib-MK-2206 (8-1 mol-mol),1.5228521171431184
NU-DHL-1,10296883,3.6667794076879594
KMS-20,JQ-1-carboplatin (1-1 mol-mol),-1.0722659574284303
SEM,crizotinib-PLX-4032 (2-1 mol-mol),0.5423441096655561
NCI-H2081,SNX-2112-bortezomib (250-1 mol-mol),-1.4836997407724497
RPMI-7951,568763,-1.4306382653254477
PaTu 8988s,2126,5.9287347992088355
LNCaP clone FGC,49766530,1.5259250948267933
HARA [Human squamous cell lung carcinoma],11964036,1.505983259630614
AN3-CA,vorinostat-navitoclax (4-1 mol-mol),1.3111669472742835
HSC-4,637858,2.398043952194309
TE-15,613000,2.1764101144480437
HCC2218,9956119,-0.5434816491483623
LNCaP clone FGC,selumetinib-tretinoin (2-1 mol-mol),5.335442917701662
SW1990,doxorubicin-navitoclax (2-1 mol-mol),-0.7027617594545444
SET-2,9884685,0.7877386877892533
KMS-20,16659841,2.744899000651292
PaTu 8988s,135875424,4.807406911194583
RPMI-7951,3062316,0.109951341405492
Aska-SS,6505803,-1.3133371843623132
NCI-H2110,219104,4.835277347970067
HEC-151,5281321,-0.7091237619824996
BT 330,4917,2.9109712569166297
D283 Med,4261,0.5418403862812319
BT 248,3854666,2.6170510866367955
MM1.S,44589607,1.0331036343158948
HCC2218,BRD9876-MK-1775 (4-1 mol-mol),1.4062073847367094
NCI-H2172,46843906,2.9426070503982684
BT 320,16725315,5.30580008906936
SNU-8,SNX-2112-bortezomib (250-1 mol-mol),-0.8626352202634525
KMS-27,12001922,1.6667680080633047
SKM-1,124202324,1.09229022845767
LoVo,17755052,-0.1303127354802701
LoVo,navitoclax-gemcitabine (1-1 mol-mol),0.8957448181446594
BT 328,doxorubicin-navitoclax (2-1 mol-mol),-0.3035540353070404
NCI-H2110,9911463,4.283441783130732
HCC2218,72376,-1.8929847607660144
KMBC-2,73707398,1.4795418187244096
KMBC-2,11404337,0.8852156711792197
BT 248,11257553,3.3794437157400754
SW1990,216468,3.5659839916407305
BT 320,11427553,4.124967356317301
KYSE-410,tanespimycin-gemcitabine (1-1 mol-mol),-0.2570017784424961
HEC-151,11214940,3.7969879904558073
Hs 683,3465537,3.213284685402938
SNU-8,54618164,4.22532753412944
SEM,44491742,3.581981402307046
D283 Med,9887053,1.695110985326941
Ku812,16115403,-5.456092150194313
SET-2,100016,6.077577626399248
AN3-CA,119607,5.088034337896445
Kasumi-2,44484893,-1.5195002495763423
D283 Med,46174525,1.3652890399217403
SNU-1272,54619267,4.134812215155654
NCI-H2110,6918736,-0.92711542269103
KMS-20,1566236,0.9059478778030634
SNU-308,crizotinib-PLX-4032 (2-1 mol-mol),2.800363734120127
EJM,navitoclax-birinapant (1-1 mol-mol),0.3808081808829636
KMRC-2,4917,3.69658277533404
Hep-G2,65064,4.407687978914002
AN3-CA,1641662,2.8953238480153836
HEC-151,135398516,2.0507188798762277
RERF-LC-Ad2,navitoclax-sorafenib (1-1 mol-mol),3.4815256316040006
EJM,11609586,2.8527211576187925
MM1.S,3854666,1.277087835200556
Aska-SS,6918837,-3.0940676227061155
CA46,54678924,0.940253932332064
Hep-G2,15983966,-0.5733589489944111
KYSE-410,56973724,2.7264787615738695
BT 248,24753719,4.394714770526552
SNU-8,6610355,3.667955701623089
LoVo,656346,0.766025679375412
NCI-H2172,17759555,5.1206120286253425
SW1990,navitoclax-gemcitabine (1-1 mol-mol),-1.7958308660531992
BT 320,doxorubicin-navitoclax (2-1 mol-mol),-0.1344051428167206
KMRC-2,11178236,-3.7450875682341143
RERF-LC-Ad1,selumetinib-navitoclax (8-1 mol-mol),2.177276245480509
TE-15,11964036,1.0660097449805117
LNCaP clone FGC,tanespimycin-gemcitabine (1-1 mol-mol),-0.8170997409283122
BT 330,11257553,2.5811561366626816
HARA [Human squamous cell lung carcinoma],135875424,5.177992671051203
Aska-SS,selumetinib-piperlongumine (8-1 mol-mol),4.134540064953037
HSC-4,53232,3.536415160688875
Raji,54618164,3.808171022146071
D283 Med,selumetinib-PLX-4032 (8-1 mol-mol),5.220725051966228
HCC2218,11396600,2.588416382808436
Ku812,ISOX-bortezomib (250-1 mol-mol),-0.3300342480244748
KMRC-2,11404337,1.481375710238033
KYSE-410,44507138,1.6682479458112085
SKM-1,1242560,3.2805801288992296
NCI-H2081,969516,2.499381781732552
AN3-CA,23635314,-4.488002581642753
BT 330,168313200,1.8051222028456737
Ku812,56946209,-4.665200171711114
OE21,25161177,4.249814406822135
KMS-20,11656518,0.4062739381385031
SKM-1,3543504,4.073022036864239
PE/CA-PJ34 (clone C12),104842,-4.003781154796879
NCI-N87,2733487,6.3981873446173285
BT 328,262093,2.379096363022233
SNU-8,60700,1.740675186077755
IST-Mes1,135398738,4.689828903809361
SNU-1272,25062766,3.227496058351171
EJM,135875424,3.8151689174566665
MM1.S,25126798,3.74177726744656
NCI-H1395,11717001,5.001255257039283
KMRC-2,2733526,4.229027911025838
SNU-8,6450551,4.187914273502316
HARA [Human squamous cell lung carcinoma],2113511,5.545523050638764
GOS-3,25102847,2.4743602573672585
BT 330,227681,3.2986722537694715
KMS-20,11485656,2.050412836201762
HSC-4,16038120,1.7232268235274473
Raji,6505803,2.919386850087895
CML-T1,451668,-2.1837981176470738
Kasumi-2,46907787,-1.0712711351942366
PE/CA-PJ34 (clone C12),5287620,-1.7203346154702173
AU565,5284616,2.6982931675931914
NCI-H2110,67291369,3.7100617261641826
HSC-4,156422,5.249929789072156
BT 139,11238147,5.399490650973942
CML-T1,135875424,3.5304182343940935
KMRC-2,10127622,3.879900327054352
D283 Med,decitabine-carboplatin (1-1 mol-mol),-0.1319093330990738
CML-T1,107985,-4.139753917879256
NCI-H2110,2729026,3.135711176833809
D283 Med,11455910,0.6480749902472364
Aska-SS,2746,3.0488180575917463
TE-15,73707398,1.075655915251324
SET-2,426756,2.384993708171705
OE21,3825829,4.065896901751797
NCI-H2172,2828334,5.9971239300966666
SEM,104842,-5.92078969792144
LNCaP clone FGC,11640390,3.376526738931285
NU-DHL-1,piperlongumine-MST-312 (1-1 mol-mol),0.314430194898088
A4/Fukuda,3136844,3.333855932915555
AU565,5329102,2.0441914674842008
BT 330,25195348,3.573752454944967
BT 328,11238147,2.054089677039581
HSC-4,107970,2.304506496588027
EJM,11964036,1.6770560082105996
SNU-1214,11609586,3.0218291311347145
D283 Med,11609586,0.9542779203239456
NCI-H2110,docetaxel-tanespimycin (2-1 mol-mol),-5.357361865620825
GOS-3,9967941,3.548284114921986
GOS-3,5738263,2.3320703610233724
SET-2,7326481,3.5585893321455724
NCI-H2110,44185566,2.8955090963041696
Hep-G2,6918837,-3.422320688651726
Kasumi-2,151289,0.8385264971723331
AN3-CA,ISOX-bortezomib (250-1 mol-mol),0.3438036244329149
YKG-1,5280436,2.781391544714978
LNCaP clone FGC,16736978,0.4632149160261901
D283 Med,11175137,1.7894441907886798
MM1.S,67156097,-2.2685663617789045
Hs 683,42642645,-0.321926076165572
NCI-H2110,445643,3.9404850685978334
BT 248,644241,1.8454939937856112
BT 330,10385095,1.0976852552783771
AN3-CA,tretinoin-carboplatin (2-1 mol-mol),6.598989461225886
Hs 683,446155,2.4006976340909083
BT 330,tretinoin-carboplatin (2-1 mol-mol),4.791093177810098
EJM,11719255,2.3281018448944195
BT 139,24180125,3.745397640720988
SEM,60750,-6.755912967661906
MCAS,4521392,4.429986941577358
Hs 683,vorinostat-carboplatin (1-1 mol-mol),3.528980222681868
BT 139,11955716,-1.697910651443111
TE 617.T,selumetinib-JQ-1 (4-1 mol-mol),1.4912652874419787
BT 328,241158,5.267624320159163
CA46,8515,3.648186715161825
SNU-1214,SNX-2112-bortezomib (250-1 mol-mol),-1.2222009804045444
